data_2odx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2odx _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 7.2 mtm . . . . . 0 N--CA 1.465 0.309 0 N-CA-C 119.438 3.125 . . . . 0.0 119.438 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -61.86 1.67 Allowed 'General case' 0 C--N 1.317 -0.811 0 O-C-N 121.792 -0.567 . . . . 0.0 112.098 167.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.8 t70 167.65 74.52 0.01 OUTLIER Pre-proline 0 CA--C 1.56 1.363 0 C-N-CA 129.581 3.152 . . . . 0.0 109.393 -155.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -92.12 -51.24 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.423 1 C-N-CA 126.842 5.028 . . . . 0.0 114.896 -170.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 mm -149.22 143.28 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 131.579 3.952 . . . . 0.0 104.221 -169.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.4 mm -113.73 131.69 64.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 124.056 0.943 . . . . 0.0 109.986 -177.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.0 mm -116.31 111.31 34.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 174.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.486 ' HA ' HD22 ' A' ' 144' ' ' ASN . 8.9 tt0 -76.82 116.31 17.37 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.855 1.262 . . . . 0.0 110.148 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.1 t -108.16 -67.83 0.94 Allowed 'General case' 0 C--O 1.225 -0.224 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -158.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 75.79 -3.9 2.48 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 126.438 1.895 . . . . 0.0 113.594 -169.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -114.21 152.33 31.4 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 128.066 2.546 . . . . 0.0 109.564 159.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -72.34 -14.6 61.77 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 120.265 -1.522 . . . . 0.0 114.767 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -134.04 6.49 3.64 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.167 -1.583 . . . . 0.0 114.248 -158.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -61.96 154.82 25.34 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.377 1.871 . . . . 0.0 115.327 -166.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -77.09 171.63 14.51 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.622 1.569 . . . . 0.0 114.195 173.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.9 p -135.61 148.99 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.958 2.103 . . . . 0.0 110.606 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -119.57 121.41 4.94 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 118.844 -0.975 . . . . 0.0 113.552 158.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 22.8 p -114.63 160.65 19.07 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 123.518 1.627 . . . . 0.0 113.095 167.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 47.4 p -114.91 13.36 17.05 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 113.302 -1.772 . . . . 0.0 112.695 166.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.5 -31.21 5.67 Favored Glycine 0 N--CA 1.467 0.733 0 C-N-CA 124.056 0.836 . . . . 0.0 113.828 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.1 t 169.49 159.92 0.19 Allowed Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 126.974 2.11 . . . . 0.0 107.509 -157.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -54.94 -20.56 23.33 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 121.89 1.726 . . . . 0.0 112.678 161.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.69 42.43 1.1 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.079 1.352 . . . . 0.0 112.729 174.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 51.33 33.91 32.55 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 116.986 1.554 . . . . 0.0 116.986 150.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.3 m -75.69 -48.02 23.77 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -152.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -104.88 -145.84 0.38 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.939 0.896 . . . . 0.0 112.219 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.7 t -76.56 -158.4 0.1 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.956 0.902 . . . . 0.0 112.413 163.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.4 tp -105.88 142.62 18.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 126.368 1.867 . . . . 0.0 110.481 161.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.413 ' CE ' ' CD1' ' A' ' 135' ' ' TRP . 3.8 ppp? -152.58 175.26 12.97 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.322 1.049 . . . . 0.0 112.141 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -140.71 130.69 24.63 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -165.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 mt -132.28 174.13 10.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.181 1.393 . . . . 0.0 108.725 -174.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 102.37 5.11 Favored Pre-proline 0 N--CA 1.478 0.959 0 CA-C-N 120.187 1.358 . . . . 0.0 114.495 168.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -70.9 176.94 6.93 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 CA-C-N 120.025 1.045 . . . . 0.0 109.426 161.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.7 m -139.71 158.97 43.23 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.745 2.018 . . . . 0.0 105.777 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.5 p -49.21 -37.97 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 120.028 1.285 . . . . 0.0 113.456 -178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -80.9 -8.24 59.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.549 1.539 . . . . 0.0 114.078 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -140.82 -173.45 3.71 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 122.893 1.33 . . . . 0.0 113.371 -151.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 25.9 m -141.53 167.35 16.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 128.322 2.649 . . . . 0.0 108.966 -175.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -148.21 142.58 26.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.885 0.874 . . . . 0.0 110.506 169.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -100.04 143.52 30.16 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.79 0.836 . . . . 0.0 111.07 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . 0.627 ' SG ' ' SG ' ' A' ' 137' ' ' CYS . 45.4 t -65.1 175.15 1.68 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 122.802 1.287 . . . . 0.0 113.622 158.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.413 ' CD1' ' CE ' ' A' ' 122' ' ' MET . 40.9 p-90 -127.54 -13.27 5.44 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.287 1.835 . . . . 0.0 112.583 170.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -95.32 -60.82 1.59 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.156 0.982 . . . . 0.0 109.88 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.627 ' SG ' ' SG ' ' A' ' 134' ' ' CYS . 14.2 p -80.8 -23.45 39.25 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.997 1.319 . . . . 0.0 112.705 165.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 64.51 16.18 60.45 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.419 -1.211 . . . . 0.0 113.544 -172.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.77 137.16 53.8 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.801 1.8 . . . . 0.0 111.384 173.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 41.4 t -81.96 147.02 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 166.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -132.01 150.01 52.27 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 129.282 3.033 . . . . 0.0 110.709 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 43.9 tttt -127.01 150.05 49.62 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.102 0.953 . . . . 0.0 113.556 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.62 155.7 17.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.858 167.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.486 HD22 ' HA ' ' A' ' 101' ' ' GLU . 3.4 p30 -111.57 152.19 43.85 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 172.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -67.78 -6.01 15.81 Favored 'Trans proline' 0 C--N 1.352 0.736 1 C-N-CA 125.352 4.035 . . . . 0.0 115.154 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.9 p -36.83 133.37 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 127.837 2.455 . . . . 0.0 113.401 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.637 0 C-N-CA 127.541 2.496 . . . . 0.0 107.315 174.703 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 8.6 mtm . . . . . 0 C--O 1.225 -0.219 0 N-CA-C 118.035 2.606 . . . . 3.1600000000000001 118.035 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -57.73 11.46 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 121.191 -0.943 . . . . 2.8399999999999999 112.641 169.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.5 t70 164.88 73.77 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 129.437 3.095 . . . . 2.7400000000000002 109.703 -154.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -88.34 -46.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 1 C-N-CA 126.793 4.996 . . . . 1.0600000000000001 113.075 -174.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -154.47 143.1 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 130.451 3.5 . . . . 1.8899999999999999 105.424 -168.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.9 mm -117.45 134.23 61.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 124.579 1.152 . . . . 1.76 111.87 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.9 mm -127.42 118.6 50.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 127.142 2.177 . . . . 1.6399999999999999 108.209 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.92 133.41 44.35 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.858 1.663 . . . . 2.8300000000000001 111.442 -176.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.9 t -163.63 111.94 1.21 Allowed 'General case' 0 C--O 1.223 -0.333 0 O-C-N 121.535 -0.728 . . . . 2.9100000000000001 112.67 -175.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -82.24 16.71 1.89 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.608 1.163 . . . . 5.3099999999999996 112.184 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.436 ' CG ' HH21 ' A' ' 107' ' ' ARG . 0.3 OUTLIER -135.48 10.75 3.47 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 128.222 2.609 . . . . 3.0 113.212 -159.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 59.55 -16.73 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 129.631 3.173 . . . . 3.1099999999999999 118.686 173.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -150.88 14.63 0.73 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 119.666 -1.896 . . . . 3.6600000000000001 114.719 -168.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.436 HH21 ' CG ' ' A' ' 104' ' ' ASP . 57.1 ttm-85 -54.39 142.61 26.32 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.538 1.535 . . . . 4.3300000000000001 112.563 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -77.38 156.9 30.9 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.844 0.683 . . . . 3.6400000000000001 112.844 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.2 p -105.1 145.05 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.451 1.501 . . . . 1.7 111.073 173.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -113.4 98.12 0.91 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.957 1.265 . . . . 0.65000000000000002 112.286 164.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.7 154.86 18.25 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.373 1.469 . . . . 1.21 113.318 174.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.9 p -124.46 14.17 8.84 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.841 1.656 . . . . 1.71 115.0 171.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.16 -17.97 46.79 Favored Glycine 0 N--CA 1.476 1.338 0 O-C-N 120.46 -1.4 . . . . 2.0299999999999998 114.836 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.5 t 175.44 154.51 0.34 Allowed Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 126.089 1.756 . . . . 4.1600000000000001 109.871 -155.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -58.69 -20.56 51.51 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.298 2.666 . . . . 2.7000000000000002 113.96 170.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.85 -9.1 50.31 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 114.798 1.407 . . . . 3.2799999999999998 114.798 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.84 164.95 12.79 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 123.584 1.658 . . . . 3.1099999999999999 112.262 -147.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 36.9 m -166.62 -43.43 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 127.72 2.408 . . . . 2.21 110.628 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -107.64 -158.08 0.64 Allowed 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 109.95 -0.389 . . . . 1.5700000000000001 109.95 165.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.8 t -69.64 -158.96 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.823 0.849 . . . . 1.8200000000000001 112.531 168.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.8 tp -104.97 142.81 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 126.861 2.065 . . . . 1.96 109.987 166.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.436 ' SD ' HD21 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -145.25 173.47 11.93 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.071 0.948 . . . . 5.2199999999999998 111.051 170.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -124.03 133.17 53.72 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.773 0.829 . . . . 2.0 112.233 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.436 HD21 ' SD ' ' A' ' 122' ' ' MET . 3.4 mt -129.75 160.07 34.54 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.077 0.951 . . . . 1.9199999999999999 109.422 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.2 ttpp -125.3 85.94 57.67 Favored Pre-proline 0 N--CA 1.473 0.702 0 O-C-N 121.423 -0.798 . . . . 5.7999999999999998 113.032 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -69.57 176.61 6.4 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.207 1.938 . . . . 2.4900000000000002 109.775 166.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.3 m -142.46 158.42 43.71 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.307 1.843 . . . . 1.9199999999999999 107.494 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.7 p -55.48 -33.65 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.952 1.301 . . . . 1.7 113.737 -175.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -91.04 0.9 57.44 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.56 1.144 . . . . 2.6099999999999999 113.838 175.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -140.26 -169.63 2.8 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.789 0.835 . . . . 2.1499999999999999 112.956 -158.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.6 m -145.66 163.68 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 127.504 2.322 . . . . 1.72 109.916 -173.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -148.47 133.83 18.52 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.639 1.176 . . . . 1.72 112.07 174.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.24 139.49 47.74 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.737 1.014 . . . . 4.2800000000000002 113.737 -177.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 137' ' ' CYS . 46.8 t -70.75 156.94 38.88 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.417 1.487 . . . . 1.1599999999999999 114.863 -178.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.411 ' CZ3' ' HG2' ' A' ' 136' ' ' GLU . 43.9 p-90 -102.92 -13.28 16.99 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.425 -1.261 . . . . 1.9399999999999999 113.305 174.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.411 ' HG2' ' CZ3' ' A' ' 135' ' ' TRP . 0.8 OUTLIER -98.92 -58.34 1.97 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 120.002 1.273 . . . . 2.54 110.661 -179.062 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 134' ' ' CYS . 4.6 p -77.56 -65.93 0.9 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 122.28 1.038 . . . . 2.29 110.584 171.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.72 4.86 12.72 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.046 -1.419 . . . . 0.98999999999999999 115.882 -170.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.82 137.5 57.82 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 120.841 2.32 . . . . 1.8899999999999999 111.813 173.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 40.4 t -83.18 146.53 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 107.285 -1.376 . . . . 1.7 107.285 165.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -132.35 151.01 52.04 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 128.221 2.608 . . . . 3.79 112.076 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -133.43 146.78 51.5 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.11 1.152 . . . . 3.8300000000000001 114.11 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.8 tt -99.86 153.9 18.78 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.62 1.168 . . . . 1.6899999999999999 110.328 171.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -107.62 156.91 37.09 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 115.453 1.649 . . . . 1.4099999999999999 115.453 -175.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.93 -4.51 12.56 Favored 'Trans proline' 0 C--N 1.357 0.976 1 C-N-CA 127.314 5.343 . . . . 1.6399999999999999 115.92 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.9 p -48.69 143.89 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.246 1.818 . . . . 2.9300000000000002 110.369 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.75 0 O-C-N 120.772 -1.205 . . . . 2.9500000000000002 112.124 -163.691 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.8 mtm . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.678 0.751 . . . . 3.3900000000000001 112.794 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.7 pttm 123.39 -143.65 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.605 1 C-N-CA 133.216 4.606 . . . . 4.3399999999999999 108.419 -150.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . 0.271 21.3 t0 -128.14 72.37 79.49 Favored Pre-proline 0 CA--C 1.561 1.391 0 C-N-CA 124.761 1.224 . . . . 3.1000000000000001 108.964 -173.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.51 -53.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.046 1 C-N-CA 128.788 6.325 . . . . 0.82999999999999996 114.705 -170.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -133.04 140.11 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 128.745 2.818 . . . . 1.8500000000000001 105.156 -178.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.4 mm -110.68 133.88 54.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 C-N-CA 123.662 0.785 . . . . 2.0499999999999998 111.686 -171.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.0 mm -122.67 115.69 46.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 126.341 1.857 . . . . 1.99 108.301 173.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -65.17 124.19 21.51 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.937 1.695 . . . . 3.0800000000000001 110.464 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.6 t -146.8 122.17 10.3 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.167 0.987 . . . . 3.0 111.414 -175.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -98.55 3.18 48.06 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 112.532 0.567 . . . . 4.0800000000000001 112.532 -175.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.404 ' CG ' ' H ' ' A' ' 105' ' ' ASP . 6.0 p-10 -104.03 -101.56 0.31 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 128.699 2.8 . . . . 3.7200000000000002 111.166 168.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.404 ' H ' ' CG ' ' A' ' 104' ' ' ASP . 10.3 t0 -171.64 -38.33 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 128.094 2.558 . . . . 3.9100000000000001 109.98 -175.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -99.67 -5.08 29.51 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 120.063 -1.648 . . . . 4.8300000000000001 114.63 -165.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.16 122.39 8.49 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.371 1.868 . . . . 7.7699999999999996 114.194 -164.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -70.83 151.7 44.51 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.861 1.06 . . . . 3.73 113.861 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.7 p -108.22 146.56 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.785 1.634 . . . . 1.8700000000000001 111.838 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -111.09 108.14 2.32 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.119 0.866 . . . . 0.75 112.747 161.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 1.9 t -97.1 145.17 26.25 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.963 1.305 . . . . 1.8 112.612 172.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.7 p -116.29 18.65 15.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.491 1.517 . . . . 1.71 113.759 169.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.423 ' CA ' ' CD2' ' A' ' 119' ' ' HIS . . . 110.96 39.33 1.42 Allowed Glycine 0 N--CA 1.466 0.639 0 C-N-CA 124.611 1.101 . . . . 1.71 113.457 176.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 p 71.08 178.5 0.05 OUTLIER Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 123.966 0.907 . . . . 3.4700000000000002 110.294 -161.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -63.72 -9.6 19.17 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.256 1.971 . . . . 3.0699999999999998 115.586 -172.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.58 33.48 1.43 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.817 1.247 . . . . 3.6000000000000001 113.953 -174.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 57.8 31.66 64.65 Favored Glycine 0 N--CA 1.479 1.512 0 C-N-CA 124.252 0.929 . . . . 1.6899999999999999 115.057 163.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.0 m -84.85 -32.16 23.41 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.571 -0.958 . . . . 2.48 113.437 -148.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.485 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 18.7 p80 -123.81 -144.34 0.33 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.838 1.199 . . . . 1.3700000000000001 113.096 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.2 t -78.39 -153.73 0.07 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 118.902 0.774 . . . . 1.77 111.035 164.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.9 tp -107.5 151.03 9.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 127.761 2.424 . . . . 1.8999999999999999 110.668 164.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.495 ' HE3' ' H ' ' A' ' 135' ' ' TRP . 4.2 ppp? -160.14 161.47 33.72 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.943 1.697 . . . . 4.7400000000000002 111.492 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -130.09 132.99 46.38 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.376 0.509 . . . . 1.9199999999999999 112.376 -167.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 mt -131.86 155.55 47.63 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.469 0.707 . . . . 2.0099999999999998 110.485 -175.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.65 97.21 46.28 Favored Pre-proline 0 N--CA 1.477 0.917 0 CA-C-N 118.608 0.64 . . . . 6.3499999999999996 110.972 175.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -76.42 178.66 7.26 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 121.839 1.693 . . . . 2.5499999999999998 108.868 162.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.3 m -144.41 155.34 43.71 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.14 1.776 . . . . 1.9299999999999999 106.265 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.02 -28.07 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 122.036 2.198 . . . . 1.95 109.803 175.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -72.68 -15.12 61.7 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.543 2.737 . . . . 1.8100000000000001 114.721 171.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -145.51 178.46 8.1 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 123.215 1.483 . . . . 1.99 114.103 -159.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.68 165.35 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 128.347 2.659 . . . . 1.71 109.495 174.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.9 131.64 25.72 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.428 1.091 . . . . 1.8300000000000001 111.148 173.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.63 138.03 48.72 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.677 0.621 . . . . 4.6200000000000001 112.677 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 40.7 t -70.01 153.23 43.48 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 126.599 1.96 . . . . 1.0700000000000001 115.223 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.495 ' H ' ' HE3' ' A' ' 122' ' ' MET . 56.7 p-90 -98.6 -10.19 23.73 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.453 0.908 . . . . 1.5800000000000001 113.453 169.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.485 ' HB3' ' CD2' ' A' ' 119' ' ' HIS . 0.7 OUTLIER -96.87 -100.0 0.19 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.326 1.45 . . . . 1.73 109.48 -177.229 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 30.1 p -55.39 -29.25 58.13 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.32 1.418 . . . . 1.0600000000000001 112.12 168.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.1 23.88 75.01 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-O 118.483 -1.176 . . . . 0.72999999999999998 113.479 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.66 154.0 41.71 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.704 1.752 . . . . 1.45 111.054 165.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 74.2 t -96.55 140.97 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 105.817 -1.92 . . . . 1.77 105.817 167.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -123.56 153.91 39.98 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 128.009 2.524 . . . . 3.6000000000000001 111.737 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -140.19 157.67 45.24 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 123.013 1.387 . . . . 3.6400000000000001 114.569 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.4 tt -110.87 141.16 44.63 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 113.737 -1.574 . . . . 1.97 113.255 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -100.53 155.85 35.89 Favored Pre-proline 0 CA--C 1.555 1.148 0 N-CA-C 114.609 1.337 . . . . 1.45 114.609 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -79.38 -4.27 13.57 Favored 'Trans proline' 0 C--N 1.356 0.936 1 C-N-CA 126.307 4.671 . . . . 1.3999999999999999 115.56 -175.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.1 p -40.43 148.65 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 128.805 2.842 . . . . 3.0299999999999998 112.044 175.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.644 0 O-C-N 120.138 -1.602 . . . . 1.6399999999999999 113.49 179.267 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 13.8 mtp . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 119.635 3.198 . . . . 3.5299999999999998 119.635 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -56.85 5.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 119.264 0.938 . . . . 3.0099999999999998 112.978 174.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.2 t0 161.68 70.89 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 129.411 3.085 . . . . 2.3700000000000001 109.177 -158.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -82.46 -53.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.3 1 C-N-CA 126.082 4.522 . . . . 0.81000000000000005 112.526 -172.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -147.77 143.53 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 130.521 3.528 . . . . 1.97 104.831 -168.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.4 mm -111.21 129.98 65.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 124.525 1.13 . . . . 2.0499999999999998 109.818 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.4 mm -114.61 100.27 10.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 126.123 1.769 . . . . 1.8799999999999999 106.908 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -66.61 122.23 17.14 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 125.162 1.539 . . . . 3.1200000000000001 110.008 -174.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.4 t -145.0 110.44 5.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.741 -0.663 . . . . 3.1699999999999999 111.225 -169.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -77.1 35.33 0.16 Allowed 'General case' 0 CA--C 1.55 0.949 0 O-C-N 121.693 -0.63 . . . . 3.6400000000000001 112.633 172.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -157.73 137.9 12.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 130.801 3.64 . . . . 3.1600000000000001 106.788 -173.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -60.26 -11.57 6.72 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.818 1.044 . . . . 2.98 113.818 175.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -139.05 126.35 21.47 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.758 2.423 . . . . 3.8399999999999999 111.47 -170.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.528 HH11 ' CG ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -146.27 174.74 11.07 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.887 1.275 . . . . 5.1699999999999999 113.74 171.516 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -100.4 168.05 10.0 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.723 -0.671 . . . . 3.54 111.926 157.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.96 145.9 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 126.029 1.732 . . . . 1.8999999999999999 110.414 168.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -129.34 107.84 0.84 Allowed Glycine 0 N--CA 1.473 1.116 0 CA-C-O 119.154 -0.803 . . . . 0.77000000000000002 113.773 170.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.532 ' H ' ' CE ' ' A' ' 122' ' ' MET . 12.7 p -109.75 164.11 12.87 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.485 1.914 . . . . 1.5600000000000001 114.167 172.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.8 p -124.71 5.52 8.15 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.263 1.425 . . . . 1.75 114.724 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.5 -21.67 12.62 Favored Glycine 0 N--CA 1.476 1.315 0 N-CA-C 116.334 1.294 . . . . 2.1099999999999999 116.334 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.94 177.34 0.54 Allowed Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 127.541 2.336 . . . . 4.4699999999999998 109.501 -178.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -59.54 -26.22 81.34 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.507 2.138 . . . . 3.23 113.541 170.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.52 -2.0 58.32 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.291 1.219 . . . . 3.1499999999999999 114.291 172.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.77 -169.01 52.89 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-O 123.267 1.481 . . . . 3.54 111.458 -150.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.0 t -177.82 -36.19 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 128.278 2.631 . . . . 3.54 110.656 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -118.57 -153.15 0.52 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.495 1.518 . . . . 1.3600000000000001 110.603 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.9 t -74.78 -155.39 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 O-C-N 121.39 -0.819 . . . . 1.78 112.202 167.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.5 tp -108.28 146.28 14.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 127.6 2.36 . . . . 2.1400000000000001 109.797 163.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.532 ' CE ' ' H ' ' A' ' 111' ' ' CYS . 0.0 OUTLIER -141.69 -179.87 6.43 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.922 1.289 . . . . 5.3700000000000001 110.597 173.081 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -140.25 124.06 17.34 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.589 0.631 . . . . 2.04 111.751 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.445 HD22 ' SD ' ' A' ' 122' ' ' MET . 2.4 mt -118.78 172.64 7.38 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.154 0.981 . . . . 1.9099999999999999 110.202 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -139.58 90.97 10.99 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-O 118.488 -0.768 . . . . 8.1600000000000001 112.749 -175.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -85.8 167.27 9.89 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.979 2.452 . . . . 2.6899999999999999 110.601 172.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.5 m -139.75 152.73 46.86 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.962 2.105 . . . . 1.8100000000000001 108.577 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.7 p -42.48 -43.85 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 116.988 2.218 . . . . 2.3900000000000001 116.988 -173.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -89.58 3.25 53.13 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.44 1.096 . . . . 2.2400000000000002 112.846 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -140.8 -177.85 5.27 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.59 1.156 . . . . 3.2999999999999998 113.759 -149.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.1 m -139.99 152.2 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 113.672 -1.604 . . . . 1.6699999999999999 112.384 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -129.23 143.45 50.86 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.871 0.868 . . . . 1.8400000000000001 109.844 168.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -111.64 141.07 45.71 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.886 0.874 . . . . 5.4800000000000004 111.488 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 49.3 t -59.76 159.17 9.16 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 124.587 1.179 . . . . 1.04 112.88 163.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 58.6 p-90 -107.31 -9.02 16.16 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.825 1.25 . . . . 1.3700000000000001 112.559 170.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -100.09 -94.18 0.27 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.076 1.75 . . . . 1.6200000000000001 108.998 -177.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 28.3 p -62.29 -16.37 53.45 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 120.416 -1.427 . . . . 1.28 112.587 171.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 59.22 27.32 62.64 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 124.894 1.235 . . . . 0.81999999999999995 112.607 175.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.431 ' HG ' ' HE1' ' A' ' 141' ' ' TYR . 1.4 p -67.59 132.59 47.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.975 1.388 . . . . 1.52 108.879 164.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 41.4 t -76.97 150.85 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.426 -0.953 . . . . 1.79 108.426 159.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.431 ' HE1' ' HG ' ' A' ' 139' ' ' SER . 83.0 m-85 -134.19 147.21 50.72 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 130.028 3.331 . . . . 3.02 110.439 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -124.81 145.7 49.63 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 113.397 0.888 . . . . 3.6000000000000001 113.397 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.3 tt -91.76 154.36 18.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 122.278 1.037 . . . . 2.1899999999999999 109.094 165.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -117.2 152.66 49.32 Favored Pre-proline 0 CA--C 1.552 1.037 0 CA-C-N 114.685 -1.143 . . . . 1.48 113.319 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.49 -4.39 14.42 Favored 'Trans proline' 0 CA--C 1.539 0.761 1 C-N-CA 125.964 4.443 . . . . 1.6699999999999999 115.731 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.1 p -43.66 149.54 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 128.356 2.663 . . . . 3.2000000000000002 112.812 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 125.04 1.305 . . . . 1.96 110.185 -174.843 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.6 mtm . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 124.28 1.99 . . . . 3.5600000000000001 111.918 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -173.21 -122.41 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 130.922 3.689 . . . . 3.0099999999999998 106.717 172.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . 0.303 38.0 t70 -133.39 78.11 64.1 Favored Pre-proline 0 N--CA 1.434 -1.251 0 N-CA-C 106.975 -1.491 . . . . 2.77 106.975 177.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.418 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 70.4 Cg_endo -83.12 -81.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.786 1 C-N-CA 127.573 5.515 . . . . 1.21 113.687 -170.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.418 ' H ' ' HG2' ' A' ' 97' ' ' PRO . 0.6 OUTLIER -102.07 143.39 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 C-N-CA 127.854 2.462 . . . . 1.95 106.187 171.48 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.0 mm -109.53 135.25 49.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.28 -0.873 . . . . 1.8799999999999999 111.786 -172.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.9 mm -123.55 114.05 40.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 126.96 2.104 . . . . 1.97 108.453 173.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.4 132.13 46.51 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.463 1.505 . . . . 3.0800000000000001 110.706 169.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 61.7 m -161.09 125.19 3.45 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.088 -1.007 . . . . 4.6900000000000004 109.14 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.7 m-30 -87.97 28.35 1.05 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 121.366 0.603 . . . . 4.0300000000000002 111.24 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.99 109.96 4.52 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 129.336 3.054 . . . . 3.75 108.235 -171.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -53.85 -16.08 1.62 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.974 2.51 . . . . 3.3999999999999999 115.44 -169.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.91 5.76 3.91 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 126.769 2.028 . . . . 3.6299999999999999 113.79 -167.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.5 ttt85 -48.2 156.75 0.36 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.366 1.866 . . . . 5.8499999999999996 113.654 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -87.72 155.55 19.86 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.738 -0.602 . . . . 3.52 112.308 162.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.23 142.65 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 127.08 2.152 . . . . 1.74 111.543 170.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -104.67 100.95 1.86 Allowed Glycine 0 CA--C 1.533 1.217 0 CA-C-O 117.95 -1.472 . . . . 0.69999999999999996 113.663 164.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 3.6 p -107.22 145.06 33.12 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.459 1.629 . . . . 1.3100000000000001 113.424 171.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.5 p -114.25 23.31 12.97 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 113.901 -1.499 . . . . 2.0099999999999998 112.874 175.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.83 -16.28 55.22 Favored Glycine 0 N--CA 1.476 1.36 0 O-C-N 120.201 -1.562 . . . . 1.76 114.395 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.8 p 175.36 162.29 0.4 Allowed Pre-proline 0 C--O 1.241 0.64 0 C-N-CA 128.693 2.797 . . . . 4.29 107.888 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.05 -15.42 39.16 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.02 2.48 . . . . 3.04 113.184 165.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.55 7.22 46.4 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.326 1.05 . . . . 2.6899999999999999 112.469 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 62.25 71.67 0.78 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 125.177 1.37 . . . . 1.6399999999999999 111.921 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 56.8 m -76.24 -42.51 45.59 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.925 0.89 . . . . 2.4100000000000001 112.175 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.6 p80 -100.8 -148.73 0.37 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.342 0.974 . . . . 1.46 112.226 171.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.28 13.6 t -77.67 -134.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.048 -1.093 . . . . 1.97 108.048 158.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.6 tp -129.95 142.1 44.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 131.06 3.744 . . . . 1.8999999999999999 111.108 174.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 19.3 mmm -129.54 167.15 18.34 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.629 1.972 . . . . 4.8600000000000003 115.112 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -136.06 102.48 5.04 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.88 0.472 . . . . 1.8999999999999999 110.936 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 mt -116.22 160.03 21.0 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.78 0.832 . . . . 1.8600000000000001 110.499 -169.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -119.94 76.22 21.74 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 114.931 1.456 . . . . 5.8600000000000003 114.931 -170.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -92.15 43.43 0.36 Allowed 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.477 3.452 . . . . 3.0699999999999998 116.161 -165.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 m -28.61 151.0 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 130.301 3.44 . . . . 1.9199999999999999 114.94 -170.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -52.15 -33.33 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 O-C-N 120.199 -1.563 . . . . 2.1699999999999999 113.836 175.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -79.24 -7.99 58.69 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.461 1.504 . . . . 1.73 114.071 175.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -141.39 -166.38 2.18 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.867 1.267 . . . . 2.1200000000000001 111.575 -157.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.6 m -147.55 158.28 9.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 131.151 3.78 . . . . 1.76 107.3 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -141.92 140.24 32.75 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.923 0.783 . . . . 1.8600000000000001 110.966 168.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -91.97 141.97 28.05 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.322 0.649 . . . . 4.4199999999999999 109.784 172.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.3 t -62.21 162.74 9.2 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.42 1.088 . . . . 1.1200000000000001 111.396 155.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 28.8 p-90 -104.0 -20.13 13.97 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.79 -0.641 . . . . 1.8500000000000001 112.099 163.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -81.41 -88.23 0.08 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.829 0.852 . . . . 2.2799999999999998 109.752 -174.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.7 p -64.93 -23.97 67.38 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 122.057 -0.402 . . . . 1.1599999999999999 111.933 171.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.16 21.68 75.74 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 118.814 0.734 . . . . 0.71999999999999997 113.557 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.17 154.86 38.61 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.765 1.283 . . . . 1.77 110.334 162.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 76.1 t -100.64 135.82 34.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 N-CA-C 105.749 -1.945 . . . . 1.8 105.749 164.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -116.62 146.92 42.36 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 126.748 2.019 . . . . 3.0 108.74 -176.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -134.08 151.37 51.37 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 122.366 1.079 . . . . 3.3599999999999999 113.56 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.0 tt -107.13 142.7 36.39 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 113.322 -1.763 . . . . 1.8700000000000001 111.827 -177.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -101.03 154.09 37.36 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 113.296 -1.775 . . . . 1.3799999999999999 111.259 -173.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.3 -4.39 15.13 Favored 'Trans proline' 0 N--CA 1.48 0.702 1 C-N-CA 125.577 4.184 . . . . 1.28 115.302 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.9 p -43.26 148.63 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 128.254 2.622 . . . . 2.8399999999999999 112.693 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.855 0 CA-C-O 123.361 1.534 . . . . 2.04 112.197 179.019 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 23.3 mtt . . . . . 0 C--O 1.214 -0.793 0 N-CA-C 106.889 -1.523 . . . . 4.2000000000000002 106.889 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -4.0 -66.21 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 128.564 2.746 . . . . 3.0499999999999998 117.823 171.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.3 t70 176.69 77.77 0.1 OUTLIER Pre-proline 0 CA--C 1.564 1.481 0 C-N-CA 130.742 3.617 . . . . 2.5699999999999998 109.857 -163.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -94.01 -51.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 1 C-N-CA 126.819 5.013 . . . . 1.1000000000000001 113.606 -173.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.82 142.23 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 131.153 3.781 . . . . 2.0800000000000001 104.488 -173.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.4 mm -114.51 134.62 56.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 C-N-CA 124.161 0.984 . . . . 1.73 110.199 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.3 mm -120.24 114.55 44.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 125.345 1.458 . . . . 2.0 107.781 174.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -71.49 122.1 19.84 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.911 1.284 . . . . 2.5600000000000001 110.466 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.5 m -158.43 105.13 1.86 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.728 -1.233 . . . . 4.6100000000000003 113.344 -172.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -75.03 40.02 0.14 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 127.161 2.184 . . . . 3.5499999999999998 113.051 -175.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.34 -2.18 0.69 Allowed 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.129 1.159 . . . . 3.4900000000000002 114.129 -168.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 63.25 -16.46 0.06 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 128.602 2.761 . . . . 3.27 115.046 -176.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -151.68 27.47 0.64 Allowed 'General case' 0 C--O 1.244 0.784 0 O-C-N 119.841 -1.787 . . . . 3.9700000000000002 113.193 -170.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -65.47 160.62 21.75 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.551 1.167 . . . . 4.7199999999999998 111.283 171.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -82.65 167.76 17.94 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.913 -1.04 . . . . 3.1600000000000001 113.036 167.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.9 p -118.61 141.9 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 127.916 2.487 . . . . 1.75 111.191 169.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.53 105.41 2.04 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.691 1.139 . . . . 0.82999999999999996 112.168 164.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.11 153.28 21.1 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.036 1.334 . . . . 1.1599999999999999 112.543 169.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 18.2 p -121.37 24.24 10.03 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.784 1.634 . . . . 1.9399999999999999 113.933 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.22 -28.29 6.29 Favored Glycine 0 N--CA 1.472 1.054 0 O-C-N 120.692 -1.255 . . . . 2.0299999999999998 112.775 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 83.0 p -175.87 163.03 2.0 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 128.521 2.728 . . . . 4.3499999999999996 107.67 -172.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.8 -3.7 10.9 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.31 2.673 . . . . 2.5600000000000001 113.906 172.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.88 0.31 18.63 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.671 1.189 . . . . 2.9700000000000002 114.059 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.29 91.57 0.39 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.533 1.063 . . . . 1.77 111.119 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.6 m -103.0 -30.35 10.83 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.011 0.745 . . . . 2.25 113.011 173.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -125.15 -151.37 0.48 Allowed 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 119.125 0.875 . . . . 1.52 111.544 166.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.3 t -73.02 -157.68 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 O-C-N 121.032 -1.043 . . . . 2.1800000000000002 111.371 166.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.4 tp -103.78 145.81 12.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 127.17 2.188 . . . . 2.3500000000000001 108.815 164.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.442 ' SD ' HD21 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -145.85 166.68 25.23 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.418 0.687 . . . . 5.4000000000000004 111.501 170.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -117.89 130.34 56.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.781 0.832 . . . . 2.04 112.147 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.442 HD21 ' SD ' ' A' ' 122' ' ' MET . 2.2 mt -128.84 163.78 24.48 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.452 1.101 . . . . 2.02 109.452 175.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 32.8 mttt -131.79 105.36 14.1 Favored Pre-proline 0 N--CA 1.48 1.027 0 CA-C-O 117.434 -1.27 . . . . 7.8399999999999999 110.957 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -71.82 -69.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.26 1.973 . . . . 3.21 112.96 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.9 m 100.94 147.37 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 130.287 3.435 . . . . 2.0899999999999999 108.82 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.4 p -44.38 -41.1 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 127.506 2.322 . . . . 1.98 114.733 -172.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -83.84 -22.52 31.7 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.27 1.028 . . . . 4.4100000000000001 112.317 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -131.82 179.08 6.29 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.948 1.699 . . . . 4.3200000000000003 114.913 -143.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 20.4 m -131.16 147.97 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 112.874 -1.966 . . . . 1.9099999999999999 114.757 -165.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -142.5 141.22 32.07 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.979 1.312 . . . . 1.8400000000000001 112.335 174.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -122.61 139.56 53.79 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.855 1.262 . . . . 5.5499999999999998 113.565 -170.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . 0.487 ' SG ' ' SG ' ' A' ' 137' ' ' CYS . 42.6 t -72.4 145.34 47.75 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 116.448 2.018 . . . . 1.27 116.448 -174.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.421 ' CZ3' ' HG2' ' A' ' 136' ' ' GLU . 58.5 p-90 -95.5 -10.7 29.01 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 117.421 -1.276 . . . . 2.9399999999999999 113.765 175.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.421 ' HG2' ' CZ3' ' A' ' 135' ' ' TRP . 1.3 mm-40 -93.27 -66.3 0.93 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 120.089 1.313 . . . . 2.5099999999999998 108.345 175.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.487 ' SG ' ' SG ' ' A' ' 134' ' ' CYS . 12.4 p -74.86 -77.13 0.13 Allowed 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 121.844 0.83 . . . . 2.8999999999999999 110.927 173.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 125.0 18.58 2.57 Favored Glycine 0 N--CA 1.472 1.046 0 N-CA-C 117.692 1.837 . . . . 0.88 117.692 -165.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.4 p -74.92 142.63 43.98 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 120.655 2.228 . . . . 1.77 110.859 166.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 50.8 t -90.98 138.16 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 107.559 -1.275 . . . . 1.97 107.559 167.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -117.65 142.69 46.93 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.457 1.903 . . . . 3.0699999999999998 112.382 176.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -115.58 149.09 38.78 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.285 1.04 . . . . 3.0600000000000001 112.259 173.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.3 tt -99.45 158.07 15.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.151 -0.931 . . . . 1.95 110.071 168.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -114.3 156.01 44.94 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 114.82 1.415 . . . . 1.3500000000000001 114.82 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.08 -5.36 16.24 Favored 'Trans proline' 0 C--N 1.355 0.9 1 C-N-CA 125.65 4.233 . . . . 1.21 115.288 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.5 p -45.11 138.01 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 126.273 1.829 . . . . 2.9199999999999999 111.127 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.594 0 CA-C-O 122.851 1.251 . . . . 2.04 112.369 -174.647 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.7 mtt . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 119.445 3.128 . . . . 3.9100000000000001 119.445 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -58.88 6.67 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 120.969 -1.082 . . . . 2.8599999999999999 112.481 171.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 t0 165.32 71.75 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 129.461 3.105 . . . . 2.1099999999999999 108.906 -157.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.95 -50.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.391 1 C-N-CA 126.552 4.835 . . . . 0.81000000000000005 113.252 -171.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -150.63 141.64 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 1 C-N-CA 132.587 4.355 . . . . 1.72 104.141 -170.07 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 mm -109.88 136.14 46.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 125.163 1.385 . . . . 1.71 109.004 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.1 mm -116.75 143.01 28.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 105.299 -2.111 . . . . 1.8400000000000001 105.299 170.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -108.24 146.03 33.44 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.102 0.876 . . . . 3.1899999999999999 110.116 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.2 t -137.67 -54.71 0.67 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.852 1.427 . . . . 3.0899999999999999 114.852 -167.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 81.59 11.23 0.77 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 127.947 2.499 . . . . 3.9399999999999999 113.759 -167.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -149.12 156.76 42.68 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 129.396 3.079 . . . . 2.7400000000000002 107.351 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.48 -18.16 26.78 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.285 1.217 . . . . 2.9300000000000002 114.285 174.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.68 81.55 1.16 Allowed 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.86 1.43 . . . . 4.2599999999999998 114.86 -158.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -127.39 167.91 15.57 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 120.898 -1.126 . . . . 6.3200000000000003 113.219 167.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -90.8 171.32 9.41 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.306 1.443 . . . . 3.4300000000000002 113.882 -174.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.4 p -124.98 143.12 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 126.685 1.994 . . . . 1.8700000000000001 111.228 171.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.26 92.76 1.01 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.585 1.564 . . . . 0.73999999999999999 112.081 162.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -106.19 146.55 30.13 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.553 1.676 . . . . 1.26 113.727 176.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.9 p -115.54 4.79 14.28 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.358 1.463 . . . . 1.8999999999999999 114.166 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 138.07 -27.13 2.8 Favored Glycine 0 N--CA 1.468 0.777 0 O-C-N 121.405 -0.809 . . . . 2.5800000000000001 114.898 -169.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.0 t 106.12 144.85 0.01 OUTLIER Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 128.091 2.556 . . . . 4.5499999999999998 106.681 -138.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.15 93.76 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.95 2.433 . . . . 4.1500000000000004 110.76 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 176.86 21.32 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 129.256 3.022 . . . . 2.8599999999999999 113.412 166.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 67.2 43.21 90.03 Favored Glycine 0 C--N 1.341 0.837 0 O-C-N 121.133 -0.979 . . . . 2.25 113.777 167.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 5.3 t -60.68 -36.35 78.55 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.156 0.978 . . . . 3.8399999999999999 111.905 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 26.4 p80 -135.65 -141.1 0.17 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.017 1.327 . . . . 1.5800000000000001 112.323 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.4 t -85.13 -141.39 0.08 Allowed 'General case' 0 C--O 1.218 -0.583 0 C-N-CA 124.14 0.976 . . . . 2.3500000000000001 108.812 158.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.7 tp -123.08 141.22 44.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 130.23 3.412 . . . . 2.25 111.689 174.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.409 ' SD ' ' NE1' ' A' ' 135' ' ' TRP . 12.9 mmt -136.47 154.57 50.72 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 116.379 1.992 . . . . 5.6399999999999997 116.379 -173.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -115.65 87.79 2.74 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.753 -0.658 . . . . 1.97 111.789 -170.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 mt -103.1 167.99 9.47 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.487 -0.758 . . . . 2.1099999999999999 109.354 -174.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.57 88.86 2.73 Favored Pre-proline 0 N--CA 1.475 0.789 0 O-C-N 121.033 -1.042 . . . . 8.5600000000000005 112.556 -167.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -81.37 173.4 11.64 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.477 2.784 . . . . 2.3399999999999999 109.933 170.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -113.55 156.83 22.91 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.45 1.9 . . . . 1.95 107.883 169.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 p -50.3 -39.53 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-N 119.992 1.269 . . . . 1.9099999999999999 113.952 170.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -79.59 -5.59 55.31 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.263 0.838 . . . . 1.8999999999999999 113.263 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -143.16 -164.14 1.79 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.561 0.744 . . . . 2.2200000000000002 111.773 -155.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.4 m -149.74 158.57 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.731 2.012 . . . . 1.8300000000000001 110.263 -171.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -143.62 139.61 29.72 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.224 1.01 . . . . 1.8400000000000001 111.637 170.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.9 ttt-85 -97.96 146.14 25.78 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.457 0.703 . . . . 5.1699999999999999 110.32 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 9.7 t -60.2 160.35 8.46 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.545 1.538 . . . . 1.0900000000000001 110.627 159.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.409 ' NE1' ' SD ' ' A' ' 122' ' ' MET . 27.7 p-90 -99.86 -17.71 17.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 117.479 -1.248 . . . . 1.6100000000000001 111.822 160.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -86.25 -95.38 0.08 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.923 1.289 . . . . 1.51 109.502 -173.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.3 p -64.28 -13.33 49.05 Favored 'General case' 0 CA--C 1.557 1.233 0 O-C-N 119.963 -1.711 . . . . 1.1599999999999999 114.929 -177.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.75 16.8 80.15 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.95 1.738 . . . . 0.75 114.909 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.82 142.4 49.63 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.399 1.6 . . . . 1.74 110.56 169.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.26 147.94 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 108.355 -0.979 . . . . 1.6599999999999999 108.355 158.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -126.27 153.49 44.7 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 128.928 2.891 . . . . 3.02 111.037 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 46.7 tttt -130.39 152.89 49.31 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.621 0.768 . . . . 3.7599999999999998 112.763 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.642 HD21 ' H ' ' A' ' 144' ' ' ASN . 0.8 OUTLIER -99.34 164.92 11.92 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.874 1.321 . . . . 3.5800000000000001 111.283 161.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.642 ' H ' HD21 ' A' ' 143' ' ' LEU . 27.7 p30 -123.96 167.56 15.0 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 127.538 2.335 . . . . 1.52 110.804 -177.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -83.75 -26.42 2.04 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.717 2.278 . . . . 1.3600000000000001 113.776 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.7 m 38.66 -164.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 129.976 3.31 . . . . 3.7799999999999998 117.238 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.833 0 CA-C-O 123.746 1.748 . . . . 2.1200000000000001 113.174 132.031 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.0 mtt . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 118.749 2.87 . . . . 4.2400000000000002 118.749 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.22 -80.67 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.306 0.574 . . . . 3.5299999999999998 110.188 161.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.8 t0 177.13 77.78 0.11 Allowed Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 127.073 2.149 . . . . 2.3799999999999999 108.1 -162.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -93.96 -57.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 1 C-N-CA 127.053 5.168 . . . . 0.97999999999999998 115.402 -162.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.15 140.92 29.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 1 C-N-CA 131.803 4.041 . . . . 2.0 103.709 -170.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 mm -111.69 135.92 49.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 123.633 0.773 . . . . 2.1000000000000001 110.502 -175.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.2 mm -123.89 100.18 7.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 126.584 1.954 . . . . 2.1200000000000001 106.23 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -78.8 120.41 23.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 113.547 -1.661 . . . . 2.5600000000000001 110.455 -163.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.7 t -110.28 -65.74 1.13 Allowed 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 115.049 1.5 . . . . 2.7599999999999998 115.049 -154.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 71.86 11.13 6.26 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.826 2.05 . . . . 3.4700000000000002 112.555 -171.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -138.1 153.37 49.28 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 130.046 3.338 . . . . 2.8300000000000001 107.306 163.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -71.29 -9.26 57.83 Favored 'General case' 0 CA--C 1.552 1.054 0 O-C-N 120.645 -1.284 . . . . 3.1499999999999999 113.032 172.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -141.45 104.07 4.52 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.417 2.287 . . . . 3.8199999999999998 111.405 -164.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -148.94 168.79 22.13 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.709 -1.244 . . . . 4.5599999999999996 112.306 174.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -103.94 158.11 16.63 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.727 0.811 . . . . 3.8300000000000001 111.32 166.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.6 p -102.33 141.12 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.238 1.415 . . . . 2.3300000000000001 110.291 169.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -106.92 78.54 0.25 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.341 1.448 . . . . 1.1899999999999999 112.867 169.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 12.9 p -94.95 143.0 26.82 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 119.596 1.698 . . . . 1.45 113.285 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 35.6 p -105.95 19.02 21.21 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-N 112.532 -2.122 . . . . 1.78 112.141 169.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.07 60.84 0.34 Allowed Glycine 0 C--N 1.334 0.47 0 CA-C-O 119.033 -0.871 . . . . 1.72 113.675 176.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 68.59 -166.06 0.01 OUTLIER Pre-proline 0 CA--C 1.556 1.204 0 CA-C-O 117.836 -1.078 . . . . 6.2699999999999996 109.874 171.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.85 52.09 3.87 Favored 'Trans proline' 0 C--N 1.354 0.837 0 CA-C-N 122.768 2.024 . . . . 4.6799999999999997 111.598 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -163.1 7.54 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 116.031 1.863 . . . . 4.7800000000000002 116.031 -160.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 51.87 47.95 52.35 Favored Glycine 0 N--CA 1.475 1.29 0 N-CA-C 115.061 0.784 . . . . 2.6499999999999999 115.061 159.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.2 m -113.83 -21.73 10.52 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 116.331 1.975 . . . . 2.52 116.331 -151.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -123.57 -148.5 0.4 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 121.096 1.771 . . . . 1.3700000000000001 113.904 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.6 t -72.68 -153.23 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.323 0.649 . . . . 1.6599999999999999 110.946 162.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.2 tp -117.12 136.53 53.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 126.466 1.906 . . . . 1.8300000000000001 112.488 167.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.461 ' CE ' ' HE1' ' A' ' 135' ' ' TRP . 17.3 mmm -131.62 155.83 46.87 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.818 -1.537 . . . . 5.0 114.688 -176.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -123.59 111.77 16.64 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.816 -1.084 . . . . 1.8999999999999999 109.956 -177.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 mt -124.01 148.9 46.64 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.648 -0.501 . . . . 2.1099999999999999 109.648 -171.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.26 108.3 58.67 Favored Pre-proline 0 N--CA 1.484 1.242 0 CA-C-O 118.798 -0.62 . . . . 6.5 111.789 -175.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -89.87 -175.21 0.96 Allowed 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.126 2.55 . . . . 2.73 109.895 154.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 94.8 m -158.92 157.44 31.41 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.72 2.808 . . . . 2.3300000000000001 105.199 173.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.417 HG12 HD21 ' A' ' 129' ' ' ASN . 7.5 p -49.71 -32.41 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 115.309 1.596 . . . . 1.9099999999999999 115.309 -176.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.417 HD21 HG12 ' A' ' 128' ' ' VAL . 1.7 m-80 -79.27 -0.81 33.83 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.027 1.331 . . . . 2.4300000000000002 113.949 177.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -141.29 -175.83 4.49 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 123.545 1.64 . . . . 2.7400000000000002 114.503 -151.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.5 m -139.22 168.08 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 130.244 3.418 . . . . 1.97 107.267 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -147.82 128.11 13.88 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 123.924 0.89 . . . . 1.8600000000000001 111.13 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -92.33 141.17 28.84 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.937 0.789 . . . . 5.2400000000000002 110.351 173.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 9.2 t -63.54 174.81 1.2 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 122.789 1.281 . . . . 1.1899999999999999 112.446 159.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.461 ' HE1' ' CE ' ' A' ' 122' ' ' MET . 20.8 p-90 -111.34 -18.37 12.93 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.316 -0.856 . . . . 1.8100000000000001 111.983 161.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.9 -87.7 0.14 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.67 1.988 . . . . 1.71 108.092 -171.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 24.3 p -59.84 -19.68 52.53 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 120.477 -1.39 . . . . 1.1000000000000001 112.664 168.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.98 15.89 22.89 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.669 1.604 . . . . 0.92000000000000004 114.186 -175.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.1 p -75.04 142.24 43.79 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 119.122 1.461 . . . . 1.28 110.722 172.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 52.8 t -80.72 147.61 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.455 -0.942 . . . . 1.6499999999999999 108.455 167.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -130.84 158.47 40.09 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 130.231 3.413 . . . . 3.79 109.457 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -140.39 147.0 39.08 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 113.759 1.022 . . . . 4.25 113.759 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.7 tt -93.4 145.13 24.71 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 115.36 -0.836 . . . . 1.78 110.771 170.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -112.21 147.36 36.79 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 124.618 1.167 . . . . 1.3999999999999999 110.392 171.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -69.98 -27.57 25.25 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.549 2.166 . . . . 1.8200000000000001 112.497 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.6 m 41.5 -158.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 129.002 2.921 . . . . 3.3399999999999999 114.933 -174.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.419 0 CA-C-O 122.228 0.904 . . . . 3.0699999999999998 112.477 157.746 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.9 mtt . . . . . 0 CA--C 1.521 -0.156 0 CA-C-O 123.911 1.815 . . . . 3.48 111.779 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 177.09 -123.48 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.119 1 C-N-CA 132.108 4.163 . . . . 2.9700000000000002 107.077 178.13 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . 0.27 30.0 t70 -131.33 78.6 71.76 Favored Pre-proline 0 N--CA 1.432 -1.334 0 C-N-CA 126.6 1.96 . . . . 2.54 107.699 176.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.417 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 74.4 Cg_endo -83.13 -84.06 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.6 1 C-N-CA 126.876 5.05 . . . . 1.23 113.14 -171.33 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.417 ' H ' ' HG2' ' A' ' 97' ' ' PRO . 0.7 OUTLIER -102.65 147.56 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 C-N-CA 127.835 2.454 . . . . 1.8600000000000001 106.406 171.744 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.2 mm -105.77 136.05 41.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.932 -0.576 . . . . 1.8400000000000001 111.21 -174.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.5 mm -119.25 99.12 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 126.169 1.788 . . . . 1.8600000000000001 107.572 169.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -70.39 122.86 20.41 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.543 1.537 . . . . 3.0 108.968 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.6 m -162.23 123.49 2.65 Favored 'General case' 0 C--O 1.221 -0.442 0 O-C-N 121.06 -1.025 . . . . 4.9000000000000004 112.687 -165.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -83.47 25.71 0.73 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.203 1.001 . . . . 3.79 113.316 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -140.95 124.6 16.89 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.766 2.026 . . . . 2.6699999999999999 107.967 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -62.51 7.99 0.06 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 127.771 2.428 . . . . 3.3799999999999999 117.468 -169.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.08 22.8 0.07 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.761 2.424 . . . . 3.6299999999999999 112.458 -165.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.2 ttt-85 -67.39 150.12 49.38 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.503 1.121 . . . . 4.9199999999999999 113.387 -174.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -82.99 150.91 26.09 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.893 0.701 . . . . 3.5 112.893 176.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.5 p -108.07 138.8 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.502 1.521 . . . . 1.8400000000000001 111.168 169.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -108.66 103.14 1.79 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.492 -1.443 . . . . 0.69999999999999996 109.492 159.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.04 155.8 17.25 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.949 0.9 . . . . 1.24 110.554 166.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 120' ' ' THR . 40.9 p -118.11 4.94 11.99 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 116.463 2.023 . . . . 1.8400000000000001 116.463 172.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.71 56.3 0.29 Allowed Glycine 0 C--N 1.33 0.224 0 CA-C-O 119.443 -0.643 . . . . 2.0800000000000001 113.016 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 79.5 -162.2 0.0 OUTLIER Pre-proline 0 CA--C 1.565 1.528 0 CA-C-O 116.61 -1.662 . . . . 3.77 109.245 -168.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -80.55 45.93 2.11 Favored 'Trans proline' 0 C--N 1.358 1.053 0 CA-C-N 124.524 2.651 . . . . 2.6499999999999999 112.915 -173.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -166.55 163.7 17.04 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.025 1.33 . . . . 3.9300000000000002 110.785 -169.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.89 42.41 2.49 Favored Glycine 0 N--CA 1.473 1.125 0 C-N-CA 124.478 1.037 . . . . 2.5600000000000001 114.048 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.1 m -68.93 -40.6 78.93 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.657 1.229 . . . . 2.5299999999999998 114.028 -160.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -106.27 -73.23 0.69 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.04 0.756 . . . . 1.8999999999999999 113.04 173.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 112' ' ' THR . 7.0 t -178.99 -166.12 0.09 Allowed 'General case' 0 N--CA 1.475 0.789 1 C-N-CA 132.685 4.394 . . . . 1.97 106.609 -175.339 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.6 tp -98.77 138.42 23.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 119.771 1.169 . . . . 1.95 110.729 173.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.435 ' SD ' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -141.02 163.43 32.99 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.121 1.368 . . . . 5.2300000000000004 110.441 166.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.3 m95 -130.22 87.67 2.54 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.868 -0.52 . . . . 3.1600000000000001 111.611 -155.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.435 HD22 ' SD ' ' A' ' 122' ' ' MET . 3.2 mt -95.64 167.42 11.3 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 120.498 -1.376 . . . . 1.8500000000000001 110.746 -171.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.35 88.02 15.19 Favored Pre-proline 0 N--CA 1.472 0.675 0 C-N-CA 123.592 0.757 . . . . 8.2599999999999998 111.29 -176.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -77.27 166.61 26.01 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.575 2.184 . . . . 2.3700000000000001 110.412 165.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 m -120.18 154.86 34.2 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 127.097 2.159 . . . . 1.97 108.295 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.4 p -54.95 -34.21 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 112.939 0.718 . . . . 1.98 112.939 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -82.17 -10.07 59.29 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.62 1.168 . . . . 1.6799999999999999 113.508 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -140.02 -168.34 2.5 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.696 0.68 . . . . 2.5499999999999998 112.649 -155.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.83 157.67 23.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 126.93 2.092 . . . . 1.76 109.385 -171.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.2 144.89 36.82 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.113 0.965 . . . . 1.6200000000000001 110.968 172.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.4 ttp180 -111.74 139.3 47.33 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.443 1.02 . . . . 4.8499999999999996 112.557 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 37.8 t -60.34 156.33 15.97 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.244 1.418 . . . . 1.02 112.484 163.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -100.43 -12.85 19.03 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.063 -0.971 . . . . 1.4199999999999999 112.766 169.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -103.39 -78.99 0.54 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.163 0.892 . . . . 2.5800000000000001 111.246 -169.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 26.6 p -70.02 -22.19 63.12 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.853 0.861 . . . . 1.3700000000000001 112.407 172.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.58 33.36 80.93 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.441 1.02 . . . . 1.0800000000000001 113.273 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.11 152.67 42.18 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.839 1.319 . . . . 1.96 110.508 158.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.1 t -100.24 135.4 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 106.335 -1.728 . . . . 1.5900000000000001 106.335 159.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -117.4 140.47 49.53 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 127.735 2.414 . . . . 2.8799999999999999 110.875 -176.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.8 tttm -106.14 147.47 28.96 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.639 -0.71 . . . . 3.6800000000000002 112.704 173.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.43 144.78 25.48 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 114.847 -1.069 . . . . 2.0 110.168 155.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -106.66 159.34 30.22 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 124.596 1.158 . . . . 1.3100000000000001 113.006 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -71.8 -5.16 16.51 Favored 'Trans proline' 0 C--N 1.354 0.861 1 C-N-CA 126.274 4.65 . . . . 1.3100000000000001 115.983 -177.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.9 p -48.11 142.42 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 126.141 1.777 . . . . 2.8199999999999998 111.511 177.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.717 0 CA-C-O 122.993 1.33 . . . . 2.1800000000000002 112.674 179.353 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 10.9 mtm . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 118.428 2.751 . . . . 3.5600000000000001 118.428 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.32 -59.66 2.62 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.791 0.663 . . . . 3.4100000000000001 112.791 169.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 167.05 70.44 0.0 OUTLIER Pre-proline 0 CA--C 1.566 1.571 0 C-N-CA 129.674 3.189 . . . . 3.0 110.167 -150.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -89.02 -50.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.334 -0.229 1 C-N-CA 125.529 4.152 . . . . 0.73999999999999999 113.358 -174.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.98 141.74 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 1 C-N-CA 131.954 4.102 . . . . 1.76 104.207 -172.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.3 mm -119.48 129.43 75.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 124.303 1.041 . . . . 1.9399999999999999 111.153 -175.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 42.0 mm -115.39 98.21 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 125.688 1.595 . . . . 1.74 107.515 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -71.12 99.67 1.9 Allowed 'General case' 0 C--N 1.328 -0.361 0 O-C-N 125.569 1.793 . . . . 2.54 108.333 176.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.7 p -104.92 -43.6 5.03 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.041 1.126 . . . . 3.7000000000000002 114.041 -157.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . 0.252 35.5 m-85 72.32 9.77 5.86 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 127.742 2.417 . . . . 3.8999999999999999 114.45 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -132.66 150.21 52.19 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.58 -0.896 . . . . 3.1099999999999999 108.58 134.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.05 -28.01 22.55 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.969 2.507 . . . . 3.4399999999999999 114.91 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -127.1 12.77 7.19 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.525 1.53 . . . . 3.98 114.044 -161.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -56.57 175.28 0.12 Allowed 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 122.458 1.123 . . . . 4.71 113.25 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -95.41 169.32 10.14 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.582 -0.699 . . . . 3.8100000000000001 111.348 157.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.7 p -116.22 143.16 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 126.884 2.074 . . . . 2.0600000000000001 111.472 171.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -104.69 101.33 1.92 Allowed Glycine 0 CA--C 1.532 1.142 0 CA-C-O 117.974 -1.459 . . . . 0.82999999999999996 114.142 165.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 13.8 p -107.43 145.61 32.77 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-O 123.908 1.813 . . . . 1.6599999999999999 113.386 160.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 74.3 p -102.44 16.4 26.4 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 112.494 -2.139 . . . . 1.8 111.627 165.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 142.45 176.0 16.2 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-O 123.693 1.718 . . . . 3.4500000000000002 114.599 -171.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.6 m -3.47 133.68 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.242 0 CA-C-N 111.757 -2.222 . . . . 4.2300000000000004 115.785 103.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.85 57.39 4.46 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 125.131 3.887 . . . . 3.1200000000000001 114.476 -169.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -169.27 48.74 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.815 1.246 . . . . 2.6200000000000001 111.622 -167.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 55.7 24.69 41.25 Favored Glycine 0 N--CA 1.48 1.627 0 C-N-CA 125.077 1.322 . . . . 2.1299999999999999 115.925 166.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.2 m -77.38 -41.6 39.55 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.754 1.02 . . . . 2.7000000000000002 113.754 -144.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -115.12 -149.01 0.44 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.937 1.295 . . . . 1.51 112.395 -176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.4 t -71.92 -155.43 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.692 0.678 . . . . 2.1499999999999999 110.987 160.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.5 tp -115.37 138.68 44.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 C-N-CA 126.483 1.913 . . . . 1.96 111.082 165.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.505 ' CE ' ' HE1' ' A' ' 135' ' ' TRP . 13.2 mmm -131.95 153.38 50.36 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 115.144 1.535 . . . . 4.8499999999999996 115.144 -174.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -118.33 99.57 6.93 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 124.528 1.143 . . . . 1.98 110.309 -173.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.3 mt -109.45 162.47 14.34 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.498 0.719 . . . . 1.99 109.63 -173.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -121.89 74.57 36.87 Favored Pre-proline 0 N--CA 1.487 1.38 0 O-C-N 120.425 -1.422 . . . . 5.4100000000000001 114.782 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -86.47 39.56 0.65 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.908 3.072 . . . . 3.3399999999999999 114.922 -171.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.8 m -28.02 151.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 1 C-N-CA 132.206 4.202 . . . . 2.0499999999999998 115.27 -169.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.4 p -45.66 -39.02 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 114.703 1.372 . . . . 1.8600000000000001 114.703 177.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -81.48 -8.63 59.75 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.403 1.481 . . . . 1.74 113.823 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.406 ' O ' ' HE3' ' A' ' 142' ' ' LYS . 30.3 mt-10 -136.17 -159.53 0.97 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.34 1.056 . . . . 2.1299999999999999 110.52 -156.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 20.9 m -157.81 153.53 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 130.246 3.419 . . . . 1.99 106.15 177.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -142.38 143.52 32.73 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.535 0.607 . . . . 1.8500000000000001 111.044 171.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -100.35 142.6 31.61 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.285 0.634 . . . . 5.6600000000000001 110.446 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 14.6 t -60.05 159.06 9.98 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 124.514 1.134 . . . . 1.04 111.52 161.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.505 ' HE1' ' CE ' ' A' ' 122' ' ' MET . 20.6 p-90 -103.96 -12.79 16.62 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.6 -0.727 . . . . 1.5700000000000001 111.703 163.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -89.65 -87.05 0.18 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.933 1.293 . . . . 1.55 108.842 -176.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 23.0 p -74.65 -15.16 60.82 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.256 1.206 . . . . 1.4299999999999999 114.256 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 66.85 18.94 69.09 Favored Glycine 0 N--CA 1.469 0.876 0 C-N-CA 126.318 1.913 . . . . 0.73999999999999999 115.075 172.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.27 141.83 57.89 Favored 'General case' 0 N--CA 1.46 0.059 0 C-N-CA 118.593 -1.243 . . . . 1.75 110.349 163.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 45.9 t -78.94 141.8 14.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 107.782 -1.192 . . . . 2.0600000000000001 107.782 159.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -122.52 156.61 33.8 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 128.082 2.553 . . . . 2.9399999999999999 110.219 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.406 ' HE3' ' O ' ' A' ' 130' ' ' GLU . 66.5 tttt -136.64 152.76 50.78 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 122.315 1.055 . . . . 3.1400000000000001 113.027 173.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.3 tt -112.16 167.4 10.44 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.561 1.545 . . . . 2.0800000000000001 109.252 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -126.52 165.7 26.51 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.507 1.523 . . . . 1.45 113.581 -168.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.32 -4.43 15.4 Favored 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 124.07 3.18 . . . . 1.55 115.256 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.8 p -44.54 140.35 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 127.974 2.51 . . . . 2.75 114.026 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.734 0 C-N-CA 126.541 2.02 . . . . 2.6600000000000001 110.335 -179.473 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.2 mtp . . . . . 0 C--O 1.224 -0.24 0 N-CA-C 116.985 2.217 . . . . 4.25 116.985 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.462 ' CG ' ' H ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -121.33 -74.69 0.61 Allowed 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 124.305 1.042 . . . . 3.27 109.29 173.639 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.462 ' H ' ' CG ' ' A' ' 95' ' ' LYS . 38.4 t70 179.44 75.9 0.17 Allowed Pre-proline 0 CA--C 1.559 1.324 0 C-N-CA 128.242 2.617 . . . . 2.5899999999999999 107.893 -166.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -89.23 -51.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.551 1 C-N-CA 128.582 6.188 . . . . 0.85999999999999999 113.437 -175.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -139.58 143.12 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 130.746 3.618 . . . . 1.55 104.844 -175.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.0 mm -102.76 138.34 27.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.671 -0.695 . . . . 1.8600000000000001 110.822 -176.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.3 mm -120.5 107.11 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 C-N-CA 127.036 2.134 . . . . 1.8899999999999999 107.462 170.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -78.61 134.32 37.2 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 124.601 1.188 . . . . 3.2200000000000002 110.867 -174.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 104' ' ' ASP . 13.2 t -162.24 107.22 1.21 Allowed 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 113.144 0.794 . . . . 2.71 113.144 -163.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.3 m-30 -77.33 41.53 0.31 Allowed 'General case' 0 N--CA 1.48 1.063 0 O-C-N 120.524 -1.36 . . . . 3.8199999999999998 110.762 171.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 102' ' ' SER . 0.0 OUTLIER -159.37 123.71 3.93 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.956 2.902 . . . . 3.1699999999999999 107.965 -166.091 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.54 -3.6 31.86 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 115.582 1.697 . . . . 3.3399999999999999 115.582 -166.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.36 21.64 1.06 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 125.112 1.365 . . . . 3.3399999999999999 113.662 -156.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.04 154.06 18.34 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 120.148 -1.595 . . . . 6.8899999999999997 114.991 -154.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.8 161.18 31.38 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.319 1.229 . . . . 3.3300000000000001 114.319 -177.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.4 p -129.6 145.84 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 127.455 2.302 . . . . 2.1600000000000001 109.84 171.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.17 126.74 6.39 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.155 0.883 . . . . 0.81999999999999995 111.605 164.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.97 151.97 39.09 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.366 1.867 . . . . 1.52 111.94 169.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 34.0 p -117.83 25.97 10.01 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.164 1.385 . . . . 1.95 113.385 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.85 68.27 1.03 Allowed Glycine 0 N--CA 1.462 0.428 0 O-C-N 120.844 -1.16 . . . . 2.4900000000000002 111.017 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.46 177.71 0.06 OUTLIER Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 123.521 0.728 . . . . 3.5800000000000001 110.01 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.23 38.96 0.76 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.061 2.507 . . . . 3.1200000000000001 112.705 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -151.93 3.2 0.38 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.851 1.797 . . . . 3.3700000000000001 115.851 -165.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.38 72.22 0.98 Allowed Glycine 0 N--CA 1.474 1.188 0 C-N-CA 124.849 1.214 . . . . 1.8600000000000001 114.206 167.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.5 t -103.63 -30.38 10.5 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 115.338 1.607 . . . . 3.1299999999999999 115.338 -174.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.406 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 9.1 p80 -128.32 -148.12 0.37 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.631 0.773 . . . . 1.3300000000000001 112.042 -176.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.2 t -78.16 -152.34 0.05 Allowed 'General case' 0 N--CA 1.479 1.016 0 O-C-N 121.268 -0.895 . . . . 1.9099999999999999 111.376 167.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.5 tp -106.65 149.91 9.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 127.667 2.387 . . . . 2.1200000000000001 110.212 164.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.18 172.35 12.88 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.806 1.242 . . . . 5.8099999999999996 110.036 170.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -137.45 124.96 22.08 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.004 0.521 . . . . 1.9399999999999999 111.493 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.61 179.75 4.13 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.981 0.912 . . . . 1.98 109.185 176.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.27 102.6 2.95 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.973 0.909 . . . . 7.2400000000000002 111.738 174.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -80.4 171.63 14.6 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.144 2.563 . . . . 2.3199999999999998 110.22 164.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.8 m -122.72 155.97 35.37 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 127.2 2.2 . . . . 2.0800000000000001 107.628 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.4 p -55.2 -30.9 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 120.571 1.532 . . . . 1.8700000000000001 112.485 175.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -82.93 -7.52 59.66 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.12 1.768 . . . . 1.6000000000000001 113.521 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -147.42 -169.67 3.37 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.29 1.036 . . . . 2.1600000000000001 112.146 -156.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.8 m -142.18 170.31 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 127.757 2.423 . . . . 1.8100000000000001 109.739 -170.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -150.85 147.55 27.38 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.019 0.927 . . . . 1.6699999999999999 111.505 172.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.6 ttt-85 -114.11 139.2 49.52 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.64 0.776 . . . . 5.46 112.333 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 40.1 t -56.78 157.67 5.32 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.817 1.247 . . . . 1.0 112.71 159.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 67.2 p-90 -109.68 -9.05 14.87 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.307 -0.871 . . . . 1.3400000000000001 112.691 167.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.406 ' HB3' ' CD2' ' A' ' 119' ' ' HIS . 4.0 mm-40 -96.22 -83.8 0.37 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.992 1.317 . . . . 1.6699999999999999 109.682 -173.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.4 p -72.43 -14.99 61.83 Favored 'General case' 0 CA--C 1.551 0.983 0 O-C-N 120.644 -1.285 . . . . 1.22 112.651 167.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.49 22.64 76.57 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 119.075 -0.847 . . . . 0.76000000000000001 113.725 169.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.476 ' HG ' ' HE1' ' A' ' 141' ' ' TYR . 5.5 p -71.21 130.48 41.55 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 118.388 1.094 . . . . 1.6000000000000001 110.186 170.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.5 t -77.23 147.16 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.451 -0.574 . . . . 1.8200000000000001 109.451 161.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.476 ' HE1' ' HG ' ' A' ' 139' ' ' SER . 83.3 m-85 -131.52 156.61 45.4 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 130.544 3.538 . . . . 3.1600000000000001 110.523 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -140.27 153.2 46.43 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 113.59 0.959 . . . . 3.0899999999999999 113.59 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.2 tt -100.66 144.1 30.03 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 122.042 0.925 . . . . 1.6899999999999999 112.372 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -99.37 162.94 19.64 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.249 1.02 . . . . 1.3100000000000001 112.824 -174.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -75.51 -28.01 8.72 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.606 2.871 . . . . 1.53 113.837 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER 47.88 -161.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 128.032 2.533 . . . . 4.1799999999999997 116.781 169.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.971 0 CA-C-O 122.39 0.994 . . . . 2.0299999999999998 114.863 132.224 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.9 mtm . . . . . 0 N--CA 1.469 0.515 0 CA-C-O 121.902 0.858 . . . . 3.5699999999999998 112.756 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 129.73 -132.0 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.763 1 C-N-CA 132.676 4.39 . . . . 3.96 107.822 -156.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -126.54 91.58 47.15 Favored Pre-proline 0 N--CA 1.436 -1.155 0 C-N-CA 128.882 2.873 . . . . 2.23 107.185 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -95.99 -49.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.373 1 C-N-CA 126.649 4.899 . . . . 0.70999999999999996 112.737 -178.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -150.62 138.48 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 131.5 3.92 . . . . 1.8100000000000001 103.934 -171.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.5 mm -115.48 134.95 57.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 124.635 1.174 . . . . 2.0699999999999998 111.047 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.3 mm -121.97 112.88 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 C-N-CA 126.336 1.854 . . . . 1.7 107.416 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -82.83 136.29 34.68 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 125.023 1.452 . . . . 2.5499999999999998 111.868 -173.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.0 t -125.4 -54.59 1.57 Allowed 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 113.995 1.109 . . . . 2.8300000000000001 113.995 -154.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.538 ' H ' ' CG2' ' A' ' 146' ' ' VAL 0.29 17.0 m-85 73.21 15.54 4.38 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.915 2.086 . . . . 4.2800000000000002 113.336 -172.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -151.57 168.06 26.14 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 131.677 3.991 . . . . 2.6400000000000001 106.986 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -72.28 -8.38 54.54 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.844 1.258 . . . . 2.8900000000000001 113.547 164.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.2 120.18 8.76 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 123.651 1.691 . . . . 3.6299999999999999 115.046 -164.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 81.1 mmt-85 -143.23 177.28 8.52 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.922 2.489 . . . . 5.6500000000000004 110.09 167.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -100.66 172.92 6.79 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.659 -0.651 . . . . 3.6200000000000001 109.822 149.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.0 142.22 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.99 0.916 . . . . 1.8999999999999999 111.206 171.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -107.95 92.92 0.77 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-O 117.688 -1.618 . . . . 0.66000000000000003 113.647 169.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 12.7 p -101.24 148.26 25.32 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 119.788 1.794 . . . . 1.48 113.478 166.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.4 p -113.11 13.0 19.26 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 113.24 -1.8 . . . . 1.7 113.501 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.25 81.12 1.57 Allowed Glycine 0 N--CA 1.463 0.445 0 N-CA-C 110.42 -1.072 . . . . 2.4100000000000001 110.42 -176.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 10.1 p 58.24 -163.28 0.01 OUTLIER Pre-proline 0 CA--C 1.563 1.46 0 CA-C-O 117.106 -1.426 . . . . 3.2799999999999998 111.302 -171.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.08 -6.06 17.53 Favored 'Trans proline' 0 C--N 1.356 0.971 0 CA-C-N 123.321 2.222 . . . . 2.7000000000000002 113.711 173.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -98.66 13.65 31.36 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.01 1.485 . . . . 2.5299999999999998 115.01 -165.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.5 34.26 88.66 Favored Glycine 0 N--CA 1.476 1.32 0 O-C-N 121.15 -0.969 . . . . 1.9299999999999999 113.866 172.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.02 -39.68 83.1 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.066 1.136 . . . . 2.79 114.066 -163.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -113.29 -149.14 0.44 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.239 1.816 . . . . 1.28 112.917 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.6 t -73.41 -153.67 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 119.31 0.959 . . . . 1.98 111.115 162.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.0 tp -117.86 137.83 50.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 126.896 2.078 . . . . 1.8500000000000001 111.499 165.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.463 ' CE ' ' HE1' ' A' ' 135' ' ' TRP . 13.6 mmm -131.66 151.74 51.4 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 115.527 1.676 . . . . 4.8499999999999996 115.527 -172.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -117.01 103.8 10.62 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 124.209 0.943 . . . . 1.9299999999999999 110.515 -174.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.9 mt -111.53 161.91 15.67 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.202 0.601 . . . . 2.04 110.423 -174.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.72 84.62 10.42 Favored Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 114.517 1.303 . . . . 7.0599999999999996 114.517 -171.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -88.63 14.96 2.17 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.59 2.86 . . . . 3.1000000000000001 116.265 -164.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.8 m -29.85 152.78 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 1 C-N-CA 131.804 4.041 . . . . 2.1000000000000001 115.322 -165.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.9 p -47.08 -43.21 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 115.174 1.546 . . . . 2.4300000000000002 115.174 -177.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -78.05 -5.52 51.68 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.795 1.638 . . . . 2.0099999999999998 114.222 178.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -131.79 -177.45 4.43 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 122.758 1.266 . . . . 3.1000000000000001 112.169 -159.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.4 m -148.81 156.1 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 128.591 2.756 . . . . 1.71 106.744 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.22 132.75 28.66 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 122.68 0.392 . . . . 2.1600000000000001 110.803 175.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.6 ttm-85 -86.22 138.19 32.06 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.189 -1.041 . . . . 5.3200000000000003 108.189 168.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 20.7 t -57.67 153.03 14.12 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 124.398 1.061 . . . . 1.23 110.942 153.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.463 ' HE1' ' CE ' ' A' ' 122' ' ' MET . 19.2 p-90 -97.45 -18.63 18.94 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.524 -0.75 . . . . 2.0 111.471 163.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -83.37 -92.31 0.07 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.129 0.971 . . . . 1.6100000000000001 108.804 -177.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 32.1 p -65.59 -15.43 62.72 Favored 'General case' 0 CA--C 1.553 1.07 0 O-C-N 120.559 -1.338 . . . . 1.3600000000000001 114.46 176.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.44 17.82 76.51 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 126.581 2.038 . . . . 0.83999999999999997 115.348 169.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.4 p -77.26 144.66 38.03 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.76 1.28 . . . . 1.5800000000000001 111.762 168.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 57.7 t -80.58 145.29 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.462 -0.57 . . . . 1.8 109.462 162.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -125.15 147.95 48.8 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 129.114 2.966 . . . . 2.9900000000000002 110.56 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.421 ' HG2' ' H ' ' A' ' 143' ' ' LEU . 48.8 tttt -124.4 154.57 40.21 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 123.746 1.736 . . . . 2.7999999999999998 113.186 169.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.421 ' H ' ' HG2' ' A' ' 142' ' ' LYS . 8.0 tt -92.04 156.38 17.44 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.542 1.537 . . . . 2.0099999999999998 110.606 165.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -120.74 139.08 28.41 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 107.434 -1.321 . . . . 1.45 107.434 164.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.3 -30.53 30.31 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.078 2.519 . . . . 2.9700000000000002 111.837 -171.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.538 ' CG2' ' H ' ' A' ' 103' ' ' TYR . 20.3 m 41.41 -157.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 129.001 2.92 . . . . 3.4399999999999999 115.587 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.395 0 C-N-CA 127.299 2.38 . . . . 2.2200000000000002 108.678 159.25 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.1 mtm . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 121.6 0.714 . . . . 3.7999999999999998 112.347 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 151.28 -76.64 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.661 1 C-N-CA 132.927 4.491 . . . . 2.6200000000000001 111.33 -176.478 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.5 t0 177.14 75.64 0.1 Allowed Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 128.373 2.669 . . . . 2.0800000000000001 109.596 -163.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -88.52 -49.68 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.387 1 C-N-CA 127.432 5.421 . . . . 0.72999999999999998 112.551 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -148.06 143.82 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 1 C-N-CA 131.916 4.086 . . . . 1.8500000000000001 104.205 -171.739 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.6 mm -107.85 146.13 14.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 124.67 1.188 . . . . 1.9299999999999999 109.568 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.8 mm -127.38 107.57 16.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 126.603 1.961 . . . . 1.8799999999999999 110.314 167.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.4 mp0 -64.12 124.87 22.75 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 123.125 1.44 . . . . 3.6499999999999999 112.61 175.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.3 t -116.78 -58.31 2.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.774 -1.557 . . . . 2.7400000000000002 114.894 -157.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.509 ' H ' ' CG2' ' A' ' 146' ' ' VAL . 14.5 m-85 64.45 25.53 13.33 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.82 1.248 . . . . 4.4900000000000002 110.636 -168.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -167.4 148.92 5.68 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 128.345 2.658 . . . . 2.21 108.917 -170.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.418 ' HB2' ' CD2' ' A' ' 106' ' ' TYR . 8.5 m-20 -76.93 -25.62 53.12 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.61 -1.306 . . . . 3.1400000000000001 113.097 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.418 ' CD2' ' HB2' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -140.56 14.25 2.35 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.195 1.798 . . . . 3.77 113.991 -150.453 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -60.41 168.3 2.16 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.784 1.234 . . . . 6.7400000000000002 112.536 174.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -106.52 159.32 16.26 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.809 1.04 . . . . 3.6400000000000001 113.809 171.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.53 144.98 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 127.029 2.132 . . . . 1.9099999999999999 109.917 170.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.42 100.89 1.4 Allowed Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.921 -0.933 . . . . 0.97999999999999998 111.993 165.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 1.6 t -86.59 138.47 31.67 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.047 1.339 . . . . 1.6200000000000001 112.591 171.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.9 p -109.34 22.19 16.12 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.061 1.134 . . . . 2.0600000000000001 114.061 170.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.87 55.77 0.92 Allowed Glycine 0 N--CA 1.462 0.391 0 O-C-N 120.806 -1.184 . . . . 1.8999999999999999 110.779 -175.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 65.43 -168.04 0.01 OUTLIER Pre-proline 0 CA--C 1.566 1.577 0 CA-C-O 117.799 -1.096 . . . . 5.1600000000000001 110.886 -173.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.41 6.1 5.02 Favored 'Trans proline' 0 C--N 1.355 0.899 0 CA-C-N 123.507 2.288 . . . . 2.8599999999999999 114.885 -169.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.31 13.2 13.6 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.553 1.316 . . . . 2.8399999999999999 114.553 -166.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 64.46 61.33 6.06 Favored Glycine 0 N--CA 1.473 1.139 0 CA-C-N 118.844 0.747 . . . . 1.6899999999999999 112.956 169.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 39.7 m -100.26 -26.43 13.91 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.73 1.381 . . . . 2.3900000000000001 114.73 -169.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.474 ' CE1' ' SD ' ' A' ' 122' ' ' MET . 30.3 p80 -131.59 -158.53 0.9 Allowed 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 119.671 1.123 . . . . 1.5800000000000001 111.1 168.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.8 t -75.55 -152.97 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 O-C-N 121.088 -1.008 . . . . 2.0299999999999998 111.145 169.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.405 ' C ' ' SD ' ' A' ' 122' ' ' MET . 4.9 tp -112.6 131.3 64.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 117.72 2.489 . . . . 2.0899999999999999 117.72 -178.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.474 ' SD ' ' CE1' ' A' ' 119' ' ' HIS . 0.0 OUTLIER -132.46 126.52 33.21 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 128.745 2.818 . . . . 6.3700000000000001 114.532 -169.339 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -106.98 114.18 28.11 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.299 1.04 . . . . 2.5899999999999999 111.518 -167.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 mt -120.11 157.47 28.9 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.965 0.802 . . . . 1.96 111.231 -171.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -118.49 92.96 44.76 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.249 1.42 . . . . 6.5099999999999998 111.313 172.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -88.46 30.4 0.43 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.062 3.175 . . . . 3.46 114.383 -171.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.5 m -23.43 154.86 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 1 C-N-CA 133.829 4.852 . . . . 2.1099999999999999 117.863 -162.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.5 p -51.34 -33.99 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 120.061 -1.649 . . . . 1.8899999999999999 113.633 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -90.16 -6.0 55.84 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.276 1.83 . . . . 2.2200000000000002 114.077 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -138.05 -160.55 1.07 Allowed 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.87 0.868 . . . . 2.27 110.728 -159.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.3 m -156.98 160.31 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 131.179 3.792 . . . . 1.55 106.277 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -143.98 132.49 22.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 118.89 0.768 . . . . 1.78 111.092 174.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -90.72 129.63 36.8 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.447 0.699 . . . . 4.2699999999999996 109.128 170.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 34.1 t -55.32 140.99 37.58 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 123.955 0.784 . . . . 1.27 110.34 155.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -81.2 -14.58 57.4 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.552 -0.737 . . . . 1.48 112.534 171.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.451 ' HG3' ' SD ' ' A' ' 122' ' ' MET . 0.5 OUTLIER -96.38 -91.17 0.24 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.635 1.174 . . . . 1.77 109.239 -169.163 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 19.0 p -58.99 -25.68 63.84 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.9 -1.125 . . . . 1.1699999999999999 112.756 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.81 25.94 73.84 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.346 0.974 . . . . 1.1000000000000001 113.139 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.3 p -69.61 125.15 25.84 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 119.215 1.508 . . . . 1.79 109.749 159.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.9 t -79.18 147.37 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 107.156 -1.424 . . . . 1.9399999999999999 107.156 161.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -132.91 154.23 50.62 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 128.973 2.909 . . . . 3.8100000000000001 110.094 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -137.52 162.46 33.67 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.299 1.047 . . . . 3.4199999999999999 113.323 175.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.1 tt -113.0 144.69 42.14 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.469 1.128 . . . . 1.8999999999999999 113.234 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -111.87 144.29 30.38 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-N 114.291 -1.322 . . . . 1.3400000000000001 109.546 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -67.2 -28.1 40.75 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.832 2.355 . . . . 2.0699999999999998 112.009 -175.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.509 ' CG2' ' H ' ' A' ' 103' ' ' TYR . 22.1 m 42.12 -157.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 128.027 2.531 . . . . 3.2400000000000002 114.965 -173.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.925 0 C-N-CA 124.999 1.285 . . . . 2.29 110.794 139.331 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 33.1 mtp . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 117.754 2.501 . . . . 3.9500000000000002 117.754 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.14 -63.26 1.15 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.29 1.036 . . . . 2.8799999999999999 113.165 171.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.8 t0 163.55 77.38 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 128.502 2.721 . . . . 2.5099999999999998 110.173 -157.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -89.33 -50.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.411 1 C-N-CA 126.846 5.03 . . . . 0.81000000000000005 113.078 -174.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -154.77 142.4 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 1 C-N-CA 132.019 4.127 . . . . 1.79 104.585 -168.584 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.8 mm -118.3 137.74 51.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 123.985 0.914 . . . . 1.8200000000000001 112.129 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.8 mm -129.2 112.9 26.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 127.29 2.236 . . . . 1.9399999999999999 109.002 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.69 124.98 25.37 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.758 1.623 . . . . 2.46 112.193 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.3 t -145.17 90.51 2.04 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 115.792 1.775 . . . . 2.98 115.792 -167.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -77.25 64.1 2.59 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.561 1.144 . . . . 4.9699999999999998 110.672 174.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.41 -13.32 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.68 2.392 . . . . 3.2000000000000002 113.477 -167.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 64.82 -7.93 0.24 Allowed 'General case' 0 CA--C 1.56 1.349 0 CA-C-N 120.74 1.609 . . . . 3.0600000000000001 115.072 -170.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -152.34 24.13 0.62 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 116.928 2.196 . . . . 3.8999999999999999 116.928 -172.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -54.82 149.89 10.67 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 120.572 1.533 . . . . 4.9800000000000004 113.079 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -77.11 161.59 28.14 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.516 -0.74 . . . . 3.6699999999999999 112.18 163.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.1 p -113.76 145.66 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 126.586 1.954 . . . . 1.8200000000000001 111.511 175.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.67 113.27 4.67 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.424 1.011 . . . . 1.29 112.043 162.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 7.4 t -110.63 128.57 55.74 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.408 1.483 . . . . 1.8200000000000001 113.239 174.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 32.9 p -110.54 34.36 4.0 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.546 1.313 . . . . 1.8300000000000001 114.546 167.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.17 -31.74 3.69 Favored Glycine 0 N--CA 1.473 1.167 0 O-C-N 118.984 -2.322 . . . . 2.04 114.806 173.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.0 p 176.07 177.46 0.22 Allowed Pre-proline 0 CA--C 1.556 1.19 1 C-N-CA 132.468 4.307 . . . . 4.0999999999999996 106.67 -175.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.48 -15.02 47.61 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 121.721 1.614 . . . . 2.9900000000000002 113.302 167.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -101.85 55.43 0.81 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.935 1.694 . . . . 3.2999999999999998 111.55 177.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 55.31 20.81 23.8 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 118.061 1.984 . . . . 2.3700000000000001 118.061 154.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.3 m -71.17 -26.68 63.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 115.302 1.593 . . . . 2.3599999999999999 115.302 -140.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -108.0 -25.44 11.16 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 117.234 2.309 . . . . 2.79 117.234 169.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.319 4.8 t 121.12 -152.58 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 131.559 3.944 . . . . 2.8700000000000001 108.563 -145.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.8 tp -130.15 142.74 43.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 130.463 3.505 . . . . 2.5899999999999999 112.383 -175.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.419 ' CE ' ' HE1' ' A' ' 135' ' ' TRP . 19.1 mmm -135.01 159.4 41.63 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 126.652 1.981 . . . . 4.7199999999999998 116.093 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.413 ' H ' ' HE2' ' A' ' 122' ' ' MET . 6.3 m95 -126.79 113.88 17.21 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.693 0.797 . . . . 2.3700000000000001 110.222 177.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 mt -122.65 159.68 27.37 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.099 0.959 . . . . 2.04 109.681 -171.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.16 80.92 70.88 Favored Pre-proline 0 N--CA 1.477 0.918 0 O-C-N 120.758 -1.214 . . . . 5.6799999999999997 113.171 -166.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.08 177.59 8.69 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.201 2.601 . . . . 2.5699999999999998 110.822 170.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.0 m -151.94 159.59 43.75 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.883 2.073 . . . . 1.6200000000000001 107.972 -177.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.6 p -53.19 -42.36 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.514 1.126 . . . . 2.3399999999999999 113.583 -172.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -77.75 -2.08 34.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.944 1.298 . . . . 1.8300000000000001 113.633 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -140.82 -172.05 3.38 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 122.227 1.013 . . . . 2.3500000000000001 112.881 -150.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.9 m -153.27 161.11 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 128.102 2.561 . . . . 1.8200000000000001 107.841 -175.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.7 130.63 24.56 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.598 1.159 . . . . 1.6100000000000001 110.884 175.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -91.55 134.59 34.53 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.136 0.88 . . . . 6.0199999999999996 109.481 171.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 24.4 t -55.64 155.2 5.88 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.99 0.916 . . . . 0.94999999999999996 111.515 162.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.419 ' HE1' ' CE ' ' A' ' 122' ' ' MET . 30.1 p-90 -89.71 -17.05 29.06 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.184 -0.948 . . . . 1.3999999999999999 111.944 166.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -89.25 -101.54 0.09 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.627 1.171 . . . . 2.2200000000000002 109.892 -175.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 27.9 p -60.57 -9.6 4.0 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 119.169 -2.207 . . . . 1.24 116.144 -178.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.37 26.83 64.68 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 127.574 2.511 . . . . 0.77000000000000002 113.836 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.26 150.48 48.21 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.768 1.784 . . . . 1.5700000000000001 109.853 161.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 69.1 t -100.54 141.11 17.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 N-CA-C 104.945 -2.243 . . . . 1.8600000000000001 104.945 169.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -123.34 139.63 53.84 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 126.877 2.071 . . . . 3.5299999999999998 110.057 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.7 tttt -121.49 145.85 47.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.233 1.016 . . . . 3.73 112.173 -175.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.9 tt -103.76 152.69 21.56 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.194 -1.366 . . . . 2.2599999999999998 110.208 175.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -111.9 154.61 44.07 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 114.022 -1.444 . . . . 1.45 112.317 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -71.62 -3.62 13.44 Favored 'Trans proline' 0 N--CA 1.482 0.838 1 C-N-CA 126.219 4.613 . . . . 1.6200000000000001 115.68 -175.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.5 p -42.97 138.65 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 127.299 2.24 . . . . 2.7799999999999998 112.026 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 122.245 0.914 . . . . 2.7599999999999998 110.959 -171.953 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.8 mtm . . . . . 0 N--CA 1.467 0.413 0 N-CA-C 116.715 2.117 . . . . 3.1200000000000001 116.715 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.84 -117.81 0.32 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.488 -1.671 . . . . 3.9300000000000002 106.488 160.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . 0.312 38.8 t70 -129.1 82.68 68.0 Favored Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 126.217 1.807 . . . . 2.6499999999999999 106.262 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -87.56 -47.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.789 1 C-N-CA 128.089 5.859 . . . . 0.76000000000000001 113.489 -171.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 mm -146.91 141.47 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 131.247 3.819 . . . . 1.8500000000000001 103.269 -171.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.1 mm -108.98 140.89 25.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 C-N-CA 124.81 1.244 . . . . 1.79 110.052 -175.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.7 mm -130.63 109.59 17.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 126.513 1.925 . . . . 1.6299999999999999 110.008 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.0 mp0 -63.82 136.92 57.79 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.709 1.604 . . . . 4.1900000000000004 112.863 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.0 t -165.67 133.88 3.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.752 -1.113 . . . . 2.7999999999999998 110.207 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 -86.99 -4.15 59.15 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 118.854 0.752 . . . . 4.1399999999999997 110.922 166.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -95.59 156.66 16.23 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.596 1.959 . . . . 2.4500000000000002 110.652 168.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -73.45 -24.38 60.22 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.903 1.681 . . . . 3.96 113.371 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -134.71 2.21 3.15 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.418 1.636 . . . . 3.7200000000000002 115.418 -164.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.68 132.19 6.5 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.544 1.537 . . . . 8.2799999999999994 113.118 -177.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -78.35 152.26 32.43 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.029 1.122 . . . . 3.75 114.029 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.0 p -101.5 144.2 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.378 1.471 . . . . 1.77 111.775 175.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.06 89.65 0.77 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.849 1.69 . . . . 0.76000000000000001 113.737 163.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 3.7 p -99.22 143.55 29.36 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 119.602 1.701 . . . . 1.54 112.156 168.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 62.9 p -114.73 23.98 12.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.214 -1.357 . . . . 1.97 111.84 174.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.53 -168.45 14.66 Favored Glycine 0 CA--C 1.503 -0.681 0 CA-C-O 124.098 1.943 . . . . 2.4399999999999999 114.025 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -37.21 139.02 0.53 Allowed Pre-proline 0 CA--C 1.549 0.924 0 CA-C-N 110.853 -2.674 . . . . 4.4100000000000001 111.453 151.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.98 -13.6 28.27 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.884 3.723 . . . . 3.3599999999999999 116.913 -155.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -85.82 6.34 28.57 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.758 1.021 . . . . 3.52 113.758 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.33 82.22 0.76 Allowed Glycine 0 C--N 1.34 0.758 0 N-CA-C 110.114 -1.194 . . . . 1.8 110.114 -176.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.88 -64.51 1.16 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.635 0.731 . . . . 2.8999999999999999 111.346 178.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -100.56 -153.54 0.45 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.335 0.865 . . . . 1.74 113.335 -164.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.8 t -70.2 -154.32 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 123.606 0.762 . . . . 2.48 109.355 161.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.2 tp -116.3 140.96 36.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 C-N-CA 127.072 2.149 . . . . 2.5800000000000001 109.827 168.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 13.6 mmm -126.35 159.42 33.26 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 114.099 1.148 . . . . 5.0199999999999996 114.099 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -125.09 67.25 1.12 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.025 0.75 . . . . 1.9399999999999999 113.025 -167.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.7 mt -87.67 157.86 18.98 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.254 -0.904 . . . . 1.74 109.572 -165.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -127.43 77.58 75.65 Favored Pre-proline 0 N--CA 1.48 1.051 0 CA-C-N 119.753 1.161 . . . . 7.9000000000000004 111.429 -166.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -89.23 33.96 0.37 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.522 3.482 . . . . 3.3599999999999999 116.318 -156.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -15.25 144.16 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.287 1 C-N-CA 133.234 4.614 . . . . 2.0 117.527 -166.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.1 p -56.14 -32.79 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 120.491 -1.381 . . . . 2.02 111.477 174.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -78.46 -11.25 59.94 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.543 1.937 . . . . 2.3799999999999999 114.456 174.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -143.19 -141.38 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.409 1.083 . . . . 1.98 111.284 -164.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.8 m -162.19 167.81 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 1 C-N-CA 134.029 4.932 . . . . 1.8100000000000001 106.504 -176.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -148.96 142.9 25.77 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.322 0.965 . . . . 1.8600000000000001 111.713 163.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -100.94 142.6 32.19 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.438 0.695 . . . . 6.3099999999999996 111.569 177.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 15.7 t -63.58 154.53 32.39 Favored 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 124.586 1.179 . . . . 1.1699999999999999 111.15 161.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 17.8 p-90 -100.56 -19.94 15.92 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.814 -1.084 . . . . 1.6599999999999999 111.463 163.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -81.5 -87.64 0.09 Allowed 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 107.555 -1.276 . . . . 1.79 107.555 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 27.4 p -72.1 -12.25 61.12 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 114.671 1.36 . . . . 1.1499999999999999 114.671 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.33 6.45 83.66 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.887 1.232 . . . . 1.24 114.688 168.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.5 p -69.28 137.43 53.04 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.051 1.74 . . . . 1.76 110.167 173.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 62.0 t -80.19 148.92 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 108.866 -0.79 . . . . 2.0099999999999998 108.866 159.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -128.47 154.41 46.12 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 129.316 3.046 . . . . 3.0800000000000001 109.724 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -137.53 157.39 46.65 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.129 0.966 . . . . 3.5600000000000001 112.535 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.2 tt -111.39 146.5 37.04 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 123.136 1.446 . . . . 2.0899999999999999 112.185 -178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -99.83 153.72 37.62 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 114.085 -1.416 . . . . 1.3400000000000001 113.585 -170.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.85 -4.85 15.59 Favored 'Trans proline' 0 C--N 1.348 0.535 1 C-N-CA 125.398 4.065 . . . . 1.51 114.984 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.9 p -43.5 142.56 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 126.766 2.027 . . . . 2.7599999999999998 112.086 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.832 0 CA-C-O 123.474 1.597 . . . . 1.5900000000000001 112.494 -177.036 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 19.2 mtt . . . . . 0 C--O 1.224 -0.288 0 N-CA-C 118.69 2.848 . . . . 3.1200000000000001 118.69 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -61.72 2.11 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.541 0.941 . . . . 2.8199999999999998 113.541 171.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.402 ' N ' ' HD3' ' A' ' 97' ' ' PRO . 0.0 OUTLIER 173.38 72.09 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 128.389 2.676 . . . . 4.5999999999999996 110.213 -150.129 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 96' ' ' ASP . 93.6 Cg_endo -96.48 -48.55 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 125.245 3.964 . . . . 0.93000000000000005 113.535 -175.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -158.55 145.51 8.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 1 C-N-CA 132.353 4.261 . . . . 1.6299999999999999 104.556 -167.326 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.5 mm -118.09 139.12 46.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 124.344 1.057 . . . . 1.6899999999999999 110.303 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.4 mm -128.39 147.18 32.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 127.067 2.147 . . . . 1.8799999999999999 106.877 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -109.64 170.15 8.25 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.579 1.152 . . . . 2.6800000000000002 110.913 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.2 t -159.2 -43.78 0.06 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.981 1.104 . . . . 3.4700000000000002 113.981 -176.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 65.61 37.88 5.69 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 124.515 1.135 . . . . 3.3199999999999998 110.117 -171.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -143.14 -84.78 0.16 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.931 2.092 . . . . 3.29 108.855 172.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t70 175.3 -39.54 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 129.293 3.037 . . . . 3.8399999999999999 109.721 -177.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -116.61 -52.38 2.56 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.012 1.486 . . . . 4.2400000000000002 115.012 -167.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 7.39 -113.37 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 129.722 3.209 . . . . 6.0899999999999999 114.648 -162.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -163.17 160.5 24.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.084 1.354 . . . . 3.4500000000000002 111.848 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.8 p -112.39 137.56 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.214 1.406 . . . . 1.8799999999999999 109.791 166.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.08 87.45 0.45 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.215 1.388 . . . . 0.88 111.915 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 7.9 p -97.74 146.34 25.46 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 123.721 1.725 . . . . 1.3200000000000001 112.999 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 56.9 p -112.2 15.62 20.39 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 112.85 -1.977 . . . . 1.8799999999999999 112.346 171.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.93 -130.54 8.08 Favored Glycine 0 C--N 1.337 0.596 0 O-C-N 120.939 -1.1 . . . . 3.1000000000000001 111.611 -171.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.56 -52.5 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 116.07 -1.919 . . . . 4.5899999999999999 113.728 -171.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -80.26 52.8 4.47 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.307 2.005 . . . . 7.9400000000000004 109.598 166.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 66.88 99.04 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.231 1.812 . . . . 4.4800000000000004 114.331 168.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 63.91 31.27 80.26 Favored Glycine 0 N--CA 1.476 1.346 0 O-C-N 120.391 -1.443 . . . . 2.0099999999999998 113.514 173.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -45.49 90.84 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.246 1.418 . . . . 2.2200000000000002 112.458 -168.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.451 ' CE1' ' SD ' ' A' ' 122' ' ' MET . 34.3 p80 -108.18 -142.31 0.38 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.768 1.627 . . . . 1.49 111.439 177.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.7 t -89.13 -141.68 0.14 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.404 1.081 . . . . 1.8100000000000001 109.273 163.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.9 tp -122.07 132.88 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 128.545 2.738 . . . . 2.0699999999999998 116.603 173.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.451 ' SD ' ' CE1' ' A' ' 119' ' ' HIS . 0.0 OUTLIER -127.69 149.02 50.4 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 129.462 3.105 . . . . 6.2999999999999998 112.814 -174.513 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -127.98 119.89 26.44 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.91 0.884 . . . . 2.1899999999999999 110.267 -174.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.57 163.18 23.97 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.834 0.854 . . . . 2.2400000000000002 110.651 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.475 ' HZ2' ' CD ' ' A' ' 130' ' ' GLU . 0.8 OUTLIER -110.4 90.0 9.53 Favored Pre-proline 0 N--CA 1.483 1.215 0 C-N-CA 124.382 1.073 . . . . 6.7300000000000004 111.793 176.274 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -76.53 -45.13 0.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 CA-C-O 116.854 -1.394 . . . . 3.1499999999999999 112.866 -169.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 68.56 145.08 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 130.372 3.469 . . . . 2.4100000000000001 110.91 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.01 -40.34 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.759 0.79 . . . . 2.5600000000000001 109.919 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -66.74 -20.73 66.02 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 126.541 1.936 . . . . 2.2599999999999998 113.336 172.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.475 ' CD ' ' HZ2' ' A' ' 125' ' ' LYS . 30.5 mt-10 -135.36 -160.27 1.04 Allowed 'General case' 0 C--N 1.342 0.253 0 CA-C-N 120.583 1.538 . . . . 2.98 110.815 -164.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.2 m -147.44 155.95 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 127.699 2.4 . . . . 1.6200000000000001 107.834 176.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.6 137.23 33.52 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.242 0.617 . . . . 1.78 111.33 170.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.2 ttp85 -98.14 138.48 35.37 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.868 0.304 . . . . 5.2999999999999998 110.774 172.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 49.6 t -61.37 156.38 19.16 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 123.045 1.402 . . . . 1.1000000000000001 111.465 160.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -98.78 -15.98 19.09 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.118 -1.401 . . . . 1.4099999999999999 112.521 169.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.424 ' HG3' ' SD ' ' A' ' 122' ' ' MET . 0.1 OUTLIER -98.65 -85.03 0.39 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.091 2.156 . . . . 1.6200000000000001 109.787 -168.262 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 29.5 p -67.35 -19.71 65.47 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 120.823 1.647 . . . . 1.28 112.797 170.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.44 16.72 80.46 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.022 0.82 . . . . 0.70999999999999996 113.786 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.98 143.92 57.08 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 119.681 1.741 . . . . 1.9399999999999999 111.453 171.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 59.6 t -92.35 136.9 23.44 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 N-CA-C 105.656 -1.979 . . . . 1.77 105.656 161.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -120.03 137.97 53.79 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 126.356 1.863 . . . . 2.9700000000000002 109.209 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -106.12 150.56 25.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 123.542 0.527 . . . . 2.6699999999999999 110.103 164.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.617 HD23 ' H ' ' A' ' 144' ' ' ASN . 0.5 OUTLIER -85.7 -171.5 3.63 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 122.309 1.052 . . . . 3.5099999999999998 108.88 158.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.617 ' H ' HD23 ' A' ' 143' ' ' LEU . 1.1 t-20 -143.93 169.09 10.97 Favored Pre-proline 0 C--N 1.318 -0.799 0 C-N-CA 126.767 2.027 . . . . 4.2599999999999998 109.709 -174.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -89.6 1.28 5.72 Favored 'Trans proline' 0 N--CA 1.46 -0.482 1 C-N-CA 125.466 4.11 . . . . 1.8999999999999999 114.576 -165.595 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.5 p -40.78 142.58 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 1 C-N-CA 132.022 4.129 . . . . 3.0099999999999998 113.56 175.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.861 0 C-N-CA 128.101 2.762 . . . . 1.8500000000000001 108.926 -166.982 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.2 mtm . . . . . 0 N--CA 1.467 0.385 0 N-CA-C 119.416 3.117 . . . . 2.8700000000000001 119.416 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.59 -62.17 1.55 Allowed 'General case' 0 C--N 1.316 -0.849 0 O-C-N 121.896 -0.502 . . . . 3.29 111.43 167.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.8 t70 168.02 66.54 0.01 OUTLIER Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 130.032 3.333 . . . . 2.73 108.659 -163.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.431 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 51.5 Cg_endo -80.08 -71.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 1 C-N-CA 128.21 5.94 . . . . 1.0 113.562 -168.596 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.431 ' H ' ' HG2' ' A' ' 97' ' ' PRO . 0.6 OUTLIER -112.37 145.87 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 130.876 3.67 . . . . 2.0600000000000001 104.473 174.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.7 mm -106.74 143.19 17.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 124.016 0.927 . . . . 1.76 111.044 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.9 mm -125.75 114.13 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 126.761 2.024 . . . . 1.8999999999999999 109.021 167.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -66.21 138.41 57.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.938 1.351 . . . . 3.71 112.249 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.4 t -160.63 118.1 2.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.097 -0.956 . . . . 3.1099999999999999 111.723 -169.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -87.74 10.0 19.77 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 118.44 0.564 . . . . 3.6299999999999999 112.088 167.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -105.66 -60.26 1.65 Allowed 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.755 1.622 . . . . 3.0699999999999998 113.162 -172.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.7 t0 119.92 -48.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 1 C-N-CA 133.55 4.74 . . . . 4.2300000000000004 109.01 -167.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.85 -3.59 59.08 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 119.906 -1.746 . . . . 3.6200000000000001 113.629 -168.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -52.25 121.75 7.44 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.846 1.658 . . . . 4.9400000000000004 113.102 -163.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -82.36 164.23 21.2 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 114.555 1.317 . . . . 3.3100000000000001 114.555 -168.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.8 t -97.98 137.43 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.543 1.937 . . . . 3.3300000000000001 112.093 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -115.27 69.35 0.26 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.952 1.263 . . . . 1.1699999999999999 111.995 164.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 4.2 t -82.53 133.92 35.19 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.994 0.918 . . . . 1.72 111.679 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 57.3 p -113.18 25.95 10.9 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.495 1.118 . . . . 1.8600000000000001 113.636 168.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.43 66.57 1.46 Allowed Glycine 0 N--CA 1.462 0.431 0 O-C-N 120.822 -1.174 . . . . 2.3999999999999999 110.793 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 68.73 174.03 0.08 OUTLIER Pre-proline 0 CA--C 1.563 1.442 0 C-N-CA 123.464 0.705 . . . . 3.4199999999999999 110.856 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.7 -8.71 22.89 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 121.881 1.72 . . . . 2.5800000000000001 114.704 -169.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.56 4.73 46.0 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.355 1.243 . . . . 2.3500000000000001 114.355 -173.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.73 81.37 0.37 Allowed Glycine 0 N--CA 1.471 1.006 0 C-N-CA 125.12 1.343 . . . . 1.6599999999999999 112.465 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.6 m -102.33 -35.91 8.65 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.413 1.264 . . . . 2.29 114.413 -174.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.404 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 6.6 p80 -122.98 -153.71 0.57 Allowed 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.611 -0.681 . . . . 1.3600000000000001 111.935 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.5 t -72.25 -154.51 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 119.423 1.01 . . . . 1.98 111.415 168.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.3 tp -108.96 146.81 14.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 126.711 2.004 . . . . 2.1000000000000001 109.816 163.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.413 ' HE1' ' H ' ' A' ' 135' ' ' TRP . 4.7 ppp? -154.76 163.5 40.16 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.189 0.811 . . . . 4.5700000000000003 113.189 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -127.8 126.92 42.63 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.601 0.963 . . . . 1.8899999999999999 113.601 -162.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.6 mt -131.92 158.35 41.62 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.553 1.141 . . . . 1.95 111.535 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.43 83.1 16.07 Favored Pre-proline 0 CA--C 1.561 1.399 0 C-N-CA 125.976 1.71 . . . . 7.0700000000000003 112.272 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -82.35 27.01 0.61 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.936 3.757 . . . . 3.27 115.704 -165.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -20.32 148.84 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 1 C-N-CA 133.169 4.588 . . . . 1.99 116.901 -163.479 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.0 p -59.15 -32.75 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 O-C-N 120.418 -1.426 . . . . 1.9199999999999999 111.124 175.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -73.35 -12.27 60.77 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 128.407 2.683 . . . . 2.29 113.977 174.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -144.61 -146.66 0.19 Allowed 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 123.761 0.824 . . . . 2.25 111.561 -161.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.0 m -159.32 170.79 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.67 1 C-N-CA 134.29 5.036 . . . . 1.8600000000000001 106.133 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -146.6 143.6 28.95 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.32 -0.862 . . . . 1.74 112.21 164.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.3 ttm-85 -100.55 136.66 40.08 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.632 1.573 . . . . 6.8799999999999999 110.045 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 52.3 t -68.29 167.32 14.66 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 122.475 1.131 . . . . 1.1299999999999999 112.945 161.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.413 ' H ' ' HE1' ' A' ' 122' ' ' MET . 46.5 p-90 -122.46 -12.24 8.21 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.449 1.5 . . . . 1.49 112.155 171.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.404 ' HB3' ' CD2' ' A' ' 119' ' ' HIS . 4.1 mm-40 -94.93 -61.73 1.44 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.685 0.794 . . . . 2.02 110.624 -174.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 29.9 p -95.12 -15.77 23.11 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.961 1.304 . . . . 1.0800000000000001 112.63 166.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.43 16.76 78.83 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 120.896 -1.127 . . . . 0.93000000000000005 114.341 174.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.488 ' HG ' ' HE1' ' A' ' 141' ' ' TYR . 7.7 p -68.32 126.73 30.5 Favored 'General case' 0 C--N 1.335 -0.041 0 CA-C-N 119.76 1.78 . . . . 1.5800000000000001 109.642 173.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.73 147.03 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 119.657 -0.817 . . . . 1.9099999999999999 109.079 161.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.488 ' HE1' ' HG ' ' A' ' 139' ' ' SER . 81.3 m-85 -128.0 152.71 47.59 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 130.097 3.359 . . . . 3.6000000000000001 110.41 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -140.4 157.74 45.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 122.257 1.027 . . . . 3.4399999999999999 113.203 174.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.3 tt -114.39 143.67 44.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 122.763 1.268 . . . . 1.72 113.085 -175.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -98.75 155.82 36.28 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-N 114.18 -1.373 . . . . 1.3 112.046 -170.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.1 -4.02 14.59 Favored 'Trans proline' 0 C--N 1.352 0.753 1 C-N-CA 125.904 4.403 . . . . 1.51 115.428 -174.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.3 p -40.94 148.61 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 128.433 2.693 . . . . 3.1699999999999999 113.736 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.545 0 O-C-N 120.809 -1.182 . . . . 1.5700000000000001 110.722 175.494 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.4 mtm . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 118.229 2.678 . . . . 2.8999999999999999 118.229 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.23 -123.9 0.06 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.741 1.258 . . . . 3.5 108.363 157.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -120.61 90.02 45.4 Favored Pre-proline 0 N--CA 1.433 -1.304 0 C-N-CA 129.222 3.009 . . . . 2.48 107.658 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -90.45 -42.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.26 1 C-N-CA 127.174 5.249 . . . . 1.03 112.352 -178.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 mm -155.68 140.16 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 130.462 3.505 . . . . 2.21 104.341 -168.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.2 mm -108.22 136.27 44.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 124.68 1.192 . . . . 1.8999999999999999 109.48 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.7 mm -130.7 112.28 22.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 127.836 2.454 . . . . 1.72 107.043 176.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -64.94 172.85 2.62 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 125.432 1.707 . . . . 3.1800000000000002 110.345 171.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 98.7 p -157.84 -57.17 0.08 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.039 -0.982 . . . . 2.9900000000000002 113.471 -166.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.414 ' H ' ' CG2' ' A' ' 146' ' ' VAL . 12.7 m-85 64.27 27.0 13.81 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 126.742 2.017 . . . . 4.29 110.825 -165.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -169.05 160.68 10.08 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 129.489 3.115 . . . . 3.6699999999999999 110.409 -174.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -83.3 3.94 29.29 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 115.422 1.638 . . . . 2.9700000000000002 115.422 -171.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -162.5 35.28 0.11 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 114.781 1.401 . . . . 3.3500000000000001 114.781 -158.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -79.99 -164.99 0.75 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.043 1.337 . . . . 6.4199999999999999 113.465 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -140.73 157.88 44.78 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.245 1.202 . . . . 3.25 114.245 -172.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.1 p -120.22 149.22 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.989 2.116 . . . . 2.0899999999999999 110.916 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.52 122.01 5.22 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 118.964 -0.909 . . . . 0.81000000000000005 112.88 157.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 15.0 p -114.32 152.48 31.35 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 123.191 1.472 . . . . 1.76 113.679 169.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 50.2 p -107.15 38.85 2.01 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 113.247 -1.797 . . . . 1.99 111.629 170.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.13 22.55 14.89 Favored Glycine 0 C--O 1.226 -0.356 0 CA-C-O 118.802 -0.999 . . . . 1.8100000000000001 113.969 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.8 p 89.24 175.09 0.04 OUTLIER Pre-proline 0 N--CA 1.483 1.22 0 C-N-CA 127.409 2.284 . . . . 3.4300000000000002 109.844 -151.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.53 -19.85 61.45 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.08 2.52 . . . . 3.48 114.617 167.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -84.67 52.7 2.46 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.564 1.074 . . . . 4.0899999999999999 112.324 178.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 38.44 59.14 1.61 Allowed Glycine 0 N--CA 1.472 1.076 0 C-N-CA 126.171 1.844 . . . . 2.7599999999999998 116.022 154.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.7 m -115.12 -19.47 10.84 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.605 1.335 . . . . 2.3700000000000001 114.605 -166.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.51 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 14.0 p80 -148.03 -158.81 0.95 Allowed 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 120.374 1.443 . . . . 1.72 114.151 171.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.2 t -66.09 -164.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.06 1.344 . . . . 1.75 111.193 169.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.9 tp -103.06 145.36 12.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 O-C-N 120.454 -1.403 . . . . 2.2400000000000002 110.625 165.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.533 ' HE2' ' H ' ' A' ' 135' ' ' TRP . 3.4 ppp? -150.66 172.71 15.12 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.081 1.752 . . . . 4.71 110.277 176.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -138.98 128.96 25.1 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.311 0.856 . . . . 2.2999999999999998 113.311 -169.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.8 mt -126.0 153.08 44.87 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.989 0.916 . . . . 1.8600000000000001 110.822 -171.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -124.39 101.22 34.52 Favored Pre-proline 0 N--CA 1.477 0.878 0 CA-C-O 118.219 -0.895 . . . . 6.0300000000000002 112.434 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -80.82 169.59 16.39 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.603 2.202 . . . . 2.3500000000000001 110.223 162.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -123.88 156.09 36.89 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.939 2.096 . . . . 2.3799999999999999 107.886 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.6 p -51.16 -35.9 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 O-C-N 120.582 -1.324 . . . . 2.3399999999999999 113.862 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -89.34 -1.83 58.21 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.176 1.176 . . . . 2.0699999999999998 114.176 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -145.03 176.3 9.6 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 123.109 1.433 . . . . 2.7000000000000002 114.472 -158.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.6 m -125.07 154.57 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 128.408 2.683 . . . . 1.5700000000000001 109.648 -172.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -132.79 139.41 47.51 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.55 1.14 . . . . 1.8500000000000001 110.674 173.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.1 ttp-105 -111.95 142.89 43.79 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.358 0.526 . . . . 6.0700000000000003 111.7 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 42.2 t -60.64 157.57 14.25 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 122.77 1.271 . . . . 0.97999999999999998 113.431 167.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.533 ' H ' ' HE2' ' A' ' 122' ' ' MET . 49.7 p-90 -107.44 -14.29 14.89 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.005 1.322 . . . . 1.52 112.055 168.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.51 ' HB3' ' CD2' ' A' ' 119' ' ' HIS . 0.1 OUTLIER -92.29 -67.85 0.83 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.726 1.21 . . . . 1.6899999999999999 110.376 -175.785 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 26.6 p -91.19 -12.71 34.55 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 126.338 1.855 . . . . 1.0800000000000001 114.095 172.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.43 12.51 69.75 Favored Glycine 0 CA--C 1.532 1.108 0 O-C-N 121.069 -1.019 . . . . 0.72999999999999998 115.267 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.4 p -73.31 134.86 44.29 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.86 2.33 . . . . 1.55 111.394 174.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.2 t -75.84 150.18 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 109.922 -0.399 . . . . 1.9199999999999999 109.922 165.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -138.59 142.17 39.19 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 130.49 3.516 . . . . 3.7000000000000002 109.073 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -127.75 153.38 46.61 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 113.224 0.824 . . . . 3.3199999999999998 113.224 -174.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.14 137.58 34.01 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.465 0.542 . . . . 2.2799999999999998 112.465 176.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 37.2 p-10 -105.31 150.18 38.59 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 108.416 -0.957 . . . . 1.52 108.416 166.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.43 -31.5 21.88 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.038 2.492 . . . . 2.3500000000000001 113.294 -172.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.414 ' CG2' ' H ' ' A' ' 103' ' ' TYR 0.266 3.5 m 47.05 -165.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 129.54 3.136 . . . . 3.7599999999999998 116.85 -179.369 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.616 0 C-N-CA 125.414 1.483 . . . . 2.46 111.614 168.217 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 9.4 mtm . . . . . 0 C--O 1.224 -0.269 0 N-CA-C 119.198 3.036 . . . . 2.9900000000000002 119.198 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -62.12 1.77 Allowed 'General case' 0 C--N 1.32 -0.699 0 O-C-N 121.993 -0.442 . . . . 3.0699999999999998 112.143 166.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.3 t70 165.43 73.1 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 128.571 2.749 . . . . 2.5299999999999998 110.486 -157.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -87.28 -98.18 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.695 1 C-N-CA 126.863 5.042 . . . . 1.5700000000000001 113.746 -168.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -87.81 147.88 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 C-N-CA 126.948 2.099 . . . . 2.0899999999999999 106.582 170.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 21.1 mm -110.26 140.31 29.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 123.423 0.689 . . . . 1.97 112.544 -170.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.6 mm -127.74 124.11 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 127.373 2.269 . . . . 1.73 109.161 173.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.66 146.5 32.44 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.729 1.212 . . . . 2.6099999999999999 111.463 174.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.1 t -151.43 -50.55 0.12 Allowed 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 117.153 2.279 . . . . 2.5099999999999998 117.153 -168.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 77.62 -11.24 1.23 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 116.644 2.09 . . . . 3.8900000000000001 116.644 176.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.22 21.43 6.72 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 127.228 2.211 . . . . 2.71 111.475 -174.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 63.53 -16.18 0.07 Allowed 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 119.251 3.056 . . . . 3.2400000000000002 119.251 174.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -129.56 -68.21 0.73 Allowed 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 122.287 2.312 . . . . 4.2199999999999998 114.952 -179.637 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 58.77 -168.79 0.14 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.081 1.752 . . . . 4.5700000000000003 113.521 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -119.5 163.2 17.63 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.048 -1.032 . . . . 3.4199999999999999 109.992 150.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.8 p -116.43 137.76 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.397 1.079 . . . . 1.79 110.514 169.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -117.03 112.72 2.57 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.042 0.829 . . . . 0.94999999999999996 111.316 168.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.55 ' H ' ' CE ' ' A' ' 122' ' ' MET . 0.8 OUTLIER -117.01 155.8 28.57 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.171 1.788 . . . . 1.3 113.447 173.242 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.9 p -125.16 16.71 8.43 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.958 1.303 . . . . 2.1299999999999999 114.054 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.74 70.21 1.18 Allowed Glycine 0 C--N 1.335 0.506 0 O-C-N 120.91 -1.119 . . . . 2.73 110.557 -177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 70.06 176.43 0.07 OUTLIER Pre-proline 0 CA--C 1.561 1.366 0 CA-C-O 118.373 -0.822 . . . . 3.6499999999999999 110.789 -176.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.99 -5.68 17.38 Favored 'Trans proline' 0 C--N 1.353 0.802 0 CA-C-N 122.353 1.876 . . . . 3.0600000000000001 114.781 -167.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.15 -6.77 19.55 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 115.245 1.572 . . . . 3.1200000000000001 115.245 -174.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.57 100.43 0.22 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.182 0.896 . . . . 1.8700000000000001 111.765 -173.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.6 m -105.79 -34.52 7.65 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.65 0.981 . . . . 2.48 113.65 173.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -116.67 -153.59 0.53 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.67 0.788 . . . . 1.3300000000000001 111.829 174.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.3 t -74.86 -147.23 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.479 0.712 . . . . 2.0 110.67 166.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.9 tt -117.27 149.21 19.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 126.778 2.031 . . . . 2.8900000000000001 111.363 166.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.55 ' CE ' ' H ' ' A' ' 111' ' ' CYS . 0.0 OUTLIER -133.65 171.82 13.59 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.871 1.668 . . . . 5.5700000000000003 109.714 169.868 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -137.06 123.53 20.83 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.64 0.776 . . . . 6.96 109.827 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.428 HD21 ' SD ' ' A' ' 122' ' ' MET . 2.2 mt -120.81 160.96 22.33 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 118.939 0.791 . . . . 2.0899999999999999 111.406 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.45 99.8 26.42 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 123.093 0.557 . . . . 6.8300000000000001 109.525 166.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -76.23 179.08 6.71 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 N-CA-C 107.528 -1.758 . . . . 2.46 107.528 159.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 106' ' ' TYR . 24.9 m -159.11 156.1 28.48 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 105.726 -1.953 . . . . 2.5699999999999998 105.726 172.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.7 p -52.35 -39.92 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 124.213 1.005 . . . . 1.8500000000000001 112.494 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -82.03 0.66 39.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.82 1.648 . . . . 1.6799999999999999 114.192 176.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -143.1 -176.92 5.11 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 122.214 1.007 . . . . 2.23 113.016 -159.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.5 m -146.4 155.35 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 127.342 2.257 . . . . 1.72 109.579 -173.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -141.7 128.55 20.56 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.648 0.779 . . . . 1.8700000000000001 112.05 -175.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.4 ttp-105 -101.45 132.45 47.04 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.191 0.905 . . . . 6.0999999999999996 112.85 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . 0.559 ' SG ' ' SG ' ' A' ' 137' ' ' CYS . 0.0 OUTLIER -71.6 -18.91 62.2 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 117.622 2.452 . . . . 3.5699999999999998 117.622 -164.932 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 13.8 p-90 59.0 -20.16 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 128.394 2.678 . . . . 2.8300000000000001 115.74 -173.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -94.43 -87.73 0.25 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 120.434 1.47 . . . . 2.75 110.341 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.559 ' SG ' ' SG ' ' A' ' 134' ' ' CYS . 30.5 p -62.88 -18.16 62.6 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.137 0.975 . . . . 1.3700000000000001 111.934 166.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 58.14 38.69 90.52 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 124.815 1.197 . . . . 1.1000000000000001 111.566 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . 0.263 0.1 OUTLIER -63.77 159.04 20.23 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 117.427 -1.709 . . . . 1.8999999999999999 109.377 155.603 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.2 t -114.15 136.44 50.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 104.074 -2.565 . . . . 1.8899999999999999 104.074 160.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -115.08 140.3 49.18 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.86 1.664 . . . . 2.9500000000000002 110.224 -176.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -104.39 156.1 18.22 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 122.662 1.22 . . . . 3.0 111.621 164.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.8 tt -100.22 154.51 18.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 112.922 -1.945 . . . . 2.0699999999999998 110.237 157.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -109.61 156.52 39.5 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.126 0.97 . . . . 1.28 113.269 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.73 -2.49 10.24 Favored 'Trans proline' 0 N--CA 1.485 0.976 1 C-N-CA 126.413 4.742 . . . . 1.55 115.877 -175.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.9 p -43.88 152.36 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 128.288 2.635 . . . . 2.96 113.049 177.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.896 0 C-N-CA 126.095 1.807 . . . . 1.6100000000000001 110.644 176.876 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 11.4 mtp . . . . . 0 CA--C 1.518 -0.254 0 CA-C-O 123.928 1.823 . . . . 4.5999999999999996 113.523 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.424 ' CG ' ' H ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -146.7 -76.46 0.19 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.033 -1.894 . . . . 3.0 109.62 173.385 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.424 ' H ' ' CG ' ' A' ' 95' ' ' LYS . 38.5 t70 -174.12 72.39 0.34 Allowed Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 127.126 2.171 . . . . 2.5299999999999998 108.903 -168.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -88.31 -48.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.496 1 C-N-CA 127.276 5.317 . . . . 0.71999999999999997 114.258 -170.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -140.96 147.76 22.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 129.938 3.295 . . . . 1.73 105.083 -175.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.5 mm -109.92 136.6 45.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 123.033 0.533 . . . . 1.8799999999999999 111.341 -176.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 51.4 mm -119.1 119.51 61.07 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 126.217 1.807 . . . . 2.1800000000000002 107.479 165.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -77.31 120.79 22.83 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 124.531 1.144 . . . . 3.4100000000000001 109.559 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.7 t -125.09 -51.7 1.66 Allowed 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 116.297 1.962 . . . . 2.3999999999999999 116.297 -164.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 64.01 14.29 8.35 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 122.132 2.242 . . . . 4.3899999999999997 111.924 -177.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -161.23 142.62 11.64 Favored 'General case' 0 CA--C 1.549 0.914 1 C-N-CA 132.312 4.245 . . . . 2.3999999999999999 106.331 -161.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -95.77 14.07 24.46 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 126.113 1.765 . . . . 4.9500000000000002 113.337 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -153.26 12.89 0.49 Allowed 'General case' 0 N--CA 1.485 1.288 0 O-C-N 118.926 -2.359 . . . . 4.0 114.599 -156.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -72.47 159.34 34.11 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.291 0.848 . . . . 5.5599999999999996 113.291 -177.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -95.6 163.36 13.24 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.965 0.728 . . . . 3.5800000000000001 112.965 163.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 p -129.33 148.09 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 127.767 2.427 . . . . 2.3500000000000001 111.102 173.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -100.95 108.78 3.52 Favored Glycine 0 CA--C 1.539 1.533 0 CA-C-O 118.756 -1.025 . . . . 1.3100000000000001 113.631 166.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 9.1 t -108.21 139.62 42.62 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.63 1.572 . . . . 1.5700000000000001 113.984 171.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 12.3 p -113.71 6.84 17.0 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 117.9 2.556 . . . . 2.0499999999999998 117.9 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.01 -23.05 22.64 Favored Glycine 0 N--CA 1.48 1.571 0 O-C-N 119.955 -1.716 . . . . 2.25 113.058 -176.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.2 t 173.52 151.93 0.24 Allowed Pre-proline 0 C--O 1.24 0.553 0 C-N-CA 127.754 2.422 . . . . 5.0499999999999998 108.228 -166.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -60.33 -23.56 74.88 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.656 2.238 . . . . 3.6099999999999999 112.369 168.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.28 9.56 25.47 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.397 1.079 . . . . 3.9500000000000002 113.73 174.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 73.75 62.67 2.94 Favored Glycine 0 C--N 1.343 0.944 0 C-N-CA 124.024 0.821 . . . . 2.27 113.66 170.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 30.7 m -71.94 -34.52 69.1 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.971 1.471 . . . . 2.7400000000000002 114.971 -172.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -107.34 -49.94 3.17 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.006 1.854 . . . . 2.8300000000000001 116.006 176.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.7 t 156.77 -159.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 1 C-N-CA 133.185 4.594 . . . . 2.0899999999999999 105.573 -158.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.8 tp -120.08 140.74 43.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 127.584 2.353 . . . . 2.3900000000000001 111.366 169.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.465 ' CE ' ' HE1' ' A' ' 135' ' ' TRP . 1.2 mmm -137.6 152.38 49.33 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 114.824 1.416 . . . . 5.5700000000000003 114.824 -176.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -110.9 99.98 8.78 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 113.898 -1.501 . . . . 2.2599999999999998 110.72 -171.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.0 mt -106.77 169.75 8.35 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.512 -0.921 . . . . 2.3300000000000001 108.512 -173.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -151.55 100.6 2.94 Favored Pre-proline 0 N--CA 1.472 0.65 0 CA-C-N 119.192 0.905 . . . . 6.4800000000000004 111.607 178.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.88 173.97 10.65 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.252 2.635 . . . . 2.2799999999999998 110.503 170.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.85 144.26 45.54 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.297 2.239 . . . . 2.9399999999999999 107.572 -170.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.7 p -60.79 -34.03 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 120.725 -1.235 . . . . 2.0299999999999998 111.741 -174.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -64.46 -21.02 66.53 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.677 1.991 . . . . 2.6400000000000001 112.922 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -161.6 -137.23 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.109 1.364 . . . . 3.4399999999999999 111.42 -156.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.3 m -156.37 170.31 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 126.884 2.074 . . . . 2.0299999999999998 110.405 -158.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -139.47 143.01 37.34 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.098 0.959 . . . . 2.02 110.595 166.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 140' ' ' VAL . 28.3 ttt-85 -95.61 140.38 30.53 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 105.132 -2.173 . . . . 6.1500000000000004 105.132 167.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 17.9 t -52.08 131.86 32.36 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 124.302 1.001 . . . . 1.1799999999999999 110.009 152.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.465 ' HE1' ' CE ' ' A' ' 122' ' ' MET . 20.0 p-90 -65.61 -20.52 66.35 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.184 -0.948 . . . . 2.1899999999999999 110.637 168.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.05 -108.57 0.07 Allowed 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 126.63 1.972 . . . . 3.1099999999999999 109.173 -172.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.8 p -53.01 -58.77 5.85 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.899 2.48 . . . . 1.73 111.939 -170.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 117.7 21.12 4.38 Favored Glycine 0 C--N 1.331 0.258 0 CA-C-N 113.106 -1.861 . . . . 1.5900000000000001 116.478 -166.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.444 ' HG ' ' HE1' ' A' ' 141' ' ' TYR . 16.2 p -71.72 101.81 2.66 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 119.142 1.471 . . . . 1.79 107.549 156.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 133' ' ' ARG . 47.1 t -62.7 145.22 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 108.475 -0.935 . . . . 1.9299999999999999 108.475 155.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.444 ' HE1' ' HG ' ' A' ' 139' ' ' SER . 75.3 m-85 -124.48 156.41 37.29 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 130.355 3.462 . . . . 3.5499999999999998 111.318 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.428 ' HG2' ' H ' ' A' ' 143' ' ' LEU . 9.2 tttm -119.59 155.38 32.37 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 123.876 1.798 . . . . 3.3100000000000001 113.605 169.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.428 ' H ' ' HG2' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -95.67 146.42 24.51 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 111.936 -2.393 . . . . 2.54 110.265 158.071 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -101.76 155.81 35.96 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 113.842 1.052 . . . . 1.54 113.842 176.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.97 -7.34 21.2 Favored 'Trans proline' 0 C--N 1.353 0.815 1 C-N-CA 125.979 4.453 . . . . 2.2999999999999998 115.788 178.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.9 p -35.54 140.54 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 128.857 2.863 . . . . 3.3900000000000001 113.145 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.706 0 C-N-CA 125.103 1.335 . . . . 3.1200000000000001 111.306 -171.955 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 46.2 mtp . . . . . 0 C--O 1.218 -0.553 0 N-CA-C 105.194 -2.15 . . . . 3.4900000000000002 105.194 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 4.27 -76.18 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 128.734 2.814 . . . . 4.6900000000000004 116.758 167.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 46.4 t0 177.84 84.68 0.14 Allowed Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 129.706 3.203 . . . . 2.2200000000000002 108.687 -166.352 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -96.99 -43.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 1 C-N-CA 126.93 5.087 . . . . 0.93999999999999995 113.168 -178.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 mm -154.35 140.51 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 128.494 2.718 . . . . 1.8500000000000001 106.454 -168.568 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.4 mm -115.8 129.15 72.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 125.806 1.643 . . . . 2.2400000000000002 110.964 -172.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.6 mm -127.11 112.9 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 126.688 1.995 . . . . 2.0099999999999998 109.532 -173.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -71.34 131.15 42.99 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.16 0.984 . . . . 2.73 110.776 -177.061 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.0 p -132.3 -56.77 0.96 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 115.533 1.679 . . . . 3.5699999999999998 115.533 -153.172 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 73.41 -18.79 0.36 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 127.334 2.253 . . . . 4.6600000000000001 114.973 173.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -125.11 145.46 49.93 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.503 2.321 . . . . 3.04 107.901 161.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.63 4.25 2.0 Allowed 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 116.777 2.14 . . . . 3.3300000000000001 116.777 -160.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -147.16 24.53 1.15 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 126.134 1.774 . . . . 3.48 114.551 -175.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.13 135.77 31.03 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 120.792 -1.192 . . . . 4.9699999999999998 112.49 173.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -67.79 163.14 22.39 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.586 0.588 . . . . 3.3799999999999999 112.586 173.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.69 142.64 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.16 1.384 . . . . 2.3199999999999998 111.015 172.118 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.48 128.36 7.68 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.034 0.826 . . . . 1.53 112.923 168.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.84 153.98 50.78 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.38 1.872 . . . . 1.45 114.78 171.197 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.6 p -111.47 14.62 21.43 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 116.219 1.933 . . . . 2.1499999999999999 116.219 173.289 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.85 -32.7 4.33 Favored Glycine 0 C--O 1.222 -0.616 0 C-N-CA 124.626 1.108 . . . . 2.29 113.622 -172.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.1 t 137.55 148.43 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 106.516 -1.661 . . . . 3.5699999999999998 106.516 -120.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.23 48.16 1.72 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 124.745 3.63 . . . . 2.8500000000000001 113.72 -177.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -156.37 27.35 0.35 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.765 1.024 . . . . 3.0899999999999999 113.765 -163.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 61.53 22.44 61.51 Favored Glycine 0 N--CA 1.475 1.295 0 N-CA-C 115.831 1.092 . . . . 2.8700000000000001 115.831 167.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 57.7 p -60.15 -50.98 71.52 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.416 1.108 . . . . 3.6600000000000001 112.835 -158.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.403 ' CG ' ' H ' ' A' ' 120' ' ' THR . 28.7 p80 -102.76 -63.62 1.15 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.765 0.426 . . . . 2.6499999999999999 110.353 -178.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.403 ' H ' ' CG ' ' A' ' 119' ' ' HIS . 5.4 t -179.51 -159.46 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.476 1 C-N-CA 132.79 4.436 . . . . 1.8999999999999999 106.849 178.346 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.0 tp -104.85 145.73 12.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 C-N-CA 125.855 1.662 . . . . 2.3199999999999998 110.056 167.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.52 175.71 9.19 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.756 1.622 . . . . 6.0099999999999998 110.236 172.354 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -136.58 126.34 25.6 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 118.562 -0.732 . . . . 2.7599999999999998 110.266 171.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 mt -115.77 155.48 27.74 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.797 1.181 . . . . 2.1899999999999999 112.054 177.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.83 101.37 20.53 Favored Pre-proline 0 N--CA 1.477 0.896 0 O-C-N 121.818 -0.551 . . . . 6.5099999999999998 110.862 172.599 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -82.96 178.28 6.08 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.447 2.098 . . . . 2.75 108.942 157.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.8 m -144.25 158.18 43.88 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.234 2.214 . . . . 1.78 105.118 171.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.0 p -58.51 -32.34 45.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-N 119.403 1.002 . . . . 1.8300000000000001 111.287 176.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -76.18 -5.28 46.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 128.053 2.541 . . . . 1.9099999999999999 114.637 174.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -145.09 -170.62 3.47 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.865 0.84 . . . . 2.3799999999999999 113.051 -159.013 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 19.3 m -147.23 156.92 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 128.239 2.616 . . . . 1.8500000000000001 108.273 -175.112 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -139.72 126.92 21.18 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.806 0.843 . . . . 1.8600000000000001 111.897 -179.094 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -99.16 134.76 41.54 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.441 0.564 . . . . 4.8799999999999999 111.784 178.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 36.4 t -58.1 141.07 51.33 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 124.361 1.038 . . . . 0.95999999999999996 110.941 165.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 58.7 p-90 -91.34 -10.49 41.08 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.924 -0.58 . . . . 2.0299999999999998 112.083 168.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -100.59 -65.63 0.96 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.262 0.625 . . . . 2.0800000000000001 111.447 -169.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 7.7 p -79.6 -41.95 26.01 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 118.922 0.783 . . . . 1.74 111.059 169.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 106.45 12.04 25.86 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.214 1.388 . . . . 1.1000000000000001 115.652 -178.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.415 ' HG ' ' HE1' ' A' ' 141' ' ' TYR . 2.9 p -80.28 137.01 36.55 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.968 1.884 . . . . 1.6399999999999999 111.179 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.38 150.45 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 118.966 0.803 . . . . 2.3500000000000001 110.296 164.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.415 ' HE1' ' HG ' ' A' ' 139' ' ' SER . 89.2 m-85 -133.81 143.92 48.67 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 129.781 3.233 . . . . 3.52 109.723 179.639 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 54.4 tttt -117.84 153.01 34.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.284 1.04 . . . . 3.0899999999999999 112.372 178.136 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.1 tt -97.89 143.68 28.24 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.502 -1.226 . . . . 1.8600000000000001 111.692 165.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.47 156.52 36.88 Favored Pre-proline 0 CA--C 1.549 0.91 0 CA-C-N 114.321 -1.308 . . . . 3.0099999999999998 110.483 -173.092 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.19 -8.96 24.58 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 124.558 3.505 . . . . 1.3600000000000001 114.509 -176.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.4 p -40.45 142.38 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 128.028 2.531 . . . . 3.0099999999999998 114.316 -177.307 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.476 0 C-N-CA 126.75 2.119 . . . . 2.0600000000000001 107.816 165.378 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 7.2 mtm . . . . . 0 N--CA 1.465 0.309 0 N-CA-C 119.438 3.125 . . . . 0.0 119.438 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -61.86 1.67 Allowed 'General case' 0 C--N 1.317 -0.811 0 O-C-N 121.792 -0.567 . . . . 0.0 112.098 167.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.8 t70 167.65 74.52 0.01 OUTLIER Pre-proline 0 CA--C 1.56 1.363 0 C-N-CA 129.581 3.152 . . . . 0.0 109.393 -155.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -92.12 -51.24 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.423 1 C-N-CA 126.842 5.028 . . . . 0.0 114.896 -170.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 mm -149.22 143.28 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 131.579 3.952 . . . . 0.0 104.221 -169.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.4 mm -113.73 131.69 64.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 124.056 0.943 . . . . 0.0 109.986 -177.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.0 mm -116.31 111.31 34.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 174.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.486 ' HA ' HD22 ' A' ' 144' ' ' ASN . 8.9 tt0 -76.82 116.31 17.37 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.855 1.262 . . . . 0.0 110.148 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.1 t -108.16 -67.83 0.94 Allowed 'General case' 0 C--O 1.225 -0.224 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -158.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 75.79 -3.9 2.48 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 126.438 1.895 . . . . 0.0 113.594 -169.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -114.21 152.33 31.4 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 128.066 2.546 . . . . 0.0 109.564 159.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -72.34 -14.6 61.77 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 120.265 -1.522 . . . . 0.0 114.767 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -134.04 6.49 3.64 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.167 -1.583 . . . . 0.0 114.248 -158.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -61.96 154.82 25.34 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.377 1.871 . . . . 0.0 115.327 -166.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -77.09 171.63 14.51 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.622 1.569 . . . . 0.0 114.195 173.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.9 p -135.61 148.99 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.958 2.103 . . . . 0.0 110.606 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -119.57 121.41 4.94 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 118.844 -0.975 . . . . 0.0 113.552 158.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 22.8 p -114.63 160.65 19.07 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 123.518 1.627 . . . . 0.0 113.095 167.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 47.4 p -114.91 13.36 17.05 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 113.302 -1.772 . . . . 0.0 112.695 166.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.5 -31.21 5.67 Favored Glycine 0 N--CA 1.467 0.733 0 C-N-CA 124.056 0.836 . . . . 0.0 113.828 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.1 t 169.49 159.92 0.19 Allowed Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 126.974 2.11 . . . . 0.0 107.509 -157.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -54.94 -20.56 23.33 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 121.89 1.726 . . . . 0.0 112.678 161.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.69 42.43 1.1 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.079 1.352 . . . . 0.0 112.729 174.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 51.33 33.91 32.55 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 116.986 1.554 . . . . 0.0 116.986 150.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.3 m -75.69 -48.02 23.77 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -152.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -104.88 -145.84 0.38 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.939 0.896 . . . . 0.0 112.219 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.7 t -76.56 -158.4 0.1 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.956 0.902 . . . . 0.0 112.413 163.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.4 tp -105.88 142.62 18.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 126.368 1.867 . . . . 0.0 110.481 161.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.413 ' CE ' ' CD1' ' A' ' 135' ' ' TRP . 3.8 ppp? -152.58 175.26 12.97 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.322 1.049 . . . . 0.0 112.141 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -140.71 130.69 24.63 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -165.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 mt -132.28 174.13 10.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.181 1.393 . . . . 0.0 108.725 -174.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 102.37 5.11 Favored Pre-proline 0 N--CA 1.478 0.959 0 CA-C-N 120.187 1.358 . . . . 0.0 114.495 168.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -70.9 176.94 6.93 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 CA-C-N 120.025 1.045 . . . . 0.0 109.426 161.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.7 m -139.71 158.97 43.23 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.745 2.018 . . . . 0.0 105.777 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.5 p -49.21 -37.97 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 120.028 1.285 . . . . 0.0 113.456 -178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -80.9 -8.24 59.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.549 1.539 . . . . 0.0 114.078 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -140.82 -173.45 3.71 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 122.893 1.33 . . . . 0.0 113.371 -151.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 25.9 m -141.53 167.35 16.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 128.322 2.649 . . . . 0.0 108.966 -175.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -148.21 142.58 26.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.885 0.874 . . . . 0.0 110.506 169.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -100.04 143.52 30.16 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.79 0.836 . . . . 0.0 111.07 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 45.4 t -65.1 175.15 1.68 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 122.802 1.287 . . . . 0.0 113.622 158.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.413 ' CD1' ' CE ' ' A' ' 122' ' ' MET . 40.9 p-90 -127.54 -13.27 5.44 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.287 1.835 . . . . 0.0 112.583 170.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -95.32 -60.82 1.59 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.156 0.982 . . . . 0.0 109.88 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 14.2 p -80.8 -23.45 39.25 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.997 1.319 . . . . 0.0 112.705 165.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 64.51 16.18 60.45 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.419 -1.211 . . . . 0.0 113.544 -172.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.77 137.16 53.8 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.801 1.8 . . . . 0.0 111.384 173.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 41.4 t -81.96 147.02 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 166.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -132.01 150.01 52.27 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 129.282 3.033 . . . . 0.0 110.709 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 43.9 tttt -127.01 150.05 49.62 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.102 0.953 . . . . 0.0 113.556 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.62 155.7 17.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.858 167.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.486 HD22 ' HA ' ' A' ' 101' ' ' GLU . 3.4 p30 -111.57 152.19 43.85 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 172.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -67.78 -6.01 15.81 Favored 'Trans proline' 0 C--N 1.352 0.736 1 C-N-CA 125.352 4.035 . . . . 0.0 115.154 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.9 p -36.83 133.37 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 127.837 2.455 . . . . 0.0 113.401 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.637 0 C-N-CA 127.541 2.496 . . . . 0.0 107.315 174.703 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 8.6 mtm . . . . . 0 C--O 1.225 -0.219 0 N-CA-C 118.035 2.606 . . . . 3.1600000000000001 118.035 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -57.73 11.46 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 121.191 -0.943 . . . . 2.8399999999999999 112.641 169.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.5 t70 164.88 73.77 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 129.437 3.095 . . . . 2.7400000000000002 109.703 -154.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -88.34 -46.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 1 C-N-CA 126.793 4.996 . . . . 1.0600000000000001 113.075 -174.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -154.47 143.1 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 130.451 3.5 . . . . 1.8899999999999999 105.424 -168.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.9 mm -117.45 134.23 61.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 124.579 1.152 . . . . 1.76 111.87 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.9 mm -127.42 118.6 50.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 127.142 2.177 . . . . 1.6399999999999999 108.209 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.92 133.41 44.35 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.858 1.663 . . . . 2.8300000000000001 111.442 -176.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.9 t -163.63 111.94 1.21 Allowed 'General case' 0 C--O 1.223 -0.333 0 O-C-N 121.535 -0.728 . . . . 2.9100000000000001 112.67 -175.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -82.24 16.71 1.89 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.608 1.163 . . . . 5.3099999999999996 112.184 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.436 ' CG ' HH21 ' A' ' 107' ' ' ARG . 0.3 OUTLIER -135.48 10.75 3.47 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 128.222 2.609 . . . . 3.0 113.212 -159.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 59.55 -16.73 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 129.631 3.173 . . . . 3.1099999999999999 118.686 173.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -150.88 14.63 0.73 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 119.666 -1.896 . . . . 3.6600000000000001 114.719 -168.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.436 HH21 ' CG ' ' A' ' 104' ' ' ASP . 57.1 ttm-85 -54.39 142.61 26.32 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.538 1.535 . . . . 4.3300000000000001 112.563 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -77.38 156.9 30.9 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.844 0.683 . . . . 3.6400000000000001 112.844 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.2 p -105.1 145.05 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.451 1.501 . . . . 1.7 111.073 173.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -113.4 98.12 0.91 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.957 1.265 . . . . 0.65000000000000002 112.286 164.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.7 154.86 18.25 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.373 1.469 . . . . 1.21 113.318 174.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.9 p -124.46 14.17 8.84 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.841 1.656 . . . . 1.71 115.0 171.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.16 -17.97 46.79 Favored Glycine 0 N--CA 1.476 1.338 0 O-C-N 120.46 -1.4 . . . . 2.0299999999999998 114.836 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.5 t 175.44 154.51 0.34 Allowed Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 126.089 1.756 . . . . 4.1600000000000001 109.871 -155.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -58.69 -20.56 51.51 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.298 2.666 . . . . 2.7000000000000002 113.96 170.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.85 -9.1 50.31 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 114.798 1.407 . . . . 3.2799999999999998 114.798 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.84 164.95 12.79 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 123.584 1.658 . . . . 3.1099999999999999 112.262 -147.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 36.9 m -166.62 -43.43 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 127.72 2.408 . . . . 2.21 110.628 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -107.64 -158.08 0.64 Allowed 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 109.95 -0.389 . . . . 1.5700000000000001 109.95 165.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.8 t -69.64 -158.96 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.823 0.849 . . . . 1.8200000000000001 112.531 168.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.8 tp -104.97 142.81 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 126.861 2.065 . . . . 1.96 109.987 166.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.436 ' SD ' HD21 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -145.25 173.47 11.93 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.071 0.948 . . . . 5.2199999999999998 111.051 170.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -124.03 133.17 53.72 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.773 0.829 . . . . 2.0 112.233 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.436 HD21 ' SD ' ' A' ' 122' ' ' MET . 3.4 mt -129.75 160.07 34.54 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.077 0.951 . . . . 1.9199999999999999 109.422 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.2 ttpp -125.3 85.94 57.67 Favored Pre-proline 0 N--CA 1.473 0.702 0 O-C-N 121.423 -0.798 . . . . 5.7999999999999998 113.032 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -69.57 176.61 6.4 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.207 1.938 . . . . 2.4900000000000002 109.775 166.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.3 m -142.46 158.42 43.71 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.307 1.843 . . . . 1.9199999999999999 107.494 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.7 p -55.48 -33.65 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.952 1.301 . . . . 1.7 113.737 -175.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -91.04 0.9 57.44 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.56 1.144 . . . . 2.6099999999999999 113.838 175.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -140.26 -169.63 2.8 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.789 0.835 . . . . 2.1499999999999999 112.956 -158.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.6 m -145.66 163.68 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 127.504 2.322 . . . . 1.72 109.916 -173.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -148.47 133.83 18.52 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.639 1.176 . . . . 1.72 112.07 174.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.24 139.49 47.74 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.737 1.014 . . . . 4.2800000000000002 113.737 -177.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 46.8 t -70.75 156.94 38.88 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.417 1.487 . . . . 1.1599999999999999 114.863 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.411 ' CZ3' ' HG2' ' A' ' 136' ' ' GLU . 43.9 p-90 -102.92 -13.28 16.99 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.425 -1.261 . . . . 1.9399999999999999 113.305 174.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.411 ' HG2' ' CZ3' ' A' ' 135' ' ' TRP . 0.8 OUTLIER -98.92 -58.34 1.97 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 120.002 1.273 . . . . 2.54 110.661 -179.062 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 4.6 p -77.56 -65.93 0.9 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 122.28 1.038 . . . . 2.29 110.584 171.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.72 4.86 12.72 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.046 -1.419 . . . . 0.98999999999999999 115.882 -170.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.82 137.5 57.82 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 120.841 2.32 . . . . 1.8899999999999999 111.813 173.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 40.4 t -83.18 146.53 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 107.285 -1.376 . . . . 1.7 107.285 165.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -132.35 151.01 52.04 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 128.221 2.608 . . . . 3.79 112.076 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -133.43 146.78 51.5 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.11 1.152 . . . . 3.8300000000000001 114.11 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.8 tt -99.86 153.9 18.78 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.62 1.168 . . . . 1.6899999999999999 110.328 171.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -107.62 156.91 37.09 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 115.453 1.649 . . . . 1.4099999999999999 115.453 -175.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.93 -4.51 12.56 Favored 'Trans proline' 0 C--N 1.357 0.976 1 C-N-CA 127.314 5.343 . . . . 1.6399999999999999 115.92 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.9 p -48.69 143.89 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.246 1.818 . . . . 2.9300000000000002 110.369 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.75 0 O-C-N 120.772 -1.205 . . . . 2.9500000000000002 112.124 -163.691 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.8 mtm . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.678 0.751 . . . . 3.3900000000000001 112.794 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.7 pttm 123.39 -143.65 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.605 1 C-N-CA 133.216 4.606 . . . . 4.3399999999999999 108.419 -150.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . 0.271 21.3 t0 -128.14 72.37 79.49 Favored Pre-proline 0 CA--C 1.561 1.391 0 C-N-CA 124.761 1.224 . . . . 3.1000000000000001 108.964 -173.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.51 -53.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.046 1 C-N-CA 128.788 6.325 . . . . 0.82999999999999996 114.705 -170.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -133.04 140.11 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 128.745 2.818 . . . . 1.8500000000000001 105.156 -178.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.4 mm -110.68 133.88 54.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 C-N-CA 123.662 0.785 . . . . 2.0499999999999998 111.686 -171.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.0 mm -122.67 115.69 46.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 126.341 1.857 . . . . 1.99 108.301 173.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -65.17 124.19 21.51 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.937 1.695 . . . . 3.0800000000000001 110.464 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.6 t -146.8 122.17 10.3 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.167 0.987 . . . . 3.0 111.414 -175.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -98.55 3.18 48.06 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 112.532 0.567 . . . . 4.0800000000000001 112.532 -175.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.404 ' CG ' ' H ' ' A' ' 105' ' ' ASP . 6.0 p-10 -104.03 -101.56 0.31 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 128.699 2.8 . . . . 3.7200000000000002 111.166 168.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.404 ' H ' ' CG ' ' A' ' 104' ' ' ASP . 10.3 t0 -171.64 -38.33 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 128.094 2.558 . . . . 3.9100000000000001 109.98 -175.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -99.67 -5.08 29.51 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 120.063 -1.648 . . . . 4.8300000000000001 114.63 -165.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.16 122.39 8.49 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.371 1.868 . . . . 7.7699999999999996 114.194 -164.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -70.83 151.7 44.51 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.861 1.06 . . . . 3.73 113.861 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.7 p -108.22 146.56 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.785 1.634 . . . . 1.8700000000000001 111.838 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -111.09 108.14 2.32 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.119 0.866 . . . . 0.75 112.747 161.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 1.9 t -97.1 145.17 26.25 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.963 1.305 . . . . 1.8 112.612 172.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.7 p -116.29 18.65 15.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.491 1.517 . . . . 1.71 113.759 169.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.423 ' CA ' ' CD2' ' A' ' 119' ' ' HIS . . . 110.96 39.33 1.42 Allowed Glycine 0 N--CA 1.466 0.639 0 C-N-CA 124.611 1.101 . . . . 1.71 113.457 176.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 p 71.08 178.5 0.05 OUTLIER Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 123.966 0.907 . . . . 3.4700000000000002 110.294 -161.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -63.72 -9.6 19.17 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.256 1.971 . . . . 3.0699999999999998 115.586 -172.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.58 33.48 1.43 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.817 1.247 . . . . 3.6000000000000001 113.953 -174.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 57.8 31.66 64.65 Favored Glycine 0 N--CA 1.479 1.512 0 C-N-CA 124.252 0.929 . . . . 1.6899999999999999 115.057 163.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.0 m -84.85 -32.16 23.41 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.571 -0.958 . . . . 2.48 113.437 -148.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.485 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 18.7 p80 -123.81 -144.34 0.33 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.838 1.199 . . . . 1.3700000000000001 113.096 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.2 t -78.39 -153.73 0.07 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 118.902 0.774 . . . . 1.77 111.035 164.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.9 tp -107.5 151.03 9.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 127.761 2.424 . . . . 1.8999999999999999 110.668 164.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.495 ' HE3' ' H ' ' A' ' 135' ' ' TRP . 4.2 ppp? -160.14 161.47 33.72 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.943 1.697 . . . . 4.7400000000000002 111.492 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -130.09 132.99 46.38 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.376 0.509 . . . . 1.9199999999999999 112.376 -167.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 mt -131.86 155.55 47.63 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.469 0.707 . . . . 2.0099999999999998 110.485 -175.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.65 97.21 46.28 Favored Pre-proline 0 N--CA 1.477 0.917 0 CA-C-N 118.608 0.64 . . . . 6.3499999999999996 110.972 175.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -76.42 178.66 7.26 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 121.839 1.693 . . . . 2.5499999999999998 108.868 162.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.3 m -144.41 155.34 43.71 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.14 1.776 . . . . 1.9299999999999999 106.265 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.02 -28.07 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 122.036 2.198 . . . . 1.95 109.803 175.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -72.68 -15.12 61.7 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.543 2.737 . . . . 1.8100000000000001 114.721 171.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -145.51 178.46 8.1 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 123.215 1.483 . . . . 1.99 114.103 -159.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.68 165.35 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 128.347 2.659 . . . . 1.71 109.495 174.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.9 131.64 25.72 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.428 1.091 . . . . 1.8300000000000001 111.148 173.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.63 138.03 48.72 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.677 0.621 . . . . 4.6200000000000001 112.677 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 40.7 t -70.01 153.23 43.48 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 126.599 1.96 . . . . 1.0700000000000001 115.223 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.495 ' H ' ' HE3' ' A' ' 122' ' ' MET . 56.7 p-90 -98.6 -10.19 23.73 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.453 0.908 . . . . 1.5800000000000001 113.453 169.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.485 ' HB3' ' CD2' ' A' ' 119' ' ' HIS . 0.7 OUTLIER -96.87 -100.0 0.19 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.326 1.45 . . . . 1.73 109.48 -177.229 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 30.1 p -55.39 -29.25 58.13 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.32 1.418 . . . . 1.0600000000000001 112.12 168.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.1 23.88 75.01 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-O 118.483 -1.176 . . . . 0.72999999999999998 113.479 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.66 154.0 41.71 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.704 1.752 . . . . 1.45 111.054 165.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 74.2 t -96.55 140.97 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 105.817 -1.92 . . . . 1.77 105.817 167.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -123.56 153.91 39.98 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 128.009 2.524 . . . . 3.6000000000000001 111.737 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -140.19 157.67 45.24 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 123.013 1.387 . . . . 3.6400000000000001 114.569 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.4 tt -110.87 141.16 44.63 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 113.737 -1.574 . . . . 1.97 113.255 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -100.53 155.85 35.89 Favored Pre-proline 0 CA--C 1.555 1.148 0 N-CA-C 114.609 1.337 . . . . 1.45 114.609 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -79.38 -4.27 13.57 Favored 'Trans proline' 0 C--N 1.356 0.936 1 C-N-CA 126.307 4.671 . . . . 1.3999999999999999 115.56 -175.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.1 p -40.43 148.65 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 128.805 2.842 . . . . 3.0299999999999998 112.044 175.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.644 0 O-C-N 120.138 -1.602 . . . . 1.6399999999999999 113.49 179.267 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 13.8 mtp . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 119.635 3.198 . . . . 3.5299999999999998 119.635 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -56.85 5.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 119.264 0.938 . . . . 3.0099999999999998 112.978 174.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.2 t0 161.68 70.89 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 129.411 3.085 . . . . 2.3700000000000001 109.177 -158.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -82.46 -53.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.3 1 C-N-CA 126.082 4.522 . . . . 0.81000000000000005 112.526 -172.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -147.77 143.53 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 130.521 3.528 . . . . 1.97 104.831 -168.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.4 mm -111.21 129.98 65.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 124.525 1.13 . . . . 2.0499999999999998 109.818 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.4 mm -114.61 100.27 10.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 126.123 1.769 . . . . 1.8799999999999999 106.908 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -66.61 122.23 17.14 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 125.162 1.539 . . . . 3.1200000000000001 110.008 -174.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.4 t -145.0 110.44 5.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.741 -0.663 . . . . 3.1699999999999999 111.225 -169.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -77.1 35.33 0.16 Allowed 'General case' 0 CA--C 1.55 0.949 0 O-C-N 121.693 -0.63 . . . . 3.6400000000000001 112.633 172.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -157.73 137.9 12.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 130.801 3.64 . . . . 3.1600000000000001 106.788 -173.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -60.26 -11.57 6.72 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.818 1.044 . . . . 2.98 113.818 175.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -139.05 126.35 21.47 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.758 2.423 . . . . 3.8399999999999999 111.47 -170.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.528 HH11 ' CG ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -146.27 174.74 11.07 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.887 1.275 . . . . 5.1699999999999999 113.74 171.516 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -100.4 168.05 10.0 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.723 -0.671 . . . . 3.54 111.926 157.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.96 145.9 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 126.029 1.732 . . . . 1.8999999999999999 110.414 168.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -129.34 107.84 0.84 Allowed Glycine 0 N--CA 1.473 1.116 0 CA-C-O 119.154 -0.803 . . . . 0.77000000000000002 113.773 170.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.532 ' H ' ' CE ' ' A' ' 122' ' ' MET . 12.7 p -109.75 164.11 12.87 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.485 1.914 . . . . 1.5600000000000001 114.167 172.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.8 p -124.71 5.52 8.15 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.263 1.425 . . . . 1.75 114.724 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.5 -21.67 12.62 Favored Glycine 0 N--CA 1.476 1.315 0 N-CA-C 116.334 1.294 . . . . 2.1099999999999999 116.334 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.94 177.34 0.54 Allowed Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 127.541 2.336 . . . . 4.4699999999999998 109.501 -178.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -59.54 -26.22 81.34 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.507 2.138 . . . . 3.23 113.541 170.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.52 -2.0 58.32 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.291 1.219 . . . . 3.1499999999999999 114.291 172.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.77 -169.01 52.89 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-O 123.267 1.481 . . . . 3.54 111.458 -150.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.0 t -177.82 -36.19 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 128.278 2.631 . . . . 3.54 110.656 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -118.57 -153.15 0.52 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.495 1.518 . . . . 1.3600000000000001 110.603 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.9 t -74.78 -155.39 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 O-C-N 121.39 -0.819 . . . . 1.78 112.202 167.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.5 tp -108.28 146.28 14.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 127.6 2.36 . . . . 2.1400000000000001 109.797 163.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.532 ' CE ' ' H ' ' A' ' 111' ' ' CYS . 0.0 OUTLIER -141.69 -179.87 6.43 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.922 1.289 . . . . 5.3700000000000001 110.597 173.081 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -140.25 124.06 17.34 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.589 0.631 . . . . 2.04 111.751 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.445 HD22 ' SD ' ' A' ' 122' ' ' MET . 2.4 mt -118.78 172.64 7.38 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.154 0.981 . . . . 1.9099999999999999 110.202 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -139.58 90.97 10.99 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-O 118.488 -0.768 . . . . 8.1600000000000001 112.749 -175.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -85.8 167.27 9.89 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.979 2.452 . . . . 2.6899999999999999 110.601 172.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.5 m -139.75 152.73 46.86 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.962 2.105 . . . . 1.8100000000000001 108.577 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.7 p -42.48 -43.85 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 116.988 2.218 . . . . 2.3900000000000001 116.988 -173.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -89.58 3.25 53.13 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.44 1.096 . . . . 2.2400000000000002 112.846 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -140.8 -177.85 5.27 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.59 1.156 . . . . 3.2999999999999998 113.759 -149.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.1 m -139.99 152.2 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 113.672 -1.604 . . . . 1.6699999999999999 112.384 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -129.23 143.45 50.86 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.871 0.868 . . . . 1.8400000000000001 109.844 168.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -111.64 141.07 45.71 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.886 0.874 . . . . 5.4800000000000004 111.488 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 49.3 t -59.76 159.17 9.16 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 124.587 1.179 . . . . 1.04 112.88 163.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 58.6 p-90 -107.31 -9.02 16.16 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.825 1.25 . . . . 1.3700000000000001 112.559 170.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -100.09 -94.18 0.27 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.076 1.75 . . . . 1.6200000000000001 108.998 -177.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 28.3 p -62.29 -16.37 53.45 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 120.416 -1.427 . . . . 1.28 112.587 171.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 59.22 27.32 62.64 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 124.894 1.235 . . . . 0.81999999999999995 112.607 175.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.431 ' HG ' ' HE1' ' A' ' 141' ' ' TYR . 1.4 p -67.59 132.59 47.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.975 1.388 . . . . 1.52 108.879 164.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 41.4 t -76.97 150.85 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.426 -0.953 . . . . 1.79 108.426 159.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.431 ' HE1' ' HG ' ' A' ' 139' ' ' SER . 83.0 m-85 -134.19 147.21 50.72 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 130.028 3.331 . . . . 3.02 110.439 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -124.81 145.7 49.63 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 113.397 0.888 . . . . 3.6000000000000001 113.397 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.3 tt -91.76 154.36 18.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 122.278 1.037 . . . . 2.1899999999999999 109.094 165.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -117.2 152.66 49.32 Favored Pre-proline 0 CA--C 1.552 1.037 0 CA-C-N 114.685 -1.143 . . . . 1.48 113.319 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.49 -4.39 14.42 Favored 'Trans proline' 0 CA--C 1.539 0.761 1 C-N-CA 125.964 4.443 . . . . 1.6699999999999999 115.731 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.1 p -43.66 149.54 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 128.356 2.663 . . . . 3.2000000000000002 112.812 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 125.04 1.305 . . . . 1.96 110.185 -174.843 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.6 mtm . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 124.28 1.99 . . . . 3.5600000000000001 111.918 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -173.21 -122.41 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 130.922 3.689 . . . . 3.0099999999999998 106.717 172.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . 0.303 38.0 t70 -133.39 78.11 64.1 Favored Pre-proline 0 N--CA 1.434 -1.251 0 N-CA-C 106.975 -1.491 . . . . 2.77 106.975 177.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.418 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 70.4 Cg_endo -83.12 -81.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.786 1 C-N-CA 127.573 5.515 . . . . 1.21 113.687 -170.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.418 ' H ' ' HG2' ' A' ' 97' ' ' PRO . 0.6 OUTLIER -102.07 143.39 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 C-N-CA 127.854 2.462 . . . . 1.95 106.187 171.48 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.0 mm -109.53 135.25 49.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.28 -0.873 . . . . 1.8799999999999999 111.786 -172.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.9 mm -123.55 114.05 40.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 126.96 2.104 . . . . 1.97 108.453 173.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.4 132.13 46.51 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.463 1.505 . . . . 3.0800000000000001 110.706 169.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 61.7 m -161.09 125.19 3.45 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.088 -1.007 . . . . 4.6900000000000004 109.14 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.7 m-30 -87.97 28.35 1.05 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 121.366 0.603 . . . . 4.0300000000000002 111.24 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.99 109.96 4.52 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 129.336 3.054 . . . . 3.75 108.235 -171.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -53.85 -16.08 1.62 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.974 2.51 . . . . 3.3999999999999999 115.44 -169.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.91 5.76 3.91 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 126.769 2.028 . . . . 3.6299999999999999 113.79 -167.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.5 ttt85 -48.2 156.75 0.36 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.366 1.866 . . . . 5.8499999999999996 113.654 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -87.72 155.55 19.86 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.738 -0.602 . . . . 3.52 112.308 162.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.23 142.65 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 127.08 2.152 . . . . 1.74 111.543 170.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -104.67 100.95 1.86 Allowed Glycine 0 CA--C 1.533 1.217 0 CA-C-O 117.95 -1.472 . . . . 0.69999999999999996 113.663 164.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 3.6 p -107.22 145.06 33.12 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.459 1.629 . . . . 1.3100000000000001 113.424 171.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.5 p -114.25 23.31 12.97 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 113.901 -1.499 . . . . 2.0099999999999998 112.874 175.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.83 -16.28 55.22 Favored Glycine 0 N--CA 1.476 1.36 0 O-C-N 120.201 -1.562 . . . . 1.76 114.395 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.8 p 175.36 162.29 0.4 Allowed Pre-proline 0 C--O 1.241 0.64 0 C-N-CA 128.693 2.797 . . . . 4.29 107.888 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.05 -15.42 39.16 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.02 2.48 . . . . 3.04 113.184 165.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.55 7.22 46.4 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.326 1.05 . . . . 2.6899999999999999 112.469 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 62.25 71.67 0.78 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 125.177 1.37 . . . . 1.6399999999999999 111.921 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 56.8 m -76.24 -42.51 45.59 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.925 0.89 . . . . 2.4100000000000001 112.175 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.6 p80 -100.8 -148.73 0.37 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.342 0.974 . . . . 1.46 112.226 171.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.28 13.6 t -77.67 -134.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.048 -1.093 . . . . 1.97 108.048 158.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.6 tp -129.95 142.1 44.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 131.06 3.744 . . . . 1.8999999999999999 111.108 174.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 19.3 mmm -129.54 167.15 18.34 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.629 1.972 . . . . 4.8600000000000003 115.112 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -136.06 102.48 5.04 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.88 0.472 . . . . 1.8999999999999999 110.936 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 mt -116.22 160.03 21.0 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.78 0.832 . . . . 1.8600000000000001 110.499 -169.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -119.94 76.22 21.74 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 114.931 1.456 . . . . 5.8600000000000003 114.931 -170.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -92.15 43.43 0.36 Allowed 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.477 3.452 . . . . 3.0699999999999998 116.161 -165.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 m -28.61 151.0 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 130.301 3.44 . . . . 1.9199999999999999 114.94 -170.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -52.15 -33.33 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 O-C-N 120.199 -1.563 . . . . 2.1699999999999999 113.836 175.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -79.24 -7.99 58.69 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.461 1.504 . . . . 1.73 114.071 175.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -141.39 -166.38 2.18 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.867 1.267 . . . . 2.1200000000000001 111.575 -157.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.6 m -147.55 158.28 9.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 131.151 3.78 . . . . 1.76 107.3 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -141.92 140.24 32.75 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.923 0.783 . . . . 1.8600000000000001 110.966 168.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -91.97 141.97 28.05 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.322 0.649 . . . . 4.4199999999999999 109.784 172.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.3 t -62.21 162.74 9.2 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.42 1.088 . . . . 1.1200000000000001 111.396 155.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 28.8 p-90 -104.0 -20.13 13.97 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.79 -0.641 . . . . 1.8500000000000001 112.099 163.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -81.41 -88.23 0.08 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.829 0.852 . . . . 2.2799999999999998 109.752 -174.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.7 p -64.93 -23.97 67.38 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 122.057 -0.402 . . . . 1.1599999999999999 111.933 171.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.16 21.68 75.74 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 118.814 0.734 . . . . 0.71999999999999997 113.557 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.17 154.86 38.61 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.765 1.283 . . . . 1.77 110.334 162.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 76.1 t -100.64 135.82 34.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 N-CA-C 105.749 -1.945 . . . . 1.8 105.749 164.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -116.62 146.92 42.36 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 126.748 2.019 . . . . 3.0 108.74 -176.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -134.08 151.37 51.37 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 122.366 1.079 . . . . 3.3599999999999999 113.56 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.0 tt -107.13 142.7 36.39 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 113.322 -1.763 . . . . 1.8700000000000001 111.827 -177.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -101.03 154.09 37.36 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 113.296 -1.775 . . . . 1.3799999999999999 111.259 -173.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.3 -4.39 15.13 Favored 'Trans proline' 0 N--CA 1.48 0.702 1 C-N-CA 125.577 4.184 . . . . 1.28 115.302 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.9 p -43.26 148.63 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 128.254 2.622 . . . . 2.8399999999999999 112.693 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.855 0 CA-C-O 123.361 1.534 . . . . 2.04 112.197 179.019 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 23.3 mtt . . . . . 0 C--O 1.214 -0.793 0 N-CA-C 106.889 -1.523 . . . . 4.2000000000000002 106.889 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -4.0 -66.21 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 128.564 2.746 . . . . 3.0499999999999998 117.823 171.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.3 t70 176.69 77.77 0.1 OUTLIER Pre-proline 0 CA--C 1.564 1.481 0 C-N-CA 130.742 3.617 . . . . 2.5699999999999998 109.857 -163.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -94.01 -51.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 1 C-N-CA 126.819 5.013 . . . . 1.1000000000000001 113.606 -173.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.82 142.23 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 131.153 3.781 . . . . 2.0800000000000001 104.488 -173.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.4 mm -114.51 134.62 56.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 C-N-CA 124.161 0.984 . . . . 1.73 110.199 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.3 mm -120.24 114.55 44.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 125.345 1.458 . . . . 2.0 107.781 174.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -71.49 122.1 19.84 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.911 1.284 . . . . 2.5600000000000001 110.466 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.5 m -158.43 105.13 1.86 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.728 -1.233 . . . . 4.6100000000000003 113.344 -172.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -75.03 40.02 0.14 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 127.161 2.184 . . . . 3.5499999999999998 113.051 -175.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.34 -2.18 0.69 Allowed 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.129 1.159 . . . . 3.4900000000000002 114.129 -168.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 63.25 -16.46 0.06 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 128.602 2.761 . . . . 3.27 115.046 -176.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -151.68 27.47 0.64 Allowed 'General case' 0 C--O 1.244 0.784 0 O-C-N 119.841 -1.787 . . . . 3.9700000000000002 113.193 -170.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -65.47 160.62 21.75 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.551 1.167 . . . . 4.7199999999999998 111.283 171.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -82.65 167.76 17.94 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.913 -1.04 . . . . 3.1600000000000001 113.036 167.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.9 p -118.61 141.9 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 127.916 2.487 . . . . 1.75 111.191 169.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.53 105.41 2.04 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.691 1.139 . . . . 0.82999999999999996 112.168 164.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.11 153.28 21.1 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.036 1.334 . . . . 1.1599999999999999 112.543 169.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 18.2 p -121.37 24.24 10.03 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.784 1.634 . . . . 1.9399999999999999 113.933 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.22 -28.29 6.29 Favored Glycine 0 N--CA 1.472 1.054 0 O-C-N 120.692 -1.255 . . . . 2.0299999999999998 112.775 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 83.0 p -175.87 163.03 2.0 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 128.521 2.728 . . . . 4.3499999999999996 107.67 -172.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.8 -3.7 10.9 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.31 2.673 . . . . 2.5600000000000001 113.906 172.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.88 0.31 18.63 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.671 1.189 . . . . 2.9700000000000002 114.059 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.29 91.57 0.39 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.533 1.063 . . . . 1.77 111.119 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.6 m -103.0 -30.35 10.83 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.011 0.745 . . . . 2.25 113.011 173.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -125.15 -151.37 0.48 Allowed 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 119.125 0.875 . . . . 1.52 111.544 166.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.3 t -73.02 -157.68 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 O-C-N 121.032 -1.043 . . . . 2.1800000000000002 111.371 166.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.4 tp -103.78 145.81 12.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 127.17 2.188 . . . . 2.3500000000000001 108.815 164.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.442 ' SD ' HD21 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -145.85 166.68 25.23 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.418 0.687 . . . . 5.4000000000000004 111.501 170.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -117.89 130.34 56.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.781 0.832 . . . . 2.04 112.147 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.442 HD21 ' SD ' ' A' ' 122' ' ' MET . 2.2 mt -128.84 163.78 24.48 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.452 1.101 . . . . 2.02 109.452 175.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 32.8 mttt -131.79 105.36 14.1 Favored Pre-proline 0 N--CA 1.48 1.027 0 CA-C-O 117.434 -1.27 . . . . 7.8399999999999999 110.957 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -71.82 -69.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.26 1.973 . . . . 3.21 112.96 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.9 m 100.94 147.37 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 130.287 3.435 . . . . 2.0899999999999999 108.82 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.4 p -44.38 -41.1 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 127.506 2.322 . . . . 1.98 114.733 -172.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -83.84 -22.52 31.7 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.27 1.028 . . . . 4.4100000000000001 112.317 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -131.82 179.08 6.29 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.948 1.699 . . . . 4.3200000000000003 114.913 -143.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 20.4 m -131.16 147.97 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 112.874 -1.966 . . . . 1.9099999999999999 114.757 -165.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -142.5 141.22 32.07 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.979 1.312 . . . . 1.8400000000000001 112.335 174.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -122.61 139.56 53.79 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.855 1.262 . . . . 5.5499999999999998 113.565 -170.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 42.6 t -72.4 145.34 47.75 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 116.448 2.018 . . . . 1.27 116.448 -174.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.421 ' CZ3' ' HG2' ' A' ' 136' ' ' GLU . 58.5 p-90 -95.5 -10.7 29.01 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 117.421 -1.276 . . . . 2.9399999999999999 113.765 175.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.421 ' HG2' ' CZ3' ' A' ' 135' ' ' TRP . 1.3 mm-40 -93.27 -66.3 0.93 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 120.089 1.313 . . . . 2.5099999999999998 108.345 175.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 12.4 p -74.86 -77.13 0.13 Allowed 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 121.844 0.83 . . . . 2.8999999999999999 110.927 173.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 125.0 18.58 2.57 Favored Glycine 0 N--CA 1.472 1.046 0 N-CA-C 117.692 1.837 . . . . 0.88 117.692 -165.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.4 p -74.92 142.63 43.98 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 120.655 2.228 . . . . 1.77 110.859 166.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 50.8 t -90.98 138.16 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 107.559 -1.275 . . . . 1.97 107.559 167.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -117.65 142.69 46.93 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.457 1.903 . . . . 3.0699999999999998 112.382 176.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -115.58 149.09 38.78 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.285 1.04 . . . . 3.0600000000000001 112.259 173.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.3 tt -99.45 158.07 15.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.151 -0.931 . . . . 1.95 110.071 168.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -114.3 156.01 44.94 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 114.82 1.415 . . . . 1.3500000000000001 114.82 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.08 -5.36 16.24 Favored 'Trans proline' 0 C--N 1.355 0.9 1 C-N-CA 125.65 4.233 . . . . 1.21 115.288 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.5 p -45.11 138.01 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 126.273 1.829 . . . . 2.9199999999999999 111.127 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.594 0 CA-C-O 122.851 1.251 . . . . 2.04 112.369 -174.647 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.7 mtt . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 119.445 3.128 . . . . 3.9100000000000001 119.445 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -58.88 6.67 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 120.969 -1.082 . . . . 2.8599999999999999 112.481 171.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 t0 165.32 71.75 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 129.461 3.105 . . . . 2.1099999999999999 108.906 -157.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.95 -50.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.391 1 C-N-CA 126.552 4.835 . . . . 0.81000000000000005 113.252 -171.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -150.63 141.64 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 1 C-N-CA 132.587 4.355 . . . . 1.72 104.141 -170.07 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 mm -109.88 136.14 46.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 125.163 1.385 . . . . 1.71 109.004 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.1 mm -116.75 143.01 28.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 105.299 -2.111 . . . . 1.8400000000000001 105.299 170.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -108.24 146.03 33.44 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.102 0.876 . . . . 3.1899999999999999 110.116 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.2 t -137.67 -54.71 0.67 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.852 1.427 . . . . 3.0899999999999999 114.852 -167.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 81.59 11.23 0.77 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 127.947 2.499 . . . . 3.9399999999999999 113.759 -167.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -149.12 156.76 42.68 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 129.396 3.079 . . . . 2.7400000000000002 107.351 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.48 -18.16 26.78 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.285 1.217 . . . . 2.9300000000000002 114.285 174.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.68 81.55 1.16 Allowed 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.86 1.43 . . . . 4.2599999999999998 114.86 -158.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -127.39 167.91 15.57 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 120.898 -1.126 . . . . 6.3200000000000003 113.219 167.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -90.8 171.32 9.41 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.306 1.443 . . . . 3.4300000000000002 113.882 -174.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.4 p -124.98 143.12 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 126.685 1.994 . . . . 1.8700000000000001 111.228 171.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.26 92.76 1.01 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.585 1.564 . . . . 0.73999999999999999 112.081 162.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -106.19 146.55 30.13 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.553 1.676 . . . . 1.26 113.727 176.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.9 p -115.54 4.79 14.28 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.358 1.463 . . . . 1.8999999999999999 114.166 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 138.07 -27.13 2.8 Favored Glycine 0 N--CA 1.468 0.777 0 O-C-N 121.405 -0.809 . . . . 2.5800000000000001 114.898 -169.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.0 t 106.12 144.85 0.01 OUTLIER Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 128.091 2.556 . . . . 4.5499999999999998 106.681 -138.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.15 93.76 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.95 2.433 . . . . 4.1500000000000004 110.76 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 176.86 21.32 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 129.256 3.022 . . . . 2.8599999999999999 113.412 166.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 67.2 43.21 90.03 Favored Glycine 0 C--N 1.341 0.837 0 O-C-N 121.133 -0.979 . . . . 2.25 113.777 167.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 5.3 t -60.68 -36.35 78.55 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.156 0.978 . . . . 3.8399999999999999 111.905 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 26.4 p80 -135.65 -141.1 0.17 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.017 1.327 . . . . 1.5800000000000001 112.323 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.4 t -85.13 -141.39 0.08 Allowed 'General case' 0 C--O 1.218 -0.583 0 C-N-CA 124.14 0.976 . . . . 2.3500000000000001 108.812 158.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.7 tp -123.08 141.22 44.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 130.23 3.412 . . . . 2.25 111.689 174.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.409 ' SD ' ' NE1' ' A' ' 135' ' ' TRP . 12.9 mmt -136.47 154.57 50.72 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 116.379 1.992 . . . . 5.6399999999999997 116.379 -173.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -115.65 87.79 2.74 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.753 -0.658 . . . . 1.97 111.789 -170.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 mt -103.1 167.99 9.47 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.487 -0.758 . . . . 2.1099999999999999 109.354 -174.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.57 88.86 2.73 Favored Pre-proline 0 N--CA 1.475 0.789 0 O-C-N 121.033 -1.042 . . . . 8.5600000000000005 112.556 -167.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -81.37 173.4 11.64 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.477 2.784 . . . . 2.3399999999999999 109.933 170.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -113.55 156.83 22.91 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.45 1.9 . . . . 1.95 107.883 169.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 p -50.3 -39.53 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-N 119.992 1.269 . . . . 1.9099999999999999 113.952 170.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -79.59 -5.59 55.31 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.263 0.838 . . . . 1.8999999999999999 113.263 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -143.16 -164.14 1.79 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.561 0.744 . . . . 2.2200000000000002 111.773 -155.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.4 m -149.74 158.57 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.731 2.012 . . . . 1.8300000000000001 110.263 -171.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -143.62 139.61 29.72 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.224 1.01 . . . . 1.8400000000000001 111.637 170.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.9 ttt-85 -97.96 146.14 25.78 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.457 0.703 . . . . 5.1699999999999999 110.32 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 9.7 t -60.2 160.35 8.46 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.545 1.538 . . . . 1.0900000000000001 110.627 159.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.409 ' NE1' ' SD ' ' A' ' 122' ' ' MET . 27.7 p-90 -99.86 -17.71 17.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 117.479 -1.248 . . . . 1.6100000000000001 111.822 160.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -86.25 -95.38 0.08 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.923 1.289 . . . . 1.51 109.502 -173.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.3 p -64.28 -13.33 49.05 Favored 'General case' 0 CA--C 1.557 1.233 0 O-C-N 119.963 -1.711 . . . . 1.1599999999999999 114.929 -177.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.75 16.8 80.15 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.95 1.738 . . . . 0.75 114.909 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.82 142.4 49.63 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.399 1.6 . . . . 1.74 110.56 169.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.26 147.94 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 108.355 -0.979 . . . . 1.6599999999999999 108.355 158.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -126.27 153.49 44.7 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 128.928 2.891 . . . . 3.02 111.037 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 46.7 tttt -130.39 152.89 49.31 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.621 0.768 . . . . 3.7599999999999998 112.763 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.642 HD21 ' H ' ' A' ' 144' ' ' ASN . 0.8 OUTLIER -99.34 164.92 11.92 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.874 1.321 . . . . 3.5800000000000001 111.283 161.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.642 ' H ' HD21 ' A' ' 143' ' ' LEU . 27.7 p30 -123.96 167.56 15.0 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 127.538 2.335 . . . . 1.52 110.804 -177.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -83.75 -26.42 2.04 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.717 2.278 . . . . 1.3600000000000001 113.776 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.7 m 38.66 -164.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 129.976 3.31 . . . . 3.7799999999999998 117.238 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.833 0 CA-C-O 123.746 1.748 . . . . 2.1200000000000001 113.174 132.031 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.0 mtt . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 118.749 2.87 . . . . 4.2400000000000002 118.749 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.22 -80.67 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.306 0.574 . . . . 3.5299999999999998 110.188 161.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.8 t0 177.13 77.78 0.11 Allowed Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 127.073 2.149 . . . . 2.3799999999999999 108.1 -162.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -93.96 -57.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 1 C-N-CA 127.053 5.168 . . . . 0.97999999999999998 115.402 -162.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.15 140.92 29.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 1 C-N-CA 131.803 4.041 . . . . 2.0 103.709 -170.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 mm -111.69 135.92 49.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 123.633 0.773 . . . . 2.1000000000000001 110.502 -175.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.2 mm -123.89 100.18 7.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 126.584 1.954 . . . . 2.1200000000000001 106.23 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -78.8 120.41 23.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 113.547 -1.661 . . . . 2.5600000000000001 110.455 -163.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.7 t -110.28 -65.74 1.13 Allowed 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 115.049 1.5 . . . . 2.7599999999999998 115.049 -154.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 71.86 11.13 6.26 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.826 2.05 . . . . 3.4700000000000002 112.555 -171.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -138.1 153.37 49.28 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 130.046 3.338 . . . . 2.8300000000000001 107.306 163.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -71.29 -9.26 57.83 Favored 'General case' 0 CA--C 1.552 1.054 0 O-C-N 120.645 -1.284 . . . . 3.1499999999999999 113.032 172.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -141.45 104.07 4.52 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.417 2.287 . . . . 3.8199999999999998 111.405 -164.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -148.94 168.79 22.13 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.709 -1.244 . . . . 4.5599999999999996 112.306 174.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -103.94 158.11 16.63 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.727 0.811 . . . . 3.8300000000000001 111.32 166.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.6 p -102.33 141.12 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.238 1.415 . . . . 2.3300000000000001 110.291 169.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -106.92 78.54 0.25 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.341 1.448 . . . . 1.1899999999999999 112.867 169.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 12.9 p -94.95 143.0 26.82 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 119.596 1.698 . . . . 1.45 113.285 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 35.6 p -105.95 19.02 21.21 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-N 112.532 -2.122 . . . . 1.78 112.141 169.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.07 60.84 0.34 Allowed Glycine 0 C--N 1.334 0.47 0 CA-C-O 119.033 -0.871 . . . . 1.72 113.675 176.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 68.59 -166.06 0.01 OUTLIER Pre-proline 0 CA--C 1.556 1.204 0 CA-C-O 117.836 -1.078 . . . . 6.2699999999999996 109.874 171.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.85 52.09 3.87 Favored 'Trans proline' 0 C--N 1.354 0.837 0 CA-C-N 122.768 2.024 . . . . 4.6799999999999997 111.598 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -163.1 7.54 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 116.031 1.863 . . . . 4.7800000000000002 116.031 -160.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 51.87 47.95 52.35 Favored Glycine 0 N--CA 1.475 1.29 0 N-CA-C 115.061 0.784 . . . . 2.6499999999999999 115.061 159.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.2 m -113.83 -21.73 10.52 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 116.331 1.975 . . . . 2.52 116.331 -151.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -123.57 -148.5 0.4 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 121.096 1.771 . . . . 1.3700000000000001 113.904 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.6 t -72.68 -153.23 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.323 0.649 . . . . 1.6599999999999999 110.946 162.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.2 tp -117.12 136.53 53.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 126.466 1.906 . . . . 1.8300000000000001 112.488 167.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.461 ' CE ' ' HE1' ' A' ' 135' ' ' TRP . 17.3 mmm -131.62 155.83 46.87 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.818 -1.537 . . . . 5.0 114.688 -176.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -123.59 111.77 16.64 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.816 -1.084 . . . . 1.8999999999999999 109.956 -177.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 mt -124.01 148.9 46.64 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.648 -0.501 . . . . 2.1099999999999999 109.648 -171.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.26 108.3 58.67 Favored Pre-proline 0 N--CA 1.484 1.242 0 CA-C-O 118.798 -0.62 . . . . 6.5 111.789 -175.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -89.87 -175.21 0.96 Allowed 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.126 2.55 . . . . 2.73 109.895 154.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 94.8 m -158.92 157.44 31.41 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.72 2.808 . . . . 2.3300000000000001 105.199 173.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.417 HG12 HD21 ' A' ' 129' ' ' ASN . 7.5 p -49.71 -32.41 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 115.309 1.596 . . . . 1.9099999999999999 115.309 -176.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.417 HD21 HG12 ' A' ' 128' ' ' VAL . 1.7 m-80 -79.27 -0.81 33.83 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.027 1.331 . . . . 2.4300000000000002 113.949 177.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -141.29 -175.83 4.49 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 123.545 1.64 . . . . 2.7400000000000002 114.503 -151.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.5 m -139.22 168.08 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 130.244 3.418 . . . . 1.97 107.267 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -147.82 128.11 13.88 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 123.924 0.89 . . . . 1.8600000000000001 111.13 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -92.33 141.17 28.84 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.937 0.789 . . . . 5.2400000000000002 110.351 173.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 9.2 t -63.54 174.81 1.2 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 122.789 1.281 . . . . 1.1899999999999999 112.446 159.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.461 ' HE1' ' CE ' ' A' ' 122' ' ' MET . 20.8 p-90 -111.34 -18.37 12.93 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.316 -0.856 . . . . 1.8100000000000001 111.983 161.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.9 -87.7 0.14 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.67 1.988 . . . . 1.71 108.092 -171.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 24.3 p -59.84 -19.68 52.53 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 120.477 -1.39 . . . . 1.1000000000000001 112.664 168.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.98 15.89 22.89 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.669 1.604 . . . . 0.92000000000000004 114.186 -175.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.1 p -75.04 142.24 43.79 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 119.122 1.461 . . . . 1.28 110.722 172.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 52.8 t -80.72 147.61 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.455 -0.942 . . . . 1.6499999999999999 108.455 167.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -130.84 158.47 40.09 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 130.231 3.413 . . . . 3.79 109.457 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -140.39 147.0 39.08 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 113.759 1.022 . . . . 4.25 113.759 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.7 tt -93.4 145.13 24.71 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 115.36 -0.836 . . . . 1.78 110.771 170.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -112.21 147.36 36.79 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 124.618 1.167 . . . . 1.3999999999999999 110.392 171.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -69.98 -27.57 25.25 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.549 2.166 . . . . 1.8200000000000001 112.497 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.6 m 41.5 -158.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 129.002 2.921 . . . . 3.3399999999999999 114.933 -174.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.419 0 CA-C-O 122.228 0.904 . . . . 3.0699999999999998 112.477 157.746 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.9 mtt . . . . . 0 CA--C 1.521 -0.156 0 CA-C-O 123.911 1.815 . . . . 3.48 111.779 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 177.09 -123.48 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.119 1 C-N-CA 132.108 4.163 . . . . 2.9700000000000002 107.077 178.13 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . 0.27 30.0 t70 -131.33 78.6 71.76 Favored Pre-proline 0 N--CA 1.432 -1.334 0 C-N-CA 126.6 1.96 . . . . 2.54 107.699 176.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.417 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 74.4 Cg_endo -83.13 -84.06 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.6 1 C-N-CA 126.876 5.05 . . . . 1.23 113.14 -171.33 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.417 ' H ' ' HG2' ' A' ' 97' ' ' PRO . 0.7 OUTLIER -102.65 147.56 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 C-N-CA 127.835 2.454 . . . . 1.8600000000000001 106.406 171.744 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.2 mm -105.77 136.05 41.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.932 -0.576 . . . . 1.8400000000000001 111.21 -174.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.5 mm -119.25 99.12 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 126.169 1.788 . . . . 1.8600000000000001 107.572 169.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -70.39 122.86 20.41 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.543 1.537 . . . . 3.0 108.968 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.6 m -162.23 123.49 2.65 Favored 'General case' 0 C--O 1.221 -0.442 0 O-C-N 121.06 -1.025 . . . . 4.9000000000000004 112.687 -165.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -83.47 25.71 0.73 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.203 1.001 . . . . 3.79 113.316 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -140.95 124.6 16.89 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.766 2.026 . . . . 2.6699999999999999 107.967 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -62.51 7.99 0.06 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 127.771 2.428 . . . . 3.3799999999999999 117.468 -169.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.08 22.8 0.07 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.761 2.424 . . . . 3.6299999999999999 112.458 -165.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.2 ttt-85 -67.39 150.12 49.38 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.503 1.121 . . . . 4.9199999999999999 113.387 -174.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -82.99 150.91 26.09 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.893 0.701 . . . . 3.5 112.893 176.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.5 p -108.07 138.8 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.502 1.521 . . . . 1.8400000000000001 111.168 169.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -108.66 103.14 1.79 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.492 -1.443 . . . . 0.69999999999999996 109.492 159.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.04 155.8 17.25 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.949 0.9 . . . . 1.24 110.554 166.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 120' ' ' THR . 40.9 p -118.11 4.94 11.99 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 116.463 2.023 . . . . 1.8400000000000001 116.463 172.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.71 56.3 0.29 Allowed Glycine 0 C--N 1.33 0.224 0 CA-C-O 119.443 -0.643 . . . . 2.0800000000000001 113.016 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 79.5 -162.2 0.0 OUTLIER Pre-proline 0 CA--C 1.565 1.528 0 CA-C-O 116.61 -1.662 . . . . 3.77 109.245 -168.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -80.55 45.93 2.11 Favored 'Trans proline' 0 C--N 1.358 1.053 0 CA-C-N 124.524 2.651 . . . . 2.6499999999999999 112.915 -173.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -166.55 163.7 17.04 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.025 1.33 . . . . 3.9300000000000002 110.785 -169.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.89 42.41 2.49 Favored Glycine 0 N--CA 1.473 1.125 0 C-N-CA 124.478 1.037 . . . . 2.5600000000000001 114.048 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.1 m -68.93 -40.6 78.93 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.657 1.229 . . . . 2.5299999999999998 114.028 -160.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -106.27 -73.23 0.69 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.04 0.756 . . . . 1.8999999999999999 113.04 173.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 112' ' ' THR . 7.0 t -178.99 -166.12 0.09 Allowed 'General case' 0 N--CA 1.475 0.789 1 C-N-CA 132.685 4.394 . . . . 1.97 106.609 -175.339 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.6 tp -98.77 138.42 23.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 119.771 1.169 . . . . 1.95 110.729 173.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.435 ' SD ' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -141.02 163.43 32.99 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.121 1.368 . . . . 5.2300000000000004 110.441 166.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.3 m95 -130.22 87.67 2.54 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.868 -0.52 . . . . 3.1600000000000001 111.611 -155.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.435 HD22 ' SD ' ' A' ' 122' ' ' MET . 3.2 mt -95.64 167.42 11.3 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 120.498 -1.376 . . . . 1.8500000000000001 110.746 -171.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.35 88.02 15.19 Favored Pre-proline 0 N--CA 1.472 0.675 0 C-N-CA 123.592 0.757 . . . . 8.2599999999999998 111.29 -176.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -77.27 166.61 26.01 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.575 2.184 . . . . 2.3700000000000001 110.412 165.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 m -120.18 154.86 34.2 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 127.097 2.159 . . . . 1.97 108.295 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.4 p -54.95 -34.21 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 112.939 0.718 . . . . 1.98 112.939 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -82.17 -10.07 59.29 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.62 1.168 . . . . 1.6799999999999999 113.508 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -140.02 -168.34 2.5 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.696 0.68 . . . . 2.5499999999999998 112.649 -155.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.83 157.67 23.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 126.93 2.092 . . . . 1.76 109.385 -171.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.2 144.89 36.82 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.113 0.965 . . . . 1.6200000000000001 110.968 172.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.4 ttp180 -111.74 139.3 47.33 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.443 1.02 . . . . 4.8499999999999996 112.557 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 37.8 t -60.34 156.33 15.97 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.244 1.418 . . . . 1.02 112.484 163.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -100.43 -12.85 19.03 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.063 -0.971 . . . . 1.4199999999999999 112.766 169.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -103.39 -78.99 0.54 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.163 0.892 . . . . 2.5800000000000001 111.246 -169.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 26.6 p -70.02 -22.19 63.12 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.853 0.861 . . . . 1.3700000000000001 112.407 172.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.58 33.36 80.93 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.441 1.02 . . . . 1.0800000000000001 113.273 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.11 152.67 42.18 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.839 1.319 . . . . 1.96 110.508 158.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.1 t -100.24 135.4 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 106.335 -1.728 . . . . 1.5900000000000001 106.335 159.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -117.4 140.47 49.53 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 127.735 2.414 . . . . 2.8799999999999999 110.875 -176.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.8 tttm -106.14 147.47 28.96 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.639 -0.71 . . . . 3.6800000000000002 112.704 173.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.43 144.78 25.48 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 114.847 -1.069 . . . . 2.0 110.168 155.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -106.66 159.34 30.22 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 124.596 1.158 . . . . 1.3100000000000001 113.006 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -71.8 -5.16 16.51 Favored 'Trans proline' 0 C--N 1.354 0.861 1 C-N-CA 126.274 4.65 . . . . 1.3100000000000001 115.983 -177.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.9 p -48.11 142.42 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 126.141 1.777 . . . . 2.8199999999999998 111.511 177.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.717 0 CA-C-O 122.993 1.33 . . . . 2.1800000000000002 112.674 179.353 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 10.9 mtm . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 118.428 2.751 . . . . 3.5600000000000001 118.428 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.32 -59.66 2.62 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.791 0.663 . . . . 3.4100000000000001 112.791 169.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 167.05 70.44 0.0 OUTLIER Pre-proline 0 CA--C 1.566 1.571 0 C-N-CA 129.674 3.189 . . . . 3.0 110.167 -150.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -89.02 -50.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.334 -0.229 1 C-N-CA 125.529 4.152 . . . . 0.73999999999999999 113.358 -174.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.98 141.74 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 1 C-N-CA 131.954 4.102 . . . . 1.76 104.207 -172.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.3 mm -119.48 129.43 75.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 124.303 1.041 . . . . 1.9399999999999999 111.153 -175.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 42.0 mm -115.39 98.21 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 125.688 1.595 . . . . 1.74 107.515 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -71.12 99.67 1.9 Allowed 'General case' 0 C--N 1.328 -0.361 0 O-C-N 125.569 1.793 . . . . 2.54 108.333 176.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.7 p -104.92 -43.6 5.03 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.041 1.126 . . . . 3.7000000000000002 114.041 -157.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . 0.252 35.5 m-85 72.32 9.77 5.86 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 127.742 2.417 . . . . 3.8999999999999999 114.45 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -132.66 150.21 52.19 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.58 -0.896 . . . . 3.1099999999999999 108.58 134.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.05 -28.01 22.55 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.969 2.507 . . . . 3.4399999999999999 114.91 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -127.1 12.77 7.19 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.525 1.53 . . . . 3.98 114.044 -161.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -56.57 175.28 0.12 Allowed 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 122.458 1.123 . . . . 4.71 113.25 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -95.41 169.32 10.14 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.582 -0.699 . . . . 3.8100000000000001 111.348 157.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.7 p -116.22 143.16 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 126.884 2.074 . . . . 2.0600000000000001 111.472 171.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -104.69 101.33 1.92 Allowed Glycine 0 CA--C 1.532 1.142 0 CA-C-O 117.974 -1.459 . . . . 0.82999999999999996 114.142 165.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 13.8 p -107.43 145.61 32.77 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-O 123.908 1.813 . . . . 1.6599999999999999 113.386 160.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 74.3 p -102.44 16.4 26.4 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 112.494 -2.139 . . . . 1.8 111.627 165.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 142.45 176.0 16.2 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-O 123.693 1.718 . . . . 3.4500000000000002 114.599 -171.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.6 m -3.47 133.68 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.242 0 CA-C-N 111.757 -2.222 . . . . 4.2300000000000004 115.785 103.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.85 57.39 4.46 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 125.131 3.887 . . . . 3.1200000000000001 114.476 -169.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -169.27 48.74 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.815 1.246 . . . . 2.6200000000000001 111.622 -167.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 55.7 24.69 41.25 Favored Glycine 0 N--CA 1.48 1.627 0 C-N-CA 125.077 1.322 . . . . 2.1299999999999999 115.925 166.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.2 m -77.38 -41.6 39.55 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.754 1.02 . . . . 2.7000000000000002 113.754 -144.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -115.12 -149.01 0.44 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.937 1.295 . . . . 1.51 112.395 -176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.4 t -71.92 -155.43 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.692 0.678 . . . . 2.1499999999999999 110.987 160.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.5 tp -115.37 138.68 44.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 C-N-CA 126.483 1.913 . . . . 1.96 111.082 165.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.505 ' CE ' ' HE1' ' A' ' 135' ' ' TRP . 13.2 mmm -131.95 153.38 50.36 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 115.144 1.535 . . . . 4.8499999999999996 115.144 -174.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -118.33 99.57 6.93 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 124.528 1.143 . . . . 1.98 110.309 -173.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.3 mt -109.45 162.47 14.34 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.498 0.719 . . . . 1.99 109.63 -173.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -121.89 74.57 36.87 Favored Pre-proline 0 N--CA 1.487 1.38 0 O-C-N 120.425 -1.422 . . . . 5.4100000000000001 114.782 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -86.47 39.56 0.65 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.908 3.072 . . . . 3.3399999999999999 114.922 -171.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.8 m -28.02 151.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 1 C-N-CA 132.206 4.202 . . . . 2.0499999999999998 115.27 -169.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.4 p -45.66 -39.02 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 114.703 1.372 . . . . 1.8600000000000001 114.703 177.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -81.48 -8.63 59.75 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.403 1.481 . . . . 1.74 113.823 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.406 ' O ' ' HE3' ' A' ' 142' ' ' LYS . 30.3 mt-10 -136.17 -159.53 0.97 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.34 1.056 . . . . 2.1299999999999999 110.52 -156.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 20.9 m -157.81 153.53 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 130.246 3.419 . . . . 1.99 106.15 177.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -142.38 143.52 32.73 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.535 0.607 . . . . 1.8500000000000001 111.044 171.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -100.35 142.6 31.61 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.285 0.634 . . . . 5.6600000000000001 110.446 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 14.6 t -60.05 159.06 9.98 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 124.514 1.134 . . . . 1.04 111.52 161.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.505 ' HE1' ' CE ' ' A' ' 122' ' ' MET . 20.6 p-90 -103.96 -12.79 16.62 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.6 -0.727 . . . . 1.5700000000000001 111.703 163.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -89.65 -87.05 0.18 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.933 1.293 . . . . 1.55 108.842 -176.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 23.0 p -74.65 -15.16 60.82 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.256 1.206 . . . . 1.4299999999999999 114.256 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 66.85 18.94 69.09 Favored Glycine 0 N--CA 1.469 0.876 0 C-N-CA 126.318 1.913 . . . . 0.73999999999999999 115.075 172.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.27 141.83 57.89 Favored 'General case' 0 N--CA 1.46 0.059 0 C-N-CA 118.593 -1.243 . . . . 1.75 110.349 163.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 45.9 t -78.94 141.8 14.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 107.782 -1.192 . . . . 2.0600000000000001 107.782 159.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -122.52 156.61 33.8 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 128.082 2.553 . . . . 2.9399999999999999 110.219 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.406 ' HE3' ' O ' ' A' ' 130' ' ' GLU . 66.5 tttt -136.64 152.76 50.78 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 122.315 1.055 . . . . 3.1400000000000001 113.027 173.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.3 tt -112.16 167.4 10.44 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.561 1.545 . . . . 2.0800000000000001 109.252 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -126.52 165.7 26.51 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.507 1.523 . . . . 1.45 113.581 -168.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.32 -4.43 15.4 Favored 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 124.07 3.18 . . . . 1.55 115.256 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.8 p -44.54 140.35 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 127.974 2.51 . . . . 2.75 114.026 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.734 0 C-N-CA 126.541 2.02 . . . . 2.6600000000000001 110.335 -179.473 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.2 mtp . . . . . 0 C--O 1.224 -0.24 0 N-CA-C 116.985 2.217 . . . . 4.25 116.985 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.462 ' CG ' ' H ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -121.33 -74.69 0.61 Allowed 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 124.305 1.042 . . . . 3.27 109.29 173.639 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.462 ' H ' ' CG ' ' A' ' 95' ' ' LYS . 38.4 t70 179.44 75.9 0.17 Allowed Pre-proline 0 CA--C 1.559 1.324 0 C-N-CA 128.242 2.617 . . . . 2.5899999999999999 107.893 -166.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -89.23 -51.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.551 1 C-N-CA 128.582 6.188 . . . . 0.85999999999999999 113.437 -175.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -139.58 143.12 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 130.746 3.618 . . . . 1.55 104.844 -175.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.0 mm -102.76 138.34 27.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.671 -0.695 . . . . 1.8600000000000001 110.822 -176.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.3 mm -120.5 107.11 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 C-N-CA 127.036 2.134 . . . . 1.8899999999999999 107.462 170.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -78.61 134.32 37.2 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 124.601 1.188 . . . . 3.2200000000000002 110.867 -174.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 104' ' ' ASP . 13.2 t -162.24 107.22 1.21 Allowed 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 113.144 0.794 . . . . 2.71 113.144 -163.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.3 m-30 -77.33 41.53 0.31 Allowed 'General case' 0 N--CA 1.48 1.063 0 O-C-N 120.524 -1.36 . . . . 3.8199999999999998 110.762 171.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 102' ' ' SER . 0.0 OUTLIER -159.37 123.71 3.93 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.956 2.902 . . . . 3.1699999999999999 107.965 -166.091 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.54 -3.6 31.86 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 115.582 1.697 . . . . 3.3399999999999999 115.582 -166.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.36 21.64 1.06 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 125.112 1.365 . . . . 3.3399999999999999 113.662 -156.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.04 154.06 18.34 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 120.148 -1.595 . . . . 6.8899999999999997 114.991 -154.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.8 161.18 31.38 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.319 1.229 . . . . 3.3300000000000001 114.319 -177.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.4 p -129.6 145.84 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 127.455 2.302 . . . . 2.1600000000000001 109.84 171.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.17 126.74 6.39 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.155 0.883 . . . . 0.81999999999999995 111.605 164.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.97 151.97 39.09 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.366 1.867 . . . . 1.52 111.94 169.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 34.0 p -117.83 25.97 10.01 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.164 1.385 . . . . 1.95 113.385 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.85 68.27 1.03 Allowed Glycine 0 N--CA 1.462 0.428 0 O-C-N 120.844 -1.16 . . . . 2.4900000000000002 111.017 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.46 177.71 0.06 OUTLIER Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 123.521 0.728 . . . . 3.5800000000000001 110.01 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.23 38.96 0.76 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.061 2.507 . . . . 3.1200000000000001 112.705 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -151.93 3.2 0.38 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.851 1.797 . . . . 3.3700000000000001 115.851 -165.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.38 72.22 0.98 Allowed Glycine 0 N--CA 1.474 1.188 0 C-N-CA 124.849 1.214 . . . . 1.8600000000000001 114.206 167.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.5 t -103.63 -30.38 10.5 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 115.338 1.607 . . . . 3.1299999999999999 115.338 -174.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.406 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 9.1 p80 -128.32 -148.12 0.37 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.631 0.773 . . . . 1.3300000000000001 112.042 -176.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.2 t -78.16 -152.34 0.05 Allowed 'General case' 0 N--CA 1.479 1.016 0 O-C-N 121.268 -0.895 . . . . 1.9099999999999999 111.376 167.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.5 tp -106.65 149.91 9.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 127.667 2.387 . . . . 2.1200000000000001 110.212 164.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.18 172.35 12.88 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.806 1.242 . . . . 5.8099999999999996 110.036 170.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -137.45 124.96 22.08 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.004 0.521 . . . . 1.9399999999999999 111.493 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.61 179.75 4.13 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.981 0.912 . . . . 1.98 109.185 176.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.27 102.6 2.95 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.973 0.909 . . . . 7.2400000000000002 111.738 174.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -80.4 171.63 14.6 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.144 2.563 . . . . 2.3199999999999998 110.22 164.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.8 m -122.72 155.97 35.37 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 127.2 2.2 . . . . 2.0800000000000001 107.628 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.4 p -55.2 -30.9 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 120.571 1.532 . . . . 1.8700000000000001 112.485 175.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -82.93 -7.52 59.66 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.12 1.768 . . . . 1.6000000000000001 113.521 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -147.42 -169.67 3.37 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.29 1.036 . . . . 2.1600000000000001 112.146 -156.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.8 m -142.18 170.31 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 127.757 2.423 . . . . 1.8100000000000001 109.739 -170.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -150.85 147.55 27.38 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.019 0.927 . . . . 1.6699999999999999 111.505 172.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.6 ttt-85 -114.11 139.2 49.52 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.64 0.776 . . . . 5.46 112.333 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 40.1 t -56.78 157.67 5.32 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.817 1.247 . . . . 1.0 112.71 159.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 67.2 p-90 -109.68 -9.05 14.87 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.307 -0.871 . . . . 1.3400000000000001 112.691 167.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.406 ' HB3' ' CD2' ' A' ' 119' ' ' HIS . 4.0 mm-40 -96.22 -83.8 0.37 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.992 1.317 . . . . 1.6699999999999999 109.682 -173.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.4 p -72.43 -14.99 61.83 Favored 'General case' 0 CA--C 1.551 0.983 0 O-C-N 120.644 -1.285 . . . . 1.22 112.651 167.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.49 22.64 76.57 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 119.075 -0.847 . . . . 0.76000000000000001 113.725 169.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.476 ' HG ' ' HE1' ' A' ' 141' ' ' TYR . 5.5 p -71.21 130.48 41.55 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 118.388 1.094 . . . . 1.6000000000000001 110.186 170.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.5 t -77.23 147.16 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.451 -0.574 . . . . 1.8200000000000001 109.451 161.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.476 ' HE1' ' HG ' ' A' ' 139' ' ' SER . 83.3 m-85 -131.52 156.61 45.4 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 130.544 3.538 . . . . 3.1600000000000001 110.523 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -140.27 153.2 46.43 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 113.59 0.959 . . . . 3.0899999999999999 113.59 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.2 tt -100.66 144.1 30.03 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 122.042 0.925 . . . . 1.6899999999999999 112.372 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -99.37 162.94 19.64 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.249 1.02 . . . . 1.3100000000000001 112.824 -174.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -75.51 -28.01 8.72 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.606 2.871 . . . . 1.53 113.837 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER 47.88 -161.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 128.032 2.533 . . . . 4.1799999999999997 116.781 169.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.971 0 CA-C-O 122.39 0.994 . . . . 2.0299999999999998 114.863 132.224 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.9 mtm . . . . . 0 N--CA 1.469 0.515 0 CA-C-O 121.902 0.858 . . . . 3.5699999999999998 112.756 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 129.73 -132.0 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.763 1 C-N-CA 132.676 4.39 . . . . 3.96 107.822 -156.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -126.54 91.58 47.15 Favored Pre-proline 0 N--CA 1.436 -1.155 0 C-N-CA 128.882 2.873 . . . . 2.23 107.185 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -95.99 -49.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.373 1 C-N-CA 126.649 4.899 . . . . 0.70999999999999996 112.737 -178.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -150.62 138.48 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 131.5 3.92 . . . . 1.8100000000000001 103.934 -171.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.5 mm -115.48 134.95 57.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 124.635 1.174 . . . . 2.0699999999999998 111.047 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.3 mm -121.97 112.88 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 C-N-CA 126.336 1.854 . . . . 1.7 107.416 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -82.83 136.29 34.68 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 125.023 1.452 . . . . 2.5499999999999998 111.868 -173.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.0 t -125.4 -54.59 1.57 Allowed 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 113.995 1.109 . . . . 2.8300000000000001 113.995 -154.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.538 ' H ' ' CG2' ' A' ' 146' ' ' VAL 0.29 17.0 m-85 73.21 15.54 4.38 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.915 2.086 . . . . 4.2800000000000002 113.336 -172.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -151.57 168.06 26.14 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 131.677 3.991 . . . . 2.6400000000000001 106.986 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -72.28 -8.38 54.54 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.844 1.258 . . . . 2.8900000000000001 113.547 164.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.2 120.18 8.76 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 123.651 1.691 . . . . 3.6299999999999999 115.046 -164.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 81.1 mmt-85 -143.23 177.28 8.52 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.922 2.489 . . . . 5.6500000000000004 110.09 167.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -100.66 172.92 6.79 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.659 -0.651 . . . . 3.6200000000000001 109.822 149.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.0 142.22 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.99 0.916 . . . . 1.8999999999999999 111.206 171.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -107.95 92.92 0.77 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-O 117.688 -1.618 . . . . 0.66000000000000003 113.647 169.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 12.7 p -101.24 148.26 25.32 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 119.788 1.794 . . . . 1.48 113.478 166.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.4 p -113.11 13.0 19.26 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 113.24 -1.8 . . . . 1.7 113.501 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.25 81.12 1.57 Allowed Glycine 0 N--CA 1.463 0.445 0 N-CA-C 110.42 -1.072 . . . . 2.4100000000000001 110.42 -176.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 10.1 p 58.24 -163.28 0.01 OUTLIER Pre-proline 0 CA--C 1.563 1.46 0 CA-C-O 117.106 -1.426 . . . . 3.2799999999999998 111.302 -171.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.08 -6.06 17.53 Favored 'Trans proline' 0 C--N 1.356 0.971 0 CA-C-N 123.321 2.222 . . . . 2.7000000000000002 113.711 173.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -98.66 13.65 31.36 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.01 1.485 . . . . 2.5299999999999998 115.01 -165.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.5 34.26 88.66 Favored Glycine 0 N--CA 1.476 1.32 0 O-C-N 121.15 -0.969 . . . . 1.9299999999999999 113.866 172.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.02 -39.68 83.1 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.066 1.136 . . . . 2.79 114.066 -163.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -113.29 -149.14 0.44 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.239 1.816 . . . . 1.28 112.917 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.6 t -73.41 -153.67 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 119.31 0.959 . . . . 1.98 111.115 162.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.0 tp -117.86 137.83 50.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 126.896 2.078 . . . . 1.8500000000000001 111.499 165.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.463 ' CE ' ' HE1' ' A' ' 135' ' ' TRP . 13.6 mmm -131.66 151.74 51.4 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 115.527 1.676 . . . . 4.8499999999999996 115.527 -172.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -117.01 103.8 10.62 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 124.209 0.943 . . . . 1.9299999999999999 110.515 -174.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.9 mt -111.53 161.91 15.67 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.202 0.601 . . . . 2.04 110.423 -174.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.72 84.62 10.42 Favored Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 114.517 1.303 . . . . 7.0599999999999996 114.517 -171.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -88.63 14.96 2.17 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.59 2.86 . . . . 3.1000000000000001 116.265 -164.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.8 m -29.85 152.78 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 1 C-N-CA 131.804 4.041 . . . . 2.1000000000000001 115.322 -165.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.9 p -47.08 -43.21 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 115.174 1.546 . . . . 2.4300000000000002 115.174 -177.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -78.05 -5.52 51.68 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.795 1.638 . . . . 2.0099999999999998 114.222 178.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -131.79 -177.45 4.43 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 122.758 1.266 . . . . 3.1000000000000001 112.169 -159.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.4 m -148.81 156.1 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 128.591 2.756 . . . . 1.71 106.744 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.22 132.75 28.66 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 122.68 0.392 . . . . 2.1600000000000001 110.803 175.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.6 ttm-85 -86.22 138.19 32.06 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.189 -1.041 . . . . 5.3200000000000003 108.189 168.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 20.7 t -57.67 153.03 14.12 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 124.398 1.061 . . . . 1.23 110.942 153.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.463 ' HE1' ' CE ' ' A' ' 122' ' ' MET . 19.2 p-90 -97.45 -18.63 18.94 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.524 -0.75 . . . . 2.0 111.471 163.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -83.37 -92.31 0.07 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.129 0.971 . . . . 1.6100000000000001 108.804 -177.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 32.1 p -65.59 -15.43 62.72 Favored 'General case' 0 CA--C 1.553 1.07 0 O-C-N 120.559 -1.338 . . . . 1.3600000000000001 114.46 176.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.44 17.82 76.51 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 126.581 2.038 . . . . 0.83999999999999997 115.348 169.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.4 p -77.26 144.66 38.03 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.76 1.28 . . . . 1.5800000000000001 111.762 168.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 57.7 t -80.58 145.29 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.462 -0.57 . . . . 1.8 109.462 162.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -125.15 147.95 48.8 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 129.114 2.966 . . . . 2.9900000000000002 110.56 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.421 ' HG2' ' H ' ' A' ' 143' ' ' LEU . 48.8 tttt -124.4 154.57 40.21 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 123.746 1.736 . . . . 2.7999999999999998 113.186 169.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.421 ' H ' ' HG2' ' A' ' 142' ' ' LYS . 8.0 tt -92.04 156.38 17.44 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.542 1.537 . . . . 2.0099999999999998 110.606 165.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -120.74 139.08 28.41 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 107.434 -1.321 . . . . 1.45 107.434 164.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.3 -30.53 30.31 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.078 2.519 . . . . 2.9700000000000002 111.837 -171.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.538 ' CG2' ' H ' ' A' ' 103' ' ' TYR . 20.3 m 41.41 -157.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 129.001 2.92 . . . . 3.4399999999999999 115.587 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.395 0 C-N-CA 127.299 2.38 . . . . 2.2200000000000002 108.678 159.25 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.1 mtm . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 121.6 0.714 . . . . 3.7999999999999998 112.347 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 151.28 -76.64 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.661 1 C-N-CA 132.927 4.491 . . . . 2.6200000000000001 111.33 -176.478 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.5 t0 177.14 75.64 0.1 Allowed Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 128.373 2.669 . . . . 2.0800000000000001 109.596 -163.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -88.52 -49.68 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.387 1 C-N-CA 127.432 5.421 . . . . 0.72999999999999998 112.551 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -148.06 143.82 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 1 C-N-CA 131.916 4.086 . . . . 1.8500000000000001 104.205 -171.739 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.6 mm -107.85 146.13 14.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 124.67 1.188 . . . . 1.9299999999999999 109.568 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.8 mm -127.38 107.57 16.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 126.603 1.961 . . . . 1.8799999999999999 110.314 167.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.4 mp0 -64.12 124.87 22.75 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 123.125 1.44 . . . . 3.6499999999999999 112.61 175.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.3 t -116.78 -58.31 2.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.774 -1.557 . . . . 2.7400000000000002 114.894 -157.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.509 ' H ' ' CG2' ' A' ' 146' ' ' VAL . 14.5 m-85 64.45 25.53 13.33 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.82 1.248 . . . . 4.4900000000000002 110.636 -168.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -167.4 148.92 5.68 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 128.345 2.658 . . . . 2.21 108.917 -170.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.418 ' HB2' ' CD2' ' A' ' 106' ' ' TYR . 8.5 m-20 -76.93 -25.62 53.12 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.61 -1.306 . . . . 3.1400000000000001 113.097 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.418 ' CD2' ' HB2' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -140.56 14.25 2.35 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.195 1.798 . . . . 3.77 113.991 -150.453 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -60.41 168.3 2.16 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.784 1.234 . . . . 6.7400000000000002 112.536 174.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -106.52 159.32 16.26 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.809 1.04 . . . . 3.6400000000000001 113.809 171.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.53 144.98 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 127.029 2.132 . . . . 1.9099999999999999 109.917 170.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.42 100.89 1.4 Allowed Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.921 -0.933 . . . . 0.97999999999999998 111.993 165.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 1.6 t -86.59 138.47 31.67 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.047 1.339 . . . . 1.6200000000000001 112.591 171.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.9 p -109.34 22.19 16.12 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.061 1.134 . . . . 2.0600000000000001 114.061 170.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.87 55.77 0.92 Allowed Glycine 0 N--CA 1.462 0.391 0 O-C-N 120.806 -1.184 . . . . 1.8999999999999999 110.779 -175.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 65.43 -168.04 0.01 OUTLIER Pre-proline 0 CA--C 1.566 1.577 0 CA-C-O 117.799 -1.096 . . . . 5.1600000000000001 110.886 -173.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.41 6.1 5.02 Favored 'Trans proline' 0 C--N 1.355 0.899 0 CA-C-N 123.507 2.288 . . . . 2.8599999999999999 114.885 -169.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.31 13.2 13.6 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.553 1.316 . . . . 2.8399999999999999 114.553 -166.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 64.46 61.33 6.06 Favored Glycine 0 N--CA 1.473 1.139 0 CA-C-N 118.844 0.747 . . . . 1.6899999999999999 112.956 169.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 39.7 m -100.26 -26.43 13.91 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.73 1.381 . . . . 2.3900000000000001 114.73 -169.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.474 ' CE1' ' SD ' ' A' ' 122' ' ' MET . 30.3 p80 -131.59 -158.53 0.9 Allowed 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 119.671 1.123 . . . . 1.5800000000000001 111.1 168.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.8 t -75.55 -152.97 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 O-C-N 121.088 -1.008 . . . . 2.0299999999999998 111.145 169.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.405 ' C ' ' SD ' ' A' ' 122' ' ' MET . 4.9 tp -112.6 131.3 64.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 117.72 2.489 . . . . 2.0899999999999999 117.72 -178.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.474 ' SD ' ' CE1' ' A' ' 119' ' ' HIS . 0.0 OUTLIER -132.46 126.52 33.21 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 128.745 2.818 . . . . 6.3700000000000001 114.532 -169.339 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -106.98 114.18 28.11 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.299 1.04 . . . . 2.5899999999999999 111.518 -167.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 mt -120.11 157.47 28.9 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.965 0.802 . . . . 1.96 111.231 -171.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -118.49 92.96 44.76 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.249 1.42 . . . . 6.5099999999999998 111.313 172.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -88.46 30.4 0.43 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.062 3.175 . . . . 3.46 114.383 -171.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.5 m -23.43 154.86 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 1 C-N-CA 133.829 4.852 . . . . 2.1099999999999999 117.863 -162.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.5 p -51.34 -33.99 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 120.061 -1.649 . . . . 1.8899999999999999 113.633 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -90.16 -6.0 55.84 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.276 1.83 . . . . 2.2200000000000002 114.077 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -138.05 -160.55 1.07 Allowed 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.87 0.868 . . . . 2.27 110.728 -159.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.3 m -156.98 160.31 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 131.179 3.792 . . . . 1.55 106.277 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -143.98 132.49 22.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 118.89 0.768 . . . . 1.78 111.092 174.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -90.72 129.63 36.8 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.447 0.699 . . . . 4.2699999999999996 109.128 170.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 34.1 t -55.32 140.99 37.58 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 123.955 0.784 . . . . 1.27 110.34 155.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -81.2 -14.58 57.4 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.552 -0.737 . . . . 1.48 112.534 171.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.451 ' HG3' ' SD ' ' A' ' 122' ' ' MET . 0.5 OUTLIER -96.38 -91.17 0.24 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.635 1.174 . . . . 1.77 109.239 -169.163 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 19.0 p -58.99 -25.68 63.84 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.9 -1.125 . . . . 1.1699999999999999 112.756 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.81 25.94 73.84 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.346 0.974 . . . . 1.1000000000000001 113.139 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.3 p -69.61 125.15 25.84 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 119.215 1.508 . . . . 1.79 109.749 159.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.9 t -79.18 147.37 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 107.156 -1.424 . . . . 1.9399999999999999 107.156 161.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -132.91 154.23 50.62 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 128.973 2.909 . . . . 3.8100000000000001 110.094 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -137.52 162.46 33.67 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.299 1.047 . . . . 3.4199999999999999 113.323 175.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.1 tt -113.0 144.69 42.14 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.469 1.128 . . . . 1.8999999999999999 113.234 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -111.87 144.29 30.38 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-N 114.291 -1.322 . . . . 1.3400000000000001 109.546 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -67.2 -28.1 40.75 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.832 2.355 . . . . 2.0699999999999998 112.009 -175.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.509 ' CG2' ' H ' ' A' ' 103' ' ' TYR . 22.1 m 42.12 -157.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 128.027 2.531 . . . . 3.2400000000000002 114.965 -173.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.925 0 C-N-CA 124.999 1.285 . . . . 2.29 110.794 139.331 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 33.1 mtp . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 117.754 2.501 . . . . 3.9500000000000002 117.754 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.14 -63.26 1.15 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.29 1.036 . . . . 2.8799999999999999 113.165 171.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.8 t0 163.55 77.38 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 128.502 2.721 . . . . 2.5099999999999998 110.173 -157.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -89.33 -50.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.411 1 C-N-CA 126.846 5.03 . . . . 0.81000000000000005 113.078 -174.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -154.77 142.4 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 1 C-N-CA 132.019 4.127 . . . . 1.79 104.585 -168.584 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.8 mm -118.3 137.74 51.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 123.985 0.914 . . . . 1.8200000000000001 112.129 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.8 mm -129.2 112.9 26.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 127.29 2.236 . . . . 1.9399999999999999 109.002 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.69 124.98 25.37 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.758 1.623 . . . . 2.46 112.193 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.3 t -145.17 90.51 2.04 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 115.792 1.775 . . . . 2.98 115.792 -167.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -77.25 64.1 2.59 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.561 1.144 . . . . 4.9699999999999998 110.672 174.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.41 -13.32 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.68 2.392 . . . . 3.2000000000000002 113.477 -167.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 64.82 -7.93 0.24 Allowed 'General case' 0 CA--C 1.56 1.349 0 CA-C-N 120.74 1.609 . . . . 3.0600000000000001 115.072 -170.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -152.34 24.13 0.62 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 116.928 2.196 . . . . 3.8999999999999999 116.928 -172.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -54.82 149.89 10.67 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 120.572 1.533 . . . . 4.9800000000000004 113.079 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -77.11 161.59 28.14 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.516 -0.74 . . . . 3.6699999999999999 112.18 163.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.1 p -113.76 145.66 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 126.586 1.954 . . . . 1.8200000000000001 111.511 175.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.67 113.27 4.67 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.424 1.011 . . . . 1.29 112.043 162.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 7.4 t -110.63 128.57 55.74 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.408 1.483 . . . . 1.8200000000000001 113.239 174.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 32.9 p -110.54 34.36 4.0 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.546 1.313 . . . . 1.8300000000000001 114.546 167.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.17 -31.74 3.69 Favored Glycine 0 N--CA 1.473 1.167 0 O-C-N 118.984 -2.322 . . . . 2.04 114.806 173.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.0 p 176.07 177.46 0.22 Allowed Pre-proline 0 CA--C 1.556 1.19 1 C-N-CA 132.468 4.307 . . . . 4.0999999999999996 106.67 -175.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.48 -15.02 47.61 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 121.721 1.614 . . . . 2.9900000000000002 113.302 167.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -101.85 55.43 0.81 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.935 1.694 . . . . 3.2999999999999998 111.55 177.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 55.31 20.81 23.8 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 118.061 1.984 . . . . 2.3700000000000001 118.061 154.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.3 m -71.17 -26.68 63.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 115.302 1.593 . . . . 2.3599999999999999 115.302 -140.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -108.0 -25.44 11.16 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 117.234 2.309 . . . . 2.79 117.234 169.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.319 4.8 t 121.12 -152.58 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 131.559 3.944 . . . . 2.8700000000000001 108.563 -145.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.8 tp -130.15 142.74 43.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 130.463 3.505 . . . . 2.5899999999999999 112.383 -175.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.419 ' CE ' ' HE1' ' A' ' 135' ' ' TRP . 19.1 mmm -135.01 159.4 41.63 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 126.652 1.981 . . . . 4.7199999999999998 116.093 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.413 ' H ' ' HE2' ' A' ' 122' ' ' MET . 6.3 m95 -126.79 113.88 17.21 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.693 0.797 . . . . 2.3700000000000001 110.222 177.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 mt -122.65 159.68 27.37 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.099 0.959 . . . . 2.04 109.681 -171.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.16 80.92 70.88 Favored Pre-proline 0 N--CA 1.477 0.918 0 O-C-N 120.758 -1.214 . . . . 5.6799999999999997 113.171 -166.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.08 177.59 8.69 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.201 2.601 . . . . 2.5699999999999998 110.822 170.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.0 m -151.94 159.59 43.75 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.883 2.073 . . . . 1.6200000000000001 107.972 -177.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.6 p -53.19 -42.36 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.514 1.126 . . . . 2.3399999999999999 113.583 -172.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -77.75 -2.08 34.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.944 1.298 . . . . 1.8300000000000001 113.633 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -140.82 -172.05 3.38 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 122.227 1.013 . . . . 2.3500000000000001 112.881 -150.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.9 m -153.27 161.11 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 128.102 2.561 . . . . 1.8200000000000001 107.841 -175.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.7 130.63 24.56 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.598 1.159 . . . . 1.6100000000000001 110.884 175.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -91.55 134.59 34.53 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.136 0.88 . . . . 6.0199999999999996 109.481 171.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 24.4 t -55.64 155.2 5.88 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.99 0.916 . . . . 0.94999999999999996 111.515 162.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.419 ' HE1' ' CE ' ' A' ' 122' ' ' MET . 30.1 p-90 -89.71 -17.05 29.06 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.184 -0.948 . . . . 1.3999999999999999 111.944 166.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -89.25 -101.54 0.09 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.627 1.171 . . . . 2.2200000000000002 109.892 -175.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 27.9 p -60.57 -9.6 4.0 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 119.169 -2.207 . . . . 1.24 116.144 -178.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.37 26.83 64.68 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 127.574 2.511 . . . . 0.77000000000000002 113.836 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.26 150.48 48.21 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.768 1.784 . . . . 1.5700000000000001 109.853 161.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 69.1 t -100.54 141.11 17.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 N-CA-C 104.945 -2.243 . . . . 1.8600000000000001 104.945 169.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -123.34 139.63 53.84 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 126.877 2.071 . . . . 3.5299999999999998 110.057 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.7 tttt -121.49 145.85 47.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.233 1.016 . . . . 3.73 112.173 -175.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.9 tt -103.76 152.69 21.56 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.194 -1.366 . . . . 2.2599999999999998 110.208 175.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -111.9 154.61 44.07 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 114.022 -1.444 . . . . 1.45 112.317 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -71.62 -3.62 13.44 Favored 'Trans proline' 0 N--CA 1.482 0.838 1 C-N-CA 126.219 4.613 . . . . 1.6200000000000001 115.68 -175.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.5 p -42.97 138.65 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 127.299 2.24 . . . . 2.7799999999999998 112.026 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 122.245 0.914 . . . . 2.7599999999999998 110.959 -171.953 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.8 mtm . . . . . 0 N--CA 1.467 0.413 0 N-CA-C 116.715 2.117 . . . . 3.1200000000000001 116.715 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.84 -117.81 0.32 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.488 -1.671 . . . . 3.9300000000000002 106.488 160.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . 0.312 38.8 t70 -129.1 82.68 68.0 Favored Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 126.217 1.807 . . . . 2.6499999999999999 106.262 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -87.56 -47.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.789 1 C-N-CA 128.089 5.859 . . . . 0.76000000000000001 113.489 -171.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 mm -146.91 141.47 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 131.247 3.819 . . . . 1.8500000000000001 103.269 -171.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.1 mm -108.98 140.89 25.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 C-N-CA 124.81 1.244 . . . . 1.79 110.052 -175.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.7 mm -130.63 109.59 17.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 126.513 1.925 . . . . 1.6299999999999999 110.008 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.0 mp0 -63.82 136.92 57.79 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.709 1.604 . . . . 4.1900000000000004 112.863 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.0 t -165.67 133.88 3.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.752 -1.113 . . . . 2.7999999999999998 110.207 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 -86.99 -4.15 59.15 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 118.854 0.752 . . . . 4.1399999999999997 110.922 166.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -95.59 156.66 16.23 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.596 1.959 . . . . 2.4500000000000002 110.652 168.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -73.45 -24.38 60.22 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.903 1.681 . . . . 3.96 113.371 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -134.71 2.21 3.15 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.418 1.636 . . . . 3.7200000000000002 115.418 -164.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.68 132.19 6.5 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.544 1.537 . . . . 8.2799999999999994 113.118 -177.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -78.35 152.26 32.43 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.029 1.122 . . . . 3.75 114.029 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.0 p -101.5 144.2 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.378 1.471 . . . . 1.77 111.775 175.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.06 89.65 0.77 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.849 1.69 . . . . 0.76000000000000001 113.737 163.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 3.7 p -99.22 143.55 29.36 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 119.602 1.701 . . . . 1.54 112.156 168.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 62.9 p -114.73 23.98 12.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.214 -1.357 . . . . 1.97 111.84 174.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.53 -168.45 14.66 Favored Glycine 0 CA--C 1.503 -0.681 0 CA-C-O 124.098 1.943 . . . . 2.4399999999999999 114.025 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -37.21 139.02 0.53 Allowed Pre-proline 0 CA--C 1.549 0.924 0 CA-C-N 110.853 -2.674 . . . . 4.4100000000000001 111.453 151.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.98 -13.6 28.27 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.884 3.723 . . . . 3.3599999999999999 116.913 -155.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -85.82 6.34 28.57 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.758 1.021 . . . . 3.52 113.758 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.33 82.22 0.76 Allowed Glycine 0 C--N 1.34 0.758 0 N-CA-C 110.114 -1.194 . . . . 1.8 110.114 -176.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.88 -64.51 1.16 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.635 0.731 . . . . 2.8999999999999999 111.346 178.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -100.56 -153.54 0.45 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.335 0.865 . . . . 1.74 113.335 -164.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.8 t -70.2 -154.32 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 123.606 0.762 . . . . 2.48 109.355 161.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.2 tp -116.3 140.96 36.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 C-N-CA 127.072 2.149 . . . . 2.5800000000000001 109.827 168.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 13.6 mmm -126.35 159.42 33.26 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 114.099 1.148 . . . . 5.0199999999999996 114.099 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -125.09 67.25 1.12 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.025 0.75 . . . . 1.9399999999999999 113.025 -167.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.7 mt -87.67 157.86 18.98 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.254 -0.904 . . . . 1.74 109.572 -165.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -127.43 77.58 75.65 Favored Pre-proline 0 N--CA 1.48 1.051 0 CA-C-N 119.753 1.161 . . . . 7.9000000000000004 111.429 -166.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -89.23 33.96 0.37 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.522 3.482 . . . . 3.3599999999999999 116.318 -156.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -15.25 144.16 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.287 1 C-N-CA 133.234 4.614 . . . . 2.0 117.527 -166.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.1 p -56.14 -32.79 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 120.491 -1.381 . . . . 2.02 111.477 174.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -78.46 -11.25 59.94 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.543 1.937 . . . . 2.3799999999999999 114.456 174.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -143.19 -141.38 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.409 1.083 . . . . 1.98 111.284 -164.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.8 m -162.19 167.81 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 1 C-N-CA 134.029 4.932 . . . . 1.8100000000000001 106.504 -176.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -148.96 142.9 25.77 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.322 0.965 . . . . 1.8600000000000001 111.713 163.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -100.94 142.6 32.19 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.438 0.695 . . . . 6.3099999999999996 111.569 177.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 15.7 t -63.58 154.53 32.39 Favored 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 124.586 1.179 . . . . 1.1699999999999999 111.15 161.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 17.8 p-90 -100.56 -19.94 15.92 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.814 -1.084 . . . . 1.6599999999999999 111.463 163.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -81.5 -87.64 0.09 Allowed 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 107.555 -1.276 . . . . 1.79 107.555 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 27.4 p -72.1 -12.25 61.12 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 114.671 1.36 . . . . 1.1499999999999999 114.671 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.33 6.45 83.66 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.887 1.232 . . . . 1.24 114.688 168.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.5 p -69.28 137.43 53.04 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.051 1.74 . . . . 1.76 110.167 173.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 62.0 t -80.19 148.92 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 108.866 -0.79 . . . . 2.0099999999999998 108.866 159.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -128.47 154.41 46.12 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 129.316 3.046 . . . . 3.0800000000000001 109.724 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -137.53 157.39 46.65 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.129 0.966 . . . . 3.5600000000000001 112.535 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.2 tt -111.39 146.5 37.04 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 123.136 1.446 . . . . 2.0899999999999999 112.185 -178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -99.83 153.72 37.62 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 114.085 -1.416 . . . . 1.3400000000000001 113.585 -170.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.85 -4.85 15.59 Favored 'Trans proline' 0 C--N 1.348 0.535 1 C-N-CA 125.398 4.065 . . . . 1.51 114.984 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.9 p -43.5 142.56 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 126.766 2.027 . . . . 2.7599999999999998 112.086 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.832 0 CA-C-O 123.474 1.597 . . . . 1.5900000000000001 112.494 -177.036 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 19.2 mtt . . . . . 0 C--O 1.224 -0.288 0 N-CA-C 118.69 2.848 . . . . 3.1200000000000001 118.69 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -61.72 2.11 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.541 0.941 . . . . 2.8199999999999998 113.541 171.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.402 ' N ' ' HD3' ' A' ' 97' ' ' PRO . 0.0 OUTLIER 173.38 72.09 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 128.389 2.676 . . . . 4.5999999999999996 110.213 -150.129 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 96' ' ' ASP . 93.6 Cg_endo -96.48 -48.55 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 125.245 3.964 . . . . 0.93000000000000005 113.535 -175.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -158.55 145.51 8.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 1 C-N-CA 132.353 4.261 . . . . 1.6299999999999999 104.556 -167.326 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.5 mm -118.09 139.12 46.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 124.344 1.057 . . . . 1.6899999999999999 110.303 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.4 mm -128.39 147.18 32.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 127.067 2.147 . . . . 1.8799999999999999 106.877 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -109.64 170.15 8.25 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.579 1.152 . . . . 2.6800000000000002 110.913 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.2 t -159.2 -43.78 0.06 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.981 1.104 . . . . 3.4700000000000002 113.981 -176.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 65.61 37.88 5.69 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 124.515 1.135 . . . . 3.3199999999999998 110.117 -171.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -143.14 -84.78 0.16 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.931 2.092 . . . . 3.29 108.855 172.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t70 175.3 -39.54 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 129.293 3.037 . . . . 3.8399999999999999 109.721 -177.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -116.61 -52.38 2.56 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.012 1.486 . . . . 4.2400000000000002 115.012 -167.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 7.39 -113.37 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 129.722 3.209 . . . . 6.0899999999999999 114.648 -162.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -163.17 160.5 24.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.084 1.354 . . . . 3.4500000000000002 111.848 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.8 p -112.39 137.56 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.214 1.406 . . . . 1.8799999999999999 109.791 166.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.08 87.45 0.45 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.215 1.388 . . . . 0.88 111.915 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 7.9 p -97.74 146.34 25.46 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 123.721 1.725 . . . . 1.3200000000000001 112.999 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 56.9 p -112.2 15.62 20.39 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 112.85 -1.977 . . . . 1.8799999999999999 112.346 171.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.93 -130.54 8.08 Favored Glycine 0 C--N 1.337 0.596 0 O-C-N 120.939 -1.1 . . . . 3.1000000000000001 111.611 -171.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.56 -52.5 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 116.07 -1.919 . . . . 4.5899999999999999 113.728 -171.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -80.26 52.8 4.47 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.307 2.005 . . . . 7.9400000000000004 109.598 166.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 66.88 99.04 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.231 1.812 . . . . 4.4800000000000004 114.331 168.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 63.91 31.27 80.26 Favored Glycine 0 N--CA 1.476 1.346 0 O-C-N 120.391 -1.443 . . . . 2.0099999999999998 113.514 173.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -45.49 90.84 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.246 1.418 . . . . 2.2200000000000002 112.458 -168.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.451 ' CE1' ' SD ' ' A' ' 122' ' ' MET . 34.3 p80 -108.18 -142.31 0.38 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.768 1.627 . . . . 1.49 111.439 177.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.7 t -89.13 -141.68 0.14 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.404 1.081 . . . . 1.8100000000000001 109.273 163.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.9 tp -122.07 132.88 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 128.545 2.738 . . . . 2.0699999999999998 116.603 173.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.451 ' SD ' ' CE1' ' A' ' 119' ' ' HIS . 0.0 OUTLIER -127.69 149.02 50.4 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 129.462 3.105 . . . . 6.2999999999999998 112.814 -174.513 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -127.98 119.89 26.44 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.91 0.884 . . . . 2.1899999999999999 110.267 -174.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.57 163.18 23.97 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.834 0.854 . . . . 2.2400000000000002 110.651 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.475 ' HZ2' ' CD ' ' A' ' 130' ' ' GLU . 0.8 OUTLIER -110.4 90.0 9.53 Favored Pre-proline 0 N--CA 1.483 1.215 0 C-N-CA 124.382 1.073 . . . . 6.7300000000000004 111.793 176.274 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -76.53 -45.13 0.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 CA-C-O 116.854 -1.394 . . . . 3.1499999999999999 112.866 -169.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 68.56 145.08 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 130.372 3.469 . . . . 2.4100000000000001 110.91 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.01 -40.34 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.759 0.79 . . . . 2.5600000000000001 109.919 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -66.74 -20.73 66.02 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 126.541 1.936 . . . . 2.2599999999999998 113.336 172.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.475 ' CD ' ' HZ2' ' A' ' 125' ' ' LYS . 30.5 mt-10 -135.36 -160.27 1.04 Allowed 'General case' 0 C--N 1.342 0.253 0 CA-C-N 120.583 1.538 . . . . 2.98 110.815 -164.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.2 m -147.44 155.95 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 127.699 2.4 . . . . 1.6200000000000001 107.834 176.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.6 137.23 33.52 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.242 0.617 . . . . 1.78 111.33 170.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.2 ttp85 -98.14 138.48 35.37 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.868 0.304 . . . . 5.2999999999999998 110.774 172.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 49.6 t -61.37 156.38 19.16 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 123.045 1.402 . . . . 1.1000000000000001 111.465 160.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -98.78 -15.98 19.09 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.118 -1.401 . . . . 1.4099999999999999 112.521 169.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.424 ' HG3' ' SD ' ' A' ' 122' ' ' MET . 0.1 OUTLIER -98.65 -85.03 0.39 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.091 2.156 . . . . 1.6200000000000001 109.787 -168.262 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 29.5 p -67.35 -19.71 65.47 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 120.823 1.647 . . . . 1.28 112.797 170.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.44 16.72 80.46 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.022 0.82 . . . . 0.70999999999999996 113.786 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.98 143.92 57.08 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 119.681 1.741 . . . . 1.9399999999999999 111.453 171.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 59.6 t -92.35 136.9 23.44 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 N-CA-C 105.656 -1.979 . . . . 1.77 105.656 161.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -120.03 137.97 53.79 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 126.356 1.863 . . . . 2.9700000000000002 109.209 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -106.12 150.56 25.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 123.542 0.527 . . . . 2.6699999999999999 110.103 164.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.617 HD23 ' H ' ' A' ' 144' ' ' ASN . 0.5 OUTLIER -85.7 -171.5 3.63 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 122.309 1.052 . . . . 3.5099999999999998 108.88 158.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.617 ' H ' HD23 ' A' ' 143' ' ' LEU . 1.1 t-20 -143.93 169.09 10.97 Favored Pre-proline 0 C--N 1.318 -0.799 0 C-N-CA 126.767 2.027 . . . . 4.2599999999999998 109.709 -174.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -89.6 1.28 5.72 Favored 'Trans proline' 0 N--CA 1.46 -0.482 1 C-N-CA 125.466 4.11 . . . . 1.8999999999999999 114.576 -165.595 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.5 p -40.78 142.58 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 1 C-N-CA 132.022 4.129 . . . . 3.0099999999999998 113.56 175.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.861 0 C-N-CA 128.101 2.762 . . . . 1.8500000000000001 108.926 -166.982 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.2 mtm . . . . . 0 N--CA 1.467 0.385 0 N-CA-C 119.416 3.117 . . . . 2.8700000000000001 119.416 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.59 -62.17 1.55 Allowed 'General case' 0 C--N 1.316 -0.849 0 O-C-N 121.896 -0.502 . . . . 3.29 111.43 167.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.8 t70 168.02 66.54 0.01 OUTLIER Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 130.032 3.333 . . . . 2.73 108.659 -163.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.431 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 51.5 Cg_endo -80.08 -71.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 1 C-N-CA 128.21 5.94 . . . . 1.0 113.562 -168.596 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.431 ' H ' ' HG2' ' A' ' 97' ' ' PRO . 0.6 OUTLIER -112.37 145.87 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 130.876 3.67 . . . . 2.0600000000000001 104.473 174.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.7 mm -106.74 143.19 17.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 124.016 0.927 . . . . 1.76 111.044 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.9 mm -125.75 114.13 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 126.761 2.024 . . . . 1.8999999999999999 109.021 167.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -66.21 138.41 57.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.938 1.351 . . . . 3.71 112.249 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.4 t -160.63 118.1 2.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.097 -0.956 . . . . 3.1099999999999999 111.723 -169.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -87.74 10.0 19.77 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 118.44 0.564 . . . . 3.6299999999999999 112.088 167.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -105.66 -60.26 1.65 Allowed 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.755 1.622 . . . . 3.0699999999999998 113.162 -172.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.7 t0 119.92 -48.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 1 C-N-CA 133.55 4.74 . . . . 4.2300000000000004 109.01 -167.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.85 -3.59 59.08 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 119.906 -1.746 . . . . 3.6200000000000001 113.629 -168.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -52.25 121.75 7.44 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.846 1.658 . . . . 4.9400000000000004 113.102 -163.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -82.36 164.23 21.2 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 114.555 1.317 . . . . 3.3100000000000001 114.555 -168.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.8 t -97.98 137.43 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.543 1.937 . . . . 3.3300000000000001 112.093 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -115.27 69.35 0.26 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.952 1.263 . . . . 1.1699999999999999 111.995 164.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 4.2 t -82.53 133.92 35.19 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.994 0.918 . . . . 1.72 111.679 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 57.3 p -113.18 25.95 10.9 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.495 1.118 . . . . 1.8600000000000001 113.636 168.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.43 66.57 1.46 Allowed Glycine 0 N--CA 1.462 0.431 0 O-C-N 120.822 -1.174 . . . . 2.3999999999999999 110.793 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 68.73 174.03 0.08 OUTLIER Pre-proline 0 CA--C 1.563 1.442 0 C-N-CA 123.464 0.705 . . . . 3.4199999999999999 110.856 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.7 -8.71 22.89 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 121.881 1.72 . . . . 2.5800000000000001 114.704 -169.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.56 4.73 46.0 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.355 1.243 . . . . 2.3500000000000001 114.355 -173.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.73 81.37 0.37 Allowed Glycine 0 N--CA 1.471 1.006 0 C-N-CA 125.12 1.343 . . . . 1.6599999999999999 112.465 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.6 m -102.33 -35.91 8.65 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.413 1.264 . . . . 2.29 114.413 -174.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.404 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 6.6 p80 -122.98 -153.71 0.57 Allowed 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.611 -0.681 . . . . 1.3600000000000001 111.935 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.5 t -72.25 -154.51 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 119.423 1.01 . . . . 1.98 111.415 168.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.3 tp -108.96 146.81 14.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 126.711 2.004 . . . . 2.1000000000000001 109.816 163.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.413 ' HE1' ' H ' ' A' ' 135' ' ' TRP . 4.7 ppp? -154.76 163.5 40.16 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.189 0.811 . . . . 4.5700000000000003 113.189 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -127.8 126.92 42.63 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.601 0.963 . . . . 1.8899999999999999 113.601 -162.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.6 mt -131.92 158.35 41.62 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.553 1.141 . . . . 1.95 111.535 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.43 83.1 16.07 Favored Pre-proline 0 CA--C 1.561 1.399 0 C-N-CA 125.976 1.71 . . . . 7.0700000000000003 112.272 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -82.35 27.01 0.61 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.936 3.757 . . . . 3.27 115.704 -165.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -20.32 148.84 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 1 C-N-CA 133.169 4.588 . . . . 1.99 116.901 -163.479 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.0 p -59.15 -32.75 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 O-C-N 120.418 -1.426 . . . . 1.9199999999999999 111.124 175.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -73.35 -12.27 60.77 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 128.407 2.683 . . . . 2.29 113.977 174.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -144.61 -146.66 0.19 Allowed 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 123.761 0.824 . . . . 2.25 111.561 -161.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.0 m -159.32 170.79 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.67 1 C-N-CA 134.29 5.036 . . . . 1.8600000000000001 106.133 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -146.6 143.6 28.95 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.32 -0.862 . . . . 1.74 112.21 164.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.3 ttm-85 -100.55 136.66 40.08 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.632 1.573 . . . . 6.8799999999999999 110.045 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 52.3 t -68.29 167.32 14.66 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 122.475 1.131 . . . . 1.1299999999999999 112.945 161.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.413 ' H ' ' HE1' ' A' ' 122' ' ' MET . 46.5 p-90 -122.46 -12.24 8.21 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.449 1.5 . . . . 1.49 112.155 171.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.404 ' HB3' ' CD2' ' A' ' 119' ' ' HIS . 4.1 mm-40 -94.93 -61.73 1.44 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.685 0.794 . . . . 2.02 110.624 -174.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 29.9 p -95.12 -15.77 23.11 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.961 1.304 . . . . 1.0800000000000001 112.63 166.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.43 16.76 78.83 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 120.896 -1.127 . . . . 0.93000000000000005 114.341 174.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.488 ' HG ' ' HE1' ' A' ' 141' ' ' TYR . 7.7 p -68.32 126.73 30.5 Favored 'General case' 0 C--N 1.335 -0.041 0 CA-C-N 119.76 1.78 . . . . 1.5800000000000001 109.642 173.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.73 147.03 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 119.657 -0.817 . . . . 1.9099999999999999 109.079 161.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.488 ' HE1' ' HG ' ' A' ' 139' ' ' SER . 81.3 m-85 -128.0 152.71 47.59 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 130.097 3.359 . . . . 3.6000000000000001 110.41 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -140.4 157.74 45.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 122.257 1.027 . . . . 3.4399999999999999 113.203 174.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.3 tt -114.39 143.67 44.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 122.763 1.268 . . . . 1.72 113.085 -175.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -98.75 155.82 36.28 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-N 114.18 -1.373 . . . . 1.3 112.046 -170.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.1 -4.02 14.59 Favored 'Trans proline' 0 C--N 1.352 0.753 1 C-N-CA 125.904 4.403 . . . . 1.51 115.428 -174.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.3 p -40.94 148.61 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 128.433 2.693 . . . . 3.1699999999999999 113.736 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.545 0 O-C-N 120.809 -1.182 . . . . 1.5700000000000001 110.722 175.494 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.4 mtm . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 118.229 2.678 . . . . 2.8999999999999999 118.229 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.23 -123.9 0.06 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.741 1.258 . . . . 3.5 108.363 157.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -120.61 90.02 45.4 Favored Pre-proline 0 N--CA 1.433 -1.304 0 C-N-CA 129.222 3.009 . . . . 2.48 107.658 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -90.45 -42.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.26 1 C-N-CA 127.174 5.249 . . . . 1.03 112.352 -178.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 mm -155.68 140.16 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 130.462 3.505 . . . . 2.21 104.341 -168.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.2 mm -108.22 136.27 44.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 124.68 1.192 . . . . 1.8999999999999999 109.48 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.7 mm -130.7 112.28 22.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 127.836 2.454 . . . . 1.72 107.043 176.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -64.94 172.85 2.62 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 125.432 1.707 . . . . 3.1800000000000002 110.345 171.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 98.7 p -157.84 -57.17 0.08 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.039 -0.982 . . . . 2.9900000000000002 113.471 -166.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.414 ' H ' ' CG2' ' A' ' 146' ' ' VAL . 12.7 m-85 64.27 27.0 13.81 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 126.742 2.017 . . . . 4.29 110.825 -165.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -169.05 160.68 10.08 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 129.489 3.115 . . . . 3.6699999999999999 110.409 -174.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -83.3 3.94 29.29 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 115.422 1.638 . . . . 2.9700000000000002 115.422 -171.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -162.5 35.28 0.11 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 114.781 1.401 . . . . 3.3500000000000001 114.781 -158.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -79.99 -164.99 0.75 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.043 1.337 . . . . 6.4199999999999999 113.465 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -140.73 157.88 44.78 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.245 1.202 . . . . 3.25 114.245 -172.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.1 p -120.22 149.22 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.989 2.116 . . . . 2.0899999999999999 110.916 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.52 122.01 5.22 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 118.964 -0.909 . . . . 0.81000000000000005 112.88 157.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 15.0 p -114.32 152.48 31.35 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 123.191 1.472 . . . . 1.76 113.679 169.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 50.2 p -107.15 38.85 2.01 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 113.247 -1.797 . . . . 1.99 111.629 170.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.13 22.55 14.89 Favored Glycine 0 C--O 1.226 -0.356 0 CA-C-O 118.802 -0.999 . . . . 1.8100000000000001 113.969 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.8 p 89.24 175.09 0.04 OUTLIER Pre-proline 0 N--CA 1.483 1.22 0 C-N-CA 127.409 2.284 . . . . 3.4300000000000002 109.844 -151.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.53 -19.85 61.45 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.08 2.52 . . . . 3.48 114.617 167.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -84.67 52.7 2.46 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.564 1.074 . . . . 4.0899999999999999 112.324 178.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 38.44 59.14 1.61 Allowed Glycine 0 N--CA 1.472 1.076 0 C-N-CA 126.171 1.844 . . . . 2.7599999999999998 116.022 154.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.7 m -115.12 -19.47 10.84 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.605 1.335 . . . . 2.3700000000000001 114.605 -166.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.51 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 14.0 p80 -148.03 -158.81 0.95 Allowed 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 120.374 1.443 . . . . 1.72 114.151 171.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.2 t -66.09 -164.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.06 1.344 . . . . 1.75 111.193 169.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.9 tp -103.06 145.36 12.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 O-C-N 120.454 -1.403 . . . . 2.2400000000000002 110.625 165.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.533 ' HE2' ' H ' ' A' ' 135' ' ' TRP . 3.4 ppp? -150.66 172.71 15.12 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.081 1.752 . . . . 4.71 110.277 176.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -138.98 128.96 25.1 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.311 0.856 . . . . 2.2999999999999998 113.311 -169.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.8 mt -126.0 153.08 44.87 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.989 0.916 . . . . 1.8600000000000001 110.822 -171.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -124.39 101.22 34.52 Favored Pre-proline 0 N--CA 1.477 0.878 0 CA-C-O 118.219 -0.895 . . . . 6.0300000000000002 112.434 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -80.82 169.59 16.39 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.603 2.202 . . . . 2.3500000000000001 110.223 162.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -123.88 156.09 36.89 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.939 2.096 . . . . 2.3799999999999999 107.886 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.6 p -51.16 -35.9 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 O-C-N 120.582 -1.324 . . . . 2.3399999999999999 113.862 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -89.34 -1.83 58.21 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.176 1.176 . . . . 2.0699999999999998 114.176 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -145.03 176.3 9.6 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 123.109 1.433 . . . . 2.7000000000000002 114.472 -158.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.6 m -125.07 154.57 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 128.408 2.683 . . . . 1.5700000000000001 109.648 -172.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -132.79 139.41 47.51 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.55 1.14 . . . . 1.8500000000000001 110.674 173.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.1 ttp-105 -111.95 142.89 43.79 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.358 0.526 . . . . 6.0700000000000003 111.7 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 42.2 t -60.64 157.57 14.25 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 122.77 1.271 . . . . 0.97999999999999998 113.431 167.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.533 ' H ' ' HE2' ' A' ' 122' ' ' MET . 49.7 p-90 -107.44 -14.29 14.89 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.005 1.322 . . . . 1.52 112.055 168.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.51 ' HB3' ' CD2' ' A' ' 119' ' ' HIS . 0.1 OUTLIER -92.29 -67.85 0.83 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.726 1.21 . . . . 1.6899999999999999 110.376 -175.785 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 26.6 p -91.19 -12.71 34.55 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 126.338 1.855 . . . . 1.0800000000000001 114.095 172.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.43 12.51 69.75 Favored Glycine 0 CA--C 1.532 1.108 0 O-C-N 121.069 -1.019 . . . . 0.72999999999999998 115.267 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.4 p -73.31 134.86 44.29 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.86 2.33 . . . . 1.55 111.394 174.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.2 t -75.84 150.18 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 109.922 -0.399 . . . . 1.9199999999999999 109.922 165.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -138.59 142.17 39.19 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 130.49 3.516 . . . . 3.7000000000000002 109.073 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -127.75 153.38 46.61 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 113.224 0.824 . . . . 3.3199999999999998 113.224 -174.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.14 137.58 34.01 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.465 0.542 . . . . 2.2799999999999998 112.465 176.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 37.2 p-10 -105.31 150.18 38.59 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 108.416 -0.957 . . . . 1.52 108.416 166.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.43 -31.5 21.88 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.038 2.492 . . . . 2.3500000000000001 113.294 -172.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.414 ' CG2' ' H ' ' A' ' 103' ' ' TYR 0.266 3.5 m 47.05 -165.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 129.54 3.136 . . . . 3.7599999999999998 116.85 -179.369 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.616 0 C-N-CA 125.414 1.483 . . . . 2.46 111.614 168.217 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 9.4 mtm . . . . . 0 C--O 1.224 -0.269 0 N-CA-C 119.198 3.036 . . . . 2.9900000000000002 119.198 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -62.12 1.77 Allowed 'General case' 0 C--N 1.32 -0.699 0 O-C-N 121.993 -0.442 . . . . 3.0699999999999998 112.143 166.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.3 t70 165.43 73.1 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 128.571 2.749 . . . . 2.5299999999999998 110.486 -157.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -87.28 -98.18 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.695 1 C-N-CA 126.863 5.042 . . . . 1.5700000000000001 113.746 -168.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -87.81 147.88 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 C-N-CA 126.948 2.099 . . . . 2.0899999999999999 106.582 170.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 21.1 mm -110.26 140.31 29.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 123.423 0.689 . . . . 1.97 112.544 -170.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.6 mm -127.74 124.11 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 127.373 2.269 . . . . 1.73 109.161 173.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.66 146.5 32.44 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.729 1.212 . . . . 2.6099999999999999 111.463 174.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.1 t -151.43 -50.55 0.12 Allowed 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 117.153 2.279 . . . . 2.5099999999999998 117.153 -168.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 77.62 -11.24 1.23 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 116.644 2.09 . . . . 3.8900000000000001 116.644 176.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.22 21.43 6.72 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 127.228 2.211 . . . . 2.71 111.475 -174.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 63.53 -16.18 0.07 Allowed 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 119.251 3.056 . . . . 3.2400000000000002 119.251 174.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -129.56 -68.21 0.73 Allowed 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 122.287 2.312 . . . . 4.2199999999999998 114.952 -179.637 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 58.77 -168.79 0.14 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.081 1.752 . . . . 4.5700000000000003 113.521 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -119.5 163.2 17.63 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.048 -1.032 . . . . 3.4199999999999999 109.992 150.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.8 p -116.43 137.76 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.397 1.079 . . . . 1.79 110.514 169.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -117.03 112.72 2.57 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.042 0.829 . . . . 0.94999999999999996 111.316 168.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.55 ' H ' ' CE ' ' A' ' 122' ' ' MET . 0.8 OUTLIER -117.01 155.8 28.57 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.171 1.788 . . . . 1.3 113.447 173.242 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.9 p -125.16 16.71 8.43 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.958 1.303 . . . . 2.1299999999999999 114.054 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.74 70.21 1.18 Allowed Glycine 0 C--N 1.335 0.506 0 O-C-N 120.91 -1.119 . . . . 2.73 110.557 -177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 70.06 176.43 0.07 OUTLIER Pre-proline 0 CA--C 1.561 1.366 0 CA-C-O 118.373 -0.822 . . . . 3.6499999999999999 110.789 -176.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.99 -5.68 17.38 Favored 'Trans proline' 0 C--N 1.353 0.802 0 CA-C-N 122.353 1.876 . . . . 3.0600000000000001 114.781 -167.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.15 -6.77 19.55 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 115.245 1.572 . . . . 3.1200000000000001 115.245 -174.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.57 100.43 0.22 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.182 0.896 . . . . 1.8700000000000001 111.765 -173.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.6 m -105.79 -34.52 7.65 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.65 0.981 . . . . 2.48 113.65 173.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -116.67 -153.59 0.53 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.67 0.788 . . . . 1.3300000000000001 111.829 174.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.3 t -74.86 -147.23 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.479 0.712 . . . . 2.0 110.67 166.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.9 tt -117.27 149.21 19.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 126.778 2.031 . . . . 2.8900000000000001 111.363 166.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.55 ' CE ' ' H ' ' A' ' 111' ' ' CYS . 0.0 OUTLIER -133.65 171.82 13.59 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.871 1.668 . . . . 5.5700000000000003 109.714 169.868 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -137.06 123.53 20.83 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.64 0.776 . . . . 6.96 109.827 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.428 HD21 ' SD ' ' A' ' 122' ' ' MET . 2.2 mt -120.81 160.96 22.33 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 118.939 0.791 . . . . 2.0899999999999999 111.406 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.45 99.8 26.42 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 123.093 0.557 . . . . 6.8300000000000001 109.525 166.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -76.23 179.08 6.71 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 N-CA-C 107.528 -1.758 . . . . 2.46 107.528 159.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 106' ' ' TYR . 24.9 m -159.11 156.1 28.48 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 105.726 -1.953 . . . . 2.5699999999999998 105.726 172.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.7 p -52.35 -39.92 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 124.213 1.005 . . . . 1.8500000000000001 112.494 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -82.03 0.66 39.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.82 1.648 . . . . 1.6799999999999999 114.192 176.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -143.1 -176.92 5.11 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 122.214 1.007 . . . . 2.23 113.016 -159.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.5 m -146.4 155.35 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 127.342 2.257 . . . . 1.72 109.579 -173.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -141.7 128.55 20.56 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.648 0.779 . . . . 1.8700000000000001 112.05 -175.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.4 ttp-105 -101.45 132.45 47.04 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.191 0.905 . . . . 6.0999999999999996 112.85 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -18.91 62.2 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 117.622 2.452 . . . . 3.5699999999999998 117.622 -164.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 13.8 p-90 59.0 -20.16 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 128.394 2.678 . . . . 2.8300000000000001 115.74 -173.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -94.43 -87.73 0.25 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 120.434 1.47 . . . . 2.75 110.341 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 30.5 p -62.88 -18.16 62.6 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.137 0.975 . . . . 1.3700000000000001 111.934 166.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 58.14 38.69 90.52 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 124.815 1.197 . . . . 1.1000000000000001 111.566 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . 0.263 0.1 OUTLIER -63.77 159.04 20.23 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 117.427 -1.709 . . . . 1.8999999999999999 109.377 155.603 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.2 t -114.15 136.44 50.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 104.074 -2.565 . . . . 1.8899999999999999 104.074 160.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -115.08 140.3 49.18 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.86 1.664 . . . . 2.9500000000000002 110.224 -176.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -104.39 156.1 18.22 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 122.662 1.22 . . . . 3.0 111.621 164.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.8 tt -100.22 154.51 18.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 112.922 -1.945 . . . . 2.0699999999999998 110.237 157.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -109.61 156.52 39.5 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.126 0.97 . . . . 1.28 113.269 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.73 -2.49 10.24 Favored 'Trans proline' 0 N--CA 1.485 0.976 1 C-N-CA 126.413 4.742 . . . . 1.55 115.877 -175.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.9 p -43.88 152.36 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 128.288 2.635 . . . . 2.96 113.049 177.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.896 0 C-N-CA 126.095 1.807 . . . . 1.6100000000000001 110.644 176.876 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 11.4 mtp . . . . . 0 CA--C 1.518 -0.254 0 CA-C-O 123.928 1.823 . . . . 4.5999999999999996 113.523 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.424 ' CG ' ' H ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -146.7 -76.46 0.19 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.033 -1.894 . . . . 3.0 109.62 173.385 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.424 ' H ' ' CG ' ' A' ' 95' ' ' LYS . 38.5 t70 -174.12 72.39 0.34 Allowed Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 127.126 2.171 . . . . 2.5299999999999998 108.903 -168.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -88.31 -48.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.496 1 C-N-CA 127.276 5.317 . . . . 0.71999999999999997 114.258 -170.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -140.96 147.76 22.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 129.938 3.295 . . . . 1.73 105.083 -175.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.5 mm -109.92 136.6 45.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 123.033 0.533 . . . . 1.8799999999999999 111.341 -176.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 51.4 mm -119.1 119.51 61.07 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 126.217 1.807 . . . . 2.1800000000000002 107.479 165.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -77.31 120.79 22.83 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 124.531 1.144 . . . . 3.4100000000000001 109.559 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.7 t -125.09 -51.7 1.66 Allowed 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 116.297 1.962 . . . . 2.3999999999999999 116.297 -164.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 64.01 14.29 8.35 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 122.132 2.242 . . . . 4.3899999999999997 111.924 -177.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -161.23 142.62 11.64 Favored 'General case' 0 CA--C 1.549 0.914 1 C-N-CA 132.312 4.245 . . . . 2.3999999999999999 106.331 -161.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -95.77 14.07 24.46 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 126.113 1.765 . . . . 4.9500000000000002 113.337 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -153.26 12.89 0.49 Allowed 'General case' 0 N--CA 1.485 1.288 0 O-C-N 118.926 -2.359 . . . . 4.0 114.599 -156.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -72.47 159.34 34.11 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.291 0.848 . . . . 5.5599999999999996 113.291 -177.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -95.6 163.36 13.24 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.965 0.728 . . . . 3.5800000000000001 112.965 163.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 p -129.33 148.09 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 127.767 2.427 . . . . 2.3500000000000001 111.102 173.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -100.95 108.78 3.52 Favored Glycine 0 CA--C 1.539 1.533 0 CA-C-O 118.756 -1.025 . . . . 1.3100000000000001 113.631 166.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 9.1 t -108.21 139.62 42.62 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.63 1.572 . . . . 1.5700000000000001 113.984 171.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 12.3 p -113.71 6.84 17.0 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 117.9 2.556 . . . . 2.0499999999999998 117.9 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.01 -23.05 22.64 Favored Glycine 0 N--CA 1.48 1.571 0 O-C-N 119.955 -1.716 . . . . 2.25 113.058 -176.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.2 t 173.52 151.93 0.24 Allowed Pre-proline 0 C--O 1.24 0.553 0 C-N-CA 127.754 2.422 . . . . 5.0499999999999998 108.228 -166.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -60.33 -23.56 74.88 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.656 2.238 . . . . 3.6099999999999999 112.369 168.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.28 9.56 25.47 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.397 1.079 . . . . 3.9500000000000002 113.73 174.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 73.75 62.67 2.94 Favored Glycine 0 C--N 1.343 0.944 0 C-N-CA 124.024 0.821 . . . . 2.27 113.66 170.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 30.7 m -71.94 -34.52 69.1 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.971 1.471 . . . . 2.7400000000000002 114.971 -172.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -107.34 -49.94 3.17 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.006 1.854 . . . . 2.8300000000000001 116.006 176.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.7 t 156.77 -159.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 1 C-N-CA 133.185 4.594 . . . . 2.0899999999999999 105.573 -158.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.8 tp -120.08 140.74 43.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 127.584 2.353 . . . . 2.3900000000000001 111.366 169.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.465 ' CE ' ' HE1' ' A' ' 135' ' ' TRP . 1.2 mmm -137.6 152.38 49.33 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 114.824 1.416 . . . . 5.5700000000000003 114.824 -176.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -110.9 99.98 8.78 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 113.898 -1.501 . . . . 2.2599999999999998 110.72 -171.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.0 mt -106.77 169.75 8.35 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.512 -0.921 . . . . 2.3300000000000001 108.512 -173.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -151.55 100.6 2.94 Favored Pre-proline 0 N--CA 1.472 0.65 0 CA-C-N 119.192 0.905 . . . . 6.4800000000000004 111.607 178.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.88 173.97 10.65 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.252 2.635 . . . . 2.2799999999999998 110.503 170.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.85 144.26 45.54 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.297 2.239 . . . . 2.9399999999999999 107.572 -170.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.7 p -60.79 -34.03 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 120.725 -1.235 . . . . 2.0299999999999998 111.741 -174.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -64.46 -21.02 66.53 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.677 1.991 . . . . 2.6400000000000001 112.922 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -161.6 -137.23 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.109 1.364 . . . . 3.4399999999999999 111.42 -156.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.3 m -156.37 170.31 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 126.884 2.074 . . . . 2.0299999999999998 110.405 -158.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -139.47 143.01 37.34 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.098 0.959 . . . . 2.02 110.595 166.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 140' ' ' VAL . 28.3 ttt-85 -95.61 140.38 30.53 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 105.132 -2.173 . . . . 6.1500000000000004 105.132 167.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 17.9 t -52.08 131.86 32.36 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 124.302 1.001 . . . . 1.1799999999999999 110.009 152.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.465 ' HE1' ' CE ' ' A' ' 122' ' ' MET . 20.0 p-90 -65.61 -20.52 66.35 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.184 -0.948 . . . . 2.1899999999999999 110.637 168.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.05 -108.57 0.07 Allowed 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 126.63 1.972 . . . . 3.1099999999999999 109.173 -172.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.8 p -53.01 -58.77 5.85 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.899 2.48 . . . . 1.73 111.939 -170.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 117.7 21.12 4.38 Favored Glycine 0 C--N 1.331 0.258 0 CA-C-N 113.106 -1.861 . . . . 1.5900000000000001 116.478 -166.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.444 ' HG ' ' HE1' ' A' ' 141' ' ' TYR . 16.2 p -71.72 101.81 2.66 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 119.142 1.471 . . . . 1.79 107.549 156.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 133' ' ' ARG . 47.1 t -62.7 145.22 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 108.475 -0.935 . . . . 1.9299999999999999 108.475 155.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.444 ' HE1' ' HG ' ' A' ' 139' ' ' SER . 75.3 m-85 -124.48 156.41 37.29 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 130.355 3.462 . . . . 3.5499999999999998 111.318 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.428 ' HG2' ' H ' ' A' ' 143' ' ' LEU . 9.2 tttm -119.59 155.38 32.37 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 123.876 1.798 . . . . 3.3100000000000001 113.605 169.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.428 ' H ' ' HG2' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -95.67 146.42 24.51 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 111.936 -2.393 . . . . 2.54 110.265 158.071 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -101.76 155.81 35.96 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 113.842 1.052 . . . . 1.54 113.842 176.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.97 -7.34 21.2 Favored 'Trans proline' 0 C--N 1.353 0.815 1 C-N-CA 125.979 4.453 . . . . 2.2999999999999998 115.788 178.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.9 p -35.54 140.54 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 128.857 2.863 . . . . 3.3900000000000001 113.145 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.706 0 C-N-CA 125.103 1.335 . . . . 3.1200000000000001 111.306 -171.955 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 46.2 mtp . . . . . 0 C--O 1.218 -0.553 0 N-CA-C 105.194 -2.15 . . . . 3.4900000000000002 105.194 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 4.27 -76.18 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 128.734 2.814 . . . . 4.6900000000000004 116.758 167.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 46.4 t0 177.84 84.68 0.14 Allowed Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 129.706 3.203 . . . . 2.2200000000000002 108.687 -166.352 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -96.99 -43.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 1 C-N-CA 126.93 5.087 . . . . 0.93999999999999995 113.168 -178.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 mm -154.35 140.51 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 128.494 2.718 . . . . 1.8500000000000001 106.454 -168.568 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.4 mm -115.8 129.15 72.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 125.806 1.643 . . . . 2.2400000000000002 110.964 -172.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.6 mm -127.11 112.9 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 126.688 1.995 . . . . 2.0099999999999998 109.532 -173.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -71.34 131.15 42.99 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.16 0.984 . . . . 2.73 110.776 -177.061 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.0 p -132.3 -56.77 0.96 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 115.533 1.679 . . . . 3.5699999999999998 115.533 -153.172 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 73.41 -18.79 0.36 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 127.334 2.253 . . . . 4.6600000000000001 114.973 173.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -125.11 145.46 49.93 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.503 2.321 . . . . 3.04 107.901 161.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.63 4.25 2.0 Allowed 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 116.777 2.14 . . . . 3.3300000000000001 116.777 -160.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -147.16 24.53 1.15 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 126.134 1.774 . . . . 3.48 114.551 -175.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.13 135.77 31.03 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 120.792 -1.192 . . . . 4.9699999999999998 112.49 173.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -67.79 163.14 22.39 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.586 0.588 . . . . 3.3799999999999999 112.586 173.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.69 142.64 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.16 1.384 . . . . 2.3199999999999998 111.015 172.118 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.48 128.36 7.68 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.034 0.826 . . . . 1.53 112.923 168.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.84 153.98 50.78 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.38 1.872 . . . . 1.45 114.78 171.197 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.6 p -111.47 14.62 21.43 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 116.219 1.933 . . . . 2.1499999999999999 116.219 173.289 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.85 -32.7 4.33 Favored Glycine 0 C--O 1.222 -0.616 0 C-N-CA 124.626 1.108 . . . . 2.29 113.622 -172.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.1 t 137.55 148.43 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 106.516 -1.661 . . . . 3.5699999999999998 106.516 -120.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.23 48.16 1.72 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 124.745 3.63 . . . . 2.8500000000000001 113.72 -177.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -156.37 27.35 0.35 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.765 1.024 . . . . 3.0899999999999999 113.765 -163.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 61.53 22.44 61.51 Favored Glycine 0 N--CA 1.475 1.295 0 N-CA-C 115.831 1.092 . . . . 2.8700000000000001 115.831 167.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 57.7 p -60.15 -50.98 71.52 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.416 1.108 . . . . 3.6600000000000001 112.835 -158.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.403 ' CG ' ' H ' ' A' ' 120' ' ' THR . 28.7 p80 -102.76 -63.62 1.15 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.765 0.426 . . . . 2.6499999999999999 110.353 -178.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.403 ' H ' ' CG ' ' A' ' 119' ' ' HIS . 5.4 t -179.51 -159.46 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.476 1 C-N-CA 132.79 4.436 . . . . 1.8999999999999999 106.849 178.346 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.0 tp -104.85 145.73 12.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 C-N-CA 125.855 1.662 . . . . 2.3199999999999998 110.056 167.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.52 175.71 9.19 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.756 1.622 . . . . 6.0099999999999998 110.236 172.354 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -136.58 126.34 25.6 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 118.562 -0.732 . . . . 2.7599999999999998 110.266 171.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 mt -115.77 155.48 27.74 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.797 1.181 . . . . 2.1899999999999999 112.054 177.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.83 101.37 20.53 Favored Pre-proline 0 N--CA 1.477 0.896 0 O-C-N 121.818 -0.551 . . . . 6.5099999999999998 110.862 172.599 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -82.96 178.28 6.08 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.447 2.098 . . . . 2.75 108.942 157.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.8 m -144.25 158.18 43.88 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.234 2.214 . . . . 1.78 105.118 171.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.0 p -58.51 -32.34 45.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-N 119.403 1.002 . . . . 1.8300000000000001 111.287 176.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -76.18 -5.28 46.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 128.053 2.541 . . . . 1.9099999999999999 114.637 174.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -145.09 -170.62 3.47 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.865 0.84 . . . . 2.3799999999999999 113.051 -159.013 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 19.3 m -147.23 156.92 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 128.239 2.616 . . . . 1.8500000000000001 108.273 -175.112 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -139.72 126.92 21.18 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.806 0.843 . . . . 1.8600000000000001 111.897 -179.094 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -99.16 134.76 41.54 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.441 0.564 . . . . 4.8799999999999999 111.784 178.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 36.4 t -58.1 141.07 51.33 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 124.361 1.038 . . . . 0.95999999999999996 110.941 165.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 58.7 p-90 -91.34 -10.49 41.08 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.924 -0.58 . . . . 2.0299999999999998 112.083 168.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -100.59 -65.63 0.96 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.262 0.625 . . . . 2.0800000000000001 111.447 -169.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 7.7 p -79.6 -41.95 26.01 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 118.922 0.783 . . . . 1.74 111.059 169.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 106.45 12.04 25.86 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.214 1.388 . . . . 1.1000000000000001 115.652 -178.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.415 ' HG ' ' HE1' ' A' ' 141' ' ' TYR . 2.9 p -80.28 137.01 36.55 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.968 1.884 . . . . 1.6399999999999999 111.179 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.38 150.45 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 118.966 0.803 . . . . 2.3500000000000001 110.296 164.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.415 ' HE1' ' HG ' ' A' ' 139' ' ' SER . 89.2 m-85 -133.81 143.92 48.67 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 129.781 3.233 . . . . 3.52 109.723 179.639 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 54.4 tttt -117.84 153.01 34.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.284 1.04 . . . . 3.0899999999999999 112.372 178.136 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.1 tt -97.89 143.68 28.24 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.502 -1.226 . . . . 1.8600000000000001 111.692 165.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.47 156.52 36.88 Favored Pre-proline 0 CA--C 1.549 0.91 0 CA-C-N 114.321 -1.308 . . . . 3.0099999999999998 110.483 -173.092 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.19 -8.96 24.58 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 124.558 3.505 . . . . 1.3600000000000001 114.509 -176.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.4 p -40.45 142.38 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 128.028 2.531 . . . . 3.0099999999999998 114.316 -177.307 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.476 0 C-N-CA 126.75 2.119 . . . . 2.0600000000000001 107.816 165.378 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 7.2 mtm . . . . . 0 N--CA 1.465 0.309 0 N-CA-C 119.438 3.125 . . . . 0.0 119.438 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -61.86 1.67 Allowed 'General case' 0 C--N 1.317 -0.811 0 O-C-N 121.792 -0.567 . . . . 0.0 112.098 167.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.8 t70 167.65 74.52 0.01 OUTLIER Pre-proline 0 CA--C 1.56 1.363 0 C-N-CA 129.581 3.152 . . . . 0.0 109.393 -155.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -92.12 -51.24 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.423 1 C-N-CA 126.842 5.028 . . . . 0.0 114.896 -170.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 mm -149.22 143.28 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 131.579 3.952 . . . . 0.0 104.221 -169.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.4 mm -113.73 131.69 64.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 124.056 0.943 . . . . 0.0 109.986 -177.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.0 mm -116.31 111.31 34.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 174.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.505 ' HA ' HD21 ' A' ' 144' ' ' ASN . 8.9 tt0 -76.82 116.31 17.37 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.855 1.262 . . . . 0.0 110.148 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.1 t -108.16 -67.83 0.94 Allowed 'General case' 0 C--O 1.225 -0.224 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -158.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.498 ' CE1' HG22 ' A' ' 146' ' ' VAL . 60.1 m-85 75.79 -3.9 2.48 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 126.438 1.895 . . . . 0.0 113.594 -169.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -114.21 152.33 31.4 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 128.066 2.546 . . . . 0.0 109.564 159.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -72.34 -14.6 61.77 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 120.265 -1.522 . . . . 0.0 114.767 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -134.04 6.49 3.64 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.167 -1.583 . . . . 0.0 114.248 -158.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -61.96 154.82 25.34 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.377 1.871 . . . . 0.0 115.327 -166.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -77.09 171.63 14.51 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.622 1.569 . . . . 0.0 114.195 173.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.9 p -135.61 148.99 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.958 2.103 . . . . 0.0 110.606 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -119.57 121.41 4.94 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 118.844 -0.975 . . . . 0.0 113.552 158.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 22.8 p -114.63 160.65 19.07 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 123.518 1.627 . . . . 0.0 113.095 167.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 47.4 p -114.91 13.36 17.05 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 113.302 -1.772 . . . . 0.0 112.695 166.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.5 -31.21 5.67 Favored Glycine 0 N--CA 1.467 0.733 0 C-N-CA 124.056 0.836 . . . . 0.0 113.828 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.1 t 169.49 159.92 0.19 Allowed Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 126.974 2.11 . . . . 0.0 107.509 -157.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -54.94 -20.56 23.33 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 121.89 1.726 . . . . 0.0 112.678 161.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.69 42.43 1.1 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.079 1.352 . . . . 0.0 112.729 174.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 51.33 33.91 32.55 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 116.986 1.554 . . . . 0.0 116.986 150.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.3 m -75.69 -48.02 23.77 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -152.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -104.88 -145.84 0.38 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.939 0.896 . . . . 0.0 112.219 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.66 HG22 ' OE1' ' A' ' 136' ' ' GLU . 3.7 t -76.56 -158.4 0.1 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.956 0.902 . . . . 0.0 112.413 163.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.4 tp -105.88 142.62 18.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 126.368 1.867 . . . . 0.0 110.481 161.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.609 ' SD ' HD21 ' A' ' 124' ' ' LEU . 3.8 ppp? -152.58 175.26 12.97 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.322 1.049 . . . . 0.0 112.141 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -140.71 130.69 24.63 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -165.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.609 HD21 ' SD ' ' A' ' 122' ' ' MET . 1.7 mt -132.28 174.13 10.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.181 1.393 . . . . 0.0 108.725 -174.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 102.37 5.11 Favored Pre-proline 0 N--CA 1.478 0.959 0 CA-C-N 120.187 1.358 . . . . 0.0 114.495 168.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -70.9 176.94 6.93 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 CA-C-N 120.025 1.045 . . . . 0.0 109.426 161.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.7 m -139.71 158.97 43.23 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.745 2.018 . . . . 0.0 105.777 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.5 p -49.21 -37.97 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 120.028 1.285 . . . . 0.0 113.456 -178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -80.9 -8.24 59.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.549 1.539 . . . . 0.0 114.078 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -140.82 -173.45 3.71 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 122.893 1.33 . . . . 0.0 113.371 -151.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 25.9 m -141.53 167.35 16.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 128.322 2.649 . . . . 0.0 108.966 -175.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -148.21 142.58 26.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.885 0.874 . . . . 0.0 110.506 169.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -100.04 143.52 30.16 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.79 0.836 . . . . 0.0 111.07 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.519 ' SG ' ' SG ' ' A' ' 137' ' ' CYS . 45.4 t -65.1 175.15 1.68 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 122.802 1.287 . . . . 0.0 113.622 158.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.413 ' CD1' ' CE ' ' A' ' 122' ' ' MET . 40.9 p-90 -127.54 -13.27 5.44 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.287 1.835 . . . . 0.0 112.583 170.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.66 ' OE1' HG22 ' A' ' 120' ' ' THR . 2.9 mm-40 -95.32 -60.82 1.59 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.156 0.982 . . . . 0.0 109.88 -177.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' CYS . . . . . 0.519 ' SG ' ' SG ' ' A' ' 134' ' ' CYS . 14.2 p -80.8 -23.45 39.25 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.997 1.319 . . . . 0.0 112.705 165.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 64.51 16.18 60.45 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.419 -1.211 . . . . 0.0 113.544 -172.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.77 137.16 53.8 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.801 1.8 . . . . 0.0 111.384 173.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 41.4 t -81.96 147.02 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 166.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -132.01 150.01 52.27 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 129.282 3.033 . . . . 0.0 110.709 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 43.9 tttt -127.01 150.05 49.62 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.102 0.953 . . . . 0.0 113.556 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.62 155.7 17.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.858 167.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.505 HD21 ' HA ' ' A' ' 101' ' ' GLU . 3.4 p30 -111.57 152.19 43.85 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 172.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -67.78 -6.01 15.81 Favored 'Trans proline' 0 C--N 1.352 0.736 1 C-N-CA 125.352 4.035 . . . . 0.0 115.154 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.498 HG22 ' CE1' ' A' ' 103' ' ' TYR . 8.9 p -36.83 133.37 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 127.837 2.455 . . . . 0.0 113.401 -177.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.637 0 C-N-CA 127.541 2.496 . . . . 0.0 107.315 174.703 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 8.6 mtm . . . . . 0 C--O 1.225 -0.219 0 N-CA-C 118.035 2.606 . . . . 2.1299999999999999 118.035 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -57.73 11.46 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 121.191 -0.943 . . . . 1.99 112.641 169.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.5 t70 164.88 73.77 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 129.437 3.095 . . . . 2.7400000000000002 109.703 -154.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -88.34 -46.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 1 C-N-CA 126.793 4.996 . . . . 1.0600000000000001 113.075 -174.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -154.47 143.1 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 130.451 3.5 . . . . 0.63 105.424 -168.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.9 mm -117.45 134.23 61.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 124.579 1.152 . . . . 0.62 111.87 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.9 mm -127.42 118.6 50.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 127.142 2.177 . . . . 0.46000000000000002 108.209 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.92 133.41 44.35 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.858 1.663 . . . . 2.8300000000000001 111.442 -176.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.9 t -163.63 111.94 1.21 Allowed 'General case' 0 C--O 1.223 -0.333 0 O-C-N 121.535 -0.728 . . . . 2.9100000000000001 112.67 -175.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -82.24 16.71 1.89 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.608 1.163 . . . . 3.7799999999999998 112.184 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.48 10.75 3.47 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 128.222 2.609 . . . . 3.0 113.212 -159.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 59.55 -16.73 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 129.631 3.173 . . . . 3.1099999999999999 118.686 173.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -150.88 14.63 0.73 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 119.666 -1.896 . . . . 2.3399999999999999 114.719 -168.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 57.1 ttm-85 -54.39 142.61 26.32 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.538 1.535 . . . . 3.6600000000000001 112.563 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -77.38 156.9 30.9 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.844 0.683 . . . . 2.23 112.844 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.2 p -105.1 145.05 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.451 1.501 . . . . 0.70999999999999996 111.073 173.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -113.4 98.12 0.91 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.957 1.265 . . . . 0.65000000000000002 112.286 164.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.7 154.86 18.25 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.373 1.469 . . . . 0.95999999999999996 113.318 174.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.9 p -124.46 14.17 8.84 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.841 1.656 . . . . 0.77000000000000002 115.0 171.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.16 -17.97 46.79 Favored Glycine 0 N--CA 1.476 1.338 0 O-C-N 120.46 -1.4 . . . . 2.0299999999999998 114.836 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.5 t 175.44 154.51 0.34 Allowed Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 126.089 1.756 . . . . 3.5 109.871 -155.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -58.69 -20.56 51.51 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.298 2.666 . . . . 2.2599999999999998 113.96 170.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.85 -9.1 50.31 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 114.798 1.407 . . . . 2.5800000000000001 114.798 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.84 164.95 12.79 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 123.584 1.658 . . . . 3.1099999999999999 112.262 -147.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 36.9 m -166.62 -43.43 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 127.72 2.408 . . . . 1.49 110.628 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -107.64 -158.08 0.64 Allowed 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 109.95 -0.389 . . . . 1.5700000000000001 109.95 165.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.706 HG22 ' OE1' ' A' ' 136' ' ' GLU . 3.8 t -69.64 -158.96 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.823 0.849 . . . . 0.81999999999999995 112.531 168.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.8 tp -104.97 142.81 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 126.861 2.065 . . . . 0.83999999999999997 109.987 166.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.524 ' SD ' HD21 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -145.25 173.47 11.93 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.071 0.948 . . . . 4.3300000000000001 111.051 170.636 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -124.03 133.17 53.72 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.773 0.829 . . . . 1.5700000000000001 112.233 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.524 HD21 ' SD ' ' A' ' 122' ' ' MET . 3.4 mt -129.75 160.07 34.54 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.077 0.951 . . . . 0.72999999999999998 109.422 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.2 ttpp -125.3 85.94 57.67 Favored Pre-proline 0 N--CA 1.473 0.702 0 O-C-N 121.423 -0.798 . . . . 5.21 113.032 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -69.57 176.61 6.4 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.207 1.938 . . . . 2.4900000000000002 109.775 166.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.3 m -142.46 158.42 43.71 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.307 1.843 . . . . 0.91000000000000003 107.494 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.7 p -55.48 -33.65 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.952 1.301 . . . . 0.81000000000000005 113.737 -175.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -91.04 0.9 57.44 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.56 1.144 . . . . 2.27 113.838 175.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -140.26 -169.63 2.8 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.789 0.835 . . . . 2.1499999999999999 112.956 -158.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.6 m -145.66 163.68 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 127.504 2.322 . . . . 0.52000000000000002 109.916 -173.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -148.47 133.83 18.52 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.639 1.176 . . . . 0.52000000000000002 112.07 174.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.24 139.49 47.74 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.737 1.014 . . . . 3.27 113.737 -177.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.563 ' HG ' ' HG ' ' A' ' 137' ' ' CYS . 46.8 t -70.75 156.94 38.88 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.417 1.487 . . . . 1.1599999999999999 114.863 -178.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.448 ' CZ3' ' HG2' ' A' ' 136' ' ' GLU . 43.9 p-90 -102.92 -13.28 16.99 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.425 -1.261 . . . . 1.76 113.305 174.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.706 ' OE1' HG22 ' A' ' 120' ' ' THR . 0.8 OUTLIER -98.92 -58.34 1.97 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 120.002 1.273 . . . . 2.54 110.661 -179.062 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' CYS . . . . . 0.563 ' HG ' ' HG ' ' A' ' 134' ' ' CYS . 4.6 p -77.56 -65.93 0.9 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 122.28 1.038 . . . . 2.29 110.584 171.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.72 4.86 12.72 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.046 -1.419 . . . . 0.98999999999999999 115.882 -170.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.82 137.5 57.82 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 120.841 2.32 . . . . 1.8899999999999999 111.813 173.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 40.4 t -83.18 146.53 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 107.285 -1.376 . . . . 0.56999999999999995 107.285 165.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -132.35 151.01 52.04 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 128.221 2.608 . . . . 2.2999999999999998 112.076 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -133.43 146.78 51.5 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.11 1.152 . . . . 2.46 114.11 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.8 tt -99.86 153.9 18.78 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.62 1.168 . . . . 0.83999999999999997 110.328 171.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -107.62 156.91 37.09 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 115.453 1.649 . . . . 1.4099999999999999 115.453 -175.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.93 -4.51 12.56 Favored 'Trans proline' 0 C--N 1.357 0.976 1 C-N-CA 127.314 5.343 . . . . 1.6399999999999999 115.92 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.9 p -48.69 143.89 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.246 1.818 . . . . 1.95 110.369 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.75 0 O-C-N 120.772 -1.205 . . . . 2.9500000000000002 112.124 -163.691 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.8 mtm . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.678 0.751 . . . . 2.8300000000000001 112.794 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.7 pttm 123.39 -143.65 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.605 1 C-N-CA 133.216 4.606 . . . . 3.3300000000000001 108.419 -150.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . 0.271 21.3 t0 -128.14 72.37 79.49 Favored Pre-proline 0 CA--C 1.561 1.391 0 C-N-CA 124.761 1.224 . . . . 3.1000000000000001 108.964 -173.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.51 -53.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.046 1 C-N-CA 128.788 6.325 . . . . 0.80000000000000004 114.705 -170.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -133.04 140.11 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 128.745 2.818 . . . . 0.57999999999999996 105.156 -178.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.4 mm -110.68 133.88 54.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 C-N-CA 123.662 0.785 . . . . 0.81000000000000005 111.686 -171.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.0 mm -122.67 115.69 46.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 126.341 1.857 . . . . 0.60999999999999999 108.301 173.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -65.17 124.19 21.51 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.937 1.695 . . . . 3.0800000000000001 110.464 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.6 t -146.8 122.17 10.3 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.167 0.987 . . . . 3.0 111.414 -175.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -98.55 3.18 48.06 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 112.532 0.567 . . . . 2.6499999999999999 112.532 -175.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -104.03 -101.56 0.31 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 128.699 2.8 . . . . 3.7200000000000002 111.166 168.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.566 ' OD1' HG12 ' A' ' 128' ' ' VAL . 10.3 t0 -171.64 -38.33 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 128.094 2.558 . . . . 3.9100000000000001 109.98 -175.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -99.67 -5.08 29.51 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 120.063 -1.648 . . . . 3.6000000000000001 114.63 -165.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.16 122.39 8.49 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.371 1.868 . . . . 6.8899999999999997 114.194 -164.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -70.83 151.7 44.51 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.861 1.06 . . . . 2.3599999999999999 113.861 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.7 p -108.22 146.56 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.785 1.634 . . . . 0.71999999999999997 111.838 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -111.09 108.14 2.32 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.119 0.866 . . . . 0.73999999999999999 112.747 161.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 1.9 t -97.1 145.17 26.25 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.963 1.305 . . . . 1.01 112.612 172.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.7 p -116.29 18.65 15.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.491 1.517 . . . . 0.73999999999999999 113.759 169.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.423 ' CA ' ' CD2' ' A' ' 119' ' ' HIS . . . 110.96 39.33 1.42 Allowed Glycine 0 N--CA 1.466 0.639 0 C-N-CA 124.611 1.101 . . . . 1.71 113.457 176.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 p 71.08 178.5 0.05 OUTLIER Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 123.966 0.907 . . . . 2.79 110.294 -161.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -63.72 -9.6 19.17 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.256 1.971 . . . . 2.6600000000000001 115.586 -172.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.58 33.48 1.43 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.817 1.247 . . . . 2.6099999999999999 113.953 -174.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 57.8 31.66 64.65 Favored Glycine 0 N--CA 1.479 1.512 0 C-N-CA 124.252 0.929 . . . . 1.6299999999999999 115.057 163.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.0 m -84.85 -32.16 23.41 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.571 -0.958 . . . . 1.7 113.437 -148.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.525 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 18.7 p80 -123.81 -144.34 0.33 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.838 1.199 . . . . 1.3700000000000001 113.096 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.633 HG22 ' OE2' ' A' ' 136' ' ' GLU . 4.2 t -78.39 -153.73 0.07 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 118.902 0.774 . . . . 0.83999999999999997 111.035 164.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.9 tp -107.5 151.03 9.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 127.761 2.424 . . . . 0.93999999999999995 110.668 164.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.629 ' CE ' HD21 ' A' ' 124' ' ' LEU . 4.2 ppp? -160.14 161.47 33.72 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.943 1.697 . . . . 3.7799999999999998 111.492 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -130.09 132.99 46.38 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.376 0.509 . . . . 1.48 112.376 -167.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.629 HD21 ' CE ' ' A' ' 122' ' ' MET . 3.3 mt -131.86 155.55 47.63 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.469 0.707 . . . . 0.71999999999999997 110.485 -175.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.65 97.21 46.28 Favored Pre-proline 0 N--CA 1.477 0.917 0 CA-C-N 118.608 0.64 . . . . 5.6600000000000001 110.972 175.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -76.42 178.66 7.26 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 121.839 1.693 . . . . 2.5499999999999998 108.868 162.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.469 HG22 ' OD1' ' A' ' 105' ' ' ASP . 1.3 m -144.41 155.34 43.71 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.14 1.776 . . . . 1.0 106.265 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.566 HG12 ' OD1' ' A' ' 105' ' ' ASP . 9.8 p -63.02 -28.07 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 122.036 2.198 . . . . 0.87 109.803 175.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -72.68 -15.12 61.7 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.543 2.737 . . . . 1.6399999999999999 114.721 171.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -145.51 178.46 8.1 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 123.215 1.483 . . . . 1.99 114.103 -159.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.482 HG12 ' HG3' ' A' ' 142' ' ' LYS . 27.4 m -120.68 165.35 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 128.347 2.659 . . . . 0.53000000000000003 109.495 174.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.9 131.64 25.72 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.428 1.091 . . . . 0.60999999999999999 111.148 173.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.473 ' CG ' HG22 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -111.63 138.03 48.72 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.677 0.621 . . . . 3.54 112.677 -177.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.423 ' HA ' ' HE1' ' A' ' 122' ' ' MET . 40.7 t -70.01 153.23 43.48 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 126.599 1.96 . . . . 1.0700000000000001 115.223 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.422 ' H ' ' HE1' ' A' ' 122' ' ' MET . 56.7 p-90 -98.6 -10.19 23.73 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.453 0.908 . . . . 1.3600000000000001 113.453 169.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.633 ' OE2' HG22 ' A' ' 120' ' ' THR . 0.7 OUTLIER -96.87 -100.0 0.19 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.326 1.45 . . . . 1.73 109.48 -177.229 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 30.1 p -55.39 -29.25 58.13 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.32 1.418 . . . . 1.0600000000000001 112.12 168.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.1 23.88 75.01 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-O 118.483 -1.176 . . . . 0.72999999999999998 113.479 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.66 154.0 41.71 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.704 1.752 . . . . 1.45 111.054 165.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.473 HG22 ' CG ' ' A' ' 133' ' ' ARG . 74.2 t -96.55 140.97 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 105.817 -1.92 . . . . 0.56999999999999995 105.817 167.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -123.56 153.91 39.98 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 128.009 2.524 . . . . 2.1200000000000001 111.737 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.482 ' HG3' HG12 ' A' ' 131' ' ' VAL . 3.4 tmtt? -140.19 157.67 45.24 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 123.013 1.387 . . . . 2.5899999999999999 114.569 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.4 tt -110.87 141.16 44.63 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 113.737 -1.574 . . . . 0.87 113.255 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -100.53 155.85 35.89 Favored Pre-proline 0 CA--C 1.555 1.148 0 N-CA-C 114.609 1.337 . . . . 1.45 114.609 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -79.38 -4.27 13.57 Favored 'Trans proline' 0 C--N 1.356 0.936 1 C-N-CA 126.307 4.671 . . . . 1.3999999999999999 115.56 -175.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.1 p -40.43 148.65 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 128.805 2.842 . . . . 2.0099999999999998 112.044 175.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.644 0 O-C-N 120.138 -1.602 . . . . 1.6399999999999999 113.49 179.267 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 13.8 mtp . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 119.635 3.198 . . . . 2.2999999999999998 119.635 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -56.85 5.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 119.264 0.938 . . . . 2.1499999999999999 112.978 174.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.2 t0 161.68 70.89 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 129.411 3.085 . . . . 2.3700000000000001 109.177 -158.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -82.46 -53.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.3 1 C-N-CA 126.082 4.522 . . . . 0.76000000000000001 112.526 -172.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -147.77 143.53 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 130.521 3.528 . . . . 0.88 104.831 -168.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.4 mm -111.21 129.98 65.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 124.525 1.13 . . . . 0.90000000000000002 109.818 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.4 mm -114.61 100.27 10.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 126.123 1.769 . . . . 0.73999999999999999 106.908 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -66.61 122.23 17.14 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 125.162 1.539 . . . . 3.1200000000000001 110.008 -174.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.4 t -145.0 110.44 5.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.741 -0.663 . . . . 3.1699999999999999 111.225 -169.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -77.1 35.33 0.16 Allowed 'General case' 0 CA--C 1.55 0.949 0 O-C-N 121.693 -0.63 . . . . 2.3900000000000001 112.633 172.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -157.73 137.9 12.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 130.801 3.64 . . . . 3.1600000000000001 106.788 -173.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -60.26 -11.57 6.72 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.818 1.044 . . . . 2.98 113.818 175.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -139.05 126.35 21.47 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.758 2.423 . . . . 3.2200000000000002 111.47 -170.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.511 HH11 ' CG ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -146.27 174.74 11.07 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.887 1.275 . . . . 4.3899999999999997 113.74 171.516 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -100.4 168.05 10.0 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.723 -0.671 . . . . 2.3100000000000001 111.926 157.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.96 145.9 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 126.029 1.732 . . . . 0.68999999999999995 110.414 168.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -129.34 107.84 0.84 Allowed Glycine 0 N--CA 1.473 1.116 0 CA-C-O 119.154 -0.803 . . . . 0.70999999999999996 113.773 170.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.553 ' H ' ' CE ' ' A' ' 122' ' ' MET . 12.7 p -109.75 164.11 12.87 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.485 1.914 . . . . 0.91000000000000003 114.167 172.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.8 p -124.71 5.52 8.15 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.263 1.425 . . . . 0.89000000000000001 114.724 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.5 -21.67 12.62 Favored Glycine 0 N--CA 1.476 1.315 0 N-CA-C 116.334 1.294 . . . . 2.1099999999999999 116.334 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.94 177.34 0.54 Allowed Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 127.541 2.336 . . . . 3.8999999999999999 109.501 -178.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -59.54 -26.22 81.34 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.507 2.138 . . . . 2.73 113.541 170.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.52 -2.0 58.32 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.291 1.219 . . . . 2.3799999999999999 114.291 172.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.77 -169.01 52.89 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-O 123.267 1.481 . . . . 3.54 111.458 -150.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.0 t -177.82 -36.19 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 128.278 2.631 . . . . 2.5299999999999998 110.656 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -118.57 -153.15 0.52 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.495 1.518 . . . . 1.3600000000000001 110.603 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.725 HG22 ' OE2' ' A' ' 136' ' ' GLU . 4.9 t -74.78 -155.39 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 O-C-N 121.39 -0.819 . . . . 0.89000000000000001 112.202 167.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.5 tp -108.28 146.28 14.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 127.6 2.36 . . . . 0.95999999999999996 109.797 163.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.56 ' SD ' HD21 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -141.69 -179.87 6.43 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.922 1.289 . . . . 4.5199999999999996 110.597 173.081 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -140.25 124.06 17.34 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.589 0.631 . . . . 1.6200000000000001 111.751 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.56 HD21 ' SD ' ' A' ' 122' ' ' MET . 2.4 mt -118.78 172.64 7.38 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.154 0.981 . . . . 0.82999999999999996 110.202 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -139.58 90.97 10.99 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-O 118.488 -0.768 . . . . 6.9699999999999998 112.749 -175.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -85.8 167.27 9.89 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.979 2.452 . . . . 2.6899999999999999 110.601 172.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.5 m -139.75 152.73 46.86 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.962 2.105 . . . . 1.3700000000000001 108.577 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.7 p -42.48 -43.85 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 116.988 2.218 . . . . 1.21 116.988 -173.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -89.58 3.25 53.13 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.44 1.096 . . . . 2.0899999999999999 112.846 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -140.8 -177.85 5.27 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.59 1.156 . . . . 3.2999999999999998 113.759 -149.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.1 m -139.99 152.2 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 113.672 -1.604 . . . . 0.60999999999999999 112.384 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -129.23 143.45 50.86 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.871 0.868 . . . . 0.66000000000000003 109.844 168.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -111.64 141.07 45.71 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.886 0.874 . . . . 4.5599999999999996 111.488 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 49.3 t -59.76 159.17 9.16 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 124.587 1.179 . . . . 1.04 112.88 163.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 58.6 p-90 -107.31 -9.02 16.16 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.825 1.25 . . . . 1.21 112.559 170.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.725 ' OE2' HG22 ' A' ' 120' ' ' THR . 2.7 mm-40 -100.09 -94.18 0.27 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.076 1.75 . . . . 1.6200000000000001 108.998 -177.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 28.3 p -62.29 -16.37 53.45 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 120.416 -1.427 . . . . 1.28 112.587 171.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 59.22 27.32 62.64 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 124.894 1.235 . . . . 0.79000000000000004 112.607 175.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.4 p -67.59 132.59 47.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.975 1.388 . . . . 1.52 108.879 164.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 41.4 t -76.97 150.85 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.426 -0.953 . . . . 0.60999999999999999 108.426 159.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -134.19 147.21 50.72 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 130.028 3.331 . . . . 1.8200000000000001 110.439 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -124.81 145.7 49.63 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 113.397 0.888 . . . . 2.7000000000000002 113.397 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.3 tt -91.76 154.36 18.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 122.278 1.037 . . . . 1.1399999999999999 109.094 165.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -117.2 152.66 49.32 Favored Pre-proline 0 CA--C 1.552 1.037 0 CA-C-N 114.685 -1.143 . . . . 1.48 113.319 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.49 -4.39 14.42 Favored 'Trans proline' 0 CA--C 1.539 0.761 1 C-N-CA 125.964 4.443 . . . . 1.6699999999999999 115.731 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.1 p -43.66 149.54 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 128.356 2.663 . . . . 2.1200000000000001 112.812 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 125.04 1.305 . . . . 1.96 110.185 -174.843 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.6 mtm . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 124.28 1.99 . . . . 2.73 111.918 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -173.21 -122.41 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 130.922 3.689 . . . . 1.95 106.717 172.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . 0.303 38.0 t70 -133.39 78.11 64.1 Favored Pre-proline 0 N--CA 1.434 -1.251 0 N-CA-C 106.975 -1.491 . . . . 2.77 106.975 177.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -83.12 -81.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.786 1 C-N-CA 127.573 5.515 . . . . 1.21 113.687 -170.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -102.07 143.39 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 C-N-CA 127.854 2.462 . . . . 0.85999999999999999 106.187 171.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.0 mm -109.53 135.25 49.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.28 -0.873 . . . . 0.87 111.786 -172.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.9 mm -123.55 114.05 40.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 126.96 2.104 . . . . 0.76000000000000001 108.453 173.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.4 132.13 46.51 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.463 1.505 . . . . 3.0800000000000001 110.706 169.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 61.7 m -161.09 125.19 3.45 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.088 -1.007 . . . . 3.3300000000000001 109.14 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.7 m-30 -87.97 28.35 1.05 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 121.366 0.603 . . . . 2.75 111.24 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.99 109.96 4.52 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 129.336 3.054 . . . . 3.75 108.235 -171.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -53.85 -16.08 1.62 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.974 2.51 . . . . 3.3999999999999999 115.44 -169.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.91 5.76 3.91 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 126.769 2.028 . . . . 2.2000000000000002 113.79 -167.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.5 ttt85 -48.2 156.75 0.36 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.366 1.866 . . . . 4.7199999999999998 113.654 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -87.72 155.55 19.86 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.738 -0.602 . . . . 2.2599999999999998 112.308 162.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.23 142.65 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 127.08 2.152 . . . . 0.68000000000000005 111.543 170.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -104.67 100.95 1.86 Allowed Glycine 0 CA--C 1.533 1.217 0 CA-C-O 117.95 -1.472 . . . . 0.69999999999999996 113.663 164.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 3.6 p -107.22 145.06 33.12 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.459 1.629 . . . . 1.28 113.424 171.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.5 p -114.25 23.31 12.97 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 113.901 -1.499 . . . . 0.69999999999999996 112.874 175.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.83 -16.28 55.22 Favored Glycine 0 N--CA 1.476 1.36 0 O-C-N 120.201 -1.562 . . . . 1.76 114.395 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.8 p 175.36 162.29 0.4 Allowed Pre-proline 0 C--O 1.241 0.64 0 C-N-CA 128.693 2.797 . . . . 4.0599999999999996 107.888 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.05 -15.42 39.16 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.02 2.48 . . . . 2.77 113.184 165.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.55 7.22 46.4 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.326 1.05 . . . . 2.2200000000000002 112.469 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 62.25 71.67 0.78 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 125.177 1.37 . . . . 1.6399999999999999 111.921 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 56.8 m -76.24 -42.51 45.59 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.925 0.89 . . . . 1.76 112.175 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.6 p80 -100.8 -148.73 0.37 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.342 0.974 . . . . 1.46 112.226 171.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.28 13.6 t -77.67 -134.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.048 -1.093 . . . . 0.81000000000000005 108.048 158.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.6 tp -129.95 142.1 44.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 131.06 3.744 . . . . 0.83999999999999997 111.108 174.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 19.3 mmm -129.54 167.15 18.34 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.629 1.972 . . . . 3.79 115.112 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -136.06 102.48 5.04 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.88 0.472 . . . . 1.47 110.936 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 mt -116.22 160.03 21.0 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.78 0.832 . . . . 0.68000000000000005 110.499 -169.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -119.94 76.22 21.74 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 114.931 1.456 . . . . 5.2400000000000002 114.931 -170.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -92.15 43.43 0.36 Allowed 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.477 3.452 . . . . 3.0699999999999998 116.161 -165.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 m -28.61 151.0 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 130.301 3.44 . . . . 0.87 114.94 -170.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -52.15 -33.33 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 O-C-N 120.199 -1.563 . . . . 0.90000000000000002 113.836 175.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -79.24 -7.99 58.69 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.461 1.504 . . . . 1.45 114.071 175.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -141.39 -166.38 2.18 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.867 1.267 . . . . 2.1200000000000001 111.575 -157.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.53 HG12 ' HG3' ' A' ' 142' ' ' LYS . 21.6 m -147.55 158.28 9.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 131.151 3.78 . . . . 0.55000000000000004 107.3 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -141.92 140.24 32.75 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.923 0.783 . . . . 0.69999999999999996 110.966 168.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -91.97 141.97 28.05 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.322 0.649 . . . . 3.6499999999999999 109.784 172.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.3 t -62.21 162.74 9.2 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.42 1.088 . . . . 1.1200000000000001 111.396 155.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 28.8 p-90 -104.0 -20.13 13.97 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.79 -0.641 . . . . 1.7 112.099 163.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -81.41 -88.23 0.08 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.829 0.852 . . . . 2.2799999999999998 109.752 -174.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.7 p -64.93 -23.97 67.38 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 122.057 -0.402 . . . . 1.1599999999999999 111.933 171.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.16 21.68 75.74 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 118.814 0.734 . . . . 0.71999999999999997 113.557 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.17 154.86 38.61 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.765 1.283 . . . . 1.77 110.334 162.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 76.1 t -100.64 135.82 34.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 N-CA-C 105.749 -1.945 . . . . 0.64000000000000001 105.749 164.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -116.62 146.92 42.36 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 126.748 2.019 . . . . 1.77 108.74 -176.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.53 ' HG3' HG12 ' A' ' 131' ' ' VAL . 6.8 tmtt? -134.08 151.37 51.37 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 122.366 1.079 . . . . 2.5099999999999998 113.56 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.0 tt -107.13 142.7 36.39 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 113.322 -1.763 . . . . 0.85999999999999999 111.827 -177.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -101.03 154.09 37.36 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 113.296 -1.775 . . . . 1.3799999999999999 111.259 -173.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.3 -4.39 15.13 Favored 'Trans proline' 0 N--CA 1.48 0.702 1 C-N-CA 125.577 4.184 . . . . 1.22 115.302 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.9 p -43.26 148.63 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 128.254 2.622 . . . . 2.21 112.693 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.855 0 CA-C-O 123.361 1.534 . . . . 2.0099999999999998 112.197 179.019 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.43 ' O ' ' HD3' ' A' ' 97' ' ' PRO . 23.3 mtt . . . . . 0 C--O 1.214 -0.793 0 N-CA-C 106.889 -1.523 . . . . 3.1000000000000001 106.889 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -4.0 -66.21 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 128.564 2.746 . . . . 2.0600000000000001 117.823 171.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.3 t70 176.69 77.77 0.1 OUTLIER Pre-proline 0 CA--C 1.564 1.481 0 C-N-CA 130.742 3.617 . . . . 2.5699999999999998 109.857 -163.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 94' ' ' MET . 59.7 Cg_endo -94.01 -51.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 1 C-N-CA 126.819 5.013 . . . . 1.1000000000000001 113.606 -173.479 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.82 142.23 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 131.153 3.781 . . . . 0.89000000000000001 104.488 -173.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.4 mm -114.51 134.62 56.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 C-N-CA 124.161 0.984 . . . . 0.88 110.199 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.3 mm -120.24 114.55 44.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 125.345 1.458 . . . . 0.62 107.781 174.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -71.49 122.1 19.84 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.911 1.284 . . . . 2.5600000000000001 110.466 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.5 m -158.43 105.13 1.86 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.728 -1.233 . . . . 3.2799999999999998 113.344 -172.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -75.03 40.02 0.14 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 127.161 2.184 . . . . 2.48 113.051 -175.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.34 -2.18 0.69 Allowed 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.129 1.159 . . . . 3.4900000000000002 114.129 -168.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 63.25 -16.46 0.06 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 128.602 2.761 . . . . 3.27 115.046 -176.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -151.68 27.47 0.64 Allowed 'General case' 0 C--O 1.244 0.784 0 O-C-N 119.841 -1.787 . . . . 2.4900000000000002 113.193 -170.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -65.47 160.62 21.75 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.551 1.167 . . . . 3.8900000000000001 111.283 171.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -82.65 167.76 17.94 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.913 -1.04 . . . . 1.9199999999999999 113.036 167.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.9 p -118.61 141.9 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 127.916 2.487 . . . . 0.69999999999999996 111.191 169.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.53 105.41 2.04 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.691 1.139 . . . . 0.82999999999999996 112.168 164.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.11 153.28 21.1 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.036 1.334 . . . . 0.95999999999999996 112.543 169.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 18.2 p -121.37 24.24 10.03 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.784 1.634 . . . . 0.84999999999999998 113.933 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.22 -28.29 6.29 Favored Glycine 0 N--CA 1.472 1.054 0 O-C-N 120.692 -1.255 . . . . 2.0299999999999998 112.775 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 83.0 p -175.87 163.03 2.0 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 128.521 2.728 . . . . 3.9399999999999999 107.67 -172.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.8 -3.7 10.9 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.31 2.673 . . . . 2.21 113.906 172.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.88 0.31 18.63 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.671 1.189 . . . . 2.29 114.059 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.29 91.57 0.39 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.533 1.063 . . . . 1.77 111.119 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.6 m -103.0 -30.35 10.83 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.011 0.745 . . . . 1.45 113.011 173.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -125.15 -151.37 0.48 Allowed 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 119.125 0.875 . . . . 1.52 111.544 166.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.708 HG22 ' OE1' ' A' ' 136' ' ' GLU . 4.3 t -73.02 -157.68 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 O-C-N 121.032 -1.043 . . . . 1.02 111.371 166.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.4 tp -103.78 145.81 12.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 127.17 2.188 . . . . 1.05 108.815 164.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.531 ' SD ' HD21 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -145.85 166.68 25.23 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.418 0.687 . . . . 4.5300000000000002 111.501 170.812 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -117.89 130.34 56.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.781 0.832 . . . . 1.6200000000000001 112.147 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.531 HD21 ' SD ' ' A' ' 122' ' ' MET . 2.2 mt -128.84 163.78 24.48 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.452 1.101 . . . . 0.82999999999999996 109.452 175.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 32.8 mttt -131.79 105.36 14.1 Favored Pre-proline 0 N--CA 1.48 1.027 0 CA-C-O 117.434 -1.27 . . . . 6.8300000000000001 110.957 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -71.82 -69.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.26 1.973 . . . . 3.21 112.96 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.9 m 100.94 147.37 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 130.287 3.435 . . . . 1.24 108.82 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.4 p -44.38 -41.1 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 127.506 2.322 . . . . 1.1699999999999999 114.733 -172.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -83.84 -22.52 31.7 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.27 1.028 . . . . 2.96 112.317 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -131.82 179.08 6.29 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.948 1.699 . . . . 4.3200000000000003 114.913 -143.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 20.4 m -131.16 147.97 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 112.874 -1.966 . . . . 0.76000000000000001 114.757 -165.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -142.5 141.22 32.07 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.979 1.312 . . . . 0.79000000000000004 112.335 174.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -122.61 139.56 53.79 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.855 1.262 . . . . 4.4500000000000002 113.565 -170.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.546 ' HG ' ' HG ' ' A' ' 137' ' ' CYS . 42.6 t -72.4 145.34 47.75 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 116.448 2.018 . . . . 1.27 116.448 -174.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.444 ' CZ3' ' HG2' ' A' ' 136' ' ' GLU . 58.5 p-90 -95.5 -10.7 29.01 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 117.421 -1.276 . . . . 2.6299999999999999 113.765 175.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.708 ' OE1' HG22 ' A' ' 120' ' ' THR . 1.3 mm-40 -93.27 -66.3 0.93 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 120.089 1.313 . . . . 2.5099999999999998 108.345 175.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' CYS . . . . . 0.546 ' HG ' ' HG ' ' A' ' 134' ' ' CYS . 12.4 p -74.86 -77.13 0.13 Allowed 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 121.844 0.83 . . . . 2.8999999999999999 110.927 173.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 125.0 18.58 2.57 Favored Glycine 0 N--CA 1.472 1.046 0 N-CA-C 117.692 1.837 . . . . 0.88 117.692 -165.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.4 p -74.92 142.63 43.98 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 120.655 2.228 . . . . 1.77 110.859 166.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 50.8 t -90.98 138.16 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 107.559 -1.275 . . . . 0.65000000000000002 107.559 167.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -117.65 142.69 46.93 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.457 1.903 . . . . 1.8500000000000001 112.382 176.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -115.58 149.09 38.78 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.285 1.04 . . . . 2.2400000000000002 112.259 173.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.3 tt -99.45 158.07 15.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.151 -0.931 . . . . 0.91000000000000003 110.071 168.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -114.3 156.01 44.94 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 114.82 1.415 . . . . 1.3500000000000001 114.82 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.08 -5.36 16.24 Favored 'Trans proline' 0 C--N 1.355 0.9 1 C-N-CA 125.65 4.233 . . . . 1.21 115.288 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.5 p -45.11 138.01 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 126.273 1.829 . . . . 2.1499999999999999 111.127 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.594 0 CA-C-O 122.851 1.251 . . . . 1.75 112.369 -174.647 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.7 mtt . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 119.445 3.128 . . . . 2.9399999999999999 119.445 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -58.88 6.67 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 120.969 -1.082 . . . . 2.1000000000000001 112.481 171.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 t0 165.32 71.75 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 129.461 3.105 . . . . 2.1099999999999999 108.906 -157.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.95 -50.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.391 1 C-N-CA 126.552 4.835 . . . . 0.81000000000000005 113.252 -171.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -150.63 141.64 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 1 C-N-CA 132.587 4.355 . . . . 0.62 104.141 -170.07 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 mm -109.88 136.14 46.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 125.163 1.385 . . . . 0.69999999999999996 109.004 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.1 mm -116.75 143.01 28.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 105.299 -2.111 . . . . 0.68999999999999995 105.299 170.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.492 ' CG ' HG11 ' A' ' 146' ' ' VAL . 9.2 tt0 -108.24 146.03 33.44 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.102 0.876 . . . . 3.1899999999999999 110.116 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.577 ' HB2' HD21 ' A' ' 143' ' ' LEU . 24.2 t -137.67 -54.71 0.67 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.852 1.427 . . . . 3.0899999999999999 114.852 -167.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 81.59 11.23 0.77 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 127.947 2.499 . . . . 2.73 113.759 -167.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -149.12 156.76 42.68 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 129.396 3.079 . . . . 2.7400000000000002 107.351 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.48 -18.16 26.78 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.285 1.217 . . . . 2.9300000000000002 114.285 174.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.68 81.55 1.16 Allowed 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.86 1.43 . . . . 2.8999999999999999 114.86 -158.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -127.39 167.91 15.57 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 120.898 -1.126 . . . . 5.5199999999999996 113.219 167.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -90.8 171.32 9.41 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.306 1.443 . . . . 2.1499999999999999 113.882 -174.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.4 p -124.98 143.12 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 126.685 1.994 . . . . 0.89000000000000001 111.228 171.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.26 92.76 1.01 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.585 1.564 . . . . 0.71999999999999997 112.081 162.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -106.19 146.55 30.13 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.553 1.676 . . . . 1.22 113.727 176.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.9 p -115.54 4.79 14.28 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.358 1.463 . . . . 1.22 114.166 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 138.07 -27.13 2.8 Favored Glycine 0 N--CA 1.468 0.777 0 O-C-N 121.405 -0.809 . . . . 2.5800000000000001 114.898 -169.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.0 t 106.12 144.85 0.01 OUTLIER Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 128.091 2.556 . . . . 3.96 106.681 -138.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.15 93.76 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.95 2.433 . . . . 3.23 110.76 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 176.86 21.32 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 129.256 3.022 . . . . 2.5 113.412 166.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 67.2 43.21 90.03 Favored Glycine 0 C--N 1.341 0.837 0 O-C-N 121.133 -0.979 . . . . 2.25 113.777 167.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 5.3 t -60.68 -36.35 78.55 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.156 0.978 . . . . 2.9700000000000002 111.905 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 26.4 p80 -135.65 -141.1 0.17 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.017 1.327 . . . . 1.5800000000000001 112.323 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.729 HG22 ' OE2' ' A' ' 136' ' ' GLU . 11.4 t -85.13 -141.39 0.08 Allowed 'General case' 0 C--O 1.218 -0.583 0 C-N-CA 124.14 0.976 . . . . 1.04 108.812 158.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.4 ' N ' HG23 ' A' ' 120' ' ' THR . 4.7 tp -123.08 141.22 44.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 130.23 3.412 . . . . 1.1499999999999999 111.689 174.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.421 ' SD ' ' NE1' ' A' ' 135' ' ' TRP . 12.9 mmt -136.47 154.57 50.72 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 116.379 1.992 . . . . 4.9199999999999999 116.379 -173.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -115.65 87.79 2.74 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.753 -0.658 . . . . 1.5800000000000001 111.789 -170.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 mt -103.1 167.99 9.47 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.487 -0.758 . . . . 0.83999999999999997 109.354 -174.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.57 88.86 2.73 Favored Pre-proline 0 N--CA 1.475 0.789 0 O-C-N 121.033 -1.042 . . . . 7.79 112.556 -167.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -81.37 173.4 11.64 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.477 2.784 . . . . 2.3399999999999999 109.933 170.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -113.55 156.83 22.91 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.45 1.9 . . . . 1.24 107.883 169.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 p -50.3 -39.53 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-N 119.992 1.269 . . . . 0.79000000000000004 113.952 170.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -79.59 -5.59 55.31 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.263 0.838 . . . . 1.8999999999999999 113.263 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -143.16 -164.14 1.79 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.561 0.744 . . . . 2.2200000000000002 111.773 -155.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.4 m -149.74 158.57 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.731 2.012 . . . . 0.55000000000000004 110.263 -171.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -143.62 139.61 29.72 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.224 1.01 . . . . 0.66000000000000003 111.637 170.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.9 ttt-85 -97.96 146.14 25.78 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.457 0.703 . . . . 4.29 110.32 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 9.7 t -60.2 160.35 8.46 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.545 1.538 . . . . 1.0900000000000001 110.627 159.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.421 ' NE1' ' SD ' ' A' ' 122' ' ' MET . 27.7 p-90 -99.86 -17.71 17.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 117.479 -1.248 . . . . 1.4199999999999999 111.822 160.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.729 ' OE2' HG22 ' A' ' 120' ' ' THR . 2.1 mm-40 -86.25 -95.38 0.08 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.923 1.289 . . . . 1.51 109.502 -173.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.3 p -64.28 -13.33 49.05 Favored 'General case' 0 CA--C 1.557 1.233 0 O-C-N 119.963 -1.711 . . . . 1.1599999999999999 114.929 -177.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.75 16.8 80.15 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.95 1.738 . . . . 0.75 114.909 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.82 142.4 49.63 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.399 1.6 . . . . 1.74 110.56 169.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.26 147.94 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 108.355 -0.979 . . . . 0.56000000000000005 108.355 158.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -126.27 153.49 44.7 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 128.928 2.891 . . . . 1.8200000000000001 111.037 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 46.7 tttt -130.39 152.89 49.31 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.621 0.768 . . . . 2.3999999999999999 112.763 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' A' ' 102' ' ' SER . 0.8 OUTLIER -99.34 164.92 11.92 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.874 1.321 . . . . 2.3399999999999999 111.283 161.784 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.461 ' H ' HD23 ' A' ' 143' ' ' LEU . 27.7 p30 -123.96 167.56 15.0 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 127.538 2.335 . . . . 1.52 110.804 -177.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -83.75 -26.42 2.04 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.717 2.278 . . . . 1.3600000000000001 113.776 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.492 HG11 ' CG ' ' A' ' 101' ' ' GLU . 35.7 m 38.66 -164.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 129.976 3.31 . . . . 3.04 117.238 -178.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.833 0 CA-C-O 123.746 1.748 . . . . 2.1200000000000001 113.174 132.031 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.0 mtt . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 118.749 2.87 . . . . 3.1400000000000001 118.749 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.22 -80.67 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.306 0.574 . . . . 2.4500000000000002 110.188 161.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.8 t0 177.13 77.78 0.11 Allowed Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 127.073 2.149 . . . . 2.3799999999999999 108.1 -162.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -93.96 -57.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 1 C-N-CA 127.053 5.168 . . . . 0.97999999999999998 115.402 -162.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.15 140.92 29.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 1 C-N-CA 131.803 4.041 . . . . 0.76000000000000001 103.709 -170.818 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 mm -111.69 135.92 49.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 123.633 0.773 . . . . 0.79000000000000004 110.502 -175.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.2 mm -123.89 100.18 7.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 126.584 1.954 . . . . 0.79000000000000004 106.23 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -78.8 120.41 23.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 113.547 -1.661 . . . . 2.5600000000000001 110.455 -163.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.7 t -110.28 -65.74 1.13 Allowed 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 115.049 1.5 . . . . 2.7599999999999998 115.049 -154.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.451 ' H ' ' CG2' ' A' ' 146' ' ' VAL . 59.7 m-85 71.86 11.13 6.26 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.826 2.05 . . . . 2.3999999999999999 112.555 -171.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -138.1 153.37 49.28 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 130.046 3.338 . . . . 2.8300000000000001 107.306 163.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -71.29 -9.26 57.83 Favored 'General case' 0 CA--C 1.552 1.054 0 O-C-N 120.645 -1.284 . . . . 3.1499999999999999 113.032 172.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -141.45 104.07 4.52 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.417 2.287 . . . . 2.8799999999999999 111.405 -164.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -148.94 168.79 22.13 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.709 -1.244 . . . . 3.9300000000000002 112.306 174.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -103.94 158.11 16.63 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.727 0.811 . . . . 2.4199999999999999 111.32 166.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.6 p -102.33 141.12 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.238 1.415 . . . . 0.87 110.291 169.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -106.92 78.54 0.25 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.341 1.448 . . . . 1.1899999999999999 112.867 169.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 12.9 p -94.95 143.0 26.82 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 119.596 1.698 . . . . 1.45 113.285 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 35.6 p -105.95 19.02 21.21 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-N 112.532 -2.122 . . . . 0.81999999999999995 112.141 169.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.07 60.84 0.34 Allowed Glycine 0 C--N 1.334 0.47 0 CA-C-O 119.033 -0.871 . . . . 1.72 113.675 176.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 68.59 -166.06 0.01 OUTLIER Pre-proline 0 CA--C 1.556 1.204 0 CA-C-O 117.836 -1.078 . . . . 5.1600000000000001 109.874 171.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.85 52.09 3.87 Favored 'Trans proline' 0 C--N 1.354 0.837 0 CA-C-N 122.768 2.024 . . . . 4.5899999999999999 111.598 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -163.1 7.54 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 116.031 1.863 . . . . 4.0999999999999996 116.031 -160.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 51.87 47.95 52.35 Favored Glycine 0 N--CA 1.475 1.29 0 N-CA-C 115.061 0.784 . . . . 2.23 115.061 159.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.2 m -113.83 -21.73 10.52 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 116.331 1.975 . . . . 1.6599999999999999 116.331 -151.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -123.57 -148.5 0.4 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 121.096 1.771 . . . . 1.3700000000000001 113.904 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.539 HG22 ' OE2' ' A' ' 136' ' ' GLU . 1.6 t -72.68 -153.23 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.323 0.649 . . . . 0.93000000000000005 110.946 162.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.457 ' N ' HG23 ' A' ' 120' ' ' THR . 5.2 tp -117.12 136.53 53.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 126.466 1.906 . . . . 0.84999999999999998 112.488 167.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.46 ' CE ' ' HE1' ' A' ' 135' ' ' TRP . 17.3 mmm -131.62 155.83 46.87 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.818 -1.537 . . . . 4.0899999999999999 114.688 -176.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -123.59 111.77 16.64 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.816 -1.084 . . . . 1.47 109.956 -177.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 mt -124.01 148.9 46.64 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.648 -0.501 . . . . 0.85999999999999999 109.648 -171.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.26 108.3 58.67 Favored Pre-proline 0 N--CA 1.484 1.242 0 CA-C-O 118.798 -0.62 . . . . 5.8399999999999999 111.789 -175.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -89.87 -175.21 0.96 Allowed 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.126 2.55 . . . . 2.73 109.895 154.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 94.8 m -158.92 157.44 31.41 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.72 2.808 . . . . 1.3300000000000001 105.199 173.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 p -49.71 -32.41 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 115.309 1.596 . . . . 0.81999999999999995 115.309 -176.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -79.27 -0.81 33.83 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.027 1.331 . . . . 2.04 113.949 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -141.29 -175.83 4.49 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 123.545 1.64 . . . . 2.7400000000000002 114.503 -151.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.5 m -139.22 168.08 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 130.244 3.418 . . . . 0.70999999999999996 107.267 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -147.82 128.11 13.88 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 123.924 0.89 . . . . 0.68000000000000005 111.13 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -92.33 141.17 28.84 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.937 0.789 . . . . 4.29 110.351 173.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 9.2 t -63.54 174.81 1.2 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 122.789 1.281 . . . . 1.1899999999999999 112.446 159.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.46 ' HE1' ' CE ' ' A' ' 122' ' ' MET . 20.8 p-90 -111.34 -18.37 12.93 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.316 -0.856 . . . . 1.6000000000000001 111.983 161.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.539 ' OE2' HG22 ' A' ' 120' ' ' THR . 0.0 OUTLIER -86.9 -87.7 0.14 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.67 1.988 . . . . 1.71 108.092 -171.431 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 24.3 p -59.84 -19.68 52.53 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 120.477 -1.39 . . . . 1.1000000000000001 112.664 168.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.98 15.89 22.89 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.669 1.604 . . . . 0.92000000000000004 114.186 -175.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.1 p -75.04 142.24 43.79 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 119.122 1.461 . . . . 1.28 110.722 172.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 52.8 t -80.72 147.61 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.455 -0.942 . . . . 0.55000000000000004 108.455 167.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -130.84 158.47 40.09 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 130.231 3.413 . . . . 2.2999999999999998 109.457 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -140.39 147.0 39.08 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 113.759 1.022 . . . . 3.0600000000000001 113.759 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.7 tt -93.4 145.13 24.71 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 115.36 -0.836 . . . . 0.91000000000000003 110.771 170.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -112.21 147.36 36.79 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 124.618 1.167 . . . . 1.3999999999999999 110.392 171.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -69.98 -27.57 25.25 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.549 2.166 . . . . 1.8200000000000001 112.497 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.451 ' CG2' ' H ' ' A' ' 103' ' ' TYR . 7.6 m 41.5 -158.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 129.002 2.921 . . . . 3.0 114.933 -174.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.419 0 CA-C-O 122.228 0.904 . . . . 2.3700000000000001 112.477 157.746 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.9 mtt . . . . . 0 CA--C 1.521 -0.156 0 CA-C-O 123.911 1.815 . . . . 2.5800000000000001 111.779 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 177.09 -123.48 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.119 1 C-N-CA 132.108 4.163 . . . . 1.9199999999999999 107.077 178.13 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . 0.27 30.0 t70 -131.33 78.6 71.76 Favored Pre-proline 0 N--CA 1.432 -1.334 0 C-N-CA 126.6 1.96 . . . . 2.54 107.699 176.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.13 -84.06 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.6 1 C-N-CA 126.876 5.05 . . . . 1.23 113.14 -171.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.65 147.56 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 C-N-CA 127.835 2.454 . . . . 0.70999999999999996 106.406 171.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.2 mm -105.77 136.05 41.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.932 -0.576 . . . . 0.84999999999999998 111.21 -174.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.5 mm -119.25 99.12 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 126.169 1.788 . . . . 0.64000000000000001 107.572 169.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -70.39 122.86 20.41 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.543 1.537 . . . . 3.0 108.968 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.6 m -162.23 123.49 2.65 Favored 'General case' 0 C--O 1.221 -0.442 0 O-C-N 121.06 -1.025 . . . . 3.48 112.687 -165.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -83.47 25.71 0.73 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.203 1.001 . . . . 2.5299999999999998 113.316 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -140.95 124.6 16.89 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.766 2.026 . . . . 2.6699999999999999 107.967 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -62.51 7.99 0.06 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 127.771 2.428 . . . . 3.3799999999999999 117.468 -169.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.08 22.8 0.07 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.761 2.424 . . . . 2.2400000000000002 112.458 -165.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.2 ttt-85 -67.39 150.12 49.38 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.503 1.121 . . . . 3.96 113.387 -174.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -82.99 150.91 26.09 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.893 0.701 . . . . 2.1899999999999999 112.893 176.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.5 p -108.07 138.8 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.502 1.521 . . . . 0.81000000000000005 111.168 169.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -108.66 103.14 1.79 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.492 -1.443 . . . . 0.69999999999999996 109.492 159.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.04 155.8 17.25 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.949 0.9 . . . . 1.24 110.554 166.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 120' ' ' THR . 40.9 p -118.11 4.94 11.99 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 116.463 2.023 . . . . 0.75 116.463 172.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.71 56.3 0.29 Allowed Glycine 0 C--N 1.33 0.224 0 CA-C-O 119.443 -0.643 . . . . 2.0800000000000001 113.016 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 79.5 -162.2 0.0 OUTLIER Pre-proline 0 CA--C 1.565 1.528 0 CA-C-O 116.61 -1.662 . . . . 3.2400000000000002 109.245 -168.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -80.55 45.93 2.11 Favored 'Trans proline' 0 C--N 1.358 1.053 0 CA-C-N 124.524 2.651 . . . . 2.2200000000000002 112.915 -173.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -166.55 163.7 17.04 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.025 1.33 . . . . 3.9300000000000002 110.785 -169.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.89 42.41 2.49 Favored Glycine 0 N--CA 1.473 1.125 0 C-N-CA 124.478 1.037 . . . . 2.2799999999999998 114.048 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.1 m -68.93 -40.6 78.93 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.657 1.229 . . . . 1.99 114.028 -160.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -106.27 -73.23 0.69 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.04 0.756 . . . . 1.8999999999999999 113.04 173.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 112' ' ' THR . 7.0 t -178.99 -166.12 0.09 Allowed 'General case' 0 N--CA 1.475 0.789 1 C-N-CA 132.685 4.394 . . . . 0.96999999999999997 106.609 -175.339 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.6 tp -98.77 138.42 23.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 119.771 1.169 . . . . 0.89000000000000001 110.729 173.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.56 ' SD ' HD21 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -141.02 163.43 32.99 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.121 1.368 . . . . 4.4500000000000002 110.441 166.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.3 m95 -130.22 87.67 2.54 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.868 -0.52 . . . . 2.3100000000000001 111.611 -155.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.56 HD21 ' SD ' ' A' ' 122' ' ' MET . 3.2 mt -95.64 167.42 11.3 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 120.498 -1.376 . . . . 0.68000000000000005 110.746 -171.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.35 88.02 15.19 Favored Pre-proline 0 N--CA 1.472 0.675 0 C-N-CA 123.592 0.757 . . . . 7.1500000000000004 111.29 -176.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -77.27 166.61 26.01 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.575 2.184 . . . . 2.3700000000000001 110.412 165.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 m -120.18 154.86 34.2 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 127.097 2.159 . . . . 1.21 108.295 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.4 p -54.95 -34.21 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 112.939 0.718 . . . . 0.75 112.939 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -82.17 -10.07 59.29 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.62 1.168 . . . . 1.6799999999999999 113.508 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -140.02 -168.34 2.5 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.696 0.68 . . . . 2.5499999999999998 112.649 -155.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.83 157.67 23.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 126.93 2.092 . . . . 0.51000000000000001 109.385 -171.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.2 144.89 36.82 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.113 0.965 . . . . 0.47999999999999998 110.968 172.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.4 ttp180 -111.74 139.3 47.33 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.443 1.02 . . . . 4.0800000000000001 112.557 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 37.8 t -60.34 156.33 15.97 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.244 1.418 . . . . 1.02 112.484 163.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -100.43 -12.85 19.03 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.063 -0.971 . . . . 1.28 112.766 169.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -103.39 -78.99 0.54 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.163 0.892 . . . . 2.5800000000000001 111.246 -169.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 26.6 p -70.02 -22.19 63.12 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.853 0.861 . . . . 1.3700000000000001 112.407 172.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.58 33.36 80.93 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.441 1.02 . . . . 1.0800000000000001 113.273 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.11 152.67 42.18 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.839 1.319 . . . . 1.96 110.508 158.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.1 t -100.24 135.4 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 106.335 -1.728 . . . . 0.57999999999999996 106.335 159.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -117.4 140.47 49.53 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 127.735 2.414 . . . . 1.6599999999999999 110.875 -176.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.8 tttm -106.14 147.47 28.96 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.639 -0.71 . . . . 2.5800000000000001 112.704 173.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.43 144.78 25.48 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 114.847 -1.069 . . . . 0.89000000000000001 110.168 155.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -106.66 159.34 30.22 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 124.596 1.158 . . . . 1.3100000000000001 113.006 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -71.8 -5.16 16.51 Favored 'Trans proline' 0 C--N 1.354 0.861 1 C-N-CA 126.274 4.65 . . . . 1.29 115.983 -177.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.9 p -48.11 142.42 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 126.141 1.777 . . . . 2.1699999999999999 111.511 177.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.717 0 CA-C-O 122.993 1.33 . . . . 1.6899999999999999 112.674 179.353 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 10.9 mtm . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 118.428 2.751 . . . . 2.54 118.428 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.32 -59.66 2.62 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.791 0.663 . . . . 2.6299999999999999 112.791 169.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.425 ' H ' ' HD3' ' A' ' 97' ' ' PRO . 0.1 OUTLIER 167.05 70.44 0.0 OUTLIER Pre-proline 0 CA--C 1.566 1.571 0 C-N-CA 129.674 3.189 . . . . 3.0 110.167 -150.201 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.425 ' HD3' ' H ' ' A' ' 96' ' ' ASP . 63.0 Cg_endo -89.02 -50.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.334 -0.229 1 C-N-CA 125.529 4.152 . . . . 0.73999999999999999 113.358 -174.244 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.98 141.74 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 1 C-N-CA 131.954 4.102 . . . . 0.53000000000000003 104.207 -172.791 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.3 mm -119.48 129.43 75.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 124.303 1.041 . . . . 0.71999999999999997 111.153 -175.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 42.0 mm -115.39 98.21 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 125.688 1.595 . . . . 0.55000000000000004 107.515 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -71.12 99.67 1.9 Allowed 'General case' 0 C--N 1.328 -0.361 0 O-C-N 125.569 1.793 . . . . 2.54 108.333 176.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.483 ' OG ' HD21 ' A' ' 143' ' ' LEU . 78.7 p -104.92 -43.6 5.03 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.041 1.126 . . . . 3.7000000000000002 114.041 -157.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . 0.252 35.5 m-85 72.32 9.77 5.86 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 127.742 2.417 . . . . 2.73 114.45 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -132.66 150.21 52.19 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.58 -0.896 . . . . 3.1099999999999999 108.58 134.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.05 -28.01 22.55 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.969 2.507 . . . . 3.4399999999999999 114.91 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -127.1 12.77 7.19 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.525 1.53 . . . . 2.4900000000000002 114.044 -161.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -56.57 175.28 0.12 Allowed 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 122.458 1.123 . . . . 4.04 113.25 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -95.41 169.32 10.14 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.582 -0.699 . . . . 2.5499999999999998 111.348 157.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.7 p -116.22 143.16 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 126.884 2.074 . . . . 0.85999999999999999 111.472 171.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -104.69 101.33 1.92 Allowed Glycine 0 CA--C 1.532 1.142 0 CA-C-O 117.974 -1.459 . . . . 0.82999999999999996 114.142 165.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 13.8 p -107.43 145.61 32.77 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-O 123.908 1.813 . . . . 1.1599999999999999 113.386 160.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 74.3 p -102.44 16.4 26.4 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 112.494 -2.139 . . . . 0.73999999999999999 111.627 165.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 142.45 176.0 16.2 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-O 123.693 1.718 . . . . 3.4500000000000002 114.599 -171.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.6 m -3.47 133.68 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.242 0 CA-C-N 111.757 -2.222 . . . . 3.9399999999999999 115.785 103.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.85 57.39 4.46 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 125.131 3.887 . . . . 2.8799999999999999 114.476 -169.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -169.27 48.74 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.815 1.246 . . . . 1.98 111.622 -167.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 55.7 24.69 41.25 Favored Glycine 0 N--CA 1.48 1.627 0 C-N-CA 125.077 1.322 . . . . 2.1299999999999999 115.925 166.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.2 m -77.38 -41.6 39.55 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.754 1.02 . . . . 2.0899999999999999 113.754 -144.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.438 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 25.2 p80 -115.12 -149.01 0.44 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.937 1.295 . . . . 1.51 112.395 -176.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.616 HG22 ' OE2' ' A' ' 136' ' ' GLU . 2.4 t -71.92 -155.43 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.692 0.678 . . . . 1.0900000000000001 110.987 160.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.5 tp -115.37 138.68 44.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 C-N-CA 126.483 1.913 . . . . 0.96999999999999997 111.082 165.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.525 ' CE ' ' HE1' ' A' ' 135' ' ' TRP . 13.2 mmm -131.95 153.38 50.36 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 115.144 1.535 . . . . 3.9700000000000002 115.144 -174.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -118.33 99.57 6.93 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 124.528 1.143 . . . . 1.5700000000000001 110.309 -173.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.3 mt -109.45 162.47 14.34 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.498 0.719 . . . . 0.77000000000000002 109.63 -173.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -121.89 74.57 36.87 Favored Pre-proline 0 N--CA 1.487 1.38 0 O-C-N 120.425 -1.422 . . . . 4.6600000000000001 114.782 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -86.47 39.56 0.65 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.908 3.072 . . . . 3.3399999999999999 114.922 -171.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.8 m -28.02 151.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 1 C-N-CA 132.206 4.202 . . . . 1.0700000000000001 115.27 -169.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.4 p -45.66 -39.02 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 114.703 1.372 . . . . 0.82999999999999996 114.703 177.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -81.48 -8.63 59.75 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.403 1.481 . . . . 1.47 113.823 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.402 ' O ' ' HE3' ' A' ' 142' ' ' LYS . 30.3 mt-10 -136.17 -159.53 0.97 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.34 1.056 . . . . 2.1299999999999999 110.52 -156.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 20.9 m -157.81 153.53 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 130.246 3.419 . . . . 0.79000000000000004 106.15 177.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -142.38 143.52 32.73 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.535 0.607 . . . . 0.79000000000000004 111.044 171.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -100.35 142.6 31.61 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.285 0.634 . . . . 4.8700000000000001 110.446 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 14.6 t -60.05 159.06 9.98 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 124.514 1.134 . . . . 1.04 111.52 161.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.525 ' HE1' ' CE ' ' A' ' 122' ' ' MET . 20.6 p-90 -103.96 -12.79 16.62 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.6 -0.727 . . . . 1.3999999999999999 111.703 163.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.616 ' OE2' HG22 ' A' ' 120' ' ' THR . 1.6 mm-40 -89.65 -87.05 0.18 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.933 1.293 . . . . 1.55 108.842 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 23.0 p -74.65 -15.16 60.82 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.256 1.206 . . . . 1.4299999999999999 114.256 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 66.85 18.94 69.09 Favored Glycine 0 N--CA 1.469 0.876 0 C-N-CA 126.318 1.913 . . . . 0.73999999999999999 115.075 172.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.27 141.83 57.89 Favored 'General case' 0 N--CA 1.46 0.059 0 C-N-CA 118.593 -1.243 . . . . 1.75 110.349 163.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 45.9 t -78.94 141.8 14.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 107.782 -1.192 . . . . 0.79000000000000004 107.782 159.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -122.52 156.61 33.8 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 128.082 2.553 . . . . 1.73 110.219 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 130' ' ' GLU . 66.5 tttt -136.64 152.76 50.78 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 122.315 1.055 . . . . 2.27 113.027 173.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.681 HD23 ' H ' ' A' ' 144' ' ' ASN . 6.3 tt -112.16 167.4 10.44 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.561 1.545 . . . . 1.04 109.252 174.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.681 ' H ' HD23 ' A' ' 143' ' ' LEU . 1.9 p30 -126.52 165.7 26.51 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.507 1.523 . . . . 1.45 113.581 -168.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 144' ' ' ASN . 65.0 Cg_endo -73.32 -4.43 15.4 Favored 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 124.07 3.18 . . . . 1.45 115.256 -176.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.8 p -44.54 140.35 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 127.974 2.51 . . . . 2.75 114.026 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.734 0 C-N-CA 126.541 2.02 . . . . 2.3300000000000001 110.335 -179.473 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.2 mtp . . . . . 0 C--O 1.224 -0.24 0 N-CA-C 116.985 2.217 . . . . 3.1699999999999999 116.985 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.33 -74.69 0.61 Allowed 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 124.305 1.042 . . . . 2.1699999999999999 109.29 173.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.4 t70 179.44 75.9 0.17 Allowed Pre-proline 0 CA--C 1.559 1.324 0 C-N-CA 128.242 2.617 . . . . 2.5899999999999999 107.893 -166.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 142' ' ' LYS . 60.7 Cg_endo -89.23 -51.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.551 1 C-N-CA 128.582 6.188 . . . . 0.75 113.437 -175.205 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -139.58 143.12 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 130.746 3.618 . . . . 0.57999999999999996 104.844 -175.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.0 mm -102.76 138.34 27.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.671 -0.695 . . . . 0.80000000000000004 110.822 -176.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.3 mm -120.5 107.11 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 C-N-CA 127.036 2.134 . . . . 0.67000000000000004 107.462 170.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -78.61 134.32 37.2 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 124.601 1.188 . . . . 3.2200000000000002 110.867 -174.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.448 ' O ' HG21 ' A' ' 146' ' ' VAL . 13.2 t -162.24 107.22 1.21 Allowed 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 113.144 0.794 . . . . 2.71 113.144 -163.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.3 m-30 -77.33 41.53 0.31 Allowed 'General case' 0 N--CA 1.48 1.063 0 O-C-N 120.524 -1.36 . . . . 2.5099999999999998 110.762 171.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.37 123.71 3.93 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.956 2.902 . . . . 3.1699999999999999 107.965 -166.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.54 -3.6 31.86 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 115.582 1.697 . . . . 3.3399999999999999 115.582 -166.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.36 21.64 1.06 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 125.112 1.365 . . . . 2.1099999999999999 113.662 -156.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.04 154.06 18.34 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 120.148 -1.595 . . . . 5.9800000000000004 114.991 -154.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.8 161.18 31.38 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.319 1.229 . . . . 2.0699999999999998 114.319 -177.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.4 p -129.6 145.84 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 127.455 2.302 . . . . 0.82999999999999996 109.84 171.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.17 126.74 6.39 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.155 0.883 . . . . 0.77000000000000002 111.605 164.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.97 151.97 39.09 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.366 1.867 . . . . 1.52 111.94 169.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 34.0 p -117.83 25.97 10.01 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.164 1.385 . . . . 0.97999999999999998 113.385 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.85 68.27 1.03 Allowed Glycine 0 N--CA 1.462 0.428 0 O-C-N 120.844 -1.16 . . . . 2.4900000000000002 111.017 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.46 177.71 0.06 OUTLIER Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 123.521 0.728 . . . . 3.0800000000000001 110.01 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.23 38.96 0.76 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.061 2.507 . . . . 2.6499999999999999 112.705 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -151.93 3.2 0.38 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.851 1.797 . . . . 2.1200000000000001 115.851 -165.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.38 72.22 0.98 Allowed Glycine 0 N--CA 1.474 1.188 0 C-N-CA 124.849 1.214 . . . . 1.8600000000000001 114.206 167.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.5 t -103.63 -30.38 10.5 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 115.338 1.607 . . . . 2.0899999999999999 115.338 -174.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.415 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 9.1 p80 -128.32 -148.12 0.37 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.631 0.773 . . . . 1.3300000000000001 112.042 -176.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.776 HG22 ' OE1' ' A' ' 136' ' ' GLU . 5.2 t -78.16 -152.34 0.05 Allowed 'General case' 0 N--CA 1.479 1.016 0 O-C-N 121.268 -0.895 . . . . 0.98999999999999999 111.376 167.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.5 tp -106.65 149.91 9.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 127.667 2.387 . . . . 1.22 110.212 164.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.18 172.35 12.88 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.806 1.242 . . . . 4.9299999999999997 110.036 170.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -137.45 124.96 22.08 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.004 0.521 . . . . 1.5 111.493 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.61 179.75 4.13 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.981 0.912 . . . . 0.84999999999999998 109.185 176.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.27 102.6 2.95 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.973 0.909 . . . . 6.5099999999999998 111.738 174.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -80.4 171.63 14.6 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.144 2.563 . . . . 2.3199999999999998 110.22 164.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.8 m -122.72 155.97 35.37 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 127.2 2.2 . . . . 1.1899999999999999 107.628 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.4 p -55.2 -30.9 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 120.571 1.532 . . . . 0.83999999999999997 112.485 175.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -82.93 -7.52 59.66 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.12 1.768 . . . . 1.4399999999999999 113.521 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -147.42 -169.67 3.37 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.29 1.036 . . . . 2.1600000000000001 112.146 -156.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.567 HG12 ' HG3' ' A' ' 142' ' ' LYS . 26.8 m -142.18 170.31 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 127.757 2.423 . . . . 0.63 109.739 -170.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -150.85 147.55 27.38 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.019 0.927 . . . . 0.52000000000000002 111.505 172.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.6 ttt-85 -114.11 139.2 49.52 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.64 0.776 . . . . 4.5599999999999996 112.333 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 40.1 t -56.78 157.67 5.32 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.817 1.247 . . . . 1.0 112.71 159.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 67.2 p-90 -109.68 -9.05 14.87 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.307 -0.871 . . . . 1.1699999999999999 112.691 167.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.776 ' OE1' HG22 ' A' ' 120' ' ' THR . 4.0 mm-40 -96.22 -83.8 0.37 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.992 1.317 . . . . 1.6699999999999999 109.682 -173.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.4 p -72.43 -14.99 61.83 Favored 'General case' 0 CA--C 1.551 0.983 0 O-C-N 120.644 -1.285 . . . . 1.22 112.651 167.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.49 22.64 76.57 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 119.075 -0.847 . . . . 0.73999999999999999 113.725 169.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.5 p -71.21 130.48 41.55 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 118.388 1.094 . . . . 1.6000000000000001 110.186 170.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.5 t -77.23 147.16 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.451 -0.574 . . . . 0.56000000000000005 109.451 161.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -131.52 156.61 45.4 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 130.544 3.538 . . . . 1.9299999999999999 110.523 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.567 ' HG3' HG12 ' A' ' 131' ' ' VAL . 9.5 tmtt? -140.27 153.2 46.43 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 113.59 0.959 . . . . 2.2799999999999998 113.59 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 144' ' ' ASN . 2.2 tt -100.66 144.1 30.03 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 122.042 0.925 . . . . 0.90000000000000002 112.372 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.418 ' O ' HD23 ' A' ' 143' ' ' LEU . 7.1 p30 -99.37 162.94 19.64 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.249 1.02 . . . . 1.3100000000000001 112.824 -174.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -75.51 -28.01 8.72 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.606 2.871 . . . . 1.3899999999999999 113.837 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 102' ' ' SER . 0.1 OUTLIER 47.88 -161.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 128.032 2.533 . . . . 3.5699999999999998 116.781 169.633 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.971 0 CA-C-O 122.39 0.994 . . . . 1.9299999999999999 114.863 132.224 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.9 mtm . . . . . 0 N--CA 1.469 0.515 0 CA-C-O 121.902 0.858 . . . . 2.7400000000000002 112.756 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 129.73 -132.0 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.763 1 C-N-CA 132.676 4.39 . . . . 2.75 107.822 -156.785 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -126.54 91.58 47.15 Favored Pre-proline 0 N--CA 1.436 -1.155 0 C-N-CA 128.882 2.873 . . . . 2.23 107.185 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -95.99 -49.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.373 1 C-N-CA 126.649 4.899 . . . . 0.70999999999999996 112.737 -178.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -150.62 138.48 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 131.5 3.92 . . . . 0.62 103.934 -171.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.5 mm -115.48 134.95 57.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 124.635 1.174 . . . . 0.75 111.047 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.3 mm -121.97 112.88 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 C-N-CA 126.336 1.854 . . . . 0.5 107.416 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -82.83 136.29 34.68 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 125.023 1.452 . . . . 2.5499999999999998 111.868 -173.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.0 t -125.4 -54.59 1.57 Allowed 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 113.995 1.109 . . . . 2.8300000000000001 113.995 -154.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.605 ' H ' ' CG2' ' A' ' 146' ' ' VAL 0.29 17.0 m-85 73.21 15.54 4.38 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.915 2.086 . . . . 3.1000000000000001 113.336 -172.932 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -151.57 168.06 26.14 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 131.677 3.991 . . . . 2.6400000000000001 106.986 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -72.28 -8.38 54.54 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.844 1.258 . . . . 2.8900000000000001 113.547 164.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.2 120.18 8.76 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 123.651 1.691 . . . . 3.3599999999999999 115.046 -164.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 81.1 mmt-85 -143.23 177.28 8.52 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.922 2.489 . . . . 4.4000000000000004 110.09 167.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -100.66 172.92 6.79 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.659 -0.651 . . . . 2.25 109.822 149.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.0 142.22 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.99 0.916 . . . . 0.68000000000000005 111.206 171.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -107.95 92.92 0.77 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-O 117.688 -1.618 . . . . 0.66000000000000003 113.647 169.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 12.7 p -101.24 148.26 25.32 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 119.788 1.794 . . . . 1.0600000000000001 113.478 166.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.4 p -113.11 13.0 19.26 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 113.24 -1.8 . . . . 0.66000000000000003 113.501 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.25 81.12 1.57 Allowed Glycine 0 N--CA 1.463 0.445 0 N-CA-C 110.42 -1.072 . . . . 2.4100000000000001 110.42 -176.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 10.1 p 58.24 -163.28 0.01 OUTLIER Pre-proline 0 CA--C 1.563 1.46 0 CA-C-O 117.106 -1.426 . . . . 2.7200000000000002 111.302 -171.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.08 -6.06 17.53 Favored 'Trans proline' 0 C--N 1.356 0.971 0 CA-C-N 123.321 2.222 . . . . 2.27 113.711 173.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -98.66 13.65 31.36 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.01 1.485 . . . . 1.8200000000000001 115.01 -165.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.5 34.26 88.66 Favored Glycine 0 N--CA 1.476 1.32 0 O-C-N 121.15 -0.969 . . . . 1.9299999999999999 113.866 172.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.02 -39.68 83.1 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.066 1.136 . . . . 1.77 114.066 -163.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.444 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 22.5 p80 -113.29 -149.14 0.44 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.239 1.816 . . . . 1.28 112.917 -176.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.642 HG22 ' OE2' ' A' ' 136' ' ' GLU . 2.6 t -73.41 -153.67 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 119.31 0.959 . . . . 1.1100000000000001 111.115 162.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.423 ' N ' HG23 ' A' ' 120' ' ' THR . 5.0 tp -117.86 137.83 50.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 126.896 2.078 . . . . 0.83999999999999997 111.499 165.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.468 ' CE ' ' HE1' ' A' ' 135' ' ' TRP . 13.6 mmm -131.66 151.74 51.4 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 115.527 1.676 . . . . 3.9100000000000001 115.527 -172.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -117.01 103.8 10.62 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 124.209 0.943 . . . . 1.55 110.515 -174.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.9 mt -111.53 161.91 15.67 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.202 0.601 . . . . 0.84999999999999998 110.423 -174.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.72 84.62 10.42 Favored Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 114.517 1.303 . . . . 6.2699999999999996 114.517 -171.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -88.63 14.96 2.17 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.59 2.86 . . . . 3.1000000000000001 116.265 -164.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.8 m -29.85 152.78 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 1 C-N-CA 131.804 4.041 . . . . 1.3500000000000001 115.322 -165.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.9 p -47.08 -43.21 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 115.174 1.546 . . . . 1.0900000000000001 115.174 -177.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -78.05 -5.52 51.68 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.795 1.638 . . . . 1.76 114.222 178.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -131.79 -177.45 4.43 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 122.758 1.266 . . . . 3.1000000000000001 112.169 -159.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.4 m -148.81 156.1 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 128.591 2.756 . . . . 0.79000000000000004 106.744 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.22 132.75 28.66 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 122.68 0.392 . . . . 0.81000000000000005 110.803 175.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.6 ttm-85 -86.22 138.19 32.06 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.189 -1.041 . . . . 4.04 108.189 168.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 20.7 t -57.67 153.03 14.12 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 124.398 1.061 . . . . 1.23 110.942 153.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.468 ' HE1' ' CE ' ' A' ' 122' ' ' MET . 19.2 p-90 -97.45 -18.63 18.94 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.524 -0.75 . . . . 1.8 111.471 163.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.642 ' OE2' HG22 ' A' ' 120' ' ' THR . 2.3 mm-40 -83.37 -92.31 0.07 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.129 0.971 . . . . 1.6100000000000001 108.804 -177.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 32.1 p -65.59 -15.43 62.72 Favored 'General case' 0 CA--C 1.553 1.07 0 O-C-N 120.559 -1.338 . . . . 1.3600000000000001 114.46 176.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.44 17.82 76.51 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 126.581 2.038 . . . . 0.83999999999999997 115.348 169.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.4 p -77.26 144.66 38.03 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.76 1.28 . . . . 1.5700000000000001 111.762 168.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 57.7 t -80.58 145.29 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.462 -0.57 . . . . 0.66000000000000003 109.462 162.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -125.15 147.95 48.8 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 129.114 2.966 . . . . 1.78 110.56 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.405 ' HG2' ' N ' ' A' ' 143' ' ' LEU . 48.8 tttt -124.4 154.57 40.21 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 123.746 1.736 . . . . 1.9299999999999999 113.186 169.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.405 ' N ' ' HG2' ' A' ' 142' ' ' LYS . 8.0 tt -92.04 156.38 17.44 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.542 1.537 . . . . 0.91000000000000003 110.606 165.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -120.74 139.08 28.41 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 107.434 -1.321 . . . . 1.3700000000000001 107.434 164.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.3 -30.53 30.31 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.078 2.519 . . . . 2.6800000000000002 111.837 -171.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.605 ' CG2' ' H ' ' A' ' 103' ' ' TYR . 20.3 m 41.41 -157.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 129.001 2.92 . . . . 2.2999999999999998 115.587 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.395 0 C-N-CA 127.299 2.38 . . . . 2.0800000000000001 108.678 159.25 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.1 mtm . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 121.6 0.714 . . . . 2.7999999999999998 112.347 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 151.28 -76.64 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.661 1 C-N-CA 132.927 4.491 . . . . 1.71 111.33 -176.478 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.5 t0 177.14 75.64 0.1 Allowed Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 128.373 2.669 . . . . 2.0800000000000001 109.596 -163.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -88.52 -49.68 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.387 1 C-N-CA 127.432 5.421 . . . . 0.72999999999999998 112.551 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -148.06 143.82 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 1 C-N-CA 131.916 4.086 . . . . 0.67000000000000004 104.205 -171.739 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.6 mm -107.85 146.13 14.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 124.67 1.188 . . . . 0.63 109.568 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.8 mm -127.38 107.57 16.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 126.603 1.961 . . . . 0.56000000000000005 110.314 167.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.4 mp0 -64.12 124.87 22.75 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 123.125 1.44 . . . . 3.6499999999999999 112.61 175.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.3 t -116.78 -58.31 2.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.774 -1.557 . . . . 2.7400000000000002 114.894 -157.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.59 ' H ' ' CG2' ' A' ' 146' ' ' VAL . 14.5 m-85 64.45 25.53 13.33 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.82 1.248 . . . . 3.0499999999999998 110.636 -168.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -167.4 148.92 5.68 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 128.345 2.658 . . . . 2.21 108.917 -170.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.426 ' HB2' ' CD2' ' A' ' 106' ' ' TYR . 8.5 m-20 -76.93 -25.62 53.12 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.61 -1.306 . . . . 3.1400000000000001 113.097 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.426 ' CD2' ' HB2' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -140.56 14.25 2.35 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.195 1.798 . . . . 2.3599999999999999 113.991 -150.453 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -60.41 168.3 2.16 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.784 1.234 . . . . 5.5499999999999998 112.536 174.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -106.52 159.32 16.26 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.809 1.04 . . . . 2.27 113.809 171.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.53 144.98 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 127.029 2.132 . . . . 1.04 109.917 170.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.42 100.89 1.4 Allowed Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.921 -0.933 . . . . 0.97999999999999998 111.993 165.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 1.6 t -86.59 138.47 31.67 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.047 1.339 . . . . 1.1299999999999999 112.591 171.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.9 p -109.34 22.19 16.12 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.061 1.134 . . . . 0.82999999999999996 114.061 170.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.87 55.77 0.92 Allowed Glycine 0 N--CA 1.462 0.391 0 O-C-N 120.806 -1.184 . . . . 1.8999999999999999 110.779 -175.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 65.43 -168.04 0.01 OUTLIER Pre-proline 0 CA--C 1.566 1.577 0 CA-C-O 117.799 -1.096 . . . . 3.9900000000000002 110.886 -173.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.41 6.1 5.02 Favored 'Trans proline' 0 C--N 1.355 0.899 0 CA-C-N 123.507 2.288 . . . . 2.4700000000000002 114.885 -169.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.31 13.2 13.6 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.553 1.316 . . . . 2.1600000000000001 114.553 -166.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 64.46 61.33 6.06 Favored Glycine 0 N--CA 1.473 1.139 0 CA-C-N 118.844 0.747 . . . . 1.6899999999999999 112.956 169.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 39.7 m -100.26 -26.43 13.91 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.73 1.381 . . . . 1.6000000000000001 114.73 -169.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.474 ' CE1' ' SD ' ' A' ' 122' ' ' MET . 30.3 p80 -131.59 -158.53 0.9 Allowed 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 119.671 1.123 . . . . 1.5800000000000001 111.1 168.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.45 HG23 ' SD ' ' A' ' 122' ' ' MET . 7.8 t -75.55 -152.97 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 O-C-N 121.088 -1.008 . . . . 0.84999999999999998 111.145 169.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.405 ' C ' ' SD ' ' A' ' 122' ' ' MET . 4.9 tp -112.6 131.3 64.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 117.72 2.489 . . . . 0.97999999999999998 117.72 -178.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.484 ' SD ' ' HG3' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -132.46 126.52 33.21 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 128.745 2.818 . . . . 5.1900000000000004 114.532 -169.339 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -106.98 114.18 28.11 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.299 1.04 . . . . 2.04 111.518 -167.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 mt -120.11 157.47 28.9 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.965 0.802 . . . . 0.79000000000000004 111.231 -171.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -118.49 92.96 44.76 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.249 1.42 . . . . 5.71 111.313 172.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -88.46 30.4 0.43 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.062 3.175 . . . . 3.46 114.383 -171.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.5 m -23.43 154.86 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 1 C-N-CA 133.829 4.852 . . . . 1.1699999999999999 117.863 -162.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.5 p -51.34 -33.99 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 120.061 -1.649 . . . . 0.84999999999999998 113.633 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -90.16 -6.0 55.84 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.276 1.83 . . . . 1.8700000000000001 114.077 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -138.05 -160.55 1.07 Allowed 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.87 0.868 . . . . 2.27 110.728 -159.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.518 HG12 ' HG3' ' A' ' 142' ' ' LYS . 27.3 m -156.98 160.31 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 131.179 3.792 . . . . 0.59999999999999998 106.277 -176.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -143.98 132.49 22.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 118.89 0.768 . . . . 0.64000000000000001 111.092 174.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 140' ' ' VAL . 8.2 ttm180 -90.72 129.63 36.8 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.447 0.699 . . . . 3.5099999999999998 109.128 170.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 34.1 t -55.32 140.99 37.58 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 123.955 0.784 . . . . 1.27 110.34 155.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -81.2 -14.58 57.4 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.552 -0.737 . . . . 1.3100000000000001 112.534 171.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.484 ' HG3' ' SD ' ' A' ' 122' ' ' MET . 0.5 OUTLIER -96.38 -91.17 0.24 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.635 1.174 . . . . 1.77 109.239 -169.163 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 19.0 p -58.99 -25.68 63.84 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.9 -1.125 . . . . 1.1699999999999999 112.756 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.81 25.94 73.84 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.346 0.974 . . . . 1.1000000000000001 113.139 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.3 p -69.61 125.15 25.84 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 119.215 1.508 . . . . 1.79 109.749 159.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 133' ' ' ARG . 39.9 t -79.18 147.37 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 107.156 -1.424 . . . . 0.67000000000000004 107.156 161.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -132.91 154.23 50.62 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 128.973 2.909 . . . . 2.2999999999999998 110.094 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.518 ' HG3' HG12 ' A' ' 131' ' ' VAL . 5.6 tmtt? -137.52 162.46 33.67 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.299 1.047 . . . . 2.4399999999999999 113.323 175.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.1 tt -113.0 144.69 42.14 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.469 1.128 . . . . 0.89000000000000001 113.234 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -111.87 144.29 30.38 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-N 114.291 -1.322 . . . . 1.3300000000000001 109.546 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -67.2 -28.1 40.75 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.832 2.355 . . . . 2.0699999999999998 112.009 -175.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.59 ' CG2' ' H ' ' A' ' 103' ' ' TYR . 22.1 m 42.12 -157.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 128.027 2.531 . . . . 2.7599999999999998 114.965 -173.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.925 0 C-N-CA 124.999 1.285 . . . . 2.29 110.794 139.331 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 33.1 mtp . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 117.754 2.501 . . . . 2.6800000000000002 117.754 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.14 -63.26 1.15 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.29 1.036 . . . . 1.9199999999999999 113.165 171.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.8 t0 163.55 77.38 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 128.502 2.721 . . . . 2.5099999999999998 110.173 -157.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -89.33 -50.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.411 1 C-N-CA 126.846 5.03 . . . . 0.81000000000000005 113.078 -174.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -154.77 142.4 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 1 C-N-CA 132.019 4.127 . . . . 0.5 104.585 -168.584 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.8 mm -118.3 137.74 51.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 123.985 0.914 . . . . 0.75 112.129 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.8 mm -129.2 112.9 26.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 127.29 2.236 . . . . 0.55000000000000004 109.002 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.69 124.98 25.37 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.758 1.623 . . . . 2.46 112.193 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.3 t -145.17 90.51 2.04 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 115.792 1.775 . . . . 2.98 115.792 -167.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -77.25 64.1 2.59 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.561 1.144 . . . . 3.4500000000000002 110.672 174.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.41 -13.32 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.68 2.392 . . . . 3.2000000000000002 113.477 -167.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 64.82 -7.93 0.24 Allowed 'General case' 0 CA--C 1.56 1.349 0 CA-C-N 120.74 1.609 . . . . 3.0600000000000001 115.072 -170.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -152.34 24.13 0.62 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 116.928 2.196 . . . . 2.46 116.928 -172.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -54.82 149.89 10.67 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 120.572 1.533 . . . . 4.2599999999999998 113.079 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -77.11 161.59 28.14 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.516 -0.74 . . . . 2.2400000000000002 112.18 163.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.1 p -113.76 145.66 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 126.586 1.954 . . . . 0.73999999999999999 111.511 175.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.67 113.27 4.67 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.424 1.011 . . . . 1.29 112.043 162.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 7.4 t -110.63 128.57 55.74 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.408 1.483 . . . . 1.04 113.239 174.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 32.9 p -110.54 34.36 4.0 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.546 1.313 . . . . 1.22 114.546 167.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.407 ' HA2' ' SG ' ' A' ' 137' ' ' CYS . . . 85.17 -31.74 3.69 Favored Glycine 0 N--CA 1.473 1.167 0 O-C-N 118.984 -2.322 . . . . 2.04 114.806 173.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.0 p 176.07 177.46 0.22 Allowed Pre-proline 0 CA--C 1.556 1.19 1 C-N-CA 132.468 4.307 . . . . 3.6699999999999999 106.67 -175.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.48 -15.02 47.61 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 121.721 1.614 . . . . 2.5499999999999998 113.302 167.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -101.85 55.43 0.81 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.935 1.694 . . . . 2.2999999999999998 111.55 177.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 55.31 20.81 23.8 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 118.061 1.984 . . . . 2.3700000000000001 118.061 154.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.3 m -71.17 -26.68 63.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 115.302 1.593 . . . . 1.6200000000000001 115.302 -140.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -108.0 -25.44 11.16 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 117.234 2.309 . . . . 2.79 117.234 169.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.319 4.8 t 121.12 -152.58 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 131.559 3.944 . . . . 1.51 108.563 -145.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.8 tp -130.15 142.74 43.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 130.463 3.505 . . . . 1.3999999999999999 112.383 -175.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.489 ' HG3' ' HG3' ' A' ' 136' ' ' GLU . 19.1 mmm -135.01 159.4 41.63 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 126.652 1.981 . . . . 3.7200000000000002 116.093 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -126.79 113.88 17.21 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.693 0.797 . . . . 1.99 110.222 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 mt -122.65 159.68 27.37 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.099 0.959 . . . . 0.89000000000000001 109.681 -171.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.16 80.92 70.88 Favored Pre-proline 0 N--CA 1.477 0.918 0 O-C-N 120.758 -1.214 . . . . 5.0999999999999996 113.171 -166.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.08 177.59 8.69 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.201 2.601 . . . . 2.5699999999999998 110.822 170.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.0 m -151.94 159.59 43.75 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.883 2.073 . . . . 0.87 107.972 -177.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.402 ' N ' HD22 ' A' ' 143' ' ' LEU . 2.6 p -53.19 -42.36 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.514 1.126 . . . . 1.02 113.583 -172.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -77.75 -2.08 34.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.944 1.298 . . . . 1.5700000000000001 113.633 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -140.82 -172.05 3.38 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 122.227 1.013 . . . . 2.3500000000000001 112.881 -150.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.9 m -153.27 161.11 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 128.102 2.561 . . . . 0.59999999999999998 107.841 -175.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.7 130.63 24.56 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.598 1.159 . . . . 0.52000000000000002 110.884 175.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.417 ' HA ' ' HA ' ' A' ' 140' ' ' VAL . 2.6 ttp180 -91.55 134.59 34.53 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.136 0.88 . . . . 5.0599999999999996 109.481 171.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 24.4 t -55.64 155.2 5.88 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.99 0.916 . . . . 0.94999999999999996 111.515 162.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.41 ' NE1' ' SD ' ' A' ' 122' ' ' MET . 30.1 p-90 -89.71 -17.05 29.06 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.184 -0.948 . . . . 1.23 111.944 166.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.489 ' HG3' ' HG3' ' A' ' 122' ' ' MET . 4.9 mt-10 -89.25 -101.54 0.09 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.627 1.171 . . . . 2.2200000000000002 109.892 -175.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' CYS . . . . . 0.407 ' SG ' ' HA2' ' A' ' 113' ' ' GLY . 27.9 p -60.57 -9.6 4.0 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 119.169 -2.207 . . . . 1.24 116.144 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.37 26.83 64.68 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 127.574 2.511 . . . . 0.77000000000000002 113.836 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.26 150.48 48.21 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.768 1.784 . . . . 1.5700000000000001 109.853 161.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 133' ' ' ARG . 69.1 t -100.54 141.11 17.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 N-CA-C 104.945 -2.243 . . . . 0.60999999999999999 104.945 169.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -123.34 139.63 53.84 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 126.877 2.071 . . . . 2.04 110.057 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.7 tttt -121.49 145.85 47.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.233 1.016 . . . . 2.8500000000000001 112.173 -175.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 128' ' ' VAL . 8.9 tt -103.76 152.69 21.56 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.194 -1.366 . . . . 1.0700000000000001 110.208 175.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -111.9 154.61 44.07 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 114.022 -1.444 . . . . 1.45 112.317 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -71.62 -3.62 13.44 Favored 'Trans proline' 0 N--CA 1.482 0.838 1 C-N-CA 126.219 4.613 . . . . 1.6200000000000001 115.68 -175.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.5 p -42.97 138.65 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 127.299 2.24 . . . . 2.3700000000000001 112.026 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 122.245 0.914 . . . . 2.75 110.959 -171.953 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.8 mtm . . . . . 0 N--CA 1.467 0.413 0 N-CA-C 116.715 2.117 . . . . 2.1899999999999999 116.715 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.464 ' HD2' ' H ' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -114.84 -117.81 0.32 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.488 -1.671 . . . . 2.8300000000000001 106.488 160.985 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.464 ' H ' ' HD2' ' A' ' 95' ' ' LYS 0.312 38.8 t70 -129.1 82.68 68.0 Favored Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 126.217 1.807 . . . . 2.6499999999999999 106.262 -178.237 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -87.56 -47.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.789 1 C-N-CA 128.089 5.859 . . . . 0.76000000000000001 113.489 -171.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 mm -146.91 141.47 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 131.247 3.819 . . . . 0.56000000000000005 103.269 -171.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.1 mm -108.98 140.89 25.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 C-N-CA 124.81 1.244 . . . . 0.65000000000000002 110.052 -175.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.7 mm -130.63 109.59 17.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 126.513 1.925 . . . . 0.51000000000000001 110.008 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.0 mp0 -63.82 136.92 57.79 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.709 1.604 . . . . 4.1900000000000004 112.863 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.0 t -165.67 133.88 3.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.752 -1.113 . . . . 2.7999999999999998 110.207 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 -86.99 -4.15 59.15 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 118.854 0.752 . . . . 2.8799999999999999 110.922 166.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -95.59 156.66 16.23 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.596 1.959 . . . . 2.4500000000000002 110.652 168.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -73.45 -24.38 60.22 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.903 1.681 . . . . 3.96 113.371 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -134.71 2.21 3.15 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.418 1.636 . . . . 2.48 115.418 -164.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.68 132.19 6.5 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.544 1.537 . . . . 7.1699999999999999 113.118 -177.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -78.35 152.26 32.43 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.029 1.122 . . . . 2.3399999999999999 114.029 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.0 p -101.5 144.2 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.378 1.471 . . . . 0.83999999999999997 111.775 175.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.06 89.65 0.77 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.849 1.69 . . . . 0.76000000000000001 113.737 163.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 3.7 p -99.22 143.55 29.36 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 119.602 1.701 . . . . 1.54 112.156 168.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 62.9 p -114.73 23.98 12.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.214 -1.357 . . . . 1.0 111.84 174.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.53 -168.45 14.66 Favored Glycine 0 CA--C 1.503 -0.681 0 CA-C-O 124.098 1.943 . . . . 2.4399999999999999 114.025 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -37.21 139.02 0.53 Allowed Pre-proline 0 CA--C 1.549 0.924 0 CA-C-N 110.853 -2.674 . . . . 3.9700000000000002 111.453 151.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.98 -13.6 28.27 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.884 3.723 . . . . 3.02 116.913 -155.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -85.82 6.34 28.57 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.758 1.021 . . . . 2.52 113.758 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.33 82.22 0.76 Allowed Glycine 0 C--N 1.34 0.758 0 N-CA-C 110.114 -1.194 . . . . 1.8 110.114 -176.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.88 -64.51 1.16 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.635 0.731 . . . . 2.3100000000000001 111.346 178.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.428 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 34.4 p80 -100.56 -153.54 0.45 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.335 0.865 . . . . 1.74 113.335 -164.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.513 HG22 ' OE2' ' A' ' 136' ' ' GLU . 5.8 t -70.2 -154.32 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 123.606 0.762 . . . . 1.9099999999999999 109.355 161.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.2 tp -116.3 140.96 36.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 C-N-CA 127.072 2.149 . . . . 1.3400000000000001 109.827 168.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 13.6 mmm -126.35 159.42 33.26 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 114.099 1.148 . . . . 4.0999999999999996 114.099 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -125.09 67.25 1.12 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.025 0.75 . . . . 1.8500000000000001 113.025 -167.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.7 mt -87.67 157.86 18.98 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.254 -0.904 . . . . 0.67000000000000004 109.572 -165.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -127.43 77.58 75.65 Favored Pre-proline 0 N--CA 1.48 1.051 0 CA-C-N 119.753 1.161 . . . . 6.75 111.429 -166.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -89.23 33.96 0.37 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.522 3.482 . . . . 3.3599999999999999 116.318 -156.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -15.25 144.16 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.287 1 C-N-CA 133.234 4.614 . . . . 0.96999999999999997 117.527 -166.595 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.407 ' HB ' HD22 ' A' ' 143' ' ' LEU . 12.1 p -56.14 -32.79 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 120.491 -1.381 . . . . 0.93999999999999995 111.477 174.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -78.46 -11.25 59.94 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.543 1.937 . . . . 2.0800000000000001 114.456 174.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -143.19 -141.38 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.409 1.083 . . . . 1.98 111.284 -164.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.43 HG12 ' HG3' ' A' ' 142' ' ' LYS . 26.8 m -162.19 167.81 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 1 C-N-CA 134.029 4.932 . . . . 0.82999999999999996 106.504 -176.429 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -148.96 142.9 25.77 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.322 0.965 . . . . 0.66000000000000003 111.713 163.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -100.94 142.6 32.19 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.438 0.695 . . . . 5.4100000000000001 111.569 177.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 15.7 t -63.58 154.53 32.39 Favored 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 124.586 1.179 . . . . 1.1699999999999999 111.15 161.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 17.8 p-90 -100.56 -19.94 15.92 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.814 -1.084 . . . . 1.48 111.463 163.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.513 ' OE2' HG22 ' A' ' 120' ' ' THR . 3.8 mm-40 -81.5 -87.64 0.09 Allowed 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 107.555 -1.276 . . . . 1.79 107.555 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 27.4 p -72.1 -12.25 61.12 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 114.671 1.36 . . . . 1.1499999999999999 114.671 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.33 6.45 83.66 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.887 1.232 . . . . 1.24 114.688 168.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.5 p -69.28 137.43 53.04 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.051 1.74 . . . . 1.76 110.167 173.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 62.0 t -80.19 148.92 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 108.866 -0.79 . . . . 0.87 108.866 159.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -128.47 154.41 46.12 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 129.316 3.046 . . . . 1.8500000000000001 109.724 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.43 ' HG3' HG12 ' A' ' 131' ' ' VAL . 8.2 tmtt? -137.53 157.39 46.65 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.129 0.966 . . . . 2.5499999999999998 112.535 178.009 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.407 HD22 ' HB ' ' A' ' 128' ' ' VAL . 8.2 tt -111.39 146.5 37.04 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 123.136 1.446 . . . . 0.91000000000000003 112.185 -178.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -99.83 153.72 37.62 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 114.085 -1.416 . . . . 1.3400000000000001 113.585 -170.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.85 -4.85 15.59 Favored 'Trans proline' 0 C--N 1.348 0.535 1 C-N-CA 125.398 4.065 . . . . 1.46 114.984 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.9 p -43.5 142.56 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 126.766 2.027 . . . . 1.8999999999999999 112.086 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.832 0 CA-C-O 123.474 1.597 . . . . 1.53 112.494 -177.036 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 19.2 mtt . . . . . 0 C--O 1.224 -0.288 0 N-CA-C 118.69 2.848 . . . . 2.1099999999999999 118.69 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -61.72 2.11 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.541 0.941 . . . . 1.98 113.541 171.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.462 ' N ' ' HD3' ' A' ' 97' ' ' PRO . 0.0 OUTLIER 173.38 72.09 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 128.389 2.676 . . . . 4.5999999999999996 110.213 -150.129 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.462 ' HD3' ' N ' ' A' ' 96' ' ' ASP . 93.6 Cg_endo -96.48 -48.55 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 125.245 3.964 . . . . 0.93000000000000005 113.535 -175.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -158.55 145.51 8.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 1 C-N-CA 132.353 4.261 . . . . 0.57999999999999996 104.556 -167.326 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.5 mm -118.09 139.12 46.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 124.344 1.057 . . . . 0.59999999999999998 110.303 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.4 mm -128.39 147.18 32.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 127.067 2.147 . . . . 0.71999999999999997 106.877 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.565 ' HG2' HG11 ' A' ' 146' ' ' VAL . 83.1 mt-10 -109.64 170.15 8.25 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.579 1.152 . . . . 2.6800000000000002 110.913 177.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.2 t -159.2 -43.78 0.06 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.981 1.104 . . . . 3.3900000000000001 113.981 -176.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 65.61 37.88 5.69 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 124.515 1.135 . . . . 2.23 110.117 -171.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -143.14 -84.78 0.16 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.931 2.092 . . . . 3.29 108.855 172.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t70 175.3 -39.54 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 129.293 3.037 . . . . 3.8399999999999999 109.721 -177.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -116.61 -52.38 2.56 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.012 1.486 . . . . 2.8399999999999999 115.012 -167.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 7.39 -113.37 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 129.722 3.209 . . . . 5.0999999999999996 114.648 -162.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -163.17 160.5 24.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.084 1.354 . . . . 2.0800000000000001 111.848 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.8 p -112.39 137.56 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.214 1.406 . . . . 0.81999999999999995 109.791 166.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.08 87.45 0.45 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.215 1.388 . . . . 0.84999999999999998 111.915 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 7.9 p -97.74 146.34 25.46 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 123.721 1.725 . . . . 1.3200000000000001 112.999 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 56.9 p -112.2 15.62 20.39 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 112.85 -1.977 . . . . 0.80000000000000004 112.346 171.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.93 -130.54 8.08 Favored Glycine 0 C--N 1.337 0.596 0 O-C-N 120.939 -1.1 . . . . 3.1000000000000001 111.611 -171.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.56 -52.5 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 116.07 -1.919 . . . . 4.04 113.728 -171.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -80.26 52.8 4.47 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.307 2.005 . . . . 6.3700000000000001 109.598 166.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 66.88 99.04 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.231 1.812 . . . . 3.0499999999999998 114.331 168.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 63.91 31.27 80.26 Favored Glycine 0 N--CA 1.476 1.346 0 O-C-N 120.391 -1.443 . . . . 2.0099999999999998 113.514 173.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -45.49 90.84 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.246 1.418 . . . . 1.3999999999999999 112.458 -168.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.451 ' CE1' ' SD ' ' A' ' 122' ' ' MET . 34.3 p80 -108.18 -142.31 0.38 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.768 1.627 . . . . 1.49 111.439 177.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.558 HG22 ' OE2' ' A' ' 136' ' ' GLU . 10.7 t -89.13 -141.68 0.14 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.404 1.081 . . . . 0.84999999999999998 109.273 163.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.456 ' N ' HG23 ' A' ' 120' ' ' THR . 4.9 tp -122.07 132.88 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 128.545 2.738 . . . . 0.94999999999999996 116.603 173.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.467 ' SD ' ' HG3' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -127.69 149.02 50.4 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 129.462 3.105 . . . . 5.1100000000000003 112.814 -174.513 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -127.98 119.89 26.44 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.91 0.884 . . . . 1.7 110.267 -174.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.57 163.18 23.97 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.834 0.854 . . . . 0.92000000000000004 110.651 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -110.4 90.0 9.53 Favored Pre-proline 0 N--CA 1.483 1.215 0 C-N-CA 124.382 1.073 . . . . 5.9000000000000004 111.793 176.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -76.53 -45.13 0.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 CA-C-O 116.854 -1.394 . . . . 3.1499999999999999 112.866 -169.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 68.56 145.08 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 130.372 3.469 . . . . 1.1499999999999999 110.91 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.01 -40.34 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.759 0.79 . . . . 1.4199999999999999 109.919 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -66.74 -20.73 66.02 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 126.541 1.936 . . . . 2.02 113.336 172.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -135.36 -160.27 1.04 Allowed 'General case' 0 C--N 1.342 0.253 0 CA-C-N 120.583 1.538 . . . . 2.98 110.815 -164.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.2 m -147.44 155.95 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 127.699 2.4 . . . . 0.52000000000000002 107.834 176.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.6 137.23 33.52 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.242 0.617 . . . . 0.58999999999999997 111.33 170.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.2 ttp85 -98.14 138.48 35.37 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.868 0.304 . . . . 4.2400000000000002 110.774 172.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 49.6 t -61.37 156.38 19.16 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 123.045 1.402 . . . . 1.1000000000000001 111.465 160.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -98.78 -15.98 19.09 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.118 -1.401 . . . . 1.28 112.521 169.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.558 ' OE2' HG22 ' A' ' 120' ' ' THR . 0.1 OUTLIER -98.65 -85.03 0.39 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.091 2.156 . . . . 1.6200000000000001 109.787 -168.262 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 29.5 p -67.35 -19.71 65.47 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 120.823 1.647 . . . . 1.28 112.797 170.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.44 16.72 80.46 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.022 0.82 . . . . 0.70999999999999996 113.786 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.98 143.92 57.08 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 119.681 1.741 . . . . 1.9399999999999999 111.453 171.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 59.6 t -92.35 136.9 23.44 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 N-CA-C 105.656 -1.979 . . . . 0.58999999999999997 105.656 161.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -120.03 137.97 53.79 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 126.356 1.863 . . . . 1.74 109.209 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -106.12 150.56 25.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 123.542 0.527 . . . . 1.8700000000000001 110.103 164.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.696 HD23 ' H ' ' A' ' 144' ' ' ASN . 0.5 OUTLIER -85.7 -171.5 3.63 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 122.309 1.052 . . . . 2.25 108.88 158.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.696 ' H ' HD23 ' A' ' 143' ' ' LEU . 1.1 t-20 -143.93 169.09 10.97 Favored Pre-proline 0 C--N 1.318 -0.799 0 C-N-CA 126.767 2.027 . . . . 4.2599999999999998 109.709 -174.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -89.6 1.28 5.72 Favored 'Trans proline' 0 N--CA 1.46 -0.482 1 C-N-CA 125.466 4.11 . . . . 1.54 114.576 -165.595 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.565 HG11 ' HG2' ' A' ' 101' ' ' GLU . 8.5 p -40.78 142.58 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 1 C-N-CA 132.022 4.129 . . . . 2.3300000000000001 113.56 175.715 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.861 0 C-N-CA 128.101 2.762 . . . . 1.76 108.926 -166.982 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.2 mtm . . . . . 0 N--CA 1.467 0.385 0 N-CA-C 119.416 3.117 . . . . 2.0099999999999998 119.416 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.59 -62.17 1.55 Allowed 'General case' 0 C--N 1.316 -0.849 0 O-C-N 121.896 -0.502 . . . . 2.3100000000000001 111.43 167.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.415 ' N ' ' HD3' ' A' ' 97' ' ' PRO . 37.8 t70 168.02 66.54 0.01 OUTLIER Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 130.032 3.333 . . . . 2.73 108.659 -163.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 142' ' ' LYS . 51.5 Cg_endo -80.08 -71.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 1 C-N-CA 128.21 5.94 . . . . 1.0 113.562 -168.596 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.45 ' H ' ' HG2' ' A' ' 97' ' ' PRO . 0.6 OUTLIER -112.37 145.87 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 130.876 3.67 . . . . 0.64000000000000001 104.473 174.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.7 mm -106.74 143.19 17.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 124.016 0.927 . . . . 0.67000000000000004 111.044 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.9 mm -125.75 114.13 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 126.761 2.024 . . . . 0.60999999999999999 109.021 167.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -66.21 138.41 57.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.938 1.351 . . . . 3.71 112.249 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.4 t -160.63 118.1 2.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.097 -0.956 . . . . 3.1099999999999999 111.723 -169.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -87.74 10.0 19.77 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 118.44 0.564 . . . . 2.3900000000000001 112.088 167.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -105.66 -60.26 1.65 Allowed 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.755 1.622 . . . . 3.0699999999999998 113.162 -172.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.579 ' OD1' HG12 ' A' ' 128' ' ' VAL . 23.7 t0 119.92 -48.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 1 C-N-CA 133.55 4.74 . . . . 4.2300000000000004 109.01 -167.511 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.85 -3.59 59.08 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 119.906 -1.746 . . . . 2.23 113.629 -168.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -52.25 121.75 7.44 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.846 1.658 . . . . 4.0999999999999996 113.102 -163.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -82.36 164.23 21.2 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 114.555 1.317 . . . . 2.0 114.555 -168.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.8 t -97.98 137.43 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.543 1.937 . . . . 2.1200000000000001 112.093 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -115.27 69.35 0.26 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.952 1.263 . . . . 1.1699999999999999 111.995 164.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 4.2 t -82.53 133.92 35.19 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.994 0.918 . . . . 0.95999999999999996 111.679 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 57.3 p -113.18 25.95 10.9 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.495 1.118 . . . . 0.85999999999999999 113.636 168.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.43 66.57 1.46 Allowed Glycine 0 N--CA 1.462 0.431 0 O-C-N 120.822 -1.174 . . . . 2.3999999999999999 110.793 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 68.73 174.03 0.08 OUTLIER Pre-proline 0 CA--C 1.563 1.442 0 C-N-CA 123.464 0.705 . . . . 2.9300000000000002 110.856 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.7 -8.71 22.89 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 121.881 1.72 . . . . 2.1800000000000002 114.704 -169.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.56 4.73 46.0 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.355 1.243 . . . . 2.02 114.355 -173.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.73 81.37 0.37 Allowed Glycine 0 N--CA 1.471 1.006 0 C-N-CA 125.12 1.343 . . . . 1.6599999999999999 112.465 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.6 m -102.33 -35.91 8.65 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.413 1.264 . . . . 1.4199999999999999 114.413 -174.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.439 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 6.6 p80 -122.98 -153.71 0.57 Allowed 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.611 -0.681 . . . . 1.3600000000000001 111.935 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.746 HG22 ' OE1' ' A' ' 136' ' ' GLU . 5.5 t -72.25 -154.51 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 119.423 1.01 . . . . 1.0700000000000001 111.415 168.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.3 tp -108.96 146.81 14.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 126.711 2.004 . . . . 1.01 109.816 163.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.613 ' SD ' HD21 ' A' ' 124' ' ' LEU . 4.7 ppp? -154.76 163.5 40.16 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.189 0.811 . . . . 3.7599999999999998 113.189 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.409 ' O ' HD23 ' A' ' 124' ' ' LEU . 5.6 m95 -127.8 126.92 42.63 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.601 0.963 . . . . 1.51 113.601 -162.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.613 HD21 ' SD ' ' A' ' 122' ' ' MET . 5.6 mt -131.92 158.35 41.62 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.553 1.141 . . . . 0.72999999999999998 111.535 -174.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.43 83.1 16.07 Favored Pre-proline 0 CA--C 1.561 1.399 0 C-N-CA 125.976 1.71 . . . . 6.0700000000000003 112.272 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -82.35 27.01 0.61 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.936 3.757 . . . . 3.27 115.704 -165.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.447 HG22 ' OD1' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -20.32 148.84 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 1 C-N-CA 133.169 4.588 . . . . 1.0 116.901 -163.479 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.579 HG12 ' OD1' ' A' ' 105' ' ' ASP . 5.0 p -59.15 -32.75 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 O-C-N 120.418 -1.426 . . . . 0.82999999999999996 111.124 175.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -73.35 -12.27 60.77 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 128.407 2.683 . . . . 2.21 113.977 174.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.418 ' HB3' ' H ' ' A' ' 131' ' ' VAL . 31.5 mt-10 -144.61 -146.66 0.19 Allowed 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 123.761 0.824 . . . . 2.25 111.561 -161.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.466 HG12 ' HG3' ' A' ' 142' ' ' LYS . 32.0 m -159.32 170.79 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.67 1 C-N-CA 134.29 5.036 . . . . 0.81000000000000005 106.133 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -146.6 143.6 28.95 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.32 -0.862 . . . . 0.51000000000000001 112.21 164.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.403 ' HG3' HG22 ' A' ' 140' ' ' VAL . 14.3 ttm-85 -100.55 136.66 40.08 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.632 1.573 . . . . 5.6299999999999999 110.045 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.475 ' HA ' ' HE1' ' A' ' 122' ' ' MET . 52.3 t -68.29 167.32 14.66 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 122.475 1.131 . . . . 1.1299999999999999 112.945 161.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 46.5 p-90 -122.46 -12.24 8.21 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.449 1.5 . . . . 1.29 112.155 171.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.746 ' OE1' HG22 ' A' ' 120' ' ' THR . 4.1 mm-40 -94.93 -61.73 1.44 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.685 0.794 . . . . 2.02 110.624 -174.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 29.9 p -95.12 -15.77 23.11 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.961 1.304 . . . . 1.0800000000000001 112.63 166.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.43 16.76 78.83 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 120.896 -1.127 . . . . 0.93000000000000005 114.341 174.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.7 p -68.32 126.73 30.5 Favored 'General case' 0 C--N 1.335 -0.041 0 CA-C-N 119.76 1.78 . . . . 1.5800000000000001 109.642 173.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.403 HG22 ' HG3' ' A' ' 133' ' ' ARG . 46.2 t -75.73 147.03 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 119.657 -0.817 . . . . 0.67000000000000004 109.079 161.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -128.0 152.71 47.59 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 130.097 3.359 . . . . 2.1000000000000001 110.41 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.492 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 9.6 tmtt? -140.4 157.74 45.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 122.257 1.027 . . . . 2.48 113.203 174.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.3 tt -114.39 143.67 44.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 122.763 1.268 . . . . 0.89000000000000001 113.085 -175.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -98.75 155.82 36.28 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-N 114.18 -1.373 . . . . 1.3 112.046 -170.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.1 -4.02 14.59 Favored 'Trans proline' 0 C--N 1.352 0.753 1 C-N-CA 125.904 4.403 . . . . 1.51 115.428 -174.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.3 p -40.94 148.61 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 128.433 2.693 . . . . 2.0099999999999998 113.736 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.545 0 O-C-N 120.809 -1.182 . . . . 1.5700000000000001 110.722 175.494 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.4 mtm . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 118.229 2.678 . . . . 2.0099999999999998 118.229 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.23 -123.9 0.06 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.741 1.258 . . . . 2.5899999999999999 108.363 157.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -120.61 90.02 45.4 Favored Pre-proline 0 N--CA 1.433 -1.304 0 C-N-CA 129.222 3.009 . . . . 2.48 107.658 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -90.45 -42.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.26 1 C-N-CA 127.174 5.249 . . . . 1.03 112.352 -178.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 mm -155.68 140.16 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 130.462 3.505 . . . . 0.96999999999999997 104.341 -168.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.2 mm -108.22 136.27 44.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 124.68 1.192 . . . . 0.76000000000000001 109.48 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.7 mm -130.7 112.28 22.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 127.836 2.454 . . . . 0.70999999999999996 107.043 176.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -64.94 172.85 2.62 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 125.432 1.707 . . . . 3.1800000000000002 110.345 171.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 98.7 p -157.84 -57.17 0.08 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.039 -0.982 . . . . 2.9900000000000002 113.471 -166.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.6 ' CD1' HG23 ' A' ' 146' ' ' VAL . 12.7 m-85 64.27 27.0 13.81 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 126.742 2.017 . . . . 3.0499999999999998 110.825 -165.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -169.05 160.68 10.08 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 129.489 3.115 . . . . 3.6699999999999999 110.409 -174.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -83.3 3.94 29.29 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 115.422 1.638 . . . . 2.9700000000000002 115.422 -171.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -162.5 35.28 0.11 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 114.781 1.401 . . . . 2.0899999999999999 114.781 -158.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -79.99 -164.99 0.75 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.043 1.337 . . . . 5.5999999999999996 113.465 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -140.73 157.88 44.78 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.245 1.202 . . . . 2.02 114.245 -172.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.1 p -120.22 149.22 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.989 2.116 . . . . 1.0800000000000001 110.916 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.52 122.01 5.22 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 118.964 -0.909 . . . . 0.76000000000000001 112.88 157.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 15.0 p -114.32 152.48 31.35 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 123.191 1.472 . . . . 1.0700000000000001 113.679 169.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 120' ' ' THR . 50.2 p -107.15 38.85 2.01 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 113.247 -1.797 . . . . 1.0 111.629 170.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.421 ' HA2' ' CD2' ' A' ' 119' ' ' HIS . . . 98.13 22.55 14.89 Favored Glycine 0 C--O 1.226 -0.356 0 CA-C-O 118.802 -0.999 . . . . 1.8100000000000001 113.969 -177.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.425 ' HB2' ' HD2' ' A' ' 115' ' ' PRO . 5.8 p 89.24 175.09 0.04 OUTLIER Pre-proline 0 N--CA 1.483 1.22 0 C-N-CA 127.409 2.284 . . . . 2.6800000000000002 109.844 -151.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 114' ' ' SER . 17.8 Cg_endo -60.53 -19.85 61.45 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.08 2.52 . . . . 2.8999999999999999 114.617 167.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -84.67 52.7 2.46 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.564 1.074 . . . . 3.7599999999999998 112.324 178.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 38.44 59.14 1.61 Allowed Glycine 0 N--CA 1.472 1.076 0 C-N-CA 126.171 1.844 . . . . 2.6400000000000001 116.022 154.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.401 ' HB2' ' HA3' ' A' ' 113' ' ' GLY . 13.7 m -115.12 -19.47 10.84 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.605 1.335 . . . . 1.78 114.605 -166.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.541 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 14.0 p80 -148.03 -158.81 0.95 Allowed 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 120.374 1.443 . . . . 1.72 114.151 171.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.624 HG22 ' OE2' ' A' ' 136' ' ' GLU . 5.2 t -66.09 -164.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.06 1.344 . . . . 0.81999999999999995 111.193 169.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.9 tp -103.06 145.36 12.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 O-C-N 120.454 -1.403 . . . . 1.1000000000000001 110.625 165.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.607 ' SD ' HD21 ' A' ' 124' ' ' LEU . 3.4 ppp? -150.66 172.71 15.12 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.081 1.752 . . . . 3.6000000000000001 110.277 176.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -138.98 128.96 25.1 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.311 0.856 . . . . 1.8999999999999999 113.311 -169.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.607 HD21 ' SD ' ' A' ' 122' ' ' MET . 5.8 mt -126.0 153.08 44.87 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.989 0.916 . . . . 0.81999999999999995 110.822 -171.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -124.39 101.22 34.52 Favored Pre-proline 0 N--CA 1.477 0.878 0 CA-C-O 118.219 -0.895 . . . . 5.0599999999999996 112.434 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -80.82 169.59 16.39 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.603 2.202 . . . . 2.3500000000000001 110.223 162.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -123.88 156.09 36.89 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.939 2.096 . . . . 1.26 107.886 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.6 p -51.16 -35.9 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 O-C-N 120.582 -1.324 . . . . 1.0600000000000001 113.862 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -89.34 -1.83 58.21 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.176 1.176 . . . . 1.72 114.176 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -145.03 176.3 9.6 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 123.109 1.433 . . . . 2.7000000000000002 114.472 -158.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.45 HG12 ' HG3' ' A' ' 142' ' ' LYS . 18.6 m -125.07 154.57 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 128.408 2.683 . . . . 0.57999999999999996 109.648 -172.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -132.79 139.41 47.51 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.55 1.14 . . . . 0.59999999999999998 110.674 173.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.1 ttp-105 -111.95 142.89 43.79 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.358 0.526 . . . . 4.6399999999999997 111.7 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 42.2 t -60.64 157.57 14.25 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 122.77 1.271 . . . . 0.97999999999999998 113.431 167.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.442 ' H ' ' HE1' ' A' ' 122' ' ' MET . 49.7 p-90 -107.44 -14.29 14.89 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.005 1.322 . . . . 1.3300000000000001 112.055 168.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.624 ' OE2' HG22 ' A' ' 120' ' ' THR . 0.1 OUTLIER -92.29 -67.85 0.83 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.726 1.21 . . . . 1.6899999999999999 110.376 -175.785 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 26.6 p -91.19 -12.71 34.55 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 126.338 1.855 . . . . 1.0800000000000001 114.095 172.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.43 12.51 69.75 Favored Glycine 0 CA--C 1.532 1.108 0 O-C-N 121.069 -1.019 . . . . 0.72999999999999998 115.267 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.4 p -73.31 134.86 44.29 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.86 2.33 . . . . 1.55 111.394 174.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.2 t -75.84 150.18 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 109.922 -0.399 . . . . 0.67000000000000004 109.922 165.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -138.59 142.17 39.19 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 130.49 3.516 . . . . 2.2200000000000002 109.073 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.45 ' HG3' HG12 ' A' ' 131' ' ' VAL . 1.6 tmtt? -127.75 153.38 46.61 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 113.224 0.824 . . . . 2.3300000000000001 113.224 -174.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.14 137.58 34.01 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.465 0.542 . . . . 1.1499999999999999 112.465 176.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 37.2 p-10 -105.31 150.18 38.59 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 108.416 -0.957 . . . . 1.29 108.416 166.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.43 -31.5 21.88 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.038 2.492 . . . . 2.3500000000000001 113.294 -172.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.6 HG23 ' CD1' ' A' ' 103' ' ' TYR 0.266 3.5 m 47.05 -165.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 129.54 3.136 . . . . 2.8399999999999999 116.85 -179.369 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.616 0 C-N-CA 125.414 1.483 . . . . 2.2799999999999998 111.614 168.217 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 9.4 mtm . . . . . 0 C--O 1.224 -0.269 0 N-CA-C 119.198 3.036 . . . . 2.0499999999999998 119.198 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -62.12 1.77 Allowed 'General case' 0 C--N 1.32 -0.699 0 O-C-N 121.993 -0.442 . . . . 2.1400000000000001 112.143 166.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.3 t70 165.43 73.1 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 128.571 2.749 . . . . 2.5299999999999998 110.486 -157.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -87.28 -98.18 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.695 1 C-N-CA 126.863 5.042 . . . . 1.5700000000000001 113.746 -168.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -87.81 147.88 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 C-N-CA 126.948 2.099 . . . . 0.80000000000000004 106.582 170.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 21.1 mm -110.26 140.31 29.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 123.423 0.689 . . . . 0.93999999999999995 112.544 -170.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.6 mm -127.74 124.11 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 127.373 2.269 . . . . 0.68999999999999995 109.161 173.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.66 146.5 32.44 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.729 1.212 . . . . 2.6099999999999999 111.463 174.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.1 t -151.43 -50.55 0.12 Allowed 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 117.153 2.279 . . . . 2.5099999999999998 117.153 -168.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 77.62 -11.24 1.23 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 116.644 2.09 . . . . 2.6400000000000001 116.644 176.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.22 21.43 6.72 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 127.228 2.211 . . . . 2.71 111.475 -174.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 63.53 -16.18 0.07 Allowed 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 119.251 3.056 . . . . 3.2400000000000002 119.251 174.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -129.56 -68.21 0.73 Allowed 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 122.287 2.312 . . . . 3.0800000000000001 114.952 -179.637 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 58.77 -168.79 0.14 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.081 1.752 . . . . 3.9100000000000001 113.521 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -119.5 163.2 17.63 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.048 -1.032 . . . . 2.1200000000000001 109.992 150.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.8 p -116.43 137.76 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.397 1.079 . . . . 0.71999999999999997 110.514 169.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -117.03 112.72 2.57 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.042 0.829 . . . . 0.80000000000000004 111.316 168.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.622 ' H ' ' HE2' ' A' ' 122' ' ' MET . 0.8 OUTLIER -117.01 155.8 28.57 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.171 1.788 . . . . 0.88 113.447 173.242 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.9 p -125.16 16.71 8.43 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.958 1.303 . . . . 0.83999999999999997 114.054 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.74 70.21 1.18 Allowed Glycine 0 C--N 1.335 0.506 0 O-C-N 120.91 -1.119 . . . . 2.73 110.557 -177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 70.06 176.43 0.07 OUTLIER Pre-proline 0 CA--C 1.561 1.366 0 CA-C-O 118.373 -0.822 . . . . 3.0699999999999998 110.789 -176.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.99 -5.68 17.38 Favored 'Trans proline' 0 C--N 1.353 0.802 0 CA-C-N 122.353 1.876 . . . . 2.8199999999999998 114.781 -167.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.15 -6.77 19.55 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 115.245 1.572 . . . . 2.8700000000000001 115.245 -174.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.57 100.43 0.22 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.182 0.896 . . . . 1.8700000000000001 111.765 -173.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.6 m -105.79 -34.52 7.65 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.65 0.981 . . . . 1.6599999999999999 113.65 173.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -116.67 -153.59 0.53 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.67 0.788 . . . . 1.3300000000000001 111.829 174.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.734 HG22 ' OE2' ' A' ' 136' ' ' GLU . 5.3 t -74.86 -147.23 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.479 0.712 . . . . 0.97999999999999998 110.67 166.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.461 ' N ' HG23 ' A' ' 120' ' ' THR . 2.9 tt -117.27 149.21 19.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 126.778 2.031 . . . . 1.4299999999999999 111.363 166.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.622 ' HE2' ' H ' ' A' ' 111' ' ' CYS . 0.0 OUTLIER -133.65 171.82 13.59 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.871 1.668 . . . . 4.6399999999999997 109.714 169.868 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -137.06 123.53 20.83 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.64 0.776 . . . . 5.0700000000000003 109.827 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.451 HD21 ' SD ' ' A' ' 122' ' ' MET . 2.2 mt -120.81 160.96 22.33 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 118.939 0.791 . . . . 0.97999999999999998 111.406 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.45 99.8 26.42 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 123.093 0.557 . . . . 5.9900000000000002 109.525 166.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -76.23 179.08 6.71 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 N-CA-C 107.528 -1.758 . . . . 2.46 107.528 159.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 106' ' ' TYR . 24.9 m -159.11 156.1 28.48 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 105.726 -1.953 . . . . 1.0800000000000001 105.726 172.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.7 p -52.35 -39.92 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 124.213 1.005 . . . . 0.87 112.494 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -82.03 0.66 39.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.82 1.648 . . . . 1.6799999999999999 114.192 176.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -143.1 -176.92 5.11 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 122.214 1.007 . . . . 2.23 113.016 -159.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.5 m -146.4 155.35 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 127.342 2.257 . . . . 0.64000000000000001 109.579 -173.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -141.7 128.55 20.56 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.648 0.779 . . . . 0.67000000000000004 112.05 -175.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.4 ttp-105 -101.45 132.45 47.04 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.191 0.905 . . . . 4.6299999999999999 112.85 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.438 ' SG ' ' SG ' ' A' ' 137' ' ' CYS . 0.0 OUTLIER -71.6 -18.91 62.2 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 117.622 2.452 . . . . 3.5699999999999998 117.622 -164.932 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 13.8 p-90 59.0 -20.16 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 128.394 2.678 . . . . 1.22 115.74 -173.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.734 ' OE2' HG22 ' A' ' 120' ' ' THR . 3.9 mm-40 -94.43 -87.73 0.25 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 120.434 1.47 . . . . 2.75 110.341 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' CYS . . . . . 0.438 ' SG ' ' SG ' ' A' ' 134' ' ' CYS . 30.5 p -62.88 -18.16 62.6 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.137 0.975 . . . . 1.3700000000000001 111.934 166.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 58.14 38.69 90.52 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 124.815 1.197 . . . . 1.1000000000000001 111.566 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . 0.263 0.1 OUTLIER -63.77 159.04 20.23 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 117.427 -1.709 . . . . 1.8999999999999999 109.377 155.603 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.2 t -114.15 136.44 50.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 104.074 -2.565 . . . . 0.68000000000000005 104.074 160.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -115.08 140.3 49.18 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.86 1.664 . . . . 1.75 110.224 -176.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -104.39 156.1 18.22 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 122.662 1.22 . . . . 2.1699999999999999 111.621 164.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.8 tt -100.22 154.51 18.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 112.922 -1.945 . . . . 0.93000000000000005 110.237 157.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -109.61 156.52 39.5 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.126 0.97 . . . . 1.28 113.269 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.73 -2.49 10.24 Favored 'Trans proline' 0 N--CA 1.485 0.976 1 C-N-CA 126.413 4.742 . . . . 1.55 115.877 -175.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.9 p -43.88 152.36 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 128.288 2.635 . . . . 1.8799999999999999 113.049 177.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.896 0 C-N-CA 126.095 1.807 . . . . 1.6100000000000001 110.644 176.876 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 11.4 mtp . . . . . 0 CA--C 1.518 -0.254 0 CA-C-O 123.928 1.823 . . . . 3.4500000000000002 113.523 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.7 -76.46 0.19 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.033 -1.894 . . . . 2.1299999999999999 109.62 173.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -174.12 72.39 0.34 Allowed Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 127.126 2.171 . . . . 2.5299999999999998 108.903 -168.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -88.31 -48.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.496 1 C-N-CA 127.276 5.317 . . . . 0.71999999999999997 114.258 -170.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -140.96 147.76 22.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 129.938 3.295 . . . . 0.71999999999999997 105.083 -175.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.5 mm -109.92 136.6 45.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 123.033 0.533 . . . . 0.69999999999999996 111.341 -176.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 51.4 mm -119.1 119.51 61.07 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 126.217 1.807 . . . . 0.93000000000000005 107.479 165.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -77.31 120.79 22.83 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 124.531 1.144 . . . . 3.4100000000000001 109.559 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.7 t -125.09 -51.7 1.66 Allowed 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 116.297 1.962 . . . . 2.1899999999999999 116.297 -164.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 64.01 14.29 8.35 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 122.132 2.242 . . . . 3.3900000000000001 111.924 -177.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -161.23 142.62 11.64 Favored 'General case' 0 CA--C 1.549 0.914 1 C-N-CA 132.312 4.245 . . . . 2.3999999999999999 106.331 -161.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.686 ' OD1' HG12 ' A' ' 128' ' ' VAL . 48.3 t0 -95.77 14.07 24.46 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 126.113 1.765 . . . . 4.9500000000000002 113.337 -177.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -153.26 12.89 0.49 Allowed 'General case' 0 N--CA 1.485 1.288 0 O-C-N 118.926 -2.359 . . . . 2.77 114.599 -156.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -72.47 159.34 34.11 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.291 0.848 . . . . 4.5899999999999999 113.291 -177.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -95.6 163.36 13.24 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.965 0.728 . . . . 2.3100000000000001 112.965 163.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 p -129.33 148.09 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 127.767 2.427 . . . . 1.1399999999999999 111.102 173.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -100.95 108.78 3.52 Favored Glycine 0 CA--C 1.539 1.533 0 CA-C-O 118.756 -1.025 . . . . 1.05 113.631 166.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 9.1 t -108.21 139.62 42.62 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.63 1.572 . . . . 1.1799999999999999 113.984 171.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 12.3 p -113.71 6.84 17.0 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 117.9 2.556 . . . . 1.0700000000000001 117.9 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.01 -23.05 22.64 Favored Glycine 0 N--CA 1.48 1.571 0 O-C-N 119.955 -1.716 . . . . 2.25 113.058 -176.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.2 t 173.52 151.93 0.24 Allowed Pre-proline 0 C--O 1.24 0.553 0 C-N-CA 127.754 2.422 . . . . 4.5199999999999996 108.228 -166.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -60.33 -23.56 74.88 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.656 2.238 . . . . 3.2599999999999998 112.369 168.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.28 9.56 25.47 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.397 1.079 . . . . 3.1600000000000001 113.73 174.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 73.75 62.67 2.94 Favored Glycine 0 C--N 1.343 0.944 0 C-N-CA 124.024 0.821 . . . . 2.27 113.66 170.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 30.7 m -71.94 -34.52 69.1 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.971 1.471 . . . . 1.7 114.971 -172.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -107.34 -49.94 3.17 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.006 1.854 . . . . 2.8300000000000001 116.006 176.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.7 t 156.77 -159.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 1 C-N-CA 133.185 4.594 . . . . 0.92000000000000004 105.573 -158.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.8 tp -120.08 140.74 43.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 127.584 2.353 . . . . 1.5 111.366 169.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.472 ' CE ' ' HE1' ' A' ' 135' ' ' TRP . 1.2 mmm -137.6 152.38 49.33 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 114.824 1.416 . . . . 4.6500000000000004 114.824 -176.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -110.9 99.98 8.78 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 113.898 -1.501 . . . . 1.8700000000000001 110.72 -171.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 134' ' ' CYS . 2.0 mt -106.77 169.75 8.35 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.512 -0.921 . . . . 1.3700000000000001 108.512 -173.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -151.55 100.6 2.94 Favored Pre-proline 0 N--CA 1.472 0.65 0 CA-C-N 119.192 0.905 . . . . 5.6799999999999997 111.607 178.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.88 173.97 10.65 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.252 2.635 . . . . 2.2799999999999998 110.503 170.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.85 144.26 45.54 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.297 2.239 . . . . 1.8100000000000001 107.572 -170.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.686 HG12 ' OD1' ' A' ' 105' ' ' ASP . 7.7 p -60.79 -34.03 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 120.725 -1.235 . . . . 1.02 111.741 -174.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -64.46 -21.02 66.53 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.677 1.991 . . . . 2.3199999999999998 112.922 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -161.6 -137.23 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.109 1.364 . . . . 2.5899999999999999 111.42 -156.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.3 m -156.37 170.31 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 126.884 2.074 . . . . 0.60999999999999999 110.405 -158.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -139.47 143.01 37.34 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.098 0.959 . . . . 0.64000000000000001 110.595 166.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 140' ' ' VAL . 28.3 ttt-85 -95.61 140.38 30.53 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 105.132 -2.173 . . . . 5.0099999999999998 105.132 167.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' ' 136' ' ' GLU . 17.9 t -52.08 131.86 32.36 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 124.302 1.001 . . . . 1.1799999999999999 110.009 152.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.472 ' HE1' ' CE ' ' A' ' 122' ' ' MET . 20.0 p-90 -65.61 -20.52 66.35 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.184 -0.948 . . . . 1.8999999999999999 110.637 168.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.416 ' HB2' ' SG ' ' A' ' 134' ' ' CYS . 0.6 OUTLIER -88.05 -108.57 0.07 Allowed 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 126.63 1.972 . . . . 3.1099999999999999 109.173 -172.562 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.8 p -53.01 -58.77 5.85 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.899 2.48 . . . . 1.73 111.939 -170.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 117.7 21.12 4.38 Favored Glycine 0 C--N 1.331 0.258 0 CA-C-N 113.106 -1.861 . . . . 1.5900000000000001 116.478 -166.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.2 p -71.72 101.81 2.66 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 119.142 1.471 . . . . 1.79 107.549 156.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 133' ' ' ARG . 47.1 t -62.7 145.22 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 108.475 -0.935 . . . . 0.69999999999999996 108.475 155.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -124.48 156.41 37.29 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 130.355 3.462 . . . . 2.3199999999999998 111.318 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.2 tttm -119.59 155.38 32.37 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 123.876 1.798 . . . . 2.3999999999999999 113.605 169.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.67 146.42 24.51 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 111.936 -2.393 . . . . 1.3600000000000001 110.265 158.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -101.76 155.81 35.96 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 113.842 1.052 . . . . 1.54 113.842 176.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.97 -7.34 21.2 Favored 'Trans proline' 0 C--N 1.353 0.815 1 C-N-CA 125.979 4.453 . . . . 2.2999999999999998 115.788 178.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.9 p -35.54 140.54 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 128.857 2.863 . . . . 2.2999999999999998 113.145 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.706 0 C-N-CA 125.103 1.335 . . . . 3.0699999999999998 111.306 -171.955 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 46.2 mtp . . . . . 0 C--O 1.218 -0.553 0 N-CA-C 105.194 -2.15 . . . . 2.8900000000000001 105.194 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 4.27 -76.18 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 128.734 2.814 . . . . 3.3999999999999999 116.758 167.899 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 46.4 t0 177.84 84.68 0.14 Allowed Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 129.706 3.203 . . . . 2.2200000000000002 108.687 -166.352 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -96.99 -43.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 1 C-N-CA 126.93 5.087 . . . . 0.93999999999999995 113.168 -178.804 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 mm -154.35 140.51 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 128.494 2.718 . . . . 0.70999999999999996 106.454 -168.568 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.424 HG23 ' ND2' ' A' ' 144' ' ' ASN . 14.4 mm -115.8 129.15 72.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 125.806 1.643 . . . . 1.02 110.964 -172.652 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.6 mm -127.11 112.9 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 126.688 1.995 . . . . 0.89000000000000001 109.532 -173.668 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -71.34 131.15 42.99 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.16 0.984 . . . . 2.73 110.776 -177.061 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.0 p -132.3 -56.77 0.96 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 115.533 1.679 . . . . 3.3399999999999999 115.533 -153.172 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 73.41 -18.79 0.36 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 127.334 2.253 . . . . 3.21 114.973 173.767 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -125.11 145.46 49.93 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.503 2.321 . . . . 3.04 107.901 161.608 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.63 4.25 2.0 Allowed 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 116.777 2.14 . . . . 3.3300000000000001 116.777 -160.905 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -147.16 24.53 1.15 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 126.134 1.774 . . . . 2.21 114.551 -175.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.13 135.77 31.03 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 120.792 -1.192 . . . . 4.2800000000000002 112.49 173.877 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -67.79 163.14 22.39 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.586 0.588 . . . . 2.1899999999999999 112.586 173.139 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.69 142.64 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.16 1.384 . . . . 1.1299999999999999 111.015 172.118 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.48 128.36 7.68 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.034 0.826 . . . . 1.53 112.923 168.031 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.84 153.98 50.78 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.38 1.872 . . . . 1.45 114.78 171.197 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.6 p -111.47 14.62 21.43 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 116.219 1.933 . . . . 1.01 116.219 173.289 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.452 ' HA3' ' OG ' ' A' ' 118' ' ' SER . . . 122.85 -32.7 4.33 Favored Glycine 0 C--O 1.222 -0.616 0 C-N-CA 124.626 1.108 . . . . 2.29 113.622 -172.529 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.1 t 137.55 148.43 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 106.516 -1.661 . . . . 3.0699999999999998 106.516 -120.819 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.23 48.16 1.72 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 124.745 3.63 . . . . 2.46 113.72 -177.585 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -156.37 27.35 0.35 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.765 1.024 . . . . 2.4900000000000002 113.765 -163.931 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 61.53 22.44 61.51 Favored Glycine 0 N--CA 1.475 1.295 0 N-CA-C 115.831 1.092 . . . . 2.8700000000000001 115.831 167.191 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.452 ' OG ' ' HA3' ' A' ' 113' ' ' GLY . 57.7 p -60.15 -50.98 71.52 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.416 1.108 . . . . 3.0099999999999998 112.835 -158.902 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -102.76 -63.62 1.15 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.765 0.426 . . . . 2.6499999999999999 110.353 -178.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.654 HG22 ' OE2' ' A' ' 136' ' ' GLU . 5.4 t -179.51 -159.46 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.476 1 C-N-CA 132.79 4.436 . . . . 0.94999999999999996 106.849 178.346 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.0 tp -104.85 145.73 12.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 C-N-CA 125.855 1.662 . . . . 1.1399999999999999 110.056 167.596 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.52 175.71 9.19 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.756 1.622 . . . . 5.0899999999999999 110.236 172.354 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -136.58 126.34 25.6 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 118.562 -0.732 . . . . 2.3900000000000001 110.266 171.084 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 mt -115.77 155.48 27.74 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.797 1.181 . . . . 1.01 112.054 177.574 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.83 101.37 20.53 Favored Pre-proline 0 N--CA 1.477 0.896 0 O-C-N 121.818 -0.551 . . . . 5.6200000000000001 110.862 172.599 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -82.96 178.28 6.08 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.447 2.098 . . . . 2.75 108.942 157.236 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.8 m -144.25 158.18 43.88 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.234 2.214 . . . . 1.05 105.118 171.494 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.0 p -58.51 -32.34 45.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-N 119.403 1.002 . . . . 0.71999999999999997 111.287 176.574 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -76.18 -5.28 46.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 128.053 2.541 . . . . 1.6399999999999999 114.637 174.243 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -145.09 -170.62 3.47 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.865 0.84 . . . . 2.3799999999999999 113.051 -159.013 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 19.3 m -147.23 156.92 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 128.239 2.616 . . . . 0.65000000000000002 108.273 -175.112 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -139.72 126.92 21.18 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.806 0.843 . . . . 0.68999999999999995 111.897 -179.094 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -99.16 134.76 41.54 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.441 0.564 . . . . 3.79 111.784 178.544 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 36.4 t -58.1 141.07 51.33 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 124.361 1.038 . . . . 0.95999999999999996 110.941 165.188 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 58.7 p-90 -91.34 -10.49 41.08 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.924 -0.58 . . . . 1.8400000000000001 112.083 168.636 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.654 ' OE2' HG22 ' A' ' 120' ' ' THR . 3.4 mm-40 -100.59 -65.63 0.96 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.262 0.625 . . . . 2.0800000000000001 111.447 -169.876 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 7.7 p -79.6 -41.95 26.01 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 118.922 0.783 . . . . 1.74 111.059 169.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 106.45 12.04 25.86 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.214 1.388 . . . . 1.1000000000000001 115.652 -178.644 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.9 p -80.28 137.01 36.55 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.968 1.884 . . . . 1.6399999999999999 111.179 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.38 150.45 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 118.966 0.803 . . . . 1.05 110.296 164.541 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -133.81 143.92 48.67 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 129.781 3.233 . . . . 2.04 109.723 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 54.4 tttt -117.84 153.01 34.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.284 1.04 . . . . 2.23 112.372 178.136 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.1 tt -97.89 143.68 28.24 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.502 -1.226 . . . . 0.93999999999999995 111.692 165.298 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.424 ' ND2' HG23 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -106.47 156.52 36.88 Favored Pre-proline 0 CA--C 1.549 0.91 0 CA-C-N 114.321 -1.308 . . . . 3.0099999999999998 110.483 -173.092 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.19 -8.96 24.58 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 124.558 3.505 . . . . 1.3300000000000001 114.509 -176.42 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.4 p -40.45 142.38 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 128.028 2.531 . . . . 2.0099999999999998 114.316 -177.307 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.476 0 C-N-CA 126.75 2.119 . . . . 2.0600000000000001 107.816 165.378 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 7.2 mtm . . . . . 0 N--CA 1.465 0.309 0 N-CA-C 119.438 3.125 . . . . 0.0 119.438 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -61.86 1.67 Allowed 'General case' 0 C--N 1.317 -0.811 0 O-C-N 121.792 -0.567 . . . . 0.0 112.098 167.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.8 t70 167.65 74.52 0.01 OUTLIER Pre-proline 0 CA--C 1.56 1.363 0 C-N-CA 129.581 3.152 . . . . 0.0 109.393 -155.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -92.12 -51.24 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.423 1 C-N-CA 126.842 5.028 . . . . 0.0 114.896 -170.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 mm -149.22 143.28 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 131.579 3.952 . . . . 0.0 104.221 -169.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.4 mm -113.73 131.69 64.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 124.056 0.943 . . . . 0.0 109.986 -177.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.0 mm -116.31 111.31 34.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 174.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.505 ' HA ' HD21 ' A' ' 144' ' ' ASN . 8.9 tt0 -76.82 116.31 17.37 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.855 1.262 . . . . 0.0 110.148 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.1 t -108.16 -67.83 0.94 Allowed 'General case' 0 C--O 1.225 -0.224 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -158.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.498 ' CE1' HG22 ' A' ' 146' ' ' VAL . 60.1 m-85 75.79 -3.9 2.48 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 126.438 1.895 . . . . 0.0 113.594 -169.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -114.21 152.33 31.4 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 128.066 2.546 . . . . 0.0 109.564 159.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -72.34 -14.6 61.77 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 120.265 -1.522 . . . . 0.0 114.767 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -134.04 6.49 3.64 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.167 -1.583 . . . . 0.0 114.248 -158.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -61.96 154.82 25.34 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.377 1.871 . . . . 0.0 115.327 -166.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -77.09 171.63 14.51 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.622 1.569 . . . . 0.0 114.195 173.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.9 p -135.61 148.99 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.958 2.103 . . . . 0.0 110.606 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -119.57 121.41 4.94 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 118.844 -0.975 . . . . 0.0 113.552 158.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 22.8 p -114.63 160.65 19.07 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 123.518 1.627 . . . . 0.0 113.095 167.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 47.4 p -114.91 13.36 17.05 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 113.302 -1.772 . . . . 0.0 112.695 166.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.5 -31.21 5.67 Favored Glycine 0 N--CA 1.467 0.733 0 C-N-CA 124.056 0.836 . . . . 0.0 113.828 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.1 t 169.49 159.92 0.19 Allowed Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 126.974 2.11 . . . . 0.0 107.509 -157.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -54.94 -20.56 23.33 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 121.89 1.726 . . . . 0.0 112.678 161.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.69 42.43 1.1 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.079 1.352 . . . . 0.0 112.729 174.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 51.33 33.91 32.55 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 116.986 1.554 . . . . 0.0 116.986 150.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.3 m -75.69 -48.02 23.77 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -152.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -104.88 -145.84 0.38 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.939 0.896 . . . . 0.0 112.219 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.66 HG22 ' OE1' ' A' ' 136' ' ' GLU . 3.7 t -76.56 -158.4 0.1 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.956 0.902 . . . . 0.0 112.413 163.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.4 tp -105.88 142.62 18.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 126.368 1.867 . . . . 0.0 110.481 161.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.609 ' SD ' HD21 ' A' ' 124' ' ' LEU . 3.8 ppp? -152.58 175.26 12.97 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.322 1.049 . . . . 0.0 112.141 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -140.71 130.69 24.63 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -165.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.609 HD21 ' SD ' ' A' ' 122' ' ' MET . 1.7 mt -132.28 174.13 10.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.181 1.393 . . . . 0.0 108.725 -174.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 102.37 5.11 Favored Pre-proline 0 N--CA 1.478 0.959 0 CA-C-N 120.187 1.358 . . . . 0.0 114.495 168.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -70.9 176.94 6.93 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 CA-C-N 120.025 1.045 . . . . 0.0 109.426 161.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.7 m -139.71 158.97 43.23 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.745 2.018 . . . . 0.0 105.777 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.5 p -49.21 -37.97 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 120.028 1.285 . . . . 0.0 113.456 -178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -80.9 -8.24 59.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.549 1.539 . . . . 0.0 114.078 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -140.82 -173.45 3.71 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 122.893 1.33 . . . . 0.0 113.371 -151.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 25.9 m -141.53 167.35 16.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 128.322 2.649 . . . . 0.0 108.966 -175.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -148.21 142.58 26.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.885 0.874 . . . . 0.0 110.506 169.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -100.04 143.52 30.16 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.79 0.836 . . . . 0.0 111.07 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 45.4 t -65.1 175.15 1.68 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 122.802 1.287 . . . . 0.0 113.622 158.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.413 ' CD1' ' CE ' ' A' ' 122' ' ' MET . 40.9 p-90 -127.54 -13.27 5.44 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.287 1.835 . . . . 0.0 112.583 170.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.66 ' OE1' HG22 ' A' ' 120' ' ' THR . 2.9 mm-40 -95.32 -60.82 1.59 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.156 0.982 . . . . 0.0 109.88 -177.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 14.2 p -80.8 -23.45 39.25 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.997 1.319 . . . . 0.0 112.705 165.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 64.51 16.18 60.45 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.419 -1.211 . . . . 0.0 113.544 -172.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.77 137.16 53.8 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.801 1.8 . . . . 0.0 111.384 173.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 41.4 t -81.96 147.02 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 166.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -132.01 150.01 52.27 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 129.282 3.033 . . . . 0.0 110.709 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 43.9 tttt -127.01 150.05 49.62 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.102 0.953 . . . . 0.0 113.556 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.62 155.7 17.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.858 167.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.505 HD21 ' HA ' ' A' ' 101' ' ' GLU . 3.4 p30 -111.57 152.19 43.85 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 172.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -67.78 -6.01 15.81 Favored 'Trans proline' 0 C--N 1.352 0.736 1 C-N-CA 125.352 4.035 . . . . 0.0 115.154 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.498 HG22 ' CE1' ' A' ' 103' ' ' TYR . 8.9 p -36.83 133.37 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 127.837 2.455 . . . . 0.0 113.401 -177.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.637 0 C-N-CA 127.541 2.496 . . . . 0.0 107.315 174.703 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 8.6 mtm . . . . . 0 C--O 1.225 -0.219 0 N-CA-C 118.035 2.606 . . . . 2.1299999999999999 118.035 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -57.73 11.46 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 121.191 -0.943 . . . . 1.99 112.641 169.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.5 t70 164.88 73.77 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 129.437 3.095 . . . . 2.7400000000000002 109.703 -154.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -88.34 -46.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 1 C-N-CA 126.793 4.996 . . . . 1.0600000000000001 113.075 -174.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -154.47 143.1 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 130.451 3.5 . . . . 0.63 105.424 -168.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.9 mm -117.45 134.23 61.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 124.579 1.152 . . . . 0.62 111.87 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.9 mm -127.42 118.6 50.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 127.142 2.177 . . . . 0.46000000000000002 108.209 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.92 133.41 44.35 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.858 1.663 . . . . 2.8300000000000001 111.442 -176.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.9 t -163.63 111.94 1.21 Allowed 'General case' 0 C--O 1.223 -0.333 0 O-C-N 121.535 -0.728 . . . . 2.9100000000000001 112.67 -175.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -82.24 16.71 1.89 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.608 1.163 . . . . 3.7799999999999998 112.184 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.48 10.75 3.47 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 128.222 2.609 . . . . 3.0 113.212 -159.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 59.55 -16.73 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 129.631 3.173 . . . . 3.1099999999999999 118.686 173.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -150.88 14.63 0.73 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 119.666 -1.896 . . . . 2.3399999999999999 114.719 -168.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 57.1 ttm-85 -54.39 142.61 26.32 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.538 1.535 . . . . 3.6600000000000001 112.563 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -77.38 156.9 30.9 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.844 0.683 . . . . 2.23 112.844 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.2 p -105.1 145.05 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.451 1.501 . . . . 0.70999999999999996 111.073 173.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -113.4 98.12 0.91 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.957 1.265 . . . . 0.65000000000000002 112.286 164.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.7 154.86 18.25 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.373 1.469 . . . . 0.95999999999999996 113.318 174.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.9 p -124.46 14.17 8.84 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.841 1.656 . . . . 0.77000000000000002 115.0 171.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.16 -17.97 46.79 Favored Glycine 0 N--CA 1.476 1.338 0 O-C-N 120.46 -1.4 . . . . 2.0299999999999998 114.836 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.5 t 175.44 154.51 0.34 Allowed Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 126.089 1.756 . . . . 3.5 109.871 -155.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -58.69 -20.56 51.51 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.298 2.666 . . . . 2.2599999999999998 113.96 170.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.85 -9.1 50.31 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 114.798 1.407 . . . . 2.5800000000000001 114.798 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.84 164.95 12.79 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 123.584 1.658 . . . . 3.1099999999999999 112.262 -147.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 36.9 m -166.62 -43.43 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 127.72 2.408 . . . . 1.49 110.628 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -107.64 -158.08 0.64 Allowed 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 109.95 -0.389 . . . . 1.5700000000000001 109.95 165.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.706 HG22 ' OE1' ' A' ' 136' ' ' GLU . 3.8 t -69.64 -158.96 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.823 0.849 . . . . 0.81999999999999995 112.531 168.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.8 tp -104.97 142.81 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 126.861 2.065 . . . . 0.83999999999999997 109.987 166.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.524 ' SD ' HD21 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -145.25 173.47 11.93 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.071 0.948 . . . . 4.3300000000000001 111.051 170.636 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -124.03 133.17 53.72 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.773 0.829 . . . . 1.5700000000000001 112.233 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.524 HD21 ' SD ' ' A' ' 122' ' ' MET . 3.4 mt -129.75 160.07 34.54 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.077 0.951 . . . . 0.72999999999999998 109.422 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.2 ttpp -125.3 85.94 57.67 Favored Pre-proline 0 N--CA 1.473 0.702 0 O-C-N 121.423 -0.798 . . . . 5.21 113.032 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -69.57 176.61 6.4 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.207 1.938 . . . . 2.4900000000000002 109.775 166.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.3 m -142.46 158.42 43.71 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.307 1.843 . . . . 0.91000000000000003 107.494 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.7 p -55.48 -33.65 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.952 1.301 . . . . 0.81000000000000005 113.737 -175.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -91.04 0.9 57.44 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.56 1.144 . . . . 2.27 113.838 175.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -140.26 -169.63 2.8 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.789 0.835 . . . . 2.1499999999999999 112.956 -158.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.6 m -145.66 163.68 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 127.504 2.322 . . . . 0.52000000000000002 109.916 -173.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -148.47 133.83 18.52 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.639 1.176 . . . . 0.52000000000000002 112.07 174.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.24 139.49 47.74 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.737 1.014 . . . . 3.27 113.737 -177.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 46.8 t -70.75 156.94 38.88 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.417 1.487 . . . . 1.1599999999999999 114.863 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.448 ' CZ3' ' HG2' ' A' ' 136' ' ' GLU . 43.9 p-90 -102.92 -13.28 16.99 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.425 -1.261 . . . . 1.76 113.305 174.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.706 ' OE1' HG22 ' A' ' 120' ' ' THR . 0.8 OUTLIER -98.92 -58.34 1.97 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 120.002 1.273 . . . . 2.54 110.661 -179.062 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 4.6 p -77.56 -65.93 0.9 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 122.28 1.038 . . . . 2.29 110.584 171.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.72 4.86 12.72 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.046 -1.419 . . . . 0.98999999999999999 115.882 -170.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.82 137.5 57.82 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 120.841 2.32 . . . . 1.8899999999999999 111.813 173.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 40.4 t -83.18 146.53 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 107.285 -1.376 . . . . 0.56999999999999995 107.285 165.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -132.35 151.01 52.04 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 128.221 2.608 . . . . 2.2999999999999998 112.076 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -133.43 146.78 51.5 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.11 1.152 . . . . 2.46 114.11 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.8 tt -99.86 153.9 18.78 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.62 1.168 . . . . 0.83999999999999997 110.328 171.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -107.62 156.91 37.09 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 115.453 1.649 . . . . 1.4099999999999999 115.453 -175.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.93 -4.51 12.56 Favored 'Trans proline' 0 C--N 1.357 0.976 1 C-N-CA 127.314 5.343 . . . . 1.6399999999999999 115.92 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.9 p -48.69 143.89 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.246 1.818 . . . . 1.95 110.369 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.75 0 O-C-N 120.772 -1.205 . . . . 2.9500000000000002 112.124 -163.691 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.8 mtm . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.678 0.751 . . . . 2.8300000000000001 112.794 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.7 pttm 123.39 -143.65 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.605 1 C-N-CA 133.216 4.606 . . . . 3.3300000000000001 108.419 -150.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . 0.271 21.3 t0 -128.14 72.37 79.49 Favored Pre-proline 0 CA--C 1.561 1.391 0 C-N-CA 124.761 1.224 . . . . 3.1000000000000001 108.964 -173.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.51 -53.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.046 1 C-N-CA 128.788 6.325 . . . . 0.80000000000000004 114.705 -170.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -133.04 140.11 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 128.745 2.818 . . . . 0.57999999999999996 105.156 -178.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.4 mm -110.68 133.88 54.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 C-N-CA 123.662 0.785 . . . . 0.81000000000000005 111.686 -171.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.0 mm -122.67 115.69 46.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 126.341 1.857 . . . . 0.60999999999999999 108.301 173.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -65.17 124.19 21.51 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.937 1.695 . . . . 3.0800000000000001 110.464 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.6 t -146.8 122.17 10.3 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.167 0.987 . . . . 3.0 111.414 -175.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -98.55 3.18 48.06 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 112.532 0.567 . . . . 2.6499999999999999 112.532 -175.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -104.03 -101.56 0.31 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 128.699 2.8 . . . . 3.7200000000000002 111.166 168.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.566 ' OD1' HG12 ' A' ' 128' ' ' VAL . 10.3 t0 -171.64 -38.33 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 128.094 2.558 . . . . 3.9100000000000001 109.98 -175.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -99.67 -5.08 29.51 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 120.063 -1.648 . . . . 3.6000000000000001 114.63 -165.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.16 122.39 8.49 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.371 1.868 . . . . 6.8899999999999997 114.194 -164.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -70.83 151.7 44.51 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.861 1.06 . . . . 2.3599999999999999 113.861 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.7 p -108.22 146.56 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.785 1.634 . . . . 0.71999999999999997 111.838 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -111.09 108.14 2.32 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.119 0.866 . . . . 0.73999999999999999 112.747 161.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 1.9 t -97.1 145.17 26.25 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.963 1.305 . . . . 1.01 112.612 172.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.7 p -116.29 18.65 15.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.491 1.517 . . . . 0.73999999999999999 113.759 169.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.423 ' CA ' ' CD2' ' A' ' 119' ' ' HIS . . . 110.96 39.33 1.42 Allowed Glycine 0 N--CA 1.466 0.639 0 C-N-CA 124.611 1.101 . . . . 1.71 113.457 176.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 p 71.08 178.5 0.05 OUTLIER Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 123.966 0.907 . . . . 2.79 110.294 -161.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -63.72 -9.6 19.17 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.256 1.971 . . . . 2.6600000000000001 115.586 -172.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.58 33.48 1.43 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.817 1.247 . . . . 2.6099999999999999 113.953 -174.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 57.8 31.66 64.65 Favored Glycine 0 N--CA 1.479 1.512 0 C-N-CA 124.252 0.929 . . . . 1.6299999999999999 115.057 163.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.0 m -84.85 -32.16 23.41 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.571 -0.958 . . . . 1.7 113.437 -148.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.525 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 18.7 p80 -123.81 -144.34 0.33 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.838 1.199 . . . . 1.3700000000000001 113.096 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.633 HG22 ' OE2' ' A' ' 136' ' ' GLU . 4.2 t -78.39 -153.73 0.07 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 118.902 0.774 . . . . 0.83999999999999997 111.035 164.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.9 tp -107.5 151.03 9.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 127.761 2.424 . . . . 0.93999999999999995 110.668 164.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.629 ' CE ' HD21 ' A' ' 124' ' ' LEU . 4.2 ppp? -160.14 161.47 33.72 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.943 1.697 . . . . 3.7799999999999998 111.492 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -130.09 132.99 46.38 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.376 0.509 . . . . 1.48 112.376 -167.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.629 HD21 ' CE ' ' A' ' 122' ' ' MET . 3.3 mt -131.86 155.55 47.63 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.469 0.707 . . . . 0.71999999999999997 110.485 -175.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.65 97.21 46.28 Favored Pre-proline 0 N--CA 1.477 0.917 0 CA-C-N 118.608 0.64 . . . . 5.6600000000000001 110.972 175.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -76.42 178.66 7.26 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 121.839 1.693 . . . . 2.5499999999999998 108.868 162.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.469 HG22 ' OD1' ' A' ' 105' ' ' ASP . 1.3 m -144.41 155.34 43.71 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.14 1.776 . . . . 1.0 106.265 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.566 HG12 ' OD1' ' A' ' 105' ' ' ASP . 9.8 p -63.02 -28.07 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 122.036 2.198 . . . . 0.87 109.803 175.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -72.68 -15.12 61.7 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.543 2.737 . . . . 1.6399999999999999 114.721 171.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -145.51 178.46 8.1 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 123.215 1.483 . . . . 1.99 114.103 -159.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.482 HG12 ' HG3' ' A' ' 142' ' ' LYS . 27.4 m -120.68 165.35 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 128.347 2.659 . . . . 0.53000000000000003 109.495 174.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.9 131.64 25.72 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.428 1.091 . . . . 0.60999999999999999 111.148 173.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.473 ' CG ' HG22 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -111.63 138.03 48.72 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.677 0.621 . . . . 3.54 112.677 -177.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.423 ' HA ' ' HE1' ' A' ' 122' ' ' MET . 40.7 t -70.01 153.23 43.48 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 126.599 1.96 . . . . 1.0700000000000001 115.223 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.422 ' H ' ' HE1' ' A' ' 122' ' ' MET . 56.7 p-90 -98.6 -10.19 23.73 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.453 0.908 . . . . 1.3600000000000001 113.453 169.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.633 ' OE2' HG22 ' A' ' 120' ' ' THR . 0.7 OUTLIER -96.87 -100.0 0.19 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.326 1.45 . . . . 1.73 109.48 -177.229 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 30.1 p -55.39 -29.25 58.13 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.32 1.418 . . . . 1.0600000000000001 112.12 168.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.1 23.88 75.01 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-O 118.483 -1.176 . . . . 0.72999999999999998 113.479 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.66 154.0 41.71 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.704 1.752 . . . . 1.45 111.054 165.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.473 HG22 ' CG ' ' A' ' 133' ' ' ARG . 74.2 t -96.55 140.97 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 105.817 -1.92 . . . . 0.56999999999999995 105.817 167.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -123.56 153.91 39.98 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 128.009 2.524 . . . . 2.1200000000000001 111.737 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.482 ' HG3' HG12 ' A' ' 131' ' ' VAL . 3.4 tmtt? -140.19 157.67 45.24 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 123.013 1.387 . . . . 2.5899999999999999 114.569 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.4 tt -110.87 141.16 44.63 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 113.737 -1.574 . . . . 0.87 113.255 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -100.53 155.85 35.89 Favored Pre-proline 0 CA--C 1.555 1.148 0 N-CA-C 114.609 1.337 . . . . 1.45 114.609 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -79.38 -4.27 13.57 Favored 'Trans proline' 0 C--N 1.356 0.936 1 C-N-CA 126.307 4.671 . . . . 1.3999999999999999 115.56 -175.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.1 p -40.43 148.65 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 128.805 2.842 . . . . 2.0099999999999998 112.044 175.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.644 0 O-C-N 120.138 -1.602 . . . . 1.6399999999999999 113.49 179.267 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 13.8 mtp . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 119.635 3.198 . . . . 2.2999999999999998 119.635 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -56.85 5.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 119.264 0.938 . . . . 2.1499999999999999 112.978 174.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.2 t0 161.68 70.89 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 129.411 3.085 . . . . 2.3700000000000001 109.177 -158.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -82.46 -53.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.3 1 C-N-CA 126.082 4.522 . . . . 0.76000000000000001 112.526 -172.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -147.77 143.53 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 130.521 3.528 . . . . 0.88 104.831 -168.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.4 mm -111.21 129.98 65.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 124.525 1.13 . . . . 0.90000000000000002 109.818 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.4 mm -114.61 100.27 10.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 126.123 1.769 . . . . 0.73999999999999999 106.908 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -66.61 122.23 17.14 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 125.162 1.539 . . . . 3.1200000000000001 110.008 -174.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.4 t -145.0 110.44 5.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.741 -0.663 . . . . 3.1699999999999999 111.225 -169.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -77.1 35.33 0.16 Allowed 'General case' 0 CA--C 1.55 0.949 0 O-C-N 121.693 -0.63 . . . . 2.3900000000000001 112.633 172.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -157.73 137.9 12.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 130.801 3.64 . . . . 3.1600000000000001 106.788 -173.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -60.26 -11.57 6.72 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.818 1.044 . . . . 2.98 113.818 175.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -139.05 126.35 21.47 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.758 2.423 . . . . 3.2200000000000002 111.47 -170.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.511 HH11 ' CG ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -146.27 174.74 11.07 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.887 1.275 . . . . 4.3899999999999997 113.74 171.516 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -100.4 168.05 10.0 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.723 -0.671 . . . . 2.3100000000000001 111.926 157.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.96 145.9 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 126.029 1.732 . . . . 0.68999999999999995 110.414 168.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -129.34 107.84 0.84 Allowed Glycine 0 N--CA 1.473 1.116 0 CA-C-O 119.154 -0.803 . . . . 0.70999999999999996 113.773 170.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.553 ' H ' ' CE ' ' A' ' 122' ' ' MET . 12.7 p -109.75 164.11 12.87 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.485 1.914 . . . . 0.91000000000000003 114.167 172.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.8 p -124.71 5.52 8.15 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.263 1.425 . . . . 0.89000000000000001 114.724 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.5 -21.67 12.62 Favored Glycine 0 N--CA 1.476 1.315 0 N-CA-C 116.334 1.294 . . . . 2.1099999999999999 116.334 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.94 177.34 0.54 Allowed Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 127.541 2.336 . . . . 3.8999999999999999 109.501 -178.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -59.54 -26.22 81.34 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.507 2.138 . . . . 2.73 113.541 170.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.52 -2.0 58.32 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.291 1.219 . . . . 2.3799999999999999 114.291 172.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.77 -169.01 52.89 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-O 123.267 1.481 . . . . 3.54 111.458 -150.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.0 t -177.82 -36.19 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 128.278 2.631 . . . . 2.5299999999999998 110.656 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -118.57 -153.15 0.52 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.495 1.518 . . . . 1.3600000000000001 110.603 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.725 HG22 ' OE2' ' A' ' 136' ' ' GLU . 4.9 t -74.78 -155.39 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 O-C-N 121.39 -0.819 . . . . 0.89000000000000001 112.202 167.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.5 tp -108.28 146.28 14.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 127.6 2.36 . . . . 0.95999999999999996 109.797 163.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.56 ' SD ' HD21 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -141.69 -179.87 6.43 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.922 1.289 . . . . 4.5199999999999996 110.597 173.081 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -140.25 124.06 17.34 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.589 0.631 . . . . 1.6200000000000001 111.751 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.56 HD21 ' SD ' ' A' ' 122' ' ' MET . 2.4 mt -118.78 172.64 7.38 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.154 0.981 . . . . 0.82999999999999996 110.202 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -139.58 90.97 10.99 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-O 118.488 -0.768 . . . . 6.9699999999999998 112.749 -175.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -85.8 167.27 9.89 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.979 2.452 . . . . 2.6899999999999999 110.601 172.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.5 m -139.75 152.73 46.86 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.962 2.105 . . . . 1.3700000000000001 108.577 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.7 p -42.48 -43.85 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 116.988 2.218 . . . . 1.21 116.988 -173.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -89.58 3.25 53.13 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.44 1.096 . . . . 2.0899999999999999 112.846 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -140.8 -177.85 5.27 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.59 1.156 . . . . 3.2999999999999998 113.759 -149.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.1 m -139.99 152.2 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 113.672 -1.604 . . . . 0.60999999999999999 112.384 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -129.23 143.45 50.86 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.871 0.868 . . . . 0.66000000000000003 109.844 168.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -111.64 141.07 45.71 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.886 0.874 . . . . 4.5599999999999996 111.488 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 49.3 t -59.76 159.17 9.16 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 124.587 1.179 . . . . 1.04 112.88 163.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 58.6 p-90 -107.31 -9.02 16.16 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.825 1.25 . . . . 1.21 112.559 170.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.725 ' OE2' HG22 ' A' ' 120' ' ' THR . 2.7 mm-40 -100.09 -94.18 0.27 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.076 1.75 . . . . 1.6200000000000001 108.998 -177.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 28.3 p -62.29 -16.37 53.45 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 120.416 -1.427 . . . . 1.28 112.587 171.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 59.22 27.32 62.64 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 124.894 1.235 . . . . 0.79000000000000004 112.607 175.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.4 p -67.59 132.59 47.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.975 1.388 . . . . 1.52 108.879 164.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 41.4 t -76.97 150.85 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.426 -0.953 . . . . 0.60999999999999999 108.426 159.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -134.19 147.21 50.72 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 130.028 3.331 . . . . 1.8200000000000001 110.439 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -124.81 145.7 49.63 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 113.397 0.888 . . . . 2.7000000000000002 113.397 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.3 tt -91.76 154.36 18.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 122.278 1.037 . . . . 1.1399999999999999 109.094 165.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -117.2 152.66 49.32 Favored Pre-proline 0 CA--C 1.552 1.037 0 CA-C-N 114.685 -1.143 . . . . 1.48 113.319 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.49 -4.39 14.42 Favored 'Trans proline' 0 CA--C 1.539 0.761 1 C-N-CA 125.964 4.443 . . . . 1.6699999999999999 115.731 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.1 p -43.66 149.54 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 128.356 2.663 . . . . 2.1200000000000001 112.812 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 125.04 1.305 . . . . 1.96 110.185 -174.843 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.6 mtm . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 124.28 1.99 . . . . 2.73 111.918 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -173.21 -122.41 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 130.922 3.689 . . . . 1.95 106.717 172.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . 0.303 38.0 t70 -133.39 78.11 64.1 Favored Pre-proline 0 N--CA 1.434 -1.251 0 N-CA-C 106.975 -1.491 . . . . 2.77 106.975 177.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -83.12 -81.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.786 1 C-N-CA 127.573 5.515 . . . . 1.21 113.687 -170.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -102.07 143.39 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 C-N-CA 127.854 2.462 . . . . 0.85999999999999999 106.187 171.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.0 mm -109.53 135.25 49.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.28 -0.873 . . . . 0.87 111.786 -172.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.9 mm -123.55 114.05 40.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 126.96 2.104 . . . . 0.76000000000000001 108.453 173.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.4 132.13 46.51 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.463 1.505 . . . . 3.0800000000000001 110.706 169.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 61.7 m -161.09 125.19 3.45 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.088 -1.007 . . . . 3.3300000000000001 109.14 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.7 m-30 -87.97 28.35 1.05 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 121.366 0.603 . . . . 2.75 111.24 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.99 109.96 4.52 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 129.336 3.054 . . . . 3.75 108.235 -171.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -53.85 -16.08 1.62 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.974 2.51 . . . . 3.3999999999999999 115.44 -169.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.91 5.76 3.91 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 126.769 2.028 . . . . 2.2000000000000002 113.79 -167.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.5 ttt85 -48.2 156.75 0.36 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.366 1.866 . . . . 4.7199999999999998 113.654 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -87.72 155.55 19.86 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.738 -0.602 . . . . 2.2599999999999998 112.308 162.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.23 142.65 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 127.08 2.152 . . . . 0.68000000000000005 111.543 170.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -104.67 100.95 1.86 Allowed Glycine 0 CA--C 1.533 1.217 0 CA-C-O 117.95 -1.472 . . . . 0.69999999999999996 113.663 164.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 3.6 p -107.22 145.06 33.12 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.459 1.629 . . . . 1.28 113.424 171.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.5 p -114.25 23.31 12.97 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 113.901 -1.499 . . . . 0.69999999999999996 112.874 175.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.83 -16.28 55.22 Favored Glycine 0 N--CA 1.476 1.36 0 O-C-N 120.201 -1.562 . . . . 1.76 114.395 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.8 p 175.36 162.29 0.4 Allowed Pre-proline 0 C--O 1.241 0.64 0 C-N-CA 128.693 2.797 . . . . 4.0599999999999996 107.888 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.05 -15.42 39.16 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.02 2.48 . . . . 2.77 113.184 165.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.55 7.22 46.4 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.326 1.05 . . . . 2.2200000000000002 112.469 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 62.25 71.67 0.78 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 125.177 1.37 . . . . 1.6399999999999999 111.921 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 56.8 m -76.24 -42.51 45.59 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.925 0.89 . . . . 1.76 112.175 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.6 p80 -100.8 -148.73 0.37 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.342 0.974 . . . . 1.46 112.226 171.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.28 13.6 t -77.67 -134.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.048 -1.093 . . . . 0.81000000000000005 108.048 158.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.6 tp -129.95 142.1 44.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 131.06 3.744 . . . . 0.83999999999999997 111.108 174.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 19.3 mmm -129.54 167.15 18.34 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.629 1.972 . . . . 3.79 115.112 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -136.06 102.48 5.04 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.88 0.472 . . . . 1.47 110.936 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 mt -116.22 160.03 21.0 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.78 0.832 . . . . 0.68000000000000005 110.499 -169.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -119.94 76.22 21.74 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 114.931 1.456 . . . . 5.2400000000000002 114.931 -170.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -92.15 43.43 0.36 Allowed 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.477 3.452 . . . . 3.0699999999999998 116.161 -165.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 m -28.61 151.0 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 130.301 3.44 . . . . 0.87 114.94 -170.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -52.15 -33.33 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 O-C-N 120.199 -1.563 . . . . 0.90000000000000002 113.836 175.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -79.24 -7.99 58.69 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.461 1.504 . . . . 1.45 114.071 175.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -141.39 -166.38 2.18 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.867 1.267 . . . . 2.1200000000000001 111.575 -157.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.53 HG12 ' HG3' ' A' ' 142' ' ' LYS . 21.6 m -147.55 158.28 9.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 131.151 3.78 . . . . 0.55000000000000004 107.3 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -141.92 140.24 32.75 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.923 0.783 . . . . 0.69999999999999996 110.966 168.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -91.97 141.97 28.05 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.322 0.649 . . . . 3.6499999999999999 109.784 172.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.3 t -62.21 162.74 9.2 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.42 1.088 . . . . 1.1200000000000001 111.396 155.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 28.8 p-90 -104.0 -20.13 13.97 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.79 -0.641 . . . . 1.7 112.099 163.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -81.41 -88.23 0.08 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.829 0.852 . . . . 2.2799999999999998 109.752 -174.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.7 p -64.93 -23.97 67.38 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 122.057 -0.402 . . . . 1.1599999999999999 111.933 171.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.16 21.68 75.74 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 118.814 0.734 . . . . 0.71999999999999997 113.557 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.17 154.86 38.61 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.765 1.283 . . . . 1.77 110.334 162.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 76.1 t -100.64 135.82 34.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 N-CA-C 105.749 -1.945 . . . . 0.64000000000000001 105.749 164.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -116.62 146.92 42.36 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 126.748 2.019 . . . . 1.77 108.74 -176.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.53 ' HG3' HG12 ' A' ' 131' ' ' VAL . 6.8 tmtt? -134.08 151.37 51.37 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 122.366 1.079 . . . . 2.5099999999999998 113.56 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.0 tt -107.13 142.7 36.39 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 113.322 -1.763 . . . . 0.85999999999999999 111.827 -177.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -101.03 154.09 37.36 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 113.296 -1.775 . . . . 1.3799999999999999 111.259 -173.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.3 -4.39 15.13 Favored 'Trans proline' 0 N--CA 1.48 0.702 1 C-N-CA 125.577 4.184 . . . . 1.22 115.302 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.9 p -43.26 148.63 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 128.254 2.622 . . . . 2.21 112.693 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.855 0 CA-C-O 123.361 1.534 . . . . 2.0099999999999998 112.197 179.019 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.43 ' O ' ' HD3' ' A' ' 97' ' ' PRO . 23.3 mtt . . . . . 0 C--O 1.214 -0.793 0 N-CA-C 106.889 -1.523 . . . . 3.1000000000000001 106.889 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -4.0 -66.21 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 128.564 2.746 . . . . 2.0600000000000001 117.823 171.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.3 t70 176.69 77.77 0.1 OUTLIER Pre-proline 0 CA--C 1.564 1.481 0 C-N-CA 130.742 3.617 . . . . 2.5699999999999998 109.857 -163.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 94' ' ' MET . 59.7 Cg_endo -94.01 -51.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 1 C-N-CA 126.819 5.013 . . . . 1.1000000000000001 113.606 -173.479 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.82 142.23 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 131.153 3.781 . . . . 0.89000000000000001 104.488 -173.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.4 mm -114.51 134.62 56.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 C-N-CA 124.161 0.984 . . . . 0.88 110.199 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.3 mm -120.24 114.55 44.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 125.345 1.458 . . . . 0.62 107.781 174.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -71.49 122.1 19.84 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.911 1.284 . . . . 2.5600000000000001 110.466 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.5 m -158.43 105.13 1.86 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.728 -1.233 . . . . 3.2799999999999998 113.344 -172.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -75.03 40.02 0.14 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 127.161 2.184 . . . . 2.48 113.051 -175.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.34 -2.18 0.69 Allowed 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.129 1.159 . . . . 3.4900000000000002 114.129 -168.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 63.25 -16.46 0.06 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 128.602 2.761 . . . . 3.27 115.046 -176.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -151.68 27.47 0.64 Allowed 'General case' 0 C--O 1.244 0.784 0 O-C-N 119.841 -1.787 . . . . 2.4900000000000002 113.193 -170.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -65.47 160.62 21.75 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.551 1.167 . . . . 3.8900000000000001 111.283 171.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -82.65 167.76 17.94 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.913 -1.04 . . . . 1.9199999999999999 113.036 167.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.9 p -118.61 141.9 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 127.916 2.487 . . . . 0.69999999999999996 111.191 169.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.53 105.41 2.04 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.691 1.139 . . . . 0.82999999999999996 112.168 164.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.11 153.28 21.1 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.036 1.334 . . . . 0.95999999999999996 112.543 169.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 18.2 p -121.37 24.24 10.03 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.784 1.634 . . . . 0.84999999999999998 113.933 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.22 -28.29 6.29 Favored Glycine 0 N--CA 1.472 1.054 0 O-C-N 120.692 -1.255 . . . . 2.0299999999999998 112.775 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 83.0 p -175.87 163.03 2.0 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 128.521 2.728 . . . . 3.9399999999999999 107.67 -172.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.8 -3.7 10.9 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.31 2.673 . . . . 2.21 113.906 172.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.88 0.31 18.63 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.671 1.189 . . . . 2.29 114.059 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.29 91.57 0.39 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.533 1.063 . . . . 1.77 111.119 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.6 m -103.0 -30.35 10.83 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.011 0.745 . . . . 1.45 113.011 173.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -125.15 -151.37 0.48 Allowed 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 119.125 0.875 . . . . 1.52 111.544 166.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.708 HG22 ' OE1' ' A' ' 136' ' ' GLU . 4.3 t -73.02 -157.68 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 O-C-N 121.032 -1.043 . . . . 1.02 111.371 166.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.4 tp -103.78 145.81 12.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 127.17 2.188 . . . . 1.05 108.815 164.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.531 ' SD ' HD21 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -145.85 166.68 25.23 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.418 0.687 . . . . 4.5300000000000002 111.501 170.812 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -117.89 130.34 56.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.781 0.832 . . . . 1.6200000000000001 112.147 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.531 HD21 ' SD ' ' A' ' 122' ' ' MET . 2.2 mt -128.84 163.78 24.48 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.452 1.101 . . . . 0.82999999999999996 109.452 175.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 32.8 mttt -131.79 105.36 14.1 Favored Pre-proline 0 N--CA 1.48 1.027 0 CA-C-O 117.434 -1.27 . . . . 6.8300000000000001 110.957 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -71.82 -69.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.26 1.973 . . . . 3.21 112.96 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.9 m 100.94 147.37 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 130.287 3.435 . . . . 1.24 108.82 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.4 p -44.38 -41.1 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 127.506 2.322 . . . . 1.1699999999999999 114.733 -172.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -83.84 -22.52 31.7 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.27 1.028 . . . . 2.96 112.317 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -131.82 179.08 6.29 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.948 1.699 . . . . 4.3200000000000003 114.913 -143.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 20.4 m -131.16 147.97 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 112.874 -1.966 . . . . 0.76000000000000001 114.757 -165.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -142.5 141.22 32.07 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.979 1.312 . . . . 0.79000000000000004 112.335 174.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -122.61 139.56 53.79 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.855 1.262 . . . . 4.4500000000000002 113.565 -170.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 42.6 t -72.4 145.34 47.75 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 116.448 2.018 . . . . 1.27 116.448 -174.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.444 ' CZ3' ' HG2' ' A' ' 136' ' ' GLU . 58.5 p-90 -95.5 -10.7 29.01 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 117.421 -1.276 . . . . 2.6299999999999999 113.765 175.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.708 ' OE1' HG22 ' A' ' 120' ' ' THR . 1.3 mm-40 -93.27 -66.3 0.93 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 120.089 1.313 . . . . 2.5099999999999998 108.345 175.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 12.4 p -74.86 -77.13 0.13 Allowed 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 121.844 0.83 . . . . 2.8999999999999999 110.927 173.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 125.0 18.58 2.57 Favored Glycine 0 N--CA 1.472 1.046 0 N-CA-C 117.692 1.837 . . . . 0.88 117.692 -165.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.4 p -74.92 142.63 43.98 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 120.655 2.228 . . . . 1.77 110.859 166.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 50.8 t -90.98 138.16 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 107.559 -1.275 . . . . 0.65000000000000002 107.559 167.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -117.65 142.69 46.93 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.457 1.903 . . . . 1.8500000000000001 112.382 176.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -115.58 149.09 38.78 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.285 1.04 . . . . 2.2400000000000002 112.259 173.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.3 tt -99.45 158.07 15.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.151 -0.931 . . . . 0.91000000000000003 110.071 168.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -114.3 156.01 44.94 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 114.82 1.415 . . . . 1.3500000000000001 114.82 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.08 -5.36 16.24 Favored 'Trans proline' 0 C--N 1.355 0.9 1 C-N-CA 125.65 4.233 . . . . 1.21 115.288 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.5 p -45.11 138.01 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 126.273 1.829 . . . . 2.1499999999999999 111.127 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.594 0 CA-C-O 122.851 1.251 . . . . 1.75 112.369 -174.647 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.7 mtt . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 119.445 3.128 . . . . 2.9399999999999999 119.445 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -58.88 6.67 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 120.969 -1.082 . . . . 2.1000000000000001 112.481 171.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 t0 165.32 71.75 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 129.461 3.105 . . . . 2.1099999999999999 108.906 -157.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.95 -50.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.391 1 C-N-CA 126.552 4.835 . . . . 0.81000000000000005 113.252 -171.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -150.63 141.64 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 1 C-N-CA 132.587 4.355 . . . . 0.62 104.141 -170.07 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 mm -109.88 136.14 46.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 125.163 1.385 . . . . 0.69999999999999996 109.004 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.1 mm -116.75 143.01 28.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 105.299 -2.111 . . . . 0.68999999999999995 105.299 170.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.492 ' CG ' HG11 ' A' ' 146' ' ' VAL . 9.2 tt0 -108.24 146.03 33.44 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.102 0.876 . . . . 3.1899999999999999 110.116 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.577 ' HB2' HD21 ' A' ' 143' ' ' LEU . 24.2 t -137.67 -54.71 0.67 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.852 1.427 . . . . 3.0899999999999999 114.852 -167.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 81.59 11.23 0.77 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 127.947 2.499 . . . . 2.73 113.759 -167.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -149.12 156.76 42.68 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 129.396 3.079 . . . . 2.7400000000000002 107.351 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.48 -18.16 26.78 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.285 1.217 . . . . 2.9300000000000002 114.285 174.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.68 81.55 1.16 Allowed 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.86 1.43 . . . . 2.8999999999999999 114.86 -158.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -127.39 167.91 15.57 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 120.898 -1.126 . . . . 5.5199999999999996 113.219 167.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -90.8 171.32 9.41 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.306 1.443 . . . . 2.1499999999999999 113.882 -174.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.4 p -124.98 143.12 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 126.685 1.994 . . . . 0.89000000000000001 111.228 171.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.26 92.76 1.01 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.585 1.564 . . . . 0.71999999999999997 112.081 162.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -106.19 146.55 30.13 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.553 1.676 . . . . 1.22 113.727 176.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.9 p -115.54 4.79 14.28 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.358 1.463 . . . . 1.22 114.166 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 138.07 -27.13 2.8 Favored Glycine 0 N--CA 1.468 0.777 0 O-C-N 121.405 -0.809 . . . . 2.5800000000000001 114.898 -169.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.0 t 106.12 144.85 0.01 OUTLIER Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 128.091 2.556 . . . . 3.96 106.681 -138.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.15 93.76 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.95 2.433 . . . . 3.23 110.76 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 176.86 21.32 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 129.256 3.022 . . . . 2.5 113.412 166.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 67.2 43.21 90.03 Favored Glycine 0 C--N 1.341 0.837 0 O-C-N 121.133 -0.979 . . . . 2.25 113.777 167.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 5.3 t -60.68 -36.35 78.55 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.156 0.978 . . . . 2.9700000000000002 111.905 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 26.4 p80 -135.65 -141.1 0.17 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.017 1.327 . . . . 1.5800000000000001 112.323 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.729 HG22 ' OE2' ' A' ' 136' ' ' GLU . 11.4 t -85.13 -141.39 0.08 Allowed 'General case' 0 C--O 1.218 -0.583 0 C-N-CA 124.14 0.976 . . . . 1.04 108.812 158.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.4 ' N ' HG23 ' A' ' 120' ' ' THR . 4.7 tp -123.08 141.22 44.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 130.23 3.412 . . . . 1.1499999999999999 111.689 174.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.421 ' SD ' ' NE1' ' A' ' 135' ' ' TRP . 12.9 mmt -136.47 154.57 50.72 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 116.379 1.992 . . . . 4.9199999999999999 116.379 -173.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -115.65 87.79 2.74 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.753 -0.658 . . . . 1.5800000000000001 111.789 -170.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 mt -103.1 167.99 9.47 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.487 -0.758 . . . . 0.83999999999999997 109.354 -174.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.57 88.86 2.73 Favored Pre-proline 0 N--CA 1.475 0.789 0 O-C-N 121.033 -1.042 . . . . 7.79 112.556 -167.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -81.37 173.4 11.64 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.477 2.784 . . . . 2.3399999999999999 109.933 170.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -113.55 156.83 22.91 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.45 1.9 . . . . 1.24 107.883 169.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 p -50.3 -39.53 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-N 119.992 1.269 . . . . 0.79000000000000004 113.952 170.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -79.59 -5.59 55.31 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.263 0.838 . . . . 1.8999999999999999 113.263 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -143.16 -164.14 1.79 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.561 0.744 . . . . 2.2200000000000002 111.773 -155.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.4 m -149.74 158.57 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.731 2.012 . . . . 0.55000000000000004 110.263 -171.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -143.62 139.61 29.72 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.224 1.01 . . . . 0.66000000000000003 111.637 170.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.9 ttt-85 -97.96 146.14 25.78 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.457 0.703 . . . . 4.29 110.32 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 9.7 t -60.2 160.35 8.46 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.545 1.538 . . . . 1.0900000000000001 110.627 159.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.421 ' NE1' ' SD ' ' A' ' 122' ' ' MET . 27.7 p-90 -99.86 -17.71 17.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 117.479 -1.248 . . . . 1.4199999999999999 111.822 160.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.729 ' OE2' HG22 ' A' ' 120' ' ' THR . 2.1 mm-40 -86.25 -95.38 0.08 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.923 1.289 . . . . 1.51 109.502 -173.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.3 p -64.28 -13.33 49.05 Favored 'General case' 0 CA--C 1.557 1.233 0 O-C-N 119.963 -1.711 . . . . 1.1599999999999999 114.929 -177.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.75 16.8 80.15 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.95 1.738 . . . . 0.75 114.909 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.82 142.4 49.63 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.399 1.6 . . . . 1.74 110.56 169.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.26 147.94 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 108.355 -0.979 . . . . 0.56000000000000005 108.355 158.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -126.27 153.49 44.7 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 128.928 2.891 . . . . 1.8200000000000001 111.037 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 46.7 tttt -130.39 152.89 49.31 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.621 0.768 . . . . 2.3999999999999999 112.763 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' A' ' 102' ' ' SER . 0.8 OUTLIER -99.34 164.92 11.92 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.874 1.321 . . . . 2.3399999999999999 111.283 161.784 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.461 ' H ' HD23 ' A' ' 143' ' ' LEU . 27.7 p30 -123.96 167.56 15.0 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 127.538 2.335 . . . . 1.52 110.804 -177.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -83.75 -26.42 2.04 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.717 2.278 . . . . 1.3600000000000001 113.776 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.492 HG11 ' CG ' ' A' ' 101' ' ' GLU . 35.7 m 38.66 -164.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 129.976 3.31 . . . . 3.04 117.238 -178.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.833 0 CA-C-O 123.746 1.748 . . . . 2.1200000000000001 113.174 132.031 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.0 mtt . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 118.749 2.87 . . . . 3.1400000000000001 118.749 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.22 -80.67 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.306 0.574 . . . . 2.4500000000000002 110.188 161.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.8 t0 177.13 77.78 0.11 Allowed Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 127.073 2.149 . . . . 2.3799999999999999 108.1 -162.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -93.96 -57.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 1 C-N-CA 127.053 5.168 . . . . 0.97999999999999998 115.402 -162.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.15 140.92 29.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 1 C-N-CA 131.803 4.041 . . . . 0.76000000000000001 103.709 -170.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 mm -111.69 135.92 49.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 123.633 0.773 . . . . 0.79000000000000004 110.502 -175.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.2 mm -123.89 100.18 7.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 126.584 1.954 . . . . 0.79000000000000004 106.23 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -78.8 120.41 23.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 113.547 -1.661 . . . . 2.5600000000000001 110.455 -163.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.7 t -110.28 -65.74 1.13 Allowed 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 115.049 1.5 . . . . 2.7599999999999998 115.049 -154.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.451 ' H ' ' CG2' ' A' ' 146' ' ' VAL . 59.7 m-85 71.86 11.13 6.26 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.826 2.05 . . . . 2.3999999999999999 112.555 -171.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -138.1 153.37 49.28 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 130.046 3.338 . . . . 2.8300000000000001 107.306 163.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -71.29 -9.26 57.83 Favored 'General case' 0 CA--C 1.552 1.054 0 O-C-N 120.645 -1.284 . . . . 3.1499999999999999 113.032 172.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -141.45 104.07 4.52 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.417 2.287 . . . . 2.8799999999999999 111.405 -164.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -148.94 168.79 22.13 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.709 -1.244 . . . . 3.9300000000000002 112.306 174.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -103.94 158.11 16.63 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.727 0.811 . . . . 2.4199999999999999 111.32 166.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.6 p -102.33 141.12 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.238 1.415 . . . . 0.87 110.291 169.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -106.92 78.54 0.25 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.341 1.448 . . . . 1.1899999999999999 112.867 169.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 12.9 p -94.95 143.0 26.82 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 119.596 1.698 . . . . 1.45 113.285 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 35.6 p -105.95 19.02 21.21 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-N 112.532 -2.122 . . . . 0.81999999999999995 112.141 169.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.07 60.84 0.34 Allowed Glycine 0 C--N 1.334 0.47 0 CA-C-O 119.033 -0.871 . . . . 1.72 113.675 176.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 68.59 -166.06 0.01 OUTLIER Pre-proline 0 CA--C 1.556 1.204 0 CA-C-O 117.836 -1.078 . . . . 5.1600000000000001 109.874 171.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.85 52.09 3.87 Favored 'Trans proline' 0 C--N 1.354 0.837 0 CA-C-N 122.768 2.024 . . . . 4.5899999999999999 111.598 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -163.1 7.54 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 116.031 1.863 . . . . 4.0999999999999996 116.031 -160.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 51.87 47.95 52.35 Favored Glycine 0 N--CA 1.475 1.29 0 N-CA-C 115.061 0.784 . . . . 2.23 115.061 159.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.2 m -113.83 -21.73 10.52 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 116.331 1.975 . . . . 1.6599999999999999 116.331 -151.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -123.57 -148.5 0.4 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 121.096 1.771 . . . . 1.3700000000000001 113.904 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.539 HG22 ' OE2' ' A' ' 136' ' ' GLU . 1.6 t -72.68 -153.23 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.323 0.649 . . . . 0.93000000000000005 110.946 162.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.457 ' N ' HG23 ' A' ' 120' ' ' THR . 5.2 tp -117.12 136.53 53.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 126.466 1.906 . . . . 0.84999999999999998 112.488 167.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.46 ' CE ' ' HE1' ' A' ' 135' ' ' TRP . 17.3 mmm -131.62 155.83 46.87 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.818 -1.537 . . . . 4.0899999999999999 114.688 -176.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -123.59 111.77 16.64 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.816 -1.084 . . . . 1.47 109.956 -177.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 mt -124.01 148.9 46.64 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.648 -0.501 . . . . 0.85999999999999999 109.648 -171.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.26 108.3 58.67 Favored Pre-proline 0 N--CA 1.484 1.242 0 CA-C-O 118.798 -0.62 . . . . 5.8399999999999999 111.789 -175.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -89.87 -175.21 0.96 Allowed 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.126 2.55 . . . . 2.73 109.895 154.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 94.8 m -158.92 157.44 31.41 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.72 2.808 . . . . 1.3300000000000001 105.199 173.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 p -49.71 -32.41 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 115.309 1.596 . . . . 0.81999999999999995 115.309 -176.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -79.27 -0.81 33.83 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.027 1.331 . . . . 2.04 113.949 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -141.29 -175.83 4.49 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 123.545 1.64 . . . . 2.7400000000000002 114.503 -151.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.5 m -139.22 168.08 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 130.244 3.418 . . . . 0.70999999999999996 107.267 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -147.82 128.11 13.88 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 123.924 0.89 . . . . 0.68000000000000005 111.13 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -92.33 141.17 28.84 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.937 0.789 . . . . 4.29 110.351 173.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 9.2 t -63.54 174.81 1.2 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 122.789 1.281 . . . . 1.1899999999999999 112.446 159.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.46 ' HE1' ' CE ' ' A' ' 122' ' ' MET . 20.8 p-90 -111.34 -18.37 12.93 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.316 -0.856 . . . . 1.6000000000000001 111.983 161.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.539 ' OE2' HG22 ' A' ' 120' ' ' THR . 0.0 OUTLIER -86.9 -87.7 0.14 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.67 1.988 . . . . 1.71 108.092 -171.431 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 24.3 p -59.84 -19.68 52.53 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 120.477 -1.39 . . . . 1.1000000000000001 112.664 168.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.98 15.89 22.89 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.669 1.604 . . . . 0.92000000000000004 114.186 -175.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.1 p -75.04 142.24 43.79 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 119.122 1.461 . . . . 1.28 110.722 172.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 52.8 t -80.72 147.61 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.455 -0.942 . . . . 0.55000000000000004 108.455 167.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -130.84 158.47 40.09 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 130.231 3.413 . . . . 2.2999999999999998 109.457 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -140.39 147.0 39.08 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 113.759 1.022 . . . . 3.0600000000000001 113.759 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.7 tt -93.4 145.13 24.71 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 115.36 -0.836 . . . . 0.91000000000000003 110.771 170.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -112.21 147.36 36.79 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 124.618 1.167 . . . . 1.3999999999999999 110.392 171.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -69.98 -27.57 25.25 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.549 2.166 . . . . 1.8200000000000001 112.497 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.451 ' CG2' ' H ' ' A' ' 103' ' ' TYR . 7.6 m 41.5 -158.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 129.002 2.921 . . . . 3.0 114.933 -174.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.419 0 CA-C-O 122.228 0.904 . . . . 2.3700000000000001 112.477 157.746 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.9 mtt . . . . . 0 CA--C 1.521 -0.156 0 CA-C-O 123.911 1.815 . . . . 2.5800000000000001 111.779 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 177.09 -123.48 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.119 1 C-N-CA 132.108 4.163 . . . . 1.9199999999999999 107.077 178.13 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . 0.27 30.0 t70 -131.33 78.6 71.76 Favored Pre-proline 0 N--CA 1.432 -1.334 0 C-N-CA 126.6 1.96 . . . . 2.54 107.699 176.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.13 -84.06 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.6 1 C-N-CA 126.876 5.05 . . . . 1.23 113.14 -171.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.65 147.56 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 C-N-CA 127.835 2.454 . . . . 0.70999999999999996 106.406 171.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.2 mm -105.77 136.05 41.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.932 -0.576 . . . . 0.84999999999999998 111.21 -174.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.5 mm -119.25 99.12 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 126.169 1.788 . . . . 0.64000000000000001 107.572 169.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -70.39 122.86 20.41 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.543 1.537 . . . . 3.0 108.968 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.6 m -162.23 123.49 2.65 Favored 'General case' 0 C--O 1.221 -0.442 0 O-C-N 121.06 -1.025 . . . . 3.48 112.687 -165.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -83.47 25.71 0.73 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.203 1.001 . . . . 2.5299999999999998 113.316 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -140.95 124.6 16.89 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.766 2.026 . . . . 2.6699999999999999 107.967 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -62.51 7.99 0.06 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 127.771 2.428 . . . . 3.3799999999999999 117.468 -169.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.08 22.8 0.07 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.761 2.424 . . . . 2.2400000000000002 112.458 -165.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.2 ttt-85 -67.39 150.12 49.38 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.503 1.121 . . . . 3.96 113.387 -174.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -82.99 150.91 26.09 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.893 0.701 . . . . 2.1899999999999999 112.893 176.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.5 p -108.07 138.8 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.502 1.521 . . . . 0.81000000000000005 111.168 169.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -108.66 103.14 1.79 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.492 -1.443 . . . . 0.69999999999999996 109.492 159.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.04 155.8 17.25 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.949 0.9 . . . . 1.24 110.554 166.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 120' ' ' THR . 40.9 p -118.11 4.94 11.99 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 116.463 2.023 . . . . 0.75 116.463 172.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.71 56.3 0.29 Allowed Glycine 0 C--N 1.33 0.224 0 CA-C-O 119.443 -0.643 . . . . 2.0800000000000001 113.016 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 79.5 -162.2 0.0 OUTLIER Pre-proline 0 CA--C 1.565 1.528 0 CA-C-O 116.61 -1.662 . . . . 3.2400000000000002 109.245 -168.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -80.55 45.93 2.11 Favored 'Trans proline' 0 C--N 1.358 1.053 0 CA-C-N 124.524 2.651 . . . . 2.2200000000000002 112.915 -173.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -166.55 163.7 17.04 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.025 1.33 . . . . 3.9300000000000002 110.785 -169.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.89 42.41 2.49 Favored Glycine 0 N--CA 1.473 1.125 0 C-N-CA 124.478 1.037 . . . . 2.2799999999999998 114.048 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.1 m -68.93 -40.6 78.93 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.657 1.229 . . . . 1.99 114.028 -160.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -106.27 -73.23 0.69 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.04 0.756 . . . . 1.8999999999999999 113.04 173.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 112' ' ' THR . 7.0 t -178.99 -166.12 0.09 Allowed 'General case' 0 N--CA 1.475 0.789 1 C-N-CA 132.685 4.394 . . . . 0.96999999999999997 106.609 -175.339 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.6 tp -98.77 138.42 23.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 119.771 1.169 . . . . 0.89000000000000001 110.729 173.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.56 ' SD ' HD21 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -141.02 163.43 32.99 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.121 1.368 . . . . 4.4500000000000002 110.441 166.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.3 m95 -130.22 87.67 2.54 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.868 -0.52 . . . . 2.3100000000000001 111.611 -155.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.56 HD21 ' SD ' ' A' ' 122' ' ' MET . 3.2 mt -95.64 167.42 11.3 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 120.498 -1.376 . . . . 0.68000000000000005 110.746 -171.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.35 88.02 15.19 Favored Pre-proline 0 N--CA 1.472 0.675 0 C-N-CA 123.592 0.757 . . . . 7.1500000000000004 111.29 -176.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -77.27 166.61 26.01 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.575 2.184 . . . . 2.3700000000000001 110.412 165.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 m -120.18 154.86 34.2 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 127.097 2.159 . . . . 1.21 108.295 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.4 p -54.95 -34.21 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 112.939 0.718 . . . . 0.75 112.939 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -82.17 -10.07 59.29 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.62 1.168 . . . . 1.6799999999999999 113.508 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -140.02 -168.34 2.5 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.696 0.68 . . . . 2.5499999999999998 112.649 -155.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.83 157.67 23.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 126.93 2.092 . . . . 0.51000000000000001 109.385 -171.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.2 144.89 36.82 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.113 0.965 . . . . 0.47999999999999998 110.968 172.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.4 ttp180 -111.74 139.3 47.33 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.443 1.02 . . . . 4.0800000000000001 112.557 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 37.8 t -60.34 156.33 15.97 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.244 1.418 . . . . 1.02 112.484 163.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -100.43 -12.85 19.03 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.063 -0.971 . . . . 1.28 112.766 169.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -103.39 -78.99 0.54 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.163 0.892 . . . . 2.5800000000000001 111.246 -169.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 26.6 p -70.02 -22.19 63.12 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.853 0.861 . . . . 1.3700000000000001 112.407 172.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.58 33.36 80.93 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.441 1.02 . . . . 1.0800000000000001 113.273 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.11 152.67 42.18 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.839 1.319 . . . . 1.96 110.508 158.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.1 t -100.24 135.4 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 106.335 -1.728 . . . . 0.57999999999999996 106.335 159.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -117.4 140.47 49.53 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 127.735 2.414 . . . . 1.6599999999999999 110.875 -176.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.8 tttm -106.14 147.47 28.96 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.639 -0.71 . . . . 2.5800000000000001 112.704 173.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.43 144.78 25.48 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 114.847 -1.069 . . . . 0.89000000000000001 110.168 155.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -106.66 159.34 30.22 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 124.596 1.158 . . . . 1.3100000000000001 113.006 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -71.8 -5.16 16.51 Favored 'Trans proline' 0 C--N 1.354 0.861 1 C-N-CA 126.274 4.65 . . . . 1.29 115.983 -177.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.9 p -48.11 142.42 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 126.141 1.777 . . . . 2.1699999999999999 111.511 177.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.717 0 CA-C-O 122.993 1.33 . . . . 1.6899999999999999 112.674 179.353 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 10.9 mtm . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 118.428 2.751 . . . . 2.54 118.428 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.32 -59.66 2.62 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.791 0.663 . . . . 2.6299999999999999 112.791 169.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.425 ' H ' ' HD3' ' A' ' 97' ' ' PRO . 0.1 OUTLIER 167.05 70.44 0.0 OUTLIER Pre-proline 0 CA--C 1.566 1.571 0 C-N-CA 129.674 3.189 . . . . 3.0 110.167 -150.201 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.425 ' HD3' ' H ' ' A' ' 96' ' ' ASP . 63.0 Cg_endo -89.02 -50.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.334 -0.229 1 C-N-CA 125.529 4.152 . . . . 0.73999999999999999 113.358 -174.244 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.98 141.74 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 1 C-N-CA 131.954 4.102 . . . . 0.53000000000000003 104.207 -172.791 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.3 mm -119.48 129.43 75.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 124.303 1.041 . . . . 0.71999999999999997 111.153 -175.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 42.0 mm -115.39 98.21 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 125.688 1.595 . . . . 0.55000000000000004 107.515 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -71.12 99.67 1.9 Allowed 'General case' 0 C--N 1.328 -0.361 0 O-C-N 125.569 1.793 . . . . 2.54 108.333 176.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.483 ' OG ' HD21 ' A' ' 143' ' ' LEU . 78.7 p -104.92 -43.6 5.03 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.041 1.126 . . . . 3.7000000000000002 114.041 -157.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . 0.252 35.5 m-85 72.32 9.77 5.86 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 127.742 2.417 . . . . 2.73 114.45 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -132.66 150.21 52.19 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.58 -0.896 . . . . 3.1099999999999999 108.58 134.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.05 -28.01 22.55 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.969 2.507 . . . . 3.4399999999999999 114.91 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -127.1 12.77 7.19 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.525 1.53 . . . . 2.4900000000000002 114.044 -161.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -56.57 175.28 0.12 Allowed 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 122.458 1.123 . . . . 4.04 113.25 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -95.41 169.32 10.14 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.582 -0.699 . . . . 2.5499999999999998 111.348 157.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.7 p -116.22 143.16 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 126.884 2.074 . . . . 0.85999999999999999 111.472 171.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -104.69 101.33 1.92 Allowed Glycine 0 CA--C 1.532 1.142 0 CA-C-O 117.974 -1.459 . . . . 0.82999999999999996 114.142 165.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 13.8 p -107.43 145.61 32.77 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-O 123.908 1.813 . . . . 1.1599999999999999 113.386 160.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 74.3 p -102.44 16.4 26.4 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 112.494 -2.139 . . . . 0.73999999999999999 111.627 165.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 142.45 176.0 16.2 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-O 123.693 1.718 . . . . 3.4500000000000002 114.599 -171.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.6 m -3.47 133.68 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.242 0 CA-C-N 111.757 -2.222 . . . . 3.9399999999999999 115.785 103.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.85 57.39 4.46 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 125.131 3.887 . . . . 2.8799999999999999 114.476 -169.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -169.27 48.74 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.815 1.246 . . . . 1.98 111.622 -167.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 55.7 24.69 41.25 Favored Glycine 0 N--CA 1.48 1.627 0 C-N-CA 125.077 1.322 . . . . 2.1299999999999999 115.925 166.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.2 m -77.38 -41.6 39.55 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.754 1.02 . . . . 2.0899999999999999 113.754 -144.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.438 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 25.2 p80 -115.12 -149.01 0.44 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.937 1.295 . . . . 1.51 112.395 -176.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.616 HG22 ' OE2' ' A' ' 136' ' ' GLU . 2.4 t -71.92 -155.43 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.692 0.678 . . . . 1.0900000000000001 110.987 160.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.5 tp -115.37 138.68 44.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 C-N-CA 126.483 1.913 . . . . 0.96999999999999997 111.082 165.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.525 ' CE ' ' HE1' ' A' ' 135' ' ' TRP . 13.2 mmm -131.95 153.38 50.36 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 115.144 1.535 . . . . 3.9700000000000002 115.144 -174.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -118.33 99.57 6.93 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 124.528 1.143 . . . . 1.5700000000000001 110.309 -173.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.3 mt -109.45 162.47 14.34 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.498 0.719 . . . . 0.77000000000000002 109.63 -173.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -121.89 74.57 36.87 Favored Pre-proline 0 N--CA 1.487 1.38 0 O-C-N 120.425 -1.422 . . . . 4.6600000000000001 114.782 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -86.47 39.56 0.65 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.908 3.072 . . . . 3.3399999999999999 114.922 -171.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.8 m -28.02 151.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 1 C-N-CA 132.206 4.202 . . . . 1.0700000000000001 115.27 -169.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.4 p -45.66 -39.02 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 114.703 1.372 . . . . 0.82999999999999996 114.703 177.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -81.48 -8.63 59.75 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.403 1.481 . . . . 1.47 113.823 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.402 ' O ' ' HE3' ' A' ' 142' ' ' LYS . 30.3 mt-10 -136.17 -159.53 0.97 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.34 1.056 . . . . 2.1299999999999999 110.52 -156.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 20.9 m -157.81 153.53 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 130.246 3.419 . . . . 0.79000000000000004 106.15 177.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -142.38 143.52 32.73 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.535 0.607 . . . . 0.79000000000000004 111.044 171.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -100.35 142.6 31.61 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.285 0.634 . . . . 4.8700000000000001 110.446 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 14.6 t -60.05 159.06 9.98 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 124.514 1.134 . . . . 1.04 111.52 161.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.525 ' HE1' ' CE ' ' A' ' 122' ' ' MET . 20.6 p-90 -103.96 -12.79 16.62 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.6 -0.727 . . . . 1.3999999999999999 111.703 163.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.616 ' OE2' HG22 ' A' ' 120' ' ' THR . 1.6 mm-40 -89.65 -87.05 0.18 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.933 1.293 . . . . 1.55 108.842 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 23.0 p -74.65 -15.16 60.82 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.256 1.206 . . . . 1.4299999999999999 114.256 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 66.85 18.94 69.09 Favored Glycine 0 N--CA 1.469 0.876 0 C-N-CA 126.318 1.913 . . . . 0.73999999999999999 115.075 172.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.27 141.83 57.89 Favored 'General case' 0 N--CA 1.46 0.059 0 C-N-CA 118.593 -1.243 . . . . 1.75 110.349 163.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 45.9 t -78.94 141.8 14.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 107.782 -1.192 . . . . 0.79000000000000004 107.782 159.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -122.52 156.61 33.8 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 128.082 2.553 . . . . 1.73 110.219 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 130' ' ' GLU . 66.5 tttt -136.64 152.76 50.78 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 122.315 1.055 . . . . 2.27 113.027 173.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.681 HD23 ' H ' ' A' ' 144' ' ' ASN . 6.3 tt -112.16 167.4 10.44 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.561 1.545 . . . . 1.04 109.252 174.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.681 ' H ' HD23 ' A' ' 143' ' ' LEU . 1.9 p30 -126.52 165.7 26.51 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.507 1.523 . . . . 1.45 113.581 -168.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 144' ' ' ASN . 65.0 Cg_endo -73.32 -4.43 15.4 Favored 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 124.07 3.18 . . . . 1.45 115.256 -176.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.8 p -44.54 140.35 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 127.974 2.51 . . . . 2.75 114.026 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.734 0 C-N-CA 126.541 2.02 . . . . 2.3300000000000001 110.335 -179.473 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.2 mtp . . . . . 0 C--O 1.224 -0.24 0 N-CA-C 116.985 2.217 . . . . 3.1699999999999999 116.985 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.33 -74.69 0.61 Allowed 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 124.305 1.042 . . . . 2.1699999999999999 109.29 173.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.4 t70 179.44 75.9 0.17 Allowed Pre-proline 0 CA--C 1.559 1.324 0 C-N-CA 128.242 2.617 . . . . 2.5899999999999999 107.893 -166.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 142' ' ' LYS . 60.7 Cg_endo -89.23 -51.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.551 1 C-N-CA 128.582 6.188 . . . . 0.75 113.437 -175.205 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -139.58 143.12 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 130.746 3.618 . . . . 0.57999999999999996 104.844 -175.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.0 mm -102.76 138.34 27.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.671 -0.695 . . . . 0.80000000000000004 110.822 -176.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.3 mm -120.5 107.11 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 C-N-CA 127.036 2.134 . . . . 0.67000000000000004 107.462 170.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -78.61 134.32 37.2 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 124.601 1.188 . . . . 3.2200000000000002 110.867 -174.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.448 ' O ' HG21 ' A' ' 146' ' ' VAL . 13.2 t -162.24 107.22 1.21 Allowed 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 113.144 0.794 . . . . 2.71 113.144 -163.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.3 m-30 -77.33 41.53 0.31 Allowed 'General case' 0 N--CA 1.48 1.063 0 O-C-N 120.524 -1.36 . . . . 2.5099999999999998 110.762 171.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.37 123.71 3.93 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.956 2.902 . . . . 3.1699999999999999 107.965 -166.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.54 -3.6 31.86 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 115.582 1.697 . . . . 3.3399999999999999 115.582 -166.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.36 21.64 1.06 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 125.112 1.365 . . . . 2.1099999999999999 113.662 -156.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.04 154.06 18.34 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 120.148 -1.595 . . . . 5.9800000000000004 114.991 -154.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.8 161.18 31.38 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.319 1.229 . . . . 2.0699999999999998 114.319 -177.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.4 p -129.6 145.84 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 127.455 2.302 . . . . 0.82999999999999996 109.84 171.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.17 126.74 6.39 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.155 0.883 . . . . 0.77000000000000002 111.605 164.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.97 151.97 39.09 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.366 1.867 . . . . 1.52 111.94 169.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 34.0 p -117.83 25.97 10.01 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.164 1.385 . . . . 0.97999999999999998 113.385 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.85 68.27 1.03 Allowed Glycine 0 N--CA 1.462 0.428 0 O-C-N 120.844 -1.16 . . . . 2.4900000000000002 111.017 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.46 177.71 0.06 OUTLIER Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 123.521 0.728 . . . . 3.0800000000000001 110.01 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.23 38.96 0.76 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.061 2.507 . . . . 2.6499999999999999 112.705 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -151.93 3.2 0.38 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.851 1.797 . . . . 2.1200000000000001 115.851 -165.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.38 72.22 0.98 Allowed Glycine 0 N--CA 1.474 1.188 0 C-N-CA 124.849 1.214 . . . . 1.8600000000000001 114.206 167.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.5 t -103.63 -30.38 10.5 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 115.338 1.607 . . . . 2.0899999999999999 115.338 -174.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.415 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 9.1 p80 -128.32 -148.12 0.37 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.631 0.773 . . . . 1.3300000000000001 112.042 -176.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.776 HG22 ' OE1' ' A' ' 136' ' ' GLU . 5.2 t -78.16 -152.34 0.05 Allowed 'General case' 0 N--CA 1.479 1.016 0 O-C-N 121.268 -0.895 . . . . 0.98999999999999999 111.376 167.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.5 tp -106.65 149.91 9.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 127.667 2.387 . . . . 1.22 110.212 164.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.18 172.35 12.88 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.806 1.242 . . . . 4.9299999999999997 110.036 170.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -137.45 124.96 22.08 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.004 0.521 . . . . 1.5 111.493 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.61 179.75 4.13 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.981 0.912 . . . . 0.84999999999999998 109.185 176.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.27 102.6 2.95 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.973 0.909 . . . . 6.5099999999999998 111.738 174.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -80.4 171.63 14.6 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.144 2.563 . . . . 2.3199999999999998 110.22 164.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.8 m -122.72 155.97 35.37 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 127.2 2.2 . . . . 1.1899999999999999 107.628 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.4 p -55.2 -30.9 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 120.571 1.532 . . . . 0.83999999999999997 112.485 175.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -82.93 -7.52 59.66 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.12 1.768 . . . . 1.4399999999999999 113.521 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -147.42 -169.67 3.37 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.29 1.036 . . . . 2.1600000000000001 112.146 -156.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.567 HG12 ' HG3' ' A' ' 142' ' ' LYS . 26.8 m -142.18 170.31 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 127.757 2.423 . . . . 0.63 109.739 -170.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -150.85 147.55 27.38 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.019 0.927 . . . . 0.52000000000000002 111.505 172.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.6 ttt-85 -114.11 139.2 49.52 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.64 0.776 . . . . 4.5599999999999996 112.333 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 40.1 t -56.78 157.67 5.32 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.817 1.247 . . . . 1.0 112.71 159.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 67.2 p-90 -109.68 -9.05 14.87 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.307 -0.871 . . . . 1.1699999999999999 112.691 167.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.776 ' OE1' HG22 ' A' ' 120' ' ' THR . 4.0 mm-40 -96.22 -83.8 0.37 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.992 1.317 . . . . 1.6699999999999999 109.682 -173.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.4 p -72.43 -14.99 61.83 Favored 'General case' 0 CA--C 1.551 0.983 0 O-C-N 120.644 -1.285 . . . . 1.22 112.651 167.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.49 22.64 76.57 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 119.075 -0.847 . . . . 0.73999999999999999 113.725 169.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.5 p -71.21 130.48 41.55 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 118.388 1.094 . . . . 1.6000000000000001 110.186 170.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.5 t -77.23 147.16 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.451 -0.574 . . . . 0.56000000000000005 109.451 161.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -131.52 156.61 45.4 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 130.544 3.538 . . . . 1.9299999999999999 110.523 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.567 ' HG3' HG12 ' A' ' 131' ' ' VAL . 9.5 tmtt? -140.27 153.2 46.43 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 113.59 0.959 . . . . 2.2799999999999998 113.59 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 144' ' ' ASN . 2.2 tt -100.66 144.1 30.03 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 122.042 0.925 . . . . 0.90000000000000002 112.372 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.418 ' O ' HD23 ' A' ' 143' ' ' LEU . 7.1 p30 -99.37 162.94 19.64 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.249 1.02 . . . . 1.3100000000000001 112.824 -174.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -75.51 -28.01 8.72 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.606 2.871 . . . . 1.3899999999999999 113.837 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 102' ' ' SER . 0.1 OUTLIER 47.88 -161.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 128.032 2.533 . . . . 3.5699999999999998 116.781 169.633 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.971 0 CA-C-O 122.39 0.994 . . . . 1.9299999999999999 114.863 132.224 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.9 mtm . . . . . 0 N--CA 1.469 0.515 0 CA-C-O 121.902 0.858 . . . . 2.7400000000000002 112.756 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 129.73 -132.0 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.763 1 C-N-CA 132.676 4.39 . . . . 2.75 107.822 -156.785 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -126.54 91.58 47.15 Favored Pre-proline 0 N--CA 1.436 -1.155 0 C-N-CA 128.882 2.873 . . . . 2.23 107.185 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -95.99 -49.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.373 1 C-N-CA 126.649 4.899 . . . . 0.70999999999999996 112.737 -178.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -150.62 138.48 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 131.5 3.92 . . . . 0.62 103.934 -171.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.5 mm -115.48 134.95 57.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 124.635 1.174 . . . . 0.75 111.047 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.3 mm -121.97 112.88 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 C-N-CA 126.336 1.854 . . . . 0.5 107.416 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -82.83 136.29 34.68 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 125.023 1.452 . . . . 2.5499999999999998 111.868 -173.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.0 t -125.4 -54.59 1.57 Allowed 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 113.995 1.109 . . . . 2.8300000000000001 113.995 -154.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.605 ' H ' ' CG2' ' A' ' 146' ' ' VAL 0.29 17.0 m-85 73.21 15.54 4.38 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.915 2.086 . . . . 3.1000000000000001 113.336 -172.932 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -151.57 168.06 26.14 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 131.677 3.991 . . . . 2.6400000000000001 106.986 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -72.28 -8.38 54.54 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.844 1.258 . . . . 2.8900000000000001 113.547 164.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.2 120.18 8.76 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 123.651 1.691 . . . . 3.3599999999999999 115.046 -164.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 81.1 mmt-85 -143.23 177.28 8.52 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.922 2.489 . . . . 4.4000000000000004 110.09 167.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -100.66 172.92 6.79 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.659 -0.651 . . . . 2.25 109.822 149.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.0 142.22 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.99 0.916 . . . . 0.68000000000000005 111.206 171.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -107.95 92.92 0.77 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-O 117.688 -1.618 . . . . 0.66000000000000003 113.647 169.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 12.7 p -101.24 148.26 25.32 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 119.788 1.794 . . . . 1.0600000000000001 113.478 166.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.4 p -113.11 13.0 19.26 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 113.24 -1.8 . . . . 0.66000000000000003 113.501 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.25 81.12 1.57 Allowed Glycine 0 N--CA 1.463 0.445 0 N-CA-C 110.42 -1.072 . . . . 2.4100000000000001 110.42 -176.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 10.1 p 58.24 -163.28 0.01 OUTLIER Pre-proline 0 CA--C 1.563 1.46 0 CA-C-O 117.106 -1.426 . . . . 2.7200000000000002 111.302 -171.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.08 -6.06 17.53 Favored 'Trans proline' 0 C--N 1.356 0.971 0 CA-C-N 123.321 2.222 . . . . 2.27 113.711 173.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -98.66 13.65 31.36 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.01 1.485 . . . . 1.8200000000000001 115.01 -165.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.5 34.26 88.66 Favored Glycine 0 N--CA 1.476 1.32 0 O-C-N 121.15 -0.969 . . . . 1.9299999999999999 113.866 172.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.02 -39.68 83.1 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.066 1.136 . . . . 1.77 114.066 -163.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.444 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 22.5 p80 -113.29 -149.14 0.44 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.239 1.816 . . . . 1.28 112.917 -176.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.642 HG22 ' OE2' ' A' ' 136' ' ' GLU . 2.6 t -73.41 -153.67 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 119.31 0.959 . . . . 1.1100000000000001 111.115 162.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.423 ' N ' HG23 ' A' ' 120' ' ' THR . 5.0 tp -117.86 137.83 50.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 126.896 2.078 . . . . 0.83999999999999997 111.499 165.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.468 ' CE ' ' HE1' ' A' ' 135' ' ' TRP . 13.6 mmm -131.66 151.74 51.4 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 115.527 1.676 . . . . 3.9100000000000001 115.527 -172.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -117.01 103.8 10.62 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 124.209 0.943 . . . . 1.55 110.515 -174.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.9 mt -111.53 161.91 15.67 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.202 0.601 . . . . 0.84999999999999998 110.423 -174.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.72 84.62 10.42 Favored Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 114.517 1.303 . . . . 6.2699999999999996 114.517 -171.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -88.63 14.96 2.17 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.59 2.86 . . . . 3.1000000000000001 116.265 -164.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.8 m -29.85 152.78 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 1 C-N-CA 131.804 4.041 . . . . 1.3500000000000001 115.322 -165.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.9 p -47.08 -43.21 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 115.174 1.546 . . . . 1.0900000000000001 115.174 -177.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -78.05 -5.52 51.68 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.795 1.638 . . . . 1.76 114.222 178.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -131.79 -177.45 4.43 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 122.758 1.266 . . . . 3.1000000000000001 112.169 -159.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.4 m -148.81 156.1 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 128.591 2.756 . . . . 0.79000000000000004 106.744 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.22 132.75 28.66 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 122.68 0.392 . . . . 0.81000000000000005 110.803 175.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.6 ttm-85 -86.22 138.19 32.06 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.189 -1.041 . . . . 4.04 108.189 168.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 20.7 t -57.67 153.03 14.12 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 124.398 1.061 . . . . 1.23 110.942 153.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.468 ' HE1' ' CE ' ' A' ' 122' ' ' MET . 19.2 p-90 -97.45 -18.63 18.94 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.524 -0.75 . . . . 1.8 111.471 163.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.642 ' OE2' HG22 ' A' ' 120' ' ' THR . 2.3 mm-40 -83.37 -92.31 0.07 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.129 0.971 . . . . 1.6100000000000001 108.804 -177.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 32.1 p -65.59 -15.43 62.72 Favored 'General case' 0 CA--C 1.553 1.07 0 O-C-N 120.559 -1.338 . . . . 1.3600000000000001 114.46 176.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.44 17.82 76.51 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 126.581 2.038 . . . . 0.83999999999999997 115.348 169.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.4 p -77.26 144.66 38.03 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.76 1.28 . . . . 1.5700000000000001 111.762 168.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 57.7 t -80.58 145.29 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.462 -0.57 . . . . 0.66000000000000003 109.462 162.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -125.15 147.95 48.8 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 129.114 2.966 . . . . 1.78 110.56 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.405 ' HG2' ' N ' ' A' ' 143' ' ' LEU . 48.8 tttt -124.4 154.57 40.21 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 123.746 1.736 . . . . 1.9299999999999999 113.186 169.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.405 ' N ' ' HG2' ' A' ' 142' ' ' LYS . 8.0 tt -92.04 156.38 17.44 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.542 1.537 . . . . 0.91000000000000003 110.606 165.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -120.74 139.08 28.41 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 107.434 -1.321 . . . . 1.3700000000000001 107.434 164.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.3 -30.53 30.31 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.078 2.519 . . . . 2.6800000000000002 111.837 -171.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.605 ' CG2' ' H ' ' A' ' 103' ' ' TYR . 20.3 m 41.41 -157.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 129.001 2.92 . . . . 2.2999999999999998 115.587 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.395 0 C-N-CA 127.299 2.38 . . . . 2.0800000000000001 108.678 159.25 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.1 mtm . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 121.6 0.714 . . . . 2.7999999999999998 112.347 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 151.28 -76.64 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.661 1 C-N-CA 132.927 4.491 . . . . 1.71 111.33 -176.478 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.5 t0 177.14 75.64 0.1 Allowed Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 128.373 2.669 . . . . 2.0800000000000001 109.596 -163.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -88.52 -49.68 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.387 1 C-N-CA 127.432 5.421 . . . . 0.72999999999999998 112.551 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -148.06 143.82 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 1 C-N-CA 131.916 4.086 . . . . 0.67000000000000004 104.205 -171.739 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.6 mm -107.85 146.13 14.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 124.67 1.188 . . . . 0.63 109.568 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.8 mm -127.38 107.57 16.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 126.603 1.961 . . . . 0.56000000000000005 110.314 167.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.4 mp0 -64.12 124.87 22.75 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 123.125 1.44 . . . . 3.6499999999999999 112.61 175.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.3 t -116.78 -58.31 2.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.774 -1.557 . . . . 2.7400000000000002 114.894 -157.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.59 ' H ' ' CG2' ' A' ' 146' ' ' VAL . 14.5 m-85 64.45 25.53 13.33 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.82 1.248 . . . . 3.0499999999999998 110.636 -168.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -167.4 148.92 5.68 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 128.345 2.658 . . . . 2.21 108.917 -170.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.426 ' HB2' ' CD2' ' A' ' 106' ' ' TYR . 8.5 m-20 -76.93 -25.62 53.12 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.61 -1.306 . . . . 3.1400000000000001 113.097 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.426 ' CD2' ' HB2' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -140.56 14.25 2.35 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.195 1.798 . . . . 2.3599999999999999 113.991 -150.453 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -60.41 168.3 2.16 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.784 1.234 . . . . 5.5499999999999998 112.536 174.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -106.52 159.32 16.26 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.809 1.04 . . . . 2.27 113.809 171.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.53 144.98 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 127.029 2.132 . . . . 1.04 109.917 170.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.42 100.89 1.4 Allowed Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.921 -0.933 . . . . 0.97999999999999998 111.993 165.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 1.6 t -86.59 138.47 31.67 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.047 1.339 . . . . 1.1299999999999999 112.591 171.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.9 p -109.34 22.19 16.12 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.061 1.134 . . . . 0.82999999999999996 114.061 170.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.87 55.77 0.92 Allowed Glycine 0 N--CA 1.462 0.391 0 O-C-N 120.806 -1.184 . . . . 1.8999999999999999 110.779 -175.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 65.43 -168.04 0.01 OUTLIER Pre-proline 0 CA--C 1.566 1.577 0 CA-C-O 117.799 -1.096 . . . . 3.9900000000000002 110.886 -173.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.41 6.1 5.02 Favored 'Trans proline' 0 C--N 1.355 0.899 0 CA-C-N 123.507 2.288 . . . . 2.4700000000000002 114.885 -169.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.31 13.2 13.6 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.553 1.316 . . . . 2.1600000000000001 114.553 -166.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 64.46 61.33 6.06 Favored Glycine 0 N--CA 1.473 1.139 0 CA-C-N 118.844 0.747 . . . . 1.6899999999999999 112.956 169.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 39.7 m -100.26 -26.43 13.91 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.73 1.381 . . . . 1.6000000000000001 114.73 -169.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.474 ' CE1' ' SD ' ' A' ' 122' ' ' MET . 30.3 p80 -131.59 -158.53 0.9 Allowed 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 119.671 1.123 . . . . 1.5800000000000001 111.1 168.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.45 HG23 ' SD ' ' A' ' 122' ' ' MET . 7.8 t -75.55 -152.97 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 O-C-N 121.088 -1.008 . . . . 0.84999999999999998 111.145 169.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.405 ' C ' ' SD ' ' A' ' 122' ' ' MET . 4.9 tp -112.6 131.3 64.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 117.72 2.489 . . . . 0.97999999999999998 117.72 -178.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.484 ' SD ' ' HG3' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -132.46 126.52 33.21 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 128.745 2.818 . . . . 5.1900000000000004 114.532 -169.339 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -106.98 114.18 28.11 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.299 1.04 . . . . 2.04 111.518 -167.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 mt -120.11 157.47 28.9 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.965 0.802 . . . . 0.79000000000000004 111.231 -171.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -118.49 92.96 44.76 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.249 1.42 . . . . 5.71 111.313 172.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -88.46 30.4 0.43 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.062 3.175 . . . . 3.46 114.383 -171.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.5 m -23.43 154.86 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 1 C-N-CA 133.829 4.852 . . . . 1.1699999999999999 117.863 -162.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.5 p -51.34 -33.99 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 120.061 -1.649 . . . . 0.84999999999999998 113.633 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -90.16 -6.0 55.84 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.276 1.83 . . . . 1.8700000000000001 114.077 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -138.05 -160.55 1.07 Allowed 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.87 0.868 . . . . 2.27 110.728 -159.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.518 HG12 ' HG3' ' A' ' 142' ' ' LYS . 27.3 m -156.98 160.31 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 131.179 3.792 . . . . 0.59999999999999998 106.277 -176.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -143.98 132.49 22.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 118.89 0.768 . . . . 0.64000000000000001 111.092 174.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 140' ' ' VAL . 8.2 ttm180 -90.72 129.63 36.8 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.447 0.699 . . . . 3.5099999999999998 109.128 170.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 34.1 t -55.32 140.99 37.58 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 123.955 0.784 . . . . 1.27 110.34 155.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -81.2 -14.58 57.4 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.552 -0.737 . . . . 1.3100000000000001 112.534 171.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.484 ' HG3' ' SD ' ' A' ' 122' ' ' MET . 0.5 OUTLIER -96.38 -91.17 0.24 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.635 1.174 . . . . 1.77 109.239 -169.163 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 19.0 p -58.99 -25.68 63.84 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.9 -1.125 . . . . 1.1699999999999999 112.756 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.81 25.94 73.84 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.346 0.974 . . . . 1.1000000000000001 113.139 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.3 p -69.61 125.15 25.84 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 119.215 1.508 . . . . 1.79 109.749 159.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 133' ' ' ARG . 39.9 t -79.18 147.37 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 107.156 -1.424 . . . . 0.67000000000000004 107.156 161.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -132.91 154.23 50.62 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 128.973 2.909 . . . . 2.2999999999999998 110.094 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.518 ' HG3' HG12 ' A' ' 131' ' ' VAL . 5.6 tmtt? -137.52 162.46 33.67 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.299 1.047 . . . . 2.4399999999999999 113.323 175.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.1 tt -113.0 144.69 42.14 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.469 1.128 . . . . 0.89000000000000001 113.234 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -111.87 144.29 30.38 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-N 114.291 -1.322 . . . . 1.3300000000000001 109.546 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -67.2 -28.1 40.75 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.832 2.355 . . . . 2.0699999999999998 112.009 -175.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.59 ' CG2' ' H ' ' A' ' 103' ' ' TYR . 22.1 m 42.12 -157.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 128.027 2.531 . . . . 2.7599999999999998 114.965 -173.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.925 0 C-N-CA 124.999 1.285 . . . . 2.29 110.794 139.331 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 33.1 mtp . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 117.754 2.501 . . . . 2.6800000000000002 117.754 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.14 -63.26 1.15 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.29 1.036 . . . . 1.9199999999999999 113.165 171.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.8 t0 163.55 77.38 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 128.502 2.721 . . . . 2.5099999999999998 110.173 -157.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -89.33 -50.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.411 1 C-N-CA 126.846 5.03 . . . . 0.81000000000000005 113.078 -174.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -154.77 142.4 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 1 C-N-CA 132.019 4.127 . . . . 0.5 104.585 -168.584 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.8 mm -118.3 137.74 51.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 123.985 0.914 . . . . 0.75 112.129 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.8 mm -129.2 112.9 26.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 127.29 2.236 . . . . 0.55000000000000004 109.002 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.69 124.98 25.37 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.758 1.623 . . . . 2.46 112.193 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.3 t -145.17 90.51 2.04 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 115.792 1.775 . . . . 2.98 115.792 -167.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -77.25 64.1 2.59 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.561 1.144 . . . . 3.4500000000000002 110.672 174.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.41 -13.32 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.68 2.392 . . . . 3.2000000000000002 113.477 -167.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 64.82 -7.93 0.24 Allowed 'General case' 0 CA--C 1.56 1.349 0 CA-C-N 120.74 1.609 . . . . 3.0600000000000001 115.072 -170.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -152.34 24.13 0.62 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 116.928 2.196 . . . . 2.46 116.928 -172.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -54.82 149.89 10.67 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 120.572 1.533 . . . . 4.2599999999999998 113.079 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -77.11 161.59 28.14 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.516 -0.74 . . . . 2.2400000000000002 112.18 163.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.1 p -113.76 145.66 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 126.586 1.954 . . . . 0.73999999999999999 111.511 175.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.67 113.27 4.67 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.424 1.011 . . . . 1.29 112.043 162.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 7.4 t -110.63 128.57 55.74 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.408 1.483 . . . . 1.04 113.239 174.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 32.9 p -110.54 34.36 4.0 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.546 1.313 . . . . 1.22 114.546 167.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.407 ' HA2' ' SG ' ' A' ' 137' ' ' CYS . . . 85.17 -31.74 3.69 Favored Glycine 0 N--CA 1.473 1.167 0 O-C-N 118.984 -2.322 . . . . 2.04 114.806 173.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.0 p 176.07 177.46 0.22 Allowed Pre-proline 0 CA--C 1.556 1.19 1 C-N-CA 132.468 4.307 . . . . 3.6699999999999999 106.67 -175.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.48 -15.02 47.61 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 121.721 1.614 . . . . 2.5499999999999998 113.302 167.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -101.85 55.43 0.81 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.935 1.694 . . . . 2.2999999999999998 111.55 177.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 55.31 20.81 23.8 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 118.061 1.984 . . . . 2.3700000000000001 118.061 154.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.3 m -71.17 -26.68 63.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 115.302 1.593 . . . . 1.6200000000000001 115.302 -140.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -108.0 -25.44 11.16 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 117.234 2.309 . . . . 2.79 117.234 169.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.319 4.8 t 121.12 -152.58 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 131.559 3.944 . . . . 1.51 108.563 -145.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.8 tp -130.15 142.74 43.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 130.463 3.505 . . . . 1.3999999999999999 112.383 -175.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.489 ' HG3' ' HG3' ' A' ' 136' ' ' GLU . 19.1 mmm -135.01 159.4 41.63 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 126.652 1.981 . . . . 3.7200000000000002 116.093 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -126.79 113.88 17.21 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.693 0.797 . . . . 1.99 110.222 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 mt -122.65 159.68 27.37 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.099 0.959 . . . . 0.89000000000000001 109.681 -171.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.16 80.92 70.88 Favored Pre-proline 0 N--CA 1.477 0.918 0 O-C-N 120.758 -1.214 . . . . 5.0999999999999996 113.171 -166.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.08 177.59 8.69 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.201 2.601 . . . . 2.5699999999999998 110.822 170.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.0 m -151.94 159.59 43.75 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.883 2.073 . . . . 0.87 107.972 -177.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.402 ' N ' HD22 ' A' ' 143' ' ' LEU . 2.6 p -53.19 -42.36 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.514 1.126 . . . . 1.02 113.583 -172.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -77.75 -2.08 34.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.944 1.298 . . . . 1.5700000000000001 113.633 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -140.82 -172.05 3.38 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 122.227 1.013 . . . . 2.3500000000000001 112.881 -150.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.9 m -153.27 161.11 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 128.102 2.561 . . . . 0.59999999999999998 107.841 -175.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.7 130.63 24.56 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.598 1.159 . . . . 0.52000000000000002 110.884 175.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.417 ' HA ' ' HA ' ' A' ' 140' ' ' VAL . 2.6 ttp180 -91.55 134.59 34.53 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.136 0.88 . . . . 5.0599999999999996 109.481 171.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 24.4 t -55.64 155.2 5.88 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.99 0.916 . . . . 0.94999999999999996 111.515 162.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.41 ' NE1' ' SD ' ' A' ' 122' ' ' MET . 30.1 p-90 -89.71 -17.05 29.06 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.184 -0.948 . . . . 1.23 111.944 166.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.489 ' HG3' ' HG3' ' A' ' 122' ' ' MET . 4.9 mt-10 -89.25 -101.54 0.09 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.627 1.171 . . . . 2.2200000000000002 109.892 -175.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' CYS . . . . . 0.407 ' SG ' ' HA2' ' A' ' 113' ' ' GLY . 27.9 p -60.57 -9.6 4.0 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 119.169 -2.207 . . . . 1.24 116.144 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.37 26.83 64.68 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 127.574 2.511 . . . . 0.77000000000000002 113.836 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.26 150.48 48.21 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.768 1.784 . . . . 1.5700000000000001 109.853 161.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 133' ' ' ARG . 69.1 t -100.54 141.11 17.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 N-CA-C 104.945 -2.243 . . . . 0.60999999999999999 104.945 169.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -123.34 139.63 53.84 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 126.877 2.071 . . . . 2.04 110.057 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.7 tttt -121.49 145.85 47.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.233 1.016 . . . . 2.8500000000000001 112.173 -175.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 128' ' ' VAL . 8.9 tt -103.76 152.69 21.56 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.194 -1.366 . . . . 1.0700000000000001 110.208 175.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -111.9 154.61 44.07 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 114.022 -1.444 . . . . 1.45 112.317 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -71.62 -3.62 13.44 Favored 'Trans proline' 0 N--CA 1.482 0.838 1 C-N-CA 126.219 4.613 . . . . 1.6200000000000001 115.68 -175.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.5 p -42.97 138.65 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 127.299 2.24 . . . . 2.3700000000000001 112.026 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 122.245 0.914 . . . . 2.75 110.959 -171.953 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.8 mtm . . . . . 0 N--CA 1.467 0.413 0 N-CA-C 116.715 2.117 . . . . 2.1899999999999999 116.715 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.464 ' HD2' ' H ' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -114.84 -117.81 0.32 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.488 -1.671 . . . . 2.8300000000000001 106.488 160.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.464 ' H ' ' HD2' ' A' ' 95' ' ' LYS 0.312 38.8 t70 -129.1 82.68 68.0 Favored Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 126.217 1.807 . . . . 2.6499999999999999 106.262 -178.237 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -87.56 -47.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.789 1 C-N-CA 128.089 5.859 . . . . 0.76000000000000001 113.489 -171.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 mm -146.91 141.47 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 131.247 3.819 . . . . 0.56000000000000005 103.269 -171.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.1 mm -108.98 140.89 25.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 C-N-CA 124.81 1.244 . . . . 0.65000000000000002 110.052 -175.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.7 mm -130.63 109.59 17.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 126.513 1.925 . . . . 0.51000000000000001 110.008 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.0 mp0 -63.82 136.92 57.79 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.709 1.604 . . . . 4.1900000000000004 112.863 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.0 t -165.67 133.88 3.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.752 -1.113 . . . . 2.7999999999999998 110.207 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 -86.99 -4.15 59.15 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 118.854 0.752 . . . . 2.8799999999999999 110.922 166.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -95.59 156.66 16.23 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.596 1.959 . . . . 2.4500000000000002 110.652 168.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -73.45 -24.38 60.22 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.903 1.681 . . . . 3.96 113.371 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -134.71 2.21 3.15 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.418 1.636 . . . . 2.48 115.418 -164.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.68 132.19 6.5 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.544 1.537 . . . . 7.1699999999999999 113.118 -177.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -78.35 152.26 32.43 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.029 1.122 . . . . 2.3399999999999999 114.029 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.0 p -101.5 144.2 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.378 1.471 . . . . 0.83999999999999997 111.775 175.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.06 89.65 0.77 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.849 1.69 . . . . 0.76000000000000001 113.737 163.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 3.7 p -99.22 143.55 29.36 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 119.602 1.701 . . . . 1.54 112.156 168.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 62.9 p -114.73 23.98 12.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.214 -1.357 . . . . 1.0 111.84 174.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.53 -168.45 14.66 Favored Glycine 0 CA--C 1.503 -0.681 0 CA-C-O 124.098 1.943 . . . . 2.4399999999999999 114.025 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -37.21 139.02 0.53 Allowed Pre-proline 0 CA--C 1.549 0.924 0 CA-C-N 110.853 -2.674 . . . . 3.9700000000000002 111.453 151.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.98 -13.6 28.27 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.884 3.723 . . . . 3.02 116.913 -155.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -85.82 6.34 28.57 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.758 1.021 . . . . 2.52 113.758 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.33 82.22 0.76 Allowed Glycine 0 C--N 1.34 0.758 0 N-CA-C 110.114 -1.194 . . . . 1.8 110.114 -176.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.88 -64.51 1.16 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.635 0.731 . . . . 2.3100000000000001 111.346 178.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.428 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 34.4 p80 -100.56 -153.54 0.45 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.335 0.865 . . . . 1.74 113.335 -164.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.513 HG22 ' OE2' ' A' ' 136' ' ' GLU . 5.8 t -70.2 -154.32 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 123.606 0.762 . . . . 1.9099999999999999 109.355 161.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.2 tp -116.3 140.96 36.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 C-N-CA 127.072 2.149 . . . . 1.3400000000000001 109.827 168.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 13.6 mmm -126.35 159.42 33.26 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 114.099 1.148 . . . . 4.0999999999999996 114.099 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -125.09 67.25 1.12 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.025 0.75 . . . . 1.8500000000000001 113.025 -167.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.7 mt -87.67 157.86 18.98 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.254 -0.904 . . . . 0.67000000000000004 109.572 -165.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -127.43 77.58 75.65 Favored Pre-proline 0 N--CA 1.48 1.051 0 CA-C-N 119.753 1.161 . . . . 6.75 111.429 -166.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -89.23 33.96 0.37 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.522 3.482 . . . . 3.3599999999999999 116.318 -156.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -15.25 144.16 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.287 1 C-N-CA 133.234 4.614 . . . . 0.96999999999999997 117.527 -166.595 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.407 ' HB ' HD22 ' A' ' 143' ' ' LEU . 12.1 p -56.14 -32.79 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 120.491 -1.381 . . . . 0.93999999999999995 111.477 174.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -78.46 -11.25 59.94 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.543 1.937 . . . . 2.0800000000000001 114.456 174.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -143.19 -141.38 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.409 1.083 . . . . 1.98 111.284 -164.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.43 HG12 ' HG3' ' A' ' 142' ' ' LYS . 26.8 m -162.19 167.81 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 1 C-N-CA 134.029 4.932 . . . . 0.82999999999999996 106.504 -176.429 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -148.96 142.9 25.77 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.322 0.965 . . . . 0.66000000000000003 111.713 163.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -100.94 142.6 32.19 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.438 0.695 . . . . 5.4100000000000001 111.569 177.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 15.7 t -63.58 154.53 32.39 Favored 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 124.586 1.179 . . . . 1.1699999999999999 111.15 161.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 17.8 p-90 -100.56 -19.94 15.92 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.814 -1.084 . . . . 1.48 111.463 163.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.513 ' OE2' HG22 ' A' ' 120' ' ' THR . 3.8 mm-40 -81.5 -87.64 0.09 Allowed 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 107.555 -1.276 . . . . 1.79 107.555 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 27.4 p -72.1 -12.25 61.12 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 114.671 1.36 . . . . 1.1499999999999999 114.671 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.33 6.45 83.66 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.887 1.232 . . . . 1.24 114.688 168.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.5 p -69.28 137.43 53.04 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.051 1.74 . . . . 1.76 110.167 173.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 62.0 t -80.19 148.92 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 108.866 -0.79 . . . . 0.87 108.866 159.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -128.47 154.41 46.12 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 129.316 3.046 . . . . 1.8500000000000001 109.724 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.43 ' HG3' HG12 ' A' ' 131' ' ' VAL . 8.2 tmtt? -137.53 157.39 46.65 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.129 0.966 . . . . 2.5499999999999998 112.535 178.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.407 HD22 ' HB ' ' A' ' 128' ' ' VAL . 8.2 tt -111.39 146.5 37.04 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 123.136 1.446 . . . . 0.91000000000000003 112.185 -178.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -99.83 153.72 37.62 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 114.085 -1.416 . . . . 1.3400000000000001 113.585 -170.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.85 -4.85 15.59 Favored 'Trans proline' 0 C--N 1.348 0.535 1 C-N-CA 125.398 4.065 . . . . 1.46 114.984 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.9 p -43.5 142.56 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 126.766 2.027 . . . . 1.8999999999999999 112.086 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.832 0 CA-C-O 123.474 1.597 . . . . 1.53 112.494 -177.036 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 19.2 mtt . . . . . 0 C--O 1.224 -0.288 0 N-CA-C 118.69 2.848 . . . . 2.1099999999999999 118.69 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -61.72 2.11 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.541 0.941 . . . . 1.98 113.541 171.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.462 ' N ' ' HD3' ' A' ' 97' ' ' PRO . 0.0 OUTLIER 173.38 72.09 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 128.389 2.676 . . . . 4.5999999999999996 110.213 -150.129 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.462 ' HD3' ' N ' ' A' ' 96' ' ' ASP . 93.6 Cg_endo -96.48 -48.55 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 125.245 3.964 . . . . 0.93000000000000005 113.535 -175.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -158.55 145.51 8.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 1 C-N-CA 132.353 4.261 . . . . 0.57999999999999996 104.556 -167.326 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.5 mm -118.09 139.12 46.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 124.344 1.057 . . . . 0.59999999999999998 110.303 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.4 mm -128.39 147.18 32.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 127.067 2.147 . . . . 0.71999999999999997 106.877 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.565 ' HG2' HG11 ' A' ' 146' ' ' VAL . 83.1 mt-10 -109.64 170.15 8.25 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.579 1.152 . . . . 2.6800000000000002 110.913 177.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.2 t -159.2 -43.78 0.06 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.981 1.104 . . . . 3.3900000000000001 113.981 -176.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 65.61 37.88 5.69 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 124.515 1.135 . . . . 2.23 110.117 -171.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -143.14 -84.78 0.16 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.931 2.092 . . . . 3.29 108.855 172.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t70 175.3 -39.54 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 129.293 3.037 . . . . 3.8399999999999999 109.721 -177.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -116.61 -52.38 2.56 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.012 1.486 . . . . 2.8399999999999999 115.012 -167.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 7.39 -113.37 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 129.722 3.209 . . . . 5.0999999999999996 114.648 -162.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -163.17 160.5 24.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.084 1.354 . . . . 2.0800000000000001 111.848 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.8 p -112.39 137.56 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.214 1.406 . . . . 0.81999999999999995 109.791 166.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.08 87.45 0.45 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.215 1.388 . . . . 0.84999999999999998 111.915 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 7.9 p -97.74 146.34 25.46 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 123.721 1.725 . . . . 1.3200000000000001 112.999 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 56.9 p -112.2 15.62 20.39 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 112.85 -1.977 . . . . 0.80000000000000004 112.346 171.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.93 -130.54 8.08 Favored Glycine 0 C--N 1.337 0.596 0 O-C-N 120.939 -1.1 . . . . 3.1000000000000001 111.611 -171.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.56 -52.5 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 116.07 -1.919 . . . . 4.04 113.728 -171.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -80.26 52.8 4.47 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.307 2.005 . . . . 6.3700000000000001 109.598 166.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 66.88 99.04 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.231 1.812 . . . . 3.0499999999999998 114.331 168.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 63.91 31.27 80.26 Favored Glycine 0 N--CA 1.476 1.346 0 O-C-N 120.391 -1.443 . . . . 2.0099999999999998 113.514 173.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -45.49 90.84 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.246 1.418 . . . . 1.3999999999999999 112.458 -168.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.451 ' CE1' ' SD ' ' A' ' 122' ' ' MET . 34.3 p80 -108.18 -142.31 0.38 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.768 1.627 . . . . 1.49 111.439 177.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.558 HG22 ' OE2' ' A' ' 136' ' ' GLU . 10.7 t -89.13 -141.68 0.14 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.404 1.081 . . . . 0.84999999999999998 109.273 163.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.456 ' N ' HG23 ' A' ' 120' ' ' THR . 4.9 tp -122.07 132.88 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 128.545 2.738 . . . . 0.94999999999999996 116.603 173.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.467 ' SD ' ' HG3' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -127.69 149.02 50.4 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 129.462 3.105 . . . . 5.1100000000000003 112.814 -174.513 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -127.98 119.89 26.44 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.91 0.884 . . . . 1.7 110.267 -174.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.57 163.18 23.97 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.834 0.854 . . . . 0.92000000000000004 110.651 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -110.4 90.0 9.53 Favored Pre-proline 0 N--CA 1.483 1.215 0 C-N-CA 124.382 1.073 . . . . 5.9000000000000004 111.793 176.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -76.53 -45.13 0.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 CA-C-O 116.854 -1.394 . . . . 3.1499999999999999 112.866 -169.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 68.56 145.08 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 130.372 3.469 . . . . 1.1499999999999999 110.91 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.01 -40.34 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.759 0.79 . . . . 1.4199999999999999 109.919 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -66.74 -20.73 66.02 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 126.541 1.936 . . . . 2.02 113.336 172.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -135.36 -160.27 1.04 Allowed 'General case' 0 C--N 1.342 0.253 0 CA-C-N 120.583 1.538 . . . . 2.98 110.815 -164.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.2 m -147.44 155.95 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 127.699 2.4 . . . . 0.52000000000000002 107.834 176.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.6 137.23 33.52 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.242 0.617 . . . . 0.58999999999999997 111.33 170.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.2 ttp85 -98.14 138.48 35.37 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.868 0.304 . . . . 4.2400000000000002 110.774 172.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 49.6 t -61.37 156.38 19.16 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 123.045 1.402 . . . . 1.1000000000000001 111.465 160.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -98.78 -15.98 19.09 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.118 -1.401 . . . . 1.28 112.521 169.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.558 ' OE2' HG22 ' A' ' 120' ' ' THR . 0.1 OUTLIER -98.65 -85.03 0.39 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.091 2.156 . . . . 1.6200000000000001 109.787 -168.262 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 29.5 p -67.35 -19.71 65.47 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 120.823 1.647 . . . . 1.28 112.797 170.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.44 16.72 80.46 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.022 0.82 . . . . 0.70999999999999996 113.786 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.98 143.92 57.08 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 119.681 1.741 . . . . 1.9399999999999999 111.453 171.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 59.6 t -92.35 136.9 23.44 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 N-CA-C 105.656 -1.979 . . . . 0.58999999999999997 105.656 161.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -120.03 137.97 53.79 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 126.356 1.863 . . . . 1.74 109.209 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -106.12 150.56 25.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 123.542 0.527 . . . . 1.8700000000000001 110.103 164.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.696 HD23 ' H ' ' A' ' 144' ' ' ASN . 0.5 OUTLIER -85.7 -171.5 3.63 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 122.309 1.052 . . . . 2.25 108.88 158.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.696 ' H ' HD23 ' A' ' 143' ' ' LEU . 1.1 t-20 -143.93 169.09 10.97 Favored Pre-proline 0 C--N 1.318 -0.799 0 C-N-CA 126.767 2.027 . . . . 4.2599999999999998 109.709 -174.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -89.6 1.28 5.72 Favored 'Trans proline' 0 N--CA 1.46 -0.482 1 C-N-CA 125.466 4.11 . . . . 1.54 114.576 -165.595 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.565 HG11 ' HG2' ' A' ' 101' ' ' GLU . 8.5 p -40.78 142.58 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 1 C-N-CA 132.022 4.129 . . . . 2.3300000000000001 113.56 175.715 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.861 0 C-N-CA 128.101 2.762 . . . . 1.76 108.926 -166.982 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.2 mtm . . . . . 0 N--CA 1.467 0.385 0 N-CA-C 119.416 3.117 . . . . 2.0099999999999998 119.416 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.59 -62.17 1.55 Allowed 'General case' 0 C--N 1.316 -0.849 0 O-C-N 121.896 -0.502 . . . . 2.3100000000000001 111.43 167.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.415 ' N ' ' HD3' ' A' ' 97' ' ' PRO . 37.8 t70 168.02 66.54 0.01 OUTLIER Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 130.032 3.333 . . . . 2.73 108.659 -163.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 142' ' ' LYS . 51.5 Cg_endo -80.08 -71.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 1 C-N-CA 128.21 5.94 . . . . 1.0 113.562 -168.596 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.45 ' H ' ' HG2' ' A' ' 97' ' ' PRO . 0.6 OUTLIER -112.37 145.87 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 130.876 3.67 . . . . 0.64000000000000001 104.473 174.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.7 mm -106.74 143.19 17.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 124.016 0.927 . . . . 0.67000000000000004 111.044 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.9 mm -125.75 114.13 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 126.761 2.024 . . . . 0.60999999999999999 109.021 167.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -66.21 138.41 57.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.938 1.351 . . . . 3.71 112.249 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.4 t -160.63 118.1 2.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.097 -0.956 . . . . 3.1099999999999999 111.723 -169.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -87.74 10.0 19.77 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 118.44 0.564 . . . . 2.3900000000000001 112.088 167.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -105.66 -60.26 1.65 Allowed 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.755 1.622 . . . . 3.0699999999999998 113.162 -172.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.579 ' OD1' HG12 ' A' ' 128' ' ' VAL . 23.7 t0 119.92 -48.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 1 C-N-CA 133.55 4.74 . . . . 4.2300000000000004 109.01 -167.511 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.85 -3.59 59.08 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 119.906 -1.746 . . . . 2.23 113.629 -168.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -52.25 121.75 7.44 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.846 1.658 . . . . 4.0999999999999996 113.102 -163.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -82.36 164.23 21.2 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 114.555 1.317 . . . . 2.0 114.555 -168.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.8 t -97.98 137.43 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.543 1.937 . . . . 2.1200000000000001 112.093 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -115.27 69.35 0.26 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.952 1.263 . . . . 1.1699999999999999 111.995 164.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 4.2 t -82.53 133.92 35.19 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.994 0.918 . . . . 0.95999999999999996 111.679 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 57.3 p -113.18 25.95 10.9 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.495 1.118 . . . . 0.85999999999999999 113.636 168.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.43 66.57 1.46 Allowed Glycine 0 N--CA 1.462 0.431 0 O-C-N 120.822 -1.174 . . . . 2.3999999999999999 110.793 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 68.73 174.03 0.08 OUTLIER Pre-proline 0 CA--C 1.563 1.442 0 C-N-CA 123.464 0.705 . . . . 2.9300000000000002 110.856 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.7 -8.71 22.89 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 121.881 1.72 . . . . 2.1800000000000002 114.704 -169.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.56 4.73 46.0 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.355 1.243 . . . . 2.02 114.355 -173.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.73 81.37 0.37 Allowed Glycine 0 N--CA 1.471 1.006 0 C-N-CA 125.12 1.343 . . . . 1.6599999999999999 112.465 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.6 m -102.33 -35.91 8.65 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.413 1.264 . . . . 1.4199999999999999 114.413 -174.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.439 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 6.6 p80 -122.98 -153.71 0.57 Allowed 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.611 -0.681 . . . . 1.3600000000000001 111.935 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.746 HG22 ' OE1' ' A' ' 136' ' ' GLU . 5.5 t -72.25 -154.51 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 119.423 1.01 . . . . 1.0700000000000001 111.415 168.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.3 tp -108.96 146.81 14.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 126.711 2.004 . . . . 1.01 109.816 163.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.613 ' SD ' HD21 ' A' ' 124' ' ' LEU . 4.7 ppp? -154.76 163.5 40.16 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.189 0.811 . . . . 3.7599999999999998 113.189 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.409 ' O ' HD23 ' A' ' 124' ' ' LEU . 5.6 m95 -127.8 126.92 42.63 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.601 0.963 . . . . 1.51 113.601 -162.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.613 HD21 ' SD ' ' A' ' 122' ' ' MET . 5.6 mt -131.92 158.35 41.62 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.553 1.141 . . . . 0.72999999999999998 111.535 -174.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.43 83.1 16.07 Favored Pre-proline 0 CA--C 1.561 1.399 0 C-N-CA 125.976 1.71 . . . . 6.0700000000000003 112.272 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -82.35 27.01 0.61 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.936 3.757 . . . . 3.27 115.704 -165.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.447 HG22 ' OD1' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -20.32 148.84 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 1 C-N-CA 133.169 4.588 . . . . 1.0 116.901 -163.479 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.579 HG12 ' OD1' ' A' ' 105' ' ' ASP . 5.0 p -59.15 -32.75 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 O-C-N 120.418 -1.426 . . . . 0.82999999999999996 111.124 175.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -73.35 -12.27 60.77 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 128.407 2.683 . . . . 2.21 113.977 174.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.418 ' HB3' ' H ' ' A' ' 131' ' ' VAL . 31.5 mt-10 -144.61 -146.66 0.19 Allowed 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 123.761 0.824 . . . . 2.25 111.561 -161.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.466 HG12 ' HG3' ' A' ' 142' ' ' LYS . 32.0 m -159.32 170.79 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.67 1 C-N-CA 134.29 5.036 . . . . 0.81000000000000005 106.133 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -146.6 143.6 28.95 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.32 -0.862 . . . . 0.51000000000000001 112.21 164.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.403 ' HG3' HG22 ' A' ' 140' ' ' VAL . 14.3 ttm-85 -100.55 136.66 40.08 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.632 1.573 . . . . 5.6299999999999999 110.045 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.475 ' HA ' ' HE1' ' A' ' 122' ' ' MET . 52.3 t -68.29 167.32 14.66 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 122.475 1.131 . . . . 1.1299999999999999 112.945 161.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 46.5 p-90 -122.46 -12.24 8.21 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.449 1.5 . . . . 1.29 112.155 171.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.746 ' OE1' HG22 ' A' ' 120' ' ' THR . 4.1 mm-40 -94.93 -61.73 1.44 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.685 0.794 . . . . 2.02 110.624 -174.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 29.9 p -95.12 -15.77 23.11 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.961 1.304 . . . . 1.0800000000000001 112.63 166.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.43 16.76 78.83 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 120.896 -1.127 . . . . 0.93000000000000005 114.341 174.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.7 p -68.32 126.73 30.5 Favored 'General case' 0 C--N 1.335 -0.041 0 CA-C-N 119.76 1.78 . . . . 1.5800000000000001 109.642 173.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.403 HG22 ' HG3' ' A' ' 133' ' ' ARG . 46.2 t -75.73 147.03 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 119.657 -0.817 . . . . 0.67000000000000004 109.079 161.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -128.0 152.71 47.59 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 130.097 3.359 . . . . 2.1000000000000001 110.41 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.492 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 9.6 tmtt? -140.4 157.74 45.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 122.257 1.027 . . . . 2.48 113.203 174.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.3 tt -114.39 143.67 44.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 122.763 1.268 . . . . 0.89000000000000001 113.085 -175.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -98.75 155.82 36.28 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-N 114.18 -1.373 . . . . 1.3 112.046 -170.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.1 -4.02 14.59 Favored 'Trans proline' 0 C--N 1.352 0.753 1 C-N-CA 125.904 4.403 . . . . 1.51 115.428 -174.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.3 p -40.94 148.61 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 128.433 2.693 . . . . 2.0099999999999998 113.736 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.545 0 O-C-N 120.809 -1.182 . . . . 1.5700000000000001 110.722 175.494 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.4 mtm . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 118.229 2.678 . . . . 2.0099999999999998 118.229 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.23 -123.9 0.06 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.741 1.258 . . . . 2.5899999999999999 108.363 157.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -120.61 90.02 45.4 Favored Pre-proline 0 N--CA 1.433 -1.304 0 C-N-CA 129.222 3.009 . . . . 2.48 107.658 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -90.45 -42.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.26 1 C-N-CA 127.174 5.249 . . . . 1.03 112.352 -178.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 mm -155.68 140.16 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 130.462 3.505 . . . . 0.96999999999999997 104.341 -168.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.2 mm -108.22 136.27 44.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 124.68 1.192 . . . . 0.76000000000000001 109.48 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.7 mm -130.7 112.28 22.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 127.836 2.454 . . . . 0.70999999999999996 107.043 176.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -64.94 172.85 2.62 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 125.432 1.707 . . . . 3.1800000000000002 110.345 171.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 98.7 p -157.84 -57.17 0.08 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.039 -0.982 . . . . 2.9900000000000002 113.471 -166.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.6 ' CD1' HG23 ' A' ' 146' ' ' VAL . 12.7 m-85 64.27 27.0 13.81 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 126.742 2.017 . . . . 3.0499999999999998 110.825 -165.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -169.05 160.68 10.08 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 129.489 3.115 . . . . 3.6699999999999999 110.409 -174.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -83.3 3.94 29.29 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 115.422 1.638 . . . . 2.9700000000000002 115.422 -171.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -162.5 35.28 0.11 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 114.781 1.401 . . . . 2.0899999999999999 114.781 -158.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -79.99 -164.99 0.75 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.043 1.337 . . . . 5.5999999999999996 113.465 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -140.73 157.88 44.78 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.245 1.202 . . . . 2.02 114.245 -172.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.1 p -120.22 149.22 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.989 2.116 . . . . 1.0800000000000001 110.916 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.52 122.01 5.22 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 118.964 -0.909 . . . . 0.76000000000000001 112.88 157.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 15.0 p -114.32 152.48 31.35 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 123.191 1.472 . . . . 1.0700000000000001 113.679 169.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 120' ' ' THR . 50.2 p -107.15 38.85 2.01 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 113.247 -1.797 . . . . 1.0 111.629 170.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.421 ' HA2' ' CD2' ' A' ' 119' ' ' HIS . . . 98.13 22.55 14.89 Favored Glycine 0 C--O 1.226 -0.356 0 CA-C-O 118.802 -0.999 . . . . 1.8100000000000001 113.969 -177.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.425 ' HB2' ' HD2' ' A' ' 115' ' ' PRO . 5.8 p 89.24 175.09 0.04 OUTLIER Pre-proline 0 N--CA 1.483 1.22 0 C-N-CA 127.409 2.284 . . . . 2.6800000000000002 109.844 -151.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 114' ' ' SER . 17.8 Cg_endo -60.53 -19.85 61.45 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.08 2.52 . . . . 2.8999999999999999 114.617 167.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -84.67 52.7 2.46 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.564 1.074 . . . . 3.7599999999999998 112.324 178.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 38.44 59.14 1.61 Allowed Glycine 0 N--CA 1.472 1.076 0 C-N-CA 126.171 1.844 . . . . 2.6400000000000001 116.022 154.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.401 ' HB2' ' HA3' ' A' ' 113' ' ' GLY . 13.7 m -115.12 -19.47 10.84 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.605 1.335 . . . . 1.78 114.605 -166.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.541 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 14.0 p80 -148.03 -158.81 0.95 Allowed 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 120.374 1.443 . . . . 1.72 114.151 171.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.624 HG22 ' OE2' ' A' ' 136' ' ' GLU . 5.2 t -66.09 -164.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.06 1.344 . . . . 0.81999999999999995 111.193 169.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.9 tp -103.06 145.36 12.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 O-C-N 120.454 -1.403 . . . . 1.1000000000000001 110.625 165.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.607 ' SD ' HD21 ' A' ' 124' ' ' LEU . 3.4 ppp? -150.66 172.71 15.12 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.081 1.752 . . . . 3.6000000000000001 110.277 176.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -138.98 128.96 25.1 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.311 0.856 . . . . 1.8999999999999999 113.311 -169.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.607 HD21 ' SD ' ' A' ' 122' ' ' MET . 5.8 mt -126.0 153.08 44.87 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.989 0.916 . . . . 0.81999999999999995 110.822 -171.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -124.39 101.22 34.52 Favored Pre-proline 0 N--CA 1.477 0.878 0 CA-C-O 118.219 -0.895 . . . . 5.0599999999999996 112.434 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -80.82 169.59 16.39 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.603 2.202 . . . . 2.3500000000000001 110.223 162.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -123.88 156.09 36.89 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.939 2.096 . . . . 1.26 107.886 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.6 p -51.16 -35.9 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 O-C-N 120.582 -1.324 . . . . 1.0600000000000001 113.862 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -89.34 -1.83 58.21 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.176 1.176 . . . . 1.72 114.176 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -145.03 176.3 9.6 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 123.109 1.433 . . . . 2.7000000000000002 114.472 -158.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.45 HG12 ' HG3' ' A' ' 142' ' ' LYS . 18.6 m -125.07 154.57 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 128.408 2.683 . . . . 0.57999999999999996 109.648 -172.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -132.79 139.41 47.51 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.55 1.14 . . . . 0.59999999999999998 110.674 173.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.1 ttp-105 -111.95 142.89 43.79 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.358 0.526 . . . . 4.6399999999999997 111.7 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 42.2 t -60.64 157.57 14.25 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 122.77 1.271 . . . . 0.97999999999999998 113.431 167.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.442 ' H ' ' HE1' ' A' ' 122' ' ' MET . 49.7 p-90 -107.44 -14.29 14.89 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.005 1.322 . . . . 1.3300000000000001 112.055 168.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.624 ' OE2' HG22 ' A' ' 120' ' ' THR . 0.1 OUTLIER -92.29 -67.85 0.83 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.726 1.21 . . . . 1.6899999999999999 110.376 -175.785 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 26.6 p -91.19 -12.71 34.55 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 126.338 1.855 . . . . 1.0800000000000001 114.095 172.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.43 12.51 69.75 Favored Glycine 0 CA--C 1.532 1.108 0 O-C-N 121.069 -1.019 . . . . 0.72999999999999998 115.267 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.4 p -73.31 134.86 44.29 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.86 2.33 . . . . 1.55 111.394 174.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.2 t -75.84 150.18 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 109.922 -0.399 . . . . 0.67000000000000004 109.922 165.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -138.59 142.17 39.19 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 130.49 3.516 . . . . 2.2200000000000002 109.073 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.45 ' HG3' HG12 ' A' ' 131' ' ' VAL . 1.6 tmtt? -127.75 153.38 46.61 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 113.224 0.824 . . . . 2.3300000000000001 113.224 -174.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.14 137.58 34.01 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.465 0.542 . . . . 1.1499999999999999 112.465 176.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 37.2 p-10 -105.31 150.18 38.59 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 108.416 -0.957 . . . . 1.29 108.416 166.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.43 -31.5 21.88 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.038 2.492 . . . . 2.3500000000000001 113.294 -172.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.6 HG23 ' CD1' ' A' ' 103' ' ' TYR 0.266 3.5 m 47.05 -165.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 129.54 3.136 . . . . 2.8399999999999999 116.85 -179.369 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.616 0 C-N-CA 125.414 1.483 . . . . 2.2799999999999998 111.614 168.217 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 9.4 mtm . . . . . 0 C--O 1.224 -0.269 0 N-CA-C 119.198 3.036 . . . . 2.0499999999999998 119.198 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -62.12 1.77 Allowed 'General case' 0 C--N 1.32 -0.699 0 O-C-N 121.993 -0.442 . . . . 2.1400000000000001 112.143 166.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.3 t70 165.43 73.1 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 128.571 2.749 . . . . 2.5299999999999998 110.486 -157.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -87.28 -98.18 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.695 1 C-N-CA 126.863 5.042 . . . . 1.5700000000000001 113.746 -168.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -87.81 147.88 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 C-N-CA 126.948 2.099 . . . . 0.80000000000000004 106.582 170.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 21.1 mm -110.26 140.31 29.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 123.423 0.689 . . . . 0.93999999999999995 112.544 -170.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.6 mm -127.74 124.11 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 127.373 2.269 . . . . 0.68999999999999995 109.161 173.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.66 146.5 32.44 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.729 1.212 . . . . 2.6099999999999999 111.463 174.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.1 t -151.43 -50.55 0.12 Allowed 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 117.153 2.279 . . . . 2.5099999999999998 117.153 -168.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 77.62 -11.24 1.23 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 116.644 2.09 . . . . 2.6400000000000001 116.644 176.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.22 21.43 6.72 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 127.228 2.211 . . . . 2.71 111.475 -174.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 63.53 -16.18 0.07 Allowed 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 119.251 3.056 . . . . 3.2400000000000002 119.251 174.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -129.56 -68.21 0.73 Allowed 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 122.287 2.312 . . . . 3.0800000000000001 114.952 -179.637 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 58.77 -168.79 0.14 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.081 1.752 . . . . 3.9100000000000001 113.521 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -119.5 163.2 17.63 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.048 -1.032 . . . . 2.1200000000000001 109.992 150.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.8 p -116.43 137.76 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.397 1.079 . . . . 0.71999999999999997 110.514 169.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -117.03 112.72 2.57 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.042 0.829 . . . . 0.80000000000000004 111.316 168.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.608 ' H ' ' HE2' ' A' ' 122' ' ' MET . 0.8 OUTLIER -117.01 155.8 28.57 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.171 1.788 . . . . 0.88 113.447 173.242 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.9 p -125.16 16.71 8.43 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.958 1.303 . . . . 0.83999999999999997 114.054 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.74 70.21 1.18 Allowed Glycine 0 C--N 1.335 0.506 0 O-C-N 120.91 -1.119 . . . . 2.73 110.557 -177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 70.06 176.43 0.07 OUTLIER Pre-proline 0 CA--C 1.561 1.366 0 CA-C-O 118.373 -0.822 . . . . 3.0699999999999998 110.789 -176.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.99 -5.68 17.38 Favored 'Trans proline' 0 C--N 1.353 0.802 0 CA-C-N 122.353 1.876 . . . . 2.8199999999999998 114.781 -167.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.15 -6.77 19.55 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 115.245 1.572 . . . . 2.8700000000000001 115.245 -174.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.57 100.43 0.22 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.182 0.896 . . . . 1.8700000000000001 111.765 -173.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.6 m -105.79 -34.52 7.65 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.65 0.981 . . . . 1.6599999999999999 113.65 173.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -116.67 -153.59 0.53 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.67 0.788 . . . . 1.3300000000000001 111.829 174.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.734 HG22 ' OE2' ' A' ' 136' ' ' GLU . 5.3 t -74.86 -147.23 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.479 0.712 . . . . 0.97999999999999998 110.67 166.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.461 ' N ' HG23 ' A' ' 120' ' ' THR . 2.9 tt -117.27 149.21 19.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 126.778 2.031 . . . . 1.4299999999999999 111.363 166.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.608 ' HE2' ' H ' ' A' ' 111' ' ' CYS . 0.0 OUTLIER -133.65 171.82 13.59 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.871 1.668 . . . . 4.6399999999999997 109.714 169.868 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -137.06 123.53 20.83 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.64 0.776 . . . . 5.0700000000000003 109.827 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.451 HD21 ' SD ' ' A' ' 122' ' ' MET . 2.2 mt -120.81 160.96 22.33 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 118.939 0.791 . . . . 0.97999999999999998 111.406 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.45 99.8 26.42 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 123.093 0.557 . . . . 5.9900000000000002 109.525 166.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -76.23 179.08 6.71 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 N-CA-C 107.528 -1.758 . . . . 2.46 107.528 159.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 106' ' ' TYR . 24.9 m -159.11 156.1 28.48 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 105.726 -1.953 . . . . 1.0800000000000001 105.726 172.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.7 p -52.35 -39.92 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 124.213 1.005 . . . . 0.87 112.494 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -82.03 0.66 39.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.82 1.648 . . . . 1.6799999999999999 114.192 176.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -143.1 -176.92 5.11 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 122.214 1.007 . . . . 2.23 113.016 -159.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.5 m -146.4 155.35 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 127.342 2.257 . . . . 0.64000000000000001 109.579 -173.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -141.7 128.55 20.56 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.648 0.779 . . . . 0.67000000000000004 112.05 -175.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.4 ttp-105 -101.45 132.45 47.04 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.191 0.905 . . . . 4.6299999999999999 112.85 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -18.91 62.2 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 117.622 2.452 . . . . 3.5699999999999998 117.622 -164.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 13.8 p-90 59.0 -20.16 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 128.394 2.678 . . . . 1.22 115.74 -173.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.734 ' OE2' HG22 ' A' ' 120' ' ' THR . 3.9 mm-40 -94.43 -87.73 0.25 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 120.434 1.47 . . . . 2.75 110.341 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 30.5 p -62.88 -18.16 62.6 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.137 0.975 . . . . 1.3700000000000001 111.934 166.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 58.14 38.69 90.52 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 124.815 1.197 . . . . 1.1000000000000001 111.566 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . 0.263 0.1 OUTLIER -63.77 159.04 20.23 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 117.427 -1.709 . . . . 1.8999999999999999 109.377 155.603 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.2 t -114.15 136.44 50.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 104.074 -2.565 . . . . 0.68000000000000005 104.074 160.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -115.08 140.3 49.18 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.86 1.664 . . . . 1.75 110.224 -176.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -104.39 156.1 18.22 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 122.662 1.22 . . . . 2.1699999999999999 111.621 164.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.8 tt -100.22 154.51 18.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 112.922 -1.945 . . . . 0.93000000000000005 110.237 157.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -109.61 156.52 39.5 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.126 0.97 . . . . 1.28 113.269 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.73 -2.49 10.24 Favored 'Trans proline' 0 N--CA 1.485 0.976 1 C-N-CA 126.413 4.742 . . . . 1.55 115.877 -175.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.9 p -43.88 152.36 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 128.288 2.635 . . . . 1.8799999999999999 113.049 177.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.896 0 C-N-CA 126.095 1.807 . . . . 1.6100000000000001 110.644 176.876 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 11.4 mtp . . . . . 0 CA--C 1.518 -0.254 0 CA-C-O 123.928 1.823 . . . . 3.4500000000000002 113.523 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.7 -76.46 0.19 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.033 -1.894 . . . . 2.1299999999999999 109.62 173.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -174.12 72.39 0.34 Allowed Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 127.126 2.171 . . . . 2.5299999999999998 108.903 -168.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -88.31 -48.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.496 1 C-N-CA 127.276 5.317 . . . . 0.71999999999999997 114.258 -170.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -140.96 147.76 22.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 129.938 3.295 . . . . 0.71999999999999997 105.083 -175.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.5 mm -109.92 136.6 45.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 123.033 0.533 . . . . 0.69999999999999996 111.341 -176.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 51.4 mm -119.1 119.51 61.07 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 126.217 1.807 . . . . 0.93000000000000005 107.479 165.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -77.31 120.79 22.83 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 124.531 1.144 . . . . 3.4100000000000001 109.559 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.7 t -125.09 -51.7 1.66 Allowed 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 116.297 1.962 . . . . 2.1899999999999999 116.297 -164.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 64.01 14.29 8.35 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 122.132 2.242 . . . . 3.3900000000000001 111.924 -177.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -161.23 142.62 11.64 Favored 'General case' 0 CA--C 1.549 0.914 1 C-N-CA 132.312 4.245 . . . . 2.3999999999999999 106.331 -161.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.686 ' OD1' HG12 ' A' ' 128' ' ' VAL . 48.3 t0 -95.77 14.07 24.46 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 126.113 1.765 . . . . 4.9500000000000002 113.337 -177.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -153.26 12.89 0.49 Allowed 'General case' 0 N--CA 1.485 1.288 0 O-C-N 118.926 -2.359 . . . . 2.77 114.599 -156.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -72.47 159.34 34.11 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.291 0.848 . . . . 4.5899999999999999 113.291 -177.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -95.6 163.36 13.24 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.965 0.728 . . . . 2.3100000000000001 112.965 163.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 p -129.33 148.09 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 127.767 2.427 . . . . 1.1399999999999999 111.102 173.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -100.95 108.78 3.52 Favored Glycine 0 CA--C 1.539 1.533 0 CA-C-O 118.756 -1.025 . . . . 1.05 113.631 166.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 9.1 t -108.21 139.62 42.62 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.63 1.572 . . . . 1.1799999999999999 113.984 171.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 12.3 p -113.71 6.84 17.0 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 117.9 2.556 . . . . 1.0700000000000001 117.9 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.01 -23.05 22.64 Favored Glycine 0 N--CA 1.48 1.571 0 O-C-N 119.955 -1.716 . . . . 2.25 113.058 -176.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.2 t 173.52 151.93 0.24 Allowed Pre-proline 0 C--O 1.24 0.553 0 C-N-CA 127.754 2.422 . . . . 4.5199999999999996 108.228 -166.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -60.33 -23.56 74.88 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.656 2.238 . . . . 3.2599999999999998 112.369 168.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.28 9.56 25.47 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.397 1.079 . . . . 3.1600000000000001 113.73 174.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 73.75 62.67 2.94 Favored Glycine 0 C--N 1.343 0.944 0 C-N-CA 124.024 0.821 . . . . 2.27 113.66 170.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 30.7 m -71.94 -34.52 69.1 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.971 1.471 . . . . 1.7 114.971 -172.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -107.34 -49.94 3.17 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.006 1.854 . . . . 2.8300000000000001 116.006 176.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.7 t 156.77 -159.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 1 C-N-CA 133.185 4.594 . . . . 0.92000000000000004 105.573 -158.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.8 tp -120.08 140.74 43.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 127.584 2.353 . . . . 1.5 111.366 169.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.472 ' CE ' ' HE1' ' A' ' 135' ' ' TRP . 1.2 mmm -137.6 152.38 49.33 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 114.824 1.416 . . . . 4.6500000000000004 114.824 -176.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -110.9 99.98 8.78 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 113.898 -1.501 . . . . 1.8700000000000001 110.72 -171.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 134' ' ' CYS . 2.0 mt -106.77 169.75 8.35 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.512 -0.921 . . . . 1.3700000000000001 108.512 -173.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -151.55 100.6 2.94 Favored Pre-proline 0 N--CA 1.472 0.65 0 CA-C-N 119.192 0.905 . . . . 5.6799999999999997 111.607 178.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.88 173.97 10.65 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.252 2.635 . . . . 2.2799999999999998 110.503 170.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.85 144.26 45.54 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.297 2.239 . . . . 1.8100000000000001 107.572 -170.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.686 HG12 ' OD1' ' A' ' 105' ' ' ASP . 7.7 p -60.79 -34.03 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 120.725 -1.235 . . . . 1.02 111.741 -174.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -64.46 -21.02 66.53 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.677 1.991 . . . . 2.3199999999999998 112.922 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -161.6 -137.23 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.109 1.364 . . . . 2.5899999999999999 111.42 -156.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.3 m -156.37 170.31 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 126.884 2.074 . . . . 0.60999999999999999 110.405 -158.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -139.47 143.01 37.34 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.098 0.959 . . . . 0.64000000000000001 110.595 166.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 140' ' ' VAL . 28.3 ttt-85 -95.61 140.38 30.53 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 105.132 -2.173 . . . . 5.0099999999999998 105.132 167.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' ' 136' ' ' GLU . 17.9 t -52.08 131.86 32.36 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 124.302 1.001 . . . . 1.1799999999999999 110.009 152.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.472 ' HE1' ' CE ' ' A' ' 122' ' ' MET . 20.0 p-90 -65.61 -20.52 66.35 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.184 -0.948 . . . . 1.8999999999999999 110.637 168.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.416 ' HB2' ' SG ' ' A' ' 134' ' ' CYS . 0.6 OUTLIER -88.05 -108.57 0.07 Allowed 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 126.63 1.972 . . . . 3.1099999999999999 109.173 -172.562 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.8 p -53.01 -58.77 5.85 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.899 2.48 . . . . 1.73 111.939 -170.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 117.7 21.12 4.38 Favored Glycine 0 C--N 1.331 0.258 0 CA-C-N 113.106 -1.861 . . . . 1.5900000000000001 116.478 -166.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.2 p -71.72 101.81 2.66 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 119.142 1.471 . . . . 1.79 107.549 156.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 133' ' ' ARG . 47.1 t -62.7 145.22 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 108.475 -0.935 . . . . 0.69999999999999996 108.475 155.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -124.48 156.41 37.29 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 130.355 3.462 . . . . 2.3199999999999998 111.318 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.2 tttm -119.59 155.38 32.37 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 123.876 1.798 . . . . 2.3999999999999999 113.605 169.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.67 146.42 24.51 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 111.936 -2.393 . . . . 1.3600000000000001 110.265 158.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -101.76 155.81 35.96 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 113.842 1.052 . . . . 1.54 113.842 176.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.97 -7.34 21.2 Favored 'Trans proline' 0 C--N 1.353 0.815 1 C-N-CA 125.979 4.453 . . . . 2.2999999999999998 115.788 178.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.9 p -35.54 140.54 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 128.857 2.863 . . . . 2.2999999999999998 113.145 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.706 0 C-N-CA 125.103 1.335 . . . . 3.0699999999999998 111.306 -171.955 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 46.2 mtp . . . . . 0 C--O 1.218 -0.553 0 N-CA-C 105.194 -2.15 . . . . 2.8900000000000001 105.194 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 4.27 -76.18 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 128.734 2.814 . . . . 3.3999999999999999 116.758 167.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 46.4 t0 177.84 84.68 0.14 Allowed Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 129.706 3.203 . . . . 2.2200000000000002 108.687 -166.352 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -96.99 -43.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 1 C-N-CA 126.93 5.087 . . . . 0.93999999999999995 113.168 -178.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 mm -154.35 140.51 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 128.494 2.718 . . . . 0.70999999999999996 106.454 -168.568 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.424 HG23 ' ND2' ' A' ' 144' ' ' ASN . 14.4 mm -115.8 129.15 72.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 125.806 1.643 . . . . 1.02 110.964 -172.652 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.6 mm -127.11 112.9 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 126.688 1.995 . . . . 0.89000000000000001 109.532 -173.668 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -71.34 131.15 42.99 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.16 0.984 . . . . 2.73 110.776 -177.061 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.0 p -132.3 -56.77 0.96 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 115.533 1.679 . . . . 3.3399999999999999 115.533 -153.172 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 73.41 -18.79 0.36 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 127.334 2.253 . . . . 3.21 114.973 173.767 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -125.11 145.46 49.93 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.503 2.321 . . . . 3.04 107.901 161.608 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.63 4.25 2.0 Allowed 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 116.777 2.14 . . . . 3.3300000000000001 116.777 -160.905 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -147.16 24.53 1.15 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 126.134 1.774 . . . . 2.21 114.551 -175.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.13 135.77 31.03 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 120.792 -1.192 . . . . 4.2800000000000002 112.49 173.877 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -67.79 163.14 22.39 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.586 0.588 . . . . 2.1899999999999999 112.586 173.139 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.69 142.64 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.16 1.384 . . . . 1.1299999999999999 111.015 172.118 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.48 128.36 7.68 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.034 0.826 . . . . 1.53 112.923 168.031 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.84 153.98 50.78 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.38 1.872 . . . . 1.45 114.78 171.197 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.6 p -111.47 14.62 21.43 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 116.219 1.933 . . . . 1.01 116.219 173.289 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.452 ' HA3' ' OG ' ' A' ' 118' ' ' SER . . . 122.85 -32.7 4.33 Favored Glycine 0 C--O 1.222 -0.616 0 C-N-CA 124.626 1.108 . . . . 2.29 113.622 -172.529 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.1 t 137.55 148.43 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 106.516 -1.661 . . . . 3.0699999999999998 106.516 -120.819 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.23 48.16 1.72 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 124.745 3.63 . . . . 2.46 113.72 -177.585 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -156.37 27.35 0.35 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.765 1.024 . . . . 2.4900000000000002 113.765 -163.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 61.53 22.44 61.51 Favored Glycine 0 N--CA 1.475 1.295 0 N-CA-C 115.831 1.092 . . . . 2.8700000000000001 115.831 167.191 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.452 ' OG ' ' HA3' ' A' ' 113' ' ' GLY . 57.7 p -60.15 -50.98 71.52 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.416 1.108 . . . . 3.0099999999999998 112.835 -158.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -102.76 -63.62 1.15 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.765 0.426 . . . . 2.6499999999999999 110.353 -178.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.654 HG22 ' OE2' ' A' ' 136' ' ' GLU . 5.4 t -179.51 -159.46 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.476 1 C-N-CA 132.79 4.436 . . . . 0.94999999999999996 106.849 178.346 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.0 tp -104.85 145.73 12.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 C-N-CA 125.855 1.662 . . . . 1.1399999999999999 110.056 167.596 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.52 175.71 9.19 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.756 1.622 . . . . 5.0899999999999999 110.236 172.354 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -136.58 126.34 25.6 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 118.562 -0.732 . . . . 2.3900000000000001 110.266 171.084 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 mt -115.77 155.48 27.74 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.797 1.181 . . . . 1.01 112.054 177.574 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.83 101.37 20.53 Favored Pre-proline 0 N--CA 1.477 0.896 0 O-C-N 121.818 -0.551 . . . . 5.6200000000000001 110.862 172.599 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -82.96 178.28 6.08 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.447 2.098 . . . . 2.75 108.942 157.236 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.8 m -144.25 158.18 43.88 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.234 2.214 . . . . 1.05 105.118 171.494 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.0 p -58.51 -32.34 45.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-N 119.403 1.002 . . . . 0.71999999999999997 111.287 176.574 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -76.18 -5.28 46.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 128.053 2.541 . . . . 1.6399999999999999 114.637 174.243 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -145.09 -170.62 3.47 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.865 0.84 . . . . 2.3799999999999999 113.051 -159.013 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 19.3 m -147.23 156.92 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 128.239 2.616 . . . . 0.65000000000000002 108.273 -175.112 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -139.72 126.92 21.18 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.806 0.843 . . . . 0.68999999999999995 111.897 -179.094 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -99.16 134.76 41.54 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.441 0.564 . . . . 3.79 111.784 178.544 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 36.4 t -58.1 141.07 51.33 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 124.361 1.038 . . . . 0.95999999999999996 110.941 165.188 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 58.7 p-90 -91.34 -10.49 41.08 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.924 -0.58 . . . . 1.8400000000000001 112.083 168.636 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.654 ' OE2' HG22 ' A' ' 120' ' ' THR . 3.4 mm-40 -100.59 -65.63 0.96 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.262 0.625 . . . . 2.0800000000000001 111.447 -169.876 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 7.7 p -79.6 -41.95 26.01 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 118.922 0.783 . . . . 1.74 111.059 169.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 106.45 12.04 25.86 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.214 1.388 . . . . 1.1000000000000001 115.652 -178.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.9 p -80.28 137.01 36.55 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.968 1.884 . . . . 1.6399999999999999 111.179 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.38 150.45 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 118.966 0.803 . . . . 1.05 110.296 164.541 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -133.81 143.92 48.67 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 129.781 3.233 . . . . 2.04 109.723 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 54.4 tttt -117.84 153.01 34.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.284 1.04 . . . . 2.23 112.372 178.136 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.1 tt -97.89 143.68 28.24 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.502 -1.226 . . . . 0.93999999999999995 111.692 165.298 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.424 ' ND2' HG23 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -106.47 156.52 36.88 Favored Pre-proline 0 CA--C 1.549 0.91 0 CA-C-N 114.321 -1.308 . . . . 3.0099999999999998 110.483 -173.092 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.19 -8.96 24.58 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 124.558 3.505 . . . . 1.3300000000000001 114.509 -176.42 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.4 p -40.45 142.38 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 128.028 2.531 . . . . 2.0099999999999998 114.316 -177.307 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.476 0 C-N-CA 126.75 2.119 . . . . 2.0600000000000001 107.816 165.378 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 7.2 mtm . . . . . 0 N--CA 1.465 0.309 0 N-CA-C 119.438 3.125 . . . . 0.0 119.438 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -61.86 1.67 Allowed 'General case' 0 C--N 1.317 -0.811 0 O-C-N 121.792 -0.567 . . . . 0.0 112.098 167.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.8 t70 167.65 74.52 0.01 OUTLIER Pre-proline 0 CA--C 1.56 1.363 0 C-N-CA 129.581 3.152 . . . . 0.0 109.393 -155.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -92.12 -51.24 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.423 1 C-N-CA 126.842 5.028 . . . . 0.0 114.896 -170.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 mm -149.22 143.28 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 131.579 3.952 . . . . 0.0 104.221 -169.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.4 mm -113.73 131.69 64.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 124.056 0.943 . . . . 0.0 109.986 -177.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.0 mm -116.31 111.31 34.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 174.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.505 ' HA ' HD21 ' A' ' 144' ' ' ASN . 8.9 tt0 -76.82 116.31 17.37 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.855 1.262 . . . . 0.0 110.148 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.1 t -108.16 -67.83 0.94 Allowed 'General case' 0 C--O 1.225 -0.224 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -158.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.498 ' CE1' HG22 ' A' ' 146' ' ' VAL . 60.1 m-85 75.79 -3.9 2.48 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 126.438 1.895 . . . . 0.0 113.594 -169.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -114.21 152.33 31.4 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 128.066 2.546 . . . . 0.0 109.564 159.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -72.34 -14.6 61.77 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 120.265 -1.522 . . . . 0.0 114.767 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -134.04 6.49 3.64 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.167 -1.583 . . . . 0.0 114.248 -158.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -61.96 154.82 25.34 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.377 1.871 . . . . 0.0 115.327 -166.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -77.09 171.63 14.51 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.622 1.569 . . . . 0.0 114.195 173.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.9 p -135.61 148.99 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.958 2.103 . . . . 0.0 110.606 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -119.57 121.41 4.94 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 118.844 -0.975 . . . . 0.0 113.552 158.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 22.8 p -114.63 160.65 19.07 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 123.518 1.627 . . . . 0.0 113.095 167.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 47.4 p -114.91 13.36 17.05 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 113.302 -1.772 . . . . 0.0 112.695 166.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.5 -31.21 5.67 Favored Glycine 0 N--CA 1.467 0.733 0 C-N-CA 124.056 0.836 . . . . 0.0 113.828 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.1 t 169.49 159.92 0.19 Allowed Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 126.974 2.11 . . . . 0.0 107.509 -157.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -54.94 -20.56 23.33 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 121.89 1.726 . . . . 0.0 112.678 161.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.69 42.43 1.1 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.079 1.352 . . . . 0.0 112.729 174.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 51.33 33.91 32.55 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 116.986 1.554 . . . . 0.0 116.986 150.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.3 m -75.69 -48.02 23.77 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -152.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -104.88 -145.84 0.38 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.939 0.896 . . . . 0.0 112.219 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.66 HG22 ' OE1' ' A' ' 136' ' ' GLU . 3.7 t -76.56 -158.4 0.1 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.956 0.902 . . . . 0.0 112.413 163.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.4 tp -105.88 142.62 18.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 126.368 1.867 . . . . 0.0 110.481 161.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.609 ' SD ' HD21 ' A' ' 124' ' ' LEU . 3.8 ppp? -152.58 175.26 12.97 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.322 1.049 . . . . 0.0 112.141 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -140.71 130.69 24.63 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -165.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.609 HD21 ' SD ' ' A' ' 122' ' ' MET . 1.7 mt -132.28 174.13 10.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.181 1.393 . . . . 0.0 108.725 -174.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 102.37 5.11 Favored Pre-proline 0 N--CA 1.478 0.959 0 CA-C-N 120.187 1.358 . . . . 0.0 114.495 168.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -70.9 176.94 6.93 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 CA-C-N 120.025 1.045 . . . . 0.0 109.426 161.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.7 m -139.71 158.97 43.23 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.745 2.018 . . . . 0.0 105.777 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.5 p -49.21 -37.97 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 120.028 1.285 . . . . 0.0 113.456 -178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -80.9 -8.24 59.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.549 1.539 . . . . 0.0 114.078 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -140.82 -173.45 3.71 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 122.893 1.33 . . . . 0.0 113.371 -151.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 25.9 m -141.53 167.35 16.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 128.322 2.649 . . . . 0.0 108.966 -175.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -148.21 142.58 26.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.885 0.874 . . . . 0.0 110.506 169.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -100.04 143.52 30.16 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.79 0.836 . . . . 0.0 111.07 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.519 ' SG ' ' SG ' ' A' ' 137' ' ' CYS . 45.4 t -65.1 175.15 1.68 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 122.802 1.287 . . . . 0.0 113.622 158.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.413 ' CD1' ' CE ' ' A' ' 122' ' ' MET . 40.9 p-90 -127.54 -13.27 5.44 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.287 1.835 . . . . 0.0 112.583 170.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.66 ' OE1' HG22 ' A' ' 120' ' ' THR . 2.9 mm-40 -95.32 -60.82 1.59 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.156 0.982 . . . . 0.0 109.88 -177.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . 0.519 ' SG ' ' SG ' ' A' ' 134' ' ' CYS . 14.2 p -80.8 -23.45 39.25 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.997 1.319 . . . . 0.0 112.705 165.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 64.51 16.18 60.45 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.419 -1.211 . . . . 0.0 113.544 -172.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.77 137.16 53.8 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.801 1.8 . . . . 0.0 111.384 173.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 41.4 t -81.96 147.02 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 166.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -132.01 150.01 52.27 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 129.282 3.033 . . . . 0.0 110.709 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 43.9 tttt -127.01 150.05 49.62 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.102 0.953 . . . . 0.0 113.556 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.62 155.7 17.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.858 167.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.505 HD21 ' HA ' ' A' ' 101' ' ' GLU . 3.4 p30 -111.57 152.19 43.85 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 172.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -67.78 -6.01 15.81 Favored 'Trans proline' 0 C--N 1.352 0.736 1 C-N-CA 125.352 4.035 . . . . 0.0 115.154 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.498 HG22 ' CE1' ' A' ' 103' ' ' TYR . 8.9 p -36.83 133.37 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 127.837 2.455 . . . . 0.0 113.401 -177.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.637 0 C-N-CA 127.541 2.496 . . . . 0.0 107.315 174.703 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 8.6 mtm . . . . . 0 C--O 1.225 -0.219 0 N-CA-C 118.035 2.606 . . . . 2.1299999999999999 118.035 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -57.73 11.46 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 121.191 -0.943 . . . . 1.99 112.641 169.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.5 t70 164.88 73.77 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 129.437 3.095 . . . . 2.7400000000000002 109.703 -154.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -88.34 -46.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 1 C-N-CA 126.793 4.996 . . . . 1.0600000000000001 113.075 -174.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -154.47 143.1 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 130.451 3.5 . . . . 0.63 105.424 -168.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.9 mm -117.45 134.23 61.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 124.579 1.152 . . . . 0.62 111.87 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.9 mm -127.42 118.6 50.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 127.142 2.177 . . . . 0.46000000000000002 108.209 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.92 133.41 44.35 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.858 1.663 . . . . 2.8300000000000001 111.442 -176.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.9 t -163.63 111.94 1.21 Allowed 'General case' 0 C--O 1.223 -0.333 0 O-C-N 121.535 -0.728 . . . . 2.9100000000000001 112.67 -175.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -82.24 16.71 1.89 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.608 1.163 . . . . 3.7799999999999998 112.184 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.48 10.75 3.47 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 128.222 2.609 . . . . 3.0 113.212 -159.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 59.55 -16.73 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 129.631 3.173 . . . . 3.1099999999999999 118.686 173.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -150.88 14.63 0.73 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 119.666 -1.896 . . . . 2.3399999999999999 114.719 -168.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 57.1 ttm-85 -54.39 142.61 26.32 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.538 1.535 . . . . 3.6600000000000001 112.563 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -77.38 156.9 30.9 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.844 0.683 . . . . 2.23 112.844 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.2 p -105.1 145.05 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.451 1.501 . . . . 0.70999999999999996 111.073 173.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -113.4 98.12 0.91 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.957 1.265 . . . . 0.65000000000000002 112.286 164.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.7 154.86 18.25 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.373 1.469 . . . . 0.95999999999999996 113.318 174.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.9 p -124.46 14.17 8.84 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.841 1.656 . . . . 0.77000000000000002 115.0 171.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.16 -17.97 46.79 Favored Glycine 0 N--CA 1.476 1.338 0 O-C-N 120.46 -1.4 . . . . 2.0299999999999998 114.836 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.5 t 175.44 154.51 0.34 Allowed Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 126.089 1.756 . . . . 3.5 109.871 -155.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -58.69 -20.56 51.51 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.298 2.666 . . . . 2.2599999999999998 113.96 170.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.85 -9.1 50.31 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 114.798 1.407 . . . . 2.5800000000000001 114.798 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.84 164.95 12.79 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 123.584 1.658 . . . . 3.1099999999999999 112.262 -147.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 36.9 m -166.62 -43.43 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 127.72 2.408 . . . . 1.49 110.628 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -107.64 -158.08 0.64 Allowed 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 109.95 -0.389 . . . . 1.5700000000000001 109.95 165.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.706 HG22 ' OE1' ' A' ' 136' ' ' GLU . 3.8 t -69.64 -158.96 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.823 0.849 . . . . 0.81999999999999995 112.531 168.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.8 tp -104.97 142.81 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 126.861 2.065 . . . . 0.83999999999999997 109.987 166.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.524 ' SD ' HD21 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -145.25 173.47 11.93 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.071 0.948 . . . . 4.3300000000000001 111.051 170.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -124.03 133.17 53.72 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.773 0.829 . . . . 1.5700000000000001 112.233 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.524 HD21 ' SD ' ' A' ' 122' ' ' MET . 3.4 mt -129.75 160.07 34.54 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.077 0.951 . . . . 0.72999999999999998 109.422 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.2 ttpp -125.3 85.94 57.67 Favored Pre-proline 0 N--CA 1.473 0.702 0 O-C-N 121.423 -0.798 . . . . 5.21 113.032 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -69.57 176.61 6.4 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.207 1.938 . . . . 2.4900000000000002 109.775 166.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.3 m -142.46 158.42 43.71 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.307 1.843 . . . . 0.91000000000000003 107.494 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.7 p -55.48 -33.65 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.952 1.301 . . . . 0.81000000000000005 113.737 -175.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -91.04 0.9 57.44 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.56 1.144 . . . . 2.27 113.838 175.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -140.26 -169.63 2.8 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.789 0.835 . . . . 2.1499999999999999 112.956 -158.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.6 m -145.66 163.68 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 127.504 2.322 . . . . 0.52000000000000002 109.916 -173.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -148.47 133.83 18.52 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.639 1.176 . . . . 0.52000000000000002 112.07 174.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.24 139.49 47.74 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.737 1.014 . . . . 3.27 113.737 -177.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.563 ' HG ' ' HG ' ' A' ' 137' ' ' CYS . 46.8 t -70.75 156.94 38.88 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.417 1.487 . . . . 1.1599999999999999 114.863 -178.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.448 ' CZ3' ' HG2' ' A' ' 136' ' ' GLU . 43.9 p-90 -102.92 -13.28 16.99 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.425 -1.261 . . . . 1.76 113.305 174.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.706 ' OE1' HG22 ' A' ' 120' ' ' THR . 0.8 OUTLIER -98.92 -58.34 1.97 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 120.002 1.273 . . . . 2.54 110.661 -179.062 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . 0.563 ' HG ' ' HG ' ' A' ' 134' ' ' CYS . 4.6 p -77.56 -65.93 0.9 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 122.28 1.038 . . . . 2.29 110.584 171.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.72 4.86 12.72 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.046 -1.419 . . . . 0.98999999999999999 115.882 -170.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.82 137.5 57.82 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 120.841 2.32 . . . . 1.8899999999999999 111.813 173.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 40.4 t -83.18 146.53 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 107.285 -1.376 . . . . 0.56999999999999995 107.285 165.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -132.35 151.01 52.04 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 128.221 2.608 . . . . 2.2999999999999998 112.076 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -133.43 146.78 51.5 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.11 1.152 . . . . 2.46 114.11 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.8 tt -99.86 153.9 18.78 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.62 1.168 . . . . 0.83999999999999997 110.328 171.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -107.62 156.91 37.09 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 115.453 1.649 . . . . 1.4099999999999999 115.453 -175.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.93 -4.51 12.56 Favored 'Trans proline' 0 C--N 1.357 0.976 1 C-N-CA 127.314 5.343 . . . . 1.6399999999999999 115.92 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.9 p -48.69 143.89 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.246 1.818 . . . . 1.95 110.369 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.75 0 O-C-N 120.772 -1.205 . . . . 2.9500000000000002 112.124 -163.691 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.8 mtm . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.678 0.751 . . . . 2.8300000000000001 112.794 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.7 pttm 123.39 -143.65 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.605 1 C-N-CA 133.216 4.606 . . . . 3.3300000000000001 108.419 -150.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . 0.271 21.3 t0 -128.14 72.37 79.49 Favored Pre-proline 0 CA--C 1.561 1.391 0 C-N-CA 124.761 1.224 . . . . 3.1000000000000001 108.964 -173.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.51 -53.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.046 1 C-N-CA 128.788 6.325 . . . . 0.80000000000000004 114.705 -170.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -133.04 140.11 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 128.745 2.818 . . . . 0.57999999999999996 105.156 -178.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.4 mm -110.68 133.88 54.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 C-N-CA 123.662 0.785 . . . . 0.81000000000000005 111.686 -171.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.0 mm -122.67 115.69 46.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 126.341 1.857 . . . . 0.60999999999999999 108.301 173.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -65.17 124.19 21.51 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.937 1.695 . . . . 3.0800000000000001 110.464 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.6 t -146.8 122.17 10.3 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.167 0.987 . . . . 3.0 111.414 -175.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -98.55 3.18 48.06 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 112.532 0.567 . . . . 2.6499999999999999 112.532 -175.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -104.03 -101.56 0.31 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 128.699 2.8 . . . . 3.7200000000000002 111.166 168.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.566 ' OD1' HG12 ' A' ' 128' ' ' VAL . 10.3 t0 -171.64 -38.33 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 128.094 2.558 . . . . 3.9100000000000001 109.98 -175.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -99.67 -5.08 29.51 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 120.063 -1.648 . . . . 3.6000000000000001 114.63 -165.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.16 122.39 8.49 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.371 1.868 . . . . 6.8899999999999997 114.194 -164.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -70.83 151.7 44.51 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.861 1.06 . . . . 2.3599999999999999 113.861 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.7 p -108.22 146.56 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.785 1.634 . . . . 0.71999999999999997 111.838 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -111.09 108.14 2.32 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.119 0.866 . . . . 0.73999999999999999 112.747 161.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 1.9 t -97.1 145.17 26.25 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.963 1.305 . . . . 1.01 112.612 172.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.7 p -116.29 18.65 15.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.491 1.517 . . . . 0.73999999999999999 113.759 169.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.423 ' CA ' ' CD2' ' A' ' 119' ' ' HIS . . . 110.96 39.33 1.42 Allowed Glycine 0 N--CA 1.466 0.639 0 C-N-CA 124.611 1.101 . . . . 1.71 113.457 176.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 p 71.08 178.5 0.05 OUTLIER Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 123.966 0.907 . . . . 2.79 110.294 -161.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -63.72 -9.6 19.17 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.256 1.971 . . . . 2.6600000000000001 115.586 -172.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.58 33.48 1.43 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.817 1.247 . . . . 2.6099999999999999 113.953 -174.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 57.8 31.66 64.65 Favored Glycine 0 N--CA 1.479 1.512 0 C-N-CA 124.252 0.929 . . . . 1.6299999999999999 115.057 163.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.0 m -84.85 -32.16 23.41 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.571 -0.958 . . . . 1.7 113.437 -148.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.525 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 18.7 p80 -123.81 -144.34 0.33 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.838 1.199 . . . . 1.3700000000000001 113.096 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.633 HG22 ' OE2' ' A' ' 136' ' ' GLU . 4.2 t -78.39 -153.73 0.07 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 118.902 0.774 . . . . 0.83999999999999997 111.035 164.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.9 tp -107.5 151.03 9.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 127.761 2.424 . . . . 0.93999999999999995 110.668 164.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.629 ' CE ' HD21 ' A' ' 124' ' ' LEU . 4.2 ppp? -160.14 161.47 33.72 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.943 1.697 . . . . 3.7799999999999998 111.492 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -130.09 132.99 46.38 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.376 0.509 . . . . 1.48 112.376 -167.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.629 HD21 ' CE ' ' A' ' 122' ' ' MET . 3.3 mt -131.86 155.55 47.63 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.469 0.707 . . . . 0.71999999999999997 110.485 -175.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.65 97.21 46.28 Favored Pre-proline 0 N--CA 1.477 0.917 0 CA-C-N 118.608 0.64 . . . . 5.6600000000000001 110.972 175.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -76.42 178.66 7.26 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 121.839 1.693 . . . . 2.5499999999999998 108.868 162.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.469 HG22 ' OD1' ' A' ' 105' ' ' ASP . 1.3 m -144.41 155.34 43.71 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.14 1.776 . . . . 1.0 106.265 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.566 HG12 ' OD1' ' A' ' 105' ' ' ASP . 9.8 p -63.02 -28.07 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 122.036 2.198 . . . . 0.87 109.803 175.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -72.68 -15.12 61.7 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.543 2.737 . . . . 1.6399999999999999 114.721 171.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -145.51 178.46 8.1 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 123.215 1.483 . . . . 1.99 114.103 -159.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.482 HG12 ' HG3' ' A' ' 142' ' ' LYS . 27.4 m -120.68 165.35 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 128.347 2.659 . . . . 0.53000000000000003 109.495 174.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.9 131.64 25.72 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.428 1.091 . . . . 0.60999999999999999 111.148 173.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.473 ' CG ' HG22 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -111.63 138.03 48.72 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.677 0.621 . . . . 3.54 112.677 -177.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.423 ' HA ' ' HE1' ' A' ' 122' ' ' MET . 40.7 t -70.01 153.23 43.48 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 126.599 1.96 . . . . 1.0700000000000001 115.223 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.422 ' H ' ' HE1' ' A' ' 122' ' ' MET . 56.7 p-90 -98.6 -10.19 23.73 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.453 0.908 . . . . 1.3600000000000001 113.453 169.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.633 ' OE2' HG22 ' A' ' 120' ' ' THR . 0.7 OUTLIER -96.87 -100.0 0.19 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.326 1.45 . . . . 1.73 109.48 -177.229 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 30.1 p -55.39 -29.25 58.13 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.32 1.418 . . . . 1.0600000000000001 112.12 168.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.1 23.88 75.01 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-O 118.483 -1.176 . . . . 0.72999999999999998 113.479 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.66 154.0 41.71 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.704 1.752 . . . . 1.45 111.054 165.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.473 HG22 ' CG ' ' A' ' 133' ' ' ARG . 74.2 t -96.55 140.97 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 105.817 -1.92 . . . . 0.56999999999999995 105.817 167.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -123.56 153.91 39.98 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 128.009 2.524 . . . . 2.1200000000000001 111.737 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.482 ' HG3' HG12 ' A' ' 131' ' ' VAL . 3.4 tmtt? -140.19 157.67 45.24 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 123.013 1.387 . . . . 2.5899999999999999 114.569 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.4 tt -110.87 141.16 44.63 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 113.737 -1.574 . . . . 0.87 113.255 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -100.53 155.85 35.89 Favored Pre-proline 0 CA--C 1.555 1.148 0 N-CA-C 114.609 1.337 . . . . 1.45 114.609 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -79.38 -4.27 13.57 Favored 'Trans proline' 0 C--N 1.356 0.936 1 C-N-CA 126.307 4.671 . . . . 1.3999999999999999 115.56 -175.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.1 p -40.43 148.65 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 128.805 2.842 . . . . 2.0099999999999998 112.044 175.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.644 0 O-C-N 120.138 -1.602 . . . . 1.6399999999999999 113.49 179.267 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 13.8 mtp . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 119.635 3.198 . . . . 2.2999999999999998 119.635 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -56.85 5.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 119.264 0.938 . . . . 2.1499999999999999 112.978 174.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.2 t0 161.68 70.89 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 129.411 3.085 . . . . 2.3700000000000001 109.177 -158.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -82.46 -53.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.3 1 C-N-CA 126.082 4.522 . . . . 0.76000000000000001 112.526 -172.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -147.77 143.53 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 130.521 3.528 . . . . 0.88 104.831 -168.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.4 mm -111.21 129.98 65.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 124.525 1.13 . . . . 0.90000000000000002 109.818 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.4 mm -114.61 100.27 10.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 126.123 1.769 . . . . 0.73999999999999999 106.908 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -66.61 122.23 17.14 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 125.162 1.539 . . . . 3.1200000000000001 110.008 -174.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.4 t -145.0 110.44 5.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.741 -0.663 . . . . 3.1699999999999999 111.225 -169.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -77.1 35.33 0.16 Allowed 'General case' 0 CA--C 1.55 0.949 0 O-C-N 121.693 -0.63 . . . . 2.3900000000000001 112.633 172.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -157.73 137.9 12.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 130.801 3.64 . . . . 3.1600000000000001 106.788 -173.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -60.26 -11.57 6.72 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.818 1.044 . . . . 2.98 113.818 175.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -139.05 126.35 21.47 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.758 2.423 . . . . 3.2200000000000002 111.47 -170.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.511 HH11 ' CG ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -146.27 174.74 11.07 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.887 1.275 . . . . 4.3899999999999997 113.74 171.516 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -100.4 168.05 10.0 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.723 -0.671 . . . . 2.3100000000000001 111.926 157.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.96 145.9 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 126.029 1.732 . . . . 0.68999999999999995 110.414 168.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -129.34 107.84 0.84 Allowed Glycine 0 N--CA 1.473 1.116 0 CA-C-O 119.154 -0.803 . . . . 0.70999999999999996 113.773 170.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.553 ' H ' ' CE ' ' A' ' 122' ' ' MET . 12.7 p -109.75 164.11 12.87 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.485 1.914 . . . . 0.91000000000000003 114.167 172.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.8 p -124.71 5.52 8.15 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.263 1.425 . . . . 0.89000000000000001 114.724 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.5 -21.67 12.62 Favored Glycine 0 N--CA 1.476 1.315 0 N-CA-C 116.334 1.294 . . . . 2.1099999999999999 116.334 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.94 177.34 0.54 Allowed Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 127.541 2.336 . . . . 3.8999999999999999 109.501 -178.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -59.54 -26.22 81.34 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.507 2.138 . . . . 2.73 113.541 170.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.52 -2.0 58.32 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.291 1.219 . . . . 2.3799999999999999 114.291 172.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.77 -169.01 52.89 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-O 123.267 1.481 . . . . 3.54 111.458 -150.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.0 t -177.82 -36.19 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 128.278 2.631 . . . . 2.5299999999999998 110.656 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -118.57 -153.15 0.52 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.495 1.518 . . . . 1.3600000000000001 110.603 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.725 HG22 ' OE2' ' A' ' 136' ' ' GLU . 4.9 t -74.78 -155.39 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 O-C-N 121.39 -0.819 . . . . 0.89000000000000001 112.202 167.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.5 tp -108.28 146.28 14.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 127.6 2.36 . . . . 0.95999999999999996 109.797 163.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.56 ' SD ' HD21 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -141.69 -179.87 6.43 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.922 1.289 . . . . 4.5199999999999996 110.597 173.081 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -140.25 124.06 17.34 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.589 0.631 . . . . 1.6200000000000001 111.751 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.56 HD21 ' SD ' ' A' ' 122' ' ' MET . 2.4 mt -118.78 172.64 7.38 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.154 0.981 . . . . 0.82999999999999996 110.202 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -139.58 90.97 10.99 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-O 118.488 -0.768 . . . . 6.9699999999999998 112.749 -175.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -85.8 167.27 9.89 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.979 2.452 . . . . 2.6899999999999999 110.601 172.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.5 m -139.75 152.73 46.86 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.962 2.105 . . . . 1.3700000000000001 108.577 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.7 p -42.48 -43.85 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 116.988 2.218 . . . . 1.21 116.988 -173.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -89.58 3.25 53.13 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.44 1.096 . . . . 2.0899999999999999 112.846 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -140.8 -177.85 5.27 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.59 1.156 . . . . 3.2999999999999998 113.759 -149.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.1 m -139.99 152.2 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 113.672 -1.604 . . . . 0.60999999999999999 112.384 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -129.23 143.45 50.86 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.871 0.868 . . . . 0.66000000000000003 109.844 168.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -111.64 141.07 45.71 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.886 0.874 . . . . 4.5599999999999996 111.488 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 49.3 t -59.76 159.17 9.16 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 124.587 1.179 . . . . 1.04 112.88 163.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 58.6 p-90 -107.31 -9.02 16.16 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.825 1.25 . . . . 1.21 112.559 170.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.725 ' OE2' HG22 ' A' ' 120' ' ' THR . 2.7 mm-40 -100.09 -94.18 0.27 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.076 1.75 . . . . 1.6200000000000001 108.998 -177.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 28.3 p -62.29 -16.37 53.45 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 120.416 -1.427 . . . . 1.28 112.587 171.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 59.22 27.32 62.64 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 124.894 1.235 . . . . 0.79000000000000004 112.607 175.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.4 p -67.59 132.59 47.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.975 1.388 . . . . 1.52 108.879 164.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 41.4 t -76.97 150.85 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.426 -0.953 . . . . 0.60999999999999999 108.426 159.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -134.19 147.21 50.72 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 130.028 3.331 . . . . 1.8200000000000001 110.439 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -124.81 145.7 49.63 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 113.397 0.888 . . . . 2.7000000000000002 113.397 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.3 tt -91.76 154.36 18.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 122.278 1.037 . . . . 1.1399999999999999 109.094 165.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -117.2 152.66 49.32 Favored Pre-proline 0 CA--C 1.552 1.037 0 CA-C-N 114.685 -1.143 . . . . 1.48 113.319 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.49 -4.39 14.42 Favored 'Trans proline' 0 CA--C 1.539 0.761 1 C-N-CA 125.964 4.443 . . . . 1.6699999999999999 115.731 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.1 p -43.66 149.54 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 128.356 2.663 . . . . 2.1200000000000001 112.812 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 125.04 1.305 . . . . 1.96 110.185 -174.843 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.6 mtm . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 124.28 1.99 . . . . 2.73 111.918 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -173.21 -122.41 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 130.922 3.689 . . . . 1.95 106.717 172.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . 0.303 38.0 t70 -133.39 78.11 64.1 Favored Pre-proline 0 N--CA 1.434 -1.251 0 N-CA-C 106.975 -1.491 . . . . 2.77 106.975 177.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -83.12 -81.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.786 1 C-N-CA 127.573 5.515 . . . . 1.21 113.687 -170.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -102.07 143.39 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 C-N-CA 127.854 2.462 . . . . 0.85999999999999999 106.187 171.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.0 mm -109.53 135.25 49.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.28 -0.873 . . . . 0.87 111.786 -172.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.9 mm -123.55 114.05 40.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 126.96 2.104 . . . . 0.76000000000000001 108.453 173.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.4 132.13 46.51 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.463 1.505 . . . . 3.0800000000000001 110.706 169.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 61.7 m -161.09 125.19 3.45 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.088 -1.007 . . . . 3.3300000000000001 109.14 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.7 m-30 -87.97 28.35 1.05 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 121.366 0.603 . . . . 2.75 111.24 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.99 109.96 4.52 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 129.336 3.054 . . . . 3.75 108.235 -171.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -53.85 -16.08 1.62 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.974 2.51 . . . . 3.3999999999999999 115.44 -169.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.91 5.76 3.91 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 126.769 2.028 . . . . 2.2000000000000002 113.79 -167.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.5 ttt85 -48.2 156.75 0.36 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.366 1.866 . . . . 4.7199999999999998 113.654 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -87.72 155.55 19.86 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.738 -0.602 . . . . 2.2599999999999998 112.308 162.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.23 142.65 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 127.08 2.152 . . . . 0.68000000000000005 111.543 170.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -104.67 100.95 1.86 Allowed Glycine 0 CA--C 1.533 1.217 0 CA-C-O 117.95 -1.472 . . . . 0.69999999999999996 113.663 164.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 3.6 p -107.22 145.06 33.12 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.459 1.629 . . . . 1.28 113.424 171.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.5 p -114.25 23.31 12.97 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 113.901 -1.499 . . . . 0.69999999999999996 112.874 175.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.83 -16.28 55.22 Favored Glycine 0 N--CA 1.476 1.36 0 O-C-N 120.201 -1.562 . . . . 1.76 114.395 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.8 p 175.36 162.29 0.4 Allowed Pre-proline 0 C--O 1.241 0.64 0 C-N-CA 128.693 2.797 . . . . 4.0599999999999996 107.888 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.05 -15.42 39.16 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.02 2.48 . . . . 2.77 113.184 165.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.55 7.22 46.4 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.326 1.05 . . . . 2.2200000000000002 112.469 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 62.25 71.67 0.78 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 125.177 1.37 . . . . 1.6399999999999999 111.921 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 56.8 m -76.24 -42.51 45.59 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.925 0.89 . . . . 1.76 112.175 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.6 p80 -100.8 -148.73 0.37 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.342 0.974 . . . . 1.46 112.226 171.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.28 13.6 t -77.67 -134.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.048 -1.093 . . . . 0.81000000000000005 108.048 158.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.6 tp -129.95 142.1 44.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 131.06 3.744 . . . . 0.83999999999999997 111.108 174.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 19.3 mmm -129.54 167.15 18.34 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.629 1.972 . . . . 3.79 115.112 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -136.06 102.48 5.04 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.88 0.472 . . . . 1.47 110.936 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 mt -116.22 160.03 21.0 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.78 0.832 . . . . 0.68000000000000005 110.499 -169.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -119.94 76.22 21.74 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 114.931 1.456 . . . . 5.2400000000000002 114.931 -170.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -92.15 43.43 0.36 Allowed 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.477 3.452 . . . . 3.0699999999999998 116.161 -165.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 m -28.61 151.0 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 130.301 3.44 . . . . 0.87 114.94 -170.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -52.15 -33.33 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 O-C-N 120.199 -1.563 . . . . 0.90000000000000002 113.836 175.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -79.24 -7.99 58.69 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.461 1.504 . . . . 1.45 114.071 175.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -141.39 -166.38 2.18 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.867 1.267 . . . . 2.1200000000000001 111.575 -157.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.53 HG12 ' HG3' ' A' ' 142' ' ' LYS . 21.6 m -147.55 158.28 9.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 131.151 3.78 . . . . 0.55000000000000004 107.3 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -141.92 140.24 32.75 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.923 0.783 . . . . 0.69999999999999996 110.966 168.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -91.97 141.97 28.05 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.322 0.649 . . . . 3.6499999999999999 109.784 172.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.3 t -62.21 162.74 9.2 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.42 1.088 . . . . 1.1200000000000001 111.396 155.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 28.8 p-90 -104.0 -20.13 13.97 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.79 -0.641 . . . . 1.7 112.099 163.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -81.41 -88.23 0.08 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.829 0.852 . . . . 2.2799999999999998 109.752 -174.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.7 p -64.93 -23.97 67.38 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 122.057 -0.402 . . . . 1.1599999999999999 111.933 171.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.16 21.68 75.74 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 118.814 0.734 . . . . 0.71999999999999997 113.557 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.17 154.86 38.61 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.765 1.283 . . . . 1.77 110.334 162.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 76.1 t -100.64 135.82 34.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 N-CA-C 105.749 -1.945 . . . . 0.64000000000000001 105.749 164.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -116.62 146.92 42.36 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 126.748 2.019 . . . . 1.77 108.74 -176.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.53 ' HG3' HG12 ' A' ' 131' ' ' VAL . 6.8 tmtt? -134.08 151.37 51.37 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 122.366 1.079 . . . . 2.5099999999999998 113.56 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.0 tt -107.13 142.7 36.39 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 113.322 -1.763 . . . . 0.85999999999999999 111.827 -177.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -101.03 154.09 37.36 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 113.296 -1.775 . . . . 1.3799999999999999 111.259 -173.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.3 -4.39 15.13 Favored 'Trans proline' 0 N--CA 1.48 0.702 1 C-N-CA 125.577 4.184 . . . . 1.22 115.302 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.9 p -43.26 148.63 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 128.254 2.622 . . . . 2.21 112.693 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.855 0 CA-C-O 123.361 1.534 . . . . 2.0099999999999998 112.197 179.019 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.43 ' O ' ' HD3' ' A' ' 97' ' ' PRO . 23.3 mtt . . . . . 0 C--O 1.214 -0.793 0 N-CA-C 106.889 -1.523 . . . . 3.1000000000000001 106.889 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -4.0 -66.21 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 128.564 2.746 . . . . 2.0600000000000001 117.823 171.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.3 t70 176.69 77.77 0.1 OUTLIER Pre-proline 0 CA--C 1.564 1.481 0 C-N-CA 130.742 3.617 . . . . 2.5699999999999998 109.857 -163.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 94' ' ' MET . 59.7 Cg_endo -94.01 -51.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 1 C-N-CA 126.819 5.013 . . . . 1.1000000000000001 113.606 -173.479 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.82 142.23 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 131.153 3.781 . . . . 0.89000000000000001 104.488 -173.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.4 mm -114.51 134.62 56.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 C-N-CA 124.161 0.984 . . . . 0.88 110.199 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.3 mm -120.24 114.55 44.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 125.345 1.458 . . . . 0.62 107.781 174.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -71.49 122.1 19.84 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.911 1.284 . . . . 2.5600000000000001 110.466 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.5 m -158.43 105.13 1.86 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.728 -1.233 . . . . 3.2799999999999998 113.344 -172.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -75.03 40.02 0.14 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 127.161 2.184 . . . . 2.48 113.051 -175.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.34 -2.18 0.69 Allowed 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.129 1.159 . . . . 3.4900000000000002 114.129 -168.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 63.25 -16.46 0.06 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 128.602 2.761 . . . . 3.27 115.046 -176.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -151.68 27.47 0.64 Allowed 'General case' 0 C--O 1.244 0.784 0 O-C-N 119.841 -1.787 . . . . 2.4900000000000002 113.193 -170.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -65.47 160.62 21.75 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.551 1.167 . . . . 3.8900000000000001 111.283 171.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -82.65 167.76 17.94 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.913 -1.04 . . . . 1.9199999999999999 113.036 167.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.9 p -118.61 141.9 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 127.916 2.487 . . . . 0.69999999999999996 111.191 169.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.53 105.41 2.04 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.691 1.139 . . . . 0.82999999999999996 112.168 164.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.11 153.28 21.1 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.036 1.334 . . . . 0.95999999999999996 112.543 169.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 18.2 p -121.37 24.24 10.03 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.784 1.634 . . . . 0.84999999999999998 113.933 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.22 -28.29 6.29 Favored Glycine 0 N--CA 1.472 1.054 0 O-C-N 120.692 -1.255 . . . . 2.0299999999999998 112.775 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 83.0 p -175.87 163.03 2.0 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 128.521 2.728 . . . . 3.9399999999999999 107.67 -172.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.8 -3.7 10.9 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.31 2.673 . . . . 2.21 113.906 172.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.88 0.31 18.63 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.671 1.189 . . . . 2.29 114.059 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.29 91.57 0.39 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.533 1.063 . . . . 1.77 111.119 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.6 m -103.0 -30.35 10.83 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.011 0.745 . . . . 1.45 113.011 173.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -125.15 -151.37 0.48 Allowed 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 119.125 0.875 . . . . 1.52 111.544 166.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.708 HG22 ' OE1' ' A' ' 136' ' ' GLU . 4.3 t -73.02 -157.68 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 O-C-N 121.032 -1.043 . . . . 1.02 111.371 166.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.4 tp -103.78 145.81 12.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 127.17 2.188 . . . . 1.05 108.815 164.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.531 ' SD ' HD21 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -145.85 166.68 25.23 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.418 0.687 . . . . 4.5300000000000002 111.501 170.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -117.89 130.34 56.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.781 0.832 . . . . 1.6200000000000001 112.147 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.531 HD21 ' SD ' ' A' ' 122' ' ' MET . 2.2 mt -128.84 163.78 24.48 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.452 1.101 . . . . 0.82999999999999996 109.452 175.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 32.8 mttt -131.79 105.36 14.1 Favored Pre-proline 0 N--CA 1.48 1.027 0 CA-C-O 117.434 -1.27 . . . . 6.8300000000000001 110.957 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -71.82 -69.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.26 1.973 . . . . 3.21 112.96 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.9 m 100.94 147.37 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 130.287 3.435 . . . . 1.24 108.82 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.4 p -44.38 -41.1 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 127.506 2.322 . . . . 1.1699999999999999 114.733 -172.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -83.84 -22.52 31.7 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.27 1.028 . . . . 2.96 112.317 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -131.82 179.08 6.29 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.948 1.699 . . . . 4.3200000000000003 114.913 -143.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 20.4 m -131.16 147.97 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 112.874 -1.966 . . . . 0.76000000000000001 114.757 -165.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -142.5 141.22 32.07 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.979 1.312 . . . . 0.79000000000000004 112.335 174.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -122.61 139.56 53.79 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.855 1.262 . . . . 4.4500000000000002 113.565 -170.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.546 ' HG ' ' HG ' ' A' ' 137' ' ' CYS . 42.6 t -72.4 145.34 47.75 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 116.448 2.018 . . . . 1.27 116.448 -174.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.444 ' CZ3' ' HG2' ' A' ' 136' ' ' GLU . 58.5 p-90 -95.5 -10.7 29.01 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 117.421 -1.276 . . . . 2.6299999999999999 113.765 175.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.708 ' OE1' HG22 ' A' ' 120' ' ' THR . 1.3 mm-40 -93.27 -66.3 0.93 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 120.089 1.313 . . . . 2.5099999999999998 108.345 175.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . 0.546 ' HG ' ' HG ' ' A' ' 134' ' ' CYS . 12.4 p -74.86 -77.13 0.13 Allowed 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 121.844 0.83 . . . . 2.8999999999999999 110.927 173.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 125.0 18.58 2.57 Favored Glycine 0 N--CA 1.472 1.046 0 N-CA-C 117.692 1.837 . . . . 0.88 117.692 -165.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.4 p -74.92 142.63 43.98 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 120.655 2.228 . . . . 1.77 110.859 166.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 50.8 t -90.98 138.16 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 107.559 -1.275 . . . . 0.65000000000000002 107.559 167.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -117.65 142.69 46.93 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.457 1.903 . . . . 1.8500000000000001 112.382 176.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -115.58 149.09 38.78 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.285 1.04 . . . . 2.2400000000000002 112.259 173.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.3 tt -99.45 158.07 15.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.151 -0.931 . . . . 0.91000000000000003 110.071 168.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -114.3 156.01 44.94 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 114.82 1.415 . . . . 1.3500000000000001 114.82 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.08 -5.36 16.24 Favored 'Trans proline' 0 C--N 1.355 0.9 1 C-N-CA 125.65 4.233 . . . . 1.21 115.288 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.5 p -45.11 138.01 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 126.273 1.829 . . . . 2.1499999999999999 111.127 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.594 0 CA-C-O 122.851 1.251 . . . . 1.75 112.369 -174.647 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.7 mtt . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 119.445 3.128 . . . . 2.9399999999999999 119.445 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -58.88 6.67 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 120.969 -1.082 . . . . 2.1000000000000001 112.481 171.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 t0 165.32 71.75 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 129.461 3.105 . . . . 2.1099999999999999 108.906 -157.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.95 -50.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.391 1 C-N-CA 126.552 4.835 . . . . 0.81000000000000005 113.252 -171.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -150.63 141.64 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 1 C-N-CA 132.587 4.355 . . . . 0.62 104.141 -170.07 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 mm -109.88 136.14 46.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 125.163 1.385 . . . . 0.69999999999999996 109.004 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.1 mm -116.75 143.01 28.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 105.299 -2.111 . . . . 0.68999999999999995 105.299 170.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.492 ' CG ' HG11 ' A' ' 146' ' ' VAL . 9.2 tt0 -108.24 146.03 33.44 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.102 0.876 . . . . 3.1899999999999999 110.116 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.577 ' HB2' HD21 ' A' ' 143' ' ' LEU . 24.2 t -137.67 -54.71 0.67 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.852 1.427 . . . . 3.0899999999999999 114.852 -167.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 81.59 11.23 0.77 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 127.947 2.499 . . . . 2.73 113.759 -167.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -149.12 156.76 42.68 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 129.396 3.079 . . . . 2.7400000000000002 107.351 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.48 -18.16 26.78 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.285 1.217 . . . . 2.9300000000000002 114.285 174.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.68 81.55 1.16 Allowed 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.86 1.43 . . . . 2.8999999999999999 114.86 -158.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -127.39 167.91 15.57 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 120.898 -1.126 . . . . 5.5199999999999996 113.219 167.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -90.8 171.32 9.41 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.306 1.443 . . . . 2.1499999999999999 113.882 -174.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.4 p -124.98 143.12 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 126.685 1.994 . . . . 0.89000000000000001 111.228 171.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.26 92.76 1.01 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.585 1.564 . . . . 0.71999999999999997 112.081 162.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -106.19 146.55 30.13 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.553 1.676 . . . . 1.22 113.727 176.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.9 p -115.54 4.79 14.28 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.358 1.463 . . . . 1.22 114.166 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 138.07 -27.13 2.8 Favored Glycine 0 N--CA 1.468 0.777 0 O-C-N 121.405 -0.809 . . . . 2.5800000000000001 114.898 -169.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.0 t 106.12 144.85 0.01 OUTLIER Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 128.091 2.556 . . . . 3.96 106.681 -138.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.15 93.76 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.95 2.433 . . . . 3.23 110.76 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 176.86 21.32 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 129.256 3.022 . . . . 2.5 113.412 166.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 67.2 43.21 90.03 Favored Glycine 0 C--N 1.341 0.837 0 O-C-N 121.133 -0.979 . . . . 2.25 113.777 167.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 5.3 t -60.68 -36.35 78.55 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.156 0.978 . . . . 2.9700000000000002 111.905 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 26.4 p80 -135.65 -141.1 0.17 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.017 1.327 . . . . 1.5800000000000001 112.323 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.729 HG22 ' OE2' ' A' ' 136' ' ' GLU . 11.4 t -85.13 -141.39 0.08 Allowed 'General case' 0 C--O 1.218 -0.583 0 C-N-CA 124.14 0.976 . . . . 1.04 108.812 158.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.4 ' N ' HG23 ' A' ' 120' ' ' THR . 4.7 tp -123.08 141.22 44.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 130.23 3.412 . . . . 1.1499999999999999 111.689 174.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.421 ' SD ' ' NE1' ' A' ' 135' ' ' TRP . 12.9 mmt -136.47 154.57 50.72 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 116.379 1.992 . . . . 4.9199999999999999 116.379 -173.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -115.65 87.79 2.74 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.753 -0.658 . . . . 1.5800000000000001 111.789 -170.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 mt -103.1 167.99 9.47 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.487 -0.758 . . . . 0.83999999999999997 109.354 -174.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.57 88.86 2.73 Favored Pre-proline 0 N--CA 1.475 0.789 0 O-C-N 121.033 -1.042 . . . . 7.79 112.556 -167.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -81.37 173.4 11.64 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.477 2.784 . . . . 2.3399999999999999 109.933 170.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -113.55 156.83 22.91 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.45 1.9 . . . . 1.24 107.883 169.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 p -50.3 -39.53 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-N 119.992 1.269 . . . . 0.79000000000000004 113.952 170.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -79.59 -5.59 55.31 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.263 0.838 . . . . 1.8999999999999999 113.263 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -143.16 -164.14 1.79 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.561 0.744 . . . . 2.2200000000000002 111.773 -155.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.4 m -149.74 158.57 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.731 2.012 . . . . 0.55000000000000004 110.263 -171.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -143.62 139.61 29.72 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.224 1.01 . . . . 0.66000000000000003 111.637 170.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.9 ttt-85 -97.96 146.14 25.78 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.457 0.703 . . . . 4.29 110.32 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 9.7 t -60.2 160.35 8.46 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.545 1.538 . . . . 1.0900000000000001 110.627 159.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.421 ' NE1' ' SD ' ' A' ' 122' ' ' MET . 27.7 p-90 -99.86 -17.71 17.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 117.479 -1.248 . . . . 1.4199999999999999 111.822 160.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.729 ' OE2' HG22 ' A' ' 120' ' ' THR . 2.1 mm-40 -86.25 -95.38 0.08 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.923 1.289 . . . . 1.51 109.502 -173.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.3 p -64.28 -13.33 49.05 Favored 'General case' 0 CA--C 1.557 1.233 0 O-C-N 119.963 -1.711 . . . . 1.1599999999999999 114.929 -177.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.75 16.8 80.15 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.95 1.738 . . . . 0.75 114.909 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.82 142.4 49.63 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.399 1.6 . . . . 1.74 110.56 169.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.26 147.94 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 108.355 -0.979 . . . . 0.56000000000000005 108.355 158.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -126.27 153.49 44.7 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 128.928 2.891 . . . . 1.8200000000000001 111.037 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 46.7 tttt -130.39 152.89 49.31 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.621 0.768 . . . . 2.3999999999999999 112.763 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' A' ' 102' ' ' SER . 0.8 OUTLIER -99.34 164.92 11.92 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.874 1.321 . . . . 2.3399999999999999 111.283 161.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.461 ' H ' HD23 ' A' ' 143' ' ' LEU . 27.7 p30 -123.96 167.56 15.0 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 127.538 2.335 . . . . 1.52 110.804 -177.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -83.75 -26.42 2.04 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.717 2.278 . . . . 1.3600000000000001 113.776 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.492 HG11 ' CG ' ' A' ' 101' ' ' GLU . 35.7 m 38.66 -164.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 129.976 3.31 . . . . 3.04 117.238 -178.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.833 0 CA-C-O 123.746 1.748 . . . . 2.1200000000000001 113.174 132.031 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.0 mtt . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 118.749 2.87 . . . . 3.1400000000000001 118.749 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.22 -80.67 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.306 0.574 . . . . 2.4500000000000002 110.188 161.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.8 t0 177.13 77.78 0.11 Allowed Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 127.073 2.149 . . . . 2.3799999999999999 108.1 -162.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -93.96 -57.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 1 C-N-CA 127.053 5.168 . . . . 0.97999999999999998 115.402 -162.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.15 140.92 29.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 1 C-N-CA 131.803 4.041 . . . . 0.76000000000000001 103.709 -170.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 mm -111.69 135.92 49.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 123.633 0.773 . . . . 0.79000000000000004 110.502 -175.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.2 mm -123.89 100.18 7.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 126.584 1.954 . . . . 0.79000000000000004 106.23 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -78.8 120.41 23.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 113.547 -1.661 . . . . 2.5600000000000001 110.455 -163.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.7 t -110.28 -65.74 1.13 Allowed 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 115.049 1.5 . . . . 2.7599999999999998 115.049 -154.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.451 ' H ' ' CG2' ' A' ' 146' ' ' VAL . 59.7 m-85 71.86 11.13 6.26 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.826 2.05 . . . . 2.3999999999999999 112.555 -171.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -138.1 153.37 49.28 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 130.046 3.338 . . . . 2.8300000000000001 107.306 163.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -71.29 -9.26 57.83 Favored 'General case' 0 CA--C 1.552 1.054 0 O-C-N 120.645 -1.284 . . . . 3.1499999999999999 113.032 172.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -141.45 104.07 4.52 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.417 2.287 . . . . 2.8799999999999999 111.405 -164.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -148.94 168.79 22.13 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.709 -1.244 . . . . 3.9300000000000002 112.306 174.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -103.94 158.11 16.63 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.727 0.811 . . . . 2.4199999999999999 111.32 166.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.6 p -102.33 141.12 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.238 1.415 . . . . 0.87 110.291 169.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -106.92 78.54 0.25 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.341 1.448 . . . . 1.1899999999999999 112.867 169.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 12.9 p -94.95 143.0 26.82 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 119.596 1.698 . . . . 1.45 113.285 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 35.6 p -105.95 19.02 21.21 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-N 112.532 -2.122 . . . . 0.81999999999999995 112.141 169.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.07 60.84 0.34 Allowed Glycine 0 C--N 1.334 0.47 0 CA-C-O 119.033 -0.871 . . . . 1.72 113.675 176.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 68.59 -166.06 0.01 OUTLIER Pre-proline 0 CA--C 1.556 1.204 0 CA-C-O 117.836 -1.078 . . . . 5.1600000000000001 109.874 171.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.85 52.09 3.87 Favored 'Trans proline' 0 C--N 1.354 0.837 0 CA-C-N 122.768 2.024 . . . . 4.5899999999999999 111.598 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -163.1 7.54 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 116.031 1.863 . . . . 4.0999999999999996 116.031 -160.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 51.87 47.95 52.35 Favored Glycine 0 N--CA 1.475 1.29 0 N-CA-C 115.061 0.784 . . . . 2.23 115.061 159.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.2 m -113.83 -21.73 10.52 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 116.331 1.975 . . . . 1.6599999999999999 116.331 -151.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -123.57 -148.5 0.4 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 121.096 1.771 . . . . 1.3700000000000001 113.904 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.539 HG22 ' OE2' ' A' ' 136' ' ' GLU . 1.6 t -72.68 -153.23 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.323 0.649 . . . . 0.93000000000000005 110.946 162.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.457 ' N ' HG23 ' A' ' 120' ' ' THR . 5.2 tp -117.12 136.53 53.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 126.466 1.906 . . . . 0.84999999999999998 112.488 167.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.46 ' CE ' ' HE1' ' A' ' 135' ' ' TRP . 17.3 mmm -131.62 155.83 46.87 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.818 -1.537 . . . . 4.0899999999999999 114.688 -176.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -123.59 111.77 16.64 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.816 -1.084 . . . . 1.47 109.956 -177.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 mt -124.01 148.9 46.64 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.648 -0.501 . . . . 0.85999999999999999 109.648 -171.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.26 108.3 58.67 Favored Pre-proline 0 N--CA 1.484 1.242 0 CA-C-O 118.798 -0.62 . . . . 5.8399999999999999 111.789 -175.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -89.87 -175.21 0.96 Allowed 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.126 2.55 . . . . 2.73 109.895 154.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 94.8 m -158.92 157.44 31.41 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.72 2.808 . . . . 1.3300000000000001 105.199 173.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.444 HG13 HD22 ' A' ' 129' ' ' ASN . 7.5 p -49.71 -32.41 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 115.309 1.596 . . . . 0.81999999999999995 115.309 -176.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.444 HD22 HG13 ' A' ' 128' ' ' VAL . 1.7 m-80 -79.27 -0.81 33.83 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.027 1.331 . . . . 2.04 113.949 177.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -141.29 -175.83 4.49 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 123.545 1.64 . . . . 2.7400000000000002 114.503 -151.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.5 m -139.22 168.08 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 130.244 3.418 . . . . 0.70999999999999996 107.267 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -147.82 128.11 13.88 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 123.924 0.89 . . . . 0.68000000000000005 111.13 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -92.33 141.17 28.84 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.937 0.789 . . . . 4.29 110.351 173.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 9.2 t -63.54 174.81 1.2 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 122.789 1.281 . . . . 1.1899999999999999 112.446 159.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.46 ' HE1' ' CE ' ' A' ' 122' ' ' MET . 20.8 p-90 -111.34 -18.37 12.93 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.316 -0.856 . . . . 1.6000000000000001 111.983 161.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.539 ' OE2' HG22 ' A' ' 120' ' ' THR . 0.0 OUTLIER -86.9 -87.7 0.14 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.67 1.988 . . . . 1.71 108.092 -171.431 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 24.3 p -59.84 -19.68 52.53 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 120.477 -1.39 . . . . 1.1000000000000001 112.664 168.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.98 15.89 22.89 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.669 1.604 . . . . 0.92000000000000004 114.186 -175.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.1 p -75.04 142.24 43.79 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 119.122 1.461 . . . . 1.28 110.722 172.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 52.8 t -80.72 147.61 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.455 -0.942 . . . . 0.55000000000000004 108.455 167.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -130.84 158.47 40.09 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 130.231 3.413 . . . . 2.2999999999999998 109.457 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -140.39 147.0 39.08 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 113.759 1.022 . . . . 3.0600000000000001 113.759 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.7 tt -93.4 145.13 24.71 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 115.36 -0.836 . . . . 0.91000000000000003 110.771 170.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -112.21 147.36 36.79 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 124.618 1.167 . . . . 1.3999999999999999 110.392 171.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -69.98 -27.57 25.25 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.549 2.166 . . . . 1.8200000000000001 112.497 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.451 ' CG2' ' H ' ' A' ' 103' ' ' TYR . 7.6 m 41.5 -158.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 129.002 2.921 . . . . 3.0 114.933 -174.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.419 0 CA-C-O 122.228 0.904 . . . . 2.3700000000000001 112.477 157.746 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.9 mtt . . . . . 0 CA--C 1.521 -0.156 0 CA-C-O 123.911 1.815 . . . . 2.5800000000000001 111.779 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 177.09 -123.48 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.119 1 C-N-CA 132.108 4.163 . . . . 1.9199999999999999 107.077 178.13 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . 0.27 30.0 t70 -131.33 78.6 71.76 Favored Pre-proline 0 N--CA 1.432 -1.334 0 C-N-CA 126.6 1.96 . . . . 2.54 107.699 176.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.13 -84.06 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.6 1 C-N-CA 126.876 5.05 . . . . 1.23 113.14 -171.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.65 147.56 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 C-N-CA 127.835 2.454 . . . . 0.70999999999999996 106.406 171.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.2 mm -105.77 136.05 41.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.932 -0.576 . . . . 0.84999999999999998 111.21 -174.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.5 mm -119.25 99.12 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 126.169 1.788 . . . . 0.64000000000000001 107.572 169.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -70.39 122.86 20.41 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.543 1.537 . . . . 3.0 108.968 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.6 m -162.23 123.49 2.65 Favored 'General case' 0 C--O 1.221 -0.442 0 O-C-N 121.06 -1.025 . . . . 3.48 112.687 -165.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -83.47 25.71 0.73 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.203 1.001 . . . . 2.5299999999999998 113.316 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -140.95 124.6 16.89 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.766 2.026 . . . . 2.6699999999999999 107.967 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -62.51 7.99 0.06 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 127.771 2.428 . . . . 3.3799999999999999 117.468 -169.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.08 22.8 0.07 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.761 2.424 . . . . 2.2400000000000002 112.458 -165.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.2 ttt-85 -67.39 150.12 49.38 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.503 1.121 . . . . 3.96 113.387 -174.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -82.99 150.91 26.09 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.893 0.701 . . . . 2.1899999999999999 112.893 176.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.5 p -108.07 138.8 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.502 1.521 . . . . 0.81000000000000005 111.168 169.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -108.66 103.14 1.79 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.492 -1.443 . . . . 0.69999999999999996 109.492 159.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.04 155.8 17.25 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.949 0.9 . . . . 1.24 110.554 166.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 120' ' ' THR . 40.9 p -118.11 4.94 11.99 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 116.463 2.023 . . . . 0.75 116.463 172.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.71 56.3 0.29 Allowed Glycine 0 C--N 1.33 0.224 0 CA-C-O 119.443 -0.643 . . . . 2.0800000000000001 113.016 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 79.5 -162.2 0.0 OUTLIER Pre-proline 0 CA--C 1.565 1.528 0 CA-C-O 116.61 -1.662 . . . . 3.2400000000000002 109.245 -168.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -80.55 45.93 2.11 Favored 'Trans proline' 0 C--N 1.358 1.053 0 CA-C-N 124.524 2.651 . . . . 2.2200000000000002 112.915 -173.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -166.55 163.7 17.04 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.025 1.33 . . . . 3.9300000000000002 110.785 -169.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.89 42.41 2.49 Favored Glycine 0 N--CA 1.473 1.125 0 C-N-CA 124.478 1.037 . . . . 2.2799999999999998 114.048 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.1 m -68.93 -40.6 78.93 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.657 1.229 . . . . 1.99 114.028 -160.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -106.27 -73.23 0.69 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.04 0.756 . . . . 1.8999999999999999 113.04 173.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 112' ' ' THR . 7.0 t -178.99 -166.12 0.09 Allowed 'General case' 0 N--CA 1.475 0.789 1 C-N-CA 132.685 4.394 . . . . 0.96999999999999997 106.609 -175.339 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.6 tp -98.77 138.42 23.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 119.771 1.169 . . . . 0.89000000000000001 110.729 173.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.56 ' SD ' HD21 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -141.02 163.43 32.99 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.121 1.368 . . . . 4.4500000000000002 110.441 166.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.3 m95 -130.22 87.67 2.54 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.868 -0.52 . . . . 2.3100000000000001 111.611 -155.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.56 HD21 ' SD ' ' A' ' 122' ' ' MET . 3.2 mt -95.64 167.42 11.3 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 120.498 -1.376 . . . . 0.68000000000000005 110.746 -171.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.35 88.02 15.19 Favored Pre-proline 0 N--CA 1.472 0.675 0 C-N-CA 123.592 0.757 . . . . 7.1500000000000004 111.29 -176.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -77.27 166.61 26.01 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.575 2.184 . . . . 2.3700000000000001 110.412 165.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 m -120.18 154.86 34.2 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 127.097 2.159 . . . . 1.21 108.295 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.4 p -54.95 -34.21 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 112.939 0.718 . . . . 0.75 112.939 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -82.17 -10.07 59.29 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.62 1.168 . . . . 1.6799999999999999 113.508 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -140.02 -168.34 2.5 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.696 0.68 . . . . 2.5499999999999998 112.649 -155.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.83 157.67 23.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 126.93 2.092 . . . . 0.51000000000000001 109.385 -171.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.2 144.89 36.82 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.113 0.965 . . . . 0.47999999999999998 110.968 172.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.4 ttp180 -111.74 139.3 47.33 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.443 1.02 . . . . 4.0800000000000001 112.557 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 37.8 t -60.34 156.33 15.97 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.244 1.418 . . . . 1.02 112.484 163.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -100.43 -12.85 19.03 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.063 -0.971 . . . . 1.28 112.766 169.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -103.39 -78.99 0.54 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.163 0.892 . . . . 2.5800000000000001 111.246 -169.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 26.6 p -70.02 -22.19 63.12 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.853 0.861 . . . . 1.3700000000000001 112.407 172.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.58 33.36 80.93 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.441 1.02 . . . . 1.0800000000000001 113.273 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.11 152.67 42.18 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.839 1.319 . . . . 1.96 110.508 158.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.1 t -100.24 135.4 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 106.335 -1.728 . . . . 0.57999999999999996 106.335 159.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -117.4 140.47 49.53 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 127.735 2.414 . . . . 1.6599999999999999 110.875 -176.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.8 tttm -106.14 147.47 28.96 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.639 -0.71 . . . . 2.5800000000000001 112.704 173.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.43 144.78 25.48 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 114.847 -1.069 . . . . 0.89000000000000001 110.168 155.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -106.66 159.34 30.22 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 124.596 1.158 . . . . 1.3100000000000001 113.006 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -71.8 -5.16 16.51 Favored 'Trans proline' 0 C--N 1.354 0.861 1 C-N-CA 126.274 4.65 . . . . 1.29 115.983 -177.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.9 p -48.11 142.42 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 126.141 1.777 . . . . 2.1699999999999999 111.511 177.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.717 0 CA-C-O 122.993 1.33 . . . . 1.6899999999999999 112.674 179.353 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 10.9 mtm . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 118.428 2.751 . . . . 2.54 118.428 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.32 -59.66 2.62 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.791 0.663 . . . . 2.6299999999999999 112.791 169.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.425 ' H ' ' HD3' ' A' ' 97' ' ' PRO . 0.1 OUTLIER 167.05 70.44 0.0 OUTLIER Pre-proline 0 CA--C 1.566 1.571 0 C-N-CA 129.674 3.189 . . . . 3.0 110.167 -150.201 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.425 ' HD3' ' H ' ' A' ' 96' ' ' ASP . 63.0 Cg_endo -89.02 -50.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.334 -0.229 1 C-N-CA 125.529 4.152 . . . . 0.73999999999999999 113.358 -174.244 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.98 141.74 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 1 C-N-CA 131.954 4.102 . . . . 0.53000000000000003 104.207 -172.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.3 mm -119.48 129.43 75.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 124.303 1.041 . . . . 0.71999999999999997 111.153 -175.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 42.0 mm -115.39 98.21 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 125.688 1.595 . . . . 0.55000000000000004 107.515 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -71.12 99.67 1.9 Allowed 'General case' 0 C--N 1.328 -0.361 0 O-C-N 125.569 1.793 . . . . 2.54 108.333 176.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.483 ' OG ' HD21 ' A' ' 143' ' ' LEU . 78.7 p -104.92 -43.6 5.03 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.041 1.126 . . . . 3.7000000000000002 114.041 -157.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . 0.252 35.5 m-85 72.32 9.77 5.86 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 127.742 2.417 . . . . 2.73 114.45 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -132.66 150.21 52.19 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.58 -0.896 . . . . 3.1099999999999999 108.58 134.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.05 -28.01 22.55 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.969 2.507 . . . . 3.4399999999999999 114.91 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -127.1 12.77 7.19 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.525 1.53 . . . . 2.4900000000000002 114.044 -161.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -56.57 175.28 0.12 Allowed 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 122.458 1.123 . . . . 4.04 113.25 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -95.41 169.32 10.14 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.582 -0.699 . . . . 2.5499999999999998 111.348 157.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.7 p -116.22 143.16 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 126.884 2.074 . . . . 0.85999999999999999 111.472 171.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -104.69 101.33 1.92 Allowed Glycine 0 CA--C 1.532 1.142 0 CA-C-O 117.974 -1.459 . . . . 0.82999999999999996 114.142 165.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 13.8 p -107.43 145.61 32.77 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-O 123.908 1.813 . . . . 1.1599999999999999 113.386 160.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 74.3 p -102.44 16.4 26.4 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 112.494 -2.139 . . . . 0.73999999999999999 111.627 165.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 142.45 176.0 16.2 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-O 123.693 1.718 . . . . 3.4500000000000002 114.599 -171.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.6 m -3.47 133.68 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.242 0 CA-C-N 111.757 -2.222 . . . . 3.9399999999999999 115.785 103.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.85 57.39 4.46 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 125.131 3.887 . . . . 2.8799999999999999 114.476 -169.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -169.27 48.74 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.815 1.246 . . . . 1.98 111.622 -167.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 55.7 24.69 41.25 Favored Glycine 0 N--CA 1.48 1.627 0 C-N-CA 125.077 1.322 . . . . 2.1299999999999999 115.925 166.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.2 m -77.38 -41.6 39.55 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.754 1.02 . . . . 2.0899999999999999 113.754 -144.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.438 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 25.2 p80 -115.12 -149.01 0.44 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.937 1.295 . . . . 1.51 112.395 -176.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.616 HG22 ' OE2' ' A' ' 136' ' ' GLU . 2.4 t -71.92 -155.43 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.692 0.678 . . . . 1.0900000000000001 110.987 160.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.5 tp -115.37 138.68 44.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 C-N-CA 126.483 1.913 . . . . 0.96999999999999997 111.082 165.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.525 ' CE ' ' HE1' ' A' ' 135' ' ' TRP . 13.2 mmm -131.95 153.38 50.36 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 115.144 1.535 . . . . 3.9700000000000002 115.144 -174.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -118.33 99.57 6.93 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 124.528 1.143 . . . . 1.5700000000000001 110.309 -173.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.3 mt -109.45 162.47 14.34 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.498 0.719 . . . . 0.77000000000000002 109.63 -173.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -121.89 74.57 36.87 Favored Pre-proline 0 N--CA 1.487 1.38 0 O-C-N 120.425 -1.422 . . . . 4.6600000000000001 114.782 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -86.47 39.56 0.65 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.908 3.072 . . . . 3.3399999999999999 114.922 -171.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.8 m -28.02 151.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 1 C-N-CA 132.206 4.202 . . . . 1.0700000000000001 115.27 -169.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.4 p -45.66 -39.02 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 114.703 1.372 . . . . 0.82999999999999996 114.703 177.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -81.48 -8.63 59.75 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.403 1.481 . . . . 1.47 113.823 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.402 ' O ' ' HE3' ' A' ' 142' ' ' LYS . 30.3 mt-10 -136.17 -159.53 0.97 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.34 1.056 . . . . 2.1299999999999999 110.52 -156.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 20.9 m -157.81 153.53 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 130.246 3.419 . . . . 0.79000000000000004 106.15 177.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -142.38 143.52 32.73 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.535 0.607 . . . . 0.79000000000000004 111.044 171.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -100.35 142.6 31.61 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.285 0.634 . . . . 4.8700000000000001 110.446 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 14.6 t -60.05 159.06 9.98 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 124.514 1.134 . . . . 1.04 111.52 161.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.525 ' HE1' ' CE ' ' A' ' 122' ' ' MET . 20.6 p-90 -103.96 -12.79 16.62 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.6 -0.727 . . . . 1.3999999999999999 111.703 163.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.616 ' OE2' HG22 ' A' ' 120' ' ' THR . 1.6 mm-40 -89.65 -87.05 0.18 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.933 1.293 . . . . 1.55 108.842 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 23.0 p -74.65 -15.16 60.82 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.256 1.206 . . . . 1.4299999999999999 114.256 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 66.85 18.94 69.09 Favored Glycine 0 N--CA 1.469 0.876 0 C-N-CA 126.318 1.913 . . . . 0.73999999999999999 115.075 172.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.27 141.83 57.89 Favored 'General case' 0 N--CA 1.46 0.059 0 C-N-CA 118.593 -1.243 . . . . 1.75 110.349 163.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 45.9 t -78.94 141.8 14.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 107.782 -1.192 . . . . 0.79000000000000004 107.782 159.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -122.52 156.61 33.8 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 128.082 2.553 . . . . 1.73 110.219 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 130' ' ' GLU . 66.5 tttt -136.64 152.76 50.78 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 122.315 1.055 . . . . 2.27 113.027 173.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.681 HD23 ' H ' ' A' ' 144' ' ' ASN . 6.3 tt -112.16 167.4 10.44 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.561 1.545 . . . . 1.04 109.252 174.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.681 ' H ' HD23 ' A' ' 143' ' ' LEU . 1.9 p30 -126.52 165.7 26.51 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.507 1.523 . . . . 1.45 113.581 -168.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 144' ' ' ASN . 65.0 Cg_endo -73.32 -4.43 15.4 Favored 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 124.07 3.18 . . . . 1.45 115.256 -176.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.8 p -44.54 140.35 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 127.974 2.51 . . . . 2.75 114.026 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.734 0 C-N-CA 126.541 2.02 . . . . 2.3300000000000001 110.335 -179.473 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.2 mtp . . . . . 0 C--O 1.224 -0.24 0 N-CA-C 116.985 2.217 . . . . 3.1699999999999999 116.985 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.33 -74.69 0.61 Allowed 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 124.305 1.042 . . . . 2.1699999999999999 109.29 173.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.4 t70 179.44 75.9 0.17 Allowed Pre-proline 0 CA--C 1.559 1.324 0 C-N-CA 128.242 2.617 . . . . 2.5899999999999999 107.893 -166.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 142' ' ' LYS . 60.7 Cg_endo -89.23 -51.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.551 1 C-N-CA 128.582 6.188 . . . . 0.75 113.437 -175.205 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -139.58 143.12 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 130.746 3.618 . . . . 0.57999999999999996 104.844 -175.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.0 mm -102.76 138.34 27.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.671 -0.695 . . . . 0.80000000000000004 110.822 -176.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.3 mm -120.5 107.11 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 C-N-CA 127.036 2.134 . . . . 0.67000000000000004 107.462 170.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -78.61 134.32 37.2 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 124.601 1.188 . . . . 3.2200000000000002 110.867 -174.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.448 ' O ' HG21 ' A' ' 146' ' ' VAL . 13.2 t -162.24 107.22 1.21 Allowed 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 113.144 0.794 . . . . 2.71 113.144 -163.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.3 m-30 -77.33 41.53 0.31 Allowed 'General case' 0 N--CA 1.48 1.063 0 O-C-N 120.524 -1.36 . . . . 2.5099999999999998 110.762 171.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.37 123.71 3.93 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.956 2.902 . . . . 3.1699999999999999 107.965 -166.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.54 -3.6 31.86 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 115.582 1.697 . . . . 3.3399999999999999 115.582 -166.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.36 21.64 1.06 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 125.112 1.365 . . . . 2.1099999999999999 113.662 -156.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.04 154.06 18.34 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 120.148 -1.595 . . . . 5.9800000000000004 114.991 -154.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.8 161.18 31.38 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.319 1.229 . . . . 2.0699999999999998 114.319 -177.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.4 p -129.6 145.84 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 127.455 2.302 . . . . 0.82999999999999996 109.84 171.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.17 126.74 6.39 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.155 0.883 . . . . 0.77000000000000002 111.605 164.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.97 151.97 39.09 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.366 1.867 . . . . 1.52 111.94 169.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 34.0 p -117.83 25.97 10.01 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.164 1.385 . . . . 0.97999999999999998 113.385 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.85 68.27 1.03 Allowed Glycine 0 N--CA 1.462 0.428 0 O-C-N 120.844 -1.16 . . . . 2.4900000000000002 111.017 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.46 177.71 0.06 OUTLIER Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 123.521 0.728 . . . . 3.0800000000000001 110.01 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.23 38.96 0.76 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.061 2.507 . . . . 2.6499999999999999 112.705 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -151.93 3.2 0.38 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.851 1.797 . . . . 2.1200000000000001 115.851 -165.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.38 72.22 0.98 Allowed Glycine 0 N--CA 1.474 1.188 0 C-N-CA 124.849 1.214 . . . . 1.8600000000000001 114.206 167.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.5 t -103.63 -30.38 10.5 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 115.338 1.607 . . . . 2.0899999999999999 115.338 -174.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.415 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 9.1 p80 -128.32 -148.12 0.37 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.631 0.773 . . . . 1.3300000000000001 112.042 -176.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.776 HG22 ' OE1' ' A' ' 136' ' ' GLU . 5.2 t -78.16 -152.34 0.05 Allowed 'General case' 0 N--CA 1.479 1.016 0 O-C-N 121.268 -0.895 . . . . 0.98999999999999999 111.376 167.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.5 tp -106.65 149.91 9.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 127.667 2.387 . . . . 1.22 110.212 164.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.18 172.35 12.88 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.806 1.242 . . . . 4.9299999999999997 110.036 170.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -137.45 124.96 22.08 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.004 0.521 . . . . 1.5 111.493 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.61 179.75 4.13 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.981 0.912 . . . . 0.84999999999999998 109.185 176.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.27 102.6 2.95 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.973 0.909 . . . . 6.5099999999999998 111.738 174.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -80.4 171.63 14.6 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.144 2.563 . . . . 2.3199999999999998 110.22 164.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.8 m -122.72 155.97 35.37 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 127.2 2.2 . . . . 1.1899999999999999 107.628 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.4 p -55.2 -30.9 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 120.571 1.532 . . . . 0.83999999999999997 112.485 175.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -82.93 -7.52 59.66 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.12 1.768 . . . . 1.4399999999999999 113.521 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -147.42 -169.67 3.37 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.29 1.036 . . . . 2.1600000000000001 112.146 -156.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.567 HG12 ' HG3' ' A' ' 142' ' ' LYS . 26.8 m -142.18 170.31 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 127.757 2.423 . . . . 0.63 109.739 -170.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -150.85 147.55 27.38 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.019 0.927 . . . . 0.52000000000000002 111.505 172.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.6 ttt-85 -114.11 139.2 49.52 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.64 0.776 . . . . 4.5599999999999996 112.333 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 40.1 t -56.78 157.67 5.32 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.817 1.247 . . . . 1.0 112.71 159.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 67.2 p-90 -109.68 -9.05 14.87 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.307 -0.871 . . . . 1.1699999999999999 112.691 167.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.776 ' OE1' HG22 ' A' ' 120' ' ' THR . 4.0 mm-40 -96.22 -83.8 0.37 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.992 1.317 . . . . 1.6699999999999999 109.682 -173.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.4 p -72.43 -14.99 61.83 Favored 'General case' 0 CA--C 1.551 0.983 0 O-C-N 120.644 -1.285 . . . . 1.22 112.651 167.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.49 22.64 76.57 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 119.075 -0.847 . . . . 0.73999999999999999 113.725 169.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.5 p -71.21 130.48 41.55 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 118.388 1.094 . . . . 1.6000000000000001 110.186 170.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.5 t -77.23 147.16 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.451 -0.574 . . . . 0.56000000000000005 109.451 161.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -131.52 156.61 45.4 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 130.544 3.538 . . . . 1.9299999999999999 110.523 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.567 ' HG3' HG12 ' A' ' 131' ' ' VAL . 9.5 tmtt? -140.27 153.2 46.43 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 113.59 0.959 . . . . 2.2799999999999998 113.59 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 144' ' ' ASN . 2.2 tt -100.66 144.1 30.03 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 122.042 0.925 . . . . 0.90000000000000002 112.372 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.418 ' O ' HD23 ' A' ' 143' ' ' LEU . 7.1 p30 -99.37 162.94 19.64 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.249 1.02 . . . . 1.3100000000000001 112.824 -174.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -75.51 -28.01 8.72 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.606 2.871 . . . . 1.3899999999999999 113.837 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 102' ' ' SER . 0.1 OUTLIER 47.88 -161.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 128.032 2.533 . . . . 3.5699999999999998 116.781 169.633 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.971 0 CA-C-O 122.39 0.994 . . . . 1.9299999999999999 114.863 132.224 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.9 mtm . . . . . 0 N--CA 1.469 0.515 0 CA-C-O 121.902 0.858 . . . . 2.7400000000000002 112.756 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 129.73 -132.0 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.763 1 C-N-CA 132.676 4.39 . . . . 2.75 107.822 -156.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -126.54 91.58 47.15 Favored Pre-proline 0 N--CA 1.436 -1.155 0 C-N-CA 128.882 2.873 . . . . 2.23 107.185 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -95.99 -49.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.373 1 C-N-CA 126.649 4.899 . . . . 0.70999999999999996 112.737 -178.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -150.62 138.48 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 131.5 3.92 . . . . 0.62 103.934 -171.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.5 mm -115.48 134.95 57.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 124.635 1.174 . . . . 0.75 111.047 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.3 mm -121.97 112.88 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 C-N-CA 126.336 1.854 . . . . 0.5 107.416 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -82.83 136.29 34.68 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 125.023 1.452 . . . . 2.5499999999999998 111.868 -173.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.0 t -125.4 -54.59 1.57 Allowed 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 113.995 1.109 . . . . 2.8300000000000001 113.995 -154.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.605 ' H ' ' CG2' ' A' ' 146' ' ' VAL 0.29 17.0 m-85 73.21 15.54 4.38 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.915 2.086 . . . . 3.1000000000000001 113.336 -172.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -151.57 168.06 26.14 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 131.677 3.991 . . . . 2.6400000000000001 106.986 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -72.28 -8.38 54.54 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.844 1.258 . . . . 2.8900000000000001 113.547 164.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.2 120.18 8.76 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 123.651 1.691 . . . . 3.3599999999999999 115.046 -164.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 81.1 mmt-85 -143.23 177.28 8.52 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.922 2.489 . . . . 4.4000000000000004 110.09 167.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -100.66 172.92 6.79 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.659 -0.651 . . . . 2.25 109.822 149.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.0 142.22 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.99 0.916 . . . . 0.68000000000000005 111.206 171.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -107.95 92.92 0.77 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-O 117.688 -1.618 . . . . 0.66000000000000003 113.647 169.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 12.7 p -101.24 148.26 25.32 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 119.788 1.794 . . . . 1.0600000000000001 113.478 166.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.4 p -113.11 13.0 19.26 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 113.24 -1.8 . . . . 0.66000000000000003 113.501 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.25 81.12 1.57 Allowed Glycine 0 N--CA 1.463 0.445 0 N-CA-C 110.42 -1.072 . . . . 2.4100000000000001 110.42 -176.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 10.1 p 58.24 -163.28 0.01 OUTLIER Pre-proline 0 CA--C 1.563 1.46 0 CA-C-O 117.106 -1.426 . . . . 2.7200000000000002 111.302 -171.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.08 -6.06 17.53 Favored 'Trans proline' 0 C--N 1.356 0.971 0 CA-C-N 123.321 2.222 . . . . 2.27 113.711 173.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -98.66 13.65 31.36 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.01 1.485 . . . . 1.8200000000000001 115.01 -165.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.5 34.26 88.66 Favored Glycine 0 N--CA 1.476 1.32 0 O-C-N 121.15 -0.969 . . . . 1.9299999999999999 113.866 172.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.02 -39.68 83.1 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.066 1.136 . . . . 1.77 114.066 -163.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.444 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 22.5 p80 -113.29 -149.14 0.44 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.239 1.816 . . . . 1.28 112.917 -176.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.642 HG22 ' OE2' ' A' ' 136' ' ' GLU . 2.6 t -73.41 -153.67 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 119.31 0.959 . . . . 1.1100000000000001 111.115 162.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.423 ' N ' HG23 ' A' ' 120' ' ' THR . 5.0 tp -117.86 137.83 50.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 126.896 2.078 . . . . 0.83999999999999997 111.499 165.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.468 ' CE ' ' HE1' ' A' ' 135' ' ' TRP . 13.6 mmm -131.66 151.74 51.4 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 115.527 1.676 . . . . 3.9100000000000001 115.527 -172.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -117.01 103.8 10.62 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 124.209 0.943 . . . . 1.55 110.515 -174.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.9 mt -111.53 161.91 15.67 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.202 0.601 . . . . 0.84999999999999998 110.423 -174.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.72 84.62 10.42 Favored Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 114.517 1.303 . . . . 6.2699999999999996 114.517 -171.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -88.63 14.96 2.17 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.59 2.86 . . . . 3.1000000000000001 116.265 -164.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.8 m -29.85 152.78 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 1 C-N-CA 131.804 4.041 . . . . 1.3500000000000001 115.322 -165.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.9 p -47.08 -43.21 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 115.174 1.546 . . . . 1.0900000000000001 115.174 -177.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -78.05 -5.52 51.68 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.795 1.638 . . . . 1.76 114.222 178.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -131.79 -177.45 4.43 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 122.758 1.266 . . . . 3.1000000000000001 112.169 -159.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.4 m -148.81 156.1 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 128.591 2.756 . . . . 0.79000000000000004 106.744 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.22 132.75 28.66 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 122.68 0.392 . . . . 0.81000000000000005 110.803 175.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.6 ttm-85 -86.22 138.19 32.06 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.189 -1.041 . . . . 4.04 108.189 168.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 20.7 t -57.67 153.03 14.12 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 124.398 1.061 . . . . 1.23 110.942 153.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.468 ' HE1' ' CE ' ' A' ' 122' ' ' MET . 19.2 p-90 -97.45 -18.63 18.94 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.524 -0.75 . . . . 1.8 111.471 163.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.642 ' OE2' HG22 ' A' ' 120' ' ' THR . 2.3 mm-40 -83.37 -92.31 0.07 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.129 0.971 . . . . 1.6100000000000001 108.804 -177.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 32.1 p -65.59 -15.43 62.72 Favored 'General case' 0 CA--C 1.553 1.07 0 O-C-N 120.559 -1.338 . . . . 1.3600000000000001 114.46 176.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.44 17.82 76.51 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 126.581 2.038 . . . . 0.83999999999999997 115.348 169.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.4 p -77.26 144.66 38.03 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.76 1.28 . . . . 1.5700000000000001 111.762 168.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 57.7 t -80.58 145.29 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.462 -0.57 . . . . 0.66000000000000003 109.462 162.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -125.15 147.95 48.8 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 129.114 2.966 . . . . 1.78 110.56 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.405 ' HG2' ' N ' ' A' ' 143' ' ' LEU . 48.8 tttt -124.4 154.57 40.21 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 123.746 1.736 . . . . 1.9299999999999999 113.186 169.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.405 ' N ' ' HG2' ' A' ' 142' ' ' LYS . 8.0 tt -92.04 156.38 17.44 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.542 1.537 . . . . 0.91000000000000003 110.606 165.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -120.74 139.08 28.41 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 107.434 -1.321 . . . . 1.3700000000000001 107.434 164.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.3 -30.53 30.31 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.078 2.519 . . . . 2.6800000000000002 111.837 -171.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.605 ' CG2' ' H ' ' A' ' 103' ' ' TYR . 20.3 m 41.41 -157.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 129.001 2.92 . . . . 2.2999999999999998 115.587 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.395 0 C-N-CA 127.299 2.38 . . . . 2.0800000000000001 108.678 159.25 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.1 mtm . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 121.6 0.714 . . . . 2.7999999999999998 112.347 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 151.28 -76.64 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.661 1 C-N-CA 132.927 4.491 . . . . 1.71 111.33 -176.478 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.5 t0 177.14 75.64 0.1 Allowed Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 128.373 2.669 . . . . 2.0800000000000001 109.596 -163.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -88.52 -49.68 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.387 1 C-N-CA 127.432 5.421 . . . . 0.72999999999999998 112.551 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -148.06 143.82 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 1 C-N-CA 131.916 4.086 . . . . 0.67000000000000004 104.205 -171.739 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.6 mm -107.85 146.13 14.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 124.67 1.188 . . . . 0.63 109.568 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.8 mm -127.38 107.57 16.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 126.603 1.961 . . . . 0.56000000000000005 110.314 167.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.4 mp0 -64.12 124.87 22.75 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 123.125 1.44 . . . . 3.6499999999999999 112.61 175.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.3 t -116.78 -58.31 2.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.774 -1.557 . . . . 2.7400000000000002 114.894 -157.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.59 ' H ' ' CG2' ' A' ' 146' ' ' VAL . 14.5 m-85 64.45 25.53 13.33 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.82 1.248 . . . . 3.0499999999999998 110.636 -168.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -167.4 148.92 5.68 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 128.345 2.658 . . . . 2.21 108.917 -170.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.426 ' HB2' ' CD2' ' A' ' 106' ' ' TYR . 8.5 m-20 -76.93 -25.62 53.12 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.61 -1.306 . . . . 3.1400000000000001 113.097 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.426 ' CD2' ' HB2' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -140.56 14.25 2.35 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.195 1.798 . . . . 2.3599999999999999 113.991 -150.453 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -60.41 168.3 2.16 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.784 1.234 . . . . 5.5499999999999998 112.536 174.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -106.52 159.32 16.26 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.809 1.04 . . . . 2.27 113.809 171.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.53 144.98 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 127.029 2.132 . . . . 1.04 109.917 170.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.42 100.89 1.4 Allowed Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.921 -0.933 . . . . 0.97999999999999998 111.993 165.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 1.6 t -86.59 138.47 31.67 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.047 1.339 . . . . 1.1299999999999999 112.591 171.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.9 p -109.34 22.19 16.12 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.061 1.134 . . . . 0.82999999999999996 114.061 170.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.87 55.77 0.92 Allowed Glycine 0 N--CA 1.462 0.391 0 O-C-N 120.806 -1.184 . . . . 1.8999999999999999 110.779 -175.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 65.43 -168.04 0.01 OUTLIER Pre-proline 0 CA--C 1.566 1.577 0 CA-C-O 117.799 -1.096 . . . . 3.9900000000000002 110.886 -173.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.41 6.1 5.02 Favored 'Trans proline' 0 C--N 1.355 0.899 0 CA-C-N 123.507 2.288 . . . . 2.4700000000000002 114.885 -169.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.31 13.2 13.6 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.553 1.316 . . . . 2.1600000000000001 114.553 -166.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 64.46 61.33 6.06 Favored Glycine 0 N--CA 1.473 1.139 0 CA-C-N 118.844 0.747 . . . . 1.6899999999999999 112.956 169.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 39.7 m -100.26 -26.43 13.91 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.73 1.381 . . . . 1.6000000000000001 114.73 -169.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.474 ' CE1' ' SD ' ' A' ' 122' ' ' MET . 30.3 p80 -131.59 -158.53 0.9 Allowed 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 119.671 1.123 . . . . 1.5800000000000001 111.1 168.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.45 HG23 ' SD ' ' A' ' 122' ' ' MET . 7.8 t -75.55 -152.97 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 O-C-N 121.088 -1.008 . . . . 0.84999999999999998 111.145 169.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.405 ' C ' ' SD ' ' A' ' 122' ' ' MET . 4.9 tp -112.6 131.3 64.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 117.72 2.489 . . . . 0.97999999999999998 117.72 -178.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.484 ' SD ' ' HG3' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -132.46 126.52 33.21 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 128.745 2.818 . . . . 5.1900000000000004 114.532 -169.339 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -106.98 114.18 28.11 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.299 1.04 . . . . 2.04 111.518 -167.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 mt -120.11 157.47 28.9 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.965 0.802 . . . . 0.79000000000000004 111.231 -171.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -118.49 92.96 44.76 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.249 1.42 . . . . 5.71 111.313 172.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -88.46 30.4 0.43 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.062 3.175 . . . . 3.46 114.383 -171.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.5 m -23.43 154.86 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 1 C-N-CA 133.829 4.852 . . . . 1.1699999999999999 117.863 -162.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.5 p -51.34 -33.99 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 120.061 -1.649 . . . . 0.84999999999999998 113.633 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -90.16 -6.0 55.84 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.276 1.83 . . . . 1.8700000000000001 114.077 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -138.05 -160.55 1.07 Allowed 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.87 0.868 . . . . 2.27 110.728 -159.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.518 HG12 ' HG3' ' A' ' 142' ' ' LYS . 27.3 m -156.98 160.31 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 131.179 3.792 . . . . 0.59999999999999998 106.277 -176.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -143.98 132.49 22.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 118.89 0.768 . . . . 0.64000000000000001 111.092 174.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 140' ' ' VAL . 8.2 ttm180 -90.72 129.63 36.8 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.447 0.699 . . . . 3.5099999999999998 109.128 170.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 34.1 t -55.32 140.99 37.58 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 123.955 0.784 . . . . 1.27 110.34 155.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -81.2 -14.58 57.4 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.552 -0.737 . . . . 1.3100000000000001 112.534 171.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.484 ' HG3' ' SD ' ' A' ' 122' ' ' MET . 0.5 OUTLIER -96.38 -91.17 0.24 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.635 1.174 . . . . 1.77 109.239 -169.163 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 19.0 p -58.99 -25.68 63.84 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.9 -1.125 . . . . 1.1699999999999999 112.756 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.81 25.94 73.84 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.346 0.974 . . . . 1.1000000000000001 113.139 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.3 p -69.61 125.15 25.84 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 119.215 1.508 . . . . 1.79 109.749 159.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 133' ' ' ARG . 39.9 t -79.18 147.37 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 107.156 -1.424 . . . . 0.67000000000000004 107.156 161.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -132.91 154.23 50.62 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 128.973 2.909 . . . . 2.2999999999999998 110.094 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.518 ' HG3' HG12 ' A' ' 131' ' ' VAL . 5.6 tmtt? -137.52 162.46 33.67 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.299 1.047 . . . . 2.4399999999999999 113.323 175.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.1 tt -113.0 144.69 42.14 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.469 1.128 . . . . 0.89000000000000001 113.234 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -111.87 144.29 30.38 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-N 114.291 -1.322 . . . . 1.3300000000000001 109.546 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -67.2 -28.1 40.75 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.832 2.355 . . . . 2.0699999999999998 112.009 -175.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.59 ' CG2' ' H ' ' A' ' 103' ' ' TYR . 22.1 m 42.12 -157.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 128.027 2.531 . . . . 2.7599999999999998 114.965 -173.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.925 0 C-N-CA 124.999 1.285 . . . . 2.29 110.794 139.331 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 33.1 mtp . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 117.754 2.501 . . . . 2.6800000000000002 117.754 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.14 -63.26 1.15 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.29 1.036 . . . . 1.9199999999999999 113.165 171.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.8 t0 163.55 77.38 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 128.502 2.721 . . . . 2.5099999999999998 110.173 -157.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -89.33 -50.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.411 1 C-N-CA 126.846 5.03 . . . . 0.81000000000000005 113.078 -174.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -154.77 142.4 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 1 C-N-CA 132.019 4.127 . . . . 0.5 104.585 -168.584 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.8 mm -118.3 137.74 51.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 123.985 0.914 . . . . 0.75 112.129 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.8 mm -129.2 112.9 26.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 127.29 2.236 . . . . 0.55000000000000004 109.002 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.69 124.98 25.37 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.758 1.623 . . . . 2.46 112.193 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.3 t -145.17 90.51 2.04 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 115.792 1.775 . . . . 2.98 115.792 -167.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -77.25 64.1 2.59 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.561 1.144 . . . . 3.4500000000000002 110.672 174.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.41 -13.32 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.68 2.392 . . . . 3.2000000000000002 113.477 -167.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 64.82 -7.93 0.24 Allowed 'General case' 0 CA--C 1.56 1.349 0 CA-C-N 120.74 1.609 . . . . 3.0600000000000001 115.072 -170.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -152.34 24.13 0.62 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 116.928 2.196 . . . . 2.46 116.928 -172.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -54.82 149.89 10.67 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 120.572 1.533 . . . . 4.2599999999999998 113.079 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -77.11 161.59 28.14 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.516 -0.74 . . . . 2.2400000000000002 112.18 163.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.1 p -113.76 145.66 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 126.586 1.954 . . . . 0.73999999999999999 111.511 175.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.67 113.27 4.67 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.424 1.011 . . . . 1.29 112.043 162.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 7.4 t -110.63 128.57 55.74 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.408 1.483 . . . . 1.04 113.239 174.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 32.9 p -110.54 34.36 4.0 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.546 1.313 . . . . 1.22 114.546 167.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.407 ' HA2' ' SG ' ' A' ' 137' ' ' CYS . . . 85.17 -31.74 3.69 Favored Glycine 0 N--CA 1.473 1.167 0 O-C-N 118.984 -2.322 . . . . 2.04 114.806 173.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.0 p 176.07 177.46 0.22 Allowed Pre-proline 0 CA--C 1.556 1.19 1 C-N-CA 132.468 4.307 . . . . 3.6699999999999999 106.67 -175.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.48 -15.02 47.61 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 121.721 1.614 . . . . 2.5499999999999998 113.302 167.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -101.85 55.43 0.81 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.935 1.694 . . . . 2.2999999999999998 111.55 177.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 55.31 20.81 23.8 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 118.061 1.984 . . . . 2.3700000000000001 118.061 154.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.3 m -71.17 -26.68 63.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 115.302 1.593 . . . . 1.6200000000000001 115.302 -140.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -108.0 -25.44 11.16 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 117.234 2.309 . . . . 2.79 117.234 169.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.319 4.8 t 121.12 -152.58 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 131.559 3.944 . . . . 1.51 108.563 -145.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.8 tp -130.15 142.74 43.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 130.463 3.505 . . . . 1.3999999999999999 112.383 -175.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.489 ' HG3' ' HG3' ' A' ' 136' ' ' GLU . 19.1 mmm -135.01 159.4 41.63 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 126.652 1.981 . . . . 3.7200000000000002 116.093 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -126.79 113.88 17.21 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.693 0.797 . . . . 1.99 110.222 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 mt -122.65 159.68 27.37 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.099 0.959 . . . . 0.89000000000000001 109.681 -171.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.16 80.92 70.88 Favored Pre-proline 0 N--CA 1.477 0.918 0 O-C-N 120.758 -1.214 . . . . 5.0999999999999996 113.171 -166.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.08 177.59 8.69 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.201 2.601 . . . . 2.5699999999999998 110.822 170.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.0 m -151.94 159.59 43.75 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.883 2.073 . . . . 0.87 107.972 -177.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.402 ' N ' HD22 ' A' ' 143' ' ' LEU . 2.6 p -53.19 -42.36 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.514 1.126 . . . . 1.02 113.583 -172.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -77.75 -2.08 34.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.944 1.298 . . . . 1.5700000000000001 113.633 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -140.82 -172.05 3.38 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 122.227 1.013 . . . . 2.3500000000000001 112.881 -150.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.9 m -153.27 161.11 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 128.102 2.561 . . . . 0.59999999999999998 107.841 -175.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.7 130.63 24.56 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.598 1.159 . . . . 0.52000000000000002 110.884 175.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.417 ' HA ' ' HA ' ' A' ' 140' ' ' VAL . 2.6 ttp180 -91.55 134.59 34.53 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.136 0.88 . . . . 5.0599999999999996 109.481 171.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 24.4 t -55.64 155.2 5.88 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.99 0.916 . . . . 0.94999999999999996 111.515 162.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.41 ' NE1' ' SD ' ' A' ' 122' ' ' MET . 30.1 p-90 -89.71 -17.05 29.06 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.184 -0.948 . . . . 1.23 111.944 166.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.489 ' HG3' ' HG3' ' A' ' 122' ' ' MET . 4.9 mt-10 -89.25 -101.54 0.09 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.627 1.171 . . . . 2.2200000000000002 109.892 -175.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . 0.407 ' SG ' ' HA2' ' A' ' 113' ' ' GLY . 27.9 p -60.57 -9.6 4.0 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 119.169 -2.207 . . . . 1.24 116.144 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.37 26.83 64.68 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 127.574 2.511 . . . . 0.77000000000000002 113.836 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.26 150.48 48.21 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.768 1.784 . . . . 1.5700000000000001 109.853 161.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 133' ' ' ARG . 69.1 t -100.54 141.11 17.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 N-CA-C 104.945 -2.243 . . . . 0.60999999999999999 104.945 169.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -123.34 139.63 53.84 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 126.877 2.071 . . . . 2.04 110.057 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.7 tttt -121.49 145.85 47.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.233 1.016 . . . . 2.8500000000000001 112.173 -175.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 128' ' ' VAL . 8.9 tt -103.76 152.69 21.56 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.194 -1.366 . . . . 1.0700000000000001 110.208 175.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -111.9 154.61 44.07 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 114.022 -1.444 . . . . 1.45 112.317 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -71.62 -3.62 13.44 Favored 'Trans proline' 0 N--CA 1.482 0.838 1 C-N-CA 126.219 4.613 . . . . 1.6200000000000001 115.68 -175.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.5 p -42.97 138.65 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 127.299 2.24 . . . . 2.3700000000000001 112.026 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 122.245 0.914 . . . . 2.75 110.959 -171.953 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.8 mtm . . . . . 0 N--CA 1.467 0.413 0 N-CA-C 116.715 2.117 . . . . 2.1899999999999999 116.715 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.464 ' HD2' ' H ' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -114.84 -117.81 0.32 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.488 -1.671 . . . . 2.8300000000000001 106.488 160.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.464 ' H ' ' HD2' ' A' ' 95' ' ' LYS 0.312 38.8 t70 -129.1 82.68 68.0 Favored Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 126.217 1.807 . . . . 2.6499999999999999 106.262 -178.237 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -87.56 -47.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.789 1 C-N-CA 128.089 5.859 . . . . 0.76000000000000001 113.489 -171.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 mm -146.91 141.47 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 131.247 3.819 . . . . 0.56000000000000005 103.269 -171.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.1 mm -108.98 140.89 25.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 C-N-CA 124.81 1.244 . . . . 0.65000000000000002 110.052 -175.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.7 mm -130.63 109.59 17.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 126.513 1.925 . . . . 0.51000000000000001 110.008 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.0 mp0 -63.82 136.92 57.79 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.709 1.604 . . . . 4.1900000000000004 112.863 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.0 t -165.67 133.88 3.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.752 -1.113 . . . . 2.7999999999999998 110.207 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 -86.99 -4.15 59.15 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 118.854 0.752 . . . . 2.8799999999999999 110.922 166.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -95.59 156.66 16.23 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.596 1.959 . . . . 2.4500000000000002 110.652 168.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -73.45 -24.38 60.22 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.903 1.681 . . . . 3.96 113.371 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -134.71 2.21 3.15 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.418 1.636 . . . . 2.48 115.418 -164.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.68 132.19 6.5 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.544 1.537 . . . . 7.1699999999999999 113.118 -177.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -78.35 152.26 32.43 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.029 1.122 . . . . 2.3399999999999999 114.029 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.0 p -101.5 144.2 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.378 1.471 . . . . 0.83999999999999997 111.775 175.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.06 89.65 0.77 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.849 1.69 . . . . 0.76000000000000001 113.737 163.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 3.7 p -99.22 143.55 29.36 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 119.602 1.701 . . . . 1.54 112.156 168.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 62.9 p -114.73 23.98 12.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.214 -1.357 . . . . 1.0 111.84 174.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.53 -168.45 14.66 Favored Glycine 0 CA--C 1.503 -0.681 0 CA-C-O 124.098 1.943 . . . . 2.4399999999999999 114.025 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -37.21 139.02 0.53 Allowed Pre-proline 0 CA--C 1.549 0.924 0 CA-C-N 110.853 -2.674 . . . . 3.9700000000000002 111.453 151.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.98 -13.6 28.27 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.884 3.723 . . . . 3.02 116.913 -155.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -85.82 6.34 28.57 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.758 1.021 . . . . 2.52 113.758 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.33 82.22 0.76 Allowed Glycine 0 C--N 1.34 0.758 0 N-CA-C 110.114 -1.194 . . . . 1.8 110.114 -176.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.88 -64.51 1.16 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.635 0.731 . . . . 2.3100000000000001 111.346 178.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.428 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 34.4 p80 -100.56 -153.54 0.45 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.335 0.865 . . . . 1.74 113.335 -164.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.513 HG22 ' OE2' ' A' ' 136' ' ' GLU . 5.8 t -70.2 -154.32 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 123.606 0.762 . . . . 1.9099999999999999 109.355 161.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.2 tp -116.3 140.96 36.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 C-N-CA 127.072 2.149 . . . . 1.3400000000000001 109.827 168.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 13.6 mmm -126.35 159.42 33.26 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 114.099 1.148 . . . . 4.0999999999999996 114.099 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -125.09 67.25 1.12 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.025 0.75 . . . . 1.8500000000000001 113.025 -167.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.7 mt -87.67 157.86 18.98 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.254 -0.904 . . . . 0.67000000000000004 109.572 -165.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -127.43 77.58 75.65 Favored Pre-proline 0 N--CA 1.48 1.051 0 CA-C-N 119.753 1.161 . . . . 6.75 111.429 -166.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -89.23 33.96 0.37 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.522 3.482 . . . . 3.3599999999999999 116.318 -156.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -15.25 144.16 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.287 1 C-N-CA 133.234 4.614 . . . . 0.96999999999999997 117.527 -166.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.407 ' HB ' HD22 ' A' ' 143' ' ' LEU . 12.1 p -56.14 -32.79 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 120.491 -1.381 . . . . 0.93999999999999995 111.477 174.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -78.46 -11.25 59.94 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.543 1.937 . . . . 2.0800000000000001 114.456 174.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -143.19 -141.38 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.409 1.083 . . . . 1.98 111.284 -164.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.43 HG12 ' HG3' ' A' ' 142' ' ' LYS . 26.8 m -162.19 167.81 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 1 C-N-CA 134.029 4.932 . . . . 0.82999999999999996 106.504 -176.429 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -148.96 142.9 25.77 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.322 0.965 . . . . 0.66000000000000003 111.713 163.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -100.94 142.6 32.19 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.438 0.695 . . . . 5.4100000000000001 111.569 177.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 15.7 t -63.58 154.53 32.39 Favored 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 124.586 1.179 . . . . 1.1699999999999999 111.15 161.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 17.8 p-90 -100.56 -19.94 15.92 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.814 -1.084 . . . . 1.48 111.463 163.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.513 ' OE2' HG22 ' A' ' 120' ' ' THR . 3.8 mm-40 -81.5 -87.64 0.09 Allowed 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 107.555 -1.276 . . . . 1.79 107.555 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 27.4 p -72.1 -12.25 61.12 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 114.671 1.36 . . . . 1.1499999999999999 114.671 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.33 6.45 83.66 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.887 1.232 . . . . 1.24 114.688 168.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.5 p -69.28 137.43 53.04 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.051 1.74 . . . . 1.76 110.167 173.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 62.0 t -80.19 148.92 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 108.866 -0.79 . . . . 0.87 108.866 159.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -128.47 154.41 46.12 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 129.316 3.046 . . . . 1.8500000000000001 109.724 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.43 ' HG3' HG12 ' A' ' 131' ' ' VAL . 8.2 tmtt? -137.53 157.39 46.65 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.129 0.966 . . . . 2.5499999999999998 112.535 178.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.407 HD22 ' HB ' ' A' ' 128' ' ' VAL . 8.2 tt -111.39 146.5 37.04 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 123.136 1.446 . . . . 0.91000000000000003 112.185 -178.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -99.83 153.72 37.62 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 114.085 -1.416 . . . . 1.3400000000000001 113.585 -170.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.85 -4.85 15.59 Favored 'Trans proline' 0 C--N 1.348 0.535 1 C-N-CA 125.398 4.065 . . . . 1.46 114.984 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.9 p -43.5 142.56 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 126.766 2.027 . . . . 1.8999999999999999 112.086 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.832 0 CA-C-O 123.474 1.597 . . . . 1.53 112.494 -177.036 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 19.2 mtt . . . . . 0 C--O 1.224 -0.288 0 N-CA-C 118.69 2.848 . . . . 2.1099999999999999 118.69 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -61.72 2.11 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.541 0.941 . . . . 1.98 113.541 171.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.462 ' N ' ' HD3' ' A' ' 97' ' ' PRO . 0.0 OUTLIER 173.38 72.09 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 128.389 2.676 . . . . 4.5999999999999996 110.213 -150.129 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.462 ' HD3' ' N ' ' A' ' 96' ' ' ASP . 93.6 Cg_endo -96.48 -48.55 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 125.245 3.964 . . . . 0.93000000000000005 113.535 -175.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -158.55 145.51 8.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 1 C-N-CA 132.353 4.261 . . . . 0.57999999999999996 104.556 -167.326 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.5 mm -118.09 139.12 46.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 124.344 1.057 . . . . 0.59999999999999998 110.303 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.4 mm -128.39 147.18 32.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 127.067 2.147 . . . . 0.71999999999999997 106.877 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.565 ' HG2' HG11 ' A' ' 146' ' ' VAL . 83.1 mt-10 -109.64 170.15 8.25 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.579 1.152 . . . . 2.6800000000000002 110.913 177.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.2 t -159.2 -43.78 0.06 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.981 1.104 . . . . 3.3900000000000001 113.981 -176.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 65.61 37.88 5.69 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 124.515 1.135 . . . . 2.23 110.117 -171.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -143.14 -84.78 0.16 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.931 2.092 . . . . 3.29 108.855 172.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t70 175.3 -39.54 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 129.293 3.037 . . . . 3.8399999999999999 109.721 -177.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -116.61 -52.38 2.56 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.012 1.486 . . . . 2.8399999999999999 115.012 -167.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 7.39 -113.37 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 129.722 3.209 . . . . 5.0999999999999996 114.648 -162.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -163.17 160.5 24.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.084 1.354 . . . . 2.0800000000000001 111.848 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.8 p -112.39 137.56 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.214 1.406 . . . . 0.81999999999999995 109.791 166.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.08 87.45 0.45 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.215 1.388 . . . . 0.84999999999999998 111.915 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 7.9 p -97.74 146.34 25.46 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 123.721 1.725 . . . . 1.3200000000000001 112.999 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 56.9 p -112.2 15.62 20.39 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 112.85 -1.977 . . . . 0.80000000000000004 112.346 171.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.93 -130.54 8.08 Favored Glycine 0 C--N 1.337 0.596 0 O-C-N 120.939 -1.1 . . . . 3.1000000000000001 111.611 -171.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.56 -52.5 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 116.07 -1.919 . . . . 4.04 113.728 -171.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -80.26 52.8 4.47 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.307 2.005 . . . . 6.3700000000000001 109.598 166.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 66.88 99.04 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.231 1.812 . . . . 3.0499999999999998 114.331 168.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 63.91 31.27 80.26 Favored Glycine 0 N--CA 1.476 1.346 0 O-C-N 120.391 -1.443 . . . . 2.0099999999999998 113.514 173.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -45.49 90.84 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.246 1.418 . . . . 1.3999999999999999 112.458 -168.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.451 ' CE1' ' SD ' ' A' ' 122' ' ' MET . 34.3 p80 -108.18 -142.31 0.38 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.768 1.627 . . . . 1.49 111.439 177.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.558 HG22 ' OE2' ' A' ' 136' ' ' GLU . 10.7 t -89.13 -141.68 0.14 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.404 1.081 . . . . 0.84999999999999998 109.273 163.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.456 ' N ' HG23 ' A' ' 120' ' ' THR . 4.9 tp -122.07 132.88 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 128.545 2.738 . . . . 0.94999999999999996 116.603 173.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.467 ' SD ' ' HG3' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -127.69 149.02 50.4 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 129.462 3.105 . . . . 5.1100000000000003 112.814 -174.513 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -127.98 119.89 26.44 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.91 0.884 . . . . 1.7 110.267 -174.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.57 163.18 23.97 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.834 0.854 . . . . 0.92000000000000004 110.651 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -110.4 90.0 9.53 Favored Pre-proline 0 N--CA 1.483 1.215 0 C-N-CA 124.382 1.073 . . . . 5.9000000000000004 111.793 176.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -76.53 -45.13 0.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 CA-C-O 116.854 -1.394 . . . . 3.1499999999999999 112.866 -169.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 68.56 145.08 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 130.372 3.469 . . . . 1.1499999999999999 110.91 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.01 -40.34 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.759 0.79 . . . . 1.4199999999999999 109.919 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -66.74 -20.73 66.02 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 126.541 1.936 . . . . 2.02 113.336 172.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -135.36 -160.27 1.04 Allowed 'General case' 0 C--N 1.342 0.253 0 CA-C-N 120.583 1.538 . . . . 2.98 110.815 -164.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.2 m -147.44 155.95 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 127.699 2.4 . . . . 0.52000000000000002 107.834 176.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.6 137.23 33.52 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.242 0.617 . . . . 0.58999999999999997 111.33 170.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.2 ttp85 -98.14 138.48 35.37 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.868 0.304 . . . . 4.2400000000000002 110.774 172.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 49.6 t -61.37 156.38 19.16 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 123.045 1.402 . . . . 1.1000000000000001 111.465 160.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -98.78 -15.98 19.09 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.118 -1.401 . . . . 1.28 112.521 169.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.558 ' OE2' HG22 ' A' ' 120' ' ' THR . 0.1 OUTLIER -98.65 -85.03 0.39 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.091 2.156 . . . . 1.6200000000000001 109.787 -168.262 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 29.5 p -67.35 -19.71 65.47 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 120.823 1.647 . . . . 1.28 112.797 170.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.44 16.72 80.46 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.022 0.82 . . . . 0.70999999999999996 113.786 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.98 143.92 57.08 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 119.681 1.741 . . . . 1.9399999999999999 111.453 171.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 59.6 t -92.35 136.9 23.44 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 N-CA-C 105.656 -1.979 . . . . 0.58999999999999997 105.656 161.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -120.03 137.97 53.79 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 126.356 1.863 . . . . 1.74 109.209 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -106.12 150.56 25.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 123.542 0.527 . . . . 1.8700000000000001 110.103 164.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.696 HD23 ' H ' ' A' ' 144' ' ' ASN . 0.5 OUTLIER -85.7 -171.5 3.63 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 122.309 1.052 . . . . 2.25 108.88 158.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.696 ' H ' HD23 ' A' ' 143' ' ' LEU . 1.1 t-20 -143.93 169.09 10.97 Favored Pre-proline 0 C--N 1.318 -0.799 0 C-N-CA 126.767 2.027 . . . . 4.2599999999999998 109.709 -174.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -89.6 1.28 5.72 Favored 'Trans proline' 0 N--CA 1.46 -0.482 1 C-N-CA 125.466 4.11 . . . . 1.54 114.576 -165.595 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.565 HG11 ' HG2' ' A' ' 101' ' ' GLU . 8.5 p -40.78 142.58 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 1 C-N-CA 132.022 4.129 . . . . 2.3300000000000001 113.56 175.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.861 0 C-N-CA 128.101 2.762 . . . . 1.76 108.926 -166.982 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.2 mtm . . . . . 0 N--CA 1.467 0.385 0 N-CA-C 119.416 3.117 . . . . 2.0099999999999998 119.416 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.59 -62.17 1.55 Allowed 'General case' 0 C--N 1.316 -0.849 0 O-C-N 121.896 -0.502 . . . . 2.3100000000000001 111.43 167.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.415 ' N ' ' HD3' ' A' ' 97' ' ' PRO . 37.8 t70 168.02 66.54 0.01 OUTLIER Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 130.032 3.333 . . . . 2.73 108.659 -163.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 142' ' ' LYS . 51.5 Cg_endo -80.08 -71.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 1 C-N-CA 128.21 5.94 . . . . 1.0 113.562 -168.596 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.45 ' H ' ' HG2' ' A' ' 97' ' ' PRO . 0.6 OUTLIER -112.37 145.87 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 130.876 3.67 . . . . 0.64000000000000001 104.473 174.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.7 mm -106.74 143.19 17.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 124.016 0.927 . . . . 0.67000000000000004 111.044 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.9 mm -125.75 114.13 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 126.761 2.024 . . . . 0.60999999999999999 109.021 167.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -66.21 138.41 57.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.938 1.351 . . . . 3.71 112.249 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.4 t -160.63 118.1 2.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.097 -0.956 . . . . 3.1099999999999999 111.723 -169.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -87.74 10.0 19.77 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 118.44 0.564 . . . . 2.3900000000000001 112.088 167.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -105.66 -60.26 1.65 Allowed 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.755 1.622 . . . . 3.0699999999999998 113.162 -172.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.579 ' OD1' HG12 ' A' ' 128' ' ' VAL . 23.7 t0 119.92 -48.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 1 C-N-CA 133.55 4.74 . . . . 4.2300000000000004 109.01 -167.511 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.85 -3.59 59.08 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 119.906 -1.746 . . . . 2.23 113.629 -168.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -52.25 121.75 7.44 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.846 1.658 . . . . 4.0999999999999996 113.102 -163.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -82.36 164.23 21.2 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 114.555 1.317 . . . . 2.0 114.555 -168.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.8 t -97.98 137.43 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.543 1.937 . . . . 2.1200000000000001 112.093 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -115.27 69.35 0.26 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.952 1.263 . . . . 1.1699999999999999 111.995 164.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 4.2 t -82.53 133.92 35.19 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.994 0.918 . . . . 0.95999999999999996 111.679 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 57.3 p -113.18 25.95 10.9 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.495 1.118 . . . . 0.85999999999999999 113.636 168.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.43 66.57 1.46 Allowed Glycine 0 N--CA 1.462 0.431 0 O-C-N 120.822 -1.174 . . . . 2.3999999999999999 110.793 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 68.73 174.03 0.08 OUTLIER Pre-proline 0 CA--C 1.563 1.442 0 C-N-CA 123.464 0.705 . . . . 2.9300000000000002 110.856 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.7 -8.71 22.89 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 121.881 1.72 . . . . 2.1800000000000002 114.704 -169.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.56 4.73 46.0 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.355 1.243 . . . . 2.02 114.355 -173.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.73 81.37 0.37 Allowed Glycine 0 N--CA 1.471 1.006 0 C-N-CA 125.12 1.343 . . . . 1.6599999999999999 112.465 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.6 m -102.33 -35.91 8.65 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.413 1.264 . . . . 1.4199999999999999 114.413 -174.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.439 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 6.6 p80 -122.98 -153.71 0.57 Allowed 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.611 -0.681 . . . . 1.3600000000000001 111.935 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.746 HG22 ' OE1' ' A' ' 136' ' ' GLU . 5.5 t -72.25 -154.51 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 119.423 1.01 . . . . 1.0700000000000001 111.415 168.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.3 tp -108.96 146.81 14.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 126.711 2.004 . . . . 1.01 109.816 163.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.613 ' SD ' HD21 ' A' ' 124' ' ' LEU . 4.7 ppp? -154.76 163.5 40.16 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.189 0.811 . . . . 3.7599999999999998 113.189 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.409 ' O ' HD23 ' A' ' 124' ' ' LEU . 5.6 m95 -127.8 126.92 42.63 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.601 0.963 . . . . 1.51 113.601 -162.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.613 HD21 ' SD ' ' A' ' 122' ' ' MET . 5.6 mt -131.92 158.35 41.62 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.553 1.141 . . . . 0.72999999999999998 111.535 -174.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.43 83.1 16.07 Favored Pre-proline 0 CA--C 1.561 1.399 0 C-N-CA 125.976 1.71 . . . . 6.0700000000000003 112.272 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -82.35 27.01 0.61 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.936 3.757 . . . . 3.27 115.704 -165.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.447 HG22 ' OD1' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -20.32 148.84 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 1 C-N-CA 133.169 4.588 . . . . 1.0 116.901 -163.479 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.579 HG12 ' OD1' ' A' ' 105' ' ' ASP . 5.0 p -59.15 -32.75 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 O-C-N 120.418 -1.426 . . . . 0.82999999999999996 111.124 175.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -73.35 -12.27 60.77 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 128.407 2.683 . . . . 2.21 113.977 174.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.418 ' HB3' ' H ' ' A' ' 131' ' ' VAL . 31.5 mt-10 -144.61 -146.66 0.19 Allowed 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 123.761 0.824 . . . . 2.25 111.561 -161.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.466 HG12 ' HG3' ' A' ' 142' ' ' LYS . 32.0 m -159.32 170.79 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.67 1 C-N-CA 134.29 5.036 . . . . 0.81000000000000005 106.133 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -146.6 143.6 28.95 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.32 -0.862 . . . . 0.51000000000000001 112.21 164.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.403 ' HG3' HG22 ' A' ' 140' ' ' VAL . 14.3 ttm-85 -100.55 136.66 40.08 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.632 1.573 . . . . 5.6299999999999999 110.045 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.475 ' HA ' ' HE1' ' A' ' 122' ' ' MET . 52.3 t -68.29 167.32 14.66 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 122.475 1.131 . . . . 1.1299999999999999 112.945 161.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 46.5 p-90 -122.46 -12.24 8.21 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.449 1.5 . . . . 1.29 112.155 171.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.746 ' OE1' HG22 ' A' ' 120' ' ' THR . 4.1 mm-40 -94.93 -61.73 1.44 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.685 0.794 . . . . 2.02 110.624 -174.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 29.9 p -95.12 -15.77 23.11 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.961 1.304 . . . . 1.0800000000000001 112.63 166.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.43 16.76 78.83 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 120.896 -1.127 . . . . 0.93000000000000005 114.341 174.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.7 p -68.32 126.73 30.5 Favored 'General case' 0 C--N 1.335 -0.041 0 CA-C-N 119.76 1.78 . . . . 1.5800000000000001 109.642 173.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.403 HG22 ' HG3' ' A' ' 133' ' ' ARG . 46.2 t -75.73 147.03 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 119.657 -0.817 . . . . 0.67000000000000004 109.079 161.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -128.0 152.71 47.59 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 130.097 3.359 . . . . 2.1000000000000001 110.41 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.492 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 9.6 tmtt? -140.4 157.74 45.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 122.257 1.027 . . . . 2.48 113.203 174.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.3 tt -114.39 143.67 44.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 122.763 1.268 . . . . 0.89000000000000001 113.085 -175.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -98.75 155.82 36.28 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-N 114.18 -1.373 . . . . 1.3 112.046 -170.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.1 -4.02 14.59 Favored 'Trans proline' 0 C--N 1.352 0.753 1 C-N-CA 125.904 4.403 . . . . 1.51 115.428 -174.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.3 p -40.94 148.61 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 128.433 2.693 . . . . 2.0099999999999998 113.736 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.545 0 O-C-N 120.809 -1.182 . . . . 1.5700000000000001 110.722 175.494 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.4 mtm . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 118.229 2.678 . . . . 2.0099999999999998 118.229 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.23 -123.9 0.06 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.741 1.258 . . . . 2.5899999999999999 108.363 157.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -120.61 90.02 45.4 Favored Pre-proline 0 N--CA 1.433 -1.304 0 C-N-CA 129.222 3.009 . . . . 2.48 107.658 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -90.45 -42.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.26 1 C-N-CA 127.174 5.249 . . . . 1.03 112.352 -178.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 mm -155.68 140.16 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 130.462 3.505 . . . . 0.96999999999999997 104.341 -168.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.2 mm -108.22 136.27 44.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 124.68 1.192 . . . . 0.76000000000000001 109.48 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.7 mm -130.7 112.28 22.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 127.836 2.454 . . . . 0.70999999999999996 107.043 176.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -64.94 172.85 2.62 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 125.432 1.707 . . . . 3.1800000000000002 110.345 171.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 98.7 p -157.84 -57.17 0.08 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.039 -0.982 . . . . 2.9900000000000002 113.471 -166.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.6 ' CD1' HG23 ' A' ' 146' ' ' VAL . 12.7 m-85 64.27 27.0 13.81 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 126.742 2.017 . . . . 3.0499999999999998 110.825 -165.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -169.05 160.68 10.08 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 129.489 3.115 . . . . 3.6699999999999999 110.409 -174.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -83.3 3.94 29.29 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 115.422 1.638 . . . . 2.9700000000000002 115.422 -171.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -162.5 35.28 0.11 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 114.781 1.401 . . . . 2.0899999999999999 114.781 -158.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -79.99 -164.99 0.75 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.043 1.337 . . . . 5.5999999999999996 113.465 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -140.73 157.88 44.78 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.245 1.202 . . . . 2.02 114.245 -172.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.1 p -120.22 149.22 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.989 2.116 . . . . 1.0800000000000001 110.916 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.52 122.01 5.22 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 118.964 -0.909 . . . . 0.76000000000000001 112.88 157.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 15.0 p -114.32 152.48 31.35 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 123.191 1.472 . . . . 1.0700000000000001 113.679 169.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 120' ' ' THR . 50.2 p -107.15 38.85 2.01 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 113.247 -1.797 . . . . 1.0 111.629 170.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.421 ' HA2' ' CD2' ' A' ' 119' ' ' HIS . . . 98.13 22.55 14.89 Favored Glycine 0 C--O 1.226 -0.356 0 CA-C-O 118.802 -0.999 . . . . 1.8100000000000001 113.969 -177.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.425 ' HB2' ' HD2' ' A' ' 115' ' ' PRO . 5.8 p 89.24 175.09 0.04 OUTLIER Pre-proline 0 N--CA 1.483 1.22 0 C-N-CA 127.409 2.284 . . . . 2.6800000000000002 109.844 -151.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 114' ' ' SER . 17.8 Cg_endo -60.53 -19.85 61.45 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.08 2.52 . . . . 2.8999999999999999 114.617 167.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -84.67 52.7 2.46 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.564 1.074 . . . . 3.7599999999999998 112.324 178.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 38.44 59.14 1.61 Allowed Glycine 0 N--CA 1.472 1.076 0 C-N-CA 126.171 1.844 . . . . 2.6400000000000001 116.022 154.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.401 ' HB2' ' HA3' ' A' ' 113' ' ' GLY . 13.7 m -115.12 -19.47 10.84 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.605 1.335 . . . . 1.78 114.605 -166.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.541 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 14.0 p80 -148.03 -158.81 0.95 Allowed 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 120.374 1.443 . . . . 1.72 114.151 171.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.624 HG22 ' OE2' ' A' ' 136' ' ' GLU . 5.2 t -66.09 -164.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.06 1.344 . . . . 0.81999999999999995 111.193 169.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.9 tp -103.06 145.36 12.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 O-C-N 120.454 -1.403 . . . . 1.1000000000000001 110.625 165.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.607 ' SD ' HD21 ' A' ' 124' ' ' LEU . 3.4 ppp? -150.66 172.71 15.12 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.081 1.752 . . . . 3.6000000000000001 110.277 176.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -138.98 128.96 25.1 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.311 0.856 . . . . 1.8999999999999999 113.311 -169.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.607 HD21 ' SD ' ' A' ' 122' ' ' MET . 5.8 mt -126.0 153.08 44.87 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.989 0.916 . . . . 0.81999999999999995 110.822 -171.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -124.39 101.22 34.52 Favored Pre-proline 0 N--CA 1.477 0.878 0 CA-C-O 118.219 -0.895 . . . . 5.0599999999999996 112.434 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -80.82 169.59 16.39 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.603 2.202 . . . . 2.3500000000000001 110.223 162.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -123.88 156.09 36.89 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.939 2.096 . . . . 1.26 107.886 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.6 p -51.16 -35.9 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 O-C-N 120.582 -1.324 . . . . 1.0600000000000001 113.862 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -89.34 -1.83 58.21 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.176 1.176 . . . . 1.72 114.176 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -145.03 176.3 9.6 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 123.109 1.433 . . . . 2.7000000000000002 114.472 -158.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.45 HG12 ' HG3' ' A' ' 142' ' ' LYS . 18.6 m -125.07 154.57 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 128.408 2.683 . . . . 0.57999999999999996 109.648 -172.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -132.79 139.41 47.51 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.55 1.14 . . . . 0.59999999999999998 110.674 173.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.1 ttp-105 -111.95 142.89 43.79 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.358 0.526 . . . . 4.6399999999999997 111.7 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 42.2 t -60.64 157.57 14.25 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 122.77 1.271 . . . . 0.97999999999999998 113.431 167.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.442 ' H ' ' HE1' ' A' ' 122' ' ' MET . 49.7 p-90 -107.44 -14.29 14.89 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.005 1.322 . . . . 1.3300000000000001 112.055 168.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.624 ' OE2' HG22 ' A' ' 120' ' ' THR . 0.1 OUTLIER -92.29 -67.85 0.83 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.726 1.21 . . . . 1.6899999999999999 110.376 -175.785 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 26.6 p -91.19 -12.71 34.55 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 126.338 1.855 . . . . 1.0800000000000001 114.095 172.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.43 12.51 69.75 Favored Glycine 0 CA--C 1.532 1.108 0 O-C-N 121.069 -1.019 . . . . 0.72999999999999998 115.267 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.4 p -73.31 134.86 44.29 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.86 2.33 . . . . 1.55 111.394 174.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.2 t -75.84 150.18 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 109.922 -0.399 . . . . 0.67000000000000004 109.922 165.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -138.59 142.17 39.19 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 130.49 3.516 . . . . 2.2200000000000002 109.073 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.45 ' HG3' HG12 ' A' ' 131' ' ' VAL . 1.6 tmtt? -127.75 153.38 46.61 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 113.224 0.824 . . . . 2.3300000000000001 113.224 -174.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.14 137.58 34.01 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.465 0.542 . . . . 1.1499999999999999 112.465 176.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 37.2 p-10 -105.31 150.18 38.59 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 108.416 -0.957 . . . . 1.29 108.416 166.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.43 -31.5 21.88 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.038 2.492 . . . . 2.3500000000000001 113.294 -172.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.6 HG23 ' CD1' ' A' ' 103' ' ' TYR 0.266 3.5 m 47.05 -165.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 129.54 3.136 . . . . 2.8399999999999999 116.85 -179.369 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.616 0 C-N-CA 125.414 1.483 . . . . 2.2799999999999998 111.614 168.217 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 9.4 mtm . . . . . 0 C--O 1.224 -0.269 0 N-CA-C 119.198 3.036 . . . . 2.0499999999999998 119.198 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -62.12 1.77 Allowed 'General case' 0 C--N 1.32 -0.699 0 O-C-N 121.993 -0.442 . . . . 2.1400000000000001 112.143 166.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.3 t70 165.43 73.1 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 128.571 2.749 . . . . 2.5299999999999998 110.486 -157.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -87.28 -98.18 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.695 1 C-N-CA 126.863 5.042 . . . . 1.5700000000000001 113.746 -168.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -87.81 147.88 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 C-N-CA 126.948 2.099 . . . . 0.80000000000000004 106.582 170.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 21.1 mm -110.26 140.31 29.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 123.423 0.689 . . . . 0.93999999999999995 112.544 -170.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.6 mm -127.74 124.11 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 127.373 2.269 . . . . 0.68999999999999995 109.161 173.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.66 146.5 32.44 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.729 1.212 . . . . 2.6099999999999999 111.463 174.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.1 t -151.43 -50.55 0.12 Allowed 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 117.153 2.279 . . . . 2.5099999999999998 117.153 -168.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 77.62 -11.24 1.23 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 116.644 2.09 . . . . 2.6400000000000001 116.644 176.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.22 21.43 6.72 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 127.228 2.211 . . . . 2.71 111.475 -174.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 63.53 -16.18 0.07 Allowed 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 119.251 3.056 . . . . 3.2400000000000002 119.251 174.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -129.56 -68.21 0.73 Allowed 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 122.287 2.312 . . . . 3.0800000000000001 114.952 -179.637 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 58.77 -168.79 0.14 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.081 1.752 . . . . 3.9100000000000001 113.521 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -119.5 163.2 17.63 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.048 -1.032 . . . . 2.1200000000000001 109.992 150.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.8 p -116.43 137.76 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.397 1.079 . . . . 0.71999999999999997 110.514 169.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -117.03 112.72 2.57 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.042 0.829 . . . . 0.80000000000000004 111.316 168.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.622 ' H ' ' HE2' ' A' ' 122' ' ' MET . 0.8 OUTLIER -117.01 155.8 28.57 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.171 1.788 . . . . 0.88 113.447 173.242 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.9 p -125.16 16.71 8.43 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.958 1.303 . . . . 0.83999999999999997 114.054 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.74 70.21 1.18 Allowed Glycine 0 C--N 1.335 0.506 0 O-C-N 120.91 -1.119 . . . . 2.73 110.557 -177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 70.06 176.43 0.07 OUTLIER Pre-proline 0 CA--C 1.561 1.366 0 CA-C-O 118.373 -0.822 . . . . 3.0699999999999998 110.789 -176.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.99 -5.68 17.38 Favored 'Trans proline' 0 C--N 1.353 0.802 0 CA-C-N 122.353 1.876 . . . . 2.8199999999999998 114.781 -167.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.15 -6.77 19.55 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 115.245 1.572 . . . . 2.8700000000000001 115.245 -174.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.57 100.43 0.22 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.182 0.896 . . . . 1.8700000000000001 111.765 -173.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.6 m -105.79 -34.52 7.65 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.65 0.981 . . . . 1.6599999999999999 113.65 173.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -116.67 -153.59 0.53 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.67 0.788 . . . . 1.3300000000000001 111.829 174.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.734 HG22 ' OE2' ' A' ' 136' ' ' GLU . 5.3 t -74.86 -147.23 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.479 0.712 . . . . 0.97999999999999998 110.67 166.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.461 ' N ' HG23 ' A' ' 120' ' ' THR . 2.9 tt -117.27 149.21 19.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 126.778 2.031 . . . . 1.4299999999999999 111.363 166.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.622 ' HE2' ' H ' ' A' ' 111' ' ' CYS . 0.0 OUTLIER -133.65 171.82 13.59 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.871 1.668 . . . . 4.6399999999999997 109.714 169.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -137.06 123.53 20.83 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.64 0.776 . . . . 5.0700000000000003 109.827 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.451 HD21 ' SD ' ' A' ' 122' ' ' MET . 2.2 mt -120.81 160.96 22.33 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 118.939 0.791 . . . . 0.97999999999999998 111.406 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.45 99.8 26.42 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 123.093 0.557 . . . . 5.9900000000000002 109.525 166.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -76.23 179.08 6.71 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 N-CA-C 107.528 -1.758 . . . . 2.46 107.528 159.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 106' ' ' TYR . 24.9 m -159.11 156.1 28.48 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 105.726 -1.953 . . . . 1.0800000000000001 105.726 172.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.7 p -52.35 -39.92 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 124.213 1.005 . . . . 0.87 112.494 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -82.03 0.66 39.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.82 1.648 . . . . 1.6799999999999999 114.192 176.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -143.1 -176.92 5.11 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 122.214 1.007 . . . . 2.23 113.016 -159.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.5 m -146.4 155.35 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 127.342 2.257 . . . . 0.64000000000000001 109.579 -173.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -141.7 128.55 20.56 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.648 0.779 . . . . 0.67000000000000004 112.05 -175.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.4 ttp-105 -101.45 132.45 47.04 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.191 0.905 . . . . 4.6299999999999999 112.85 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.438 ' SG ' ' SG ' ' A' ' 137' ' ' CYS . 0.0 OUTLIER -71.6 -18.91 62.2 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 117.622 2.452 . . . . 3.5699999999999998 117.622 -164.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 13.8 p-90 59.0 -20.16 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 128.394 2.678 . . . . 1.22 115.74 -173.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.734 ' OE2' HG22 ' A' ' 120' ' ' THR . 3.9 mm-40 -94.43 -87.73 0.25 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 120.434 1.47 . . . . 2.75 110.341 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . 0.438 ' SG ' ' SG ' ' A' ' 134' ' ' CYS . 30.5 p -62.88 -18.16 62.6 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.137 0.975 . . . . 1.3700000000000001 111.934 166.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 58.14 38.69 90.52 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 124.815 1.197 . . . . 1.1000000000000001 111.566 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . 0.263 0.1 OUTLIER -63.77 159.04 20.23 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 117.427 -1.709 . . . . 1.8999999999999999 109.377 155.603 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.2 t -114.15 136.44 50.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 104.074 -2.565 . . . . 0.68000000000000005 104.074 160.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -115.08 140.3 49.18 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.86 1.664 . . . . 1.75 110.224 -176.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -104.39 156.1 18.22 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 122.662 1.22 . . . . 2.1699999999999999 111.621 164.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.8 tt -100.22 154.51 18.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 112.922 -1.945 . . . . 0.93000000000000005 110.237 157.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -109.61 156.52 39.5 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.126 0.97 . . . . 1.28 113.269 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.73 -2.49 10.24 Favored 'Trans proline' 0 N--CA 1.485 0.976 1 C-N-CA 126.413 4.742 . . . . 1.55 115.877 -175.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.9 p -43.88 152.36 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 128.288 2.635 . . . . 1.8799999999999999 113.049 177.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.896 0 C-N-CA 126.095 1.807 . . . . 1.6100000000000001 110.644 176.876 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 11.4 mtp . . . . . 0 CA--C 1.518 -0.254 0 CA-C-O 123.928 1.823 . . . . 3.4500000000000002 113.523 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.7 -76.46 0.19 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.033 -1.894 . . . . 2.1299999999999999 109.62 173.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -174.12 72.39 0.34 Allowed Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 127.126 2.171 . . . . 2.5299999999999998 108.903 -168.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -88.31 -48.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.496 1 C-N-CA 127.276 5.317 . . . . 0.71999999999999997 114.258 -170.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -140.96 147.76 22.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 129.938 3.295 . . . . 0.71999999999999997 105.083 -175.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.5 mm -109.92 136.6 45.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 123.033 0.533 . . . . 0.69999999999999996 111.341 -176.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 51.4 mm -119.1 119.51 61.07 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 126.217 1.807 . . . . 0.93000000000000005 107.479 165.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -77.31 120.79 22.83 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 124.531 1.144 . . . . 3.4100000000000001 109.559 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.7 t -125.09 -51.7 1.66 Allowed 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 116.297 1.962 . . . . 2.1899999999999999 116.297 -164.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 64.01 14.29 8.35 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 122.132 2.242 . . . . 3.3900000000000001 111.924 -177.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -161.23 142.62 11.64 Favored 'General case' 0 CA--C 1.549 0.914 1 C-N-CA 132.312 4.245 . . . . 2.3999999999999999 106.331 -161.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.686 ' OD1' HG12 ' A' ' 128' ' ' VAL . 48.3 t0 -95.77 14.07 24.46 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 126.113 1.765 . . . . 4.9500000000000002 113.337 -177.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -153.26 12.89 0.49 Allowed 'General case' 0 N--CA 1.485 1.288 0 O-C-N 118.926 -2.359 . . . . 2.77 114.599 -156.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -72.47 159.34 34.11 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.291 0.848 . . . . 4.5899999999999999 113.291 -177.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -95.6 163.36 13.24 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.965 0.728 . . . . 2.3100000000000001 112.965 163.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 p -129.33 148.09 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 127.767 2.427 . . . . 1.1399999999999999 111.102 173.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -100.95 108.78 3.52 Favored Glycine 0 CA--C 1.539 1.533 0 CA-C-O 118.756 -1.025 . . . . 1.05 113.631 166.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 9.1 t -108.21 139.62 42.62 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.63 1.572 . . . . 1.1799999999999999 113.984 171.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 12.3 p -113.71 6.84 17.0 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 117.9 2.556 . . . . 1.0700000000000001 117.9 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.01 -23.05 22.64 Favored Glycine 0 N--CA 1.48 1.571 0 O-C-N 119.955 -1.716 . . . . 2.25 113.058 -176.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.2 t 173.52 151.93 0.24 Allowed Pre-proline 0 C--O 1.24 0.553 0 C-N-CA 127.754 2.422 . . . . 4.5199999999999996 108.228 -166.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -60.33 -23.56 74.88 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.656 2.238 . . . . 3.2599999999999998 112.369 168.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.28 9.56 25.47 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.397 1.079 . . . . 3.1600000000000001 113.73 174.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 73.75 62.67 2.94 Favored Glycine 0 C--N 1.343 0.944 0 C-N-CA 124.024 0.821 . . . . 2.27 113.66 170.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 30.7 m -71.94 -34.52 69.1 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.971 1.471 . . . . 1.7 114.971 -172.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -107.34 -49.94 3.17 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.006 1.854 . . . . 2.8300000000000001 116.006 176.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.7 t 156.77 -159.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 1 C-N-CA 133.185 4.594 . . . . 0.92000000000000004 105.573 -158.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.8 tp -120.08 140.74 43.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 127.584 2.353 . . . . 1.5 111.366 169.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.472 ' CE ' ' HE1' ' A' ' 135' ' ' TRP . 1.2 mmm -137.6 152.38 49.33 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 114.824 1.416 . . . . 4.6500000000000004 114.824 -176.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -110.9 99.98 8.78 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 113.898 -1.501 . . . . 1.8700000000000001 110.72 -171.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 134' ' ' CYS . 2.0 mt -106.77 169.75 8.35 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.512 -0.921 . . . . 1.3700000000000001 108.512 -173.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -151.55 100.6 2.94 Favored Pre-proline 0 N--CA 1.472 0.65 0 CA-C-N 119.192 0.905 . . . . 5.6799999999999997 111.607 178.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.88 173.97 10.65 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.252 2.635 . . . . 2.2799999999999998 110.503 170.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.85 144.26 45.54 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.297 2.239 . . . . 1.8100000000000001 107.572 -170.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.686 HG12 ' OD1' ' A' ' 105' ' ' ASP . 7.7 p -60.79 -34.03 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 120.725 -1.235 . . . . 1.02 111.741 -174.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -64.46 -21.02 66.53 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.677 1.991 . . . . 2.3199999999999998 112.922 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -161.6 -137.23 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.109 1.364 . . . . 2.5899999999999999 111.42 -156.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.3 m -156.37 170.31 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 126.884 2.074 . . . . 0.60999999999999999 110.405 -158.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -139.47 143.01 37.34 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.098 0.959 . . . . 0.64000000000000001 110.595 166.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 140' ' ' VAL . 28.3 ttt-85 -95.61 140.38 30.53 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 105.132 -2.173 . . . . 5.0099999999999998 105.132 167.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' ' 136' ' ' GLU . 17.9 t -52.08 131.86 32.36 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 124.302 1.001 . . . . 1.1799999999999999 110.009 152.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.472 ' HE1' ' CE ' ' A' ' 122' ' ' MET . 20.0 p-90 -65.61 -20.52 66.35 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.184 -0.948 . . . . 1.8999999999999999 110.637 168.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.416 ' HB2' ' SG ' ' A' ' 134' ' ' CYS . 0.6 OUTLIER -88.05 -108.57 0.07 Allowed 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 126.63 1.972 . . . . 3.1099999999999999 109.173 -172.562 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.8 p -53.01 -58.77 5.85 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.899 2.48 . . . . 1.73 111.939 -170.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 117.7 21.12 4.38 Favored Glycine 0 C--N 1.331 0.258 0 CA-C-N 113.106 -1.861 . . . . 1.5900000000000001 116.478 -166.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.2 p -71.72 101.81 2.66 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 119.142 1.471 . . . . 1.79 107.549 156.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 133' ' ' ARG . 47.1 t -62.7 145.22 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 108.475 -0.935 . . . . 0.69999999999999996 108.475 155.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -124.48 156.41 37.29 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 130.355 3.462 . . . . 2.3199999999999998 111.318 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.2 tttm -119.59 155.38 32.37 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 123.876 1.798 . . . . 2.3999999999999999 113.605 169.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.67 146.42 24.51 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 111.936 -2.393 . . . . 1.3600000000000001 110.265 158.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -101.76 155.81 35.96 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 113.842 1.052 . . . . 1.54 113.842 176.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.97 -7.34 21.2 Favored 'Trans proline' 0 C--N 1.353 0.815 1 C-N-CA 125.979 4.453 . . . . 2.2999999999999998 115.788 178.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.9 p -35.54 140.54 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 128.857 2.863 . . . . 2.2999999999999998 113.145 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.706 0 C-N-CA 125.103 1.335 . . . . 3.0699999999999998 111.306 -171.955 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 46.2 mtp . . . . . 0 C--O 1.218 -0.553 0 N-CA-C 105.194 -2.15 . . . . 2.8900000000000001 105.194 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 4.27 -76.18 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 128.734 2.814 . . . . 3.3999999999999999 116.758 167.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 46.4 t0 177.84 84.68 0.14 Allowed Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 129.706 3.203 . . . . 2.2200000000000002 108.687 -166.352 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -96.99 -43.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 1 C-N-CA 126.93 5.087 . . . . 0.93999999999999995 113.168 -178.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 mm -154.35 140.51 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 128.494 2.718 . . . . 0.70999999999999996 106.454 -168.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.424 HG23 ' ND2' ' A' ' 144' ' ' ASN . 14.4 mm -115.8 129.15 72.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 125.806 1.643 . . . . 1.02 110.964 -172.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.6 mm -127.11 112.9 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 126.688 1.995 . . . . 0.89000000000000001 109.532 -173.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -71.34 131.15 42.99 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.16 0.984 . . . . 2.73 110.776 -177.061 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.0 p -132.3 -56.77 0.96 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 115.533 1.679 . . . . 3.3399999999999999 115.533 -153.172 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 73.41 -18.79 0.36 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 127.334 2.253 . . . . 3.21 114.973 173.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -125.11 145.46 49.93 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.503 2.321 . . . . 3.04 107.901 161.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.63 4.25 2.0 Allowed 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 116.777 2.14 . . . . 3.3300000000000001 116.777 -160.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -147.16 24.53 1.15 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 126.134 1.774 . . . . 2.21 114.551 -175.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.13 135.77 31.03 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 120.792 -1.192 . . . . 4.2800000000000002 112.49 173.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -67.79 163.14 22.39 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.586 0.588 . . . . 2.1899999999999999 112.586 173.139 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.69 142.64 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.16 1.384 . . . . 1.1299999999999999 111.015 172.118 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.48 128.36 7.68 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.034 0.826 . . . . 1.53 112.923 168.031 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.84 153.98 50.78 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.38 1.872 . . . . 1.45 114.78 171.197 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.6 p -111.47 14.62 21.43 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 116.219 1.933 . . . . 1.01 116.219 173.289 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.452 ' HA3' ' OG ' ' A' ' 118' ' ' SER . . . 122.85 -32.7 4.33 Favored Glycine 0 C--O 1.222 -0.616 0 C-N-CA 124.626 1.108 . . . . 2.29 113.622 -172.529 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.1 t 137.55 148.43 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 106.516 -1.661 . . . . 3.0699999999999998 106.516 -120.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.23 48.16 1.72 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 124.745 3.63 . . . . 2.46 113.72 -177.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -156.37 27.35 0.35 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.765 1.024 . . . . 2.4900000000000002 113.765 -163.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 61.53 22.44 61.51 Favored Glycine 0 N--CA 1.475 1.295 0 N-CA-C 115.831 1.092 . . . . 2.8700000000000001 115.831 167.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.452 ' OG ' ' HA3' ' A' ' 113' ' ' GLY . 57.7 p -60.15 -50.98 71.52 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.416 1.108 . . . . 3.0099999999999998 112.835 -158.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -102.76 -63.62 1.15 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.765 0.426 . . . . 2.6499999999999999 110.353 -178.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.654 HG22 ' OE2' ' A' ' 136' ' ' GLU . 5.4 t -179.51 -159.46 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.476 1 C-N-CA 132.79 4.436 . . . . 0.94999999999999996 106.849 178.346 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.0 tp -104.85 145.73 12.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 C-N-CA 125.855 1.662 . . . . 1.1399999999999999 110.056 167.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.52 175.71 9.19 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.756 1.622 . . . . 5.0899999999999999 110.236 172.354 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -136.58 126.34 25.6 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 118.562 -0.732 . . . . 2.3900000000000001 110.266 171.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 mt -115.77 155.48 27.74 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.797 1.181 . . . . 1.01 112.054 177.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.83 101.37 20.53 Favored Pre-proline 0 N--CA 1.477 0.896 0 O-C-N 121.818 -0.551 . . . . 5.6200000000000001 110.862 172.599 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -82.96 178.28 6.08 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.447 2.098 . . . . 2.75 108.942 157.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.8 m -144.25 158.18 43.88 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.234 2.214 . . . . 1.05 105.118 171.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.0 p -58.51 -32.34 45.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-N 119.403 1.002 . . . . 0.71999999999999997 111.287 176.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -76.18 -5.28 46.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 128.053 2.541 . . . . 1.6399999999999999 114.637 174.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -145.09 -170.62 3.47 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.865 0.84 . . . . 2.3799999999999999 113.051 -159.013 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 19.3 m -147.23 156.92 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 128.239 2.616 . . . . 0.65000000000000002 108.273 -175.112 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -139.72 126.92 21.18 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.806 0.843 . . . . 0.68999999999999995 111.897 -179.094 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -99.16 134.76 41.54 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.441 0.564 . . . . 3.79 111.784 178.544 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 36.4 t -58.1 141.07 51.33 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 124.361 1.038 . . . . 0.95999999999999996 110.941 165.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 58.7 p-90 -91.34 -10.49 41.08 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.924 -0.58 . . . . 1.8400000000000001 112.083 168.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.654 ' OE2' HG22 ' A' ' 120' ' ' THR . 3.4 mm-40 -100.59 -65.63 0.96 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.262 0.625 . . . . 2.0800000000000001 111.447 -169.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 7.7 p -79.6 -41.95 26.01 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 118.922 0.783 . . . . 1.74 111.059 169.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 106.45 12.04 25.86 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.214 1.388 . . . . 1.1000000000000001 115.652 -178.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.9 p -80.28 137.01 36.55 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.968 1.884 . . . . 1.6399999999999999 111.179 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.38 150.45 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 118.966 0.803 . . . . 1.05 110.296 164.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -133.81 143.92 48.67 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 129.781 3.233 . . . . 2.04 109.723 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 54.4 tttt -117.84 153.01 34.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.284 1.04 . . . . 2.23 112.372 178.136 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.1 tt -97.89 143.68 28.24 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.502 -1.226 . . . . 0.93999999999999995 111.692 165.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.424 ' ND2' HG23 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -106.47 156.52 36.88 Favored Pre-proline 0 CA--C 1.549 0.91 0 CA-C-N 114.321 -1.308 . . . . 3.0099999999999998 110.483 -173.092 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.19 -8.96 24.58 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 124.558 3.505 . . . . 1.3300000000000001 114.509 -176.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.4 p -40.45 142.38 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 128.028 2.531 . . . . 2.0099999999999998 114.316 -177.307 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.476 0 C-N-CA 126.75 2.119 . . . . 2.0600000000000001 107.816 165.378 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 7.2 mtm . . . . . 0 N--CA 1.465 0.309 0 N-CA-C 119.438 3.125 . . . . 0.0 119.438 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -61.86 1.67 Allowed 'General case' 0 C--N 1.317 -0.811 0 O-C-N 121.792 -0.567 . . . . 0.0 112.098 167.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.8 t70 167.65 74.52 0.01 OUTLIER Pre-proline 0 CA--C 1.56 1.363 0 C-N-CA 129.581 3.152 . . . . 0.0 109.393 -155.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -92.12 -51.24 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.423 1 C-N-CA 126.842 5.028 . . . . 0.0 114.896 -170.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 mm -149.22 143.28 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 131.579 3.952 . . . . 0.0 104.221 -169.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.4 mm -113.73 131.69 64.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 124.056 0.943 . . . . 0.0 109.986 -177.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.0 mm -116.31 111.31 34.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 174.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.505 ' HA ' HD21 ' A' ' 144' ' ' ASN . 8.9 tt0 -76.82 116.31 17.37 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.855 1.262 . . . . 0.0 110.148 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.1 t -108.16 -67.83 0.94 Allowed 'General case' 0 C--O 1.225 -0.224 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -158.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.498 ' CE1' HG22 ' A' ' 146' ' ' VAL . 60.1 m-85 75.79 -3.9 2.48 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 126.438 1.895 . . . . 0.0 113.594 -169.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -114.21 152.33 31.4 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 128.066 2.546 . . . . 0.0 109.564 159.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -72.34 -14.6 61.77 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 120.265 -1.522 . . . . 0.0 114.767 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -134.04 6.49 3.64 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.167 -1.583 . . . . 0.0 114.248 -158.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -61.96 154.82 25.34 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.377 1.871 . . . . 0.0 115.327 -166.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -77.09 171.63 14.51 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.622 1.569 . . . . 0.0 114.195 173.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.9 p -135.61 148.99 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.958 2.103 . . . . 0.0 110.606 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -119.57 121.41 4.94 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 118.844 -0.975 . . . . 0.0 113.552 158.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 22.8 p -114.63 160.65 19.07 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 123.518 1.627 . . . . 0.0 113.095 167.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 47.4 p -114.91 13.36 17.05 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 113.302 -1.772 . . . . 0.0 112.695 166.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.5 -31.21 5.67 Favored Glycine 0 N--CA 1.467 0.733 0 C-N-CA 124.056 0.836 . . . . 0.0 113.828 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.1 t 169.49 159.92 0.19 Allowed Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 126.974 2.11 . . . . 0.0 107.509 -157.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -54.94 -20.56 23.33 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 121.89 1.726 . . . . 0.0 112.678 161.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.69 42.43 1.1 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.079 1.352 . . . . 0.0 112.729 174.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 51.33 33.91 32.55 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 116.986 1.554 . . . . 0.0 116.986 150.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.3 m -75.69 -48.02 23.77 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -152.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -104.88 -145.84 0.38 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.939 0.896 . . . . 0.0 112.219 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.66 HG22 ' OE1' ' A' ' 136' ' ' GLU . 3.7 t -76.56 -158.4 0.1 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.956 0.902 . . . . 0.0 112.413 163.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.4 tp -105.88 142.62 18.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 126.368 1.867 . . . . 0.0 110.481 161.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.609 ' SD ' HD21 ' A' ' 124' ' ' LEU . 3.8 ppp? -152.58 175.26 12.97 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.322 1.049 . . . . 0.0 112.141 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -140.71 130.69 24.63 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -165.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.609 HD21 ' SD ' ' A' ' 122' ' ' MET . 1.7 mt -132.28 174.13 10.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.181 1.393 . . . . 0.0 108.725 -174.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 102.37 5.11 Favored Pre-proline 0 N--CA 1.478 0.959 0 CA-C-N 120.187 1.358 . . . . 0.0 114.495 168.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -70.9 176.94 6.93 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 CA-C-N 120.025 1.045 . . . . 0.0 109.426 161.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.7 m -139.71 158.97 43.23 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.745 2.018 . . . . 0.0 105.777 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.5 p -49.21 -37.97 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 120.028 1.285 . . . . 0.0 113.456 -178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -80.9 -8.24 59.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.549 1.539 . . . . 0.0 114.078 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -140.82 -173.45 3.71 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 122.893 1.33 . . . . 0.0 113.371 -151.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 25.9 m -141.53 167.35 16.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 128.322 2.649 . . . . 0.0 108.966 -175.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -148.21 142.58 26.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.885 0.874 . . . . 0.0 110.506 169.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -100.04 143.52 30.16 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.79 0.836 . . . . 0.0 111.07 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 45.4 t -65.1 175.15 1.68 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 122.802 1.287 . . . . 0.0 113.622 158.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.413 ' CD1' ' CE ' ' A' ' 122' ' ' MET . 40.9 p-90 -127.54 -13.27 5.44 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.287 1.835 . . . . 0.0 112.583 170.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.66 ' OE1' HG22 ' A' ' 120' ' ' THR . 2.9 mm-40 -95.32 -60.82 1.59 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.156 0.982 . . . . 0.0 109.88 -177.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 14.2 p -80.8 -23.45 39.25 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.997 1.319 . . . . 0.0 112.705 165.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 64.51 16.18 60.45 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.419 -1.211 . . . . 0.0 113.544 -172.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.77 137.16 53.8 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.801 1.8 . . . . 0.0 111.384 173.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 41.4 t -81.96 147.02 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 166.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -132.01 150.01 52.27 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 129.282 3.033 . . . . 0.0 110.709 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 43.9 tttt -127.01 150.05 49.62 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.102 0.953 . . . . 0.0 113.556 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.62 155.7 17.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.858 167.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.505 HD21 ' HA ' ' A' ' 101' ' ' GLU . 3.4 p30 -111.57 152.19 43.85 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 172.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -67.78 -6.01 15.81 Favored 'Trans proline' 0 C--N 1.352 0.736 1 C-N-CA 125.352 4.035 . . . . 0.0 115.154 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.498 HG22 ' CE1' ' A' ' 103' ' ' TYR . 8.9 p -36.83 133.37 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 127.837 2.455 . . . . 0.0 113.401 -177.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.637 0 C-N-CA 127.541 2.496 . . . . 0.0 107.315 174.703 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 8.6 mtm . . . . . 0 C--O 1.225 -0.219 0 N-CA-C 118.035 2.606 . . . . 2.1299999999999999 118.035 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -57.73 11.46 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 121.191 -0.943 . . . . 1.99 112.641 169.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.5 t70 164.88 73.77 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 129.437 3.095 . . . . 2.7400000000000002 109.703 -154.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -88.34 -46.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 1 C-N-CA 126.793 4.996 . . . . 1.0600000000000001 113.075 -174.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -154.47 143.1 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 130.451 3.5 . . . . 0.63 105.424 -168.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.9 mm -117.45 134.23 61.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 124.579 1.152 . . . . 0.62 111.87 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.9 mm -127.42 118.6 50.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 127.142 2.177 . . . . 0.46000000000000002 108.209 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.92 133.41 44.35 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.858 1.663 . . . . 2.8300000000000001 111.442 -176.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.9 t -163.63 111.94 1.21 Allowed 'General case' 0 C--O 1.223 -0.333 0 O-C-N 121.535 -0.728 . . . . 2.9100000000000001 112.67 -175.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -82.24 16.71 1.89 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.608 1.163 . . . . 3.7799999999999998 112.184 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.48 10.75 3.47 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 128.222 2.609 . . . . 3.0 113.212 -159.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 59.55 -16.73 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 129.631 3.173 . . . . 3.1099999999999999 118.686 173.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -150.88 14.63 0.73 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 119.666 -1.896 . . . . 2.3399999999999999 114.719 -168.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 57.1 ttm-85 -54.39 142.61 26.32 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.538 1.535 . . . . 3.6600000000000001 112.563 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -77.38 156.9 30.9 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.844 0.683 . . . . 2.23 112.844 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.2 p -105.1 145.05 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.451 1.501 . . . . 0.70999999999999996 111.073 173.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -113.4 98.12 0.91 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.957 1.265 . . . . 0.65000000000000002 112.286 164.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.7 154.86 18.25 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.373 1.469 . . . . 0.95999999999999996 113.318 174.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.9 p -124.46 14.17 8.84 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.841 1.656 . . . . 0.77000000000000002 115.0 171.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.16 -17.97 46.79 Favored Glycine 0 N--CA 1.476 1.338 0 O-C-N 120.46 -1.4 . . . . 2.0299999999999998 114.836 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.5 t 175.44 154.51 0.34 Allowed Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 126.089 1.756 . . . . 3.5 109.871 -155.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -58.69 -20.56 51.51 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.298 2.666 . . . . 2.2599999999999998 113.96 170.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.85 -9.1 50.31 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 114.798 1.407 . . . . 2.5800000000000001 114.798 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.84 164.95 12.79 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 123.584 1.658 . . . . 3.1099999999999999 112.262 -147.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 36.9 m -166.62 -43.43 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 127.72 2.408 . . . . 1.49 110.628 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -107.64 -158.08 0.64 Allowed 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 109.95 -0.389 . . . . 1.5700000000000001 109.95 165.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.706 HG22 ' OE1' ' A' ' 136' ' ' GLU . 3.8 t -69.64 -158.96 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.823 0.849 . . . . 0.81999999999999995 112.531 168.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.8 tp -104.97 142.81 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 126.861 2.065 . . . . 0.83999999999999997 109.987 166.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.524 ' SD ' HD21 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -145.25 173.47 11.93 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.071 0.948 . . . . 4.3300000000000001 111.051 170.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -124.03 133.17 53.72 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.773 0.829 . . . . 1.5700000000000001 112.233 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.524 HD21 ' SD ' ' A' ' 122' ' ' MET . 3.4 mt -129.75 160.07 34.54 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.077 0.951 . . . . 0.72999999999999998 109.422 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.2 ttpp -125.3 85.94 57.67 Favored Pre-proline 0 N--CA 1.473 0.702 0 O-C-N 121.423 -0.798 . . . . 5.21 113.032 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -69.57 176.61 6.4 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.207 1.938 . . . . 2.4900000000000002 109.775 166.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.3 m -142.46 158.42 43.71 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.307 1.843 . . . . 0.91000000000000003 107.494 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.7 p -55.48 -33.65 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.952 1.301 . . . . 0.81000000000000005 113.737 -175.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -91.04 0.9 57.44 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.56 1.144 . . . . 2.27 113.838 175.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -140.26 -169.63 2.8 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.789 0.835 . . . . 2.1499999999999999 112.956 -158.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.6 m -145.66 163.68 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 127.504 2.322 . . . . 0.52000000000000002 109.916 -173.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -148.47 133.83 18.52 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.639 1.176 . . . . 0.52000000000000002 112.07 174.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.24 139.49 47.74 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.737 1.014 . . . . 3.27 113.737 -177.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 46.8 t -70.75 156.94 38.88 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.417 1.487 . . . . 1.1599999999999999 114.863 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.448 ' CZ3' ' HG2' ' A' ' 136' ' ' GLU . 43.9 p-90 -102.92 -13.28 16.99 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.425 -1.261 . . . . 1.76 113.305 174.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.706 ' OE1' HG22 ' A' ' 120' ' ' THR . 0.8 OUTLIER -98.92 -58.34 1.97 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 120.002 1.273 . . . . 2.54 110.661 -179.062 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 4.6 p -77.56 -65.93 0.9 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 122.28 1.038 . . . . 2.29 110.584 171.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.72 4.86 12.72 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.046 -1.419 . . . . 0.98999999999999999 115.882 -170.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.82 137.5 57.82 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 120.841 2.32 . . . . 1.8899999999999999 111.813 173.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 40.4 t -83.18 146.53 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 107.285 -1.376 . . . . 0.56999999999999995 107.285 165.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -132.35 151.01 52.04 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 128.221 2.608 . . . . 2.2999999999999998 112.076 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -133.43 146.78 51.5 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.11 1.152 . . . . 2.46 114.11 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.8 tt -99.86 153.9 18.78 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.62 1.168 . . . . 0.83999999999999997 110.328 171.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -107.62 156.91 37.09 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 115.453 1.649 . . . . 1.4099999999999999 115.453 -175.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.93 -4.51 12.56 Favored 'Trans proline' 0 C--N 1.357 0.976 1 C-N-CA 127.314 5.343 . . . . 1.6399999999999999 115.92 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.9 p -48.69 143.89 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.246 1.818 . . . . 1.95 110.369 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.75 0 O-C-N 120.772 -1.205 . . . . 2.9500000000000002 112.124 -163.691 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.8 mtm . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.678 0.751 . . . . 2.8300000000000001 112.794 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.7 pttm 123.39 -143.65 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.605 1 C-N-CA 133.216 4.606 . . . . 3.3300000000000001 108.419 -150.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . 0.271 21.3 t0 -128.14 72.37 79.49 Favored Pre-proline 0 CA--C 1.561 1.391 0 C-N-CA 124.761 1.224 . . . . 3.1000000000000001 108.964 -173.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.51 -53.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.046 1 C-N-CA 128.788 6.325 . . . . 0.80000000000000004 114.705 -170.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -133.04 140.11 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 128.745 2.818 . . . . 0.57999999999999996 105.156 -178.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.4 mm -110.68 133.88 54.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 C-N-CA 123.662 0.785 . . . . 0.81000000000000005 111.686 -171.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.0 mm -122.67 115.69 46.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 126.341 1.857 . . . . 0.60999999999999999 108.301 173.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -65.17 124.19 21.51 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.937 1.695 . . . . 3.0800000000000001 110.464 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.6 t -146.8 122.17 10.3 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.167 0.987 . . . . 3.0 111.414 -175.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -98.55 3.18 48.06 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 112.532 0.567 . . . . 2.6499999999999999 112.532 -175.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -104.03 -101.56 0.31 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 128.699 2.8 . . . . 3.7200000000000002 111.166 168.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.566 ' OD1' HG12 ' A' ' 128' ' ' VAL . 10.3 t0 -171.64 -38.33 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 128.094 2.558 . . . . 3.9100000000000001 109.98 -175.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -99.67 -5.08 29.51 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 120.063 -1.648 . . . . 3.6000000000000001 114.63 -165.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.16 122.39 8.49 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.371 1.868 . . . . 6.8899999999999997 114.194 -164.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -70.83 151.7 44.51 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.861 1.06 . . . . 2.3599999999999999 113.861 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.7 p -108.22 146.56 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.785 1.634 . . . . 0.71999999999999997 111.838 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -111.09 108.14 2.32 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.119 0.866 . . . . 0.73999999999999999 112.747 161.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 1.9 t -97.1 145.17 26.25 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.963 1.305 . . . . 1.01 112.612 172.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.7 p -116.29 18.65 15.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.491 1.517 . . . . 0.73999999999999999 113.759 169.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.423 ' CA ' ' CD2' ' A' ' 119' ' ' HIS . . . 110.96 39.33 1.42 Allowed Glycine 0 N--CA 1.466 0.639 0 C-N-CA 124.611 1.101 . . . . 1.71 113.457 176.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 p 71.08 178.5 0.05 OUTLIER Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 123.966 0.907 . . . . 2.79 110.294 -161.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -63.72 -9.6 19.17 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.256 1.971 . . . . 2.6600000000000001 115.586 -172.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.58 33.48 1.43 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.817 1.247 . . . . 2.6099999999999999 113.953 -174.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 57.8 31.66 64.65 Favored Glycine 0 N--CA 1.479 1.512 0 C-N-CA 124.252 0.929 . . . . 1.6299999999999999 115.057 163.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.0 m -84.85 -32.16 23.41 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.571 -0.958 . . . . 1.7 113.437 -148.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.525 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 18.7 p80 -123.81 -144.34 0.33 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.838 1.199 . . . . 1.3700000000000001 113.096 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.633 HG22 ' OE2' ' A' ' 136' ' ' GLU . 4.2 t -78.39 -153.73 0.07 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 118.902 0.774 . . . . 0.83999999999999997 111.035 164.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.9 tp -107.5 151.03 9.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 127.761 2.424 . . . . 0.93999999999999995 110.668 164.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.629 ' CE ' HD21 ' A' ' 124' ' ' LEU . 4.2 ppp? -160.14 161.47 33.72 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.943 1.697 . . . . 3.7799999999999998 111.492 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -130.09 132.99 46.38 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.376 0.509 . . . . 1.48 112.376 -167.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.629 HD21 ' CE ' ' A' ' 122' ' ' MET . 3.3 mt -131.86 155.55 47.63 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.469 0.707 . . . . 0.71999999999999997 110.485 -175.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.65 97.21 46.28 Favored Pre-proline 0 N--CA 1.477 0.917 0 CA-C-N 118.608 0.64 . . . . 5.6600000000000001 110.972 175.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -76.42 178.66 7.26 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 121.839 1.693 . . . . 2.5499999999999998 108.868 162.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.469 HG22 ' OD1' ' A' ' 105' ' ' ASP . 1.3 m -144.41 155.34 43.71 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.14 1.776 . . . . 1.0 106.265 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.566 HG12 ' OD1' ' A' ' 105' ' ' ASP . 9.8 p -63.02 -28.07 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 122.036 2.198 . . . . 0.87 109.803 175.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -72.68 -15.12 61.7 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.543 2.737 . . . . 1.6399999999999999 114.721 171.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -145.51 178.46 8.1 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 123.215 1.483 . . . . 1.99 114.103 -159.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.482 HG12 ' HG3' ' A' ' 142' ' ' LYS . 27.4 m -120.68 165.35 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 128.347 2.659 . . . . 0.53000000000000003 109.495 174.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.9 131.64 25.72 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.428 1.091 . . . . 0.60999999999999999 111.148 173.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.473 ' CG ' HG22 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -111.63 138.03 48.72 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.677 0.621 . . . . 3.54 112.677 -177.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.423 ' HA ' ' HE1' ' A' ' 122' ' ' MET . 40.7 t -70.01 153.23 43.48 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 126.599 1.96 . . . . 1.0700000000000001 115.223 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.422 ' H ' ' HE1' ' A' ' 122' ' ' MET . 56.7 p-90 -98.6 -10.19 23.73 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.453 0.908 . . . . 1.3600000000000001 113.453 169.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.633 ' OE2' HG22 ' A' ' 120' ' ' THR . 0.7 OUTLIER -96.87 -100.0 0.19 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.326 1.45 . . . . 1.73 109.48 -177.229 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 30.1 p -55.39 -29.25 58.13 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.32 1.418 . . . . 1.0600000000000001 112.12 168.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.1 23.88 75.01 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-O 118.483 -1.176 . . . . 0.72999999999999998 113.479 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.66 154.0 41.71 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.704 1.752 . . . . 1.45 111.054 165.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.473 HG22 ' CG ' ' A' ' 133' ' ' ARG . 74.2 t -96.55 140.97 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 105.817 -1.92 . . . . 0.56999999999999995 105.817 167.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -123.56 153.91 39.98 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 128.009 2.524 . . . . 2.1200000000000001 111.737 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.482 ' HG3' HG12 ' A' ' 131' ' ' VAL . 3.4 tmtt? -140.19 157.67 45.24 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 123.013 1.387 . . . . 2.5899999999999999 114.569 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.4 tt -110.87 141.16 44.63 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 113.737 -1.574 . . . . 0.87 113.255 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -100.53 155.85 35.89 Favored Pre-proline 0 CA--C 1.555 1.148 0 N-CA-C 114.609 1.337 . . . . 1.45 114.609 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -79.38 -4.27 13.57 Favored 'Trans proline' 0 C--N 1.356 0.936 1 C-N-CA 126.307 4.671 . . . . 1.3999999999999999 115.56 -175.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.1 p -40.43 148.65 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 128.805 2.842 . . . . 2.0099999999999998 112.044 175.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.644 0 O-C-N 120.138 -1.602 . . . . 1.6399999999999999 113.49 179.267 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 13.8 mtp . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 119.635 3.198 . . . . 2.2999999999999998 119.635 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -56.85 5.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 119.264 0.938 . . . . 2.1499999999999999 112.978 174.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.2 t0 161.68 70.89 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 129.411 3.085 . . . . 2.3700000000000001 109.177 -158.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -82.46 -53.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.3 1 C-N-CA 126.082 4.522 . . . . 0.76000000000000001 112.526 -172.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -147.77 143.53 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 130.521 3.528 . . . . 0.88 104.831 -168.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.4 mm -111.21 129.98 65.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 124.525 1.13 . . . . 0.90000000000000002 109.818 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.4 mm -114.61 100.27 10.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 126.123 1.769 . . . . 0.73999999999999999 106.908 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -66.61 122.23 17.14 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 125.162 1.539 . . . . 3.1200000000000001 110.008 -174.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.4 t -145.0 110.44 5.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.741 -0.663 . . . . 3.1699999999999999 111.225 -169.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -77.1 35.33 0.16 Allowed 'General case' 0 CA--C 1.55 0.949 0 O-C-N 121.693 -0.63 . . . . 2.3900000000000001 112.633 172.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -157.73 137.9 12.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 130.801 3.64 . . . . 3.1600000000000001 106.788 -173.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -60.26 -11.57 6.72 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.818 1.044 . . . . 2.98 113.818 175.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -139.05 126.35 21.47 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.758 2.423 . . . . 3.2200000000000002 111.47 -170.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.511 HH11 ' CG ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -146.27 174.74 11.07 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.887 1.275 . . . . 4.3899999999999997 113.74 171.516 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -100.4 168.05 10.0 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.723 -0.671 . . . . 2.3100000000000001 111.926 157.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.96 145.9 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 126.029 1.732 . . . . 0.68999999999999995 110.414 168.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -129.34 107.84 0.84 Allowed Glycine 0 N--CA 1.473 1.116 0 CA-C-O 119.154 -0.803 . . . . 0.70999999999999996 113.773 170.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.553 ' H ' ' CE ' ' A' ' 122' ' ' MET . 12.7 p -109.75 164.11 12.87 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.485 1.914 . . . . 0.91000000000000003 114.167 172.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.8 p -124.71 5.52 8.15 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.263 1.425 . . . . 0.89000000000000001 114.724 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.5 -21.67 12.62 Favored Glycine 0 N--CA 1.476 1.315 0 N-CA-C 116.334 1.294 . . . . 2.1099999999999999 116.334 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.94 177.34 0.54 Allowed Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 127.541 2.336 . . . . 3.8999999999999999 109.501 -178.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -59.54 -26.22 81.34 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.507 2.138 . . . . 2.73 113.541 170.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.52 -2.0 58.32 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.291 1.219 . . . . 2.3799999999999999 114.291 172.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.77 -169.01 52.89 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-O 123.267 1.481 . . . . 3.54 111.458 -150.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.0 t -177.82 -36.19 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 128.278 2.631 . . . . 2.5299999999999998 110.656 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -118.57 -153.15 0.52 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.495 1.518 . . . . 1.3600000000000001 110.603 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.725 HG22 ' OE2' ' A' ' 136' ' ' GLU . 4.9 t -74.78 -155.39 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 O-C-N 121.39 -0.819 . . . . 0.89000000000000001 112.202 167.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.5 tp -108.28 146.28 14.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 127.6 2.36 . . . . 0.95999999999999996 109.797 163.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.56 ' SD ' HD21 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -141.69 -179.87 6.43 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.922 1.289 . . . . 4.5199999999999996 110.597 173.081 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -140.25 124.06 17.34 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.589 0.631 . . . . 1.6200000000000001 111.751 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.56 HD21 ' SD ' ' A' ' 122' ' ' MET . 2.4 mt -118.78 172.64 7.38 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.154 0.981 . . . . 0.82999999999999996 110.202 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -139.58 90.97 10.99 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-O 118.488 -0.768 . . . . 6.9699999999999998 112.749 -175.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -85.8 167.27 9.89 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.979 2.452 . . . . 2.6899999999999999 110.601 172.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.5 m -139.75 152.73 46.86 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.962 2.105 . . . . 1.3700000000000001 108.577 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.7 p -42.48 -43.85 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 116.988 2.218 . . . . 1.21 116.988 -173.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -89.58 3.25 53.13 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.44 1.096 . . . . 2.0899999999999999 112.846 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -140.8 -177.85 5.27 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.59 1.156 . . . . 3.2999999999999998 113.759 -149.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.1 m -139.99 152.2 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 113.672 -1.604 . . . . 0.60999999999999999 112.384 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -129.23 143.45 50.86 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.871 0.868 . . . . 0.66000000000000003 109.844 168.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -111.64 141.07 45.71 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.886 0.874 . . . . 4.5599999999999996 111.488 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 49.3 t -59.76 159.17 9.16 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 124.587 1.179 . . . . 1.04 112.88 163.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 58.6 p-90 -107.31 -9.02 16.16 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.825 1.25 . . . . 1.21 112.559 170.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.725 ' OE2' HG22 ' A' ' 120' ' ' THR . 2.7 mm-40 -100.09 -94.18 0.27 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.076 1.75 . . . . 1.6200000000000001 108.998 -177.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 28.3 p -62.29 -16.37 53.45 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 120.416 -1.427 . . . . 1.28 112.587 171.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 59.22 27.32 62.64 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 124.894 1.235 . . . . 0.79000000000000004 112.607 175.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.4 p -67.59 132.59 47.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.975 1.388 . . . . 1.52 108.879 164.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 41.4 t -76.97 150.85 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.426 -0.953 . . . . 0.60999999999999999 108.426 159.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -134.19 147.21 50.72 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 130.028 3.331 . . . . 1.8200000000000001 110.439 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -124.81 145.7 49.63 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 113.397 0.888 . . . . 2.7000000000000002 113.397 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.3 tt -91.76 154.36 18.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 122.278 1.037 . . . . 1.1399999999999999 109.094 165.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -117.2 152.66 49.32 Favored Pre-proline 0 CA--C 1.552 1.037 0 CA-C-N 114.685 -1.143 . . . . 1.48 113.319 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.49 -4.39 14.42 Favored 'Trans proline' 0 CA--C 1.539 0.761 1 C-N-CA 125.964 4.443 . . . . 1.6699999999999999 115.731 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.1 p -43.66 149.54 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 128.356 2.663 . . . . 2.1200000000000001 112.812 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 125.04 1.305 . . . . 1.96 110.185 -174.843 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.6 mtm . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 124.28 1.99 . . . . 2.73 111.918 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -173.21 -122.41 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 130.922 3.689 . . . . 1.95 106.717 172.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . 0.303 38.0 t70 -133.39 78.11 64.1 Favored Pre-proline 0 N--CA 1.434 -1.251 0 N-CA-C 106.975 -1.491 . . . . 2.77 106.975 177.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -83.12 -81.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.786 1 C-N-CA 127.573 5.515 . . . . 1.21 113.687 -170.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -102.07 143.39 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 C-N-CA 127.854 2.462 . . . . 0.85999999999999999 106.187 171.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.0 mm -109.53 135.25 49.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.28 -0.873 . . . . 0.87 111.786 -172.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.9 mm -123.55 114.05 40.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 126.96 2.104 . . . . 0.76000000000000001 108.453 173.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.4 132.13 46.51 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.463 1.505 . . . . 3.0800000000000001 110.706 169.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 61.7 m -161.09 125.19 3.45 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.088 -1.007 . . . . 3.3300000000000001 109.14 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.7 m-30 -87.97 28.35 1.05 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 121.366 0.603 . . . . 2.75 111.24 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.99 109.96 4.52 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 129.336 3.054 . . . . 3.75 108.235 -171.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -53.85 -16.08 1.62 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.974 2.51 . . . . 3.3999999999999999 115.44 -169.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.91 5.76 3.91 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 126.769 2.028 . . . . 2.2000000000000002 113.79 -167.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.5 ttt85 -48.2 156.75 0.36 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.366 1.866 . . . . 4.7199999999999998 113.654 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -87.72 155.55 19.86 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.738 -0.602 . . . . 2.2599999999999998 112.308 162.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.23 142.65 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 127.08 2.152 . . . . 0.68000000000000005 111.543 170.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -104.67 100.95 1.86 Allowed Glycine 0 CA--C 1.533 1.217 0 CA-C-O 117.95 -1.472 . . . . 0.69999999999999996 113.663 164.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 3.6 p -107.22 145.06 33.12 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.459 1.629 . . . . 1.28 113.424 171.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.5 p -114.25 23.31 12.97 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 113.901 -1.499 . . . . 0.69999999999999996 112.874 175.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.83 -16.28 55.22 Favored Glycine 0 N--CA 1.476 1.36 0 O-C-N 120.201 -1.562 . . . . 1.76 114.395 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.8 p 175.36 162.29 0.4 Allowed Pre-proline 0 C--O 1.241 0.64 0 C-N-CA 128.693 2.797 . . . . 4.0599999999999996 107.888 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.05 -15.42 39.16 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.02 2.48 . . . . 2.77 113.184 165.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.55 7.22 46.4 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.326 1.05 . . . . 2.2200000000000002 112.469 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 62.25 71.67 0.78 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 125.177 1.37 . . . . 1.6399999999999999 111.921 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 56.8 m -76.24 -42.51 45.59 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.925 0.89 . . . . 1.76 112.175 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.6 p80 -100.8 -148.73 0.37 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.342 0.974 . . . . 1.46 112.226 171.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.28 13.6 t -77.67 -134.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.048 -1.093 . . . . 0.81000000000000005 108.048 158.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.6 tp -129.95 142.1 44.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 131.06 3.744 . . . . 0.83999999999999997 111.108 174.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 19.3 mmm -129.54 167.15 18.34 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.629 1.972 . . . . 3.79 115.112 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -136.06 102.48 5.04 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.88 0.472 . . . . 1.47 110.936 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 mt -116.22 160.03 21.0 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.78 0.832 . . . . 0.68000000000000005 110.499 -169.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -119.94 76.22 21.74 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 114.931 1.456 . . . . 5.2400000000000002 114.931 -170.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -92.15 43.43 0.36 Allowed 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.477 3.452 . . . . 3.0699999999999998 116.161 -165.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 m -28.61 151.0 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 130.301 3.44 . . . . 0.87 114.94 -170.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -52.15 -33.33 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 O-C-N 120.199 -1.563 . . . . 0.90000000000000002 113.836 175.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -79.24 -7.99 58.69 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.461 1.504 . . . . 1.45 114.071 175.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -141.39 -166.38 2.18 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.867 1.267 . . . . 2.1200000000000001 111.575 -157.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.53 HG12 ' HG3' ' A' ' 142' ' ' LYS . 21.6 m -147.55 158.28 9.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 131.151 3.78 . . . . 0.55000000000000004 107.3 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -141.92 140.24 32.75 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.923 0.783 . . . . 0.69999999999999996 110.966 168.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -91.97 141.97 28.05 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.322 0.649 . . . . 3.6499999999999999 109.784 172.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.3 t -62.21 162.74 9.2 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.42 1.088 . . . . 1.1200000000000001 111.396 155.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 28.8 p-90 -104.0 -20.13 13.97 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.79 -0.641 . . . . 1.7 112.099 163.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -81.41 -88.23 0.08 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.829 0.852 . . . . 2.2799999999999998 109.752 -174.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.7 p -64.93 -23.97 67.38 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 122.057 -0.402 . . . . 1.1599999999999999 111.933 171.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.16 21.68 75.74 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 118.814 0.734 . . . . 0.71999999999999997 113.557 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.17 154.86 38.61 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.765 1.283 . . . . 1.77 110.334 162.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 76.1 t -100.64 135.82 34.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 N-CA-C 105.749 -1.945 . . . . 0.64000000000000001 105.749 164.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -116.62 146.92 42.36 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 126.748 2.019 . . . . 1.77 108.74 -176.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.53 ' HG3' HG12 ' A' ' 131' ' ' VAL . 6.8 tmtt? -134.08 151.37 51.37 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 122.366 1.079 . . . . 2.5099999999999998 113.56 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.0 tt -107.13 142.7 36.39 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 113.322 -1.763 . . . . 0.85999999999999999 111.827 -177.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -101.03 154.09 37.36 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 113.296 -1.775 . . . . 1.3799999999999999 111.259 -173.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.3 -4.39 15.13 Favored 'Trans proline' 0 N--CA 1.48 0.702 1 C-N-CA 125.577 4.184 . . . . 1.22 115.302 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.9 p -43.26 148.63 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 128.254 2.622 . . . . 2.21 112.693 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.855 0 CA-C-O 123.361 1.534 . . . . 2.0099999999999998 112.197 179.019 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.43 ' O ' ' HD3' ' A' ' 97' ' ' PRO . 23.3 mtt . . . . . 0 C--O 1.214 -0.793 0 N-CA-C 106.889 -1.523 . . . . 3.1000000000000001 106.889 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -4.0 -66.21 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 128.564 2.746 . . . . 2.0600000000000001 117.823 171.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.3 t70 176.69 77.77 0.1 OUTLIER Pre-proline 0 CA--C 1.564 1.481 0 C-N-CA 130.742 3.617 . . . . 2.5699999999999998 109.857 -163.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 94' ' ' MET . 59.7 Cg_endo -94.01 -51.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 1 C-N-CA 126.819 5.013 . . . . 1.1000000000000001 113.606 -173.479 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.82 142.23 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 131.153 3.781 . . . . 0.89000000000000001 104.488 -173.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.4 mm -114.51 134.62 56.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 C-N-CA 124.161 0.984 . . . . 0.88 110.199 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.3 mm -120.24 114.55 44.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 125.345 1.458 . . . . 0.62 107.781 174.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -71.49 122.1 19.84 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.911 1.284 . . . . 2.5600000000000001 110.466 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.5 m -158.43 105.13 1.86 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.728 -1.233 . . . . 3.2799999999999998 113.344 -172.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -75.03 40.02 0.14 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 127.161 2.184 . . . . 2.48 113.051 -175.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.34 -2.18 0.69 Allowed 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.129 1.159 . . . . 3.4900000000000002 114.129 -168.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 63.25 -16.46 0.06 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 128.602 2.761 . . . . 3.27 115.046 -176.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -151.68 27.47 0.64 Allowed 'General case' 0 C--O 1.244 0.784 0 O-C-N 119.841 -1.787 . . . . 2.4900000000000002 113.193 -170.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -65.47 160.62 21.75 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.551 1.167 . . . . 3.8900000000000001 111.283 171.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -82.65 167.76 17.94 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.913 -1.04 . . . . 1.9199999999999999 113.036 167.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.9 p -118.61 141.9 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 127.916 2.487 . . . . 0.69999999999999996 111.191 169.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.53 105.41 2.04 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.691 1.139 . . . . 0.82999999999999996 112.168 164.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.11 153.28 21.1 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.036 1.334 . . . . 0.95999999999999996 112.543 169.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 18.2 p -121.37 24.24 10.03 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.784 1.634 . . . . 0.84999999999999998 113.933 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.22 -28.29 6.29 Favored Glycine 0 N--CA 1.472 1.054 0 O-C-N 120.692 -1.255 . . . . 2.0299999999999998 112.775 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 83.0 p -175.87 163.03 2.0 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 128.521 2.728 . . . . 3.9399999999999999 107.67 -172.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.8 -3.7 10.9 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.31 2.673 . . . . 2.21 113.906 172.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.88 0.31 18.63 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.671 1.189 . . . . 2.29 114.059 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.29 91.57 0.39 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.533 1.063 . . . . 1.77 111.119 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.6 m -103.0 -30.35 10.83 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.011 0.745 . . . . 1.45 113.011 173.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -125.15 -151.37 0.48 Allowed 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 119.125 0.875 . . . . 1.52 111.544 166.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.708 HG22 ' OE1' ' A' ' 136' ' ' GLU . 4.3 t -73.02 -157.68 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 O-C-N 121.032 -1.043 . . . . 1.02 111.371 166.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.4 tp -103.78 145.81 12.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 127.17 2.188 . . . . 1.05 108.815 164.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.531 ' SD ' HD21 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -145.85 166.68 25.23 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.418 0.687 . . . . 4.5300000000000002 111.501 170.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -117.89 130.34 56.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.781 0.832 . . . . 1.6200000000000001 112.147 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.531 HD21 ' SD ' ' A' ' 122' ' ' MET . 2.2 mt -128.84 163.78 24.48 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.452 1.101 . . . . 0.82999999999999996 109.452 175.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 32.8 mttt -131.79 105.36 14.1 Favored Pre-proline 0 N--CA 1.48 1.027 0 CA-C-O 117.434 -1.27 . . . . 6.8300000000000001 110.957 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -71.82 -69.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.26 1.973 . . . . 3.21 112.96 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.9 m 100.94 147.37 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 130.287 3.435 . . . . 1.24 108.82 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.4 p -44.38 -41.1 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 127.506 2.322 . . . . 1.1699999999999999 114.733 -172.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -83.84 -22.52 31.7 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.27 1.028 . . . . 2.96 112.317 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -131.82 179.08 6.29 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.948 1.699 . . . . 4.3200000000000003 114.913 -143.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 20.4 m -131.16 147.97 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 112.874 -1.966 . . . . 0.76000000000000001 114.757 -165.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -142.5 141.22 32.07 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.979 1.312 . . . . 0.79000000000000004 112.335 174.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -122.61 139.56 53.79 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.855 1.262 . . . . 4.4500000000000002 113.565 -170.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 42.6 t -72.4 145.34 47.75 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 116.448 2.018 . . . . 1.27 116.448 -174.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.444 ' CZ3' ' HG2' ' A' ' 136' ' ' GLU . 58.5 p-90 -95.5 -10.7 29.01 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 117.421 -1.276 . . . . 2.6299999999999999 113.765 175.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.708 ' OE1' HG22 ' A' ' 120' ' ' THR . 1.3 mm-40 -93.27 -66.3 0.93 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 120.089 1.313 . . . . 2.5099999999999998 108.345 175.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 12.4 p -74.86 -77.13 0.13 Allowed 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 121.844 0.83 . . . . 2.8999999999999999 110.927 173.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 125.0 18.58 2.57 Favored Glycine 0 N--CA 1.472 1.046 0 N-CA-C 117.692 1.837 . . . . 0.88 117.692 -165.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.4 p -74.92 142.63 43.98 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 120.655 2.228 . . . . 1.77 110.859 166.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 50.8 t -90.98 138.16 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 107.559 -1.275 . . . . 0.65000000000000002 107.559 167.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -117.65 142.69 46.93 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.457 1.903 . . . . 1.8500000000000001 112.382 176.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -115.58 149.09 38.78 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.285 1.04 . . . . 2.2400000000000002 112.259 173.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.3 tt -99.45 158.07 15.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.151 -0.931 . . . . 0.91000000000000003 110.071 168.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -114.3 156.01 44.94 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 114.82 1.415 . . . . 1.3500000000000001 114.82 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.08 -5.36 16.24 Favored 'Trans proline' 0 C--N 1.355 0.9 1 C-N-CA 125.65 4.233 . . . . 1.21 115.288 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.5 p -45.11 138.01 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 126.273 1.829 . . . . 2.1499999999999999 111.127 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.594 0 CA-C-O 122.851 1.251 . . . . 1.75 112.369 -174.647 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.7 mtt . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 119.445 3.128 . . . . 2.9399999999999999 119.445 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -58.88 6.67 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 120.969 -1.082 . . . . 2.1000000000000001 112.481 171.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 t0 165.32 71.75 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 129.461 3.105 . . . . 2.1099999999999999 108.906 -157.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.95 -50.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.391 1 C-N-CA 126.552 4.835 . . . . 0.81000000000000005 113.252 -171.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -150.63 141.64 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 1 C-N-CA 132.587 4.355 . . . . 0.62 104.141 -170.07 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 mm -109.88 136.14 46.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 125.163 1.385 . . . . 0.69999999999999996 109.004 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.1 mm -116.75 143.01 28.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 105.299 -2.111 . . . . 0.68999999999999995 105.299 170.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.492 ' CG ' HG11 ' A' ' 146' ' ' VAL . 9.2 tt0 -108.24 146.03 33.44 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.102 0.876 . . . . 3.1899999999999999 110.116 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.577 ' HB2' HD21 ' A' ' 143' ' ' LEU . 24.2 t -137.67 -54.71 0.67 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.852 1.427 . . . . 3.0899999999999999 114.852 -167.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 81.59 11.23 0.77 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 127.947 2.499 . . . . 2.73 113.759 -167.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -149.12 156.76 42.68 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 129.396 3.079 . . . . 2.7400000000000002 107.351 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.48 -18.16 26.78 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.285 1.217 . . . . 2.9300000000000002 114.285 174.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.68 81.55 1.16 Allowed 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.86 1.43 . . . . 2.8999999999999999 114.86 -158.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -127.39 167.91 15.57 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 120.898 -1.126 . . . . 5.5199999999999996 113.219 167.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -90.8 171.32 9.41 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.306 1.443 . . . . 2.1499999999999999 113.882 -174.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.4 p -124.98 143.12 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 126.685 1.994 . . . . 0.89000000000000001 111.228 171.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.26 92.76 1.01 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.585 1.564 . . . . 0.71999999999999997 112.081 162.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -106.19 146.55 30.13 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.553 1.676 . . . . 1.22 113.727 176.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.9 p -115.54 4.79 14.28 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.358 1.463 . . . . 1.22 114.166 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 138.07 -27.13 2.8 Favored Glycine 0 N--CA 1.468 0.777 0 O-C-N 121.405 -0.809 . . . . 2.5800000000000001 114.898 -169.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.0 t 106.12 144.85 0.01 OUTLIER Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 128.091 2.556 . . . . 3.96 106.681 -138.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.15 93.76 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.95 2.433 . . . . 3.23 110.76 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 176.86 21.32 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 129.256 3.022 . . . . 2.5 113.412 166.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 67.2 43.21 90.03 Favored Glycine 0 C--N 1.341 0.837 0 O-C-N 121.133 -0.979 . . . . 2.25 113.777 167.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 5.3 t -60.68 -36.35 78.55 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.156 0.978 . . . . 2.9700000000000002 111.905 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 26.4 p80 -135.65 -141.1 0.17 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.017 1.327 . . . . 1.5800000000000001 112.323 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.729 HG22 ' OE2' ' A' ' 136' ' ' GLU . 11.4 t -85.13 -141.39 0.08 Allowed 'General case' 0 C--O 1.218 -0.583 0 C-N-CA 124.14 0.976 . . . . 1.04 108.812 158.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.4 ' N ' HG23 ' A' ' 120' ' ' THR . 4.7 tp -123.08 141.22 44.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 130.23 3.412 . . . . 1.1499999999999999 111.689 174.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.421 ' SD ' ' NE1' ' A' ' 135' ' ' TRP . 12.9 mmt -136.47 154.57 50.72 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 116.379 1.992 . . . . 4.9199999999999999 116.379 -173.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -115.65 87.79 2.74 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.753 -0.658 . . . . 1.5800000000000001 111.789 -170.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 mt -103.1 167.99 9.47 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.487 -0.758 . . . . 0.83999999999999997 109.354 -174.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.57 88.86 2.73 Favored Pre-proline 0 N--CA 1.475 0.789 0 O-C-N 121.033 -1.042 . . . . 7.79 112.556 -167.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -81.37 173.4 11.64 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.477 2.784 . . . . 2.3399999999999999 109.933 170.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -113.55 156.83 22.91 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.45 1.9 . . . . 1.24 107.883 169.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 p -50.3 -39.53 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-N 119.992 1.269 . . . . 0.79000000000000004 113.952 170.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -79.59 -5.59 55.31 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.263 0.838 . . . . 1.8999999999999999 113.263 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -143.16 -164.14 1.79 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.561 0.744 . . . . 2.2200000000000002 111.773 -155.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.4 m -149.74 158.57 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.731 2.012 . . . . 0.55000000000000004 110.263 -171.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -143.62 139.61 29.72 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.224 1.01 . . . . 0.66000000000000003 111.637 170.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.9 ttt-85 -97.96 146.14 25.78 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.457 0.703 . . . . 4.29 110.32 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 9.7 t -60.2 160.35 8.46 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.545 1.538 . . . . 1.0900000000000001 110.627 159.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.421 ' NE1' ' SD ' ' A' ' 122' ' ' MET . 27.7 p-90 -99.86 -17.71 17.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 117.479 -1.248 . . . . 1.4199999999999999 111.822 160.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.729 ' OE2' HG22 ' A' ' 120' ' ' THR . 2.1 mm-40 -86.25 -95.38 0.08 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.923 1.289 . . . . 1.51 109.502 -173.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.3 p -64.28 -13.33 49.05 Favored 'General case' 0 CA--C 1.557 1.233 0 O-C-N 119.963 -1.711 . . . . 1.1599999999999999 114.929 -177.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.75 16.8 80.15 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.95 1.738 . . . . 0.75 114.909 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.82 142.4 49.63 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.399 1.6 . . . . 1.74 110.56 169.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.26 147.94 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 108.355 -0.979 . . . . 0.56000000000000005 108.355 158.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -126.27 153.49 44.7 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 128.928 2.891 . . . . 1.8200000000000001 111.037 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 46.7 tttt -130.39 152.89 49.31 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.621 0.768 . . . . 2.3999999999999999 112.763 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' A' ' 102' ' ' SER . 0.8 OUTLIER -99.34 164.92 11.92 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.874 1.321 . . . . 2.3399999999999999 111.283 161.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.461 ' H ' HD23 ' A' ' 143' ' ' LEU . 27.7 p30 -123.96 167.56 15.0 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 127.538 2.335 . . . . 1.52 110.804 -177.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -83.75 -26.42 2.04 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.717 2.278 . . . . 1.3600000000000001 113.776 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.492 HG11 ' CG ' ' A' ' 101' ' ' GLU . 35.7 m 38.66 -164.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 129.976 3.31 . . . . 3.04 117.238 -178.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.833 0 CA-C-O 123.746 1.748 . . . . 2.1200000000000001 113.174 132.031 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.0 mtt . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 118.749 2.87 . . . . 3.1400000000000001 118.749 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.22 -80.67 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.306 0.574 . . . . 2.4500000000000002 110.188 161.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.8 t0 177.13 77.78 0.11 Allowed Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 127.073 2.149 . . . . 2.3799999999999999 108.1 -162.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -93.96 -57.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 1 C-N-CA 127.053 5.168 . . . . 0.97999999999999998 115.402 -162.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.15 140.92 29.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 1 C-N-CA 131.803 4.041 . . . . 0.76000000000000001 103.709 -170.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 mm -111.69 135.92 49.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 123.633 0.773 . . . . 0.79000000000000004 110.502 -175.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.2 mm -123.89 100.18 7.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 126.584 1.954 . . . . 0.79000000000000004 106.23 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -78.8 120.41 23.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 113.547 -1.661 . . . . 2.5600000000000001 110.455 -163.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.7 t -110.28 -65.74 1.13 Allowed 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 115.049 1.5 . . . . 2.7599999999999998 115.049 -154.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.451 ' H ' ' CG2' ' A' ' 146' ' ' VAL . 59.7 m-85 71.86 11.13 6.26 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.826 2.05 . . . . 2.3999999999999999 112.555 -171.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -138.1 153.37 49.28 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 130.046 3.338 . . . . 2.8300000000000001 107.306 163.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -71.29 -9.26 57.83 Favored 'General case' 0 CA--C 1.552 1.054 0 O-C-N 120.645 -1.284 . . . . 3.1499999999999999 113.032 172.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -141.45 104.07 4.52 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.417 2.287 . . . . 2.8799999999999999 111.405 -164.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -148.94 168.79 22.13 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.709 -1.244 . . . . 3.9300000000000002 112.306 174.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -103.94 158.11 16.63 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.727 0.811 . . . . 2.4199999999999999 111.32 166.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.6 p -102.33 141.12 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.238 1.415 . . . . 0.87 110.291 169.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -106.92 78.54 0.25 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.341 1.448 . . . . 1.1899999999999999 112.867 169.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 12.9 p -94.95 143.0 26.82 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 119.596 1.698 . . . . 1.45 113.285 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 35.6 p -105.95 19.02 21.21 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-N 112.532 -2.122 . . . . 0.81999999999999995 112.141 169.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.07 60.84 0.34 Allowed Glycine 0 C--N 1.334 0.47 0 CA-C-O 119.033 -0.871 . . . . 1.72 113.675 176.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 68.59 -166.06 0.01 OUTLIER Pre-proline 0 CA--C 1.556 1.204 0 CA-C-O 117.836 -1.078 . . . . 5.1600000000000001 109.874 171.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.85 52.09 3.87 Favored 'Trans proline' 0 C--N 1.354 0.837 0 CA-C-N 122.768 2.024 . . . . 4.5899999999999999 111.598 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -163.1 7.54 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 116.031 1.863 . . . . 4.0999999999999996 116.031 -160.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 51.87 47.95 52.35 Favored Glycine 0 N--CA 1.475 1.29 0 N-CA-C 115.061 0.784 . . . . 2.23 115.061 159.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.2 m -113.83 -21.73 10.52 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 116.331 1.975 . . . . 1.6599999999999999 116.331 -151.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -123.57 -148.5 0.4 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 121.096 1.771 . . . . 1.3700000000000001 113.904 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.539 HG22 ' OE2' ' A' ' 136' ' ' GLU . 1.6 t -72.68 -153.23 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.323 0.649 . . . . 0.93000000000000005 110.946 162.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.457 ' N ' HG23 ' A' ' 120' ' ' THR . 5.2 tp -117.12 136.53 53.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 126.466 1.906 . . . . 0.84999999999999998 112.488 167.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.46 ' CE ' ' HE1' ' A' ' 135' ' ' TRP . 17.3 mmm -131.62 155.83 46.87 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.818 -1.537 . . . . 4.0899999999999999 114.688 -176.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -123.59 111.77 16.64 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.816 -1.084 . . . . 1.47 109.956 -177.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 mt -124.01 148.9 46.64 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.648 -0.501 . . . . 0.85999999999999999 109.648 -171.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.26 108.3 58.67 Favored Pre-proline 0 N--CA 1.484 1.242 0 CA-C-O 118.798 -0.62 . . . . 5.8399999999999999 111.789 -175.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -89.87 -175.21 0.96 Allowed 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.126 2.55 . . . . 2.73 109.895 154.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 94.8 m -158.92 157.44 31.41 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.72 2.808 . . . . 1.3300000000000001 105.199 173.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.444 HG13 HD22 ' A' ' 129' ' ' ASN . 7.5 p -49.71 -32.41 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 115.309 1.596 . . . . 0.81999999999999995 115.309 -176.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.444 HD22 HG13 ' A' ' 128' ' ' VAL . 1.7 m-80 -79.27 -0.81 33.83 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.027 1.331 . . . . 2.04 113.949 177.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -141.29 -175.83 4.49 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 123.545 1.64 . . . . 2.7400000000000002 114.503 -151.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.5 m -139.22 168.08 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 130.244 3.418 . . . . 0.70999999999999996 107.267 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -147.82 128.11 13.88 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 123.924 0.89 . . . . 0.68000000000000005 111.13 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -92.33 141.17 28.84 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.937 0.789 . . . . 4.29 110.351 173.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 9.2 t -63.54 174.81 1.2 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 122.789 1.281 . . . . 1.1899999999999999 112.446 159.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.46 ' HE1' ' CE ' ' A' ' 122' ' ' MET . 20.8 p-90 -111.34 -18.37 12.93 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.316 -0.856 . . . . 1.6000000000000001 111.983 161.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.539 ' OE2' HG22 ' A' ' 120' ' ' THR . 0.0 OUTLIER -86.9 -87.7 0.14 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.67 1.988 . . . . 1.71 108.092 -171.431 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 24.3 p -59.84 -19.68 52.53 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 120.477 -1.39 . . . . 1.1000000000000001 112.664 168.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.98 15.89 22.89 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.669 1.604 . . . . 0.92000000000000004 114.186 -175.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.1 p -75.04 142.24 43.79 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 119.122 1.461 . . . . 1.28 110.722 172.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 52.8 t -80.72 147.61 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.455 -0.942 . . . . 0.55000000000000004 108.455 167.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -130.84 158.47 40.09 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 130.231 3.413 . . . . 2.2999999999999998 109.457 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -140.39 147.0 39.08 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 113.759 1.022 . . . . 3.0600000000000001 113.759 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.7 tt -93.4 145.13 24.71 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 115.36 -0.836 . . . . 0.91000000000000003 110.771 170.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -112.21 147.36 36.79 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 124.618 1.167 . . . . 1.3999999999999999 110.392 171.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -69.98 -27.57 25.25 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.549 2.166 . . . . 1.8200000000000001 112.497 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.451 ' CG2' ' H ' ' A' ' 103' ' ' TYR . 7.6 m 41.5 -158.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 129.002 2.921 . . . . 3.0 114.933 -174.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.419 0 CA-C-O 122.228 0.904 . . . . 2.3700000000000001 112.477 157.746 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.9 mtt . . . . . 0 CA--C 1.521 -0.156 0 CA-C-O 123.911 1.815 . . . . 2.5800000000000001 111.779 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 177.09 -123.48 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.119 1 C-N-CA 132.108 4.163 . . . . 1.9199999999999999 107.077 178.13 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . 0.27 30.0 t70 -131.33 78.6 71.76 Favored Pre-proline 0 N--CA 1.432 -1.334 0 C-N-CA 126.6 1.96 . . . . 2.54 107.699 176.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.13 -84.06 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.6 1 C-N-CA 126.876 5.05 . . . . 1.23 113.14 -171.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.65 147.56 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 C-N-CA 127.835 2.454 . . . . 0.70999999999999996 106.406 171.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.2 mm -105.77 136.05 41.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.932 -0.576 . . . . 0.84999999999999998 111.21 -174.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.5 mm -119.25 99.12 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 126.169 1.788 . . . . 0.64000000000000001 107.572 169.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -70.39 122.86 20.41 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.543 1.537 . . . . 3.0 108.968 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.6 m -162.23 123.49 2.65 Favored 'General case' 0 C--O 1.221 -0.442 0 O-C-N 121.06 -1.025 . . . . 3.48 112.687 -165.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -83.47 25.71 0.73 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.203 1.001 . . . . 2.5299999999999998 113.316 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -140.95 124.6 16.89 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.766 2.026 . . . . 2.6699999999999999 107.967 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -62.51 7.99 0.06 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 127.771 2.428 . . . . 3.3799999999999999 117.468 -169.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.08 22.8 0.07 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.761 2.424 . . . . 2.2400000000000002 112.458 -165.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.2 ttt-85 -67.39 150.12 49.38 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.503 1.121 . . . . 3.96 113.387 -174.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -82.99 150.91 26.09 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.893 0.701 . . . . 2.1899999999999999 112.893 176.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.5 p -108.07 138.8 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.502 1.521 . . . . 0.81000000000000005 111.168 169.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -108.66 103.14 1.79 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.492 -1.443 . . . . 0.69999999999999996 109.492 159.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.04 155.8 17.25 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.949 0.9 . . . . 1.24 110.554 166.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 120' ' ' THR . 40.9 p -118.11 4.94 11.99 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 116.463 2.023 . . . . 0.75 116.463 172.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 117.71 56.3 0.29 Allowed Glycine 0 C--N 1.33 0.224 0 CA-C-O 119.443 -0.643 . . . . 2.0800000000000001 113.016 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 79.5 -162.2 0.0 OUTLIER Pre-proline 0 CA--C 1.565 1.528 0 CA-C-O 116.61 -1.662 . . . . 3.2400000000000002 109.245 -168.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -80.55 45.93 2.11 Favored 'Trans proline' 0 C--N 1.358 1.053 0 CA-C-N 124.524 2.651 . . . . 2.2200000000000002 112.915 -173.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -166.55 163.7 17.04 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.025 1.33 . . . . 3.9300000000000002 110.785 -169.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.89 42.41 2.49 Favored Glycine 0 N--CA 1.473 1.125 0 C-N-CA 124.478 1.037 . . . . 2.2799999999999998 114.048 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.1 m -68.93 -40.6 78.93 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.657 1.229 . . . . 1.99 114.028 -160.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -106.27 -73.23 0.69 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.04 0.756 . . . . 1.8999999999999999 113.04 173.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 112' ' ' THR . 7.0 t -178.99 -166.12 0.09 Allowed 'General case' 0 N--CA 1.475 0.789 1 C-N-CA 132.685 4.394 . . . . 0.96999999999999997 106.609 -175.339 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.6 tp -98.77 138.42 23.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 119.771 1.169 . . . . 0.89000000000000001 110.729 173.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.56 ' SD ' HD21 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -141.02 163.43 32.99 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.121 1.368 . . . . 4.4500000000000002 110.441 166.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.3 m95 -130.22 87.67 2.54 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.868 -0.52 . . . . 2.3100000000000001 111.611 -155.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.56 HD21 ' SD ' ' A' ' 122' ' ' MET . 3.2 mt -95.64 167.42 11.3 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 120.498 -1.376 . . . . 0.68000000000000005 110.746 -171.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.35 88.02 15.19 Favored Pre-proline 0 N--CA 1.472 0.675 0 C-N-CA 123.592 0.757 . . . . 7.1500000000000004 111.29 -176.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -77.27 166.61 26.01 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.575 2.184 . . . . 2.3700000000000001 110.412 165.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 m -120.18 154.86 34.2 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 127.097 2.159 . . . . 1.21 108.295 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.4 p -54.95 -34.21 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 112.939 0.718 . . . . 0.75 112.939 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -82.17 -10.07 59.29 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.62 1.168 . . . . 1.6799999999999999 113.508 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -140.02 -168.34 2.5 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.696 0.68 . . . . 2.5499999999999998 112.649 -155.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.83 157.67 23.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 126.93 2.092 . . . . 0.51000000000000001 109.385 -171.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.2 144.89 36.82 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.113 0.965 . . . . 0.47999999999999998 110.968 172.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.4 ttp180 -111.74 139.3 47.33 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.443 1.02 . . . . 4.0800000000000001 112.557 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 37.8 t -60.34 156.33 15.97 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.244 1.418 . . . . 1.02 112.484 163.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -100.43 -12.85 19.03 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.063 -0.971 . . . . 1.28 112.766 169.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -103.39 -78.99 0.54 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.163 0.892 . . . . 2.5800000000000001 111.246 -169.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 26.6 p -70.02 -22.19 63.12 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.853 0.861 . . . . 1.3700000000000001 112.407 172.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.58 33.36 80.93 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.441 1.02 . . . . 1.0800000000000001 113.273 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.11 152.67 42.18 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.839 1.319 . . . . 1.96 110.508 158.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.1 t -100.24 135.4 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 106.335 -1.728 . . . . 0.57999999999999996 106.335 159.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -117.4 140.47 49.53 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 127.735 2.414 . . . . 1.6599999999999999 110.875 -176.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.8 tttm -106.14 147.47 28.96 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.639 -0.71 . . . . 2.5800000000000001 112.704 173.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.43 144.78 25.48 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 114.847 -1.069 . . . . 0.89000000000000001 110.168 155.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -106.66 159.34 30.22 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 124.596 1.158 . . . . 1.3100000000000001 113.006 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -71.8 -5.16 16.51 Favored 'Trans proline' 0 C--N 1.354 0.861 1 C-N-CA 126.274 4.65 . . . . 1.29 115.983 -177.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.9 p -48.11 142.42 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 126.141 1.777 . . . . 2.1699999999999999 111.511 177.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.717 0 CA-C-O 122.993 1.33 . . . . 1.6899999999999999 112.674 179.353 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 10.9 mtm . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 118.428 2.751 . . . . 2.54 118.428 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.32 -59.66 2.62 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.791 0.663 . . . . 2.6299999999999999 112.791 169.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.425 ' H ' ' HD3' ' A' ' 97' ' ' PRO . 0.1 OUTLIER 167.05 70.44 0.0 OUTLIER Pre-proline 0 CA--C 1.566 1.571 0 C-N-CA 129.674 3.189 . . . . 3.0 110.167 -150.201 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.425 ' HD3' ' H ' ' A' ' 96' ' ' ASP . 63.0 Cg_endo -89.02 -50.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.334 -0.229 1 C-N-CA 125.529 4.152 . . . . 0.73999999999999999 113.358 -174.244 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.98 141.74 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 1 C-N-CA 131.954 4.102 . . . . 0.53000000000000003 104.207 -172.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.3 mm -119.48 129.43 75.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 124.303 1.041 . . . . 0.71999999999999997 111.153 -175.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 42.0 mm -115.39 98.21 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 125.688 1.595 . . . . 0.55000000000000004 107.515 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -71.12 99.67 1.9 Allowed 'General case' 0 C--N 1.328 -0.361 0 O-C-N 125.569 1.793 . . . . 2.54 108.333 176.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.483 ' OG ' HD21 ' A' ' 143' ' ' LEU . 78.7 p -104.92 -43.6 5.03 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.041 1.126 . . . . 3.7000000000000002 114.041 -157.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . 0.252 35.5 m-85 72.32 9.77 5.86 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 127.742 2.417 . . . . 2.73 114.45 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -132.66 150.21 52.19 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.58 -0.896 . . . . 3.1099999999999999 108.58 134.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.05 -28.01 22.55 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.969 2.507 . . . . 3.4399999999999999 114.91 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -127.1 12.77 7.19 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.525 1.53 . . . . 2.4900000000000002 114.044 -161.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -56.57 175.28 0.12 Allowed 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 122.458 1.123 . . . . 4.04 113.25 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -95.41 169.32 10.14 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.582 -0.699 . . . . 2.5499999999999998 111.348 157.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.7 p -116.22 143.16 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 126.884 2.074 . . . . 0.85999999999999999 111.472 171.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -104.69 101.33 1.92 Allowed Glycine 0 CA--C 1.532 1.142 0 CA-C-O 117.974 -1.459 . . . . 0.82999999999999996 114.142 165.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 13.8 p -107.43 145.61 32.77 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-O 123.908 1.813 . . . . 1.1599999999999999 113.386 160.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 74.3 p -102.44 16.4 26.4 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 112.494 -2.139 . . . . 0.73999999999999999 111.627 165.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 142.45 176.0 16.2 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-O 123.693 1.718 . . . . 3.4500000000000002 114.599 -171.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.6 m -3.47 133.68 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.242 0 CA-C-N 111.757 -2.222 . . . . 3.9399999999999999 115.785 103.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.85 57.39 4.46 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 125.131 3.887 . . . . 2.8799999999999999 114.476 -169.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -169.27 48.74 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.815 1.246 . . . . 1.98 111.622 -167.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 55.7 24.69 41.25 Favored Glycine 0 N--CA 1.48 1.627 0 C-N-CA 125.077 1.322 . . . . 2.1299999999999999 115.925 166.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.2 m -77.38 -41.6 39.55 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.754 1.02 . . . . 2.0899999999999999 113.754 -144.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.438 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 25.2 p80 -115.12 -149.01 0.44 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.937 1.295 . . . . 1.51 112.395 -176.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.616 HG22 ' OE2' ' A' ' 136' ' ' GLU . 2.4 t -71.92 -155.43 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.692 0.678 . . . . 1.0900000000000001 110.987 160.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.5 tp -115.37 138.68 44.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 C-N-CA 126.483 1.913 . . . . 0.96999999999999997 111.082 165.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.525 ' CE ' ' HE1' ' A' ' 135' ' ' TRP . 13.2 mmm -131.95 153.38 50.36 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 115.144 1.535 . . . . 3.9700000000000002 115.144 -174.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -118.33 99.57 6.93 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 124.528 1.143 . . . . 1.5700000000000001 110.309 -173.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.3 mt -109.45 162.47 14.34 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.498 0.719 . . . . 0.77000000000000002 109.63 -173.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -121.89 74.57 36.87 Favored Pre-proline 0 N--CA 1.487 1.38 0 O-C-N 120.425 -1.422 . . . . 4.6600000000000001 114.782 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -86.47 39.56 0.65 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.908 3.072 . . . . 3.3399999999999999 114.922 -171.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.8 m -28.02 151.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 1 C-N-CA 132.206 4.202 . . . . 1.0700000000000001 115.27 -169.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.4 p -45.66 -39.02 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 114.703 1.372 . . . . 0.82999999999999996 114.703 177.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -81.48 -8.63 59.75 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.403 1.481 . . . . 1.47 113.823 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.402 ' O ' ' HE3' ' A' ' 142' ' ' LYS . 30.3 mt-10 -136.17 -159.53 0.97 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.34 1.056 . . . . 2.1299999999999999 110.52 -156.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 20.9 m -157.81 153.53 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 130.246 3.419 . . . . 0.79000000000000004 106.15 177.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -142.38 143.52 32.73 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.535 0.607 . . . . 0.79000000000000004 111.044 171.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -100.35 142.6 31.61 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.285 0.634 . . . . 4.8700000000000001 110.446 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 14.6 t -60.05 159.06 9.98 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 124.514 1.134 . . . . 1.04 111.52 161.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.525 ' HE1' ' CE ' ' A' ' 122' ' ' MET . 20.6 p-90 -103.96 -12.79 16.62 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.6 -0.727 . . . . 1.3999999999999999 111.703 163.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.616 ' OE2' HG22 ' A' ' 120' ' ' THR . 1.6 mm-40 -89.65 -87.05 0.18 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.933 1.293 . . . . 1.55 108.842 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 23.0 p -74.65 -15.16 60.82 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.256 1.206 . . . . 1.4299999999999999 114.256 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 66.85 18.94 69.09 Favored Glycine 0 N--CA 1.469 0.876 0 C-N-CA 126.318 1.913 . . . . 0.73999999999999999 115.075 172.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.27 141.83 57.89 Favored 'General case' 0 N--CA 1.46 0.059 0 C-N-CA 118.593 -1.243 . . . . 1.75 110.349 163.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 45.9 t -78.94 141.8 14.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 107.782 -1.192 . . . . 0.79000000000000004 107.782 159.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -122.52 156.61 33.8 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 128.082 2.553 . . . . 1.73 110.219 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 130' ' ' GLU . 66.5 tttt -136.64 152.76 50.78 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 122.315 1.055 . . . . 2.27 113.027 173.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.681 HD23 ' H ' ' A' ' 144' ' ' ASN . 6.3 tt -112.16 167.4 10.44 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.561 1.545 . . . . 1.04 109.252 174.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.681 ' H ' HD23 ' A' ' 143' ' ' LEU . 1.9 p30 -126.52 165.7 26.51 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.507 1.523 . . . . 1.45 113.581 -168.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 144' ' ' ASN . 65.0 Cg_endo -73.32 -4.43 15.4 Favored 'Trans proline' 0 N--CA 1.482 0.847 0 C-N-CA 124.07 3.18 . . . . 1.45 115.256 -176.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.8 p -44.54 140.35 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 127.974 2.51 . . . . 2.75 114.026 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.734 0 C-N-CA 126.541 2.02 . . . . 2.3300000000000001 110.335 -179.473 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.2 mtp . . . . . 0 C--O 1.224 -0.24 0 N-CA-C 116.985 2.217 . . . . 3.1699999999999999 116.985 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.33 -74.69 0.61 Allowed 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 124.305 1.042 . . . . 2.1699999999999999 109.29 173.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.4 t70 179.44 75.9 0.17 Allowed Pre-proline 0 CA--C 1.559 1.324 0 C-N-CA 128.242 2.617 . . . . 2.5899999999999999 107.893 -166.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 142' ' ' LYS . 60.7 Cg_endo -89.23 -51.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.551 1 C-N-CA 128.582 6.188 . . . . 0.75 113.437 -175.205 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -139.58 143.12 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 130.746 3.618 . . . . 0.57999999999999996 104.844 -175.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.0 mm -102.76 138.34 27.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.671 -0.695 . . . . 0.80000000000000004 110.822 -176.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.3 mm -120.5 107.11 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 C-N-CA 127.036 2.134 . . . . 0.67000000000000004 107.462 170.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -78.61 134.32 37.2 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 124.601 1.188 . . . . 3.2200000000000002 110.867 -174.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.448 ' O ' HG21 ' A' ' 146' ' ' VAL . 13.2 t -162.24 107.22 1.21 Allowed 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 113.144 0.794 . . . . 2.71 113.144 -163.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.3 m-30 -77.33 41.53 0.31 Allowed 'General case' 0 N--CA 1.48 1.063 0 O-C-N 120.524 -1.36 . . . . 2.5099999999999998 110.762 171.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.37 123.71 3.93 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.956 2.902 . . . . 3.1699999999999999 107.965 -166.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.54 -3.6 31.86 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 115.582 1.697 . . . . 3.3399999999999999 115.582 -166.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.36 21.64 1.06 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 125.112 1.365 . . . . 2.1099999999999999 113.662 -156.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.04 154.06 18.34 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 120.148 -1.595 . . . . 5.9800000000000004 114.991 -154.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.8 161.18 31.38 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.319 1.229 . . . . 2.0699999999999998 114.319 -177.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.4 p -129.6 145.84 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 127.455 2.302 . . . . 0.82999999999999996 109.84 171.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.17 126.74 6.39 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.155 0.883 . . . . 0.77000000000000002 111.605 164.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.97 151.97 39.09 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.366 1.867 . . . . 1.52 111.94 169.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 34.0 p -117.83 25.97 10.01 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.164 1.385 . . . . 0.97999999999999998 113.385 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.85 68.27 1.03 Allowed Glycine 0 N--CA 1.462 0.428 0 O-C-N 120.844 -1.16 . . . . 2.4900000000000002 111.017 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.46 177.71 0.06 OUTLIER Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 123.521 0.728 . . . . 3.0800000000000001 110.01 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.23 38.96 0.76 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.061 2.507 . . . . 2.6499999999999999 112.705 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -151.93 3.2 0.38 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.851 1.797 . . . . 2.1200000000000001 115.851 -165.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.38 72.22 0.98 Allowed Glycine 0 N--CA 1.474 1.188 0 C-N-CA 124.849 1.214 . . . . 1.8600000000000001 114.206 167.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.5 t -103.63 -30.38 10.5 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 115.338 1.607 . . . . 2.0899999999999999 115.338 -174.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.415 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 9.1 p80 -128.32 -148.12 0.37 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.631 0.773 . . . . 1.3300000000000001 112.042 -176.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.776 HG22 ' OE1' ' A' ' 136' ' ' GLU . 5.2 t -78.16 -152.34 0.05 Allowed 'General case' 0 N--CA 1.479 1.016 0 O-C-N 121.268 -0.895 . . . . 0.98999999999999999 111.376 167.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.5 tp -106.65 149.91 9.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 127.667 2.387 . . . . 1.22 110.212 164.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.18 172.35 12.88 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.806 1.242 . . . . 4.9299999999999997 110.036 170.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -137.45 124.96 22.08 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.004 0.521 . . . . 1.5 111.493 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.61 179.75 4.13 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.981 0.912 . . . . 0.84999999999999998 109.185 176.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.27 102.6 2.95 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.973 0.909 . . . . 6.5099999999999998 111.738 174.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -80.4 171.63 14.6 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.144 2.563 . . . . 2.3199999999999998 110.22 164.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.8 m -122.72 155.97 35.37 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 127.2 2.2 . . . . 1.1899999999999999 107.628 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.4 p -55.2 -30.9 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 120.571 1.532 . . . . 0.83999999999999997 112.485 175.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -82.93 -7.52 59.66 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.12 1.768 . . . . 1.4399999999999999 113.521 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -147.42 -169.67 3.37 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.29 1.036 . . . . 2.1600000000000001 112.146 -156.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.567 HG12 ' HG3' ' A' ' 142' ' ' LYS . 26.8 m -142.18 170.31 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 127.757 2.423 . . . . 0.63 109.739 -170.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -150.85 147.55 27.38 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.019 0.927 . . . . 0.52000000000000002 111.505 172.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.6 ttt-85 -114.11 139.2 49.52 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.64 0.776 . . . . 4.5599999999999996 112.333 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 40.1 t -56.78 157.67 5.32 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.817 1.247 . . . . 1.0 112.71 159.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 67.2 p-90 -109.68 -9.05 14.87 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.307 -0.871 . . . . 1.1699999999999999 112.691 167.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.776 ' OE1' HG22 ' A' ' 120' ' ' THR . 4.0 mm-40 -96.22 -83.8 0.37 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.992 1.317 . . . . 1.6699999999999999 109.682 -173.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.4 p -72.43 -14.99 61.83 Favored 'General case' 0 CA--C 1.551 0.983 0 O-C-N 120.644 -1.285 . . . . 1.22 112.651 167.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.49 22.64 76.57 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 119.075 -0.847 . . . . 0.73999999999999999 113.725 169.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.5 p -71.21 130.48 41.55 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 118.388 1.094 . . . . 1.6000000000000001 110.186 170.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.5 t -77.23 147.16 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.451 -0.574 . . . . 0.56000000000000005 109.451 161.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -131.52 156.61 45.4 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 130.544 3.538 . . . . 1.9299999999999999 110.523 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.567 ' HG3' HG12 ' A' ' 131' ' ' VAL . 9.5 tmtt? -140.27 153.2 46.43 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 113.59 0.959 . . . . 2.2799999999999998 113.59 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 144' ' ' ASN . 2.2 tt -100.66 144.1 30.03 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 122.042 0.925 . . . . 0.90000000000000002 112.372 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.418 ' O ' HD23 ' A' ' 143' ' ' LEU . 7.1 p30 -99.37 162.94 19.64 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.249 1.02 . . . . 1.3100000000000001 112.824 -174.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -75.51 -28.01 8.72 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.606 2.871 . . . . 1.3899999999999999 113.837 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 102' ' ' SER . 0.1 OUTLIER 47.88 -161.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 128.032 2.533 . . . . 3.5699999999999998 116.781 169.633 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.971 0 CA-C-O 122.39 0.994 . . . . 1.9299999999999999 114.863 132.224 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.9 mtm . . . . . 0 N--CA 1.469 0.515 0 CA-C-O 121.902 0.858 . . . . 2.7400000000000002 112.756 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 129.73 -132.0 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.763 1 C-N-CA 132.676 4.39 . . . . 2.75 107.822 -156.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -126.54 91.58 47.15 Favored Pre-proline 0 N--CA 1.436 -1.155 0 C-N-CA 128.882 2.873 . . . . 2.23 107.185 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -95.99 -49.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.373 1 C-N-CA 126.649 4.899 . . . . 0.70999999999999996 112.737 -178.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -150.62 138.48 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 131.5 3.92 . . . . 0.62 103.934 -171.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.5 mm -115.48 134.95 57.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 124.635 1.174 . . . . 0.75 111.047 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.3 mm -121.97 112.88 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 C-N-CA 126.336 1.854 . . . . 0.5 107.416 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -82.83 136.29 34.68 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 125.023 1.452 . . . . 2.5499999999999998 111.868 -173.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.0 t -125.4 -54.59 1.57 Allowed 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 113.995 1.109 . . . . 2.8300000000000001 113.995 -154.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.605 ' H ' ' CG2' ' A' ' 146' ' ' VAL 0.29 17.0 m-85 73.21 15.54 4.38 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.915 2.086 . . . . 3.1000000000000001 113.336 -172.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -151.57 168.06 26.14 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 131.677 3.991 . . . . 2.6400000000000001 106.986 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -72.28 -8.38 54.54 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.844 1.258 . . . . 2.8900000000000001 113.547 164.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.2 120.18 8.76 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 123.651 1.691 . . . . 3.3599999999999999 115.046 -164.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 81.1 mmt-85 -143.23 177.28 8.52 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.922 2.489 . . . . 4.4000000000000004 110.09 167.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -100.66 172.92 6.79 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.659 -0.651 . . . . 2.25 109.822 149.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.0 142.22 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.99 0.916 . . . . 0.68000000000000005 111.206 171.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -107.95 92.92 0.77 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-O 117.688 -1.618 . . . . 0.66000000000000003 113.647 169.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 12.7 p -101.24 148.26 25.32 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 119.788 1.794 . . . . 1.0600000000000001 113.478 166.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.4 p -113.11 13.0 19.26 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 113.24 -1.8 . . . . 0.66000000000000003 113.501 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.25 81.12 1.57 Allowed Glycine 0 N--CA 1.463 0.445 0 N-CA-C 110.42 -1.072 . . . . 2.4100000000000001 110.42 -176.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 10.1 p 58.24 -163.28 0.01 OUTLIER Pre-proline 0 CA--C 1.563 1.46 0 CA-C-O 117.106 -1.426 . . . . 2.7200000000000002 111.302 -171.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.08 -6.06 17.53 Favored 'Trans proline' 0 C--N 1.356 0.971 0 CA-C-N 123.321 2.222 . . . . 2.27 113.711 173.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -98.66 13.65 31.36 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.01 1.485 . . . . 1.8200000000000001 115.01 -165.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.5 34.26 88.66 Favored Glycine 0 N--CA 1.476 1.32 0 O-C-N 121.15 -0.969 . . . . 1.9299999999999999 113.866 172.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.02 -39.68 83.1 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.066 1.136 . . . . 1.77 114.066 -163.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.444 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 22.5 p80 -113.29 -149.14 0.44 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.239 1.816 . . . . 1.28 112.917 -176.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.642 HG22 ' OE2' ' A' ' 136' ' ' GLU . 2.6 t -73.41 -153.67 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 119.31 0.959 . . . . 1.1100000000000001 111.115 162.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.423 ' N ' HG23 ' A' ' 120' ' ' THR . 5.0 tp -117.86 137.83 50.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 126.896 2.078 . . . . 0.83999999999999997 111.499 165.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.468 ' CE ' ' HE1' ' A' ' 135' ' ' TRP . 13.6 mmm -131.66 151.74 51.4 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 115.527 1.676 . . . . 3.9100000000000001 115.527 -172.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -117.01 103.8 10.62 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 124.209 0.943 . . . . 1.55 110.515 -174.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.9 mt -111.53 161.91 15.67 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.202 0.601 . . . . 0.84999999999999998 110.423 -174.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.72 84.62 10.42 Favored Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 114.517 1.303 . . . . 6.2699999999999996 114.517 -171.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -88.63 14.96 2.17 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.59 2.86 . . . . 3.1000000000000001 116.265 -164.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.8 m -29.85 152.78 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 1 C-N-CA 131.804 4.041 . . . . 1.3500000000000001 115.322 -165.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.9 p -47.08 -43.21 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 115.174 1.546 . . . . 1.0900000000000001 115.174 -177.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -78.05 -5.52 51.68 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.795 1.638 . . . . 1.76 114.222 178.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -131.79 -177.45 4.43 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 122.758 1.266 . . . . 3.1000000000000001 112.169 -159.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.4 m -148.81 156.1 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 128.591 2.756 . . . . 0.79000000000000004 106.744 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.22 132.75 28.66 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 122.68 0.392 . . . . 0.81000000000000005 110.803 175.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.6 ttm-85 -86.22 138.19 32.06 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.189 -1.041 . . . . 4.04 108.189 168.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 20.7 t -57.67 153.03 14.12 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 124.398 1.061 . . . . 1.23 110.942 153.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.468 ' HE1' ' CE ' ' A' ' 122' ' ' MET . 19.2 p-90 -97.45 -18.63 18.94 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.524 -0.75 . . . . 1.8 111.471 163.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.642 ' OE2' HG22 ' A' ' 120' ' ' THR . 2.3 mm-40 -83.37 -92.31 0.07 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.129 0.971 . . . . 1.6100000000000001 108.804 -177.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 32.1 p -65.59 -15.43 62.72 Favored 'General case' 0 CA--C 1.553 1.07 0 O-C-N 120.559 -1.338 . . . . 1.3600000000000001 114.46 176.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.44 17.82 76.51 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 126.581 2.038 . . . . 0.83999999999999997 115.348 169.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.4 p -77.26 144.66 38.03 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.76 1.28 . . . . 1.5700000000000001 111.762 168.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 57.7 t -80.58 145.29 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.462 -0.57 . . . . 0.66000000000000003 109.462 162.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -125.15 147.95 48.8 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 129.114 2.966 . . . . 1.78 110.56 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.405 ' HG2' ' N ' ' A' ' 143' ' ' LEU . 48.8 tttt -124.4 154.57 40.21 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 123.746 1.736 . . . . 1.9299999999999999 113.186 169.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.405 ' N ' ' HG2' ' A' ' 142' ' ' LYS . 8.0 tt -92.04 156.38 17.44 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.542 1.537 . . . . 0.91000000000000003 110.606 165.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -120.74 139.08 28.41 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 107.434 -1.321 . . . . 1.3700000000000001 107.434 164.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.3 -30.53 30.31 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.078 2.519 . . . . 2.6800000000000002 111.837 -171.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.605 ' CG2' ' H ' ' A' ' 103' ' ' TYR . 20.3 m 41.41 -157.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 129.001 2.92 . . . . 2.2999999999999998 115.587 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.395 0 C-N-CA 127.299 2.38 . . . . 2.0800000000000001 108.678 159.25 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.1 mtm . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 121.6 0.714 . . . . 2.7999999999999998 112.347 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 151.28 -76.64 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.661 1 C-N-CA 132.927 4.491 . . . . 1.71 111.33 -176.478 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.5 t0 177.14 75.64 0.1 Allowed Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 128.373 2.669 . . . . 2.0800000000000001 109.596 -163.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -88.52 -49.68 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.387 1 C-N-CA 127.432 5.421 . . . . 0.72999999999999998 112.551 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -148.06 143.82 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 1 C-N-CA 131.916 4.086 . . . . 0.67000000000000004 104.205 -171.739 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.6 mm -107.85 146.13 14.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 124.67 1.188 . . . . 0.63 109.568 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.8 mm -127.38 107.57 16.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 126.603 1.961 . . . . 0.56000000000000005 110.314 167.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.4 mp0 -64.12 124.87 22.75 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 123.125 1.44 . . . . 3.6499999999999999 112.61 175.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.3 t -116.78 -58.31 2.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.774 -1.557 . . . . 2.7400000000000002 114.894 -157.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.59 ' H ' ' CG2' ' A' ' 146' ' ' VAL . 14.5 m-85 64.45 25.53 13.33 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.82 1.248 . . . . 3.0499999999999998 110.636 -168.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -167.4 148.92 5.68 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 128.345 2.658 . . . . 2.21 108.917 -170.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.426 ' HB2' ' CD2' ' A' ' 106' ' ' TYR . 8.5 m-20 -76.93 -25.62 53.12 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.61 -1.306 . . . . 3.1400000000000001 113.097 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.426 ' CD2' ' HB2' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -140.56 14.25 2.35 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.195 1.798 . . . . 2.3599999999999999 113.991 -150.453 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -60.41 168.3 2.16 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.784 1.234 . . . . 5.5499999999999998 112.536 174.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -106.52 159.32 16.26 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.809 1.04 . . . . 2.27 113.809 171.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.53 144.98 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 127.029 2.132 . . . . 1.04 109.917 170.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.42 100.89 1.4 Allowed Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.921 -0.933 . . . . 0.97999999999999998 111.993 165.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 1.6 t -86.59 138.47 31.67 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.047 1.339 . . . . 1.1299999999999999 112.591 171.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.9 p -109.34 22.19 16.12 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.061 1.134 . . . . 0.82999999999999996 114.061 170.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.87 55.77 0.92 Allowed Glycine 0 N--CA 1.462 0.391 0 O-C-N 120.806 -1.184 . . . . 1.8999999999999999 110.779 -175.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 65.43 -168.04 0.01 OUTLIER Pre-proline 0 CA--C 1.566 1.577 0 CA-C-O 117.799 -1.096 . . . . 3.9900000000000002 110.886 -173.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.41 6.1 5.02 Favored 'Trans proline' 0 C--N 1.355 0.899 0 CA-C-N 123.507 2.288 . . . . 2.4700000000000002 114.885 -169.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.31 13.2 13.6 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.553 1.316 . . . . 2.1600000000000001 114.553 -166.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 64.46 61.33 6.06 Favored Glycine 0 N--CA 1.473 1.139 0 CA-C-N 118.844 0.747 . . . . 1.6899999999999999 112.956 169.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 39.7 m -100.26 -26.43 13.91 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.73 1.381 . . . . 1.6000000000000001 114.73 -169.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.474 ' CE1' ' SD ' ' A' ' 122' ' ' MET . 30.3 p80 -131.59 -158.53 0.9 Allowed 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 119.671 1.123 . . . . 1.5800000000000001 111.1 168.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.45 HG23 ' SD ' ' A' ' 122' ' ' MET . 7.8 t -75.55 -152.97 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 O-C-N 121.088 -1.008 . . . . 0.84999999999999998 111.145 169.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.405 ' C ' ' SD ' ' A' ' 122' ' ' MET . 4.9 tp -112.6 131.3 64.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 117.72 2.489 . . . . 0.97999999999999998 117.72 -178.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.484 ' SD ' ' HG3' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -132.46 126.52 33.21 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 128.745 2.818 . . . . 5.1900000000000004 114.532 -169.339 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -106.98 114.18 28.11 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.299 1.04 . . . . 2.04 111.518 -167.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 mt -120.11 157.47 28.9 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.965 0.802 . . . . 0.79000000000000004 111.231 -171.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -118.49 92.96 44.76 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.249 1.42 . . . . 5.71 111.313 172.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -88.46 30.4 0.43 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.062 3.175 . . . . 3.46 114.383 -171.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.5 m -23.43 154.86 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 1 C-N-CA 133.829 4.852 . . . . 1.1699999999999999 117.863 -162.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.5 p -51.34 -33.99 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 120.061 -1.649 . . . . 0.84999999999999998 113.633 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -90.16 -6.0 55.84 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.276 1.83 . . . . 1.8700000000000001 114.077 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -138.05 -160.55 1.07 Allowed 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.87 0.868 . . . . 2.27 110.728 -159.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.518 HG12 ' HG3' ' A' ' 142' ' ' LYS . 27.3 m -156.98 160.31 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 131.179 3.792 . . . . 0.59999999999999998 106.277 -176.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -143.98 132.49 22.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 118.89 0.768 . . . . 0.64000000000000001 111.092 174.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 140' ' ' VAL . 8.2 ttm180 -90.72 129.63 36.8 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.447 0.699 . . . . 3.5099999999999998 109.128 170.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 34.1 t -55.32 140.99 37.58 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 123.955 0.784 . . . . 1.27 110.34 155.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -81.2 -14.58 57.4 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.552 -0.737 . . . . 1.3100000000000001 112.534 171.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.484 ' HG3' ' SD ' ' A' ' 122' ' ' MET . 0.5 OUTLIER -96.38 -91.17 0.24 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.635 1.174 . . . . 1.77 109.239 -169.163 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 19.0 p -58.99 -25.68 63.84 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.9 -1.125 . . . . 1.1699999999999999 112.756 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.81 25.94 73.84 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.346 0.974 . . . . 1.1000000000000001 113.139 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.3 p -69.61 125.15 25.84 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 119.215 1.508 . . . . 1.79 109.749 159.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 133' ' ' ARG . 39.9 t -79.18 147.37 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 107.156 -1.424 . . . . 0.67000000000000004 107.156 161.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -132.91 154.23 50.62 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 128.973 2.909 . . . . 2.2999999999999998 110.094 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.518 ' HG3' HG12 ' A' ' 131' ' ' VAL . 5.6 tmtt? -137.52 162.46 33.67 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.299 1.047 . . . . 2.4399999999999999 113.323 175.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.1 tt -113.0 144.69 42.14 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.469 1.128 . . . . 0.89000000000000001 113.234 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -111.87 144.29 30.38 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-N 114.291 -1.322 . . . . 1.3300000000000001 109.546 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -67.2 -28.1 40.75 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.832 2.355 . . . . 2.0699999999999998 112.009 -175.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.59 ' CG2' ' H ' ' A' ' 103' ' ' TYR . 22.1 m 42.12 -157.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 128.027 2.531 . . . . 2.7599999999999998 114.965 -173.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.925 0 C-N-CA 124.999 1.285 . . . . 2.29 110.794 139.331 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 33.1 mtp . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 117.754 2.501 . . . . 2.6800000000000002 117.754 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.14 -63.26 1.15 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.29 1.036 . . . . 1.9199999999999999 113.165 171.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.8 t0 163.55 77.38 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 128.502 2.721 . . . . 2.5099999999999998 110.173 -157.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -89.33 -50.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.411 1 C-N-CA 126.846 5.03 . . . . 0.81000000000000005 113.078 -174.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -154.77 142.4 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 1 C-N-CA 132.019 4.127 . . . . 0.5 104.585 -168.584 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.8 mm -118.3 137.74 51.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 123.985 0.914 . . . . 0.75 112.129 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.8 mm -129.2 112.9 26.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 127.29 2.236 . . . . 0.55000000000000004 109.002 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.69 124.98 25.37 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.758 1.623 . . . . 2.46 112.193 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.3 t -145.17 90.51 2.04 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 115.792 1.775 . . . . 2.98 115.792 -167.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -77.25 64.1 2.59 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.561 1.144 . . . . 3.4500000000000002 110.672 174.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.41 -13.32 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.68 2.392 . . . . 3.2000000000000002 113.477 -167.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 64.82 -7.93 0.24 Allowed 'General case' 0 CA--C 1.56 1.349 0 CA-C-N 120.74 1.609 . . . . 3.0600000000000001 115.072 -170.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -152.34 24.13 0.62 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 116.928 2.196 . . . . 2.46 116.928 -172.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -54.82 149.89 10.67 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 120.572 1.533 . . . . 4.2599999999999998 113.079 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -77.11 161.59 28.14 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.516 -0.74 . . . . 2.2400000000000002 112.18 163.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.1 p -113.76 145.66 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 126.586 1.954 . . . . 0.73999999999999999 111.511 175.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.67 113.27 4.67 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.424 1.011 . . . . 1.29 112.043 162.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 7.4 t -110.63 128.57 55.74 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.408 1.483 . . . . 1.04 113.239 174.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 32.9 p -110.54 34.36 4.0 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.546 1.313 . . . . 1.22 114.546 167.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.407 ' HA2' ' SG ' ' A' ' 137' ' ' CYS . . . 85.17 -31.74 3.69 Favored Glycine 0 N--CA 1.473 1.167 0 O-C-N 118.984 -2.322 . . . . 2.04 114.806 173.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.0 p 176.07 177.46 0.22 Allowed Pre-proline 0 CA--C 1.556 1.19 1 C-N-CA 132.468 4.307 . . . . 3.6699999999999999 106.67 -175.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.48 -15.02 47.61 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 121.721 1.614 . . . . 2.5499999999999998 113.302 167.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -101.85 55.43 0.81 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.935 1.694 . . . . 2.2999999999999998 111.55 177.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 55.31 20.81 23.8 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 118.061 1.984 . . . . 2.3700000000000001 118.061 154.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.3 m -71.17 -26.68 63.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 115.302 1.593 . . . . 1.6200000000000001 115.302 -140.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -108.0 -25.44 11.16 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 117.234 2.309 . . . . 2.79 117.234 169.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.319 4.8 t 121.12 -152.58 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 131.559 3.944 . . . . 1.51 108.563 -145.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.8 tp -130.15 142.74 43.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 130.463 3.505 . . . . 1.3999999999999999 112.383 -175.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.489 ' HG3' ' HG3' ' A' ' 136' ' ' GLU . 19.1 mmm -135.01 159.4 41.63 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 126.652 1.981 . . . . 3.7200000000000002 116.093 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -126.79 113.88 17.21 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.693 0.797 . . . . 1.99 110.222 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 mt -122.65 159.68 27.37 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.099 0.959 . . . . 0.89000000000000001 109.681 -171.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.16 80.92 70.88 Favored Pre-proline 0 N--CA 1.477 0.918 0 O-C-N 120.758 -1.214 . . . . 5.0999999999999996 113.171 -166.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.08 177.59 8.69 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.201 2.601 . . . . 2.5699999999999998 110.822 170.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.0 m -151.94 159.59 43.75 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.883 2.073 . . . . 0.87 107.972 -177.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.402 ' N ' HD22 ' A' ' 143' ' ' LEU . 2.6 p -53.19 -42.36 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.514 1.126 . . . . 1.02 113.583 -172.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -77.75 -2.08 34.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.944 1.298 . . . . 1.5700000000000001 113.633 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -140.82 -172.05 3.38 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 122.227 1.013 . . . . 2.3500000000000001 112.881 -150.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.9 m -153.27 161.11 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 128.102 2.561 . . . . 0.59999999999999998 107.841 -175.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.7 130.63 24.56 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.598 1.159 . . . . 0.52000000000000002 110.884 175.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.417 ' HA ' ' HA ' ' A' ' 140' ' ' VAL . 2.6 ttp180 -91.55 134.59 34.53 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.136 0.88 . . . . 5.0599999999999996 109.481 171.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 24.4 t -55.64 155.2 5.88 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.99 0.916 . . . . 0.94999999999999996 111.515 162.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.41 ' NE1' ' SD ' ' A' ' 122' ' ' MET . 30.1 p-90 -89.71 -17.05 29.06 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.184 -0.948 . . . . 1.23 111.944 166.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.489 ' HG3' ' HG3' ' A' ' 122' ' ' MET . 4.9 mt-10 -89.25 -101.54 0.09 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.627 1.171 . . . . 2.2200000000000002 109.892 -175.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . 0.407 ' SG ' ' HA2' ' A' ' 113' ' ' GLY . 27.9 p -60.57 -9.6 4.0 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 119.169 -2.207 . . . . 1.24 116.144 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.37 26.83 64.68 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 127.574 2.511 . . . . 0.77000000000000002 113.836 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.26 150.48 48.21 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.768 1.784 . . . . 1.5700000000000001 109.853 161.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 133' ' ' ARG . 69.1 t -100.54 141.11 17.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 N-CA-C 104.945 -2.243 . . . . 0.60999999999999999 104.945 169.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -123.34 139.63 53.84 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 126.877 2.071 . . . . 2.04 110.057 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.7 tttt -121.49 145.85 47.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.233 1.016 . . . . 2.8500000000000001 112.173 -175.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 128' ' ' VAL . 8.9 tt -103.76 152.69 21.56 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.194 -1.366 . . . . 1.0700000000000001 110.208 175.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -111.9 154.61 44.07 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 114.022 -1.444 . . . . 1.45 112.317 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -71.62 -3.62 13.44 Favored 'Trans proline' 0 N--CA 1.482 0.838 1 C-N-CA 126.219 4.613 . . . . 1.6200000000000001 115.68 -175.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.5 p -42.97 138.65 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 127.299 2.24 . . . . 2.3700000000000001 112.026 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 122.245 0.914 . . . . 2.75 110.959 -171.953 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.8 mtm . . . . . 0 N--CA 1.467 0.413 0 N-CA-C 116.715 2.117 . . . . 2.1899999999999999 116.715 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.464 ' HD2' ' H ' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -114.84 -117.81 0.32 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.488 -1.671 . . . . 2.8300000000000001 106.488 160.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.464 ' H ' ' HD2' ' A' ' 95' ' ' LYS 0.312 38.8 t70 -129.1 82.68 68.0 Favored Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 126.217 1.807 . . . . 2.6499999999999999 106.262 -178.237 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -87.56 -47.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.789 1 C-N-CA 128.089 5.859 . . . . 0.76000000000000001 113.489 -171.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 mm -146.91 141.47 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 131.247 3.819 . . . . 0.56000000000000005 103.269 -171.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.1 mm -108.98 140.89 25.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 C-N-CA 124.81 1.244 . . . . 0.65000000000000002 110.052 -175.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.7 mm -130.63 109.59 17.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 126.513 1.925 . . . . 0.51000000000000001 110.008 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.0 mp0 -63.82 136.92 57.79 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.709 1.604 . . . . 4.1900000000000004 112.863 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.0 t -165.67 133.88 3.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.752 -1.113 . . . . 2.7999999999999998 110.207 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 -86.99 -4.15 59.15 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 118.854 0.752 . . . . 2.8799999999999999 110.922 166.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -95.59 156.66 16.23 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.596 1.959 . . . . 2.4500000000000002 110.652 168.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -73.45 -24.38 60.22 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.903 1.681 . . . . 3.96 113.371 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -134.71 2.21 3.15 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.418 1.636 . . . . 2.48 115.418 -164.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.68 132.19 6.5 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.544 1.537 . . . . 7.1699999999999999 113.118 -177.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -78.35 152.26 32.43 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.029 1.122 . . . . 2.3399999999999999 114.029 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.0 p -101.5 144.2 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.378 1.471 . . . . 0.83999999999999997 111.775 175.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.06 89.65 0.77 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.849 1.69 . . . . 0.76000000000000001 113.737 163.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 3.7 p -99.22 143.55 29.36 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 119.602 1.701 . . . . 1.54 112.156 168.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 62.9 p -114.73 23.98 12.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.214 -1.357 . . . . 1.0 111.84 174.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.53 -168.45 14.66 Favored Glycine 0 CA--C 1.503 -0.681 0 CA-C-O 124.098 1.943 . . . . 2.4399999999999999 114.025 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -37.21 139.02 0.53 Allowed Pre-proline 0 CA--C 1.549 0.924 0 CA-C-N 110.853 -2.674 . . . . 3.9700000000000002 111.453 151.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.98 -13.6 28.27 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.884 3.723 . . . . 3.02 116.913 -155.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -85.82 6.34 28.57 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.758 1.021 . . . . 2.52 113.758 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.33 82.22 0.76 Allowed Glycine 0 C--N 1.34 0.758 0 N-CA-C 110.114 -1.194 . . . . 1.8 110.114 -176.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.88 -64.51 1.16 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.635 0.731 . . . . 2.3100000000000001 111.346 178.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.428 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 34.4 p80 -100.56 -153.54 0.45 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.335 0.865 . . . . 1.74 113.335 -164.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.513 HG22 ' OE2' ' A' ' 136' ' ' GLU . 5.8 t -70.2 -154.32 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 123.606 0.762 . . . . 1.9099999999999999 109.355 161.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.2 tp -116.3 140.96 36.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 C-N-CA 127.072 2.149 . . . . 1.3400000000000001 109.827 168.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 13.6 mmm -126.35 159.42 33.26 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 114.099 1.148 . . . . 4.0999999999999996 114.099 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -125.09 67.25 1.12 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.025 0.75 . . . . 1.8500000000000001 113.025 -167.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.7 mt -87.67 157.86 18.98 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.254 -0.904 . . . . 0.67000000000000004 109.572 -165.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -127.43 77.58 75.65 Favored Pre-proline 0 N--CA 1.48 1.051 0 CA-C-N 119.753 1.161 . . . . 6.75 111.429 -166.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -89.23 33.96 0.37 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.522 3.482 . . . . 3.3599999999999999 116.318 -156.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -15.25 144.16 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.287 1 C-N-CA 133.234 4.614 . . . . 0.96999999999999997 117.527 -166.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.407 ' HB ' HD22 ' A' ' 143' ' ' LEU . 12.1 p -56.14 -32.79 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 120.491 -1.381 . . . . 0.93999999999999995 111.477 174.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -78.46 -11.25 59.94 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.543 1.937 . . . . 2.0800000000000001 114.456 174.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -143.19 -141.38 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.409 1.083 . . . . 1.98 111.284 -164.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.43 HG12 ' HG3' ' A' ' 142' ' ' LYS . 26.8 m -162.19 167.81 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 1 C-N-CA 134.029 4.932 . . . . 0.82999999999999996 106.504 -176.429 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -148.96 142.9 25.77 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.322 0.965 . . . . 0.66000000000000003 111.713 163.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -100.94 142.6 32.19 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.438 0.695 . . . . 5.4100000000000001 111.569 177.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 15.7 t -63.58 154.53 32.39 Favored 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 124.586 1.179 . . . . 1.1699999999999999 111.15 161.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 17.8 p-90 -100.56 -19.94 15.92 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.814 -1.084 . . . . 1.48 111.463 163.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.513 ' OE2' HG22 ' A' ' 120' ' ' THR . 3.8 mm-40 -81.5 -87.64 0.09 Allowed 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 107.555 -1.276 . . . . 1.79 107.555 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 27.4 p -72.1 -12.25 61.12 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 114.671 1.36 . . . . 1.1499999999999999 114.671 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.33 6.45 83.66 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.887 1.232 . . . . 1.24 114.688 168.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.5 p -69.28 137.43 53.04 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.051 1.74 . . . . 1.76 110.167 173.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 62.0 t -80.19 148.92 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 108.866 -0.79 . . . . 0.87 108.866 159.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -128.47 154.41 46.12 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 129.316 3.046 . . . . 1.8500000000000001 109.724 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.43 ' HG3' HG12 ' A' ' 131' ' ' VAL . 8.2 tmtt? -137.53 157.39 46.65 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.129 0.966 . . . . 2.5499999999999998 112.535 178.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.407 HD22 ' HB ' ' A' ' 128' ' ' VAL . 8.2 tt -111.39 146.5 37.04 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 123.136 1.446 . . . . 0.91000000000000003 112.185 -178.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -99.83 153.72 37.62 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 114.085 -1.416 . . . . 1.3400000000000001 113.585 -170.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.85 -4.85 15.59 Favored 'Trans proline' 0 C--N 1.348 0.535 1 C-N-CA 125.398 4.065 . . . . 1.46 114.984 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.9 p -43.5 142.56 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 126.766 2.027 . . . . 1.8999999999999999 112.086 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.832 0 CA-C-O 123.474 1.597 . . . . 1.53 112.494 -177.036 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 19.2 mtt . . . . . 0 C--O 1.224 -0.288 0 N-CA-C 118.69 2.848 . . . . 2.1099999999999999 118.69 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -61.72 2.11 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.541 0.941 . . . . 1.98 113.541 171.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.462 ' N ' ' HD3' ' A' ' 97' ' ' PRO . 0.0 OUTLIER 173.38 72.09 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 128.389 2.676 . . . . 4.5999999999999996 110.213 -150.129 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.462 ' HD3' ' N ' ' A' ' 96' ' ' ASP . 93.6 Cg_endo -96.48 -48.55 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 125.245 3.964 . . . . 0.93000000000000005 113.535 -175.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -158.55 145.51 8.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 1 C-N-CA 132.353 4.261 . . . . 0.57999999999999996 104.556 -167.326 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.5 mm -118.09 139.12 46.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 124.344 1.057 . . . . 0.59999999999999998 110.303 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.4 mm -128.39 147.18 32.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 127.067 2.147 . . . . 0.71999999999999997 106.877 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.565 ' HG2' HG11 ' A' ' 146' ' ' VAL . 83.1 mt-10 -109.64 170.15 8.25 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.579 1.152 . . . . 2.6800000000000002 110.913 177.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.2 t -159.2 -43.78 0.06 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.981 1.104 . . . . 3.3900000000000001 113.981 -176.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 65.61 37.88 5.69 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 124.515 1.135 . . . . 2.23 110.117 -171.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -143.14 -84.78 0.16 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.931 2.092 . . . . 3.29 108.855 172.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t70 175.3 -39.54 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 129.293 3.037 . . . . 3.8399999999999999 109.721 -177.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -116.61 -52.38 2.56 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.012 1.486 . . . . 2.8399999999999999 115.012 -167.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 7.39 -113.37 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 129.722 3.209 . . . . 5.0999999999999996 114.648 -162.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -163.17 160.5 24.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.084 1.354 . . . . 2.0800000000000001 111.848 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.8 p -112.39 137.56 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.214 1.406 . . . . 0.81999999999999995 109.791 166.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.08 87.45 0.45 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.215 1.388 . . . . 0.84999999999999998 111.915 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 7.9 p -97.74 146.34 25.46 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 123.721 1.725 . . . . 1.3200000000000001 112.999 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 56.9 p -112.2 15.62 20.39 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 112.85 -1.977 . . . . 0.80000000000000004 112.346 171.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.93 -130.54 8.08 Favored Glycine 0 C--N 1.337 0.596 0 O-C-N 120.939 -1.1 . . . . 3.1000000000000001 111.611 -171.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.56 -52.5 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 116.07 -1.919 . . . . 4.04 113.728 -171.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -80.26 52.8 4.47 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.307 2.005 . . . . 6.3700000000000001 109.598 166.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 66.88 99.04 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.231 1.812 . . . . 3.0499999999999998 114.331 168.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 63.91 31.27 80.26 Favored Glycine 0 N--CA 1.476 1.346 0 O-C-N 120.391 -1.443 . . . . 2.0099999999999998 113.514 173.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -45.49 90.84 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.246 1.418 . . . . 1.3999999999999999 112.458 -168.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.451 ' CE1' ' SD ' ' A' ' 122' ' ' MET . 34.3 p80 -108.18 -142.31 0.38 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.768 1.627 . . . . 1.49 111.439 177.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.558 HG22 ' OE2' ' A' ' 136' ' ' GLU . 10.7 t -89.13 -141.68 0.14 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.404 1.081 . . . . 0.84999999999999998 109.273 163.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.456 ' N ' HG23 ' A' ' 120' ' ' THR . 4.9 tp -122.07 132.88 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 128.545 2.738 . . . . 0.94999999999999996 116.603 173.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.467 ' SD ' ' HG3' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -127.69 149.02 50.4 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 129.462 3.105 . . . . 5.1100000000000003 112.814 -174.513 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -127.98 119.89 26.44 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.91 0.884 . . . . 1.7 110.267 -174.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.57 163.18 23.97 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.834 0.854 . . . . 0.92000000000000004 110.651 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -110.4 90.0 9.53 Favored Pre-proline 0 N--CA 1.483 1.215 0 C-N-CA 124.382 1.073 . . . . 5.9000000000000004 111.793 176.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -76.53 -45.13 0.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 CA-C-O 116.854 -1.394 . . . . 3.1499999999999999 112.866 -169.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 68.56 145.08 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 130.372 3.469 . . . . 1.1499999999999999 110.91 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.01 -40.34 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.759 0.79 . . . . 1.4199999999999999 109.919 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -66.74 -20.73 66.02 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 126.541 1.936 . . . . 2.02 113.336 172.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -135.36 -160.27 1.04 Allowed 'General case' 0 C--N 1.342 0.253 0 CA-C-N 120.583 1.538 . . . . 2.98 110.815 -164.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.2 m -147.44 155.95 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 127.699 2.4 . . . . 0.52000000000000002 107.834 176.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.6 137.23 33.52 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.242 0.617 . . . . 0.58999999999999997 111.33 170.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.2 ttp85 -98.14 138.48 35.37 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.868 0.304 . . . . 4.2400000000000002 110.774 172.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 49.6 t -61.37 156.38 19.16 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 123.045 1.402 . . . . 1.1000000000000001 111.465 160.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -98.78 -15.98 19.09 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.118 -1.401 . . . . 1.28 112.521 169.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.558 ' OE2' HG22 ' A' ' 120' ' ' THR . 0.1 OUTLIER -98.65 -85.03 0.39 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.091 2.156 . . . . 1.6200000000000001 109.787 -168.262 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 29.5 p -67.35 -19.71 65.47 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 120.823 1.647 . . . . 1.28 112.797 170.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.44 16.72 80.46 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.022 0.82 . . . . 0.70999999999999996 113.786 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.98 143.92 57.08 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 119.681 1.741 . . . . 1.9399999999999999 111.453 171.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 59.6 t -92.35 136.9 23.44 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 N-CA-C 105.656 -1.979 . . . . 0.58999999999999997 105.656 161.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -120.03 137.97 53.79 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 126.356 1.863 . . . . 1.74 109.209 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -106.12 150.56 25.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 123.542 0.527 . . . . 1.8700000000000001 110.103 164.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.696 HD23 ' H ' ' A' ' 144' ' ' ASN . 0.5 OUTLIER -85.7 -171.5 3.63 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 122.309 1.052 . . . . 2.25 108.88 158.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.696 ' H ' HD23 ' A' ' 143' ' ' LEU . 1.1 t-20 -143.93 169.09 10.97 Favored Pre-proline 0 C--N 1.318 -0.799 0 C-N-CA 126.767 2.027 . . . . 4.2599999999999998 109.709 -174.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -89.6 1.28 5.72 Favored 'Trans proline' 0 N--CA 1.46 -0.482 1 C-N-CA 125.466 4.11 . . . . 1.54 114.576 -165.595 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.565 HG11 ' HG2' ' A' ' 101' ' ' GLU . 8.5 p -40.78 142.58 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 1 C-N-CA 132.022 4.129 . . . . 2.3300000000000001 113.56 175.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.861 0 C-N-CA 128.101 2.762 . . . . 1.76 108.926 -166.982 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.2 mtm . . . . . 0 N--CA 1.467 0.385 0 N-CA-C 119.416 3.117 . . . . 2.0099999999999998 119.416 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.59 -62.17 1.55 Allowed 'General case' 0 C--N 1.316 -0.849 0 O-C-N 121.896 -0.502 . . . . 2.3100000000000001 111.43 167.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.415 ' N ' ' HD3' ' A' ' 97' ' ' PRO . 37.8 t70 168.02 66.54 0.01 OUTLIER Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 130.032 3.333 . . . . 2.73 108.659 -163.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 142' ' ' LYS . 51.5 Cg_endo -80.08 -71.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 1 C-N-CA 128.21 5.94 . . . . 1.0 113.562 -168.596 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.45 ' H ' ' HG2' ' A' ' 97' ' ' PRO . 0.6 OUTLIER -112.37 145.87 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 130.876 3.67 . . . . 0.64000000000000001 104.473 174.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.7 mm -106.74 143.19 17.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 124.016 0.927 . . . . 0.67000000000000004 111.044 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.9 mm -125.75 114.13 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 126.761 2.024 . . . . 0.60999999999999999 109.021 167.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -66.21 138.41 57.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.938 1.351 . . . . 3.71 112.249 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.4 t -160.63 118.1 2.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.097 -0.956 . . . . 3.1099999999999999 111.723 -169.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -87.74 10.0 19.77 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 118.44 0.564 . . . . 2.3900000000000001 112.088 167.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -105.66 -60.26 1.65 Allowed 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.755 1.622 . . . . 3.0699999999999998 113.162 -172.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.579 ' OD1' HG12 ' A' ' 128' ' ' VAL . 23.7 t0 119.92 -48.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 1 C-N-CA 133.55 4.74 . . . . 4.2300000000000004 109.01 -167.511 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.85 -3.59 59.08 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 119.906 -1.746 . . . . 2.23 113.629 -168.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -52.25 121.75 7.44 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.846 1.658 . . . . 4.0999999999999996 113.102 -163.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -82.36 164.23 21.2 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 114.555 1.317 . . . . 2.0 114.555 -168.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.8 t -97.98 137.43 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.543 1.937 . . . . 2.1200000000000001 112.093 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -115.27 69.35 0.26 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.952 1.263 . . . . 1.1699999999999999 111.995 164.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 4.2 t -82.53 133.92 35.19 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.994 0.918 . . . . 0.95999999999999996 111.679 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 57.3 p -113.18 25.95 10.9 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.495 1.118 . . . . 0.85999999999999999 113.636 168.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.43 66.57 1.46 Allowed Glycine 0 N--CA 1.462 0.431 0 O-C-N 120.822 -1.174 . . . . 2.3999999999999999 110.793 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 68.73 174.03 0.08 OUTLIER Pre-proline 0 CA--C 1.563 1.442 0 C-N-CA 123.464 0.705 . . . . 2.9300000000000002 110.856 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.7 -8.71 22.89 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 121.881 1.72 . . . . 2.1800000000000002 114.704 -169.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.56 4.73 46.0 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.355 1.243 . . . . 2.02 114.355 -173.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.73 81.37 0.37 Allowed Glycine 0 N--CA 1.471 1.006 0 C-N-CA 125.12 1.343 . . . . 1.6599999999999999 112.465 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.6 m -102.33 -35.91 8.65 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.413 1.264 . . . . 1.4199999999999999 114.413 -174.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.439 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 6.6 p80 -122.98 -153.71 0.57 Allowed 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.611 -0.681 . . . . 1.3600000000000001 111.935 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.746 HG22 ' OE1' ' A' ' 136' ' ' GLU . 5.5 t -72.25 -154.51 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 119.423 1.01 . . . . 1.0700000000000001 111.415 168.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.3 tp -108.96 146.81 14.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 126.711 2.004 . . . . 1.01 109.816 163.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.613 ' SD ' HD21 ' A' ' 124' ' ' LEU . 4.7 ppp? -154.76 163.5 40.16 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.189 0.811 . . . . 3.7599999999999998 113.189 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.409 ' O ' HD23 ' A' ' 124' ' ' LEU . 5.6 m95 -127.8 126.92 42.63 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.601 0.963 . . . . 1.51 113.601 -162.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.613 HD21 ' SD ' ' A' ' 122' ' ' MET . 5.6 mt -131.92 158.35 41.62 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.553 1.141 . . . . 0.72999999999999998 111.535 -174.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.43 83.1 16.07 Favored Pre-proline 0 CA--C 1.561 1.399 0 C-N-CA 125.976 1.71 . . . . 6.0700000000000003 112.272 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -82.35 27.01 0.61 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.936 3.757 . . . . 3.27 115.704 -165.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.447 HG22 ' OD1' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -20.32 148.84 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 1 C-N-CA 133.169 4.588 . . . . 1.0 116.901 -163.479 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.579 HG12 ' OD1' ' A' ' 105' ' ' ASP . 5.0 p -59.15 -32.75 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 O-C-N 120.418 -1.426 . . . . 0.82999999999999996 111.124 175.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -73.35 -12.27 60.77 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 128.407 2.683 . . . . 2.21 113.977 174.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.418 ' HB3' ' H ' ' A' ' 131' ' ' VAL . 31.5 mt-10 -144.61 -146.66 0.19 Allowed 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 123.761 0.824 . . . . 2.25 111.561 -161.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.466 HG12 ' HG3' ' A' ' 142' ' ' LYS . 32.0 m -159.32 170.79 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.67 1 C-N-CA 134.29 5.036 . . . . 0.81000000000000005 106.133 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -146.6 143.6 28.95 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.32 -0.862 . . . . 0.51000000000000001 112.21 164.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.403 ' HG3' HG22 ' A' ' 140' ' ' VAL . 14.3 ttm-85 -100.55 136.66 40.08 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.632 1.573 . . . . 5.6299999999999999 110.045 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.475 ' HA ' ' HE1' ' A' ' 122' ' ' MET . 52.3 t -68.29 167.32 14.66 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 122.475 1.131 . . . . 1.1299999999999999 112.945 161.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 46.5 p-90 -122.46 -12.24 8.21 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.449 1.5 . . . . 1.29 112.155 171.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.746 ' OE1' HG22 ' A' ' 120' ' ' THR . 4.1 mm-40 -94.93 -61.73 1.44 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.685 0.794 . . . . 2.02 110.624 -174.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 29.9 p -95.12 -15.77 23.11 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.961 1.304 . . . . 1.0800000000000001 112.63 166.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.43 16.76 78.83 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 120.896 -1.127 . . . . 0.93000000000000005 114.341 174.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.7 p -68.32 126.73 30.5 Favored 'General case' 0 C--N 1.335 -0.041 0 CA-C-N 119.76 1.78 . . . . 1.5800000000000001 109.642 173.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.403 HG22 ' HG3' ' A' ' 133' ' ' ARG . 46.2 t -75.73 147.03 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 119.657 -0.817 . . . . 0.67000000000000004 109.079 161.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -128.0 152.71 47.59 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 130.097 3.359 . . . . 2.1000000000000001 110.41 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.492 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 9.6 tmtt? -140.4 157.74 45.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 122.257 1.027 . . . . 2.48 113.203 174.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.3 tt -114.39 143.67 44.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 122.763 1.268 . . . . 0.89000000000000001 113.085 -175.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -98.75 155.82 36.28 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-N 114.18 -1.373 . . . . 1.3 112.046 -170.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.1 -4.02 14.59 Favored 'Trans proline' 0 C--N 1.352 0.753 1 C-N-CA 125.904 4.403 . . . . 1.51 115.428 -174.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.3 p -40.94 148.61 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 128.433 2.693 . . . . 2.0099999999999998 113.736 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.545 0 O-C-N 120.809 -1.182 . . . . 1.5700000000000001 110.722 175.494 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.4 mtm . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 118.229 2.678 . . . . 2.0099999999999998 118.229 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.23 -123.9 0.06 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.741 1.258 . . . . 2.5899999999999999 108.363 157.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -120.61 90.02 45.4 Favored Pre-proline 0 N--CA 1.433 -1.304 0 C-N-CA 129.222 3.009 . . . . 2.48 107.658 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -90.45 -42.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.26 1 C-N-CA 127.174 5.249 . . . . 1.03 112.352 -178.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 mm -155.68 140.16 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 130.462 3.505 . . . . 0.96999999999999997 104.341 -168.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.2 mm -108.22 136.27 44.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 124.68 1.192 . . . . 0.76000000000000001 109.48 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.7 mm -130.7 112.28 22.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 127.836 2.454 . . . . 0.70999999999999996 107.043 176.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -64.94 172.85 2.62 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 125.432 1.707 . . . . 3.1800000000000002 110.345 171.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 98.7 p -157.84 -57.17 0.08 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.039 -0.982 . . . . 2.9900000000000002 113.471 -166.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.6 ' CD1' HG23 ' A' ' 146' ' ' VAL . 12.7 m-85 64.27 27.0 13.81 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 126.742 2.017 . . . . 3.0499999999999998 110.825 -165.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -169.05 160.68 10.08 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 129.489 3.115 . . . . 3.6699999999999999 110.409 -174.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -83.3 3.94 29.29 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 115.422 1.638 . . . . 2.9700000000000002 115.422 -171.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -162.5 35.28 0.11 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 114.781 1.401 . . . . 2.0899999999999999 114.781 -158.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -79.99 -164.99 0.75 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.043 1.337 . . . . 5.5999999999999996 113.465 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -140.73 157.88 44.78 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.245 1.202 . . . . 2.02 114.245 -172.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.1 p -120.22 149.22 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.989 2.116 . . . . 1.0800000000000001 110.916 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.52 122.01 5.22 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 118.964 -0.909 . . . . 0.76000000000000001 112.88 157.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 15.0 p -114.32 152.48 31.35 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 123.191 1.472 . . . . 1.0700000000000001 113.679 169.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 120' ' ' THR . 50.2 p -107.15 38.85 2.01 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 113.247 -1.797 . . . . 1.0 111.629 170.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.421 ' HA2' ' CD2' ' A' ' 119' ' ' HIS . . . 98.13 22.55 14.89 Favored Glycine 0 C--O 1.226 -0.356 0 CA-C-O 118.802 -0.999 . . . . 1.8100000000000001 113.969 -177.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.425 ' HB2' ' HD2' ' A' ' 115' ' ' PRO . 5.8 p 89.24 175.09 0.04 OUTLIER Pre-proline 0 N--CA 1.483 1.22 0 C-N-CA 127.409 2.284 . . . . 2.6800000000000002 109.844 -151.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 114' ' ' SER . 17.8 Cg_endo -60.53 -19.85 61.45 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.08 2.52 . . . . 2.8999999999999999 114.617 167.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -84.67 52.7 2.46 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.564 1.074 . . . . 3.7599999999999998 112.324 178.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 38.44 59.14 1.61 Allowed Glycine 0 N--CA 1.472 1.076 0 C-N-CA 126.171 1.844 . . . . 2.6400000000000001 116.022 154.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.401 ' HB2' ' HA3' ' A' ' 113' ' ' GLY . 13.7 m -115.12 -19.47 10.84 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.605 1.335 . . . . 1.78 114.605 -166.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.541 ' CD2' ' HB3' ' A' ' 136' ' ' GLU . 14.0 p80 -148.03 -158.81 0.95 Allowed 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 120.374 1.443 . . . . 1.72 114.151 171.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.624 HG22 ' OE2' ' A' ' 136' ' ' GLU . 5.2 t -66.09 -164.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.06 1.344 . . . . 0.81999999999999995 111.193 169.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.9 tp -103.06 145.36 12.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 O-C-N 120.454 -1.403 . . . . 1.1000000000000001 110.625 165.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.607 ' SD ' HD21 ' A' ' 124' ' ' LEU . 3.4 ppp? -150.66 172.71 15.12 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.081 1.752 . . . . 3.6000000000000001 110.277 176.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -138.98 128.96 25.1 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.311 0.856 . . . . 1.8999999999999999 113.311 -169.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.607 HD21 ' SD ' ' A' ' 122' ' ' MET . 5.8 mt -126.0 153.08 44.87 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.989 0.916 . . . . 0.81999999999999995 110.822 -171.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -124.39 101.22 34.52 Favored Pre-proline 0 N--CA 1.477 0.878 0 CA-C-O 118.219 -0.895 . . . . 5.0599999999999996 112.434 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -80.82 169.59 16.39 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.603 2.202 . . . . 2.3500000000000001 110.223 162.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -123.88 156.09 36.89 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.939 2.096 . . . . 1.26 107.886 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.6 p -51.16 -35.9 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 O-C-N 120.582 -1.324 . . . . 1.0600000000000001 113.862 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -89.34 -1.83 58.21 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.176 1.176 . . . . 1.72 114.176 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -145.03 176.3 9.6 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 123.109 1.433 . . . . 2.7000000000000002 114.472 -158.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.45 HG12 ' HG3' ' A' ' 142' ' ' LYS . 18.6 m -125.07 154.57 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 128.408 2.683 . . . . 0.57999999999999996 109.648 -172.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -132.79 139.41 47.51 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.55 1.14 . . . . 0.59999999999999998 110.674 173.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.1 ttp-105 -111.95 142.89 43.79 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.358 0.526 . . . . 4.6399999999999997 111.7 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 42.2 t -60.64 157.57 14.25 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 122.77 1.271 . . . . 0.97999999999999998 113.431 167.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.442 ' H ' ' HE1' ' A' ' 122' ' ' MET . 49.7 p-90 -107.44 -14.29 14.89 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.005 1.322 . . . . 1.3300000000000001 112.055 168.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.624 ' OE2' HG22 ' A' ' 120' ' ' THR . 0.1 OUTLIER -92.29 -67.85 0.83 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.726 1.21 . . . . 1.6899999999999999 110.376 -175.785 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 26.6 p -91.19 -12.71 34.55 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 126.338 1.855 . . . . 1.0800000000000001 114.095 172.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.43 12.51 69.75 Favored Glycine 0 CA--C 1.532 1.108 0 O-C-N 121.069 -1.019 . . . . 0.72999999999999998 115.267 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.4 p -73.31 134.86 44.29 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.86 2.33 . . . . 1.55 111.394 174.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.2 t -75.84 150.18 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 109.922 -0.399 . . . . 0.67000000000000004 109.922 165.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -138.59 142.17 39.19 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 130.49 3.516 . . . . 2.2200000000000002 109.073 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.45 ' HG3' HG12 ' A' ' 131' ' ' VAL . 1.6 tmtt? -127.75 153.38 46.61 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 113.224 0.824 . . . . 2.3300000000000001 113.224 -174.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.14 137.58 34.01 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.465 0.542 . . . . 1.1499999999999999 112.465 176.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 37.2 p-10 -105.31 150.18 38.59 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 108.416 -0.957 . . . . 1.29 108.416 166.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.43 -31.5 21.88 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.038 2.492 . . . . 2.3500000000000001 113.294 -172.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.6 HG23 ' CD1' ' A' ' 103' ' ' TYR 0.266 3.5 m 47.05 -165.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 129.54 3.136 . . . . 2.8399999999999999 116.85 -179.369 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.616 0 C-N-CA 125.414 1.483 . . . . 2.2799999999999998 111.614 168.217 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 9.4 mtm . . . . . 0 C--O 1.224 -0.269 0 N-CA-C 119.198 3.036 . . . . 2.0499999999999998 119.198 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -62.12 1.77 Allowed 'General case' 0 C--N 1.32 -0.699 0 O-C-N 121.993 -0.442 . . . . 2.1400000000000001 112.143 166.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.3 t70 165.43 73.1 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 128.571 2.749 . . . . 2.5299999999999998 110.486 -157.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -87.28 -98.18 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.695 1 C-N-CA 126.863 5.042 . . . . 1.5700000000000001 113.746 -168.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -87.81 147.88 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 C-N-CA 126.948 2.099 . . . . 0.80000000000000004 106.582 170.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 21.1 mm -110.26 140.31 29.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 123.423 0.689 . . . . 0.93999999999999995 112.544 -170.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.6 mm -127.74 124.11 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 127.373 2.269 . . . . 0.68999999999999995 109.161 173.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.66 146.5 32.44 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.729 1.212 . . . . 2.6099999999999999 111.463 174.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.1 t -151.43 -50.55 0.12 Allowed 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 117.153 2.279 . . . . 2.5099999999999998 117.153 -168.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 77.62 -11.24 1.23 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 116.644 2.09 . . . . 2.6400000000000001 116.644 176.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.22 21.43 6.72 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 127.228 2.211 . . . . 2.71 111.475 -174.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 63.53 -16.18 0.07 Allowed 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 119.251 3.056 . . . . 3.2400000000000002 119.251 174.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -129.56 -68.21 0.73 Allowed 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 122.287 2.312 . . . . 3.0800000000000001 114.952 -179.637 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 58.77 -168.79 0.14 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.081 1.752 . . . . 3.9100000000000001 113.521 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -119.5 163.2 17.63 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.048 -1.032 . . . . 2.1200000000000001 109.992 150.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.8 p -116.43 137.76 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.397 1.079 . . . . 0.71999999999999997 110.514 169.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -117.03 112.72 2.57 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.042 0.829 . . . . 0.80000000000000004 111.316 168.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.608 ' H ' ' HE2' ' A' ' 122' ' ' MET . 0.8 OUTLIER -117.01 155.8 28.57 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.171 1.788 . . . . 0.88 113.447 173.242 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.9 p -125.16 16.71 8.43 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.958 1.303 . . . . 0.83999999999999997 114.054 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.74 70.21 1.18 Allowed Glycine 0 C--N 1.335 0.506 0 O-C-N 120.91 -1.119 . . . . 2.73 110.557 -177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 70.06 176.43 0.07 OUTLIER Pre-proline 0 CA--C 1.561 1.366 0 CA-C-O 118.373 -0.822 . . . . 3.0699999999999998 110.789 -176.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.99 -5.68 17.38 Favored 'Trans proline' 0 C--N 1.353 0.802 0 CA-C-N 122.353 1.876 . . . . 2.8199999999999998 114.781 -167.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.15 -6.77 19.55 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 115.245 1.572 . . . . 2.8700000000000001 115.245 -174.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.57 100.43 0.22 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.182 0.896 . . . . 1.8700000000000001 111.765 -173.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.6 m -105.79 -34.52 7.65 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.65 0.981 . . . . 1.6599999999999999 113.65 173.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -116.67 -153.59 0.53 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.67 0.788 . . . . 1.3300000000000001 111.829 174.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.734 HG22 ' OE2' ' A' ' 136' ' ' GLU . 5.3 t -74.86 -147.23 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.479 0.712 . . . . 0.97999999999999998 110.67 166.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.461 ' N ' HG23 ' A' ' 120' ' ' THR . 2.9 tt -117.27 149.21 19.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 126.778 2.031 . . . . 1.4299999999999999 111.363 166.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.608 ' HE2' ' H ' ' A' ' 111' ' ' CYS . 0.0 OUTLIER -133.65 171.82 13.59 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.871 1.668 . . . . 4.6399999999999997 109.714 169.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -137.06 123.53 20.83 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.64 0.776 . . . . 5.0700000000000003 109.827 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.451 HD21 ' SD ' ' A' ' 122' ' ' MET . 2.2 mt -120.81 160.96 22.33 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 118.939 0.791 . . . . 0.97999999999999998 111.406 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.45 99.8 26.42 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 123.093 0.557 . . . . 5.9900000000000002 109.525 166.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -76.23 179.08 6.71 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 N-CA-C 107.528 -1.758 . . . . 2.46 107.528 159.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 106' ' ' TYR . 24.9 m -159.11 156.1 28.48 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 105.726 -1.953 . . . . 1.0800000000000001 105.726 172.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.7 p -52.35 -39.92 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 124.213 1.005 . . . . 0.87 112.494 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -82.03 0.66 39.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.82 1.648 . . . . 1.6799999999999999 114.192 176.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -143.1 -176.92 5.11 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 122.214 1.007 . . . . 2.23 113.016 -159.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.5 m -146.4 155.35 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 127.342 2.257 . . . . 0.64000000000000001 109.579 -173.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -141.7 128.55 20.56 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.648 0.779 . . . . 0.67000000000000004 112.05 -175.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.4 ttp-105 -101.45 132.45 47.04 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.191 0.905 . . . . 4.6299999999999999 112.85 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -18.91 62.2 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 117.622 2.452 . . . . 3.5699999999999998 117.622 -164.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 13.8 p-90 59.0 -20.16 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 128.394 2.678 . . . . 1.22 115.74 -173.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.734 ' OE2' HG22 ' A' ' 120' ' ' THR . 3.9 mm-40 -94.43 -87.73 0.25 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 120.434 1.47 . . . . 2.75 110.341 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 30.5 p -62.88 -18.16 62.6 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.137 0.975 . . . . 1.3700000000000001 111.934 166.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 58.14 38.69 90.52 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 124.815 1.197 . . . . 1.1000000000000001 111.566 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . 0.263 0.1 OUTLIER -63.77 159.04 20.23 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 117.427 -1.709 . . . . 1.8999999999999999 109.377 155.603 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.2 t -114.15 136.44 50.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 104.074 -2.565 . . . . 0.68000000000000005 104.074 160.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -115.08 140.3 49.18 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.86 1.664 . . . . 1.75 110.224 -176.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -104.39 156.1 18.22 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 122.662 1.22 . . . . 2.1699999999999999 111.621 164.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.8 tt -100.22 154.51 18.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 112.922 -1.945 . . . . 0.93000000000000005 110.237 157.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -109.61 156.52 39.5 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.126 0.97 . . . . 1.28 113.269 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.73 -2.49 10.24 Favored 'Trans proline' 0 N--CA 1.485 0.976 1 C-N-CA 126.413 4.742 . . . . 1.55 115.877 -175.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.9 p -43.88 152.36 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 128.288 2.635 . . . . 1.8799999999999999 113.049 177.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.896 0 C-N-CA 126.095 1.807 . . . . 1.6100000000000001 110.644 176.876 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 11.4 mtp . . . . . 0 CA--C 1.518 -0.254 0 CA-C-O 123.928 1.823 . . . . 3.4500000000000002 113.523 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.7 -76.46 0.19 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.033 -1.894 . . . . 2.1299999999999999 109.62 173.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -174.12 72.39 0.34 Allowed Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 127.126 2.171 . . . . 2.5299999999999998 108.903 -168.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -88.31 -48.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.496 1 C-N-CA 127.276 5.317 . . . . 0.71999999999999997 114.258 -170.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -140.96 147.76 22.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 129.938 3.295 . . . . 0.71999999999999997 105.083 -175.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.5 mm -109.92 136.6 45.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 123.033 0.533 . . . . 0.69999999999999996 111.341 -176.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 51.4 mm -119.1 119.51 61.07 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 126.217 1.807 . . . . 0.93000000000000005 107.479 165.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -77.31 120.79 22.83 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 124.531 1.144 . . . . 3.4100000000000001 109.559 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.7 t -125.09 -51.7 1.66 Allowed 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 116.297 1.962 . . . . 2.1899999999999999 116.297 -164.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 64.01 14.29 8.35 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 122.132 2.242 . . . . 3.3900000000000001 111.924 -177.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -161.23 142.62 11.64 Favored 'General case' 0 CA--C 1.549 0.914 1 C-N-CA 132.312 4.245 . . . . 2.3999999999999999 106.331 -161.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.686 ' OD1' HG12 ' A' ' 128' ' ' VAL . 48.3 t0 -95.77 14.07 24.46 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 126.113 1.765 . . . . 4.9500000000000002 113.337 -177.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -153.26 12.89 0.49 Allowed 'General case' 0 N--CA 1.485 1.288 0 O-C-N 118.926 -2.359 . . . . 2.77 114.599 -156.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -72.47 159.34 34.11 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.291 0.848 . . . . 4.5899999999999999 113.291 -177.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -95.6 163.36 13.24 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.965 0.728 . . . . 2.3100000000000001 112.965 163.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 p -129.33 148.09 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 127.767 2.427 . . . . 1.1399999999999999 111.102 173.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -100.95 108.78 3.52 Favored Glycine 0 CA--C 1.539 1.533 0 CA-C-O 118.756 -1.025 . . . . 1.05 113.631 166.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 9.1 t -108.21 139.62 42.62 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.63 1.572 . . . . 1.1799999999999999 113.984 171.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 12.3 p -113.71 6.84 17.0 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 117.9 2.556 . . . . 1.0700000000000001 117.9 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.01 -23.05 22.64 Favored Glycine 0 N--CA 1.48 1.571 0 O-C-N 119.955 -1.716 . . . . 2.25 113.058 -176.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.2 t 173.52 151.93 0.24 Allowed Pre-proline 0 C--O 1.24 0.553 0 C-N-CA 127.754 2.422 . . . . 4.5199999999999996 108.228 -166.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -60.33 -23.56 74.88 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.656 2.238 . . . . 3.2599999999999998 112.369 168.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.28 9.56 25.47 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.397 1.079 . . . . 3.1600000000000001 113.73 174.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 73.75 62.67 2.94 Favored Glycine 0 C--N 1.343 0.944 0 C-N-CA 124.024 0.821 . . . . 2.27 113.66 170.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 30.7 m -71.94 -34.52 69.1 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.971 1.471 . . . . 1.7 114.971 -172.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -107.34 -49.94 3.17 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.006 1.854 . . . . 2.8300000000000001 116.006 176.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.7 t 156.77 -159.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 1 C-N-CA 133.185 4.594 . . . . 0.92000000000000004 105.573 -158.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.8 tp -120.08 140.74 43.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 127.584 2.353 . . . . 1.5 111.366 169.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.472 ' CE ' ' HE1' ' A' ' 135' ' ' TRP . 1.2 mmm -137.6 152.38 49.33 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 114.824 1.416 . . . . 4.6500000000000004 114.824 -176.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -110.9 99.98 8.78 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 113.898 -1.501 . . . . 1.8700000000000001 110.72 -171.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 134' ' ' CYS . 2.0 mt -106.77 169.75 8.35 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.512 -0.921 . . . . 1.3700000000000001 108.512 -173.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -151.55 100.6 2.94 Favored Pre-proline 0 N--CA 1.472 0.65 0 CA-C-N 119.192 0.905 . . . . 5.6799999999999997 111.607 178.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.88 173.97 10.65 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.252 2.635 . . . . 2.2799999999999998 110.503 170.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.85 144.26 45.54 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.297 2.239 . . . . 1.8100000000000001 107.572 -170.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.686 HG12 ' OD1' ' A' ' 105' ' ' ASP . 7.7 p -60.79 -34.03 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 120.725 -1.235 . . . . 1.02 111.741 -174.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -64.46 -21.02 66.53 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.677 1.991 . . . . 2.3199999999999998 112.922 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -161.6 -137.23 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.109 1.364 . . . . 2.5899999999999999 111.42 -156.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.3 m -156.37 170.31 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 126.884 2.074 . . . . 0.60999999999999999 110.405 -158.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -139.47 143.01 37.34 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.098 0.959 . . . . 0.64000000000000001 110.595 166.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 140' ' ' VAL . 28.3 ttt-85 -95.61 140.38 30.53 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 105.132 -2.173 . . . . 5.0099999999999998 105.132 167.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' ' 136' ' ' GLU . 17.9 t -52.08 131.86 32.36 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 124.302 1.001 . . . . 1.1799999999999999 110.009 152.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.472 ' HE1' ' CE ' ' A' ' 122' ' ' MET . 20.0 p-90 -65.61 -20.52 66.35 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.184 -0.948 . . . . 1.8999999999999999 110.637 168.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.416 ' HB2' ' SG ' ' A' ' 134' ' ' CYS . 0.6 OUTLIER -88.05 -108.57 0.07 Allowed 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 126.63 1.972 . . . . 3.1099999999999999 109.173 -172.562 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 5.8 p -53.01 -58.77 5.85 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.899 2.48 . . . . 1.73 111.939 -170.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 117.7 21.12 4.38 Favored Glycine 0 C--N 1.331 0.258 0 CA-C-N 113.106 -1.861 . . . . 1.5900000000000001 116.478 -166.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.2 p -71.72 101.81 2.66 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 119.142 1.471 . . . . 1.79 107.549 156.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 133' ' ' ARG . 47.1 t -62.7 145.22 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 108.475 -0.935 . . . . 0.69999999999999996 108.475 155.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -124.48 156.41 37.29 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 130.355 3.462 . . . . 2.3199999999999998 111.318 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.2 tttm -119.59 155.38 32.37 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 123.876 1.798 . . . . 2.3999999999999999 113.605 169.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.67 146.42 24.51 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 111.936 -2.393 . . . . 1.3600000000000001 110.265 158.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -101.76 155.81 35.96 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 113.842 1.052 . . . . 1.54 113.842 176.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.97 -7.34 21.2 Favored 'Trans proline' 0 C--N 1.353 0.815 1 C-N-CA 125.979 4.453 . . . . 2.2999999999999998 115.788 178.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.9 p -35.54 140.54 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 128.857 2.863 . . . . 2.2999999999999998 113.145 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.706 0 C-N-CA 125.103 1.335 . . . . 3.0699999999999998 111.306 -171.955 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 46.2 mtp . . . . . 0 C--O 1.218 -0.553 0 N-CA-C 105.194 -2.15 . . . . 2.8900000000000001 105.194 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 4.27 -76.18 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 128.734 2.814 . . . . 3.3999999999999999 116.758 167.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 46.4 t0 177.84 84.68 0.14 Allowed Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 129.706 3.203 . . . . 2.2200000000000002 108.687 -166.352 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -96.99 -43.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 1 C-N-CA 126.93 5.087 . . . . 0.93999999999999995 113.168 -178.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 mm -154.35 140.51 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 128.494 2.718 . . . . 0.70999999999999996 106.454 -168.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.424 HG23 ' ND2' ' A' ' 144' ' ' ASN . 14.4 mm -115.8 129.15 72.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 125.806 1.643 . . . . 1.02 110.964 -172.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.6 mm -127.11 112.9 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 126.688 1.995 . . . . 0.89000000000000001 109.532 -173.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -71.34 131.15 42.99 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.16 0.984 . . . . 2.73 110.776 -177.061 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.0 p -132.3 -56.77 0.96 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 115.533 1.679 . . . . 3.3399999999999999 115.533 -153.172 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 73.41 -18.79 0.36 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 127.334 2.253 . . . . 3.21 114.973 173.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -125.11 145.46 49.93 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.503 2.321 . . . . 3.04 107.901 161.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.63 4.25 2.0 Allowed 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 116.777 2.14 . . . . 3.3300000000000001 116.777 -160.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -147.16 24.53 1.15 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 126.134 1.774 . . . . 2.21 114.551 -175.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.13 135.77 31.03 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 120.792 -1.192 . . . . 4.2800000000000002 112.49 173.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -67.79 163.14 22.39 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.586 0.588 . . . . 2.1899999999999999 112.586 173.139 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.69 142.64 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.16 1.384 . . . . 1.1299999999999999 111.015 172.118 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.48 128.36 7.68 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.034 0.826 . . . . 1.53 112.923 168.031 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.84 153.98 50.78 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.38 1.872 . . . . 1.45 114.78 171.197 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.6 p -111.47 14.62 21.43 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 116.219 1.933 . . . . 1.01 116.219 173.289 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.452 ' HA3' ' OG ' ' A' ' 118' ' ' SER . . . 122.85 -32.7 4.33 Favored Glycine 0 C--O 1.222 -0.616 0 C-N-CA 124.626 1.108 . . . . 2.29 113.622 -172.529 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.1 t 137.55 148.43 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 106.516 -1.661 . . . . 3.0699999999999998 106.516 -120.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.23 48.16 1.72 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 124.745 3.63 . . . . 2.46 113.72 -177.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -156.37 27.35 0.35 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.765 1.024 . . . . 2.4900000000000002 113.765 -163.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 61.53 22.44 61.51 Favored Glycine 0 N--CA 1.475 1.295 0 N-CA-C 115.831 1.092 . . . . 2.8700000000000001 115.831 167.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.452 ' OG ' ' HA3' ' A' ' 113' ' ' GLY . 57.7 p -60.15 -50.98 71.52 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.416 1.108 . . . . 3.0099999999999998 112.835 -158.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -102.76 -63.62 1.15 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.765 0.426 . . . . 2.6499999999999999 110.353 -178.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.654 HG22 ' OE2' ' A' ' 136' ' ' GLU . 5.4 t -179.51 -159.46 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.476 1 C-N-CA 132.79 4.436 . . . . 0.94999999999999996 106.849 178.346 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.0 tp -104.85 145.73 12.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 C-N-CA 125.855 1.662 . . . . 1.1399999999999999 110.056 167.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.52 175.71 9.19 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.756 1.622 . . . . 5.0899999999999999 110.236 172.354 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -136.58 126.34 25.6 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 118.562 -0.732 . . . . 2.3900000000000001 110.266 171.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 mt -115.77 155.48 27.74 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.797 1.181 . . . . 1.01 112.054 177.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.83 101.37 20.53 Favored Pre-proline 0 N--CA 1.477 0.896 0 O-C-N 121.818 -0.551 . . . . 5.6200000000000001 110.862 172.599 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -82.96 178.28 6.08 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.447 2.098 . . . . 2.75 108.942 157.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.8 m -144.25 158.18 43.88 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.234 2.214 . . . . 1.05 105.118 171.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.0 p -58.51 -32.34 45.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-N 119.403 1.002 . . . . 0.71999999999999997 111.287 176.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -76.18 -5.28 46.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 128.053 2.541 . . . . 1.6399999999999999 114.637 174.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -145.09 -170.62 3.47 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.865 0.84 . . . . 2.3799999999999999 113.051 -159.013 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 19.3 m -147.23 156.92 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 128.239 2.616 . . . . 0.65000000000000002 108.273 -175.112 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -139.72 126.92 21.18 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.806 0.843 . . . . 0.68999999999999995 111.897 -179.094 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -99.16 134.76 41.54 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.441 0.564 . . . . 3.79 111.784 178.544 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 36.4 t -58.1 141.07 51.33 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 124.361 1.038 . . . . 0.95999999999999996 110.941 165.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 58.7 p-90 -91.34 -10.49 41.08 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.924 -0.58 . . . . 1.8400000000000001 112.083 168.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.654 ' OE2' HG22 ' A' ' 120' ' ' THR . 3.4 mm-40 -100.59 -65.63 0.96 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.262 0.625 . . . . 2.0800000000000001 111.447 -169.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 7.7 p -79.6 -41.95 26.01 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 118.922 0.783 . . . . 1.74 111.059 169.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 106.45 12.04 25.86 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.214 1.388 . . . . 1.1000000000000001 115.652 -178.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.9 p -80.28 137.01 36.55 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.968 1.884 . . . . 1.6399999999999999 111.179 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.38 150.45 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 118.966 0.803 . . . . 1.05 110.296 164.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -133.81 143.92 48.67 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 129.781 3.233 . . . . 2.04 109.723 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 54.4 tttt -117.84 153.01 34.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.284 1.04 . . . . 2.23 112.372 178.136 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.1 tt -97.89 143.68 28.24 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.502 -1.226 . . . . 0.93999999999999995 111.692 165.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.424 ' ND2' HG23 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -106.47 156.52 36.88 Favored Pre-proline 0 CA--C 1.549 0.91 0 CA-C-N 114.321 -1.308 . . . . 3.0099999999999998 110.483 -173.092 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.19 -8.96 24.58 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 124.558 3.505 . . . . 1.3300000000000001 114.509 -176.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.4 p -40.45 142.38 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 128.028 2.531 . . . . 2.0099999999999998 114.316 -177.307 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.476 0 C-N-CA 126.75 2.119 . . . . 2.0600000000000001 107.816 165.378 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_